data_1wrf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1wrf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.526 ' HA ' ' CB ' ' A' ' 17' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.39 -0.596 . . . . 2.0600000000000001 109.39 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.536 ' HA ' ' CA ' ' A' ' 23' ' ' GLY . 1.3 m -106.29 165.48 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 1.3799999999999999 109.609 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -87.1 119.19 27.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 1.5900000000000001 109.509 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 m -150.88 157.04 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 1.45 109.224 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.04 108.57 14.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 4.1399999999999997 109.383 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.407 ' CG ' ' HB ' ' A' ' 13' ' ' ILE . 2.3 m-20 -52.49 114.76 1.48 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.27 -0.894 . . . . 2.3500000000000001 109.354 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -85.32 9.55 15.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.92000000000000004 109.326 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.503 ' N ' ' HB3' ' A' ' 119' ' ' CYS . . . -90.55 -69.93 0.7 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.905 . . . . 0.60999999999999999 109.702 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 9' ' ' ALA . 0.8 OUTLIER 171.74 57.67 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.461 -0.775 . . . . 2.3999999999999999 109.252 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 64.83 13.66 8.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.126 -0.984 . . . . 2.3700000000000001 108.924 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' O ' ' CE ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -63.17 -67.1 0.45 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.366 -0.834 . . . . 1.71 109.771 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -56.78 130.28 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.65000000000000002 109.478 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 8.8 mmpt? -88.12 -13.95 40.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.325 -0.86 . . . . 1.6899999999999999 109.454 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.2 ttpt 161.86 128.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 2.1699999999999999 109.585 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.587 ' CG2' ' CB ' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -116.85 127.01 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.38 -0.825 . . . . 0.92000000000000004 108.958 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.526 ' CB ' ' HA ' ' A' ' 2' ' ' GLN . 0.2 OUTLIER -122.53 156.67 33.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.059 -1.025 . . . . 1.24 110.191 -179.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.637 ' CG1' ' CE2' ' A' ' 35' ' ' PHE . 52.8 t -127.63 148.54 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.76000000000000001 109.176 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.503 ' N ' HG13 ' A' ' 18' ' ' VAL . 22.5 t0 -89.66 75.54 7.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 2.3199999999999998 109.424 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.75 -69.75 0.14 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.89 -1.284 . . . . 1.3999999999999999 109.89 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.7 t -67.88 168.1 12.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -1.191 . . . . 1.6699999999999999 109.841 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -107.22 -9.3 16.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 3.6499999999999999 109.68 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' A' ' 3' ' ' VAL . . . 103.37 -104.21 2.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.008 -1.237 . . . . 1.9199999999999999 110.008 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' GLY . 9.3 t -41.71 -39.66 1.75 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.421 -1.047 . . . . 2.3799999999999999 109.683 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.491 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -68.52 173.18 3.63 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 1.75 109.258 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 35.4 Cg_endo -77.67 152.62 29.47 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.715 2.277 . . . . 1.1699999999999999 110.333 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.4 m -116.42 130.02 56.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 1.47 109.382 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.506 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 36.8 mm -106.06 102.57 14.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.072 -1.018 . . . . 0.80000000000000004 108.81 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 mp -88.7 118.23 33.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.163 -0.961 . . . . 0.84999999999999998 109.141 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.466 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 8.2 m-70 -89.04 102.53 15.18 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.351 -0.843 . . . . 1.5 109.044 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.473 ' HD2' ' O ' ' A' ' 98' ' ' ALA . 5.2 ptt180 -43.1 138.89 1.98 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.873 . . . . 1.6799999999999999 110.064 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.494 ' CA ' ' HD2' ' A' ' 96' ' ' LYS . . . 97.61 -14.63 62.97 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.084 -1.206 . . . . 0.60999999999999999 110.084 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.483 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -103.14 150.96 38.39 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.247 . . . . 2.3199999999999998 109.812 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 36.5 Cg_endo -79.94 113.56 3.02 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.902 2.401 . . . . 0.47999999999999998 111.138 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.637 ' CE2' ' CG1' ' A' ' 18' ' ' VAL . 5.8 t80 -99.4 122.1 42.04 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.428 -1.323 . . . . 0.75 107.428 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.521 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 71.7 m -102.76 138.79 39.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.857 -1.152 . . . . 0.98999999999999999 111.075 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -140.21 128.51 22.53 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.086 -0.709 . . . . 2.6699999999999999 109.086 178.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.449 ' HG3' ' HA ' ' A' ' 89' ' ' LYS . 2.4 tt0 -104.97 126.26 51.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.835 -1.166 . . . . 1.3400000000000001 108.076 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 16' ' ' VAL . . . -124.72 122.8 38.51 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.733 -1.23 . . . . 0.37 110.668 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 7.9 mt -89.59 144.01 26.35 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.5 -1.667 . . . . 0.76000000000000001 106.5 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.637 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 32.7 p90 -159.87 138.4 10.49 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.702 -1.249 . . . . 0.23999999999999999 109.877 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.6 m-20 -85.05 113.59 21.58 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.346 -0.942 . . . . 1.1499999999999999 108.698 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . -44.71 113.28 0.53 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.046 -0.724 . . . . 0.25 109.046 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.451 ' C ' ' HG3' ' A' ' 82' ' ' LYS . 4.9 p30 -81.62 7.75 11.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.237 -0.914 . . . . 1.1200000000000001 109.554 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.532 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 1.1 pt20 -170.5 163.88 8.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.213 -0.929 . . . . 0.93000000000000005 109.835 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 8.9 p30 -92.38 121.77 34.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 2.4900000000000002 109.309 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.455 HG22 ' HA3' ' A' ' 112' ' ' GLY . 2.5 t -141.83 156.33 45.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.177 -0.952 . . . . 0.62 109.78 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -95.68 -14.5 23.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -0.847 . . . . 2.4300000000000002 109.499 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.401 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 6.1 p -141.3 137.88 32.77 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.947 0.879 . . . . 1.27 109.862 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -129.62 152.69 48.87 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.482 -0.932 . . . . 0.69999999999999996 108.482 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.541 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 1.3 mtmt -133.93 140.36 46.73 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.048 -1.061 . . . . 1.29 110.505 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 69' ' ' ASP . 3.1 tt -94.39 149.01 4.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.617 -1.253 . . . . 0.90000000000000002 107.617 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -137.24 115.06 11.37 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.216 -0.927 . . . . 1.48 109.758 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 107' ' ' THR . 2.1 mp -113.99 117.79 56.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 120.971 -1.081 . . . . 0.51000000000000001 108.948 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.46 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 21.0 mttt -119.71 131.16 55.33 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.18 -0.95 . . . . 1.6299999999999999 109.396 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.62 133.37 52.16 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.173 -0.954 . . . . 0.81000000000000005 110.424 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -98.49 151.32 20.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 2.0899999999999999 109.085 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 59' ' ' ASP . 34.3 mt -109.2 49.16 0.83 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.091 -1.005 . . . . 1.27 109.86 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 58' ' ' LEU . 20.7 t0 44.4 26.64 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.897 . . . . 1.46 109.305 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.91 -55.16 0.17 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.319 -1.513 . . . . 0.94999999999999996 109.319 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 1.2 tp -102.99 113.94 27.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -1.133 . . . . 2.6400000000000001 109.141 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.435 ' O ' HD13 ' A' ' 61' ' ' LEU . 37.0 tt0 -81.62 133.6 35.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.955 . . . . 2.4500000000000002 109.398 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.594 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 40.8 mt -126.66 168.69 19.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.008 0.908 . . . . 1.9099999999999999 109.215 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.594 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 63.3 m-20 -111.87 141.85 44.98 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.732 -1.21 . . . . 1.8500000000000001 107.732 178.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.628 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 6.2 t -108.32 105.39 56.55 Favored Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 121.03 -1.044 . . . . 0.56999999999999995 110.472 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 37.3 Cg_endo -82.56 -156.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.475 2.784 . . . . 0.48999999999999999 110.189 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.37 17.58 47.34 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.576 -1.41 . . . . 0.85999999999999999 109.576 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.577 HG22 ' CD1' ' A' ' 92' ' ' TRP . 50.1 pt -104.67 -167.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -1.138 . . . . 0.71999999999999997 109.432 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.574 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 24.3 t0 -98.8 109.75 22.46 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.362 -0.836 . . . . 0.96999999999999997 109.382 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.541 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 1.2 p -86.74 47.47 1.49 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.283 -0.886 . . . . 1.1499999999999999 108.83 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 54.5 t-20 177.75 81.86 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.858 -1.164 . . . . 1.6100000000000001 107.858 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.93 -5.57 9.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.572 -0.705 . . . . 0.47999999999999998 111.822 -177.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.494 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.3 t -64.39 -12.13 39.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.587 -1.321 . . . . 1.2 109.058 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.81 -23.19 55.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.051 -1.031 . . . . 1.3799999999999999 109.845 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.421 ' HB2' HG13 ' A' ' 88' ' ' ILE . 79.4 m-85 -110.27 -24.49 10.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.67000000000000004 109.098 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.587 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 1.2 m -107.66 162.6 5.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.122 -1.066 . . . . 0.42999999999999999 108.122 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.613 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -88.54 93.82 9.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.931 -1.106 . . . . 2.5699999999999998 111.222 -178.357 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.473 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 14.3 p -88.92 153.91 49.67 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 107.544 -1.28 . . . . 0.89000000000000001 107.544 177.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.661 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 26.3 Cg_endo -69.92 134.8 31.22 Favored 'Cis proline' 0 C--N 1.311 -1.396 0 C-N-CA 124.206 -1.164 . . . . 0.34999999999999998 112.346 2.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.633 ' CD2' ' CD2' ' A' ' 86' ' ' TYR . 7.3 mt -76.13 116.97 17.35 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.263 -1.384 . . . . 0.91000000000000003 107.263 178.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.7 t -89.06 136.94 22.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 121.736 0.779 . . . . 0.62 110.543 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 2.6 ttmt -58.15 118.62 5.66 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.73 0.776 . . . . 1.9099999999999999 110.269 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.51 -15.11 13.01 Favored Glycine 0 N--CA 1.479 1.549 0 C-N-CA 119.723 -1.227 . . . . 0.37 110.355 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.588 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 4.9 tp60 -102.43 156.68 17.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.042 -1.269 . . . . 1.6100000000000001 108.044 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -109.26 149.28 29.66 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.107 -0.995 . . . . 1.75 108.502 179.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.633 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 32.4 m-85 -131.5 149.64 52.45 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.289 -0.882 . . . . 0.72999999999999998 110.001 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.502 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 3.3 p30 -117.43 115.03 24.38 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.162 -1.051 . . . . 1.4099999999999999 108.162 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.587 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 3.8 tt -106.62 120.74 58.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.121 -0.987 . . . . 0.45000000000000001 111.153 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.449 ' HA ' ' HG3' ' A' ' 38' ' ' GLU . 69.0 tttt -103.09 101.55 11.53 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.099 -2.186 . . . . 2.98 105.099 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 20.0 t80 -118.45 140.16 50.29 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.19 -0.944 . . . . 0.77000000000000002 111.535 -176.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.76 107.71 19.4 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.489 -1.3 . . . . 1.21 107.489 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.628 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 28.8 t90 -85.09 93.94 8.73 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.408 0.623 . . . . 1.05 109.628 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -61.51 108.85 1.03 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.395 -0.815 . . . . 2.2799999999999998 109.6 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.535 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 21.6 t -64.41 140.42 97.96 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.371 -0.831 . . . . 1.21 108.792 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.544 ' HD3' ' CG1' ' A' ' 65' ' ' VAL . 34.3 Cg_endo -74.98 140.19 25.21 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.206 1.937 . . . . 2.2200000000000002 110.167 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.494 ' HD2' ' CA ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -77.48 4.54 10.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.323 -0.861 . . . . 3.3900000000000001 109.724 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.482 HG12 ' HB2' ' A' ' 95' ' ' PRO . 9.2 pt -92.93 -28.0 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.043 -1.036 . . . . 1.0600000000000001 109.649 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -39.57 115.72 1.05 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 109.174 -0.676 . . . . 0.51000000000000001 109.174 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 101' ' ' SER . 36.6 Cg_endo -83.02 139.54 9.62 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.753 2.302 . . . . 0.63 109.461 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 1.7 mtmt -50.36 90.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.498 -0.927 . . . . 3.3599999999999999 108.498 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 99' ' ' PRO . 2.0 t -96.24 120.47 36.59 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.47 -0.769 . . . . 1.3200000000000001 109.244 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' A' ' 103' ' ' ASN . 11.8 pt-20 -41.02 -47.49 3.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.507 -0.746 . . . . 1.9099999999999999 109.657 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.523 ' N ' ' CG ' ' A' ' 102' ' ' GLU . 0.8 OUTLIER -131.57 134.15 45.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 2.2999999999999998 109.72 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.582 ' CG2' ' CD1' ' A' ' 127' ' ' ILE . 2.5 t -129.68 150.55 34.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.387 -0.821 . . . . 0.92000000000000004 109.14 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 74.2 t -126.62 119.03 52.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.409 -0.96 . . . . 1.03 108.409 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.56 138.93 20.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.093 -1.004 . . . . 0.56999999999999995 109.617 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 32.9 m -120.39 115.68 23.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.392 -0.818 . . . . 1.1399999999999999 109.831 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.92 127.39 48.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.62 -1.252 . . . . 0.41999999999999998 107.62 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.593 ' CD ' ' CG1' ' A' ' 116' ' ' VAL . 1.4 ttmm -137.92 129.74 28.45 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.518 -1.364 . . . . 2.1000000000000001 110.733 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.637 ' CD1' ' CE2' ' A' ' 41' ' ' PHE . 14.0 mt -104.21 138.34 40.82 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.376 -1.342 . . . . 0.93000000000000005 107.376 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.511 HD11 ' N ' ' A' ' 111' ' ' ILE . 4.1 mp -133.7 116.94 25.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.149 -0.97 . . . . 0.47999999999999998 109.852 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.455 ' HA3' HG22 ' A' ' 47' ' ' THR . . . -89.67 -126.34 2.98 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.112 -1.595 . . . . 0.54000000000000004 109.112 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.17 -1.89 11.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -1.172 . . . . 1.3200000000000001 109.565 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -115.22 -3.56 12.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 3.6099999999999999 109.867 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.427 ' O ' HG21 ' A' ' 111' ' ' ILE . . . 151.55 -148.8 20.26 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.756 -1.338 . . . . 0.38 109.756 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.593 ' CG1' ' CD ' ' A' ' 109' ' ' LYS . 2.0 t -90.06 110.21 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -1.176 . . . . 0.69999999999999996 109.851 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 110' ' ' LEU . 53.2 mt -53.74 -39.59 65.43 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.386 -0.821 . . . . 0.89000000000000001 109.981 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.464 ' HB2' HG12 ' A' ' 13' ' ' ILE . . . -156.87 -165.05 1.76 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.784 -1.197 . . . . 0.68999999999999995 109.442 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.503 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 50.3 t -174.98 156.13 2.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.035 -1.04 . . . . 0.65000000000000002 109.72 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -154.11 142.11 20.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.914 . . . . 0.46000000000000002 109.409 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.437 HD12 ' CB ' ' A' ' 8' ' ' CYS . 26.0 mt -134.1 118.89 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 1.04 109.178 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.1 142.75 27.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.103 -0.998 . . . . 0.73999999999999999 109.49 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -86.99 0.34 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.886 . . . . 2.1800000000000002 109.592 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -49.12 115.8 1.44 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 3.0499999999999998 109.667 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -159.6 149.81 19.78 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.297 -1.521 . . . . 1.0 109.297 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 13.8 mttt -152.6 136.0 15.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.42 -1.047 . . . . 2.3199999999999998 108.524 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.582 ' CD1' ' CG2' ' A' ' 104' ' ' VAL . 75.6 mt -106.87 141.17 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.633 -1.292 . . . . 0.64000000000000001 110.095 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.506 ' HB2' ' CG2' ' A' ' 28' ' ' ILE . 19.3 mtt180 -131.18 177.31 7.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.562 -0.711 . . . . 3.1000000000000001 109.151 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.0 t70 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.05 -0.976 . . . . 1.72 109.422 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.528 ' CB ' ' HG2' ' A' ' 17' ' ' MET . 2.6 pt20 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.287 0.565 . . . . 0.89000000000000001 109.77 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 1.4 m -104.78 143.36 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.342 -0.849 . . . . 0.77000000000000002 109.258 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.473 ' O ' HG11 ' A' ' 5' ' ' VAL . 8.5 t70 -71.25 117.91 13.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.77000000000000002 110.1 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.473 HG11 ' O ' ' A' ' 4' ' ' ASP . 30.2 m -142.72 154.13 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.552 -0.907 . . . . 1.05 108.552 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.46 107.69 17.45 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.121 -0.987 . . . . 2.3900000000000001 109.127 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 2.2 p30 -59.63 135.86 57.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 3.6899999999999999 109.154 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.81 -7.45 14.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.128 -0.983 . . . . 1.0900000000000001 109.192 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 10' ' ' ASN . . . -67.54 -63.83 0.98 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.68999999999999995 109.666 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER 166.64 49.88 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.438 -0.789 . . . . 1.04 109.152 -178.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m120 64.32 28.58 13.78 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.217 -1.031 . . . . 4.1399999999999997 108.217 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.471 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -77.07 -70.99 0.43 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.646 -0.659 . . . . 1.1100000000000001 109.407 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.589 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -55.09 122.76 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.93999999999999995 109.798 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -66.67 -28.0 68.11 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.359 -0.838 . . . . 2.6000000000000001 108.947 179.594 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 12.6 pttt 165.8 135.01 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.837 -1.171 . . . . 1.79 107.837 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.587 ' CG2' ' CB ' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -111.94 119.17 59.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 O-C-N 121.257 -0.902 . . . . 0.56000000000000005 108.701 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.528 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 1.1 mtm -108.64 157.13 18.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.857 . . . . 0.78000000000000003 110.483 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.551 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 48.4 t -124.11 141.52 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.468 -0.938 . . . . 0.40000000000000002 108.468 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -85.19 82.36 8.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.015 -1.053 . . . . 0.56999999999999995 109.493 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.48 -72.59 0.23 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.995 -1.242 . . . . 0.56000000000000005 109.995 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -51.99 164.67 0.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -1.16 . . . . 1.7 110.322 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.59 -3.54 20.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.485 -0.759 . . . . 2.2599999999999998 109.4 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 3' ' ' VAL . . . 95.27 -122.24 7.16 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.251 -1.54 . . . . 0.57999999999999996 109.251 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' GLY . 17.8 t -40.69 -40.87 1.4 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.471 -1.017 . . . . 2.6000000000000001 109.438 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.556 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -51.05 179.86 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 1.4099999999999999 108.917 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 32.7 Cg_endo -76.13 142.43 24.55 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.226 1.951 . . . . 1.9199999999999999 110.343 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.96 119.71 38.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 1.6899999999999999 109.715 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.462 HD13 HG21 ' A' ' 28' ' ' ILE . 29.3 mm -111.81 107.91 24.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.007 -1.058 . . . . 0.89000000000000001 108.991 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 mt -94.37 118.77 41.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.268 -0.895 . . . . 1.2 109.411 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.487 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 14.5 m-70 -91.19 114.92 27.58 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.124 -1.065 . . . . 1.1200000000000001 108.124 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.532 ' HA ' HG11 ' A' ' 94' ' ' VAL . 12.1 ptt180 -57.36 158.64 5.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.838 -1.164 . . . . 1.46 109.924 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.488 ' HA2' ' CD ' ' A' ' 96' ' ' LYS . . . 87.86 -19.39 34.04 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.479 -1.449 . . . . 0.56999999999999995 109.479 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.487 ' HD2' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -100.7 152.53 37.87 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.198 -1.178 . . . . 1.49 110.163 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.36 120.46 3.64 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.845 2.363 . . . . 0.52000000000000002 110.785 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.551 ' CZ ' HG12 ' A' ' 18' ' ' VAL . 4.3 t80 -96.76 121.31 38.47 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.868 -1.16 . . . . 0.48999999999999999 107.868 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.472 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 2.6 m -100.76 134.65 43.42 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.064 -1.022 . . . . 1.1699999999999999 110.587 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.649 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -144.71 124.74 13.57 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.253 -1.017 . . . . 2.0699999999999998 108.253 178.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.44 133.41 48.53 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.371 -0.974 . . . . 1.9299999999999999 108.371 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 16' ' ' VAL . . . -130.2 119.74 23.41 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.056 -1.058 . . . . 0.39000000000000001 110.6 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 12.9 mt -89.71 141.57 28.49 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.154 -2.165 . . . . 1.05 105.154 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.647 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 28.7 p90 -156.78 137.32 13.11 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.341 -1.343 . . . . 0.28999999999999998 110.037 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.523 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.7 OUTLIER -82.45 112.43 19.38 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.327 -0.949 . . . . 0.52000000000000002 108.584 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 81' ' ' VAL . . . -44.46 115.54 0.87 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.564 -0.532 . . . . 0.17999999999999999 109.564 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.455 ' C ' ' HG3' ' A' ' 82' ' ' LYS . 4.7 p30 -80.42 5.77 14.1 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.269 -0.894 . . . . 0.13 109.113 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.548 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 1.3 pt20 -169.5 170.33 8.32 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.34 -0.85 . . . . 0.65000000000000002 109.357 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -101.18 121.07 41.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 1.1000000000000001 108.927 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 t -137.88 146.08 42.93 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.234 -0.916 . . . . 1.1299999999999999 109.867 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.652 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 10.0 mmmt -86.18 -12.76 48.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.416 -0.802 . . . . 0.97999999999999998 109.578 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.6 p -141.92 149.65 40.44 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.831 -0.748 . . . . 1.1100000000000001 109.418 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -145.07 156.64 44.04 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.247 -0.908 . . . . 0.94999999999999996 109.55 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.551 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 0.9 OUTLIER -136.79 140.03 42.22 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.189 -0.944 . . . . 0.31 110.475 -179.313 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 69' ' ' ASP . 3.5 tt -92.94 153.04 3.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.177 -1.416 . . . . 1.1000000000000001 107.177 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' CB ' ' HB3' ' A' ' 109' ' ' LYS . 2.4 tt0 -139.91 117.34 11.39 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.925 -1.109 . . . . 0.17000000000000001 110.039 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 107' ' ' THR . 3.2 mp -119.37 116.32 50.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.027 -1.046 . . . . 0.40999999999999998 109.458 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.6 mtmp? -115.98 157.37 24.7 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.197 -0.939 . . . . 2.6800000000000002 108.712 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -134.22 123.7 24.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.819 -1.175 . . . . 0.68000000000000005 110.305 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -93.63 150.04 20.74 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.852 -0.796 . . . . 1.1799999999999999 108.852 179.181 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 58' ' ' LEU . 15.4 mt -106.72 45.0 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.69999999999999996 109.704 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.59 17.89 3.31 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.392 -0.818 . . . . 0.81999999999999995 109.413 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.84 -45.6 0.07 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.806 -1.318 . . . . 0.35999999999999999 109.806 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.1 tp -109.3 112.33 24.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.173 -1.192 . . . . 0.95999999999999996 109.548 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.17 125.39 29.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.992 -1.068 . . . . 1.4299999999999999 108.95 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.597 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 43.8 mt -117.2 167.31 10.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 122.117 0.961 . . . . 0.71999999999999997 109.812 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.597 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 7.5 t70 -112.4 136.67 51.6 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.061 -1.829 . . . . 4.2000000000000002 106.061 176.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.628 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 1.5 t -101.72 110.16 61.27 Favored Pre-proline 0 C--N 1.293 -1.868 0 C-N-CA 118.866 -1.134 . . . . 0.83999999999999997 111.039 -177.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.5 Cg_endo -81.72 -163.18 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.98 2.453 . . . . 0.75 109.766 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.63 50.75 62.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.959 -1.256 . . . . 1.1799999999999999 109.959 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.593 HG22 ' CD1' ' A' ' 92' ' ' TRP . 13.4 pt -139.88 -156.82 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -1.103 . . . . 0.87 109.035 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.589 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 29.6 t70 -110.05 106.39 15.87 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.441 -0.787 . . . . 0.71999999999999997 109.753 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.551 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -87.12 48.19 1.61 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.19 -0.944 . . . . 0.56999999999999995 108.562 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 9.9 t-20 178.41 79.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.462 -1.31 . . . . 2.8399999999999999 107.462 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.44 -4.05 1.7 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.643 -0.661 . . . . 0.42999999999999999 111.902 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.458 ' HA ' HG23 ' A' ' 76' ' ' VAL . 91.6 m -64.53 -10.58 26.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.539 -1.351 . . . . 3.0099999999999998 109.481 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.71 -20.72 45.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.83999999999999997 109.552 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CE2' ' CD1' ' A' ' 90' ' ' TYR . 79.4 m-85 -112.19 -20.88 11.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.275 -0.89 . . . . 0.34999999999999998 109.289 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.606 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 2.1 m -112.35 166.25 6.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.616 -0.883 . . . . 0.42999999999999999 108.616 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.638 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -91.9 94.8 9.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.001 -1.062 . . . . 2.0800000000000001 111.305 -178.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.459 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 51.6 m -84.99 148.93 52.0 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 107.899 -1.149 . . . . 2.8999999999999999 107.899 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.652 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 25.7 Cg_endo -71.1 136.01 39.43 Favored 'Cis proline' 0 C--N 1.312 -1.367 0 C-N-CA 124.207 -1.164 . . . . 0.23999999999999999 112.664 1.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.581 HD23 ' CD2' ' A' ' 86' ' ' TYR . 16.5 mt -71.7 146.74 48.01 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.333 -2.099 . . . . 1.26 105.333 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 59.4 t -117.22 142.09 32.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 O-C-N 120.337 -1.477 . . . . 1.29 111.17 -177.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 6.2 ttmt -65.34 105.86 1.23 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.59 0.709 . . . . 0.71999999999999997 109.905 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 122.72 -19.36 7.94 Favored Glycine 0 N--CA 1.48 1.583 0 C-N-CA 119.638 -1.268 . . . . 0.23000000000000001 110.066 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.562 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 7.9 tp60 -95.41 159.48 14.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.075 -1.25 . . . . 0.44 107.804 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.54 ' N ' ' HG3' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -110.49 148.43 32.09 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.878 -1.129 . . . . 0.46000000000000002 108.371 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.638 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 28.6 m-85 -128.43 148.76 50.73 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.32 -0.863 . . . . 1.51 109.908 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.495 ' CB ' ' CD2' ' A' ' 40' ' ' LEU . 10.7 p-10 -118.69 113.93 21.94 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.605 -0.887 . . . . 0.97999999999999998 108.605 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.606 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 2.4 tt -108.91 119.16 57.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.272 -0.893 . . . . 0.23999999999999999 111.139 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -99.72 107.68 19.82 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 104.649 -2.352 . . . . 4.5199999999999996 104.649 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.589 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 24.5 t80 -124.12 141.98 51.6 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.577 -1.249 . . . . 0.56000000000000005 113.076 -175.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.586 ' O ' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.29 145.25 24.81 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 106.262 -1.755 . . . . 2.0800000000000001 106.262 176.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.628 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 26.9 t90 -124.71 82.8 2.08 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.797 -1.19 . . . . 1.24 109.867 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -60.71 106.07 0.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.525 -0.734 . . . . 1.6200000000000001 109.442 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.639 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 22.1 t -55.99 144.72 57.35 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.157 -1.053 . . . . 1.3999999999999999 108.157 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.639 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 24.0 Cg_endo -64.36 -7.48 14.22 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.211 1.941 . . . . 3.7000000000000002 112.192 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 95' ' ' PRO . 0.0 OUTLIER 75.38 -10.74 1.19 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.154 -0.966 . . . . 3.6600000000000001 109.88 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.513 ' O ' ' C ' ' A' ' 98' ' ' ALA . 19.9 pt -91.11 -28.42 4.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 108.1 -1.074 . . . . 0.63 108.1 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.513 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -37.3 113.65 0.65 Allowed Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 107.926 -1.138 . . . . 0.65000000000000002 107.926 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.3 177.83 8.3 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 122.769 2.313 . . . . 1.3200000000000001 110.459 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.513 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 4.5 mtmt -82.19 68.74 8.72 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.573 -1.269 . . . . 0.66000000000000003 107.573 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 102' ' ' GLU . 4.0 t -70.86 118.85 14.16 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.495 -0.753 . . . . 0.51000000000000001 109.615 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 1.1 pt-20 -41.16 -47.36 3.25 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.671 -0.863 . . . . 1.99 108.671 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 3.5 t-20 -130.72 141.62 50.39 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.051 -0.722 . . . . 3.1600000000000001 109.051 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.528 ' CG2' HD11 ' A' ' 127' ' ' ILE . 0.9 OUTLIER -131.93 142.65 42.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.101 -1.0 . . . . 0.84999999999999998 109.467 179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 2.7 t -118.27 117.63 55.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.671 -1.233 . . . . 1.1699999999999999 107.671 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 2.2 t -101.89 135.92 36.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 120.768 -1.207 . . . . 0.52000000000000002 110.186 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 94.2 m -116.25 116.59 28.05 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.246 -0.909 . . . . 1.1799999999999999 109.974 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.42 132.23 39.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 106.834 -1.543 . . . . 0.25 106.834 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.642 ' CG ' ' CG1' ' A' ' 116' ' ' VAL . 0.6 OUTLIER -142.03 129.67 21.51 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.327 -1.483 . . . . 2.1899999999999999 112.112 -177.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.647 ' CD1' ' CE2' ' A' ' 41' ' ' PHE . 9.1 mt -103.31 137.97 40.71 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.552 -1.647 . . . . 0.34000000000000002 106.552 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.531 ' CG1' ' HD3' ' A' ' 109' ' ' LYS . 4.2 mp -134.11 116.29 22.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.961 -1.087 . . . . 0.44 110.162 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.07 -135.62 4.48 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.943 -1.663 . . . . 0.25 108.943 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.65 -3.53 17.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -1.16 . . . . 0.82999999999999996 109.403 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -112.85 -7.42 13.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 5.5800000000000001 110.277 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.408 ' O ' HG21 ' A' ' 111' ' ' ILE . . . 156.97 -147.02 14.73 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.274 -1.441 . . . . 0.25 110.483 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.642 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 2.0 t -92.57 107.64 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.433 -1.039 . . . . 1.0700000000000001 109.731 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 110' ' ' LEU . 29.2 mt -56.02 -42.71 76.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.485 -0.759 . . . . 0.41999999999999998 110.488 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.472 ' O ' HG11 ' A' ' 116' ' ' VAL . . . -149.07 -177.01 5.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.909 -1.119 . . . . 0.54000000000000004 109.247 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -170.68 150.24 3.29 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.184 -1.006 . . . . 0.62 109.913 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.401 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -150.81 146.82 26.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.219 -0.926 . . . . 0.28999999999999998 109.626 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 52.4 mt -133.23 116.73 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.957 . . . . 0.48999999999999999 108.936 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.03 142.35 27.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.074 -1.016 . . . . 0.44 109.31 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.0 p -102.7 -87.68 0.41 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 1.4199999999999999 109.59 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -45.66 116.5 1.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 2.9100000000000001 109.011 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -166.62 144.59 9.22 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.795 -1.322 . . . . 0.23000000000000001 109.795 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 1.8 mtmp? -150.55 135.75 17.79 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.075 -1.083 . . . . 2.52 108.075 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.528 HD11 ' CG2' ' A' ' 104' ' ' VAL . 82.3 mt -106.69 143.03 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.639 -1.288 . . . . 0.72999999999999998 110.62 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.513 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 22.4 mtm180 -129.59 177.45 7.21 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.955 -0.757 . . . . 3.29 108.955 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.475 ' HB2' ' HD3' ' A' ' 100' ' ' LYS . 20.5 t70 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.987 -1.006 . . . . 0.80000000000000004 109.636 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.524 ' HG2' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.33 0.586 . . . . 2.4199999999999999 109.501 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.524 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 33.8 m -105.53 165.53 3.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.192 -0.942 . . . . 1.1899999999999999 109.371 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.405 ' C ' HG11 ' A' ' 5' ' ' VAL . 21.2 t0 -90.39 122.76 33.55 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.315 -0.866 . . . . 1.74 109.944 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG11 ' C ' ' A' ' 4' ' ' ASP . 11.5 m -148.13 156.47 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.413 -0.804 . . . . 1.76 109.079 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -120.08 105.53 11.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.172 -0.955 . . . . 3.46 108.958 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.47 ' OD2' HG13 ' A' ' 13' ' ' ILE . 1.1 m-20 -54.99 141.13 35.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 2.2999999999999998 109.788 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -112.66 -12.12 13.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.269 -0.894 . . . . 1.05 108.71 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 10' ' ' ASN . . . -60.38 -79.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.949 0.88 . . . . 0.39000000000000001 109.581 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 59.7 t-20 -179.16 37.73 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.594 -0.891 . . . . 2.96 108.594 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 20.1 t-20 76.08 30.12 0.73 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.411 -0.959 . . . . 2.3399999999999999 108.411 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.446 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 60.8 mm-40 -76.77 -62.34 1.67 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.491 -0.756 . . . . 2.8300000000000001 109.903 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -61.63 121.73 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.931 -1.105 . . . . 1.0800000000000001 109.94 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.552 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -66.9 -30.41 70.55 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.245 -1.02 . . . . 2.3799999999999999 108.245 178.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.552 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 164.62 131.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.32 -0.622 . . . . 2.71 109.32 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.548 ' HB ' ' CB ' ' A' ' 39' ' ' ALA . 2.1 p -120.75 125.91 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.962 -1.086 . . . . 2.8100000000000001 108.705 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.424 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -109.6 159.28 17.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.375 -0.828 . . . . 0.75 110.879 -178.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.568 HG11 ' CE2' ' A' ' 35' ' ' PHE . 92.5 t -120.8 147.65 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.947 -0.76 . . . . 0.40999999999999998 108.947 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.504 ' N ' HG13 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -100.48 57.89 0.94 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.244 -0.91 . . . . 3.2200000000000002 109.46 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.41 27.71 0.07 OUTLIER Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.309 -1.424 . . . . 2.8399999999999999 110.871 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 m -140.42 -167.26 2.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.864 -1.374 . . . . 2.02 109.812 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 25' ' ' ASP . 4.2 m-70 -128.94 -8.9 4.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.994 . . . . 4.4299999999999997 110.265 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 107.72 -132.76 11.29 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.728 -1.349 . . . . 2.1000000000000001 109.728 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -42.54 -38.43 1.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -1.12 . . . . 1.6000000000000001 109.662 -179.668 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -52.13 170.53 0.23 Allowed Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 121.254 -0.904 . . . . 1.4199999999999999 108.693 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 25' ' ' ASP . 31.6 Cg_endo -75.48 153.59 39.63 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.413 2.075 . . . . 0.65000000000000002 110.184 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.2 m -112.79 136.39 52.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.89000000000000001 109.281 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.461 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 29.1 mm -111.35 107.7 23.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.049 -1.032 . . . . 0.83999999999999997 109.216 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.406 ' HB ' HG12 ' A' ' 127' ' ' ILE . 2.4 mt -88.99 121.62 39.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.29 -0.881 . . . . 0.83999999999999997 108.979 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.478 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 32.2 m-70 -84.87 133.91 34.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.464 -0.773 . . . . 1.1000000000000001 109.971 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.563 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 6.0 mtm180 -57.6 140.09 51.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.533 -0.729 . . . . 2.5 110.409 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 94' ' ' VAL . . . 67.19 1.58 14.46 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.528 -0.844 . . . . 1.1699999999999999 111.274 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.478 ' HE3' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -88.71 149.76 44.61 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 120.755 -1.438 . . . . 1.3400000000000001 109.78 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.459 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 36.6 Cg_endo -81.12 113.74 2.75 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.971 2.447 . . . . 0.76000000000000001 111.031 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CE2' HG11 ' A' ' 18' ' ' VAL . 2.0 t80 -97.61 115.22 27.47 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.345 -1.354 . . . . 0.97999999999999998 107.345 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.434 ' C ' HD13 ' A' ' 37' ' ' LEU . 29.9 m -107.72 129.2 55.05 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.974 -1.079 . . . . 0.75 111.168 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.666 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -143.63 126.26 15.99 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.903 -0.777 . . . . 2.7599999999999998 108.903 179.045 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 12.6 tt0 -94.64 134.44 37.22 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.016 -1.105 . . . . 1.55 108.016 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.548 ' CB ' ' HB ' ' A' ' 16' ' ' VAL . . . -129.5 126.06 37.76 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.868 -1.145 . . . . 0.63 110.48 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 5.1 mt -93.92 144.84 25.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.467 -1.679 . . . . 0.97999999999999998 106.467 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -161.69 139.28 8.85 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.757 -1.177 . . . . 0.40999999999999998 109.517 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.56 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.2 m-20 -86.67 114.47 23.4 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.083 -1.047 . . . . 3.4500000000000002 109.179 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.15 112.55 0.54 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.111 -0.7 . . . . 0.35999999999999999 109.111 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 44' ' ' ASN . 3.0 p30 -82.66 10.27 7.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.063 -1.023 . . . . 0.46000000000000002 109.477 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.578 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 4.6 pt20 -167.23 147.28 5.38 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.418 -0.801 . . . . 0.57999999999999996 109.052 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 2.8 p-10 -84.21 114.17 21.62 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.061 -1.024 . . . . 4.2800000000000002 109.06 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.48 HG22 ' HA3' ' A' ' 112' ' ' GLY . 1.7 t -131.55 155.12 48.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.332 -0.855 . . . . 0.17999999999999999 109.855 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.681 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 9.3 mmmt -92.16 -10.58 38.28 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.263 -0.898 . . . . 1.0 109.982 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.8 p -147.41 139.44 24.32 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.265 -0.897 . . . . 1.55 110.098 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -128.51 153.56 47.05 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.48 -0.762 . . . . 0.65000000000000002 109.13 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -133.32 136.38 45.38 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.374 -0.931 . . . . 0.70999999999999996 110.745 -178.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.419 ' CG2' ' O ' ' A' ' 69' ' ' ASP . 4.9 tt -90.26 151.95 3.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.363 -1.347 . . . . 0.98999999999999999 107.363 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' LYS . 2.7 mt-10 -138.54 116.28 11.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.026 -1.046 . . . . 0.62 110.291 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 107' ' ' THR . 3.3 mp -117.53 112.77 40.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.742 -1.223 . . . . 0.37 109.396 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 40.3 mtmt -111.75 152.4 27.85 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.034 -1.098 . . . . 2.6800000000000002 108.034 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -122.59 156.35 34.43 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.209 -1.396 . . . . 0.93000000000000005 110.737 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.519 ' CB ' ' HB ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -117.06 150.48 38.58 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.796 -0.816 . . . . 1.1899999999999999 108.796 179.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.48 HD21 ' HB2' ' A' ' 101' ' ' SER . 12.7 mt -115.92 43.49 2.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.946 -1.096 . . . . 0.73999999999999999 109.267 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 57.3 t0 51.16 21.95 1.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 1.1699999999999999 108.953 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.44 -53.96 0.17 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.976 -1.65 . . . . 0.20000000000000001 108.976 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 58' ' ' LEU . 2.4 mp -102.67 116.1 31.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.346 -1.09 . . . . 5.9500000000000002 108.945 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.7 mt-10 -91.76 120.78 32.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.035 -1.041 . . . . 3.3100000000000001 109.519 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.594 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 49.2 mt -104.83 169.58 2.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 122.135 0.969 . . . . 1.3 110.011 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.594 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 43.4 m-20 -109.4 138.33 45.92 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.583 -1.636 . . . . 0.66000000000000003 106.583 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.605 HG13 ' CZ2' ' A' ' 92' ' ' TRP . 1.6 t -106.68 107.4 60.16 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.791 -1.193 . . . . 0.67000000000000004 111.406 -177.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.7 Cg_endo -82.83 -158.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 123.236 2.624 . . . . 0.17999999999999999 109.752 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.87 45.82 93.15 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.31 -1.116 . . . . 0.78000000000000003 110.31 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.513 ' CG2' ' CD1' ' A' ' 92' ' ' TRP . 32.3 pt -136.21 -156.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.163 -1.198 . . . . 0.80000000000000004 108.951 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.55 ' N ' ' OH ' ' A' ' 90' ' ' TYR . 31.4 t70 -107.97 105.74 15.66 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.251 -0.906 . . . . 0.93000000000000005 109.473 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.498 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -87.35 48.06 1.59 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.316 -0.994 . . . . 1.51 108.316 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 26.2 t-20 178.08 77.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.691 -1.226 . . . . 1.6899999999999999 107.691 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.464 ' HB1' ' CD1' ' A' ' 88' ' ' ILE . . . -61.96 -5.67 2.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.22 112.009 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.489 ' HA ' HG23 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -63.94 -12.49 37.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.384 -1.448 . . . . 0.27000000000000002 108.987 179.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -75.53 -22.77 56.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.069 -1.02 . . . . 2.0499999999999998 110.156 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.49 ' HB2' HG13 ' A' ' 88' ' ' ILE . 58.7 m-85 -109.42 -30.75 7.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.79000000000000004 108.79 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.599 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 2.1 m -99.23 165.82 2.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.086 -1.079 . . . . 0.34999999999999998 108.086 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.596 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -91.28 91.23 8.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.14 -0.975 . . . . 3.0099999999999998 111.411 -178.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.48 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 11.5 p -89.14 153.59 49.02 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 107.541 -1.281 . . . . 0.32000000000000001 107.541 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.681 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 23.2 Cg_endo -68.53 130.16 14.67 Favored 'Cis proline' 0 C--N 1.313 -1.339 0 C-N-CA 124.474 -1.053 . . . . 0.48999999999999999 112.785 2.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.641 ' CD2' ' CD2' ' A' ' 86' ' ' TYR . 11.1 mt -74.13 115.69 13.91 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.962 -1.495 . . . . 1.1000000000000001 106.962 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.9 t -83.45 141.25 15.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 C-N-CA 119.084 -1.047 . . . . 0.65000000000000002 110.125 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.578 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 3.7 tttt -64.99 116.9 6.89 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.851 0.834 . . . . 3.3399999999999999 110.195 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.06 -11.39 14.85 Favored Glycine 0 N--CA 1.479 1.505 0 N-CA-C 109.43 -1.468 . . . . 0.46999999999999997 109.43 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.544 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 4.2 tp-100 -100.72 156.54 17.28 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.668 -1.234 . . . . 3.7200000000000002 107.668 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -109.3 149.99 28.64 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.363 -0.977 . . . . 1.6200000000000001 108.363 179.508 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.641 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 36.6 m-85 -132.07 149.35 52.43 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.145 -0.972 . . . . 1.04 110.258 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.498 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 9.7 p-10 -117.94 113.69 22.08 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.555 -0.905 . . . . 0.67000000000000004 108.555 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.599 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 7.4 tt -108.15 124.83 64.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.195 -0.941 . . . . 0.47999999999999998 111.626 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.427 ' HD3' ' OE1' ' A' ' 38' ' ' GLU . 5.2 tptt -100.49 105.0 16.41 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.353 -2.091 . . . . 4.4699999999999998 105.353 176.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.594 ' CE2' ' O ' ' A' ' 91' ' ' THR . 27.5 t80 -119.8 141.86 49.11 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 118.579 -1.249 . . . . 0.58999999999999997 113.143 -176.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.594 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -94.38 144.18 25.77 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.482 -1.673 . . . . 1.02 106.482 177.064 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.605 ' CZ2' HG13 ' A' ' 65' ' ' VAL . 22.2 t90 -122.74 89.48 3.12 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.798 -1.189 . . . . 1.1499999999999999 111.162 -177.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -62.39 107.74 0.98 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.239 -0.913 . . . . 2.4100000000000001 108.655 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.562 HG21 ' CZ3' ' A' ' 92' ' ' TRP . 53.8 t -74.9 144.42 79.67 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.474 -0.766 . . . . 1.6599999999999999 109.149 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.553 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 29.8 Cg_endo -70.77 136.15 29.68 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.897 1.731 . . . . 0.98999999999999999 109.573 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.14 4.81 3.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.483 -0.761 . . . . 4.0599999999999996 111.299 -178.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 98' ' ' ALA . 13.2 pt -89.9 -25.93 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.673 -1.267 . . . . 1.6200000000000001 109.047 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.563 ' O ' ' CD ' ' A' ' 31' ' ' ARG . . . -36.17 117.54 0.67 Allowed Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 109.396 -0.594 . . . . 0.53000000000000003 109.396 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -83.01 167.0 14.47 Favored 'Trans proline' 0 C--N 1.298 -2.097 0 C-N-CA 122.595 2.197 . . . . 0.87 109.221 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.549 ' CD ' ' HA ' ' A' ' 128' ' ' ARG . 6.2 mmtp -79.31 77.86 5.82 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.682 -1.229 . . . . 5.3899999999999997 107.682 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.48 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -80.8 118.55 22.42 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.951 -0.759 . . . . 2.1899999999999999 108.951 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 0.7 OUTLIER -37.32 -50.63 1.04 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.604 -0.685 . . . . 2.75 109.911 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.518 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 24.5 m120 -129.96 139.0 51.15 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.077 -1.014 . . . . 3.8300000000000001 110.058 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.522 HG11 ' N ' ' A' ' 105' ' ' VAL . 74.0 t -129.88 149.35 33.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.326 -0.859 . . . . 1.28 109.405 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.522 ' N ' HG11 ' A' ' 104' ' ' VAL . 1.0 OUTLIER -124.13 122.45 64.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.988 -1.116 . . . . 1.76 107.988 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 20.1 t -103.94 144.09 14.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.239 -0.913 . . . . 0.56999999999999995 109.779 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 36.9 m -123.67 114.45 19.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.366 -0.834 . . . . 0.75 109.676 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -95.24 127.52 47.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.289 -1.375 . . . . 0.40000000000000002 107.289 178.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.632 ' CG ' ' CG1' ' A' ' 116' ' ' VAL . 8.5 ttmt -142.58 127.05 17.82 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.387 -1.446 . . . . 3.2000000000000002 111.468 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 1.4 mp -103.46 137.37 41.64 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.472 -1.307 . . . . 3.0499999999999998 107.472 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.516 HD12 ' CD ' ' A' ' 109' ' ' LYS . 4.2 mp -131.09 121.54 49.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.41 -0.806 . . . . 0.72999999999999998 109.856 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.48 ' HA3' HG22 ' A' ' 47' ' ' THR . . . -80.92 -129.88 0.96 Allowed Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.455 -1.858 . . . . 0.5 108.455 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.34 -3.57 11.92 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.284 -1.127 . . . . 0.77000000000000002 109.12 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.401 ' O ' ' CG ' ' A' ' 114' ' ' ASN . 1.3 t30 -116.77 -10.96 10.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.242 -0.911 . . . . 4.9900000000000002 110.708 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.426 ' O ' HG21 ' A' ' 111' ' ' ILE . . . 168.35 -158.47 31.2 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.467 -1.349 . . . . 0.29999999999999999 110.573 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.632 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -87.74 109.84 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -1.107 . . . . 0.51000000000000001 110.162 -179.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.464 ' HG ' ' N ' ' A' ' 112' ' ' GLY . 85.1 mt -53.95 -43.11 69.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 1.3200000000000001 108.999 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HB2' HG12 ' A' ' 13' ' ' ILE . . . -155.46 -162.53 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.095 -1.003 . . . . 0.60999999999999999 109.465 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -178.59 155.24 0.82 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.208 -0.933 . . . . 0.81000000000000005 109.158 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.06 143.97 23.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.011 -1.056 . . . . 0.37 109.925 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.0 mt -133.17 116.92 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.106 -0.996 . . . . 1.3799999999999999 108.41 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.1 146.62 24.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.993 -1.067 . . . . 0.88 110.517 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.5 HG22 ' N ' ' A' ' 124' ' ' HIS . 88.3 m -116.65 162.65 17.31 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.148 -0.686 . . . . 2.6800000000000002 109.148 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.5 ' N ' HG22 ' A' ' 123' ' ' THR . 5.0 t-160 54.03 75.05 0.29 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 2.7200000000000002 109.93 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -131.7 161.62 23.73 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.717 -1.753 . . . . 0.82999999999999996 108.717 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 46.3 mttt -152.85 139.52 18.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.219 -1.166 . . . . 1.8899999999999999 109.255 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.498 HD11 HG23 ' A' ' 104' ' ' VAL . 64.2 mt -106.55 139.83 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.621 -1.3 . . . . 0.51000000000000001 109.677 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.549 ' HA ' ' CD ' ' A' ' 100' ' ' LYS . 22.0 mtt180 -132.92 178.53 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.383 -0.823 . . . . 4.6100000000000003 109.307 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.995 -1.002 . . . . 2.7799999999999998 109.449 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 9.4 pt20 . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.266 -0.642 . . . . 1.99 109.266 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.46 HG13 ' HB ' ' A' ' 18' ' ' VAL . 28.2 m -104.76 160.72 5.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.307 -0.87 . . . . 1.1000000000000001 108.903 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.461 ' C ' HG11 ' A' ' 5' ' ' VAL . 56.6 t0 -92.82 118.19 30.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.991 -1.068 . . . . 0.82999999999999996 110.139 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.461 HG11 ' C ' ' A' ' 4' ' ' ASP . 23.2 m -142.17 157.51 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.329 -0.989 . . . . 1.5600000000000001 108.329 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 109.17 17.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.058 -1.026 . . . . 5.4000000000000004 109.596 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 16.9 p-10 -45.06 132.51 7.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 3.73 109.805 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -108.7 -2.9 18.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.805 . . . . 0.56999999999999995 109.505 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.538 ' N ' ' HB3' ' A' ' 119' ' ' CYS . . . -75.33 -74.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.59999999999999998 109.668 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.434 ' CG ' ' O ' ' A' ' 9' ' ' ALA . 7.4 m-20 178.49 55.64 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.557 -0.905 . . . . 3.02 108.557 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.411 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 1.3 t30 65.28 42.85 3.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.446 -0.946 . . . . 3.4100000000000001 108.446 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.472 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -98.9 -63.18 1.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -0.852 . . . . 1.8300000000000001 110.485 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 1.2 mt -60.25 128.05 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.951 -1.093 . . . . 0.98999999999999999 110.417 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.613 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -81.86 -15.64 53.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.31 -0.869 . . . . 1.96 109.358 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.613 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 156.98 141.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.15 -1.056 . . . . 3.9500000000000002 108.15 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.58 ' CG2' ' CB ' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -121.99 126.27 74.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.876 -0.787 . . . . 0.40999999999999998 108.876 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.479 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -112.41 156.45 22.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.005 -1.06 . . . . 2.0699999999999998 110.213 -179.258 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.475 HG11 ' CE2' ' A' ' 35' ' ' PHE . 2.4 t -133.26 143.36 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.302 -0.874 . . . . 1.79 108.718 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.64 100.58 11.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.99 . . . . 3.1800000000000002 109.639 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.47 -56.15 0.52 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.753 -1.339 . . . . 0.58999999999999997 109.753 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 66.8 m -59.65 -167.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -1.128 . . . . 2.7999999999999998 109.232 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -144.31 15.3 1.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.136 -0.977 . . . . 3.0899999999999999 109.834 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 77.55 145.92 2.42 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.74 -1.344 . . . . 3.7000000000000002 109.74 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER 38.14 46.72 0.88 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.595 -0.944 . . . . 4.0800000000000001 110.321 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.436 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER -156.75 170.9 8.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 2.0600000000000001 109.322 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 34.9 Cg_endo -77.71 148.04 25.3 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.707 2.271 . . . . 1.01 111.027 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 87.3 m -116.76 134.27 54.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.383 -0.823 . . . . 0.82999999999999996 109.255 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.465 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 37.6 mm -101.15 104.08 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.77 -1.206 . . . . 1.0800000000000001 108.519 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.44 119.14 35.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.568 -0.853 . . . . 0.78000000000000003 109.469 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -95.34 106.56 18.62 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.028 -1.101 . . . . 1.53 108.028 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 9.2 ptt180 -52.03 154.65 2.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.977 -1.077 . . . . 2.3900000000000001 110.004 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.88 -10.69 64.49 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.392 -1.483 . . . . 0.45000000000000001 109.392 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HG3' ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -108.79 154.61 41.68 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.279 -1.13 . . . . 1.96 109.565 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.418 ' HD2' ' HG3' ' A' ' 33' ' ' LYS . 34.4 Cg_endo -79.84 114.45 3.18 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.812 2.342 . . . . 0.35999999999999999 110.884 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.475 ' CE2' HG11 ' A' ' 18' ' ' VAL . 3.7 t80 -96.37 132.91 41.4 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.55 -1.278 . . . . 0.75 107.55 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.497 HG21 ' N ' ' A' ' 37' ' ' LEU . 91.8 m -113.39 140.79 47.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.675 -1.265 . . . . 0.81999999999999995 110.879 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.497 ' N ' HG21 ' A' ' 36' ' ' THR . 0.3 OUTLIER -146.55 122.44 10.65 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.86 -0.792 . . . . 4.6299999999999999 108.86 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 3.0 tt0 -101.08 127.82 47.42 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.72 -1.215 . . . . 2.1400000000000001 107.72 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.58 ' CB ' ' CG2' ' A' ' 16' ' ' VAL . . . -126.6 122.98 36.6 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.746 -1.221 . . . . 0.22 110.413 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.53 HD21 ' CB ' ' A' ' 87' ' ' ASP . 20.2 mt -89.69 142.61 27.52 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.606 -1.627 . . . . 1.1899999999999999 106.606 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.644 ' CE1' ' CD1' ' A' ' 110' ' ' LEU . 35.3 p90 -157.85 137.67 12.25 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.823 -1.173 . . . . 0.34000000000000002 109.669 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.5 m-20 -84.73 111.58 19.72 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.239 -0.985 . . . . 1.53 108.928 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -47.84 114.22 0.87 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.298 -0.63 . . . . 0.32000000000000001 109.298 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 117' ' ' LEU . 0.6 OUTLIER -91.87 14.07 16.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 3.5099999999999998 108.944 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.634 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 1.8 pt20 -164.78 138.98 5.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.436 -0.79 . . . . 1.0900000000000001 109.022 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -81.51 123.63 28.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.126 -0.984 . . . . 4.7199999999999998 109.355 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 79' ' ' PRO . 2.6 t -145.13 153.94 41.93 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.225 -0.922 . . . . 0.88 109.382 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 3.2 mmmt -89.43 -12.75 39.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 1.8400000000000001 109.724 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.0 p -147.2 136.7 22.79 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.354 -0.938 . . . . 1.5700000000000001 110.189 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -127.57 155.79 43.26 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.477 -0.934 . . . . 0.66000000000000003 108.477 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.539 ' CD ' ' HB ' ' A' ' 70' ' ' THR . 0.3 OUTLIER -134.55 145.06 48.36 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.422 -0.799 . . . . 3.5699999999999998 110.37 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG2' ' O ' ' A' ' 69' ' ' ASP . 5.6 tt -95.22 154.46 3.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.012 -1.055 . . . . 1.6799999999999999 108.917 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 0.9 OUTLIER -141.04 114.14 8.54 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.538 -0.912 . . . . 1.24 108.538 -179.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 107' ' ' THR . 2.5 mp -113.99 130.81 67.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.95 -1.093 . . . . 0.95999999999999996 109.097 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -126.05 134.03 51.54 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.161 -0.962 . . . . 1.76 108.716 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -122.28 131.5 53.95 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.607 -1.237 . . . . 0.91000000000000003 111.16 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.24 148.21 23.33 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.206 -1.035 . . . . 0.76000000000000001 108.206 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.443 ' O ' ' C ' ' A' ' 59' ' ' ASP . 17.2 mt -109.26 56.97 0.61 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.134 -0.979 . . . . 1.0900000000000001 109.668 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 58' ' ' LEU . 3.4 t70 41.47 27.95 0.06 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.649 -0.657 . . . . 1.53 109.726 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 174.23 -49.89 0.14 Allowed Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.754 -1.212 . . . . 1.22 110.093 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.489 ' HG ' HG13 ' A' ' 63' ' ' ILE . 3.8 tp -108.43 112.73 25.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.021 -1.282 . . . . 0.90000000000000002 110.069 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -79.14 124.58 28.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.127 -0.983 . . . . 1.5600000000000001 108.975 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 71.4 mt -121.21 165.95 16.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.991 0.9 . . . . 0.68000000000000005 110.203 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.56 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 0.9 OUTLIER -112.44 108.71 17.95 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 105.881 -1.896 . . . . 1.3600000000000001 105.881 176.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.613 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 10.3 t -71.34 114.13 25.25 Favored Pre-proline 0 C--N 1.298 -1.663 0 O-C-N 121.501 -0.749 . . . . 0.96999999999999997 111.904 -177.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 37.6 Cg_endo -86.56 -157.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 123.278 2.652 . . . . 0.68000000000000005 109.241 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.27 36.13 61.85 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.247 -0.978 . . . . 0.95999999999999996 110.825 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.598 HG22 ' CD1' ' A' ' 92' ' ' TRP . 9.0 pt -120.72 -157.66 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.957 -1.319 . . . . 0.75 108.849 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.579 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 47.9 t0 -108.29 107.69 18.39 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.381 -0.824 . . . . 0.64000000000000001 109.367 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.539 ' HB ' ' CD ' ' A' ' 51' ' ' LYS . 64.4 p -86.8 45.08 1.22 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.052 -1.03 . . . . 1.3200000000000001 108.443 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 58.2 t30 175.32 83.6 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.4 -1.333 . . . . 1.05 107.4 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.428 ' O ' HG23 ' A' ' 76' ' ' VAL . . . -72.33 4.35 3.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.464 -0.772 . . . . 0.58999999999999997 113.016 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.501 ' HA ' HG23 ' A' ' 76' ' ' VAL . 2.2 t -64.89 -13.91 58.1 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.189 -1.569 . . . . 0.54000000000000004 108.675 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -75.05 -23.98 58.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.222 -0.923 . . . . 2.6699999999999999 109.728 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.52 ' CB ' HG13 ' A' ' 88' ' ' ILE . 74.1 m-85 -109.34 -16.54 14.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 1.1799999999999999 109.203 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.608 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 2.3 m -117.7 166.78 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.246 -1.02 . . . . 0.51000000000000001 108.246 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.625 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -92.25 90.69 7.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.995 -1.065 . . . . 3.6200000000000001 111.536 -178.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.463 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 17.5 p -84.28 151.11 59.08 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 107.077 -1.453 . . . . 0.59999999999999998 107.077 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.665 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.6 Cg_endo -70.11 132.55 23.09 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 124.416 -1.077 . . . . 0.93999999999999995 112.806 2.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.625 HD23 ' CE2' ' A' ' 86' ' ' TYR . 12.8 mt -75.95 113.87 13.94 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.555 -1.646 . . . . 0.79000000000000004 106.555 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' ' 82' ' ' LYS . 55.1 t -79.45 143.31 12.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 C-N-CA 119.53 -0.868 . . . . 1.0800000000000001 110.204 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.634 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 11.4 ttpt -71.5 99.8 2.1 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.824 0.821 . . . . 2.1600000000000001 110.127 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 136.5 -15.97 3.85 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 109.621 -1.392 . . . . 0.68999999999999995 109.621 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.558 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 26.9 tp60 -97.88 156.02 16.79 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.837 -1.172 . . . . 1.6200000000000001 107.837 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -106.94 142.84 35.93 Favored 'General case' 0 C--N 1.294 -1.848 0 O-C-N 120.936 -1.102 . . . . 0.94999999999999996 108.08 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.625 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 21.0 m-85 -122.96 150.65 42.7 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.469 -0.769 . . . . 1.1899999999999999 110.559 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.53 ' CB ' HD21 ' A' ' 40' ' ' LEU . 3.9 p30 -116.7 113.92 23.29 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.171 -1.048 . . . . 0.31 108.171 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.608 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 4.8 tt -106.93 120.05 57.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.032 -1.043 . . . . 1.01 111.793 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.504 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 5.0 tttp -98.36 104.44 16.48 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 104.574 -2.38 . . . . 2.8999999999999999 104.574 175.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.579 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 20.9 t80 -119.13 137.06 53.85 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.045 -1.062 . . . . 0.90000000000000002 112.004 -176.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.59 98.07 10.56 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.656 -1.609 . . . . 2.0 106.656 177.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.613 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 33.6 t90 -72.18 97.02 1.88 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.822 -0.627 . . . . 0.46999999999999997 109.797 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.26 105.16 0.46 Allowed 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.565 -0.854 . . . . 2.46 108.742 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.584 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 64.5 t -65.49 143.19 98.61 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.445 -0.784 . . . . 1.27 109.156 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.584 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 30.1 Cg_endo -72.52 129.2 14.41 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.136 1.89 . . . . 0.65000000000000002 109.726 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -1.27 4.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.573 -0.704 . . . . 3.3700000000000001 110.182 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 98' ' ' ALA . 9.5 pt -90.2 -27.52 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.834 -1.166 . . . . 1.28 110.084 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.519 ' O ' ' CD ' ' A' ' 31' ' ' ARG . . . -34.83 118.8 0.57 Allowed Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 109.428 -0.582 . . . . 0.26000000000000001 109.428 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.57 ' O ' ' N ' ' A' ' 101' ' ' SER . 36.8 Cg_endo -85.02 139.95 7.54 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.852 2.368 . . . . 0.32000000000000001 109.696 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.476 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 7.4 mtmt -52.76 89.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.994 -1.113 . . . . 0.97999999999999998 107.994 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 99' ' ' PRO . 3.4 t -93.71 122.46 36.19 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.439 -0.788 . . . . 0.59999999999999998 109.151 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 8.3 pt-20 -41.39 -44.54 2.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.523 -0.736 . . . . 1.0700000000000001 109.456 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 14.5 t30 -132.17 140.49 48.76 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.521 -0.737 . . . . 1.6100000000000001 109.722 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.524 HG22 ' CD1' ' A' ' 127' ' ' ILE . 1.0 OUTLIER -130.69 143.92 39.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.338 -0.851 . . . . 1.02 109.191 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 2.9 t -118.87 118.7 58.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.217 -1.031 . . . . 2.0899999999999999 108.217 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.8 t -104.61 140.78 21.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.731 -1.231 . . . . 0.88 110.646 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 89.8 m -122.1 127.07 49.71 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.008 -0.738 . . . . 2.0299999999999998 109.008 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -104.79 132.89 50.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 107.853 -1.166 . . . . 0.54000000000000004 107.853 178.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.634 ' CG ' ' CG1' ' A' ' 116' ' ' VAL . 0.3 OUTLIER -141.56 128.63 20.81 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.419 -1.426 . . . . 2.5 111.79 -178.397 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.644 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 13.3 mt -104.55 141.79 35.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.151 -1.425 . . . . 0.26000000000000001 107.151 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.53 ' CD1' ' HD3' ' A' ' 109' ' ' LYS . 4.4 mp -135.57 121.86 32.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.218 -0.926 . . . . 0.40999999999999998 110.039 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.435 ' N ' ' HG ' ' A' ' 117' ' ' LEU . . . -99.71 -144.53 16.43 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.788 -1.725 . . . . 0.56999999999999995 108.788 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.6 -0.28 46.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -1.173 . . . . 1.53 109.747 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.81 -4.15 13.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 2.0600000000000001 110.372 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.45 ' O ' HG21 ' A' ' 111' ' ' ILE . . . 144.27 -147.63 18.98 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.886 -1.286 . . . . 0.28999999999999998 109.886 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.634 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 2.1 t -86.82 108.98 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -1.166 . . . . 0.20999999999999999 109.878 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.468 ' O ' ' OD1' ' A' ' 44' ' ' ASN . 22.1 mt -56.46 -35.12 67.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 1.3100000000000001 109.84 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.412 ' O ' HG11 ' A' ' 116' ' ' VAL . . . -163.03 179.31 7.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.716 -1.24 . . . . 0.35999999999999999 109.515 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.538 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 14.5 t -165.08 157.61 15.94 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.319 -0.863 . . . . 0.48999999999999999 109.314 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.447 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -152.92 147.06 25.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.035 -1.041 . . . . 0.57999999999999996 109.483 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 65.7 mt -134.0 120.9 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.92000000000000004 109.554 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.8 147.53 22.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.144 -0.972 . . . . 0.85999999999999999 109.697 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -78.47 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.89000000000000001 109.837 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -56.91 -177.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 4.6200000000000001 109.353 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . 141.51 138.86 3.58 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.869 -1.292 . . . . 1.4199999999999999 109.869 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 7.8 mtmt -151.09 134.86 16.47 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.455 -1.026 . . . . 2.1299999999999999 108.614 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.524 ' CD1' HG22 ' A' ' 104' ' ' VAL . 58.6 mt -105.8 140.39 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.822 -1.174 . . . . 0.64000000000000001 110.485 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.476 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -133.5 173.5 11.43 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.74 -0.837 . . . . 3.7799999999999998 108.74 178.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.028 -1.045 . . . . 1.1599999999999999 109.513 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.516 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.211 -0.663 . . . . 3.4100000000000001 109.211 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.574 ' HA ' ' CA ' ' A' ' 23' ' ' GLY . 2.4 m -109.54 168.8 3.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.339 -0.851 . . . . 2.71 110.184 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -80.16 128.63 33.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.412 -0.805 . . . . 1.1399999999999999 110.952 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.7 m -147.49 159.3 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.703 -1.221 . . . . 1.8300000000000001 107.703 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.68 108.62 15.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.805 -1.184 . . . . 3.6499999999999999 109.462 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -52.76 130.29 32.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.90000000000000002 109.106 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.414 ' CB ' HD12 ' A' ' 121' ' ' ILE . 0.5 OUTLIER -102.4 3.96 38.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.46999999999999997 109.49 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 10' ' ' ASN . . . -81.52 -57.5 3.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.277 -0.889 . . . . 0.63 109.21 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER 161.64 -31.26 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.244 -1.021 . . . . 3.4399999999999999 108.244 -178.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 0.3 OUTLIER 159.61 39.51 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.255 -1.017 . . . . 2.71 108.255 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.479 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 77.1 mm-40 -90.82 -52.75 4.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 2.8799999999999999 110.386 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -73.97 131.8 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.702 -1.249 . . . . 0.82999999999999996 110.082 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 39.2 mmtt -85.95 -22.59 27.31 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.849 -1.167 . . . . 2.0299999999999998 107.849 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.1 ttpt 160.9 128.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.211 -0.662 . . . . 2.79 109.211 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.556 ' HB ' ' CB ' ' A' ' 39' ' ' ALA . 1.5 p -119.31 122.77 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.044 -1.035 . . . . 2.6200000000000001 109.086 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.516 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -105.23 158.69 16.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.261 -0.899 . . . . 1.47 110.41 -178.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.543 ' CG1' ' CE1' ' A' ' 35' ' ' PHE . 24.7 t -127.9 115.69 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.873 . . . . 1.0700000000000001 108.66 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -68.15 89.82 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 3.48 109.749 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.38 -63.54 0.26 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.404 -1.478 . . . . 0.81999999999999995 109.404 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.6 t -90.18 154.08 20.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -1.133 . . . . 1.0700000000000001 109.243 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.444 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 12.2 m80 -94.01 -169.16 2.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 3.5299999999999998 109.789 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.574 ' CA ' ' HA ' ' A' ' 3' ' ' VAL . . . -108.09 154.82 16.44 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.361 -1.496 . . . . 3.9100000000000001 109.361 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.0 6.18 4.55 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.161 -1.199 . . . . 1.8799999999999999 109.079 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -128.57 158.5 71.69 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 108.497 -0.927 . . . . 2.75 108.497 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.78 147.36 21.65 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.708 2.272 . . . . 1.1000000000000001 110.368 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.2 m -115.69 154.42 29.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 1.3100000000000001 109.7 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.481 HG21 ' HG3' ' A' ' 128' ' ' ARG . 45.9 mm -111.95 113.16 43.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.353 -0.842 . . . . 0.63 109.206 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.49 ' HB ' HG12 ' A' ' 127' ' ' ILE . 10.1 mt -94.94 120.89 44.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.249 -0.907 . . . . 1.3899999999999999 108.931 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.485 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 3.9 m-70 -87.43 133.97 33.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.35 -0.844 . . . . 3.0299999999999998 109.639 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.501 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 9.2 mtm180 -54.81 135.06 48.07 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.159 -0.963 . . . . 2.8399999999999999 108.922 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.5 ' N ' ' HB ' ' A' ' 94' ' ' VAL . . . 69.26 20.47 75.12 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.397 -0.906 . . . . 1.21 111.041 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.548 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -109.64 137.76 20.45 Favored Pre-proline 0 N--CA 1.482 1.175 0 O-C-N 120.594 -1.533 . . . . 4.79 108.305 179.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.491 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 33.9 Cg_endo -74.18 115.56 4.36 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.844 2.363 . . . . 0.55000000000000004 112.089 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.543 ' CE1' ' CG1' ' A' ' 18' ' ' VAL . 1.5 t80 -98.97 111.74 24.05 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.166 -1.05 . . . . 1.5600000000000001 108.166 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.477 ' O ' HG13 ' A' ' 18' ' ' VAL . 96.2 m -88.04 128.71 35.4 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.087 -1.008 . . . . 1.3100000000000001 109.944 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.404 ' CD1' HG23 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -140.66 123.68 16.49 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.475 -0.765 . . . . 4.6299999999999999 109.238 179.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.473 ' O ' HG23 ' A' ' 16' ' ' VAL . 4.5 tt0 -105.28 126.78 52.48 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.642 -1.244 . . . . 0.92000000000000004 107.642 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.556 ' CB ' ' HB ' ' A' ' 16' ' ' VAL . . . -129.42 132.08 46.92 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.676 -1.265 . . . . 0.57999999999999996 110.975 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 5.4 mt -94.85 144.39 25.69 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.092 -1.447 . . . . 0.51000000000000001 107.092 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.638 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 35.2 p90 -159.36 136.53 9.68 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.785 -1.166 . . . . 0.35999999999999999 109.864 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.4 m-20 -84.2 112.25 20.1 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.292 -0.963 . . . . 1.3899999999999999 108.611 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -45.19 110.88 0.27 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.759 -0.83 . . . . 0.29999999999999999 108.759 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -80.03 4.65 16.4 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.154 -0.966 . . . . 1.5900000000000001 109.5 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.539 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 4.3 pt20 -164.84 156.75 15.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.028 -1.045 . . . . 1.72 109.676 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.463 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 1.9 p-10 -84.79 121.67 28.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 3.79 109.271 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -141.46 139.26 33.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.056 -1.028 . . . . 1.5 110.287 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.676 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 3.2 mmmm -80.92 -10.87 59.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.384 -0.822 . . . . 2.1600000000000001 109.477 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 47' ' ' THR . 12.7 p -147.03 137.86 23.78 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.985 0.897 . . . . 0.60999999999999999 109.714 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -126.3 149.81 48.89 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.815 -0.809 . . . . 0.55000000000000004 108.815 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.554 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 2.2 mtmt -129.28 136.2 49.76 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.114 -1.034 . . . . 0.80000000000000004 110.401 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.468 HG12 HD11 ' A' ' 54' ' ' ILE . 12.2 tt -92.17 151.28 3.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 107.085 -1.45 . . . . 1.1699999999999999 107.085 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -142.13 115.38 8.89 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.089 -1.007 . . . . 0.56000000000000005 109.468 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.585 ' CD1' ' N ' ' A' ' 54' ' ' ILE . 2.3 mp -112.63 111.41 36.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.044 -1.035 . . . . 0.25 109.13 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -106.57 160.57 15.33 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.263 -1.014 . . . . 1.1799999999999999 108.263 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -134.67 150.63 50.66 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.494 -1.379 . . . . 1.3700000000000001 110.829 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 4.6 m -116.26 151.56 35.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.875 -1.157 . . . . 3.3799999999999999 107.875 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.429 HD13 ' HG ' ' A' ' 61' ' ' LEU . 10.9 mt -123.66 60.1 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.648 -1.282 . . . . 2.0499999999999998 110.312 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.4 OUTLIER 44.01 24.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.554 -0.716 . . . . 0.83999999999999997 110.005 179.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 162.85 -47.23 0.33 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.01 -1.236 . . . . 0.35999999999999999 110.01 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.429 ' HG ' HD13 ' A' ' 58' ' ' LEU . 12.3 tp -107.67 117.63 34.61 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.117 -1.225 . . . . 1.51 109.051 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.6 mt-10 -100.8 128.26 46.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 3.9100000000000001 109.937 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.644 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -117.1 178.05 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 122.419 1.104 . . . . 1.9199999999999999 110.04 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.644 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -110.49 143.03 41.44 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.8 -1.185 . . . . 3.7200000000000002 107.8 178.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.665 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 2.9 t -110.87 104.27 55.87 Favored Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 120.977 -1.077 . . . . 0.34999999999999998 111.523 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 95' ' ' PRO . 36.4 Cg_endo -81.81 -154.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.4 2.733 . . . . 0.23000000000000001 109.639 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.91 29.39 64.81 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.792 -1.323 . . . . 0.54000000000000004 109.792 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.512 HD11 ' CD1' ' A' ' 54' ' ' ILE . 9.3 pt -120.44 -162.13 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.153 -1.204 . . . . 0.57999999999999996 109.195 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.544 ' N ' ' OH ' ' A' ' 90' ' ' TYR . 16.6 t70 -103.55 107.05 17.73 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.445 -0.784 . . . . 0.83999999999999997 109.062 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.554 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 1.0 OUTLIER -85.76 44.55 1.12 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.268 -0.895 . . . . 1.6699999999999999 108.682 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 49.2 t30 -177.63 69.65 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.532 -1.285 . . . . 0.95999999999999996 107.532 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.4 -11.2 1.14 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.563 -0.71 . . . . 0.44 111.868 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.506 ' HA ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -61.23 -15.18 31.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.534 -1.354 . . . . 0.47999999999999998 109.379 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.22 -25.06 60.59 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.082 -1.011 . . . . 1.27 109.917 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.509 ' CB ' HG13 ' A' ' 88' ' ' ILE . 78.3 m-85 -102.54 -35.9 8.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.203 -0.936 . . . . 0.46000000000000002 109.189 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.626 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 2.0 m -96.02 166.07 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.134 -1.061 . . . . 0.90000000000000002 108.134 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.619 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -88.24 93.1 9.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.945 -1.097 . . . . 1.51 110.692 -178.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.491 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 11.9 p -90.06 154.04 47.15 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 107.682 -1.229 . . . . 0.20000000000000001 107.682 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.676 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 26.3 Cg_endo -68.7 133.56 24.26 Favored 'Cis proline' 0 C--N 1.312 -1.359 0 C-N-CA 124.223 -1.157 . . . . 0.17000000000000001 112.513 2.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.617 HD23 ' CE2' ' A' ' 86' ' ' TYR . 13.1 mt -76.86 112.42 13.44 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.782 -1.562 . . . . 1.1299999999999999 106.782 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.8 t -80.77 136.79 22.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 C-N-CA 119.707 -0.797 . . . . 0.39000000000000001 110.114 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 25.0 tttm -60.54 110.42 1.27 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.648 0.737 . . . . 4.2699999999999996 110.253 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 126.71 -16.46 6.54 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 110.264 -1.134 . . . . 0.46000000000000002 110.264 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.565 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 13.6 tp60 -97.99 157.39 16.14 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.125 -1.22 . . . . 0.72999999999999998 108.162 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -110.68 143.13 41.63 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.074 -1.084 . . . . 1.3899999999999999 108.074 179.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.619 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 19.0 m-85 -125.94 152.83 45.12 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.409 -0.807 . . . . 0.20000000000000001 110.438 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.467 ' OD2' HD21 ' A' ' 40' ' ' LEU . 24.0 t0 -119.49 113.18 20.35 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.882 -1.155 . . . . 4.0700000000000003 107.882 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.626 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 9.1 tt -106.71 126.75 62.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.361 -0.936 . . . . 0.78000000000000003 111.506 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.43 ' HA ' ' HG3' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -100.59 119.89 39.21 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 105.124 -2.176 . . . . 2.71 105.124 176.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.544 ' OH ' ' N ' ' A' ' 69' ' ' ASP . 34.4 t80 -138.03 140.74 40.24 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.051 -1.46 . . . . 0.78000000000000003 112.698 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.501 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -92.74 138.96 31.04 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.512 -1.662 . . . . 1.3200000000000001 106.512 177.058 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.665 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 26.4 t90 -120.27 82.73 1.94 Allowed 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.949 -1.094 . . . . 1.1699999999999999 109.472 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -61.28 108.51 0.93 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.591 -0.693 . . . . 1.99 109.958 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.609 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 33.9 t -47.39 144.04 4.87 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.134 -1.062 . . . . 1.3899999999999999 108.134 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.609 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 26.7 Cg_endo -68.67 -8.7 24.03 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.854 2.369 . . . . 3.7200000000000002 113.038 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 0.9 OUTLIER 77.84 -17.82 0.54 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.913 -1.117 . . . . 3.6899999999999999 110.665 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.523 ' O ' ' C ' ' A' ' 98' ' ' ALA . 11.8 pt -88.11 -25.62 5.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 120.704 -1.247 . . . . 1.1799999999999999 108.335 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.523 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -33.84 116.77 0.48 Allowed Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.92 -0.771 . . . . 0.56999999999999995 108.92 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.606 ' O ' ' N ' ' A' ' 101' ' ' SER . 36.0 Cg_endo -83.6 129.41 4.93 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.674 2.249 . . . . 0.90000000000000002 109.165 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.469 ' HG2' ' HA ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -46.93 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.457 -0.942 . . . . 4.4199999999999999 108.457 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -103.38 124.42 48.67 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.167 -0.679 . . . . 2.4900000000000002 109.167 -178.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 6.4 pt-20 -41.65 -46.38 3.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.443 -0.786 . . . . 0.93000000000000005 110.022 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -129.36 140.68 51.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.901 -1.124 . . . . 0.81000000000000005 110.223 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 57' ' ' SER . 2.7 t -133.1 147.22 31.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.531 -0.731 . . . . 0.31 109.377 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 57' ' ' SER . 2.7 t -123.31 118.85 55.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.516 -1.29 . . . . 1.0 107.516 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.1 t -100.92 142.49 15.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.281 -0.887 . . . . 0.80000000000000004 110.039 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 24.1 m -122.52 117.15 25.24 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.607 -0.683 . . . . 1.04 109.358 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -94.9 129.12 45.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 107.001 -1.481 . . . . 0.39000000000000001 107.001 178.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.623 ' CG ' ' CG1' ' A' ' 116' ' ' VAL . 0.7 OUTLIER -140.08 130.79 25.8 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.363 -1.461 . . . . 2.27 112.05 -177.119 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.638 ' CD1' ' CZ ' ' A' ' 41' ' ' PHE . 14.1 mt -101.79 143.01 32.23 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.945 -1.502 . . . . 1.77 106.945 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.541 ' CD1' ' HD3' ' A' ' 109' ' ' LYS . 4.2 mp -136.4 116.89 17.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 120.823 -1.173 . . . . 0.72999999999999998 111.065 -177.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.43 -169.71 41.96 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.202 -1.959 . . . . 0.95999999999999996 108.202 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.58 1.67 25.15 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.035 -1.274 . . . . 1.1399999999999999 109.709 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.37 -6.51 12.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.197 -0.939 . . . . 4.71 110.702 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.47 ' O ' HG21 ' A' ' 111' ' ' ILE . . . 149.91 -153.12 24.91 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.537 -1.316 . . . . 0.52000000000000002 110.209 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.623 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -85.08 110.03 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.382 -1.069 . . . . 1.8300000000000001 109.606 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.467 HD12 HD13 ' A' ' 80' ' ' LEU . 26.7 mt -58.66 -39.89 81.92 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.206 -0.934 . . . . 0.63 109.816 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 119' ' ' CYS . . . -154.87 -162.64 1.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.989 -1.07 . . . . 0.93000000000000005 109.468 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.48 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 53.4 t 178.88 154.6 0.42 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.029 -1.045 . . . . 0.32000000000000001 109.499 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.27 152.31 32.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.03 -1.044 . . . . 0.44 109.695 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.414 HD12 ' CB ' ' A' ' 8' ' ' CYS . 53.5 mt -134.99 140.2 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.2 -0.937 . . . . 1.1000000000000001 109.083 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.19 119.46 38.9 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.456 -1.402 . . . . 0.72999999999999998 108.571 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 51.3 p -70.12 -33.24 71.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -0.839 . . . . 3.1800000000000002 110.498 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -120.97 154.89 35.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.95 -1.094 . . . . 1.8300000000000001 110.098 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 126' ' ' LYS . . . 166.1 155.3 8.71 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.476 -1.449 . . . . 0.76000000000000001 109.476 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 30.6 mttt -154.88 138.09 15.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -1.197 . . . . 2.5899999999999999 108.563 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.49 HG12 ' HB ' ' A' ' 29' ' ' ILE . 67.0 mt -104.17 140.7 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.508 -1.37 . . . . 0.93000000000000005 109.769 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.481 ' HG3' HG21 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -124.86 154.21 41.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.465 -0.772 . . . . 5.75 109.824 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.413 ' HB3' ' HG3' ' A' ' 100' ' ' LYS . 2.9 p30 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 118.0 -1.0 . . . . 4.6799999999999997 109.563 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.358 0.599 . . . . 3.52 109.483 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' A' ' 21' ' ' CYS . 3.0 m -99.16 167.24 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 1.2 109.307 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 51.9 t0 -92.53 124.21 36.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.87 110.211 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.3 m -146.27 148.93 16.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.464 -0.939 . . . . 0.95999999999999996 108.464 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.23 110.33 21.5 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.095 -1.003 . . . . 4.1699999999999999 109.609 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -53.91 142.92 22.89 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.335 -0.853 . . . . 3.54 109.374 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.92 -14.17 11.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.344 -0.847 . . . . 0.95999999999999996 108.963 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.94 -65.65 0.67 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.868 0.842 . . . . 0.40999999999999998 109.199 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.47 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 3.4 t-20 173.98 59.23 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.134 -1.061 . . . . 4.4500000000000002 108.134 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 53.12 21.37 2.12 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.972 -1.08 . . . . 2.4399999999999999 108.087 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.473 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 19.7 mm-40 -64.67 -61.27 2.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.582 -0.699 . . . . 3.52 109.363 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -58.95 127.35 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.34999999999999998 109.459 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.565 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 11.4 mmpt? -77.13 -19.83 56.4 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.242 -0.911 . . . . 0.68000000000000005 108.899 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 0.8 OUTLIER 156.59 128.54 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.882 -0.784 . . . . 2.8100000000000001 108.882 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.584 ' CG2' ' CB ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -108.33 123.18 63.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.377 -0.972 . . . . 0.67000000000000004 108.377 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.471 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 1.3 mtm -117.03 148.05 41.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.049 -1.032 . . . . 2.29 110.796 -178.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.468 HG13 ' OD1' ' A' ' 19' ' ' ASP . 31.6 t -103.9 158.03 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.385 -0.968 . . . . 1.0600000000000001 108.385 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.468 ' OD1' HG13 ' A' ' 18' ' ' VAL . 8.8 p-10 -44.12 -31.28 0.92 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.092 -1.005 . . . . 4.1100000000000003 109.802 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.92 97.45 0.12 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.57 -1.3 . . . . 3.8199999999999998 110.27 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -108.48 -66.78 1.02 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -1.135 . . . . 3.4300000000000002 108.913 179.266 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.489 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER 168.93 -27.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.833 . . . . 5.71 109.66 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 101.13 -135.71 12.31 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.957 -1.257 . . . . 2.1600000000000001 109.957 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 23' ' ' GLY . 29.1 t -40.4 -34.68 0.36 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.534 -0.98 . . . . 2.27 109.988 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.412 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -67.12 164.92 31.55 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 2.25 109.42 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 25' ' ' ASP . 34.3 Cg_endo -78.03 162.18 29.21 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.692 2.261 . . . . 2.6699999999999999 109.844 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.6 m -116.62 153.51 32.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.909 . . . . 1.3300000000000001 109.371 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.505 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 47.8 mm -107.37 109.13 27.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.911 -1.118 . . . . 0.54000000000000004 108.872 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.453 HG21 HG23 ' A' ' 94' ' ' VAL . 1.9 mt -91.19 119.31 38.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.444 -0.785 . . . . 0.5 109.357 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.44 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 24.6 m-70 -84.41 114.57 22.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.368 -0.832 . . . . 1.3400000000000001 110.122 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.554 ' CD ' ' HB2' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -48.12 148.41 1.79 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.566 -0.709 . . . . 3.5800000000000001 111.127 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.73 -22.55 4.03 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.923 -0.871 . . . . 0.93000000000000005 110.923 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.471 ' O ' HG22 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -93.01 155.18 41.53 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.77 -1.43 . . . . 3.77 109.745 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.442 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 36.4 Cg_endo -79.11 162.21 26.06 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.863 2.376 . . . . 1.3999999999999999 110.689 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.466 ' HB3' ' HB3' ' A' ' 92' ' ' TRP . 2.5 t80 -135.08 122.14 21.33 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.172 -1.048 . . . . 1.0900000000000001 108.172 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.451 ' O ' HG11 ' A' ' 18' ' ' VAL . 2.9 m -96.36 128.2 43.06 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.77 -1.207 . . . . 1.95 110.427 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.41 123.44 15.47 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.359 -0.838 . . . . 4.71 108.767 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 16' ' ' VAL . 5.6 mt-10 -96.96 126.9 42.43 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.31 -0.996 . . . . 2.3999999999999999 108.31 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.584 ' CB ' ' CG2' ' A' ' 16' ' ' VAL . . . -123.97 118.96 28.2 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.875 -1.13 . . . . 0.44 110.386 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 5.9 mt -92.76 141.9 27.94 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.505 -1.665 . . . . 0.53000000000000003 106.505 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.621 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 27.8 p90 -158.23 142.13 15.58 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 120.695 -1.253 . . . . 0.28000000000000003 109.751 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.466 ' O ' ' OE1' ' A' ' 12' ' ' GLU . 1.8 m-20 -87.06 110.88 20.39 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.408 -0.917 . . . . 0.60999999999999999 108.728 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.3 114.1 0.74 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.61 -0.681 . . . . 0.16 109.398 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.425 ' OD1' ' C ' ' A' ' 44' ' ' ASN . 4.0 p30 -85.31 9.76 14.47 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.191 -0.943 . . . . 0.37 109.425 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.566 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 6.0 pt20 -166.24 149.16 7.17 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.297 -0.877 . . . . 0.80000000000000004 109.412 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -86.27 106.16 17.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.057 -1.027 . . . . 2.5699999999999998 108.963 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.88 154.32 38.47 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.293 -0.879 . . . . 1.54 109.787 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.687 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 11.0 mmmt -89.22 -12.44 40.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 1.78 109.755 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 p -146.47 137.35 24.17 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.156 0.979 . . . . 0.79000000000000004 110.195 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -127.93 149.17 50.44 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.357 -1.349 . . . . 0.51000000000000001 107.357 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.56 ' HD2' ' CB ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -135.27 140.58 45.31 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.646 -0.822 . . . . 3.7400000000000002 110.492 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.479 HG13 HD21 ' A' ' 110' ' ' LEU . 7.0 tt -109.6 124.66 66.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.271 -0.893 . . . . 1.3799999999999999 108.836 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 11.4 pt-20 -129.79 117.71 20.66 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.478 -1.304 . . . . 3.8300000000000001 107.478 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 107' ' ' THR . 3.8 mp -93.14 136.24 25.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 121.448 -0.782 . . . . 1.04 109.146 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -119.05 131.9 55.99 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.225 -1.028 . . . . 1.05 108.225 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -116.33 154.38 30.3 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 120.7 -1.25 . . . . 1.1100000000000001 111.608 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -120.14 150.75 40.13 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.71 -1.219 . . . . 1.28 107.71 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.532 ' CD2' ' HD2' ' A' ' 99' ' ' PRO . 3.4 mt -132.55 75.02 1.61 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.823 -1.173 . . . . 2.6800000000000002 110.428 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER 40.51 25.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.596 -0.69 . . . . 1.73 110.274 179.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 152.35 -29.52 0.87 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.387 -1.387 . . . . 1.54 110.443 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.477 ' HG ' HD11 ' A' ' 58' ' ' LEU . 4.9 tp -110.3 110.02 20.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.848 -1.384 . . . . 2.79 110.112 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 2.0 tt0 -112.75 119.85 39.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.201 -0.937 . . . . 1.75 108.887 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.623 HG13 ' N ' ' A' ' 64' ' ' ASP . 2.2 tp -126.32 164.44 26.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 122.171 0.986 . . . . 6.1399999999999997 109.65 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.623 ' N ' HG13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -83.38 110.15 17.91 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 105.64 -1.985 . . . . 1.5900000000000001 105.64 177.056 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.651 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 3.0 t -66.5 113.68 13.89 Favored Pre-proline 0 C--N 1.293 -1.867 0 O-C-N 121.322 -0.862 . . . . 0.97999999999999998 110.786 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 37.5 Cg_endo -81.91 -165.7 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 123.121 2.547 . . . . 0.87 109.757 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 93' ' ' ASN . . . 58.0 56.83 23.03 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.796 -1.322 . . . . 1.3799999999999999 109.796 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.555 HG22 ' CD1' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -149.12 -155.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.216 -1.167 . . . . 1.5800000000000001 109.002 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.532 ' N ' ' OH ' ' A' ' 90' ' ' TYR . 38.6 t0 -114.18 112.13 22.67 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.096 -0.642 . . . . 0.72999999999999998 109.575 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.56 ' CB ' ' HD2' ' A' ' 51' ' ' LYS . 21.2 p -90.39 42.41 1.1 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.645 -1.242 . . . . 1.3799999999999999 107.645 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 8.3 t30 176.94 88.33 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.497 -1.298 . . . . 2.29 107.497 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.503 ' HB2' ' CD1' ' A' ' 88' ' ' ILE . . . -76.45 7.35 4.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.91000000000000003 112.613 -176.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.483 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.6 t -65.82 -12.99 58.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.225 -1.547 . . . . 0.28000000000000003 108.837 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -78.56 -21.02 49.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.056 -1.027 . . . . 0.69999999999999996 109.819 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.416 ' CB ' HG13 ' A' ' 88' ' ' ILE . 72.1 m-85 -108.74 -20.93 12.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 0.22 108.681 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.624 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 2.0 m -113.94 165.58 8.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.687 -1.227 . . . . 0.32000000000000001 107.687 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.595 ' HG2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -92.54 93.05 8.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.983 -1.073 . . . . 2.5099999999999998 111.202 -178.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.473 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 15.7 p -86.69 153.06 55.12 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 107.316 -1.364 . . . . 0.14000000000000001 107.316 177.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.687 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.5 Cg_endo -69.52 132.13 21.04 Favored 'Cis proline' 0 C--N 1.311 -1.401 0 C-N-CA 124.363 -1.099 . . . . 0.28999999999999998 112.778 2.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.624 HD23 ' CE2' ' A' ' 86' ' ' TYR . 11.1 mt -77.12 111.11 12.38 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.777 -1.564 . . . . 1.46 106.777 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.6 t -78.32 144.31 11.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 121.715 0.769 . . . . 0.45000000000000001 110.782 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.566 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 14.2 ttpt -67.17 110.95 3.67 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.799 0.809 . . . . 1.3700000000000001 109.858 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 124.12 -12.24 8.1 Favored Glycine 0 C--N 1.298 -1.578 0 N-CA-C 109.479 -1.448 . . . . 0.33000000000000002 109.479 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.618 ' CG ' ' CE1' ' A' ' 86' ' ' TYR . 6.8 tp60 -103.28 151.6 22.5 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.839 -1.171 . . . . 0.34000000000000002 107.839 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -103.97 144.98 30.82 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.92 -1.141 . . . . 2.7200000000000002 107.92 179.037 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.624 ' CE2' HD23 ' A' ' 80' ' ' LEU . 38.9 m-85 -125.67 143.56 50.98 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.008 -1.057 . . . . 0.68000000000000005 110.212 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.482 ' HB3' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -109.29 115.7 30.49 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.845 -0.798 . . . . 2.8199999999999998 108.845 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.624 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 3.4 tt -111.06 119.1 58.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.109 -0.995 . . . . 0.28000000000000003 111.406 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -94.39 119.35 33.0 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 104.662 -2.347 . . . . 2.8500000000000001 104.662 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.607 ' CE2' ' O ' ' A' ' 91' ' ' THR . 24.0 t80 -132.7 143.04 49.36 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 117.539 -1.664 . . . . 0.75 113.982 -175.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.607 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -92.44 144.33 25.47 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 105.742 -1.947 . . . . 1.1499999999999999 105.742 176.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.651 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 22.7 t90 -127.39 97.69 4.99 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.667 -1.271 . . . . 1.3899999999999999 110.724 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 2.9 m-80 -61.75 103.08 0.31 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.646 -0.872 . . . . 2.8399999999999999 108.646 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.603 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 88.3 t -59.23 144.02 83.96 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.325 -0.859 . . . . 1.02 108.747 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.61 ' HD3' ' CG1' ' A' ' 65' ' ' VAL . 29.4 Cg_endo -71.23 121.37 7.73 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.0 1.8 . . . . 1.28 110.165 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.459 ' HA ' ' HG2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -66.56 -0.98 3.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.818 -0.551 . . . . 4.3499999999999996 110.971 -178.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.498 ' O ' ' C ' ' A' ' 98' ' ' ALA . 9.4 pt -92.41 -25.09 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.706 -1.246 . . . . 1.71 109.29 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.554 ' HB2' ' CD ' ' A' ' 31' ' ' ARG . . . -28.62 122.45 0.26 Allowed Pre-proline 0 N--CA 1.491 1.613 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.782 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.599 ' O ' ' N ' ' A' ' 101' ' ' SER . 36.8 Cg_endo -87.01 115.57 1.19 Allowed 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.377 2.052 . . . . 1.23 107.995 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.506 ' CD ' ' HA ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -38.42 92.44 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.742 0.782 . . . . 5.0300000000000002 108.946 -179.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 99' ' ' PRO . 1.4 t -102.76 115.03 29.79 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.33 -0.619 . . . . 1.3799999999999999 109.33 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.452 ' O ' ' HE2' ' A' ' 126' ' ' LYS . 0.1 OUTLIER -41.15 -36.28 0.71 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.684 -0.635 . . . . 3.8399999999999999 109.573 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 1.5 t30 -128.48 138.36 52.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 3.23 110.097 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.543 ' CG2' HG13 ' A' ' 127' ' ' ILE . 20.2 t -135.79 150.54 28.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.573 -0.704 . . . . 1.8300000000000001 109.896 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 57' ' ' SER . 2.9 t -123.33 117.62 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.229 -1.026 . . . . 1.46 108.229 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.31 142.22 15.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 120.966 -1.084 . . . . 0.80000000000000004 110.195 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 34.3 m -125.9 117.05 22.49 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.802 -0.561 . . . . 0.63 109.586 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER -96.78 125.79 49.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 106.945 -1.502 . . . . 0.40999999999999998 106.945 178.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.568 ' CD ' ' CG1' ' A' ' 116' ' ' VAL . 0.9 OUTLIER -135.41 137.03 41.86 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.552 -1.342 . . . . 1.9199999999999999 111.504 -177.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.621 ' CD1' ' CZ ' ' A' ' 41' ' ' PHE . 10.0 mt -113.87 139.97 48.73 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.66 -1.607 . . . . 0.5 106.66 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.524 ' CD1' ' HD2' ' A' ' 109' ' ' LYS . 3.7 mp -134.17 115.99 21.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 120.707 -1.245 . . . . 0.55000000000000004 110.769 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.08 -150.85 16.26 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.364 -1.894 . . . . 0.62 108.364 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -96.65 -0.6 48.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.082 -1.246 . . . . 1.22 109.551 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.98 -2.52 12.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.095 -1.003 . . . . 4.25 110.401 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.28 -164.65 29.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.847 -1.301 . . . . 0.29999999999999999 109.847 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.568 ' CG1' ' CD ' ' A' ' 109' ' ' LYS . 1.8 t -77.97 112.02 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -1.128 . . . . 0.58999999999999997 109.671 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 50' ' ' ALA . 25.7 mt -57.93 -38.67 76.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 2.2400000000000002 110.014 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.463 ' O ' HG11 ' A' ' 116' ' ' VAL . . . -157.07 -171.05 3.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.001 -1.062 . . . . 0.65000000000000002 109.128 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -177.44 151.24 0.75 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.263 -0.898 . . . . 1.04 109.393 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -149.63 153.2 36.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.045 . . . . 0.53000000000000003 109.771 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.5 mt -134.81 138.91 48.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.371 -0.831 . . . . 1.99 108.783 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.07 133.62 34.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.84 -1.162 . . . . 0.91000000000000003 109.732 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -68.41 0.34 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.466 -0.771 . . . . 3.04 109.928 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -128.76 142.07 51.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.9 . . . . 5.8399999999999999 110.322 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -156.83 175.32 34.4 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.895 -1.682 . . . . 0.75 108.895 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.467 ' HB3' HD11 ' A' ' 28' ' ' ILE . 31.0 ttmt -153.07 138.44 17.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -1.14 . . . . 4.0700000000000003 108.45 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.543 HG13 ' CG2' ' A' ' 104' ' ' VAL . 62.0 mt -106.61 140.31 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.427 -1.421 . . . . 0.81000000000000005 109.738 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.506 ' HA ' ' CD ' ' A' ' 100' ' ' LYS . 10.4 mtt180 -132.42 174.93 9.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.401 -0.812 . . . . 2.48 108.948 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.2 t0 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.005 -1.06 . . . . 2.5699999999999998 109.702 -179.759 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.52 ' CB ' ' HG2' ' A' ' 17' ' ' MET . 1.5 pt20 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.39 0.614 . . . . 2.02 109.991 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 21' ' ' CYS . 2.3 m -105.58 162.97 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.33 -0.857 . . . . 0.34000000000000002 109.121 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.32 126.28 38.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 3.3599999999999999 109.141 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 121' ' ' ILE . 27.6 m -143.69 162.64 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.874 -0.787 . . . . 0.92000000000000004 108.874 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -112.82 104.42 12.43 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.151 -1.055 . . . . 5.1699999999999999 108.151 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -45.14 113.04 0.51 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.406 -0.809 . . . . 1.9399999999999999 110.18 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.467 ' HB3' HG13 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -83.84 -7.47 59.44 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.636 -0.875 . . . . 1.3300000000000001 108.636 179.225 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.528 ' N ' ' HB3' ' A' ' 119' ' ' CYS . . . -88.54 -79.52 0.31 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.371 -0.83 . . . . 0.96999999999999997 109.5 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 178.83 61.13 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.761 -0.776 . . . . 1.6399999999999999 109.682 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 57.93 17.98 4.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.293 -0.879 . . . . 1.1499999999999999 109.362 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.83 -66.81 0.52 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.355 -0.841 . . . . 1.4099999999999999 109.606 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -56.23 120.0 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.0 -1.063 . . . . 0.60999999999999999 109.769 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.584 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -61.0 -29.08 69.49 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.443 -0.786 . . . . 3.02 109.452 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.584 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 6.9 pttt 168.07 131.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.579 -0.897 . . . . 1.5800000000000001 108.579 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.55 ' CG2' ' CB ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -108.18 130.79 60.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.054 -1.091 . . . . 0.75 108.054 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.52 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 8.2 mtm -122.63 153.22 39.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.074 -1.016 . . . . 0.87 111.012 -177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.634 ' CG1' ' CE2' ' A' ' 35' ' ' PHE . 2.5 t -127.0 128.36 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.577 -0.898 . . . . 0.97999999999999998 108.577 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.79 -17.39 35.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.149 -0.969 . . . . 2.4500000000000002 110.496 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 21' ' ' CYS . . . -88.33 -94.68 1.01 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.646 -1.381 . . . . 2.1299999999999999 109.646 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' O ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -47.53 173.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.213 -1.169 . . . . 0.79000000000000004 108.975 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.493 ' NE2' ' CB ' ' A' ' 25' ' ' ASP . 5.5 p80 -139.48 3.34 2.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.927 -1.108 . . . . 5.1399999999999997 110.594 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.13 -157.51 27.91 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.054 -1.545 . . . . 1.9299999999999999 110.951 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.468 ' O ' ' C ' ' A' ' 25' ' ' ASP . 5.0 t -41.35 -36.27 0.79 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.613 -0.934 . . . . 4.4000000000000004 110.553 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.493 ' CB ' ' NE2' ' A' ' 22' ' ' HIS . 0.7 OUTLIER -39.92 157.18 0.15 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.5 -0.75 . . . . 2.1200000000000001 109.607 -179.648 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.82 138.88 19.22 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.957 2.438 . . . . 0.82999999999999996 110.746 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -116.25 132.66 56.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.446 -0.784 . . . . 1.3200000000000001 109.331 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.543 HG23 ' CD2' ' A' ' 30' ' ' HIS . 46.6 mm -101.97 109.31 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.019 -1.051 . . . . 0.98999999999999999 108.616 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.3 mt -92.53 113.43 27.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.212 -0.93 . . . . 1.01 109.391 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.543 ' CD2' HG23 ' A' ' 28' ' ' ILE . 5.7 m170 -89.63 105.97 18.15 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.468 -1.308 . . . . 1.73 107.468 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.487 ' HD2' ' O ' ' A' ' 98' ' ' ALA . 2.6 ptt180 -45.26 152.55 0.27 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.055 -1.028 . . . . 1.21 110.051 -178.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 96' ' ' LYS . . . 94.58 -15.88 62.36 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.57 -1.412 . . . . 0.46000000000000002 109.57 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.483 ' HE2' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -102.3 152.51 38.3 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.178 -1.189 . . . . 3.5699999999999998 109.445 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -81.3 119.85 3.53 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.886 2.391 . . . . 0.56000000000000005 110.825 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.634 ' CE2' ' CG1' ' A' ' 18' ' ' VAL . 5.2 t80 -97.83 116.81 30.78 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.945 -1.502 . . . . 0.78000000000000003 106.945 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.445 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 28.3 m -96.21 131.03 43.12 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.15 -0.969 . . . . 0.85999999999999999 110.838 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.633 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -134.64 141.63 46.64 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.696 -0.854 . . . . 2.1000000000000001 108.696 178.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 0.7 OUTLIER -121.66 127.09 50.42 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.293 -1.003 . . . . 1.1599999999999999 108.293 -179.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.55 ' CB ' ' CG2' ' A' ' 16' ' ' VAL . . . -132.75 121.51 23.16 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.597 -1.314 . . . . 0.59999999999999998 110.513 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 2.3 mt -88.28 145.03 26.08 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 105.488 -2.041 . . . . 1.2 105.488 177.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.659 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 28.2 p90 -157.15 141.93 16.84 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.143 -1.423 . . . . 0.31 110.38 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 26.8 m-20 -85.51 111.01 19.61 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.202 -0.936 . . . . 1.3600000000000001 108.79 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.82 114.8 0.9 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.703 -0.623 . . . . 0.28999999999999998 109.329 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.427 ' C ' ' HG3' ' A' ' 82' ' ' LYS . 38.8 p30 -83.66 7.85 16.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.096 -1.003 . . . . 1.9199999999999999 109.847 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.537 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 3.5 pt20 -168.39 162.02 12.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.068 -1.02 . . . . 1.0600000000000001 109.685 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 46' ' ' ASN . 10.7 p-10 -89.1 120.55 30.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.215 -0.928 . . . . 4.2800000000000002 109.245 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -141.6 141.74 33.46 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.63 110.17 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.646 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 8.0 mmmt -84.12 -11.45 56.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.54 -0.725 . . . . 1.1499999999999999 109.688 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.2 p -144.75 138.1 26.94 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.977 0.894 . . . . 0.93999999999999995 109.729 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -126.57 153.23 45.52 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.691 -0.855 . . . . 0.51000000000000001 108.691 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.505 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 0.5 OUTLIER -132.09 136.92 47.52 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.959 -1.088 . . . . 1.3500000000000001 110.833 -179.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.505 HD11 HG22 ' A' ' 52' ' ' ILE . 4.5 tt -93.61 148.95 4.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.527 -1.286 . . . . 0.97999999999999998 107.527 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -139.07 116.8 11.47 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.146 -0.972 . . . . 0.77000000000000002 109.142 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 107' ' ' THR . 2.8 mp -116.12 116.84 53.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 119.256 -0.978 . . . . 0.51000000000000001 109.259 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -114.87 159.45 20.65 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.181 -0.95 . . . . 1.54 108.993 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.59 122.56 22.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.884 -1.135 . . . . 0.92000000000000004 110.482 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -93.21 150.85 20.2 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.777 -0.823 . . . . 3.3599999999999999 108.777 179.261 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.462 HD23 HD11 ' A' ' 63' ' ' ILE . 20.4 mt -103.29 38.78 1.7 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.193 -0.942 . . . . 1.3 109.491 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 4.3 t0 72.58 5.46 5.24 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.512 -0.743 . . . . 2.0600000000000001 109.324 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.06 -35.68 0.03 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.911 -1.275 . . . . 1.8600000000000001 109.911 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.05 113.41 24.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.988 -1.301 . . . . 6.2699999999999996 109.664 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 17.0 tt0 -77.78 137.05 38.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.967 -1.083 . . . . 1.71 109.936 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 64' ' ' ASP . 74.0 mt -123.01 169.54 14.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-O 121.687 0.756 . . . . 1.47 109.079 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.535 ' N ' HG22 ' A' ' 63' ' ' ILE . 3.6 m-20 -114.18 129.59 56.62 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.198 -1.408 . . . . 2.1800000000000002 107.198 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.648 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 2.7 t -103.26 112.67 65.86 Favored Pre-proline 0 C--N 1.303 -1.451 0 O-C-N 120.848 -1.157 . . . . 0.45000000000000001 111.418 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -82.71 -154.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.261 2.641 . . . . 0.45000000000000001 109.522 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.23 31.86 74.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.641 -1.384 . . . . 0.93000000000000005 109.641 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.561 HD11 ' CD1' ' A' ' 54' ' ' ILE . 17.8 pt -125.79 -165.33 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.315 -1.109 . . . . 0.5 108.968 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.609 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 38.7 t0 -103.05 112.32 25.1 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.221 -0.924 . . . . 1.47 109.495 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.505 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 10.3 p -87.11 45.46 1.27 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.492 -0.929 . . . . 0.56000000000000005 108.492 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 23.8 t30 -179.85 74.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.429 -1.322 . . . . 1.3999999999999999 107.429 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.44 ' HB1' ' CD1' ' A' ' 88' ' ' ILE . . . -59.5 -5.84 0.93 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.629 -0.669 . . . . 0.28999999999999998 112.1 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.525 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.3 t -62.71 -14.34 43.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.43 -1.419 . . . . 0.20000000000000001 108.621 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -25.81 63.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.964 . . . . 1.1899999999999999 109.858 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.464 ' HB2' HG13 ' A' ' 88' ' ' ILE . 68.2 m-85 -111.62 -23.8 10.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.838 . . . . 0.38 109.896 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.637 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 1.5 m -104.42 171.69 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.047 -1.094 . . . . 0.90000000000000002 108.047 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.589 ' HG3' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -94.27 92.43 7.21 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.156 -0.965 . . . . 2.5800000000000001 110.82 -178.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.484 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 15.3 p -90.12 149.62 41.82 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 107.579 -1.267 . . . . 0.20999999999999999 107.579 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.646 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.7 Cg_endo -70.17 133.86 27.98 Favored 'Cis proline' 0 C--N 1.312 -1.367 0 C-N-CA 124.171 -1.179 . . . . 0.20999999999999999 112.906 2.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.622 HD23 ' CD2' ' A' ' 86' ' ' TYR . 14.0 mt -75.54 112.89 12.34 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.832 -1.544 . . . . 1.9099999999999999 106.832 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.8 t -80.85 138.91 18.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 CA-C-O 121.668 0.746 . . . . 0.94999999999999996 110.679 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.537 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 34.9 tttt -64.24 112.43 3.04 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.666 0.746 . . . . 3.7599999999999998 109.326 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.87 -14.25 9.73 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 109.927 -1.269 . . . . 0.42999999999999999 109.927 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.598 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 2.9 tp-100 -101.17 153.12 19.87 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.83 -1.174 . . . . 3.9100000000000001 107.83 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -102.61 155.52 18.24 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.811 -1.181 . . . . 3.3300000000000001 107.811 178.644 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.622 ' CD2' HD23 ' A' ' 80' ' ' LEU . 63.3 m-85 -134.81 151.8 51.23 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.065 -1.022 . . . . 0.51000000000000001 109.981 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.475 ' HB3' HD21 ' A' ' 40' ' ' LEU . 4.5 p-10 -120.62 113.43 20.23 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.253 -0.905 . . . . 0.65000000000000002 109.624 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.637 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 5.4 tt -110.78 121.59 63.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.271 -0.893 . . . . 0.28000000000000003 111.705 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.401 ' HA ' ' CG ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -104.11 109.75 21.66 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 104.741 -2.318 . . . . 3.3300000000000001 104.741 175.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.632 ' CE2' ' O ' ' A' ' 91' ' ' THR . 39.7 t80 -125.42 142.33 51.56 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.83 -1.169 . . . . 0.57999999999999996 113.174 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.632 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.2 144.14 25.93 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.625 -1.62 . . . . 1.46 106.625 176.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.648 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 24.7 t90 -118.83 87.79 2.8 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.896 -1.128 . . . . 1.23 110.328 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -64.19 104.12 0.7 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.471 0.653 . . . . 2.1699999999999999 109.351 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.585 HG12 ' HD2' ' A' ' 95' ' ' PRO . 52.2 t -56.14 143.56 63.1 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.524 -0.735 . . . . 2.7000000000000002 109.312 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.585 ' HD2' HG12 ' A' ' 94' ' ' VAL . 25.0 Cg_endo -64.92 -3.35 6.86 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.835 2.356 . . . . 3.9300000000000002 111.992 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.477 ' HA ' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER 66.81 1.38 2.22 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.982 -1.074 . . . . 3.79 109.515 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.519 ' O ' ' C ' ' A' ' 98' ' ' ALA . 10.0 pt -100.45 -30.16 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 120.96 -1.087 . . . . 0.59999999999999998 108.399 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -33.15 117.93 0.44 Allowed Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.637 -0.875 . . . . 0.53000000000000003 108.637 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -79.18 174.5 11.97 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.541 2.161 . . . . 0.98999999999999999 110.19 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.491 ' HE3' ' HG2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -80.84 72.32 7.82 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.513 -0.921 . . . . 5.0499999999999998 108.513 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.477 ' OG ' HG22 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -81.84 103.85 11.8 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.595 -0.891 . . . . 2.4900000000000002 108.595 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.548 ' HG3' ' N ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -41.3 -30.17 0.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.34 -0.85 . . . . 5.0300000000000002 109.565 -179.161 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.548 ' N ' ' HG3' ' A' ' 102' ' ' GLU . 0.6 OUTLIER -132.96 132.01 41.46 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.152 -0.967 . . . . 4.0700000000000003 109.542 179.219 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.54 ' CG2' HD11 ' A' ' 127' ' ' ILE . 0.9 OUTLIER -132.05 144.59 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.342 -0.849 . . . . 1.1899999999999999 109.978 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 122' ' ' ALA . 31.8 t -119.79 113.83 42.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.468 -1.308 . . . . 1.1899999999999999 107.468 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.58 137.6 23.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 120.721 -1.237 . . . . 0.92000000000000004 110.361 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.604 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 81.5 m -118.59 125.27 49.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.811 -0.556 . . . . 1.49 109.76 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -102.42 129.9 53.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.322 -1.362 . . . . 0.40999999999999998 107.322 178.2 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.548 ' HG2' ' CG1' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -141.04 131.15 24.74 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.078 -1.639 . . . . 2.8999999999999999 112.296 -178.082 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.659 ' CD1' ' CE2' ' A' ' 41' ' ' PHE . 16.2 mt -104.36 139.62 39.06 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.671 -1.603 . . . . 0.47999999999999998 106.671 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 116' ' ' VAL . 5.1 mp -138.66 112.06 7.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 120.66 -1.275 . . . . 0.60999999999999999 110.289 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.75 -150.19 7.81 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.481 -1.847 . . . . 0.56000000000000005 108.481 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.28 -1.74 50.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.219 -1.165 . . . . 1.6799999999999999 109.759 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -115.04 -0.36 13.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -0.956 . . . . 3.0800000000000001 110.714 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.62 -169.61 27.78 Favored Glycine 0 N--CA 1.496 2.662 0 C-N-CA 119.525 -1.322 . . . . 0.58999999999999997 110.305 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.548 ' CG1' ' HG2' ' A' ' 109' ' ' LYS . 44.4 t -77.5 111.2 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.296 -1.12 . . . . 1.7 109.867 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.473 HD23 ' HG2' ' A' ' 45' ' ' GLN . 28.3 mt -60.35 -41.37 93.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.47999999999999998 109.874 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.506 ' O ' HG11 ' A' ' 116' ' ' VAL . . . -151.75 176.15 11.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.967 -1.083 . . . . 0.68999999999999995 109.526 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.528 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 42.8 t -164.13 154.05 14.53 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.042 -1.036 . . . . 0.56999999999999995 109.007 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -150.44 154.95 38.62 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.837 -1.164 . . . . 0.64000000000000001 110.353 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.497 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 72.4 mt -130.87 140.37 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.318 -0.864 . . . . 1.46 109.003 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.429 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -120.1 145.79 46.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.45 -1.406 . . . . 0.93999999999999995 109.033 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.92 170.45 15.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.084 -1.01 . . . . 2.7000000000000002 109.731 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 9.0 m80 64.34 40.52 6.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -0.848 . . . . 5.2199999999999998 109.801 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -111.13 162.78 12.37 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.273 -1.531 . . . . 0.81999999999999995 109.273 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -149.56 137.34 20.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -1.179 . . . . 5.5999999999999996 108.615 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.54 HD11 ' CG2' ' A' ' 104' ' ' VAL . 61.2 mt -105.53 139.74 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.604 -1.31 . . . . 0.90000000000000002 110.255 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.509 ' HB2' ' CG2' ' A' ' 28' ' ' ILE . 1.4 mtm180 -133.76 162.87 30.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.467 -0.77 . . . . 5.5800000000000001 109.216 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.061 -0.971 . . . . 4.9299999999999997 109.201 179.559 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.407 -0.59 . . . . 4.1799999999999997 109.407 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 3.0 m -105.49 169.03 2.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.226 -0.922 . . . . 2.0099999999999998 109.337 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -75.77 122.67 24.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 1.77 110.851 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.465 HG11 ' CA ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -150.41 157.42 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.987 -1.116 . . . . 2.9500000000000002 107.987 178.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -117.42 110.26 17.79 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.083 -1.011 . . . . 4.3600000000000003 109.715 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.473 ' OD2' ' HB ' ' A' ' 13' ' ' ILE . 0.8 OUTLIER -49.65 152.49 1.42 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.482 -0.761 . . . . 1.6200000000000001 109.909 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.469 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.1 OUTLIER -128.47 27.24 5.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.264 -0.898 . . . . 2.6699999999999999 108.791 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.43 ' O ' ' OD1' ' A' ' 10' ' ' ASN . . . -116.25 -76.56 0.57 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.394 -0.816 . . . . 0.87 109.773 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER 174.21 68.6 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.069 -0.715 . . . . 1.4399999999999999 109.069 -178.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 55.08 35.59 25.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.194 -0.941 . . . . 3.3700000000000001 108.874 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.505 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -87.3 -79.2 0.28 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.456 -0.777 . . . . 1.1799999999999999 109.805 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -46.36 127.64 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.85999999999999999 109.682 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.562 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -77.65 -24.99 49.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.477 -0.935 . . . . 1.9399999999999999 108.477 179.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 167.61 129.56 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.781 -0.822 . . . . 3.0600000000000001 108.781 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.585 ' CG2' ' CB ' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -111.87 121.51 64.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.176 -1.046 . . . . 0.47999999999999998 108.176 179.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 3.4 mtm -110.48 150.78 28.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.924 -1.11 . . . . 1.54 110.895 -178.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.586 HG12 ' CE2' ' A' ' 35' ' ' PHE . 51.5 t -119.0 159.42 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.411 -0.959 . . . . 1.29 108.411 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.54 ' N ' HG13 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -105.12 69.19 0.84 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.017 -1.052 . . . . 1.3400000000000001 109.57 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.89 -50.41 0.27 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.648 -1.263 . . . . 0.96999999999999997 110.231 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 39.7 t -80.71 150.89 29.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.988 -1.301 . . . . 1.25 110.011 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.47 -177.08 3.97 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.415 -0.803 . . . . 4.7199999999999998 109.262 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 3' ' ' VAL . . . -65.0 -120.55 0.01 OUTLIER Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.069 -1.212 . . . . 3.4399999999999999 110.069 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLY . 14.1 p -38.55 -44.73 0.99 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.653 -0.91 . . . . 2.6099999999999999 110.234 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -44.53 156.91 0.32 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.106 -0.996 . . . . 1.51 109.221 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 124' ' ' HIS . 35.9 Cg_endo -77.82 173.28 14.31 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.645 2.23 . . . . 1.52 110.183 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 5.4 m -122.11 135.91 54.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.068 -1.02 . . . . 0.79000000000000004 110.037 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.7 mm -110.35 107.96 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.276 -0.89 . . . . 1.3100000000000001 108.664 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 mp -87.76 122.74 39.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.184 -0.948 . . . . 1.01 109.632 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 12.7 m-70 -90.22 101.6 14.32 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.673 0.749 . . . . 1.4299999999999999 109.215 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.547 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -37.74 146.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.61 0.719 . . . . 3.2200000000000002 111.114 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.67 -5.63 56.49 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.678 -0.969 . . . . 0.94999999999999996 110.678 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -104.85 152.24 39.52 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.758 -1.436 . . . . 2.5899999999999999 110.214 -179.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.81 118.41 3.1 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.101 2.534 . . . . 0.54000000000000004 111.291 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.586 ' CE2' HG12 ' A' ' 18' ' ' VAL . 2.6 t80 -97.75 123.69 41.79 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.135 -1.431 . . . . 0.76000000000000001 107.135 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.8 m -107.37 136.16 47.63 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.515 -1.365 . . . . 1.23 110.813 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.664 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -141.21 123.59 15.79 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.938 -0.764 . . . . 2.4199999999999999 108.938 179.224 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 16' ' ' VAL . 25.2 tt0 -102.43 134.02 46.42 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.899 -1.148 . . . . 1.24 107.899 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.585 ' CB ' ' CG2' ' A' ' 16' ' ' VAL . . . -129.62 120.14 24.76 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 118.767 -1.173 . . . . 0.42999999999999999 110.683 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.558 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 15.8 mt -89.56 140.63 29.35 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 105.378 -2.082 . . . . 1.1299999999999999 105.378 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 27.3 p90 -155.2 139.2 16.38 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.046 -1.462 . . . . 0.42999999999999999 110.528 -178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.3 m-20 -84.54 108.96 17.58 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.987 -1.116 . . . . 1.1399999999999999 107.987 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -44.3 113.77 0.58 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.801 -0.814 . . . . 0.28000000000000003 108.801 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.459 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 7.2 p30 -83.5 10.3 9.25 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.073 -1.017 . . . . 0.57999999999999996 109.595 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.551 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 0.9 OUTLIER -168.28 158.11 9.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.382 -0.824 . . . . 0.73999999999999999 109.312 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -88.35 120.36 29.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.177 -0.952 . . . . 1.8899999999999999 109.537 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.513 ' O ' ' CA ' ' A' ' 79' ' ' PRO . 3.3 t -143.74 153.09 42.07 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.244 -0.91 . . . . 0.45000000000000001 109.313 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.639 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -98.61 -25.84 14.59 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.663 -1.236 . . . . 7.0099999999999998 107.663 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.6 p -111.3 138.33 47.91 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 122.134 0.968 . . . . 2.5299999999999998 109.766 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -142.21 154.23 44.64 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.837 -0.801 . . . . 0.71999999999999997 108.837 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.498 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 1.6 mtmt -145.29 141.06 28.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.009 -1.057 . . . . 1.27 111.038 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.552 ' CG2' ' O ' ' A' ' 69' ' ' ASP . 9.7 tt -94.69 152.05 3.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.227 -1.397 . . . . 0.95999999999999996 107.227 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -140.45 118.1 11.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.93 -1.106 . . . . 0.39000000000000001 110.15 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 107' ' ' THR . 2.2 mp -117.78 115.56 48.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.017 -1.052 . . . . 0.37 109.267 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 13.6 mttm -115.6 157.4 24.21 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.466 -0.938 . . . . 2.7200000000000002 108.466 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.52 123.95 26.09 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.692 -1.255 . . . . 0.66000000000000003 110.576 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -90.37 146.3 24.28 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.451 -0.944 . . . . 3.2599999999999998 108.451 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 61' ' ' LEU . 15.9 mt -113.18 48.27 1.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.027 -1.045 . . . . 1.8899999999999999 109.989 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.401 ' OD2' ' CG ' ' A' ' 102' ' ' GLU . 0.4 OUTLIER 58.0 14.99 2.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.482 -0.761 . . . . 1.45 109.866 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.75 -41.61 0.16 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.964 -1.254 . . . . 1.04 109.964 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 9.7 tp -106.53 111.32 23.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.204 -1.174 . . . . 1.0900000000000001 109.304 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.96 134.51 34.65 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.289 -0.882 . . . . 1.02 108.751 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 79.8 mt -124.89 166.46 20.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 122.011 0.91 . . . . 0.85999999999999999 109.596 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.568 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -115.23 108.83 17.1 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 106.426 -1.694 . . . . 1.21 106.426 177.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.641 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 2.5 t -73.61 113.72 25.31 Favored Pre-proline 0 C--N 1.297 -1.688 0 O-C-N 121.267 -0.895 . . . . 0.59999999999999998 111.027 -177.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.7 Cg_endo -83.41 -159.4 0.1 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.956 2.437 . . . . 0.81999999999999995 109.806 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.43 20.67 38.36 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.031 -1.228 . . . . 0.47999999999999998 110.031 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.587 HG22 ' CD1' ' A' ' 92' ' ' TRP . 34.0 pt -105.93 -165.93 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -1.177 . . . . 0.45000000000000001 109.09 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.6 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 3.1 t70 -105.41 106.44 16.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 1.24 110.083 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.498 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -86.74 47.56 1.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.361 -0.977 . . . . 1.45 108.361 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.474 ' OD1' ' HB2' ' A' ' 73' ' ' CYS . 17.9 t-20 176.72 85.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.609 -1.256 . . . . 2.6699999999999999 107.609 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.02 8.07 1.76 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.333 -0.854 . . . . 0.40999999999999998 112.057 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.474 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 2.1 m -65.13 -13.27 57.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.698 -1.251 . . . . 2.6400000000000001 109.485 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -82.27 -14.78 54.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.23 -0.919 . . . . 1.0600000000000001 109.864 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.54 ' CB ' HG13 ' A' ' 88' ' ' ILE . 35.0 m-85 -121.64 -14.15 8.22 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.205 -0.935 . . . . 0.65000000000000002 109.42 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.627 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 1.4 m -119.51 162.64 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.208 -0.932 . . . . 0.59999999999999998 108.602 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.598 ' HG3' ' CE2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -96.65 84.2 3.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.221 -0.924 . . . . 6.9199999999999999 111.136 -178.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.513 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 5.0 p -83.09 159.51 62.4 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.694 -1.254 . . . . 1.1399999999999999 107.944 178.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.639 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 23.7 Cg_endo -67.14 130.52 13.6 Favored 'Cis proline' 0 C--N 1.311 -1.422 0 C-N-CA 124.25 -1.146 . . . . 0.54000000000000004 112.281 2.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.595 HD23 ' CD2' ' A' ' 86' ' ' TYR . 14.7 mt -71.67 107.84 4.71 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.75 -1.204 . . . . 0.66000000000000003 107.75 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.69 136.11 24.54 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 CA-C-O 121.742 0.782 . . . . 0.52000000000000002 110.211 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.551 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 23.3 tttt -62.51 110.09 1.58 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.708 0.766 . . . . 4.0499999999999998 110.12 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 126.28 -16.76 6.69 Favored Glycine 0 N--CA 1.48 1.63 0 N-CA-C 110.185 -1.166 . . . . 0.16 110.185 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.558 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 3.3 tp-100 -101.95 156.48 17.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.066 -1.255 . . . . 3.4900000000000002 108.141 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.555 ' C ' ' CD1' ' A' ' 86' ' ' TYR . 1.2 tt0 -106.02 153.69 21.68 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.096 -1.076 . . . . 3.1600000000000001 108.096 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.598 ' CE2' ' HG3' ' A' ' 77' ' ' LYS . 23.4 m-85 -131.5 151.45 51.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.055 -1.028 . . . . 0.60999999999999999 110.218 -178.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.558 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -118.27 113.86 22.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.527 -0.733 . . . . 2.1899999999999999 110.063 -178.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.627 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 1.8 tt -115.59 119.41 61.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.181 -0.949 . . . . 0.58999999999999997 111.353 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -101.39 106.88 18.08 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 104.87 -2.27 . . . . 3.1299999999999999 104.87 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.6 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 32.2 t80 -119.97 141.23 49.87 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.869 -1.133 . . . . 0.75 112.544 -176.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.541 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -91.67 145.34 24.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.55 -1.648 . . . . 1.25 106.55 177.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.641 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 51.3 t90 -127.03 94.26 3.98 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.243 -0.911 . . . . 1.26 109.495 -177.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -57.42 104.88 0.19 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.66 -0.816 . . . . 2.8999999999999999 108.8 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.519 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 71.4 t -58.85 141.56 85.38 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 107.879 -1.156 . . . . 0.88 107.879 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.553 ' HD3' ' CG1' ' A' ' 65' ' ' VAL . 29.8 Cg_endo -71.58 124.66 10.48 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 C-N-CA 121.781 1.654 . . . . 0.55000000000000004 109.992 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.515 ' HA ' ' HG2' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -67.87 -2.75 7.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.534 -0.729 . . . . 4.6900000000000004 109.681 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.503 ' O ' ' C ' ' A' ' 98' ' ' ALA . 3.8 pt -88.23 -24.59 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 1.1299999999999999 109.318 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.547 ' O ' ' CD ' ' A' ' 31' ' ' ARG . . . -29.07 120.04 0.28 Allowed Pre-proline 0 N--CA 1.492 1.635 0 CA-C-N 116.054 -0.521 . . . . 1.04 110.76 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.59 ' O ' ' N ' ' A' ' 101' ' ' SER . 37.3 Cg_endo -86.09 133.29 4.07 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.565 2.176 . . . . 0.69999999999999996 108.688 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.556 ' N ' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -50.98 91.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.851 -1.156 . . . . 5.9100000000000001 107.913 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 99' ' ' PRO . 3.6 t -94.51 114.45 26.45 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.576 -0.702 . . . . 0.54000000000000004 109.465 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 11.4 pt-20 -38.85 -41.43 0.74 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.218 -0.66 . . . . 1.6000000000000001 109.218 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.429 ' N ' ' CG ' ' A' ' 102' ' ' GLU . 1.7 t-20 -134.67 140.73 46.23 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.497 -0.752 . . . . 3.0800000000000001 109.016 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.53 ' CG2' HD11 ' A' ' 127' ' ' ILE . 0.9 OUTLIER -133.47 146.74 31.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 121.344 -0.848 . . . . 1.0 108.99 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 t -126.53 114.81 39.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.815 -1.18 . . . . 1.24 107.815 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 38.9 t -97.5 137.94 23.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.293 -0.963 . . . . 0.94999999999999996 109.897 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 81.1 m -117.52 115.74 25.75 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.605 -0.684 . . . . 0.66000000000000003 109.617 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -94.79 128.57 45.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.466 -1.679 . . . . 0.48999999999999999 106.466 177.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.55 ' HG2' ' CG1' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -141.24 130.45 23.5 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.281 -1.512 . . . . 1.6799999999999999 112.378 -177.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.643 ' CD1' ' CE2' ' A' ' 41' ' ' PHE . 2.4 mt -102.53 139.49 38.06 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.165 -1.791 . . . . 1.22 106.165 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 116' ' ' VAL . 4.5 mp -137.07 114.73 13.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.746 -1.221 . . . . 0.58999999999999997 110.25 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.97 -139.66 6.52 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.358 -1.897 . . . . 0.73999999999999999 108.358 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.99 -0.0 27.29 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.192 -1.181 . . . . 2.0499999999999998 109.592 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -116.41 4.53 13.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 2.6499999999999999 110.479 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 142.42 -160.23 27.26 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.709 -1.357 . . . . 0.65000000000000002 109.709 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.55 ' CG1' ' HG2' ' A' ' 109' ' ' LYS . 72.1 t -85.12 110.48 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -1.156 . . . . 1.74 109.589 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 110' ' ' LEU . 77.6 mt -57.87 -39.16 77.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.5 110.56 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.516 ' O ' HG11 ' A' ' 116' ' ' VAL . . . -152.08 175.11 12.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.933 -1.104 . . . . 1.3 109.227 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 42.4 t -168.11 153.76 7.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.571 -1.33 . . . . 0.56999999999999995 110.018 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.13 149.79 29.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.05 -1.031 . . . . 0.54000000000000004 110.102 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 8' ' ' CYS . 4.3 mt -134.58 116.66 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.941 -1.133 . . . . 1.3200000000000001 107.941 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.465 ' CA ' HG11 ' A' ' 5' ' ' VAL . . . -105.71 121.1 43.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.908 -1.12 . . . . 1.48 110.264 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.28 -156.79 0.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.438 -0.789 . . . . 3.02 108.885 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 0.2 OUTLIER 46.54 30.41 1.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.003 -1.061 . . . . 2.9399999999999999 108.997 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -100.09 155.91 19.59 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.889 -1.148 . . . . 1.2 110.535 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 39.7 mttm -154.0 136.33 14.92 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.435 -1.32 . . . . 3.77 107.435 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.53 HD11 ' CG2' ' A' ' 104' ' ' VAL . 60.3 mt -107.68 134.71 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.327 -1.483 . . . . 0.70999999999999996 111.52 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.55 ' HA ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -116.15 177.02 4.84 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.797 -0.816 . . . . 4.2000000000000002 108.797 178.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.551 ' N ' ' HD2' ' A' ' 100' ' ' LYS . 24.6 t0 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.073 -0.965 . . . . 1.2 109.61 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.474 ' HB2' ' HG2' ' A' ' 17' ' ' MET . 9.3 tt0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.18 0.515 . . . . 2.3700000000000001 109.746 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.5 ' HA ' ' CA ' ' A' ' 23' ' ' GLY . 3.7 m -101.85 169.36 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.295 -0.878 . . . . 2.0 109.155 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.424 ' O ' HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -90.59 122.91 33.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 3.1099999999999999 110.806 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.454 HG12 HG23 ' A' ' 3' ' ' VAL . 29.6 m -153.47 149.56 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.015 -1.106 . . . . 0.95999999999999996 108.015 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.27 110.31 20.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.781 -1.199 . . . . 6.3399999999999999 110.569 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.32 134.49 39.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 2.8399999999999999 108.916 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.3 p -106.61 -2.87 21.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.131 -0.98 . . . . 1.3700000000000001 110.017 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 10' ' ' ASN . . . -73.81 -58.29 3.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.13 -0.981 . . . . 1.02 109.435 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER 167.2 50.86 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.85 -1.167 . . . . 3.4399999999999999 107.85 -178.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' A' ' 10' ' ' ASN . 3.9 t-20 63.8 15.83 9.34 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.017 -1.105 . . . . 2.7400000000000002 108.017 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.498 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -58.74 -62.1 2.12 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.501 -0.749 . . . . 1.28 109.266 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -59.19 128.27 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.39000000000000001 109.583 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.567 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 9.9 mmpt? -85.35 -13.98 47.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.461 -0.775 . . . . 1.3600000000000001 109.856 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.567 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.9 ttpt 156.96 127.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.06 -0.718 . . . . 2.21 109.06 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.617 ' CG2' ' CB ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -114.3 123.92 70.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.367 -0.833 . . . . 0.65000000000000002 108.949 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.474 ' HG2' ' HB2' ' A' ' 2' ' ' GLN . 2.8 mtm -115.76 147.84 40.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.13 -0.981 . . . . 1.1899999999999999 110.268 -179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.568 HG12 ' CE2' ' A' ' 35' ' ' PHE . 44.3 t -127.07 129.21 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.936 -0.764 . . . . 1.29 108.936 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -83.27 87.26 6.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 1.47 109.783 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.44 -68.07 0.22 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.531 -1.428 . . . . 0.95999999999999996 109.531 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . 6.5 m -76.95 -167.6 0.89 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.354 -1.086 . . . . 3.25 109.418 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -141.57 175.83 9.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.041 -1.037 . . . . 5.1900000000000004 109.813 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.5 ' CA ' ' HA ' ' A' ' 3' ' ' VAL . . . -114.09 150.44 18.6 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.364 -1.494 . . . . 3.3100000000000001 109.364 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER 72.71 1.5 4.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.042 -1.269 . . . . 2.3199999999999998 109.116 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.481 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 1.1 m-20 -135.43 176.01 3.18 Favored Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 108.267 -1.012 . . . . 1.6399999999999999 108.267 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 25' ' ' ASP . 34.4 Cg_endo -76.33 135.97 17.29 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.933 1.755 . . . . 0.80000000000000004 109.66 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -111.66 139.34 47.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.369 -0.832 . . . . 2.5 108.819 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.554 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 46.6 mm -112.11 115.78 50.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.167 -0.958 . . . . 0.91000000000000003 109.841 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.3 mt -103.93 118.13 50.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.505 -0.924 . . . . 1.2 108.505 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.528 ' HB2' ' CE ' ' A' ' 33' ' ' LYS . 17.4 m-70 -84.87 125.02 32.28 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.156 -0.965 . . . . 1.04 109.241 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.518 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 3.2 ptt180 -70.78 125.47 26.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.124 -0.985 . . . . 1.5700000000000001 109.84 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.56 -9.17 26.15 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.745 -1.342 . . . . 0.53000000000000003 109.745 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.528 ' CE ' ' HB2' ' A' ' 30' ' ' HIS . 1.6 ptpt -112.38 158.51 37.01 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.174 -1.192 . . . . 2.2400000000000002 109.647 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 33' ' ' LYS . 36.2 Cg_endo -78.01 136.38 14.7 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 C-N-CA 122.981 2.454 . . . . 0.42999999999999999 111.484 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CE2' HG12 ' A' ' 18' ' ' VAL . 2.5 t80 -117.67 116.88 27.94 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.673 -1.232 . . . . 1.0 107.673 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.1 m -96.93 137.16 36.45 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.95 -1.094 . . . . 1.5800000000000001 110.76 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.82 125.84 12.08 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.843 -0.799 . . . . 4.9800000000000004 108.843 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -100.23 125.32 46.38 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.723 -1.214 . . . . 1.4099999999999999 107.723 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.617 ' CB ' ' CG2' ' A' ' 16' ' ' VAL . . . -124.43 118.39 26.56 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.986 -1.086 . . . . 0.46999999999999997 110.809 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 12.3 mt -91.04 140.82 29.48 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.487 -1.671 . . . . 1.1299999999999999 106.487 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.621 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 25.1 p90 -156.68 141.24 16.8 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 120.898 -1.126 . . . . 0.34000000000000002 109.193 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 7.7 m-20 -84.81 111.48 19.66 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 118.938 -1.105 . . . . 1.3600000000000001 109.057 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.33 113.46 0.58 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.958 -0.756 . . . . 0.20999999999999999 108.958 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.409 ' C ' ' OD1' ' A' ' 44' ' ' ASN . 36.0 p30 -88.35 10.08 21.11 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.291 -0.88 . . . . 1.6399999999999999 109.382 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.588 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 1.5 pt20 -165.95 144.09 5.74 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.285 -0.884 . . . . 2.46 110.005 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -80.57 119.1 22.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -0.856 . . . . 1.76 108.998 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.478 HG22 ' HA3' ' A' ' 112' ' ' GLY . 0.1 OUTLIER -138.98 144.59 39.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.924 -1.11 . . . . 1.0900000000000001 109.849 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.659 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 20.0 mmmt -85.14 -9.37 57.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -0.888 . . . . 1.2 109.676 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 48' ' ' LYS . 9.7 p -151.01 139.75 20.76 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.762 0.791 . . . . 0.68000000000000005 109.42 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.534 ' HB3' ' CD1' ' A' ' 117' ' ' LEU . . . -129.9 156.1 44.95 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 121.72 -0.613 . . . . 1.05 109.384 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.537 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 0.1 OUTLIER -128.98 127.61 42.02 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.327 -0.858 . . . . 1.3300000000000001 111.174 -178.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.494 HG23 ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -101.57 127.58 54.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.834 -1.543 . . . . 1.8300000000000001 106.834 176.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.589 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -140.71 116.68 10.44 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.1 -1.0 . . . . 4.6600000000000001 108.43 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 107' ' ' THR . 4.2 mp -94.2 129.94 43.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 109.335 -0.617 . . . . 1.1399999999999999 109.335 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -115.0 138.17 51.16 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.327 -0.858 . . . . 1.3999999999999999 109.64 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.43 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . . . -119.63 128.17 53.61 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.492 -0.883 . . . . 1.3200000000000001 110.399 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.52 108.92 16.08 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.343 -0.984 . . . . 4.3899999999999997 108.343 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -77.87 -173.44 3.09 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.474 -0.766 . . . . 2.8399999999999999 110.141 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -52.57 -34.24 49.62 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.518 -0.739 . . . . 5.4199999999999999 110.371 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.67 1.06 0.8 Allowed Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.882 -1.628 . . . . 2.71 111.571 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.5 HD13 HG12 ' A' ' 63' ' ' ILE . 12.9 tp -113.39 107.69 16.2 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.528 -1.572 . . . . 3.96 109.353 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -96.07 127.5 42.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.915 -1.116 . . . . 6.0999999999999996 108.501 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.65 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -149.13 171.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 122.302 1.048 . . . . 5.7400000000000002 109.438 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.65 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -110.89 116.32 31.04 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 106.789 -1.559 . . . . 4.6500000000000004 106.789 177.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.635 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 15.6 t -66.94 110.31 4.83 Favored Pre-proline 0 C--N 1.295 -1.766 0 O-C-N 121.667 -0.645 . . . . 0.70999999999999996 110.594 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 42.2 Cg_endo -89.17 -157.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.719 2.946 . . . . 0.65000000000000002 109.99 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.433 ' C ' HG23 ' A' ' 68' ' ' ILE . . . 50.85 45.86 49.29 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.26 -1.136 . . . . 0.91000000000000003 110.26 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.573 ' CA ' ' OH ' ' A' ' 90' ' ' TYR . 2.5 pt -140.43 -138.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.07 -1.253 . . . . 1.6000000000000001 109.59 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.502 ' N ' ' OH ' ' A' ' 90' ' ' TYR . 1.1 t70 -117.21 105.34 12.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.923 -1.111 . . . . 1.6000000000000001 111.178 -178.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.537 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 11.0 p -92.44 49.92 1.55 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.366 -1.346 . . . . 1.1299999999999999 107.366 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 38.4 t30 177.55 81.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.231 -1.396 . . . . 0.73999999999999999 107.231 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.444 ' O ' HG23 ' A' ' 76' ' ' VAL . . . -65.58 -3.97 5.38 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.327 0.862 . . . . 1.28 113.327 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.485 ' HA ' HG23 ' A' ' 76' ' ' VAL . 9.7 t -65.9 -9.19 27.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 119.928 -1.732 . . . . 0.45000000000000001 109.352 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.489 ' O ' ' CD2' ' A' ' 74' ' ' HIS . 3.3 t60 -76.26 -30.88 58.01 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.037 -1.04 . . . . 5.4299999999999997 108.34 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CD1' ' O ' ' A' ' 89' ' ' LYS . 88.3 m-85 -105.4 -17.88 14.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.1 -1.0 . . . . 0.72999999999999998 110.321 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.626 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 2.5 m -115.0 169.71 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.406 -0.961 . . . . 0.58999999999999997 108.406 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.609 ' HG3' ' CE2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -95.61 91.32 6.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.16 -0.963 . . . . 5.1500000000000004 111.723 -177.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.48 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 20.1 p -84.16 151.89 60.76 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 107.636 -1.246 . . . . 0.48999999999999999 107.636 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.659 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.0 Cg_endo -69.84 132.68 23.1 Favored 'Cis proline' 0 C--N 1.314 -1.259 0 C-N-CA 124.281 -1.133 . . . . 0.26000000000000001 112.226 2.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.63 HD23 ' CD2' ' A' ' 86' ' ' TYR . 16.1 mt -74.91 104.24 5.44 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.514 -1.291 . . . . 0.88 107.514 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.2 t -71.66 139.03 20.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-O 121.559 0.695 . . . . 0.83999999999999997 109.919 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.588 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 14.5 ttpp -69.27 107.22 3.17 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.539 0.685 . . . . 3.54 109.688 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 131.8 -18.08 4.87 Favored Glycine 0 N--CA 1.481 1.641 0 C-N-CA 119.584 -1.294 . . . . 0.56000000000000005 110.249 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.59 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 5.3 tp60 -98.86 151.42 20.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.102 -1.234 . . . . 0.56000000000000005 108.306 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 1.9 tt0 -99.26 142.63 30.49 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.292 -1.373 . . . . 1.3400000000000001 107.292 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.63 ' CD2' HD23 ' A' ' 80' ' ' LEU . 32.9 m-85 -120.7 150.44 40.95 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.24 -0.913 . . . . 0.47999999999999998 110.295 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.536 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -115.63 115.06 25.77 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.415 -0.957 . . . . 2.1400000000000001 108.415 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.626 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 1.8 tt -108.2 116.54 51.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.031 -1.043 . . . . 0.29999999999999999 111.427 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.566 ' O ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -97.08 113.08 24.61 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 104.457 -2.423 . . . . 5.21 104.457 176.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.585 ' CZ ' ' O ' ' A' ' 91' ' ' THR . 12.8 t80 -130.84 138.91 50.08 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.365 -1.334 . . . . 1.0800000000000001 113.082 -175.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.585 ' O ' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -89.56 142.25 27.85 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 105.583 -2.006 . . . . 1.6100000000000001 105.583 176.582 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.635 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 21.1 t90 -123.75 89.01 3.01 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 120.571 -1.331 . . . . 1.3200000000000001 110.731 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -60.58 103.55 0.26 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.468 -0.938 . . . . 3.5600000000000001 108.468 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.57 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 40.5 t -62.88 142.34 97.4 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.812 -0.81 . . . . 0.59999999999999998 108.812 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.57 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 29.2 Cg_endo -71.17 127.55 13.63 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.764 1.642 . . . . 0.55000000000000004 109.389 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -69.19 3.25 2.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.506 -0.746 . . . . 4.8799999999999999 111.021 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 98' ' ' ALA . 12.5 pt -89.38 -26.29 5.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 O-C-N 120.708 -1.245 . . . . 0.97999999999999998 108.85 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.518 ' O ' ' CD ' ' A' ' 31' ' ' ARG . . . -39.38 116.62 1.09 Allowed Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 109.414 -0.587 . . . . 0.16 109.414 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.546 ' HD2' ' CD1' ' A' ' 58' ' ' LEU . 36.6 Cg_endo -85.4 137.88 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 123.244 2.63 . . . . 0.20000000000000001 109.139 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.51 ' HG2' ' HA ' ' A' ' 128' ' ' ARG . 5.8 mtmt -54.59 90.88 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.015 -1.053 . . . . 3.4399999999999999 108.732 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.579 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -98.84 129.27 45.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.585 -0.697 . . . . 2.4100000000000001 109.587 -179.031 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.5 ' HG3' ' N ' ' A' ' 103' ' ' ASN . 17.7 pt-20 -39.11 -48.19 1.66 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.47 -0.769 . . . . 1.1799999999999999 110.595 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.5 ' N ' ' HG3' ' A' ' 102' ' ' GLU . 4.2 m120 -132.89 145.8 51.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.989 -1.069 . . . . 2.3599999999999999 110.478 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.513 HG22 HG13 ' A' ' 127' ' ' ILE . 82.9 t -135.87 149.17 27.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.777 -0.823 . . . . 1.1599999999999999 108.777 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 98.2 t -121.31 117.8 53.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.045 -1.094 . . . . 1.1599999999999999 108.045 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.1 t -98.78 140.23 18.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 120.76 -1.212 . . . . 0.93999999999999995 109.965 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 27.0 m -126.7 118.79 25.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.68 -0.638 . . . . 2.0299999999999998 109.714 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.498 ' O ' ' CG1' ' A' ' 108' ' ' VAL . 0.4 OUTLIER -96.75 125.88 49.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.216 -1.402 . . . . 0.59999999999999998 107.216 177.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.565 ' HD2' ' CD1' ' A' ' 111' ' ' ILE . 0.4 OUTLIER -133.99 150.85 51.27 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 120.647 -1.283 . . . . 1.4199999999999999 111.435 -177.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.621 ' CD1' ' CZ ' ' A' ' 41' ' ' PHE . 13.4 mt -129.79 137.11 50.33 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.142 -1.429 . . . . 0.45000000000000001 107.142 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.565 ' CD1' ' HD2' ' A' ' 109' ' ' LYS . 4.5 mp -134.78 117.64 23.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.857 -1.152 . . . . 0.81999999999999995 110.205 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.478 ' HA3' HG22 ' A' ' 47' ' ' THR . . . -86.94 -120.02 1.27 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.003 -1.639 . . . . 0.16 109.003 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -123.49 -4.98 8.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -1.089 . . . . 2.6400000000000001 109.403 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.453 ' HB3' ' OE1' ' A' ' 45' ' ' GLN . 4.1 t30 -114.5 -5.91 12.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 5.5999999999999996 110.116 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.506 ' N ' ' OE1' ' A' ' 45' ' ' GLN . . . 156.98 -162.53 31.78 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.714 -1.354 . . . . 0.52000000000000002 109.714 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.557 ' CG1' ' HG2' ' A' ' 109' ' ' LYS . 3.8 t -82.88 109.36 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -1.133 . . . . 0.79000000000000004 109.719 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.534 ' CD1' ' HB3' ' A' ' 50' ' ' ALA . 6.4 mt -51.19 -38.62 53.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 1.8400000000000001 110.749 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.468 ' O ' HG11 ' A' ' 116' ' ' VAL . . . -155.32 -166.0 2.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.759 -1.213 . . . . 0.93000000000000005 109.401 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER 175.53 147.95 0.09 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.162 -0.962 . . . . 0.95999999999999996 109.529 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -147.05 146.35 29.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.958 -1.088 . . . . 0.58999999999999997 109.254 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.4 HD12 ' SG ' ' A' ' 119' ' ' CYS . 3.4 mp -133.75 136.11 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.128 -0.982 . . . . 2.75 109.418 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -112.76 132.75 55.09 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.185 -0.947 . . . . 0.88 109.109 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.4 p -116.37 57.22 0.77 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.128 -0.983 . . . . 3.29 109.383 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.85 60.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.628 -0.878 . . . . 2.3599999999999999 108.628 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.47 ' C ' ' HG3' ' A' ' 126' ' ' LYS . . . -130.57 164.06 23.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.804 -1.318 . . . . 1.1899999999999999 109.804 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 15.3 mtpt -152.07 145.11 24.52 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.964 -1.124 . . . . 2.8799999999999999 107.964 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.513 HG13 HG22 ' A' ' 104' ' ' VAL . 52.3 mt -106.39 140.89 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.407 -1.433 . . . . 0.80000000000000004 110.319 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.554 ' HB2' ' CG2' ' A' ' 28' ' ' ILE . 11.1 mtt180 -128.95 179.69 5.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.444 -0.785 . . . . 2.0699999999999998 109.275 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.5 t0 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.111 -0.947 . . . . 1.6399999999999999 109.649 -179.814 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.526 ' CB ' ' HG2' ' A' ' 17' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.324 0.583 . . . . 2.3799999999999999 109.889 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.515 ' CG1' HG21 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -103.55 159.48 4.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.29 -0.881 . . . . 3.04 109.13 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -70.12 119.23 14.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.086 -1.009 . . . . 1.4099999999999999 109.837 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.6 140.16 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.383 -0.823 . . . . 2.3300000000000001 109.324 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.49 109.32 19.2 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.206 -0.934 . . . . 4.3099999999999996 109.385 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.426 ' CG ' ' HB ' ' A' ' 13' ' ' ILE . 1.4 m-20 -60.37 120.4 9.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 2.2400000000000002 108.943 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 p -95.59 23.12 6.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.03 -1.044 . . . . 0.34000000000000002 109.635 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 10' ' ' ASN . . . -96.52 -82.29 0.4 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.279 -0.888 . . . . 0.46999999999999997 109.829 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 0.8 OUTLIER 178.24 56.39 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.025 -0.67 . . . . 2.6600000000000001 109.396 -178.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 10' ' ' ASN . 3.3 m120 67.26 51.61 0.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 4.7599999999999998 109.137 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.484 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -113.33 -61.72 1.7 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 1.0800000000000001 109.897 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 1.1 mm -57.45 123.42 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.049 -1.032 . . . . 0.72999999999999998 109.939 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.606 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 4.6 mmpt? -71.77 -17.55 62.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.382 -0.824 . . . . 1.97 108.808 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.606 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 6.6 pttm 147.6 140.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.328 -1.36 . . . . 2.3500000000000001 107.328 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.572 ' CG2' ' CB ' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -115.27 128.91 72.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.271 -1.011 . . . . 0.5 108.271 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.526 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -125.37 145.33 50.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.124 -0.985 . . . . 1.0700000000000001 110.434 -178.201 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.515 HG21 ' CG1' ' A' ' 3' ' ' VAL . 50.2 t -98.24 165.63 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.403 -0.811 . . . . 1.79 108.918 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.467 ' N ' HG13 ' A' ' 18' ' ' VAL . 1.6 p-10 -47.29 -30.33 3.04 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.014 -1.054 . . . . 3.9300000000000002 108.919 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.405 ' N ' ' OD1' ' A' ' 19' ' ' ASP . . . 149.69 100.5 0.22 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.592 -1.29 . . . . 4.2199999999999998 110.741 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 22' ' ' HIS . 3.5 t -128.48 -51.52 1.27 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.185 -1.185 . . . . 3.6600000000000001 109.139 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.489 ' CB ' ' O ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER 166.52 -84.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 4.46 110.136 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 119.22 -107.45 1.38 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.571 -1.812 . . . . 1.51 108.571 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 23' ' ' GLY . 9.5 p -47.43 -40.99 19.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.97 -1.312 . . . . 2.3700000000000001 108.422 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -72.78 175.02 3.67 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 109.086 -0.709 . . . . 2.21 109.086 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 25' ' ' ASP . 34.8 Cg_endo -79.51 135.09 11.54 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.216 1.944 . . . . 1.3300000000000001 110.344 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.5 t -112.45 143.44 43.59 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.31 -0.996 . . . . 3.27 108.31 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.451 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 46.9 mm -108.57 118.18 55.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.104 -0.998 . . . . 1.1000000000000001 110.247 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 127' ' ' ILE . 23.0 mt -98.79 118.36 45.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.245 -1.02 . . . . 1.3799999999999999 108.245 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -95.43 122.43 38.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.946 . . . . 1.6100000000000001 110.163 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.512 ' HA ' HG11 ' A' ' 94' ' ' VAL . 16.6 ptt180 -66.1 151.52 46.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 2.3700000000000001 109.475 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.9 -17.32 57.07 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.902 -1.679 . . . . 0.67000000000000004 108.902 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.462 ' O ' HG22 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -107.45 148.68 37.65 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.282 -1.128 . . . . 2.0800000000000001 109.143 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 36.3 Cg_endo -78.44 122.41 5.57 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.7 2.267 . . . . 0.35999999999999999 111.147 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.429 ' CZ ' HG12 ' A' ' 18' ' ' VAL . 4.7 t80 -100.55 122.55 43.43 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.149 -1.056 . . . . 0.32000000000000001 108.149 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.499 ' O ' HG11 ' A' ' 18' ' ' VAL . 64.2 m -100.7 137.55 38.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.898 -1.126 . . . . 0.80000000000000004 110.752 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.34 128.09 16.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.483 -0.76 . . . . 3.8300000000000001 109.05 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 16' ' ' VAL . 2.3 mt-10 -105.07 129.58 53.46 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.547 -0.909 . . . . 1.3799999999999999 108.547 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.572 ' CB ' ' CG2' ' A' ' 16' ' ' VAL . . . -128.14 120.92 28.32 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.793 -1.192 . . . . 0.19 110.306 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.526 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 4.2 mt -91.16 140.95 29.32 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.332 -1.729 . . . . 0.97999999999999998 106.332 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.659 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 32.0 p90 -156.5 135.58 11.98 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.709 -1.196 . . . . 0.19 109.778 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.6 OUTLIER -83.35 112.81 20.25 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.351 -0.981 . . . . 1.1699999999999999 108.351 179.309 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -46.22 112.48 0.49 Allowed 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.672 -0.862 . . . . 0.28999999999999998 108.672 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 44' ' ' ASN . 2.3 p30 -84.93 10.94 10.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.112 -0.993 . . . . 0.89000000000000001 109.45 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.562 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 1.8 pt20 -167.93 145.38 4.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.459 -0.776 . . . . 0.73999999999999999 108.968 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 2.4 p30 -84.46 119.17 24.83 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.145 -0.972 . . . . 0.77000000000000002 109.36 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.489 ' O ' ' CA ' ' A' ' 79' ' ' PRO . 2.6 t -137.2 159.68 41.2 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.265 -0.897 . . . . 0.46000000000000002 109.249 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.583 ' N ' ' CD ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -100.49 -28.54 12.85 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.127 -1.435 . . . . 7.2699999999999996 107.127 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.465 ' OG1' ' OD1' ' A' ' 113' ' ' ASP . 34.2 p -111.51 138.9 47.43 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 122.146 0.974 . . . . 1.8700000000000001 109.522 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -142.88 152.66 42.34 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 108.85 -0.796 . . . . 1.05 108.85 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.467 ' HD2' ' HB ' ' A' ' 70' ' ' THR . 6.4 mtmt -142.59 141.07 31.91 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.18 -0.95 . . . . 0.65000000000000002 110.332 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.534 ' CG2' ' O ' ' A' ' 69' ' ' ASP . 11.0 tt -94.28 150.46 4.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.193 -1.41 . . . . 0.77000000000000002 107.193 177.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' OE1' HD12 ' A' ' 111' ' ' ILE . 1.8 mt-10 -140.15 116.27 10.47 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.079 -1.013 . . . . 1.1799999999999999 110.156 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 107' ' ' THR . 2.7 mp -112.97 114.08 45.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.074 -1.016 . . . . 0.46999999999999997 108.51 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -115.17 130.65 56.98 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.109 -0.994 . . . . 1.26 109.271 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -107.92 128.45 54.64 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.192 -0.942 . . . . 0.56000000000000005 110.528 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.458 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . 42.7 t -97.26 150.55 20.81 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.537 -0.912 . . . . 1.8300000000000001 108.537 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.467 HD13 ' CD1' ' A' ' 63' ' ' ILE . 35.8 mt -105.86 38.2 2.06 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.092 -1.005 . . . . 0.89000000000000001 109.961 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.44 12.24 5.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -0.872 . . . . 1.6899999999999999 109.456 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.26 -44.34 0.06 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.461 -1.456 . . . . 0.98999999999999999 109.461 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.92 111.31 23.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -1.168 . . . . 5.7300000000000004 108.997 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -79.82 133.43 36.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.021 -1.049 . . . . 2.04 109.83 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.552 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 98.0 mt -123.87 167.24 17.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.177 -0.952 . . . . 1.24 109.444 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.552 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 35.9 m-20 -114.63 115.24 26.81 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.754 -1.573 . . . . 1.03 106.754 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.627 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 2.8 t -83.36 115.17 57.86 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.946 . . . . 0.63 111.458 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 37.5 Cg_endo -85.04 -156.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 123.1 2.533 . . . . 0.23999999999999999 109.342 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.62 35.83 82.73 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.286 -1.126 . . . . 0.71999999999999997 110.286 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.594 ' CG2' ' CD1' ' A' ' 92' ' ' TRP . 18.2 pt -127.06 -156.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.157 -1.201 . . . . 0.46000000000000002 108.83 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.576 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 38.7 t0 -108.58 108.75 19.76 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.244 -0.91 . . . . 1.4099999999999999 109.464 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.467 ' HB ' ' HD2' ' A' ' 51' ' ' LYS . 1.4 p -88.07 46.56 1.4 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.628 -1.249 . . . . 1.4099999999999999 107.628 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 23.1 t30 175.49 83.54 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.645 -1.613 . . . . 1.8799999999999999 106.645 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 76' ' ' VAL . . . -66.24 1.6 1.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.53 -0.731 . . . . 0.67000000000000004 111.822 -177.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 20.2 m -61.92 -13.65 26.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.817 -1.177 . . . . 2.9900000000000002 109.674 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -81.84 -14.69 55.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.111 -0.993 . . . . 1.0 110.156 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.701 ' CE2' ' CD1' ' A' ' 90' ' ' TYR . 19.7 m-85 -122.54 -15.27 7.6 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.367 -0.833 . . . . 1.4399999999999999 109.739 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.621 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 3.1 m -122.15 169.05 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.35 -0.982 . . . . 0.98999999999999999 108.35 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.598 ' HG2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -100.76 87.59 3.37 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.221 -0.925 . . . . 3.1099999999999999 112.248 -178.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.529 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 20.4 p -87.62 157.44 52.43 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.445 -1.41 . . . . 0.97999999999999998 107.91 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.582 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 21.8 Cg_endo -65.08 125.19 5.16 Favored 'Cis proline' 0 C--N 1.314 -1.261 0 O-C-N 123.105 1.055 . . . . 0.68000000000000005 112.947 2.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.617 ' CD2' ' CD2' ' A' ' 86' ' ' TYR . 13.8 mt -70.75 117.06 11.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.531 -1.655 . . . . 1.6599999999999999 106.531 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 43.6 t -83.55 139.84 17.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 C-N-CA 119.606 -0.838 . . . . 0.93000000000000005 110.926 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.562 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 16.8 ttpt -66.48 108.51 2.42 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.644 0.735 . . . . 1.51 109.562 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.66 -19.14 5.93 Favored Glycine 0 C--N 1.298 -1.555 0 N-CA-C 109.519 -1.432 . . . . 0.41999999999999998 109.519 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.581 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 4.0 tp60 -97.91 152.06 19.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.169 -1.195 . . . . 0.71999999999999997 107.799 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -104.96 143.63 32.91 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 118.99 -1.084 . . . . 0.32000000000000001 108.511 179.388 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.617 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 25.9 m-85 -121.05 150.06 41.76 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.279 -0.888 . . . . 0.80000000000000004 109.606 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.526 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 8.8 p-10 -119.76 109.85 16.1 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.951 -1.129 . . . . 0.62 107.951 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.621 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 6.9 tt -106.43 122.12 59.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.007 0.908 . . . . 0.72999999999999998 111.839 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -101.85 112.58 25.25 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 104.637 -2.357 . . . . 1.4099999999999999 104.637 176.033 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.701 ' CD1' ' CE2' ' A' ' 75' ' ' PHE . 31.5 t80 -127.51 139.5 52.74 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.734 -1.229 . . . . 1.1000000000000001 112.405 -175.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.66 106.83 18.83 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.202 -1.407 . . . . 1.3100000000000001 107.202 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.627 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 29.9 t90 -82.2 94.32 7.26 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.494 0.664 . . . . 0.56999999999999995 109.832 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -67.71 109.82 3.49 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.487 -0.758 . . . . 2.8799999999999999 109.35 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.636 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 12.4 t -60.2 142.97 89.4 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.124 -1.065 . . . . 1.1899999999999999 108.124 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.636 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 23.7 Cg_endo -66.97 -11.84 33.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.508 2.139 . . . . 3.7999999999999998 111.755 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 0.0 OUTLIER 76.21 -7.23 1.86 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 4.0300000000000002 109.485 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.525 ' O ' ' C ' ' A' ' 98' ' ' ALA . 12.7 pt -93.5 -27.97 4.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 O-C-N 121.114 -0.991 . . . . 1.6399999999999999 108.444 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.525 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -32.84 117.6 0.43 Allowed Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 108.575 -0.898 . . . . 0.58999999999999997 108.575 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.594 ' O ' ' N ' ' A' ' 101' ' ' SER . 37.3 Cg_endo -83.86 138.94 8.36 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.747 2.298 . . . . 0.75 110.015 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.52 ' HE3' ' HG2' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -50.22 90.47 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.897 -1.149 . . . . 4.3200000000000003 107.897 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 99' ' ' PRO . 1.8 t -94.32 124.18 38.18 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.506 -0.746 . . . . 0.56000000000000005 109.271 -178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -43.13 -45.3 5.39 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.591 -0.892 . . . . 1.8500000000000001 108.591 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.418 ' N ' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -131.44 141.48 49.82 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.497 -0.752 . . . . 1.23 109.195 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.542 HG23 ' CD1' ' A' ' 127' ' ' ILE . 2.1 t -131.41 145.4 35.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.268 -0.895 . . . . 0.89000000000000001 109.497 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 57' ' ' SER . 73.4 t -126.27 114.72 39.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.878 -1.156 . . . . 0.82999999999999996 107.878 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.489 HG13 ' CG2' ' A' ' 54' ' ' ILE . 1.8 t -95.66 137.29 24.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.92 -1.112 . . . . 0.62 109.372 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.603 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 34.3 m -118.72 112.24 19.51 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.15 -0.969 . . . . 0.93000000000000005 109.584 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.426 HG11 ' HB2' ' A' ' 120' ' ' ALA . 0.5 OUTLIER -92.7 125.25 45.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 106.647 -1.612 . . . . 0.53000000000000003 106.647 178.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.64 ' CG ' ' CG1' ' A' ' 116' ' ' VAL . 9.0 ttmt -141.26 131.51 24.97 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.134 -1.427 . . . . 3.3399999999999999 112.117 -176.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.659 ' CD1' ' CZ ' ' A' ' 41' ' ' PHE . 9.0 mt -104.16 138.15 41.07 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.209 -1.404 . . . . 1.3300000000000001 107.209 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.526 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 3.2 mp -129.69 120.57 50.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.101 -1.0 . . . . 0.39000000000000001 109.922 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.416 ' HA3' HG22 ' A' ' 47' ' ' THR . . . -92.74 -145.95 17.92 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.754 -1.738 . . . . 0.85999999999999999 108.754 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.465 ' OD1' ' OG1' ' A' ' 49' ' ' THR . 0.1 OUTLIER -99.93 -1.5 37.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.128 -1.219 . . . . 1.24 109.941 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 114' ' ' ASN . 0.4 OUTLIER -114.68 -10.5 12.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.97 -1.081 . . . . 6.0599999999999996 110.247 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.458 ' O ' HG21 ' A' ' 111' ' ' ILE . . . 159.32 -148.0 16.2 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.521 -1.323 . . . . 0.34999999999999998 110.13 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.64 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 2.1 t -91.99 109.87 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -1.136 . . . . 0.28999999999999998 110.13 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.459 HD11 HD11 ' A' ' 80' ' ' LEU . 41.0 mt -52.85 -43.67 66.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.446 -0.784 . . . . 1.1100000000000001 109.782 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.459 ' O ' HG11 ' A' ' 116' ' ' VAL . . . -158.71 -178.1 7.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.093 -1.005 . . . . 0.68000000000000005 109.357 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.9 OUTLIER -166.36 156.07 11.75 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.044 -1.035 . . . . 0.77000000000000002 110.191 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.4 149.63 28.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.105 -0.997 . . . . 0.51000000000000001 109.833 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.2 mt -138.1 121.08 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.068 -1.02 . . . . 1.6000000000000001 109.794 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.27 140.82 30.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.995 -1.065 . . . . 1.48 108.923 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 55.1 p -125.02 171.81 9.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.134 -0.979 . . . . 2.75 109.873 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 61.55 29.5 18.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -0.811 . . . . 2.5699999999999998 109.513 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -98.93 162.85 20.27 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.728 -1.349 . . . . 1.26 109.728 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 11.2 mtmt -151.2 134.19 15.86 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.465 -1.021 . . . . 1.28 108.308 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.542 ' CD1' HG23 ' A' ' 104' ' ' VAL . 55.9 mt -99.22 141.5 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.692 -1.255 . . . . 0.89000000000000001 110.218 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.52 ' HG2' ' HE3' ' A' ' 100' ' ' LYS . 12.4 mtm180 -132.5 177.2 7.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.535 -0.728 . . . . 2.4100000000000001 109.299 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.049 -0.977 . . . . 2.3999999999999999 109.457 179.572 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.53 ' CA ' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.514 0.673 . . . . 3.6499999999999999 110.031 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.18 163.95 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.489 -0.757 . . . . 2.6499999999999999 109.096 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -71.74 119.02 15.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.103 -0.998 . . . . 2.1499999999999999 109.546 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.09 173.34 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.382 -0.824 . . . . 2.5600000000000001 109.156 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.32 108.56 13.38 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.262 -0.899 . . . . 6.8499999999999996 109.616 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -77.41 118.88 20.3 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.213 -0.929 . . . . 2.6000000000000001 108.81 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.1 p -98.65 13.54 31.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.004 -1.06 . . . . 1.3100000000000001 110.107 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 10' ' ' ASN . . . -93.65 -72.99 0.58 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.946 -1.096 . . . . 0.83999999999999997 109.425 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.472 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 19.8 t-20 172.5 63.48 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.762 -1.199 . . . . 5.0 107.762 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 11' ' ' ASN . 47.1 t-20 60.45 18.4 8.16 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.861 -1.163 . . . . 2.73 107.861 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.474 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 0.8 OUTLIER -57.79 -81.67 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.728 -0.607 . . . . 3.5899999999999999 109.57 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -56.43 125.73 12.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.32 -0.952 . . . . 0.55000000000000004 109.423 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.6 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 1.2 mmtt -75.57 -24.89 56.68 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.369 -0.832 . . . . 1.24 108.866 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.6 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 167.88 126.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.372 -0.973 . . . . 4.3700000000000001 108.372 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.615 ' CG2' ' CB ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -105.26 125.14 60.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.092 -1.077 . . . . 0.81000000000000005 108.092 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.537 ' HE2' ' CG ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -111.84 150.22 30.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.962 -1.086 . . . . 2.3500000000000001 110.811 -177.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.586 HG12 ' CE2' ' A' ' 35' ' ' PHE . 46.6 t -109.48 163.52 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.3 -1.0 . . . . 1.22 108.3 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -86.49 64.12 8.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.07 -1.018 . . . . 1.45 109.713 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 21' ' ' CYS . . . 163.02 -95.71 0.13 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.881 -1.288 . . . . 2.5600000000000001 109.881 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.414 ' C ' ' O ' ' A' ' 20' ' ' GLY . 93.5 m -42.39 155.11 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.339 -1.095 . . . . 1.8700000000000001 109.974 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.585 ' CG ' ' O ' ' A' ' 22' ' ' HIS . 13.9 p-80 -162.87 107.66 1.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.324 -0.86 . . . . 5.3399999999999999 110.103 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.59 -148.45 16.69 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.912 -1.275 . . . . 4.3799999999999999 109.912 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.0 t -87.4 21.82 2.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.338 -1.095 . . . . 2.5699999999999998 109.729 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.59 157.29 80.08 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.13 -0.982 . . . . 2.3300000000000001 109.313 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.8 158.84 31.47 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.743 2.295 . . . . 1.04 110.257 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.5 141.91 50.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 2.6699999999999999 109.421 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.548 HG23 ' CD2' ' A' ' 30' ' ' HIS . 51.0 mm -113.0 113.31 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.061 -1.024 . . . . 0.93000000000000005 109.065 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.499 HG12 ' CE1' ' A' ' 35' ' ' PHE . 32.5 mt -99.22 112.34 31.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.201 -0.937 . . . . 1.3300000000000001 109.031 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.548 ' CD2' HG23 ' A' ' 28' ' ' ILE . 47.3 m170 -88.35 105.16 17.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.057 -1.09 . . . . 3.1200000000000001 108.057 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.498 ' HA ' HG11 ' A' ' 94' ' ' VAL . 8.1 ptt180 -45.54 123.31 4.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.992 -1.068 . . . . 1.03 109.822 -178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.551 ' HA2' ' CD ' ' A' ' 96' ' ' LYS . . . 116.87 -11.85 15.13 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.058 -1.617 . . . . 0.41999999999999998 109.058 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.523 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -103.87 149.97 37.73 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.355 -1.085 . . . . 1.96 108.754 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 36.5 Cg_endo -79.44 121.66 4.83 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 122.379 2.053 . . . . 0.38 110.718 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.586 ' CE2' HG12 ' A' ' 18' ' ' VAL . 2.3 t80 -97.12 120.86 38.25 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.445 -1.317 . . . . 1.24 107.445 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.48 HG22 ' HE3' ' A' ' 89' ' ' LYS . 73.3 m -100.99 127.32 47.54 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.684 -1.26 . . . . 1.1899999999999999 110.68 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.655 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -138.19 124.12 20.08 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.96 -0.755 . . . . 1.8600000000000001 108.96 178.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 16' ' ' VAL . 38.6 tt0 -104.33 135.88 44.95 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.699 -1.223 . . . . 1.71 107.699 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.615 ' CB ' ' CG2' ' A' ' 16' ' ' VAL . . . -133.04 123.19 25.34 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.841 -1.143 . . . . 0.23999999999999999 110.562 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.571 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 8.7 mt -88.39 137.21 32.53 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.56 -2.015 . . . . 0.68000000000000005 105.56 177.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.639 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 34.8 p90 -152.12 134.81 15.46 Favored 'General case' 0 C--N 1.288 -2.107 0 C-N-CA 118.171 -1.412 . . . . 0.26000000000000001 110.168 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.8 OUTLIER -82.72 107.81 15.63 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.446 -0.946 . . . . 0.66000000000000003 108.446 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -45.67 114.36 0.75 Allowed 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.136 -0.69 . . . . 0.42999999999999999 109.136 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 44' ' ' ASN . 1.3 p30 -84.24 10.6 9.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.056 -1.027 . . . . 0.76000000000000001 109.23 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.58 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 8.4 pt20 -166.53 145.02 5.43 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.312 -0.868 . . . . 1.4399999999999999 109.253 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 9.4 p30 -83.93 110.04 18.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.82999999999999996 109.12 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.464 HG22 ' HA3' ' A' ' 112' ' ' GLY . 1.5 t -126.7 151.15 48.51 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.189 -0.944 . . . . 0.52000000000000002 109.795 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.747 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 1.1 mmmt -86.39 -20.61 27.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.332 -0.855 . . . . 0.83999999999999997 109.156 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 p -132.29 138.91 48.02 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.109 0.957 . . . . 1.4199999999999999 110.137 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -139.34 148.12 42.48 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.675 -1.232 . . . . 1.75 107.675 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.555 ' HD2' ' HA ' ' A' ' 70' ' ' THR . 1.0 OUTLIER -141.12 142.31 34.11 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.251 -0.906 . . . . 3.8900000000000001 110.339 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.461 ' HA ' HD21 ' A' ' 110' ' ' LEU . 5.3 tt -91.84 149.47 4.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 107.622 -1.251 . . . . 0.90000000000000002 107.622 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.442 ' OE2' ' N ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -145.01 117.24 8.41 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.598 -0.89 . . . . 4.8399999999999999 108.598 -177.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 107' ' ' THR . 3.4 mp -109.67 134.95 50.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.806 -1.184 . . . . 1.0700000000000001 110.596 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -125.17 131.65 53.18 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.161 -0.962 . . . . 2.46 108.952 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.25 146.96 34.75 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.71 -1.244 . . . . 1.1000000000000001 111.4 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.24 150.86 26.18 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.033 -1.099 . . . . 0.79000000000000004 108.033 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.48 HD13 ' HG2' ' A' ' 99' ' ' PRO . 44.4 mt -120.69 61.33 0.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.864 -1.148 . . . . 1.5700000000000001 110.486 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 58' ' ' LEU . 5.7 t0 41.71 26.72 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.593 -0.692 . . . . 1.1000000000000001 110.081 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 158.24 -49.35 0.42 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.597 -1.401 . . . . 0.40999999999999998 109.597 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.407 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 8.2 tp -97.93 113.03 24.76 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.394 -1.062 . . . . 1.3300000000000001 108.873 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -93.08 123.25 36.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.14 -0.975 . . . . 5.4699999999999998 109.636 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.611 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 12.8 mt -118.15 169.36 8.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 122.15 0.976 . . . . 0.72999999999999998 109.348 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.611 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 18.9 m-20 -108.52 134.56 51.13 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.131 -1.433 . . . . 0.67000000000000004 107.131 177.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.597 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -104.05 107.82 58.2 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.839 -1.163 . . . . 1.25 110.632 -178.44 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.3 Cg_endo -81.32 -154.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 123.151 2.567 . . . . 0.55000000000000004 109.914 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.85 34.09 86.11 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.333 -1.507 . . . . 0.89000000000000001 109.333 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.606 HG22 ' CE2' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -108.04 179.84 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.354 -1.086 . . . . 3.7000000000000002 109.378 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.592 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -86.01 -1.1 57.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.92 -1.112 . . . . 3.1499999999999999 109.318 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.555 ' HA ' ' HD2' ' A' ' 51' ' ' LYS . 29.3 p 30.19 36.36 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.678 0.752 . . . . 2.0800000000000001 109.921 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.561 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 14.7 t-20 174.56 90.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.685 -1.228 . . . . 1.74 107.685 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.609 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -75.29 2.05 12.12 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.589 -0.694 . . . . 0.71999999999999997 110.973 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.433 ' HA ' HG23 ' A' ' 76' ' ' VAL . 84.2 m -66.79 -9.42 36.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.015 -1.053 . . . . 2.6699999999999999 109.229 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.14 -17.42 35.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 1.3400000000000001 109.522 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 75' ' ' PHE . 2.8 m-85 -116.87 -12.01 10.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 1.22 109.111 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.622 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 1.7 m -120.99 165.73 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.362 -0.977 . . . . 0.58999999999999997 108.362 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.614 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -90.0 98.87 12.02 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.921 -1.112 . . . . 2.9300000000000002 110.864 -178.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.479 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 18.2 m -91.48 152.23 43.38 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.219 -0.926 . . . . 2.79 108.674 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.747 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.2 Cg_endo -70.13 139.26 54.62 Favored 'Cis proline' 0 C--N 1.312 -1.383 0 C-N-CA 124.117 -1.201 . . . . 0.40000000000000002 112.332 0.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.595 HD23 ' CE2' ' A' ' 86' ' ' TYR . 13.1 mt -77.86 112.14 14.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.625 -1.62 . . . . 1.1000000000000001 106.625 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 82' ' ' LYS . 10.9 t -82.92 144.95 9.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 121.841 0.829 . . . . 1.0700000000000001 110.946 -177.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.58 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 8.2 ttpt -68.53 117.42 10.26 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.703 0.763 . . . . 1.24 109.754 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 119.43 -11.08 11.41 Favored Glycine 0 C--N 1.296 -1.675 0 N-CA-C 109.514 -1.434 . . . . 0.26000000000000001 109.514 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.536 ' HG3' ' N ' ' A' ' 85' ' ' GLN . 4.6 tp60 -107.8 157.02 18.5 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.144 -1.058 . . . . 0.80000000000000004 108.144 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.536 ' N ' ' HG3' ' A' ' 84' ' ' GLN . 1.5 tt0 -109.93 144.29 38.65 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.049 -1.032 . . . . 2.3100000000000001 108.438 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.614 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 38.6 m-85 -125.75 145.95 49.98 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.201 -0.937 . . . . 0.89000000000000001 110.033 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.571 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -111.45 113.62 26.18 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.759 -0.83 . . . . 1.71 108.759 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.622 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 2.3 tt -109.87 117.36 54.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.058 -1.026 . . . . 0.5 111.199 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.48 ' HE3' HG22 ' A' ' 36' ' ' THR . 3.0 tttp -94.35 114.91 27.04 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.624 -2.362 . . . . 2.1800000000000002 104.624 176.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.606 ' CE2' HG22 ' A' ' 68' ' ' ILE . 27.8 t80 -126.09 139.64 53.22 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.113 -1.435 . . . . 0.83999999999999997 113.366 -175.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.496 ' O ' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -93.08 131.67 37.9 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 105.119 -2.178 . . . . 1.9199999999999999 105.119 175.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.597 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 29.9 t90 -109.92 96.81 6.48 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 121.351 -0.843 . . . . 1.05 109.826 -176.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -68.32 104.49 1.87 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.347 0.594 . . . . 3.1699999999999999 109.868 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.631 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 30.0 t -61.55 143.83 93.11 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.324 -0.991 . . . . 1.8400000000000001 108.324 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.631 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 23.4 Cg_endo -64.55 -6.33 11.87 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.377 2.052 . . . . 3.9700000000000002 112.182 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.551 ' CD ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER 67.98 -4.13 1.08 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.998 -1.064 . . . . 3.2599999999999998 110.425 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.528 ' O ' ' C ' ' A' ' 98' ' ' ALA . 16.2 pt -94.49 -26.52 4.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 O-C-N 120.789 -1.195 . . . . 1.8600000000000001 107.948 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -30.59 118.49 0.34 Allowed Pre-proline 0 N--CA 1.488 1.47 0 CA-C-N 115.813 -0.63 . . . . 0.5 109.376 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 101' ' ' SER . 35.8 Cg_endo -82.99 131.46 5.98 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.689 2.259 . . . . 0.59999999999999998 108.473 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.613 ' CG ' ' HA ' ' A' ' 128' ' ' ARG . 1.6 ttpt -48.33 91.03 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.334 -0.946 . . . . 2.6899999999999999 108.952 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 99' ' ' PRO . 1.2 t -94.16 116.91 29.38 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.842 -0.799 . . . . 0.82999999999999996 108.842 -179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 101' ' ' SER . 5.4 pt-20 -35.03 -47.5 0.37 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.805 -0.559 . . . . 1.4199999999999999 110.54 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -129.06 140.46 51.59 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.192 -0.942 . . . . 1.5600000000000001 109.154 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.52 ' CG2' ' CD1' ' A' ' 127' ' ' ILE . 0.9 OUTLIER -131.75 143.58 39.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.358 -0.839 . . . . 1.25 109.831 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 122' ' ' ALA . 11.8 t -124.6 117.1 49.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.791 -1.559 . . . . 1.52 106.791 178.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.15 141.68 14.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 C-N-CA 119.466 -0.893 . . . . 0.65000000000000002 110.594 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.599 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 51.7 m -116.15 138.27 51.41 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.387 -0.968 . . . . 1.78 108.387 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER -119.63 127.49 75.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 106.738 -1.579 . . . . 0.48999999999999999 106.738 178.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.561 ' HG2' ' CG1' ' A' ' 116' ' ' VAL . 3.9 ttmt -140.14 129.1 23.43 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.1 -1.44 . . . . 3.2599999999999998 111.693 -177.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.639 ' CD1' ' CE2' ' A' ' 41' ' ' PHE . 6.5 mt -103.17 138.7 39.63 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.98 -1.489 . . . . 0.62 106.98 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 116' ' ' VAL . 4.5 mp -133.25 115.87 24.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.967 -1.083 . . . . 0.52000000000000002 109.731 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.464 ' HA3' HG22 ' A' ' 47' ' ' THR . . . -87.87 -133.7 4.25 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.082 -1.607 . . . . 0.28000000000000003 109.082 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -110.53 -2.36 16.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -1.146 . . . . 2.9100000000000001 109.709 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.46 -0.09 12.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.073 -1.017 . . . . 2.79 110.257 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 151.37 -157.31 27.14 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.916 -1.274 . . . . 0.35999999999999999 109.916 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.561 ' CG1' ' HG2' ' A' ' 109' ' ' LYS . 21.3 t -86.48 110.54 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -1.14 . . . . 1.6499999999999999 109.626 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 50' ' ' ALA . 20.2 mt -58.03 -39.35 78.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.439 -0.788 . . . . 0.75 110.735 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.529 ' O ' HG11 ' A' ' 116' ' ' VAL . . . -150.43 177.2 10.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.721 -1.237 . . . . 1.23 109.534 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -170.04 148.07 3.35 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.875 -1.141 . . . . 0.85999999999999999 109.588 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -151.76 149.66 29.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.014 -1.054 . . . . 0.76000000000000001 109.743 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 85.0 mt -136.71 119.86 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.099 -1.001 . . . . 1.24 109.39 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.473 ' O ' ' CG1' ' A' ' 105' ' ' VAL . . . -88.36 150.88 22.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.857 -1.152 . . . . 0.67000000000000004 109.934 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.3 t -111.61 3.95 18.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.23 -0.919 . . . . 3.5699999999999998 110.424 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.421 ' CD2' ' C ' ' A' ' 124' ' ' HIS . 1.4 p-80 -133.46 173.81 11.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.889 -1.132 . . . . 8.0800000000000001 109.561 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 129.21 155.05 8.4 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.748 -1.215 . . . . 1.79 110.369 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 6.0 mtmp? -152.08 141.14 21.23 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.146 -1.427 . . . . 3.6499999999999999 107.146 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.52 ' CD1' ' CG2' ' A' ' 104' ' ' VAL . 81.6 mt -104.35 140.75 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.429 -1.42 . . . . 0.82999999999999996 111.147 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.613 ' HA ' ' CG ' ' A' ' 100' ' ' LYS . 4.4 mtt85 -127.85 174.82 8.83 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.274 -1.01 . . . . 4.5899999999999999 108.274 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 120.967 -1.083 . . . . 0.96999999999999997 109.527 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.258 0.551 . . . . 1.96 109.525 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.526 ' HA ' ' CB ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -77.64 152.72 33.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 2.0600000000000001 109.39 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.536 ' HA ' ' CA ' ' A' ' 23' ' ' GLY . 1.3 m -106.29 165.48 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 1.3799999999999999 109.609 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -87.1 119.19 27.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 1.5900000000000001 109.509 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 m -150.88 157.04 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 1.45 109.224 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.04 108.57 14.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 4.1399999999999997 109.383 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.407 ' CG ' ' HB ' ' A' ' 13' ' ' ILE . 2.3 m-20 -52.49 114.76 1.48 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.27 -0.894 . . . . 2.3500000000000001 109.354 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -85.32 9.55 15.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.92000000000000004 109.326 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.503 ' N ' ' HB3' ' A' ' 119' ' ' CYS . . . -90.55 -69.93 0.7 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.905 . . . . 0.60999999999999999 109.702 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 9' ' ' ALA . 0.8 OUTLIER 171.74 57.67 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.461 -0.775 . . . . 2.3999999999999999 109.252 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 64.83 13.66 8.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.126 -0.984 . . . . 2.3700000000000001 108.924 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' O ' ' CE ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -63.17 -67.1 0.45 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.366 -0.834 . . . . 1.71 109.771 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -56.78 130.28 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.65000000000000002 109.478 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 8.8 mmpt? -88.12 -13.95 40.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.325 -0.86 . . . . 1.6899999999999999 109.454 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.2 ttpt 161.86 128.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 2.1699999999999999 109.585 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.587 ' CG2' ' CB ' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -116.85 127.01 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.38 -0.825 . . . . 0.92000000000000004 108.958 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.526 ' CB ' ' HA ' ' A' ' 2' ' ' GLN . 0.2 OUTLIER -122.53 156.67 33.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.059 -1.025 . . . . 1.24 110.191 -179.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.637 ' CG1' ' CE2' ' A' ' 35' ' ' PHE . 52.8 t -127.63 148.54 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.76000000000000001 109.176 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.503 ' N ' HG13 ' A' ' 18' ' ' VAL . 22.5 t0 -89.66 75.54 7.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 2.3199999999999998 109.424 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.75 -69.75 0.14 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.89 -1.284 . . . . 1.3999999999999999 109.89 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.7 t -67.88 168.1 12.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -1.191 . . . . 1.6699999999999999 109.841 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -107.22 -9.3 16.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 3.6499999999999999 109.68 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' A' ' 3' ' ' VAL . . . 103.37 -104.21 2.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.008 -1.237 . . . . 1.9199999999999999 110.008 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' GLY . 9.3 t -41.71 -39.66 1.75 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.421 -1.047 . . . . 2.3799999999999999 109.683 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.491 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -68.52 173.18 3.63 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 1.75 109.258 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 35.4 Cg_endo -77.67 152.62 29.47 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.715 2.277 . . . . 1.1699999999999999 110.333 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.4 m -116.42 130.02 56.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 1.47 109.382 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.506 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 36.8 mm -106.06 102.57 14.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.072 -1.018 . . . . 0.80000000000000004 108.81 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 mp -88.7 118.23 33.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.163 -0.961 . . . . 0.84999999999999998 109.141 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.466 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 8.2 m-70 -89.04 102.53 15.18 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.351 -0.843 . . . . 1.5 109.044 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.473 ' HD2' ' O ' ' A' ' 98' ' ' ALA . 5.2 ptt180 -43.1 138.89 1.98 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.873 . . . . 1.6799999999999999 110.064 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.494 ' CA ' ' HD2' ' A' ' 96' ' ' LYS . . . 97.61 -14.63 62.97 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.084 -1.206 . . . . 0.60999999999999999 110.084 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.483 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -103.14 150.96 38.39 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.247 . . . . 2.3199999999999998 109.812 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 36.5 Cg_endo -79.94 113.56 3.02 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.902 2.401 . . . . 0.47999999999999998 111.138 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.637 ' CE2' ' CG1' ' A' ' 18' ' ' VAL . 5.8 t80 -99.4 122.1 42.04 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.428 -1.323 . . . . 0.75 107.428 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.521 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 71.7 m -102.76 138.79 39.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.857 -1.152 . . . . 0.98999999999999999 111.075 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -140.21 128.51 22.53 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.086 -0.709 . . . . 2.6699999999999999 109.086 178.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.449 ' HG3' ' HA ' ' A' ' 89' ' ' LYS . 2.4 tt0 -104.97 126.26 51.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.835 -1.166 . . . . 1.3400000000000001 108.076 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 16' ' ' VAL . . . -124.72 122.8 38.51 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.733 -1.23 . . . . 0.37 110.668 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 7.9 mt -89.59 144.01 26.35 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.5 -1.667 . . . . 0.76000000000000001 106.5 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.637 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 32.7 p90 -159.87 138.4 10.49 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.702 -1.249 . . . . 0.23999999999999999 109.877 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.6 m-20 -85.05 113.59 21.58 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.346 -0.942 . . . . 1.1499999999999999 108.698 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . -44.71 113.28 0.53 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.046 -0.724 . . . . 0.25 109.046 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.451 ' C ' ' HG3' ' A' ' 82' ' ' LYS . 4.9 p30 -81.62 7.75 11.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.237 -0.914 . . . . 1.1200000000000001 109.554 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.532 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 1.1 pt20 -170.5 163.88 8.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.213 -0.929 . . . . 0.93000000000000005 109.835 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 8.9 p30 -92.38 121.77 34.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 2.4900000000000002 109.309 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.455 HG22 ' HA3' ' A' ' 112' ' ' GLY . 2.5 t -141.83 156.33 45.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.177 -0.952 . . . . 0.62 109.78 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -95.68 -14.5 23.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -0.847 . . . . 2.4300000000000002 109.499 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.401 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 6.1 p -141.3 137.88 32.77 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.947 0.879 . . . . 1.27 109.862 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -129.62 152.69 48.87 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.482 -0.932 . . . . 0.69999999999999996 108.482 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.541 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 1.3 mtmt -133.93 140.36 46.73 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.048 -1.061 . . . . 1.29 110.505 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 69' ' ' ASP . 3.1 tt -94.39 149.01 4.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.617 -1.253 . . . . 0.90000000000000002 107.617 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -137.24 115.06 11.37 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.216 -0.927 . . . . 1.48 109.758 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 107' ' ' THR . 2.1 mp -113.99 117.79 56.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 120.971 -1.081 . . . . 0.51000000000000001 108.948 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.46 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 21.0 mttt -119.71 131.16 55.33 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.18 -0.95 . . . . 1.6299999999999999 109.396 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.62 133.37 52.16 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.173 -0.954 . . . . 0.81000000000000005 110.424 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -98.49 151.32 20.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 2.0899999999999999 109.085 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 59' ' ' ASP . 34.3 mt -109.2 49.16 0.83 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.091 -1.005 . . . . 1.27 109.86 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 58' ' ' LEU . 20.7 t0 44.4 26.64 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.897 . . . . 1.46 109.305 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.91 -55.16 0.17 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.319 -1.513 . . . . 0.94999999999999996 109.319 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 1.2 tp -102.99 113.94 27.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -1.133 . . . . 2.6400000000000001 109.141 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.435 ' O ' HD13 ' A' ' 61' ' ' LEU . 37.0 tt0 -81.62 133.6 35.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.955 . . . . 2.4500000000000002 109.398 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.594 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 40.8 mt -126.66 168.69 19.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.008 0.908 . . . . 1.9099999999999999 109.215 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.594 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 63.3 m-20 -111.87 141.85 44.98 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.732 -1.21 . . . . 1.8500000000000001 107.732 178.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.628 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 6.2 t -108.32 105.39 56.55 Favored Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 121.03 -1.044 . . . . 0.56999999999999995 110.472 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 37.3 Cg_endo -82.56 -156.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.475 2.784 . . . . 0.48999999999999999 110.189 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.37 17.58 47.34 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.576 -1.41 . . . . 0.85999999999999999 109.576 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.577 HG22 ' CD1' ' A' ' 92' ' ' TRP . 50.1 pt -104.67 -167.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -1.138 . . . . 0.71999999999999997 109.432 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.574 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 24.3 t0 -98.8 109.75 22.46 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.362 -0.836 . . . . 0.96999999999999997 109.382 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.541 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 1.2 p -86.74 47.47 1.49 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.283 -0.886 . . . . 1.1499999999999999 108.83 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 54.5 t-20 177.75 81.86 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.858 -1.164 . . . . 1.6100000000000001 107.858 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.93 -5.57 9.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.572 -0.705 . . . . 0.47999999999999998 111.822 -177.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.494 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.3 t -64.39 -12.13 39.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.587 -1.321 . . . . 1.2 109.058 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.81 -23.19 55.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.051 -1.031 . . . . 1.3799999999999999 109.845 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.421 ' HB2' HG13 ' A' ' 88' ' ' ILE . 79.4 m-85 -110.27 -24.49 10.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.67000000000000004 109.098 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.587 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 1.2 m -107.66 162.6 5.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.122 -1.066 . . . . 0.42999999999999999 108.122 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.613 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -88.54 93.82 9.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.931 -1.106 . . . . 2.5699999999999998 111.222 -178.357 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.473 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 14.3 p -88.92 153.91 49.67 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 107.544 -1.28 . . . . 0.89000000000000001 107.544 177.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.661 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 26.3 Cg_endo -69.92 134.8 31.22 Favored 'Cis proline' 0 C--N 1.311 -1.396 0 C-N-CA 124.206 -1.164 . . . . 0.34999999999999998 112.346 2.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.633 ' CD2' ' CD2' ' A' ' 86' ' ' TYR . 7.3 mt -76.13 116.97 17.35 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.263 -1.384 . . . . 0.91000000000000003 107.263 178.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.7 t -89.06 136.94 22.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 121.736 0.779 . . . . 0.62 110.543 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 2.6 ttmt -58.15 118.62 5.66 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.73 0.776 . . . . 1.9099999999999999 110.269 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.51 -15.11 13.01 Favored Glycine 0 N--CA 1.479 1.549 0 C-N-CA 119.723 -1.227 . . . . 0.37 110.355 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.588 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 4.9 tp60 -102.43 156.68 17.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.042 -1.269 . . . . 1.6100000000000001 108.044 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -109.26 149.28 29.66 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.107 -0.995 . . . . 1.75 108.502 179.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.633 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 32.4 m-85 -131.5 149.64 52.45 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.289 -0.882 . . . . 0.72999999999999998 110.001 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.502 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 3.3 p30 -117.43 115.03 24.38 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.162 -1.051 . . . . 1.4099999999999999 108.162 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.587 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 3.8 tt -106.62 120.74 58.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.121 -0.987 . . . . 0.45000000000000001 111.153 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.449 ' HA ' ' HG3' ' A' ' 38' ' ' GLU . 69.0 tttt -103.09 101.55 11.53 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.099 -2.186 . . . . 2.98 105.099 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 20.0 t80 -118.45 140.16 50.29 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.19 -0.944 . . . . 0.77000000000000002 111.535 -176.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.76 107.71 19.4 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.489 -1.3 . . . . 1.21 107.489 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.628 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 28.8 t90 -85.09 93.94 8.73 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.408 0.623 . . . . 1.05 109.628 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -61.51 108.85 1.03 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.395 -0.815 . . . . 2.2799999999999998 109.6 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.535 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 21.6 t -64.41 140.42 97.96 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.371 -0.831 . . . . 1.21 108.792 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.544 ' HD3' ' CG1' ' A' ' 65' ' ' VAL . 34.3 Cg_endo -74.98 140.19 25.21 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.206 1.937 . . . . 2.2200000000000002 110.167 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.494 ' HD2' ' CA ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -77.48 4.54 10.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.323 -0.861 . . . . 3.3900000000000001 109.724 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.482 HG12 ' HB2' ' A' ' 95' ' ' PRO . 9.2 pt -92.93 -28.0 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.043 -1.036 . . . . 1.0600000000000001 109.649 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -39.57 115.72 1.05 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 109.174 -0.676 . . . . 0.51000000000000001 109.174 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 101' ' ' SER . 36.6 Cg_endo -83.02 139.54 9.62 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.753 2.302 . . . . 0.63 109.461 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 1.7 mtmt -50.36 90.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.498 -0.927 . . . . 3.3599999999999999 108.498 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 99' ' ' PRO . 2.0 t -96.24 120.47 36.59 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.47 -0.769 . . . . 1.3200000000000001 109.244 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' A' ' 103' ' ' ASN . 11.8 pt-20 -41.02 -47.49 3.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.507 -0.746 . . . . 1.9099999999999999 109.657 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.523 ' N ' ' CG ' ' A' ' 102' ' ' GLU . 0.8 OUTLIER -131.57 134.15 45.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 2.2999999999999998 109.72 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.582 ' CG2' ' CD1' ' A' ' 127' ' ' ILE . 2.5 t -129.68 150.55 34.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.387 -0.821 . . . . 0.92000000000000004 109.14 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 74.2 t -126.62 119.03 52.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.409 -0.96 . . . . 1.03 108.409 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.56 138.93 20.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.093 -1.004 . . . . 0.56999999999999995 109.617 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 32.9 m -120.39 115.68 23.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.392 -0.818 . . . . 1.1399999999999999 109.831 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.92 127.39 48.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.62 -1.252 . . . . 0.41999999999999998 107.62 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.593 ' CD ' ' CG1' ' A' ' 116' ' ' VAL . 1.4 ttmm -137.92 129.74 28.45 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.518 -1.364 . . . . 2.1000000000000001 110.733 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.637 ' CD1' ' CE2' ' A' ' 41' ' ' PHE . 14.0 mt -104.21 138.34 40.82 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.376 -1.342 . . . . 0.93000000000000005 107.376 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.511 HD11 ' N ' ' A' ' 111' ' ' ILE . 4.1 mp -133.7 116.94 25.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.149 -0.97 . . . . 0.47999999999999998 109.852 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.455 ' HA3' HG22 ' A' ' 47' ' ' THR . . . -89.67 -126.34 2.98 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.112 -1.595 . . . . 0.54000000000000004 109.112 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.17 -1.89 11.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -1.172 . . . . 1.3200000000000001 109.565 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -115.22 -3.56 12.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 3.6099999999999999 109.867 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.427 ' O ' HG21 ' A' ' 111' ' ' ILE . . . 151.55 -148.8 20.26 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.756 -1.338 . . . . 0.38 109.756 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.593 ' CG1' ' CD ' ' A' ' 109' ' ' LYS . 2.0 t -90.06 110.21 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -1.176 . . . . 0.69999999999999996 109.851 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 110' ' ' LEU . 53.2 mt -53.74 -39.59 65.43 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.386 -0.821 . . . . 0.89000000000000001 109.981 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.464 ' HB2' HG12 ' A' ' 13' ' ' ILE . . . -156.87 -165.05 1.76 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.784 -1.197 . . . . 0.68999999999999995 109.442 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.503 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 50.3 t -174.98 156.13 2.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.035 -1.04 . . . . 0.65000000000000002 109.72 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -154.11 142.11 20.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.914 . . . . 0.46000000000000002 109.409 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.437 HD12 ' CB ' ' A' ' 8' ' ' CYS . 26.0 mt -134.1 118.89 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 1.04 109.178 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.1 142.75 27.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.103 -0.998 . . . . 0.73999999999999999 109.49 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -86.99 0.34 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.886 . . . . 2.1800000000000002 109.592 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -49.12 115.8 1.44 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 3.0499999999999998 109.667 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -159.6 149.81 19.78 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.297 -1.521 . . . . 1.0 109.297 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 13.8 mttt -152.6 136.0 15.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.42 -1.047 . . . . 2.3199999999999998 108.524 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.582 ' CD1' ' CG2' ' A' ' 104' ' ' VAL . 75.6 mt -106.87 141.17 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.633 -1.292 . . . . 0.64000000000000001 110.095 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.506 ' HB2' ' CG2' ' A' ' 28' ' ' ILE . 19.3 mtt180 -131.18 177.31 7.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.562 -0.711 . . . . 3.1000000000000001 109.151 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.0 t70 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.05 -0.976 . . . . 1.72 109.422 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.445 -0.576 . . . . 2.25 109.445 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.528 ' CB ' ' HG2' ' A' ' 17' ' ' MET . 2.6 pt20 -91.46 154.89 18.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.319 -0.863 . . . . 0.89000000000000001 109.77 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 1.4 m -104.78 143.36 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.342 -0.849 . . . . 0.77000000000000002 109.258 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.473 ' O ' HG11 ' A' ' 5' ' ' VAL . 8.5 t70 -71.25 117.91 13.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.77000000000000002 110.1 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.473 HG11 ' O ' ' A' ' 4' ' ' ASP . 30.2 m -142.72 154.13 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.552 -0.907 . . . . 1.05 108.552 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.46 107.69 17.45 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.121 -0.987 . . . . 2.3900000000000001 109.127 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 2.2 p30 -59.63 135.86 57.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 3.6899999999999999 109.154 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.81 -7.45 14.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.128 -0.983 . . . . 1.0900000000000001 109.192 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 10' ' ' ASN . . . -67.54 -63.83 0.98 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.68999999999999995 109.666 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER 166.64 49.88 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.438 -0.789 . . . . 1.04 109.152 -178.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m120 64.32 28.58 13.78 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.217 -1.031 . . . . 4.1399999999999997 108.217 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -77.07 -70.99 0.43 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.646 -0.659 . . . . 1.1100000000000001 109.407 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.589 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -55.09 122.76 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.93999999999999995 109.798 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -66.67 -28.0 68.11 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.359 -0.838 . . . . 2.6000000000000001 108.947 179.594 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 12.6 pttt 165.8 135.01 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.837 -1.171 . . . . 1.79 107.837 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.587 ' CG2' ' CB ' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -111.94 119.17 59.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 O-C-N 121.257 -0.902 . . . . 0.56000000000000005 108.701 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.528 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 1.1 mtm -108.64 157.13 18.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.857 . . . . 0.78000000000000003 110.483 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.551 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 48.4 t -124.11 141.52 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.468 -0.938 . . . . 0.40000000000000002 108.468 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -85.19 82.36 8.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.015 -1.053 . . . . 0.56999999999999995 109.493 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.48 -72.59 0.23 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.995 -1.242 . . . . 0.56000000000000005 109.995 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -51.99 164.67 0.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -1.16 . . . . 1.7 110.322 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.59 -3.54 20.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.485 -0.759 . . . . 2.2599999999999998 109.4 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 3' ' ' VAL . . . 95.27 -122.24 7.16 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.251 -1.54 . . . . 0.57999999999999996 109.251 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' GLY . 17.8 t -40.69 -40.87 1.4 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.471 -1.017 . . . . 2.6000000000000001 109.438 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.556 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -51.05 179.86 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 1.4099999999999999 108.917 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 32.7 Cg_endo -76.13 142.43 24.55 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.226 1.951 . . . . 1.9199999999999999 110.343 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.96 119.71 38.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 1.6899999999999999 109.715 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.462 HD13 HG21 ' A' ' 28' ' ' ILE . 29.3 mm -111.81 107.91 24.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.007 -1.058 . . . . 0.89000000000000001 108.991 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 mt -94.37 118.77 41.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.268 -0.895 . . . . 1.2 109.411 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.487 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 14.5 m-70 -91.19 114.92 27.58 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.124 -1.065 . . . . 1.1200000000000001 108.124 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.532 ' HA ' HG11 ' A' ' 94' ' ' VAL . 12.1 ptt180 -57.36 158.64 5.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.838 -1.164 . . . . 1.46 109.924 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' HA2' ' CD ' ' A' ' 96' ' ' LYS . . . 87.86 -19.39 34.04 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.479 -1.449 . . . . 0.56999999999999995 109.479 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.487 ' HD2' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -100.7 152.53 37.87 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.198 -1.178 . . . . 1.49 110.163 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.36 120.46 3.64 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.845 2.363 . . . . 0.52000000000000002 110.785 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.551 ' CZ ' HG12 ' A' ' 18' ' ' VAL . 4.3 t80 -96.76 121.31 38.47 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.868 -1.16 . . . . 0.48999999999999999 107.868 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.472 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 2.6 m -100.76 134.65 43.42 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.064 -1.022 . . . . 1.1699999999999999 110.587 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.649 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -144.71 124.74 13.57 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.253 -1.017 . . . . 2.0699999999999998 108.253 178.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.44 133.41 48.53 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.371 -0.974 . . . . 1.9299999999999999 108.371 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 16' ' ' VAL . . . -130.2 119.74 23.41 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.056 -1.058 . . . . 0.39000000000000001 110.6 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 12.9 mt -89.71 141.57 28.49 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.154 -2.165 . . . . 1.05 105.154 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.647 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 28.7 p90 -156.78 137.32 13.11 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.341 -1.343 . . . . 0.28999999999999998 110.037 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.523 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.7 OUTLIER -82.45 112.43 19.38 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.327 -0.949 . . . . 0.52000000000000002 108.584 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 81' ' ' VAL . . . -44.46 115.54 0.87 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.564 -0.532 . . . . 0.17999999999999999 109.564 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.455 ' C ' ' HG3' ' A' ' 82' ' ' LYS . 4.7 p30 -80.42 5.77 14.1 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.269 -0.894 . . . . 0.13 109.113 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.548 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 1.3 pt20 -169.5 170.33 8.32 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.34 -0.85 . . . . 0.65000000000000002 109.357 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -101.18 121.07 41.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 1.1000000000000001 108.927 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 t -137.88 146.08 42.93 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.234 -0.916 . . . . 1.1299999999999999 109.867 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.652 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 10.0 mmmt -86.18 -12.76 48.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.416 -0.802 . . . . 0.97999999999999998 109.578 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.6 p -141.92 149.65 40.44 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.831 -0.748 . . . . 1.1100000000000001 109.418 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -145.07 156.64 44.04 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.247 -0.908 . . . . 0.94999999999999996 109.55 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.551 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 0.9 OUTLIER -136.79 140.03 42.22 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.189 -0.944 . . . . 0.31 110.475 -179.313 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 69' ' ' ASP . 3.5 tt -92.94 153.04 3.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.177 -1.416 . . . . 1.1000000000000001 107.177 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' CB ' ' HB3' ' A' ' 109' ' ' LYS . 2.4 tt0 -139.91 117.34 11.39 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.925 -1.109 . . . . 0.17000000000000001 110.039 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 107' ' ' THR . 3.2 mp -119.37 116.32 50.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.027 -1.046 . . . . 0.40999999999999998 109.458 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.6 mtmp? -115.98 157.37 24.7 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.197 -0.939 . . . . 2.6800000000000002 108.712 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -134.22 123.7 24.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.819 -1.175 . . . . 0.68000000000000005 110.305 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -93.63 150.04 20.74 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.852 -0.796 . . . . 1.1799999999999999 108.852 179.181 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 58' ' ' LEU . 15.4 mt -106.72 45.0 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.69999999999999996 109.704 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.59 17.89 3.31 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.392 -0.818 . . . . 0.81999999999999995 109.413 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.84 -45.6 0.07 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.806 -1.318 . . . . 0.35999999999999999 109.806 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.1 tp -109.3 112.33 24.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.173 -1.192 . . . . 0.95999999999999996 109.548 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.17 125.39 29.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.992 -1.068 . . . . 1.4299999999999999 108.95 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.597 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 43.8 mt -117.2 167.31 10.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 122.117 0.961 . . . . 0.71999999999999997 109.812 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.597 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 7.5 t70 -112.4 136.67 51.6 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.061 -1.829 . . . . 4.2000000000000002 106.061 176.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.628 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 1.5 t -101.72 110.16 61.27 Favored Pre-proline 0 C--N 1.293 -1.868 0 C-N-CA 118.866 -1.134 . . . . 0.83999999999999997 111.039 -177.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.5 Cg_endo -81.72 -163.18 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.98 2.453 . . . . 0.75 109.766 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.63 50.75 62.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.959 -1.256 . . . . 1.1799999999999999 109.959 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.593 HG22 ' CD1' ' A' ' 92' ' ' TRP . 13.4 pt -139.88 -156.82 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -1.103 . . . . 0.87 109.035 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.589 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 29.6 t70 -110.05 106.39 15.87 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.441 -0.787 . . . . 0.71999999999999997 109.753 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.551 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -87.12 48.19 1.61 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.19 -0.944 . . . . 0.56999999999999995 108.562 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 9.9 t-20 178.41 79.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.462 -1.31 . . . . 2.8399999999999999 107.462 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.44 -4.05 1.7 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.643 -0.661 . . . . 0.42999999999999999 111.902 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.458 ' HA ' HG23 ' A' ' 76' ' ' VAL . 91.6 m -64.53 -10.58 26.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.539 -1.351 . . . . 3.0099999999999998 109.481 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.71 -20.72 45.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.83999999999999997 109.552 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CE2' ' CD1' ' A' ' 90' ' ' TYR . 79.4 m-85 -112.19 -20.88 11.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.275 -0.89 . . . . 0.34999999999999998 109.289 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.606 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 2.1 m -112.35 166.25 6.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.616 -0.883 . . . . 0.42999999999999999 108.616 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.638 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -91.9 94.8 9.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.001 -1.062 . . . . 2.0800000000000001 111.305 -178.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.459 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 51.6 m -84.99 148.93 52.0 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 107.899 -1.149 . . . . 2.8999999999999999 107.899 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.652 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 25.7 Cg_endo -71.1 136.01 39.43 Favored 'Cis proline' 0 C--N 1.312 -1.367 0 C-N-CA 124.207 -1.164 . . . . 0.23999999999999999 112.664 1.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.581 HD23 ' CD2' ' A' ' 86' ' ' TYR . 16.5 mt -71.7 146.74 48.01 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.333 -2.099 . . . . 1.26 105.333 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 59.4 t -117.22 142.09 32.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 O-C-N 120.337 -1.477 . . . . 1.29 111.17 -177.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 6.2 ttmt -65.34 105.86 1.23 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.59 0.709 . . . . 0.71999999999999997 109.905 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 122.72 -19.36 7.94 Favored Glycine 0 N--CA 1.48 1.583 0 C-N-CA 119.638 -1.268 . . . . 0.23000000000000001 110.066 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.562 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 7.9 tp60 -95.41 159.48 14.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.075 -1.25 . . . . 0.44 107.804 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.54 ' N ' ' HG3' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -110.49 148.43 32.09 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.878 -1.129 . . . . 0.46000000000000002 108.371 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.638 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 28.6 m-85 -128.43 148.76 50.73 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.32 -0.863 . . . . 1.51 109.908 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.495 ' CB ' ' CD2' ' A' ' 40' ' ' LEU . 10.7 p-10 -118.69 113.93 21.94 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.605 -0.887 . . . . 0.97999999999999998 108.605 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.606 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 2.4 tt -108.91 119.16 57.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.272 -0.893 . . . . 0.23999999999999999 111.139 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -99.72 107.68 19.82 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 104.649 -2.352 . . . . 4.5199999999999996 104.649 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.589 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 24.5 t80 -124.12 141.98 51.6 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.577 -1.249 . . . . 0.56000000000000005 113.076 -175.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.586 ' O ' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.29 145.25 24.81 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 106.262 -1.755 . . . . 2.0800000000000001 106.262 176.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.628 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 26.9 t90 -124.71 82.8 2.08 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.797 -1.19 . . . . 1.24 109.867 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -60.71 106.07 0.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.525 -0.734 . . . . 1.6200000000000001 109.442 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.639 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 22.1 t -55.99 144.72 57.35 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.157 -1.053 . . . . 1.3999999999999999 108.157 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.639 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 24.0 Cg_endo -64.36 -7.48 14.22 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.211 1.941 . . . . 3.7000000000000002 112.192 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 95' ' ' PRO . 0.0 OUTLIER 75.38 -10.74 1.19 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.154 -0.966 . . . . 3.6600000000000001 109.88 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.513 ' O ' ' C ' ' A' ' 98' ' ' ALA . 19.9 pt -91.11 -28.42 4.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 108.1 -1.074 . . . . 0.63 108.1 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.513 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -37.3 113.65 0.65 Allowed Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 107.926 -1.138 . . . . 0.65000000000000002 107.926 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.3 177.83 8.3 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 122.769 2.313 . . . . 1.3200000000000001 110.459 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.513 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 4.5 mtmt -82.19 68.74 8.72 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.573 -1.269 . . . . 0.66000000000000003 107.573 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 102' ' ' GLU . 4.0 t -70.86 118.85 14.16 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.495 -0.753 . . . . 0.51000000000000001 109.615 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 1.1 pt-20 -41.16 -47.36 3.25 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.671 -0.863 . . . . 1.99 108.671 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 3.5 t-20 -130.72 141.62 50.39 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.051 -0.722 . . . . 3.1600000000000001 109.051 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.528 ' CG2' HD11 ' A' ' 127' ' ' ILE . 0.9 OUTLIER -131.93 142.65 42.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.101 -1.0 . . . . 0.84999999999999998 109.467 179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 2.7 t -118.27 117.63 55.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.671 -1.233 . . . . 1.1699999999999999 107.671 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 2.2 t -101.89 135.92 36.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 120.768 -1.207 . . . . 0.52000000000000002 110.186 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 94.2 m -116.25 116.59 28.05 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.246 -0.909 . . . . 1.1799999999999999 109.974 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.42 132.23 39.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 106.834 -1.543 . . . . 0.25 106.834 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.642 ' CG ' ' CG1' ' A' ' 116' ' ' VAL . 0.6 OUTLIER -142.03 129.67 21.51 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.327 -1.483 . . . . 2.1899999999999999 112.112 -177.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.647 ' CD1' ' CE2' ' A' ' 41' ' ' PHE . 9.1 mt -103.31 137.97 40.71 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.552 -1.647 . . . . 0.34000000000000002 106.552 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.531 ' CG1' ' HD3' ' A' ' 109' ' ' LYS . 4.2 mp -134.11 116.29 22.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.961 -1.087 . . . . 0.44 110.162 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.07 -135.62 4.48 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.943 -1.663 . . . . 0.25 108.943 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.65 -3.53 17.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -1.16 . . . . 0.82999999999999996 109.403 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -112.85 -7.42 13.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 5.5800000000000001 110.277 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.408 ' O ' HG21 ' A' ' 111' ' ' ILE . . . 156.97 -147.02 14.73 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.274 -1.441 . . . . 0.25 110.483 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.642 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 2.0 t -92.57 107.64 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.433 -1.039 . . . . 1.0700000000000001 109.731 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 110' ' ' LEU . 29.2 mt -56.02 -42.71 76.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.485 -0.759 . . . . 0.41999999999999998 110.488 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.472 ' O ' HG11 ' A' ' 116' ' ' VAL . . . -149.07 -177.01 5.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.909 -1.119 . . . . 0.54000000000000004 109.247 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -170.68 150.24 3.29 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.184 -1.006 . . . . 0.62 109.913 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.401 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -150.81 146.82 26.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.219 -0.926 . . . . 0.28999999999999998 109.626 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 52.4 mt -133.23 116.73 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.957 . . . . 0.48999999999999999 108.936 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.03 142.35 27.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.074 -1.016 . . . . 0.44 109.31 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.0 p -102.7 -87.68 0.41 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 1.4199999999999999 109.59 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -45.66 116.5 1.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 2.9100000000000001 109.011 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -166.62 144.59 9.22 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.795 -1.322 . . . . 0.23000000000000001 109.795 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 1.8 mtmp? -150.55 135.75 17.79 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.075 -1.083 . . . . 2.52 108.075 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.528 HD11 ' CG2' ' A' ' 104' ' ' VAL . 82.3 mt -106.69 143.03 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.639 -1.288 . . . . 0.72999999999999998 110.62 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.513 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 22.4 mtm180 -129.59 177.45 7.21 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.955 -0.757 . . . . 3.29 108.955 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.475 ' HB2' ' HD3' ' A' ' 100' ' ' LYS . 20.5 t70 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.987 -1.006 . . . . 0.80000000000000004 109.636 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.142 0.496 . . . . 3.2000000000000002 109.733 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.524 ' HG2' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -82.85 142.27 31.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 2.4199999999999999 109.501 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.524 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 33.8 m -105.53 165.53 3.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.192 -0.942 . . . . 1.1899999999999999 109.371 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.405 ' C ' HG11 ' A' ' 5' ' ' VAL . 21.2 t0 -90.39 122.76 33.55 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.315 -0.866 . . . . 1.74 109.944 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.405 HG11 ' C ' ' A' ' 4' ' ' ASP . 11.5 m -148.13 156.47 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.413 -0.804 . . . . 1.76 109.079 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -120.08 105.53 11.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.172 -0.955 . . . . 3.46 108.958 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.47 ' OD2' HG13 ' A' ' 13' ' ' ILE . 1.1 m-20 -54.99 141.13 35.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 2.2999999999999998 109.788 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -112.66 -12.12 13.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.269 -0.894 . . . . 1.05 108.71 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 10' ' ' ASN . . . -60.38 -79.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.949 0.88 . . . . 0.39000000000000001 109.581 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 59.7 t-20 -179.16 37.73 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.594 -0.891 . . . . 2.96 108.594 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 20.1 t-20 76.08 30.12 0.73 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.411 -0.959 . . . . 2.3399999999999999 108.411 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.446 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 60.8 mm-40 -76.77 -62.34 1.67 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.491 -0.756 . . . . 2.8300000000000001 109.903 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -61.63 121.73 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.931 -1.105 . . . . 1.0800000000000001 109.94 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.552 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -66.9 -30.41 70.55 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.245 -1.02 . . . . 2.3799999999999999 108.245 178.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.552 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 164.62 131.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.32 -0.622 . . . . 2.71 109.32 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.548 ' HB ' ' CB ' ' A' ' 39' ' ' ALA . 2.1 p -120.75 125.91 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.962 -1.086 . . . . 2.8100000000000001 108.705 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.424 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -109.6 159.28 17.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.375 -0.828 . . . . 0.75 110.879 -178.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.568 HG11 ' CE2' ' A' ' 35' ' ' PHE . 92.5 t -120.8 147.65 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.947 -0.76 . . . . 0.40999999999999998 108.947 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.504 ' N ' HG13 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -100.48 57.89 0.94 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.244 -0.91 . . . . 3.2200000000000002 109.46 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.41 27.71 0.07 OUTLIER Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.309 -1.424 . . . . 2.8399999999999999 110.871 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 m -140.42 -167.26 2.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.864 -1.374 . . . . 2.02 109.812 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 25' ' ' ASP . 4.2 m-70 -128.94 -8.9 4.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.994 . . . . 4.4299999999999997 110.265 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 107.72 -132.76 11.29 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.728 -1.349 . . . . 2.1000000000000001 109.728 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -42.54 -38.43 1.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -1.12 . . . . 1.6000000000000001 109.662 -179.668 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -52.13 170.53 0.23 Allowed Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 121.254 -0.904 . . . . 1.4199999999999999 108.693 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 25' ' ' ASP . 31.6 Cg_endo -75.48 153.59 39.63 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.413 2.075 . . . . 0.65000000000000002 110.184 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.2 m -112.79 136.39 52.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.89000000000000001 109.281 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.461 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 29.1 mm -111.35 107.7 23.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.049 -1.032 . . . . 0.83999999999999997 109.216 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.406 ' HB ' HG12 ' A' ' 127' ' ' ILE . 2.4 mt -88.99 121.62 39.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.29 -0.881 . . . . 0.83999999999999997 108.979 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.478 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 32.2 m-70 -84.87 133.91 34.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.464 -0.773 . . . . 1.1000000000000001 109.971 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.563 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 6.0 mtm180 -57.6 140.09 51.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.533 -0.729 . . . . 2.5 110.409 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 94' ' ' VAL . . . 67.19 1.58 14.46 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.528 -0.844 . . . . 1.1699999999999999 111.274 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.478 ' HE3' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -88.71 149.76 44.61 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 120.755 -1.438 . . . . 1.3400000000000001 109.78 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.459 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 36.6 Cg_endo -81.12 113.74 2.75 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.971 2.447 . . . . 0.76000000000000001 111.031 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CE2' HG11 ' A' ' 18' ' ' VAL . 2.0 t80 -97.61 115.22 27.47 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.345 -1.354 . . . . 0.97999999999999998 107.345 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.434 ' C ' HD13 ' A' ' 37' ' ' LEU . 29.9 m -107.72 129.2 55.05 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.974 -1.079 . . . . 0.75 111.168 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.666 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -143.63 126.26 15.99 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.903 -0.777 . . . . 2.7599999999999998 108.903 179.045 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 12.6 tt0 -94.64 134.44 37.22 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.016 -1.105 . . . . 1.55 108.016 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.548 ' CB ' ' HB ' ' A' ' 16' ' ' VAL . . . -129.5 126.06 37.76 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.868 -1.145 . . . . 0.63 110.48 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 5.1 mt -93.92 144.84 25.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.467 -1.679 . . . . 0.97999999999999998 106.467 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -161.69 139.28 8.85 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.757 -1.177 . . . . 0.40999999999999998 109.517 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.56 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.2 m-20 -86.67 114.47 23.4 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.083 -1.047 . . . . 3.4500000000000002 109.179 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.15 112.55 0.54 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.111 -0.7 . . . . 0.35999999999999999 109.111 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 44' ' ' ASN . 3.0 p30 -82.66 10.27 7.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.063 -1.023 . . . . 0.46000000000000002 109.477 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.578 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 4.6 pt20 -167.23 147.28 5.38 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.418 -0.801 . . . . 0.57999999999999996 109.052 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 2.8 p-10 -84.21 114.17 21.62 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.061 -1.024 . . . . 4.2800000000000002 109.06 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.48 HG22 ' HA3' ' A' ' 112' ' ' GLY . 1.7 t -131.55 155.12 48.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.332 -0.855 . . . . 0.17999999999999999 109.855 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.681 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 9.3 mmmt -92.16 -10.58 38.28 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.263 -0.898 . . . . 1.0 109.982 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.8 p -147.41 139.44 24.32 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.265 -0.897 . . . . 1.55 110.098 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -128.51 153.56 47.05 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.48 -0.762 . . . . 0.65000000000000002 109.13 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -133.32 136.38 45.38 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.374 -0.931 . . . . 0.70999999999999996 110.745 -178.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.419 ' CG2' ' O ' ' A' ' 69' ' ' ASP . 4.9 tt -90.26 151.95 3.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.363 -1.347 . . . . 0.98999999999999999 107.363 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' LYS . 2.7 mt-10 -138.54 116.28 11.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.026 -1.046 . . . . 0.62 110.291 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 107' ' ' THR . 3.3 mp -117.53 112.77 40.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.742 -1.223 . . . . 0.37 109.396 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 40.3 mtmt -111.75 152.4 27.85 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.034 -1.098 . . . . 2.6800000000000002 108.034 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -122.59 156.35 34.43 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.209 -1.396 . . . . 0.93000000000000005 110.737 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.519 ' CB ' ' HB ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -117.06 150.48 38.58 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.796 -0.816 . . . . 1.1899999999999999 108.796 179.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.48 HD21 ' HB2' ' A' ' 101' ' ' SER . 12.7 mt -115.92 43.49 2.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.946 -1.096 . . . . 0.73999999999999999 109.267 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 57.3 t0 51.16 21.95 1.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 1.1699999999999999 108.953 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.44 -53.96 0.17 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.976 -1.65 . . . . 0.20000000000000001 108.976 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 58' ' ' LEU . 2.4 mp -102.67 116.1 31.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.346 -1.09 . . . . 5.9500000000000002 108.945 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.7 mt-10 -91.76 120.78 32.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.035 -1.041 . . . . 3.3100000000000001 109.519 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.594 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 49.2 mt -104.83 169.58 2.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 122.135 0.969 . . . . 1.3 110.011 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.594 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 43.4 m-20 -109.4 138.33 45.92 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.583 -1.636 . . . . 0.66000000000000003 106.583 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.605 HG13 ' CZ2' ' A' ' 92' ' ' TRP . 1.6 t -106.68 107.4 60.16 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.791 -1.193 . . . . 0.67000000000000004 111.406 -177.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.7 Cg_endo -82.83 -158.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 123.236 2.624 . . . . 0.17999999999999999 109.752 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.87 45.82 93.15 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.31 -1.116 . . . . 0.78000000000000003 110.31 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.513 ' CG2' ' CD1' ' A' ' 92' ' ' TRP . 32.3 pt -136.21 -156.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.163 -1.198 . . . . 0.80000000000000004 108.951 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.55 ' N ' ' OH ' ' A' ' 90' ' ' TYR . 31.4 t70 -107.97 105.74 15.66 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.251 -0.906 . . . . 0.93000000000000005 109.473 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.498 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -87.35 48.06 1.59 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.316 -0.994 . . . . 1.51 108.316 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 26.2 t-20 178.08 77.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.691 -1.226 . . . . 1.6899999999999999 107.691 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.464 ' HB1' ' CD1' ' A' ' 88' ' ' ILE . . . -61.96 -5.67 2.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.22 112.009 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.489 ' HA ' HG23 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -63.94 -12.49 37.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.384 -1.448 . . . . 0.27000000000000002 108.987 179.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -75.53 -22.77 56.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.069 -1.02 . . . . 2.0499999999999998 110.156 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.49 ' HB2' HG13 ' A' ' 88' ' ' ILE . 58.7 m-85 -109.42 -30.75 7.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.79000000000000004 108.79 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.599 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 2.1 m -99.23 165.82 2.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.086 -1.079 . . . . 0.34999999999999998 108.086 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.596 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -91.28 91.23 8.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.14 -0.975 . . . . 3.0099999999999998 111.411 -178.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.48 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 11.5 p -89.14 153.59 49.02 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 107.541 -1.281 . . . . 0.32000000000000001 107.541 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.681 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 23.2 Cg_endo -68.53 130.16 14.67 Favored 'Cis proline' 0 C--N 1.313 -1.339 0 C-N-CA 124.474 -1.053 . . . . 0.48999999999999999 112.785 2.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.641 ' CD2' ' CD2' ' A' ' 86' ' ' TYR . 11.1 mt -74.13 115.69 13.91 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.962 -1.495 . . . . 1.1000000000000001 106.962 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.9 t -83.45 141.25 15.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 C-N-CA 119.084 -1.047 . . . . 0.65000000000000002 110.125 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.578 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 3.7 tttt -64.99 116.9 6.89 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.851 0.834 . . . . 3.3399999999999999 110.195 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.06 -11.39 14.85 Favored Glycine 0 N--CA 1.479 1.505 0 N-CA-C 109.43 -1.468 . . . . 0.46999999999999997 109.43 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.544 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 4.2 tp-100 -100.72 156.54 17.28 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.668 -1.234 . . . . 3.7200000000000002 107.668 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -109.3 149.99 28.64 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.363 -0.977 . . . . 1.6200000000000001 108.363 179.508 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.641 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 36.6 m-85 -132.07 149.35 52.43 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.145 -0.972 . . . . 1.04 110.258 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.498 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 9.7 p-10 -117.94 113.69 22.08 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.555 -0.905 . . . . 0.67000000000000004 108.555 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.599 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 7.4 tt -108.15 124.83 64.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.195 -0.941 . . . . 0.47999999999999998 111.626 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.427 ' HD3' ' OE1' ' A' ' 38' ' ' GLU . 5.2 tptt -100.49 105.0 16.41 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.353 -2.091 . . . . 4.4699999999999998 105.353 176.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.594 ' CE2' ' O ' ' A' ' 91' ' ' THR . 27.5 t80 -119.8 141.86 49.11 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 118.579 -1.249 . . . . 0.58999999999999997 113.143 -176.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.594 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -94.38 144.18 25.77 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.482 -1.673 . . . . 1.02 106.482 177.064 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.605 ' CZ2' HG13 ' A' ' 65' ' ' VAL . 22.2 t90 -122.74 89.48 3.12 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.798 -1.189 . . . . 1.1499999999999999 111.162 -177.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -62.39 107.74 0.98 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.239 -0.913 . . . . 2.4100000000000001 108.655 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.562 HG21 ' CZ3' ' A' ' 92' ' ' TRP . 53.8 t -74.9 144.42 79.67 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.474 -0.766 . . . . 1.6599999999999999 109.149 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.553 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 29.8 Cg_endo -70.77 136.15 29.68 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.897 1.731 . . . . 0.98999999999999999 109.573 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.14 4.81 3.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.483 -0.761 . . . . 4.0599999999999996 111.299 -178.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 98' ' ' ALA . 13.2 pt -89.9 -25.93 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.673 -1.267 . . . . 1.6200000000000001 109.047 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.563 ' O ' ' CD ' ' A' ' 31' ' ' ARG . . . -36.17 117.54 0.67 Allowed Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 109.396 -0.594 . . . . 0.53000000000000003 109.396 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -83.01 167.0 14.47 Favored 'Trans proline' 0 C--N 1.298 -2.097 0 C-N-CA 122.595 2.197 . . . . 0.87 109.221 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.549 ' CD ' ' HA ' ' A' ' 128' ' ' ARG . 6.2 mmtp -79.31 77.86 5.82 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.682 -1.229 . . . . 5.3899999999999997 107.682 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.48 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -80.8 118.55 22.42 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.951 -0.759 . . . . 2.1899999999999999 108.951 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 0.7 OUTLIER -37.32 -50.63 1.04 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.604 -0.685 . . . . 2.75 109.911 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.518 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 24.5 m120 -129.96 139.0 51.15 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.077 -1.014 . . . . 3.8300000000000001 110.058 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.522 HG11 ' N ' ' A' ' 105' ' ' VAL . 74.0 t -129.88 149.35 33.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.326 -0.859 . . . . 1.28 109.405 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.522 ' N ' HG11 ' A' ' 104' ' ' VAL . 1.0 OUTLIER -124.13 122.45 64.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.988 -1.116 . . . . 1.76 107.988 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 20.1 t -103.94 144.09 14.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.239 -0.913 . . . . 0.56999999999999995 109.779 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 36.9 m -123.67 114.45 19.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.366 -0.834 . . . . 0.75 109.676 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -95.24 127.52 47.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.289 -1.375 . . . . 0.40000000000000002 107.289 178.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.632 ' CG ' ' CG1' ' A' ' 116' ' ' VAL . 8.5 ttmt -142.58 127.05 17.82 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.387 -1.446 . . . . 3.2000000000000002 111.468 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 1.4 mp -103.46 137.37 41.64 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.472 -1.307 . . . . 3.0499999999999998 107.472 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.516 HD12 ' CD ' ' A' ' 109' ' ' LYS . 4.2 mp -131.09 121.54 49.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.41 -0.806 . . . . 0.72999999999999998 109.856 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.48 ' HA3' HG22 ' A' ' 47' ' ' THR . . . -80.92 -129.88 0.96 Allowed Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.455 -1.858 . . . . 0.5 108.455 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.34 -3.57 11.92 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.284 -1.127 . . . . 0.77000000000000002 109.12 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.401 ' O ' ' CG ' ' A' ' 114' ' ' ASN . 1.3 t30 -116.77 -10.96 10.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.242 -0.911 . . . . 4.9900000000000002 110.708 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.426 ' O ' HG21 ' A' ' 111' ' ' ILE . . . 168.35 -158.47 31.2 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.467 -1.349 . . . . 0.29999999999999999 110.573 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.632 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -87.74 109.84 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -1.107 . . . . 0.51000000000000001 110.162 -179.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.464 ' HG ' ' N ' ' A' ' 112' ' ' GLY . 85.1 mt -53.95 -43.11 69.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 1.3200000000000001 108.999 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HB2' HG12 ' A' ' 13' ' ' ILE . . . -155.46 -162.53 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.095 -1.003 . . . . 0.60999999999999999 109.465 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -178.59 155.24 0.82 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.208 -0.933 . . . . 0.81000000000000005 109.158 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.06 143.97 23.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.011 -1.056 . . . . 0.37 109.925 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.0 mt -133.17 116.92 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.106 -0.996 . . . . 1.3799999999999999 108.41 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.1 146.62 24.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.993 -1.067 . . . . 0.88 110.517 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.5 HG22 ' N ' ' A' ' 124' ' ' HIS . 88.3 m -116.65 162.65 17.31 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.148 -0.686 . . . . 2.6800000000000002 109.148 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.5 ' N ' HG22 ' A' ' 123' ' ' THR . 5.0 t-160 54.03 75.05 0.29 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 2.7200000000000002 109.93 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -131.7 161.62 23.73 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.717 -1.753 . . . . 0.82999999999999996 108.717 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 46.3 mttt -152.85 139.52 18.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.219 -1.166 . . . . 1.8899999999999999 109.255 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.498 HD11 HG23 ' A' ' 104' ' ' VAL . 64.2 mt -106.55 139.83 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.621 -1.3 . . . . 0.51000000000000001 109.677 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.549 ' HA ' ' CD ' ' A' ' 100' ' ' LYS . 22.0 mtt180 -132.92 178.53 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.383 -0.823 . . . . 4.6100000000000003 109.307 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.995 -1.002 . . . . 2.7799999999999998 109.449 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.278 0.561 . . . . 1.3400000000000001 109.502 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 9.4 pt20 -95.89 152.49 18.45 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.322 -0.861 . . . . 1.99 109.266 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.46 HG13 ' HB ' ' A' ' 18' ' ' VAL . 28.2 m -104.76 160.72 5.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.307 -0.87 . . . . 1.1000000000000001 108.903 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.461 ' C ' HG11 ' A' ' 5' ' ' VAL . 56.6 t0 -92.82 118.19 30.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.991 -1.068 . . . . 0.82999999999999996 110.139 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.461 HG11 ' C ' ' A' ' 4' ' ' ASP . 23.2 m -142.17 157.51 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.329 -0.989 . . . . 1.5600000000000001 108.329 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 109.17 17.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.058 -1.026 . . . . 5.4000000000000004 109.596 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 16.9 p-10 -45.06 132.51 7.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 3.73 109.805 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -108.7 -2.9 18.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.805 . . . . 0.56999999999999995 109.505 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.538 ' N ' ' HB3' ' A' ' 119' ' ' CYS . . . -75.33 -74.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.59999999999999998 109.668 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.434 ' CG ' ' O ' ' A' ' 9' ' ' ALA . 7.4 m-20 178.49 55.64 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.557 -0.905 . . . . 3.02 108.557 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.411 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 1.3 t30 65.28 42.85 3.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.446 -0.946 . . . . 3.4100000000000001 108.446 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.472 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -98.9 -63.18 1.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -0.852 . . . . 1.8300000000000001 110.485 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 1.2 mt -60.25 128.05 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.951 -1.093 . . . . 0.98999999999999999 110.417 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.613 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -81.86 -15.64 53.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.31 -0.869 . . . . 1.96 109.358 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.613 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 156.98 141.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.15 -1.056 . . . . 3.9500000000000002 108.15 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.58 ' CG2' ' CB ' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -121.99 126.27 74.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.876 -0.787 . . . . 0.40999999999999998 108.876 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.479 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -112.41 156.45 22.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.005 -1.06 . . . . 2.0699999999999998 110.213 -179.258 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.475 HG11 ' CE2' ' A' ' 35' ' ' PHE . 2.4 t -133.26 143.36 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.302 -0.874 . . . . 1.79 108.718 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.64 100.58 11.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.99 . . . . 3.1800000000000002 109.639 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.47 -56.15 0.52 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.753 -1.339 . . . . 0.58999999999999997 109.753 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 66.8 m -59.65 -167.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -1.128 . . . . 2.7999999999999998 109.232 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -144.31 15.3 1.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.136 -0.977 . . . . 3.0899999999999999 109.834 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 77.55 145.92 2.42 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.74 -1.344 . . . . 3.7000000000000002 109.74 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER 38.14 46.72 0.88 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.595 -0.944 . . . . 4.0800000000000001 110.321 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.436 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER -156.75 170.9 8.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 2.0600000000000001 109.322 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 34.9 Cg_endo -77.71 148.04 25.3 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.707 2.271 . . . . 1.01 111.027 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 87.3 m -116.76 134.27 54.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.383 -0.823 . . . . 0.82999999999999996 109.255 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.465 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 37.6 mm -101.15 104.08 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.77 -1.206 . . . . 1.0800000000000001 108.519 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.4 mt -88.44 119.14 35.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.568 -0.853 . . . . 0.78000000000000003 109.469 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -95.34 106.56 18.62 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.028 -1.101 . . . . 1.53 108.028 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 9.2 ptt180 -52.03 154.65 2.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.977 -1.077 . . . . 2.3900000000000001 110.004 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.88 -10.69 64.49 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.392 -1.483 . . . . 0.45000000000000001 109.392 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HG3' ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -108.79 154.61 41.68 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.279 -1.13 . . . . 1.96 109.565 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.418 ' HD2' ' HG3' ' A' ' 33' ' ' LYS . 34.4 Cg_endo -79.84 114.45 3.18 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.812 2.342 . . . . 0.35999999999999999 110.884 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.475 ' CE2' HG11 ' A' ' 18' ' ' VAL . 3.7 t80 -96.37 132.91 41.4 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.55 -1.278 . . . . 0.75 107.55 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.497 HG21 ' N ' ' A' ' 37' ' ' LEU . 91.8 m -113.39 140.79 47.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.675 -1.265 . . . . 0.81999999999999995 110.879 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.497 ' N ' HG21 ' A' ' 36' ' ' THR . 0.3 OUTLIER -146.55 122.44 10.65 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.86 -0.792 . . . . 4.6299999999999999 108.86 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 3.0 tt0 -101.08 127.82 47.42 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.72 -1.215 . . . . 2.1400000000000001 107.72 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.58 ' CB ' ' CG2' ' A' ' 16' ' ' VAL . . . -126.6 122.98 36.6 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.746 -1.221 . . . . 0.22 110.413 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.53 HD21 ' CB ' ' A' ' 87' ' ' ASP . 20.2 mt -89.69 142.61 27.52 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.606 -1.627 . . . . 1.1899999999999999 106.606 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.644 ' CE1' ' CD1' ' A' ' 110' ' ' LEU . 35.3 p90 -157.85 137.67 12.25 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.823 -1.173 . . . . 0.34000000000000002 109.669 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.5 m-20 -84.73 111.58 19.72 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.239 -0.985 . . . . 1.53 108.928 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -47.84 114.22 0.87 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.298 -0.63 . . . . 0.32000000000000001 109.298 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 117' ' ' LEU . 0.6 OUTLIER -91.87 14.07 16.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 3.5099999999999998 108.944 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.634 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 1.8 pt20 -164.78 138.98 5.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.436 -0.79 . . . . 1.0900000000000001 109.022 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -81.51 123.63 28.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.126 -0.984 . . . . 4.7199999999999998 109.355 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 79' ' ' PRO . 2.6 t -145.13 153.94 41.93 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.225 -0.922 . . . . 0.88 109.382 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 3.2 mmmt -89.43 -12.75 39.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 1.8400000000000001 109.724 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.0 p -147.2 136.7 22.79 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.354 -0.938 . . . . 1.5700000000000001 110.189 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -127.57 155.79 43.26 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.477 -0.934 . . . . 0.66000000000000003 108.477 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.539 ' CD ' ' HB ' ' A' ' 70' ' ' THR . 0.3 OUTLIER -134.55 145.06 48.36 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.422 -0.799 . . . . 3.5699999999999998 110.37 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG2' ' O ' ' A' ' 69' ' ' ASP . 5.6 tt -95.22 154.46 3.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.012 -1.055 . . . . 1.6799999999999999 108.917 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 0.9 OUTLIER -141.04 114.14 8.54 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.538 -0.912 . . . . 1.24 108.538 -179.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 107' ' ' THR . 2.5 mp -113.99 130.81 67.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.95 -1.093 . . . . 0.95999999999999996 109.097 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -126.05 134.03 51.54 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.161 -0.962 . . . . 1.76 108.716 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -122.28 131.5 53.95 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.607 -1.237 . . . . 0.91000000000000003 111.16 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.24 148.21 23.33 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.206 -1.035 . . . . 0.76000000000000001 108.206 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.443 ' O ' ' C ' ' A' ' 59' ' ' ASP . 17.2 mt -109.26 56.97 0.61 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.134 -0.979 . . . . 1.0900000000000001 109.668 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 58' ' ' LEU . 3.4 t70 41.47 27.95 0.06 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.649 -0.657 . . . . 1.53 109.726 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 174.23 -49.89 0.14 Allowed Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.754 -1.212 . . . . 1.22 110.093 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.489 ' HG ' HG13 ' A' ' 63' ' ' ILE . 3.8 tp -108.43 112.73 25.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.021 -1.282 . . . . 0.90000000000000002 110.069 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -79.14 124.58 28.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.127 -0.983 . . . . 1.5600000000000001 108.975 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 71.4 mt -121.21 165.95 16.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.991 0.9 . . . . 0.68000000000000005 110.203 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.56 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 0.9 OUTLIER -112.44 108.71 17.95 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 105.881 -1.896 . . . . 1.3600000000000001 105.881 176.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.613 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 10.3 t -71.34 114.13 25.25 Favored Pre-proline 0 C--N 1.298 -1.663 0 O-C-N 121.501 -0.749 . . . . 0.96999999999999997 111.904 -177.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 37.6 Cg_endo -86.56 -157.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 123.278 2.652 . . . . 0.68000000000000005 109.241 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.27 36.13 61.85 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.247 -0.978 . . . . 0.95999999999999996 110.825 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.598 HG22 ' CD1' ' A' ' 92' ' ' TRP . 9.0 pt -120.72 -157.66 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.957 -1.319 . . . . 0.75 108.849 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.579 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 47.9 t0 -108.29 107.69 18.39 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.381 -0.824 . . . . 0.64000000000000001 109.367 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.539 ' HB ' ' CD ' ' A' ' 51' ' ' LYS . 64.4 p -86.8 45.08 1.22 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.052 -1.03 . . . . 1.3200000000000001 108.443 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 58.2 t30 175.32 83.6 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.4 -1.333 . . . . 1.05 107.4 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.428 ' O ' HG23 ' A' ' 76' ' ' VAL . . . -72.33 4.35 3.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.464 -0.772 . . . . 0.58999999999999997 113.016 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.501 ' HA ' HG23 ' A' ' 76' ' ' VAL . 2.2 t -64.89 -13.91 58.1 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.189 -1.569 . . . . 0.54000000000000004 108.675 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -75.05 -23.98 58.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.222 -0.923 . . . . 2.6699999999999999 109.728 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.52 ' CB ' HG13 ' A' ' 88' ' ' ILE . 74.1 m-85 -109.34 -16.54 14.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 1.1799999999999999 109.203 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.608 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 2.3 m -117.7 166.78 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.246 -1.02 . . . . 0.51000000000000001 108.246 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.625 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -92.25 90.69 7.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.995 -1.065 . . . . 3.6200000000000001 111.536 -178.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.463 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 17.5 p -84.28 151.11 59.08 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 107.077 -1.453 . . . . 0.59999999999999998 107.077 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.665 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.6 Cg_endo -70.11 132.55 23.09 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 124.416 -1.077 . . . . 0.93999999999999995 112.806 2.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.625 HD23 ' CE2' ' A' ' 86' ' ' TYR . 12.8 mt -75.95 113.87 13.94 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.555 -1.646 . . . . 0.79000000000000004 106.555 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' ' 82' ' ' LYS . 55.1 t -79.45 143.31 12.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 C-N-CA 119.53 -0.868 . . . . 1.0800000000000001 110.204 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.634 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 11.4 ttpt -71.5 99.8 2.1 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.824 0.821 . . . . 2.1600000000000001 110.127 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 136.5 -15.97 3.85 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 109.621 -1.392 . . . . 0.68999999999999995 109.621 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.558 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 26.9 tp60 -97.88 156.02 16.79 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.837 -1.172 . . . . 1.6200000000000001 107.837 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -106.94 142.84 35.93 Favored 'General case' 0 C--N 1.294 -1.848 0 O-C-N 120.936 -1.102 . . . . 0.94999999999999996 108.08 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.625 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 21.0 m-85 -122.96 150.65 42.7 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.469 -0.769 . . . . 1.1899999999999999 110.559 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.53 ' CB ' HD21 ' A' ' 40' ' ' LEU . 3.9 p30 -116.7 113.92 23.29 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.171 -1.048 . . . . 0.31 108.171 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.608 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 4.8 tt -106.93 120.05 57.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.032 -1.043 . . . . 1.01 111.793 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.504 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 5.0 tttp -98.36 104.44 16.48 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 104.574 -2.38 . . . . 2.8999999999999999 104.574 175.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.579 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 20.9 t80 -119.13 137.06 53.85 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.045 -1.062 . . . . 0.90000000000000002 112.004 -176.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.59 98.07 10.56 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.656 -1.609 . . . . 2.0 106.656 177.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.613 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 33.6 t90 -72.18 97.02 1.88 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.822 -0.627 . . . . 0.46999999999999997 109.797 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.26 105.16 0.46 Allowed 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.565 -0.854 . . . . 2.46 108.742 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.584 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 64.5 t -65.49 143.19 98.61 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.445 -0.784 . . . . 1.27 109.156 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.584 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 30.1 Cg_endo -72.52 129.2 14.41 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.136 1.89 . . . . 0.65000000000000002 109.726 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -1.27 4.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.573 -0.704 . . . . 3.3700000000000001 110.182 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 98' ' ' ALA . 9.5 pt -90.2 -27.52 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.834 -1.166 . . . . 1.28 110.084 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.519 ' O ' ' CD ' ' A' ' 31' ' ' ARG . . . -34.83 118.8 0.57 Allowed Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 109.428 -0.582 . . . . 0.26000000000000001 109.428 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.57 ' O ' ' N ' ' A' ' 101' ' ' SER . 36.8 Cg_endo -85.02 139.95 7.54 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.852 2.368 . . . . 0.32000000000000001 109.696 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.476 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 7.4 mtmt -52.76 89.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.994 -1.113 . . . . 0.97999999999999998 107.994 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 99' ' ' PRO . 3.4 t -93.71 122.46 36.19 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.439 -0.788 . . . . 0.59999999999999998 109.151 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 8.3 pt-20 -41.39 -44.54 2.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.523 -0.736 . . . . 1.0700000000000001 109.456 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 14.5 t30 -132.17 140.49 48.76 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.521 -0.737 . . . . 1.6100000000000001 109.722 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.524 HG22 ' CD1' ' A' ' 127' ' ' ILE . 1.0 OUTLIER -130.69 143.92 39.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.338 -0.851 . . . . 1.02 109.191 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 2.9 t -118.87 118.7 58.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.217 -1.031 . . . . 2.0899999999999999 108.217 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.8 t -104.61 140.78 21.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.731 -1.231 . . . . 0.88 110.646 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 89.8 m -122.1 127.07 49.71 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.008 -0.738 . . . . 2.0299999999999998 109.008 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -104.79 132.89 50.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 107.853 -1.166 . . . . 0.54000000000000004 107.853 178.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.634 ' CG ' ' CG1' ' A' ' 116' ' ' VAL . 0.3 OUTLIER -141.56 128.63 20.81 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.419 -1.426 . . . . 2.5 111.79 -178.397 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.644 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 13.3 mt -104.55 141.79 35.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.151 -1.425 . . . . 0.26000000000000001 107.151 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.53 ' CD1' ' HD3' ' A' ' 109' ' ' LYS . 4.4 mp -135.57 121.86 32.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.218 -0.926 . . . . 0.40999999999999998 110.039 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.435 ' N ' ' HG ' ' A' ' 117' ' ' LEU . . . -99.71 -144.53 16.43 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.788 -1.725 . . . . 0.56999999999999995 108.788 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.6 -0.28 46.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -1.173 . . . . 1.53 109.747 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.81 -4.15 13.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 2.0600000000000001 110.372 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.45 ' O ' HG21 ' A' ' 111' ' ' ILE . . . 144.27 -147.63 18.98 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.886 -1.286 . . . . 0.28999999999999998 109.886 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.634 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 2.1 t -86.82 108.98 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -1.166 . . . . 0.20999999999999999 109.878 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.468 ' O ' ' OD1' ' A' ' 44' ' ' ASN . 22.1 mt -56.46 -35.12 67.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 1.3100000000000001 109.84 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.412 ' O ' HG11 ' A' ' 116' ' ' VAL . . . -163.03 179.31 7.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.716 -1.24 . . . . 0.35999999999999999 109.515 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.538 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 14.5 t -165.08 157.61 15.94 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.319 -0.863 . . . . 0.48999999999999999 109.314 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.447 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -152.92 147.06 25.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.035 -1.041 . . . . 0.57999999999999996 109.483 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 65.7 mt -134.0 120.9 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.92000000000000004 109.554 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.8 147.53 22.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.144 -0.972 . . . . 0.85999999999999999 109.697 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -78.47 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.89000000000000001 109.837 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -56.91 -177.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 4.6200000000000001 109.353 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . 141.51 138.86 3.58 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.869 -1.292 . . . . 1.4199999999999999 109.869 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 7.8 mtmt -151.09 134.86 16.47 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.455 -1.026 . . . . 2.1299999999999999 108.614 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.524 ' CD1' HG22 ' A' ' 104' ' ' VAL . 58.6 mt -105.8 140.39 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.822 -1.174 . . . . 0.64000000000000001 110.485 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.476 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -133.5 173.5 11.43 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.74 -0.837 . . . . 3.7799999999999998 108.74 178.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.028 -1.045 . . . . 1.1599999999999999 109.513 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.418 -0.586 . . . . 0.97999999999999998 109.418 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.516 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 0.0 OUTLIER -69.46 141.31 54.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.219 -0.926 . . . . 3.4100000000000001 109.211 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.574 ' HA ' ' CA ' ' A' ' 23' ' ' GLY . 2.4 m -109.54 168.8 3.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.339 -0.851 . . . . 2.71 110.184 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -80.16 128.63 33.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.412 -0.805 . . . . 1.1399999999999999 110.952 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.7 m -147.49 159.3 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.703 -1.221 . . . . 1.8300000000000001 107.703 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.68 108.62 15.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.805 -1.184 . . . . 3.6499999999999999 109.462 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -52.76 130.29 32.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.90000000000000002 109.106 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.414 ' CB ' HD12 ' A' ' 121' ' ' ILE . 0.5 OUTLIER -102.4 3.96 38.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.46999999999999997 109.49 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 10' ' ' ASN . . . -81.52 -57.5 3.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.277 -0.889 . . . . 0.63 109.21 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER 161.64 -31.26 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.244 -1.021 . . . . 3.4399999999999999 108.244 -178.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 0.3 OUTLIER 159.61 39.51 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.255 -1.017 . . . . 2.71 108.255 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.479 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 77.1 mm-40 -90.82 -52.75 4.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 2.8799999999999999 110.386 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -73.97 131.8 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.702 -1.249 . . . . 0.82999999999999996 110.082 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 39.2 mmtt -85.95 -22.59 27.31 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.849 -1.167 . . . . 2.0299999999999998 107.849 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.1 ttpt 160.9 128.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.211 -0.662 . . . . 2.79 109.211 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.556 ' HB ' ' CB ' ' A' ' 39' ' ' ALA . 1.5 p -119.31 122.77 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.044 -1.035 . . . . 2.6200000000000001 109.086 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.516 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -105.23 158.69 16.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.261 -0.899 . . . . 1.47 110.41 -178.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.543 ' CG1' ' CE1' ' A' ' 35' ' ' PHE . 24.7 t -127.9 115.69 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.873 . . . . 1.0700000000000001 108.66 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -68.15 89.82 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 3.48 109.749 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.38 -63.54 0.26 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.404 -1.478 . . . . 0.81999999999999995 109.404 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.6 t -90.18 154.08 20.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -1.133 . . . . 1.0700000000000001 109.243 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.444 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 12.2 m80 -94.01 -169.16 2.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 3.5299999999999998 109.789 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.574 ' CA ' ' HA ' ' A' ' 3' ' ' VAL . . . -108.09 154.82 16.44 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.361 -1.496 . . . . 3.9100000000000001 109.361 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.0 6.18 4.55 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.161 -1.199 . . . . 1.8799999999999999 109.079 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -128.57 158.5 71.69 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 108.497 -0.927 . . . . 2.75 108.497 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.78 147.36 21.65 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.708 2.272 . . . . 1.1000000000000001 110.368 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.2 m -115.69 154.42 29.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 1.3100000000000001 109.7 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.481 HG21 ' HG3' ' A' ' 128' ' ' ARG . 45.9 mm -111.95 113.16 43.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.353 -0.842 . . . . 0.63 109.206 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.49 ' HB ' HG12 ' A' ' 127' ' ' ILE . 10.1 mt -94.94 120.89 44.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.249 -0.907 . . . . 1.3899999999999999 108.931 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.485 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 3.9 m-70 -87.43 133.97 33.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.35 -0.844 . . . . 3.0299999999999998 109.639 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.501 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 9.2 mtm180 -54.81 135.06 48.07 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.159 -0.963 . . . . 2.8399999999999999 108.922 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.5 ' N ' ' HB ' ' A' ' 94' ' ' VAL . . . 69.26 20.47 75.12 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.397 -0.906 . . . . 1.21 111.041 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -109.64 137.76 20.45 Favored Pre-proline 0 N--CA 1.482 1.175 0 O-C-N 120.594 -1.533 . . . . 4.79 108.305 179.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.491 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 33.9 Cg_endo -74.18 115.56 4.36 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.844 2.363 . . . . 0.55000000000000004 112.089 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.543 ' CE1' ' CG1' ' A' ' 18' ' ' VAL . 1.5 t80 -98.97 111.74 24.05 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.166 -1.05 . . . . 1.5600000000000001 108.166 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.477 ' O ' HG13 ' A' ' 18' ' ' VAL . 96.2 m -88.04 128.71 35.4 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.087 -1.008 . . . . 1.3100000000000001 109.944 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.404 ' CD1' HG23 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -140.66 123.68 16.49 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.475 -0.765 . . . . 4.6299999999999999 109.238 179.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.473 ' O ' HG23 ' A' ' 16' ' ' VAL . 4.5 tt0 -105.28 126.78 52.48 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.642 -1.244 . . . . 0.92000000000000004 107.642 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.556 ' CB ' ' HB ' ' A' ' 16' ' ' VAL . . . -129.42 132.08 46.92 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.676 -1.265 . . . . 0.57999999999999996 110.975 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 5.4 mt -94.85 144.39 25.69 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.092 -1.447 . . . . 0.51000000000000001 107.092 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.638 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 35.2 p90 -159.36 136.53 9.68 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.785 -1.166 . . . . 0.35999999999999999 109.864 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.4 m-20 -84.2 112.25 20.1 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.292 -0.963 . . . . 1.3899999999999999 108.611 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -45.19 110.88 0.27 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.759 -0.83 . . . . 0.29999999999999999 108.759 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -80.03 4.65 16.4 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.154 -0.966 . . . . 1.5900000000000001 109.5 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.539 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 4.3 pt20 -164.84 156.75 15.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.028 -1.045 . . . . 1.72 109.676 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.463 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 1.9 p-10 -84.79 121.67 28.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 3.79 109.271 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -141.46 139.26 33.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.056 -1.028 . . . . 1.5 110.287 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.676 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 3.2 mmmm -80.92 -10.87 59.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.384 -0.822 . . . . 2.1600000000000001 109.477 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 47' ' ' THR . 12.7 p -147.03 137.86 23.78 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.985 0.897 . . . . 0.60999999999999999 109.714 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -126.3 149.81 48.89 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.815 -0.809 . . . . 0.55000000000000004 108.815 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.554 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 2.2 mtmt -129.28 136.2 49.76 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.114 -1.034 . . . . 0.80000000000000004 110.401 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.468 HG12 HD11 ' A' ' 54' ' ' ILE . 12.2 tt -92.17 151.28 3.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 107.085 -1.45 . . . . 1.1699999999999999 107.085 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -142.13 115.38 8.89 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.089 -1.007 . . . . 0.56000000000000005 109.468 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.585 ' CD1' ' N ' ' A' ' 54' ' ' ILE . 2.3 mp -112.63 111.41 36.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.044 -1.035 . . . . 0.25 109.13 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -106.57 160.57 15.33 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.263 -1.014 . . . . 1.1799999999999999 108.263 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -134.67 150.63 50.66 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.494 -1.379 . . . . 1.3700000000000001 110.829 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 4.6 m -116.26 151.56 35.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.875 -1.157 . . . . 3.3799999999999999 107.875 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.429 HD13 ' HG ' ' A' ' 61' ' ' LEU . 10.9 mt -123.66 60.1 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.648 -1.282 . . . . 2.0499999999999998 110.312 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.4 OUTLIER 44.01 24.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.554 -0.716 . . . . 0.83999999999999997 110.005 179.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 162.85 -47.23 0.33 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.01 -1.236 . . . . 0.35999999999999999 110.01 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.429 ' HG ' HD13 ' A' ' 58' ' ' LEU . 12.3 tp -107.67 117.63 34.61 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.117 -1.225 . . . . 1.51 109.051 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.6 mt-10 -100.8 128.26 46.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 3.9100000000000001 109.937 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.644 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -117.1 178.05 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 122.419 1.104 . . . . 1.9199999999999999 110.04 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.644 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -110.49 143.03 41.44 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.8 -1.185 . . . . 3.7200000000000002 107.8 178.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.665 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 2.9 t -110.87 104.27 55.87 Favored Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 120.977 -1.077 . . . . 0.34999999999999998 111.523 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 95' ' ' PRO . 36.4 Cg_endo -81.81 -154.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.4 2.733 . . . . 0.23000000000000001 109.639 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.91 29.39 64.81 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.792 -1.323 . . . . 0.54000000000000004 109.792 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.512 HD11 ' CD1' ' A' ' 54' ' ' ILE . 9.3 pt -120.44 -162.13 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.153 -1.204 . . . . 0.57999999999999996 109.195 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.544 ' N ' ' OH ' ' A' ' 90' ' ' TYR . 16.6 t70 -103.55 107.05 17.73 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.445 -0.784 . . . . 0.83999999999999997 109.062 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.554 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 1.0 OUTLIER -85.76 44.55 1.12 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.268 -0.895 . . . . 1.6699999999999999 108.682 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 49.2 t30 -177.63 69.65 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.532 -1.285 . . . . 0.95999999999999996 107.532 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.4 -11.2 1.14 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.563 -0.71 . . . . 0.44 111.868 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.506 ' HA ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -61.23 -15.18 31.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.534 -1.354 . . . . 0.47999999999999998 109.379 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.22 -25.06 60.59 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.082 -1.011 . . . . 1.27 109.917 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.509 ' CB ' HG13 ' A' ' 88' ' ' ILE . 78.3 m-85 -102.54 -35.9 8.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.203 -0.936 . . . . 0.46000000000000002 109.189 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.626 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 2.0 m -96.02 166.07 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.134 -1.061 . . . . 0.90000000000000002 108.134 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.619 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -88.24 93.1 9.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.945 -1.097 . . . . 1.51 110.692 -178.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.491 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 11.9 p -90.06 154.04 47.15 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 107.682 -1.229 . . . . 0.20000000000000001 107.682 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.676 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 26.3 Cg_endo -68.7 133.56 24.26 Favored 'Cis proline' 0 C--N 1.312 -1.359 0 C-N-CA 124.223 -1.157 . . . . 0.17000000000000001 112.513 2.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.617 HD23 ' CE2' ' A' ' 86' ' ' TYR . 13.1 mt -76.86 112.42 13.44 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.782 -1.562 . . . . 1.1299999999999999 106.782 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.8 t -80.77 136.79 22.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 C-N-CA 119.707 -0.797 . . . . 0.39000000000000001 110.114 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 25.0 tttm -60.54 110.42 1.27 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.648 0.737 . . . . 4.2699999999999996 110.253 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 126.71 -16.46 6.54 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 110.264 -1.134 . . . . 0.46000000000000002 110.264 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.565 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 13.6 tp60 -97.99 157.39 16.14 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.125 -1.22 . . . . 0.72999999999999998 108.162 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -110.68 143.13 41.63 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.074 -1.084 . . . . 1.3899999999999999 108.074 179.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.619 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 19.0 m-85 -125.94 152.83 45.12 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.409 -0.807 . . . . 0.20000000000000001 110.438 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.467 ' OD2' HD21 ' A' ' 40' ' ' LEU . 24.0 t0 -119.49 113.18 20.35 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.882 -1.155 . . . . 4.0700000000000003 107.882 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.626 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 9.1 tt -106.71 126.75 62.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.361 -0.936 . . . . 0.78000000000000003 111.506 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.43 ' HA ' ' HG3' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -100.59 119.89 39.21 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 105.124 -2.176 . . . . 2.71 105.124 176.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.544 ' OH ' ' N ' ' A' ' 69' ' ' ASP . 34.4 t80 -138.03 140.74 40.24 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.051 -1.46 . . . . 0.78000000000000003 112.698 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.501 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -92.74 138.96 31.04 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.512 -1.662 . . . . 1.3200000000000001 106.512 177.058 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.665 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 26.4 t90 -120.27 82.73 1.94 Allowed 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.949 -1.094 . . . . 1.1699999999999999 109.472 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -61.28 108.51 0.93 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.591 -0.693 . . . . 1.99 109.958 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.609 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 33.9 t -47.39 144.04 4.87 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.134 -1.062 . . . . 1.3899999999999999 108.134 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.609 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 26.7 Cg_endo -68.67 -8.7 24.03 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.854 2.369 . . . . 3.7200000000000002 113.038 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 0.9 OUTLIER 77.84 -17.82 0.54 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.913 -1.117 . . . . 3.6899999999999999 110.665 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.523 ' O ' ' C ' ' A' ' 98' ' ' ALA . 11.8 pt -88.11 -25.62 5.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 120.704 -1.247 . . . . 1.1799999999999999 108.335 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.523 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -33.84 116.77 0.48 Allowed Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.92 -0.771 . . . . 0.56999999999999995 108.92 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.606 ' O ' ' N ' ' A' ' 101' ' ' SER . 36.0 Cg_endo -83.6 129.41 4.93 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.674 2.249 . . . . 0.90000000000000002 109.165 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.469 ' HG2' ' HA ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -46.93 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.457 -0.942 . . . . 4.4199999999999999 108.457 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -103.38 124.42 48.67 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.167 -0.679 . . . . 2.4900000000000002 109.167 -178.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 6.4 pt-20 -41.65 -46.38 3.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.443 -0.786 . . . . 0.93000000000000005 110.022 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -129.36 140.68 51.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.901 -1.124 . . . . 0.81000000000000005 110.223 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 57' ' ' SER . 2.7 t -133.1 147.22 31.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.531 -0.731 . . . . 0.31 109.377 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 57' ' ' SER . 2.7 t -123.31 118.85 55.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.516 -1.29 . . . . 1.0 107.516 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.1 t -100.92 142.49 15.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.281 -0.887 . . . . 0.80000000000000004 110.039 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 24.1 m -122.52 117.15 25.24 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.607 -0.683 . . . . 1.04 109.358 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -94.9 129.12 45.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 107.001 -1.481 . . . . 0.39000000000000001 107.001 178.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.623 ' CG ' ' CG1' ' A' ' 116' ' ' VAL . 0.7 OUTLIER -140.08 130.79 25.8 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.363 -1.461 . . . . 2.27 112.05 -177.119 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.638 ' CD1' ' CZ ' ' A' ' 41' ' ' PHE . 14.1 mt -101.79 143.01 32.23 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.945 -1.502 . . . . 1.77 106.945 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.541 ' CD1' ' HD3' ' A' ' 109' ' ' LYS . 4.2 mp -136.4 116.89 17.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 120.823 -1.173 . . . . 0.72999999999999998 111.065 -177.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.43 -169.71 41.96 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.202 -1.959 . . . . 0.95999999999999996 108.202 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.58 1.67 25.15 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.035 -1.274 . . . . 1.1399999999999999 109.709 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.37 -6.51 12.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.197 -0.939 . . . . 4.71 110.702 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.47 ' O ' HG21 ' A' ' 111' ' ' ILE . . . 149.91 -153.12 24.91 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.537 -1.316 . . . . 0.52000000000000002 110.209 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.623 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -85.08 110.03 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.382 -1.069 . . . . 1.8300000000000001 109.606 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.467 HD12 HD13 ' A' ' 80' ' ' LEU . 26.7 mt -58.66 -39.89 81.92 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.206 -0.934 . . . . 0.63 109.816 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 119' ' ' CYS . . . -154.87 -162.64 1.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.989 -1.07 . . . . 0.93000000000000005 109.468 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.48 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 53.4 t 178.88 154.6 0.42 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.029 -1.045 . . . . 0.32000000000000001 109.499 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.27 152.31 32.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.03 -1.044 . . . . 0.44 109.695 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.414 HD12 ' CB ' ' A' ' 8' ' ' CYS . 53.5 mt -134.99 140.2 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.2 -0.937 . . . . 1.1000000000000001 109.083 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.19 119.46 38.9 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.456 -1.402 . . . . 0.72999999999999998 108.571 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 51.3 p -70.12 -33.24 71.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -0.839 . . . . 3.1800000000000002 110.498 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -120.97 154.89 35.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.95 -1.094 . . . . 1.8300000000000001 110.098 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 126' ' ' LYS . . . 166.1 155.3 8.71 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.476 -1.449 . . . . 0.76000000000000001 109.476 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 30.6 mttt -154.88 138.09 15.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -1.197 . . . . 2.5899999999999999 108.563 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.49 HG12 ' HB ' ' A' ' 29' ' ' ILE . 67.0 mt -104.17 140.7 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.508 -1.37 . . . . 0.93000000000000005 109.769 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.481 ' HG3' HG21 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -124.86 154.21 41.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.465 -0.772 . . . . 5.75 109.824 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.413 ' HB3' ' HG3' ' A' ' 100' ' ' LYS . 2.9 p30 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 118.0 -1.0 . . . . 4.6799999999999997 109.563 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.334 0.588 . . . . 2.5499999999999998 109.492 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 0.0 OUTLIER -66.55 159.69 26.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 3.52 109.483 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' A' ' 21' ' ' CYS . 3.0 m -99.16 167.24 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 1.2 109.307 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 51.9 t0 -92.53 124.21 36.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.87 110.211 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.3 m -146.27 148.93 16.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.464 -0.939 . . . . 0.95999999999999996 108.464 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.23 110.33 21.5 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.095 -1.003 . . . . 4.1699999999999999 109.609 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -53.91 142.92 22.89 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.335 -0.853 . . . . 3.54 109.374 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.92 -14.17 11.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.344 -0.847 . . . . 0.95999999999999996 108.963 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.94 -65.65 0.67 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.868 0.842 . . . . 0.40999999999999998 109.199 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.47 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 3.4 t-20 173.98 59.23 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.134 -1.061 . . . . 4.4500000000000002 108.134 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 53.12 21.37 2.12 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.972 -1.08 . . . . 2.4399999999999999 108.087 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.473 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 19.7 mm-40 -64.67 -61.27 2.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.582 -0.699 . . . . 3.52 109.363 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -58.95 127.35 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.34999999999999998 109.459 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.565 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 11.4 mmpt? -77.13 -19.83 56.4 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.242 -0.911 . . . . 0.68000000000000005 108.899 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 0.8 OUTLIER 156.59 128.54 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.882 -0.784 . . . . 2.8100000000000001 108.882 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.584 ' CG2' ' CB ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -108.33 123.18 63.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.377 -0.972 . . . . 0.67000000000000004 108.377 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.471 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 1.3 mtm -117.03 148.05 41.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.049 -1.032 . . . . 2.29 110.796 -178.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.468 HG13 ' OD1' ' A' ' 19' ' ' ASP . 31.6 t -103.9 158.03 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.385 -0.968 . . . . 1.0600000000000001 108.385 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.468 ' OD1' HG13 ' A' ' 18' ' ' VAL . 8.8 p-10 -44.12 -31.28 0.92 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.092 -1.005 . . . . 4.1100000000000003 109.802 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.92 97.45 0.12 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.57 -1.3 . . . . 3.8199999999999998 110.27 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -108.48 -66.78 1.02 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -1.135 . . . . 3.4300000000000002 108.913 179.266 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.489 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER 168.93 -27.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.833 . . . . 5.71 109.66 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 101.13 -135.71 12.31 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.957 -1.257 . . . . 2.1600000000000001 109.957 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 23' ' ' GLY . 29.1 t -40.4 -34.68 0.36 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.534 -0.98 . . . . 2.27 109.988 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.412 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -67.12 164.92 31.55 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 2.25 109.42 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 25' ' ' ASP . 34.3 Cg_endo -78.03 162.18 29.21 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.692 2.261 . . . . 2.6699999999999999 109.844 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.6 m -116.62 153.51 32.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.909 . . . . 1.3300000000000001 109.371 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.505 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 47.8 mm -107.37 109.13 27.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.911 -1.118 . . . . 0.54000000000000004 108.872 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.453 HG21 HG23 ' A' ' 94' ' ' VAL . 1.9 mt -91.19 119.31 38.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.444 -0.785 . . . . 0.5 109.357 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.44 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 24.6 m-70 -84.41 114.57 22.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.368 -0.832 . . . . 1.3400000000000001 110.122 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.554 ' CD ' ' HB2' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -48.12 148.41 1.79 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.566 -0.709 . . . . 3.5800000000000001 111.127 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.73 -22.55 4.03 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.923 -0.871 . . . . 0.93000000000000005 110.923 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.471 ' O ' HG22 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -93.01 155.18 41.53 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.77 -1.43 . . . . 3.77 109.745 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.442 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 36.4 Cg_endo -79.11 162.21 26.06 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.863 2.376 . . . . 1.3999999999999999 110.689 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.466 ' HB3' ' HB3' ' A' ' 92' ' ' TRP . 2.5 t80 -135.08 122.14 21.33 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.172 -1.048 . . . . 1.0900000000000001 108.172 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.451 ' O ' HG11 ' A' ' 18' ' ' VAL . 2.9 m -96.36 128.2 43.06 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.77 -1.207 . . . . 1.95 110.427 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.41 123.44 15.47 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.359 -0.838 . . . . 4.71 108.767 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 16' ' ' VAL . 5.6 mt-10 -96.96 126.9 42.43 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.31 -0.996 . . . . 2.3999999999999999 108.31 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.584 ' CB ' ' CG2' ' A' ' 16' ' ' VAL . . . -123.97 118.96 28.2 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.875 -1.13 . . . . 0.44 110.386 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 5.9 mt -92.76 141.9 27.94 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.505 -1.665 . . . . 0.53000000000000003 106.505 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.621 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 27.8 p90 -158.23 142.13 15.58 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 120.695 -1.253 . . . . 0.28000000000000003 109.751 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.466 ' O ' ' OE1' ' A' ' 12' ' ' GLU . 1.8 m-20 -87.06 110.88 20.39 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.408 -0.917 . . . . 0.60999999999999999 108.728 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.3 114.1 0.74 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.61 -0.681 . . . . 0.16 109.398 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.425 ' OD1' ' C ' ' A' ' 44' ' ' ASN . 4.0 p30 -85.31 9.76 14.47 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.191 -0.943 . . . . 0.37 109.425 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.566 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 6.0 pt20 -166.24 149.16 7.17 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.297 -0.877 . . . . 0.80000000000000004 109.412 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -86.27 106.16 17.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.057 -1.027 . . . . 2.5699999999999998 108.963 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.88 154.32 38.47 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.293 -0.879 . . . . 1.54 109.787 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.687 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 11.0 mmmt -89.22 -12.44 40.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 1.78 109.755 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 p -146.47 137.35 24.17 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.156 0.979 . . . . 0.79000000000000004 110.195 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -127.93 149.17 50.44 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.357 -1.349 . . . . 0.51000000000000001 107.357 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.56 ' HD2' ' CB ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -135.27 140.58 45.31 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.646 -0.822 . . . . 3.7400000000000002 110.492 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.479 HG13 HD21 ' A' ' 110' ' ' LEU . 7.0 tt -109.6 124.66 66.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.271 -0.893 . . . . 1.3799999999999999 108.836 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 11.4 pt-20 -129.79 117.71 20.66 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.478 -1.304 . . . . 3.8300000000000001 107.478 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 107' ' ' THR . 3.8 mp -93.14 136.24 25.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 121.448 -0.782 . . . . 1.04 109.146 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -119.05 131.9 55.99 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.225 -1.028 . . . . 1.05 108.225 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -116.33 154.38 30.3 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 120.7 -1.25 . . . . 1.1100000000000001 111.608 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -120.14 150.75 40.13 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.71 -1.219 . . . . 1.28 107.71 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.532 ' CD2' ' HD2' ' A' ' 99' ' ' PRO . 3.4 mt -132.55 75.02 1.61 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.823 -1.173 . . . . 2.6800000000000002 110.428 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER 40.51 25.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.596 -0.69 . . . . 1.73 110.274 179.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 152.35 -29.52 0.87 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.387 -1.387 . . . . 1.54 110.443 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.477 ' HG ' HD11 ' A' ' 58' ' ' LEU . 4.9 tp -110.3 110.02 20.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.848 -1.384 . . . . 2.79 110.112 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 2.0 tt0 -112.75 119.85 39.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.201 -0.937 . . . . 1.75 108.887 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.623 HG13 ' N ' ' A' ' 64' ' ' ASP . 2.2 tp -126.32 164.44 26.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 122.171 0.986 . . . . 6.1399999999999997 109.65 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.623 ' N ' HG13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -83.38 110.15 17.91 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 105.64 -1.985 . . . . 1.5900000000000001 105.64 177.056 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.651 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 3.0 t -66.5 113.68 13.89 Favored Pre-proline 0 C--N 1.293 -1.867 0 O-C-N 121.322 -0.862 . . . . 0.97999999999999998 110.786 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 37.5 Cg_endo -81.91 -165.7 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 123.121 2.547 . . . . 0.87 109.757 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 93' ' ' ASN . . . 58.0 56.83 23.03 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.796 -1.322 . . . . 1.3799999999999999 109.796 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.555 HG22 ' CD1' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -149.12 -155.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.216 -1.167 . . . . 1.5800000000000001 109.002 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.532 ' N ' ' OH ' ' A' ' 90' ' ' TYR . 38.6 t0 -114.18 112.13 22.67 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.096 -0.642 . . . . 0.72999999999999998 109.575 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.56 ' CB ' ' HD2' ' A' ' 51' ' ' LYS . 21.2 p -90.39 42.41 1.1 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.645 -1.242 . . . . 1.3799999999999999 107.645 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 8.3 t30 176.94 88.33 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.497 -1.298 . . . . 2.29 107.497 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.503 ' HB2' ' CD1' ' A' ' 88' ' ' ILE . . . -76.45 7.35 4.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.91000000000000003 112.613 -176.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.483 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.6 t -65.82 -12.99 58.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.225 -1.547 . . . . 0.28000000000000003 108.837 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -78.56 -21.02 49.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.056 -1.027 . . . . 0.69999999999999996 109.819 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.416 ' CB ' HG13 ' A' ' 88' ' ' ILE . 72.1 m-85 -108.74 -20.93 12.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 0.22 108.681 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.624 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 2.0 m -113.94 165.58 8.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.687 -1.227 . . . . 0.32000000000000001 107.687 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.595 ' HG2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -92.54 93.05 8.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.983 -1.073 . . . . 2.5099999999999998 111.202 -178.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.473 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 15.7 p -86.69 153.06 55.12 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 107.316 -1.364 . . . . 0.14000000000000001 107.316 177.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.687 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.5 Cg_endo -69.52 132.13 21.04 Favored 'Cis proline' 0 C--N 1.311 -1.401 0 C-N-CA 124.363 -1.099 . . . . 0.28999999999999998 112.778 2.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.624 HD23 ' CE2' ' A' ' 86' ' ' TYR . 11.1 mt -77.12 111.11 12.38 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.777 -1.564 . . . . 1.46 106.777 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.6 t -78.32 144.31 11.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 121.715 0.769 . . . . 0.45000000000000001 110.782 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.566 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 14.2 ttpt -67.17 110.95 3.67 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.799 0.809 . . . . 1.3700000000000001 109.858 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 124.12 -12.24 8.1 Favored Glycine 0 C--N 1.298 -1.578 0 N-CA-C 109.479 -1.448 . . . . 0.33000000000000002 109.479 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.618 ' CG ' ' CE1' ' A' ' 86' ' ' TYR . 6.8 tp60 -103.28 151.6 22.5 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.839 -1.171 . . . . 0.34000000000000002 107.839 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -103.97 144.98 30.82 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.92 -1.141 . . . . 2.7200000000000002 107.92 179.037 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.624 ' CE2' HD23 ' A' ' 80' ' ' LEU . 38.9 m-85 -125.67 143.56 50.98 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.008 -1.057 . . . . 0.68000000000000005 110.212 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.482 ' HB3' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -109.29 115.7 30.49 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.845 -0.798 . . . . 2.8199999999999998 108.845 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.624 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 3.4 tt -111.06 119.1 58.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.109 -0.995 . . . . 0.28000000000000003 111.406 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -94.39 119.35 33.0 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 104.662 -2.347 . . . . 2.8500000000000001 104.662 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.607 ' CE2' ' O ' ' A' ' 91' ' ' THR . 24.0 t80 -132.7 143.04 49.36 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 117.539 -1.664 . . . . 0.75 113.982 -175.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.607 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -92.44 144.33 25.47 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 105.742 -1.947 . . . . 1.1499999999999999 105.742 176.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.651 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 22.7 t90 -127.39 97.69 4.99 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.667 -1.271 . . . . 1.3899999999999999 110.724 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 2.9 m-80 -61.75 103.08 0.31 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.646 -0.872 . . . . 2.8399999999999999 108.646 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.603 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 88.3 t -59.23 144.02 83.96 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.325 -0.859 . . . . 1.02 108.747 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.61 ' HD3' ' CG1' ' A' ' 65' ' ' VAL . 29.4 Cg_endo -71.23 121.37 7.73 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.0 1.8 . . . . 1.28 110.165 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.459 ' HA ' ' HG2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -66.56 -0.98 3.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.818 -0.551 . . . . 4.3499999999999996 110.971 -178.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.498 ' O ' ' C ' ' A' ' 98' ' ' ALA . 9.4 pt -92.41 -25.09 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.706 -1.246 . . . . 1.71 109.29 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.554 ' HB2' ' CD ' ' A' ' 31' ' ' ARG . . . -28.62 122.45 0.26 Allowed Pre-proline 0 N--CA 1.491 1.613 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.782 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.599 ' O ' ' N ' ' A' ' 101' ' ' SER . 36.8 Cg_endo -87.01 115.57 1.19 Allowed 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.377 2.052 . . . . 1.23 107.995 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.506 ' CD ' ' HA ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -38.42 92.44 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.742 0.782 . . . . 5.0300000000000002 108.946 -179.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 99' ' ' PRO . 1.4 t -102.76 115.03 29.79 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.33 -0.619 . . . . 1.3799999999999999 109.33 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.452 ' O ' ' HE2' ' A' ' 126' ' ' LYS . 0.1 OUTLIER -41.15 -36.28 0.71 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.684 -0.635 . . . . 3.8399999999999999 109.573 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 1.5 t30 -128.48 138.36 52.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 3.23 110.097 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.543 ' CG2' HG13 ' A' ' 127' ' ' ILE . 20.2 t -135.79 150.54 28.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.573 -0.704 . . . . 1.8300000000000001 109.896 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 57' ' ' SER . 2.9 t -123.33 117.62 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.229 -1.026 . . . . 1.46 108.229 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.31 142.22 15.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 120.966 -1.084 . . . . 0.80000000000000004 110.195 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 34.3 m -125.9 117.05 22.49 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.802 -0.561 . . . . 0.63 109.586 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER -96.78 125.79 49.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 106.945 -1.502 . . . . 0.40999999999999998 106.945 178.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.568 ' CD ' ' CG1' ' A' ' 116' ' ' VAL . 0.9 OUTLIER -135.41 137.03 41.86 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.552 -1.342 . . . . 1.9199999999999999 111.504 -177.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.621 ' CD1' ' CZ ' ' A' ' 41' ' ' PHE . 10.0 mt -113.87 139.97 48.73 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.66 -1.607 . . . . 0.5 106.66 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.524 ' CD1' ' HD2' ' A' ' 109' ' ' LYS . 3.7 mp -134.17 115.99 21.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 120.707 -1.245 . . . . 0.55000000000000004 110.769 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.08 -150.85 16.26 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.364 -1.894 . . . . 0.62 108.364 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -96.65 -0.6 48.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.082 -1.246 . . . . 1.22 109.551 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.98 -2.52 12.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.095 -1.003 . . . . 4.25 110.401 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.28 -164.65 29.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.847 -1.301 . . . . 0.29999999999999999 109.847 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.568 ' CG1' ' CD ' ' A' ' 109' ' ' LYS . 1.8 t -77.97 112.02 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -1.128 . . . . 0.58999999999999997 109.671 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 50' ' ' ALA . 25.7 mt -57.93 -38.67 76.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 2.2400000000000002 110.014 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.463 ' O ' HG11 ' A' ' 116' ' ' VAL . . . -157.07 -171.05 3.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.001 -1.062 . . . . 0.65000000000000002 109.128 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -177.44 151.24 0.75 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.263 -0.898 . . . . 1.04 109.393 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -149.63 153.2 36.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.045 . . . . 0.53000000000000003 109.771 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.5 mt -134.81 138.91 48.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.371 -0.831 . . . . 1.99 108.783 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.07 133.62 34.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.84 -1.162 . . . . 0.91000000000000003 109.732 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -68.41 0.34 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.466 -0.771 . . . . 3.04 109.928 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -128.76 142.07 51.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.9 . . . . 5.8399999999999999 110.322 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -156.83 175.32 34.4 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.895 -1.682 . . . . 0.75 108.895 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.467 ' HB3' HD11 ' A' ' 28' ' ' ILE . 31.0 ttmt -153.07 138.44 17.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -1.14 . . . . 4.0700000000000003 108.45 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.543 HG13 ' CG2' ' A' ' 104' ' ' VAL . 62.0 mt -106.61 140.31 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.427 -1.421 . . . . 0.81000000000000005 109.738 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.506 ' HA ' ' CD ' ' A' ' 100' ' ' LYS . 10.4 mtt180 -132.42 174.93 9.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.401 -0.812 . . . . 2.48 108.948 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.2 t0 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.005 -1.06 . . . . 2.5699999999999998 109.702 -179.759 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' A' ' 17' ' ' MET . 4.3 m-20 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.203 -0.665 . . . . 2.5800000000000001 109.203 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.52 ' CB ' ' HG2' ' A' ' 17' ' ' MET . 1.5 pt20 -109.08 154.33 22.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.166 -0.959 . . . . 2.02 109.991 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 21' ' ' CYS . 2.3 m -105.58 162.97 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.33 -0.857 . . . . 0.34000000000000002 109.121 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.32 126.28 38.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 3.3599999999999999 109.141 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 121' ' ' ILE . 27.6 m -143.69 162.64 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.874 -0.787 . . . . 0.92000000000000004 108.874 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -112.82 104.42 12.43 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.151 -1.055 . . . . 5.1699999999999999 108.151 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -45.14 113.04 0.51 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.406 -0.809 . . . . 1.9399999999999999 110.18 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.467 ' HB3' HG13 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -83.84 -7.47 59.44 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.636 -0.875 . . . . 1.3300000000000001 108.636 179.225 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.528 ' N ' ' HB3' ' A' ' 119' ' ' CYS . . . -88.54 -79.52 0.31 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.371 -0.83 . . . . 0.96999999999999997 109.5 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 178.83 61.13 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.761 -0.776 . . . . 1.6399999999999999 109.682 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 57.93 17.98 4.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.293 -0.879 . . . . 1.1499999999999999 109.362 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.83 -66.81 0.52 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.355 -0.841 . . . . 1.4099999999999999 109.606 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -56.23 120.0 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.0 -1.063 . . . . 0.60999999999999999 109.769 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.584 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -61.0 -29.08 69.49 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.443 -0.786 . . . . 3.02 109.452 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.584 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 6.9 pttt 168.07 131.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.579 -0.897 . . . . 1.5800000000000001 108.579 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.55 ' CG2' ' CB ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -108.18 130.79 60.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.054 -1.091 . . . . 0.75 108.054 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.52 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 8.2 mtm -122.63 153.22 39.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.074 -1.016 . . . . 0.87 111.012 -177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.634 ' CG1' ' CE2' ' A' ' 35' ' ' PHE . 2.5 t -127.0 128.36 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.577 -0.898 . . . . 0.97999999999999998 108.577 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.79 -17.39 35.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.149 -0.969 . . . . 2.4500000000000002 110.496 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 21' ' ' CYS . . . -88.33 -94.68 1.01 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.646 -1.381 . . . . 2.1299999999999999 109.646 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' O ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -47.53 173.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.213 -1.169 . . . . 0.79000000000000004 108.975 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.493 ' NE2' ' CB ' ' A' ' 25' ' ' ASP . 5.5 p80 -139.48 3.34 2.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.927 -1.108 . . . . 5.1399999999999997 110.594 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.13 -157.51 27.91 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.054 -1.545 . . . . 1.9299999999999999 110.951 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.468 ' O ' ' C ' ' A' ' 25' ' ' ASP . 5.0 t -41.35 -36.27 0.79 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.613 -0.934 . . . . 4.4000000000000004 110.553 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.493 ' CB ' ' NE2' ' A' ' 22' ' ' HIS . 0.7 OUTLIER -39.92 157.18 0.15 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.5 -0.75 . . . . 2.1200000000000001 109.607 -179.648 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.82 138.88 19.22 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.957 2.438 . . . . 0.82999999999999996 110.746 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -116.25 132.66 56.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.446 -0.784 . . . . 1.3200000000000001 109.331 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.543 HG23 ' CD2' ' A' ' 30' ' ' HIS . 46.6 mm -101.97 109.31 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.019 -1.051 . . . . 0.98999999999999999 108.616 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.3 mt -92.53 113.43 27.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.212 -0.93 . . . . 1.01 109.391 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.543 ' CD2' HG23 ' A' ' 28' ' ' ILE . 5.7 m170 -89.63 105.97 18.15 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.468 -1.308 . . . . 1.73 107.468 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.487 ' HD2' ' O ' ' A' ' 98' ' ' ALA . 2.6 ptt180 -45.26 152.55 0.27 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.055 -1.028 . . . . 1.21 110.051 -178.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 96' ' ' LYS . . . 94.58 -15.88 62.36 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.57 -1.412 . . . . 0.46000000000000002 109.57 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.483 ' HE2' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -102.3 152.51 38.3 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.178 -1.189 . . . . 3.5699999999999998 109.445 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -81.3 119.85 3.53 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.886 2.391 . . . . 0.56000000000000005 110.825 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.634 ' CE2' ' CG1' ' A' ' 18' ' ' VAL . 5.2 t80 -97.83 116.81 30.78 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.945 -1.502 . . . . 0.78000000000000003 106.945 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.445 ' C ' ' CD1' ' A' ' 37' ' ' LEU . 28.3 m -96.21 131.03 43.12 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.15 -0.969 . . . . 0.85999999999999999 110.838 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.633 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -134.64 141.63 46.64 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.696 -0.854 . . . . 2.1000000000000001 108.696 178.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 0.7 OUTLIER -121.66 127.09 50.42 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.293 -1.003 . . . . 1.1599999999999999 108.293 -179.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.55 ' CB ' ' CG2' ' A' ' 16' ' ' VAL . . . -132.75 121.51 23.16 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.597 -1.314 . . . . 0.59999999999999998 110.513 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 2.3 mt -88.28 145.03 26.08 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 105.488 -2.041 . . . . 1.2 105.488 177.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.659 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 28.2 p90 -157.15 141.93 16.84 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.143 -1.423 . . . . 0.31 110.38 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 26.8 m-20 -85.51 111.01 19.61 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.202 -0.936 . . . . 1.3600000000000001 108.79 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.82 114.8 0.9 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.703 -0.623 . . . . 0.28999999999999998 109.329 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.427 ' C ' ' HG3' ' A' ' 82' ' ' LYS . 38.8 p30 -83.66 7.85 16.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.096 -1.003 . . . . 1.9199999999999999 109.847 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.537 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 3.5 pt20 -168.39 162.02 12.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.068 -1.02 . . . . 1.0600000000000001 109.685 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 46' ' ' ASN . 10.7 p-10 -89.1 120.55 30.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.215 -0.928 . . . . 4.2800000000000002 109.245 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -141.6 141.74 33.46 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.63 110.17 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.646 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 8.0 mmmt -84.12 -11.45 56.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.54 -0.725 . . . . 1.1499999999999999 109.688 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.2 p -144.75 138.1 26.94 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.977 0.894 . . . . 0.93999999999999995 109.729 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -126.57 153.23 45.52 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.691 -0.855 . . . . 0.51000000000000001 108.691 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.505 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 0.5 OUTLIER -132.09 136.92 47.52 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.959 -1.088 . . . . 1.3500000000000001 110.833 -179.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.505 HD11 HG22 ' A' ' 52' ' ' ILE . 4.5 tt -93.61 148.95 4.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.527 -1.286 . . . . 0.97999999999999998 107.527 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -139.07 116.8 11.47 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.146 -0.972 . . . . 0.77000000000000002 109.142 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 107' ' ' THR . 2.8 mp -116.12 116.84 53.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 119.256 -0.978 . . . . 0.51000000000000001 109.259 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -114.87 159.45 20.65 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.181 -0.95 . . . . 1.54 108.993 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.59 122.56 22.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.884 -1.135 . . . . 0.92000000000000004 110.482 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -93.21 150.85 20.2 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.777 -0.823 . . . . 3.3599999999999999 108.777 179.261 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.462 HD23 HD11 ' A' ' 63' ' ' ILE . 20.4 mt -103.29 38.78 1.7 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.193 -0.942 . . . . 1.3 109.491 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 4.3 t0 72.58 5.46 5.24 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.512 -0.743 . . . . 2.0600000000000001 109.324 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.06 -35.68 0.03 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.911 -1.275 . . . . 1.8600000000000001 109.911 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.05 113.41 24.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.988 -1.301 . . . . 6.2699999999999996 109.664 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 17.0 tt0 -77.78 137.05 38.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.967 -1.083 . . . . 1.71 109.936 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 64' ' ' ASP . 74.0 mt -123.01 169.54 14.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-O 121.687 0.756 . . . . 1.47 109.079 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.535 ' N ' HG22 ' A' ' 63' ' ' ILE . 3.6 m-20 -114.18 129.59 56.62 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.198 -1.408 . . . . 2.1800000000000002 107.198 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.648 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 2.7 t -103.26 112.67 65.86 Favored Pre-proline 0 C--N 1.303 -1.451 0 O-C-N 120.848 -1.157 . . . . 0.45000000000000001 111.418 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -82.71 -154.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.261 2.641 . . . . 0.45000000000000001 109.522 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.23 31.86 74.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.641 -1.384 . . . . 0.93000000000000005 109.641 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.561 HD11 ' CD1' ' A' ' 54' ' ' ILE . 17.8 pt -125.79 -165.33 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.315 -1.109 . . . . 0.5 108.968 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.609 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 38.7 t0 -103.05 112.32 25.1 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.221 -0.924 . . . . 1.47 109.495 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.505 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 10.3 p -87.11 45.46 1.27 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.492 -0.929 . . . . 0.56000000000000005 108.492 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 23.8 t30 -179.85 74.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.429 -1.322 . . . . 1.3999999999999999 107.429 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.44 ' HB1' ' CD1' ' A' ' 88' ' ' ILE . . . -59.5 -5.84 0.93 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.629 -0.669 . . . . 0.28999999999999998 112.1 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.525 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.3 t -62.71 -14.34 43.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.43 -1.419 . . . . 0.20000000000000001 108.621 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -25.81 63.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.964 . . . . 1.1899999999999999 109.858 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.464 ' HB2' HG13 ' A' ' 88' ' ' ILE . 68.2 m-85 -111.62 -23.8 10.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.838 . . . . 0.38 109.896 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.637 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 1.5 m -104.42 171.69 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.047 -1.094 . . . . 0.90000000000000002 108.047 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.589 ' HG3' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -94.27 92.43 7.21 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.156 -0.965 . . . . 2.5800000000000001 110.82 -178.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.484 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 15.3 p -90.12 149.62 41.82 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 107.579 -1.267 . . . . 0.20999999999999999 107.579 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.646 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.7 Cg_endo -70.17 133.86 27.98 Favored 'Cis proline' 0 C--N 1.312 -1.367 0 C-N-CA 124.171 -1.179 . . . . 0.20999999999999999 112.906 2.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.622 HD23 ' CD2' ' A' ' 86' ' ' TYR . 14.0 mt -75.54 112.89 12.34 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.832 -1.544 . . . . 1.9099999999999999 106.832 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.8 t -80.85 138.91 18.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 CA-C-O 121.668 0.746 . . . . 0.94999999999999996 110.679 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.537 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 34.9 tttt -64.24 112.43 3.04 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.666 0.746 . . . . 3.7599999999999998 109.326 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.87 -14.25 9.73 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 109.927 -1.269 . . . . 0.42999999999999999 109.927 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.598 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 2.9 tp-100 -101.17 153.12 19.87 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.83 -1.174 . . . . 3.9100000000000001 107.83 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -102.61 155.52 18.24 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.811 -1.181 . . . . 3.3300000000000001 107.811 178.644 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.622 ' CD2' HD23 ' A' ' 80' ' ' LEU . 63.3 m-85 -134.81 151.8 51.23 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.065 -1.022 . . . . 0.51000000000000001 109.981 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.475 ' HB3' HD21 ' A' ' 40' ' ' LEU . 4.5 p-10 -120.62 113.43 20.23 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.253 -0.905 . . . . 0.65000000000000002 109.624 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.637 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 5.4 tt -110.78 121.59 63.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.271 -0.893 . . . . 0.28000000000000003 111.705 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.401 ' HA ' ' CG ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -104.11 109.75 21.66 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 104.741 -2.318 . . . . 3.3300000000000001 104.741 175.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.632 ' CE2' ' O ' ' A' ' 91' ' ' THR . 39.7 t80 -125.42 142.33 51.56 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.83 -1.169 . . . . 0.57999999999999996 113.174 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.632 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.2 144.14 25.93 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.625 -1.62 . . . . 1.46 106.625 176.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.648 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 24.7 t90 -118.83 87.79 2.8 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.896 -1.128 . . . . 1.23 110.328 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -64.19 104.12 0.7 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.471 0.653 . . . . 2.1699999999999999 109.351 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.585 HG12 ' HD2' ' A' ' 95' ' ' PRO . 52.2 t -56.14 143.56 63.1 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.524 -0.735 . . . . 2.7000000000000002 109.312 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.585 ' HD2' HG12 ' A' ' 94' ' ' VAL . 25.0 Cg_endo -64.92 -3.35 6.86 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.835 2.356 . . . . 3.9300000000000002 111.992 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.477 ' HA ' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER 66.81 1.38 2.22 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.982 -1.074 . . . . 3.79 109.515 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.519 ' O ' ' C ' ' A' ' 98' ' ' ALA . 10.0 pt -100.45 -30.16 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 120.96 -1.087 . . . . 0.59999999999999998 108.399 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -33.15 117.93 0.44 Allowed Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.637 -0.875 . . . . 0.53000000000000003 108.637 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -79.18 174.5 11.97 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.541 2.161 . . . . 0.98999999999999999 110.19 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.491 ' HE3' ' HG2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -80.84 72.32 7.82 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.513 -0.921 . . . . 5.0499999999999998 108.513 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.477 ' OG ' HG22 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -81.84 103.85 11.8 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.595 -0.891 . . . . 2.4900000000000002 108.595 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.548 ' HG3' ' N ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -41.3 -30.17 0.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.34 -0.85 . . . . 5.0300000000000002 109.565 -179.161 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.548 ' N ' ' HG3' ' A' ' 102' ' ' GLU . 0.6 OUTLIER -132.96 132.01 41.46 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.152 -0.967 . . . . 4.0700000000000003 109.542 179.219 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.54 ' CG2' HD11 ' A' ' 127' ' ' ILE . 0.9 OUTLIER -132.05 144.59 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.342 -0.849 . . . . 1.1899999999999999 109.978 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 122' ' ' ALA . 31.8 t -119.79 113.83 42.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.468 -1.308 . . . . 1.1899999999999999 107.468 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.58 137.6 23.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 120.721 -1.237 . . . . 0.92000000000000004 110.361 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.604 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 81.5 m -118.59 125.27 49.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.811 -0.556 . . . . 1.49 109.76 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -102.42 129.9 53.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.322 -1.362 . . . . 0.40999999999999998 107.322 178.2 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.548 ' HG2' ' CG1' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -141.04 131.15 24.74 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.078 -1.639 . . . . 2.8999999999999999 112.296 -178.082 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.659 ' CD1' ' CE2' ' A' ' 41' ' ' PHE . 16.2 mt -104.36 139.62 39.06 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.671 -1.603 . . . . 0.47999999999999998 106.671 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 116' ' ' VAL . 5.1 mp -138.66 112.06 7.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 120.66 -1.275 . . . . 0.60999999999999999 110.289 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.75 -150.19 7.81 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.481 -1.847 . . . . 0.56000000000000005 108.481 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.28 -1.74 50.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.219 -1.165 . . . . 1.6799999999999999 109.759 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -115.04 -0.36 13.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -0.956 . . . . 3.0800000000000001 110.714 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.62 -169.61 27.78 Favored Glycine 0 N--CA 1.496 2.662 0 C-N-CA 119.525 -1.322 . . . . 0.58999999999999997 110.305 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.548 ' CG1' ' HG2' ' A' ' 109' ' ' LYS . 44.4 t -77.5 111.2 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.296 -1.12 . . . . 1.7 109.867 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.473 HD23 ' HG2' ' A' ' 45' ' ' GLN . 28.3 mt -60.35 -41.37 93.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.47999999999999998 109.874 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.506 ' O ' HG11 ' A' ' 116' ' ' VAL . . . -151.75 176.15 11.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.967 -1.083 . . . . 0.68999999999999995 109.526 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.528 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 42.8 t -164.13 154.05 14.53 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.042 -1.036 . . . . 0.56999999999999995 109.007 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -150.44 154.95 38.62 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.837 -1.164 . . . . 0.64000000000000001 110.353 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.497 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 72.4 mt -130.87 140.37 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.318 -0.864 . . . . 1.46 109.003 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.429 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -120.1 145.79 46.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.45 -1.406 . . . . 0.93999999999999995 109.033 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.92 170.45 15.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.084 -1.01 . . . . 2.7000000000000002 109.731 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 9.0 m80 64.34 40.52 6.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -0.848 . . . . 5.2199999999999998 109.801 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -111.13 162.78 12.37 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.273 -1.531 . . . . 0.81999999999999995 109.273 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -149.56 137.34 20.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -1.179 . . . . 5.5999999999999996 108.615 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.54 HD11 ' CG2' ' A' ' 104' ' ' VAL . 61.2 mt -105.53 139.74 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.604 -1.31 . . . . 0.90000000000000002 110.255 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.509 ' HB2' ' CG2' ' A' ' 28' ' ' ILE . 1.4 mtm180 -133.76 162.87 30.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.467 -0.77 . . . . 5.5800000000000001 109.216 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.061 -0.971 . . . . 4.9299999999999997 109.201 179.559 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.438 -0.579 . . . . 2.9900000000000002 109.438 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -71.81 135.26 46.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.228 -0.92 . . . . 4.1799999999999997 109.407 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 3.0 m -105.49 169.03 2.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.226 -0.922 . . . . 2.0099999999999998 109.337 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -75.77 122.67 24.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 1.77 110.851 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.465 HG11 ' CA ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -150.41 157.42 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.987 -1.116 . . . . 2.9500000000000002 107.987 178.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -117.42 110.26 17.79 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.083 -1.011 . . . . 4.3600000000000003 109.715 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.473 ' OD2' ' HB ' ' A' ' 13' ' ' ILE . 0.8 OUTLIER -49.65 152.49 1.42 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.482 -0.761 . . . . 1.6200000000000001 109.909 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.469 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.1 OUTLIER -128.47 27.24 5.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.264 -0.898 . . . . 2.6699999999999999 108.791 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.43 ' O ' ' OD1' ' A' ' 10' ' ' ASN . . . -116.25 -76.56 0.57 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.394 -0.816 . . . . 0.87 109.773 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER 174.21 68.6 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.069 -0.715 . . . . 1.4399999999999999 109.069 -178.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 55.08 35.59 25.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.194 -0.941 . . . . 3.3700000000000001 108.874 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.505 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -87.3 -79.2 0.28 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.456 -0.777 . . . . 1.1799999999999999 109.805 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -46.36 127.64 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.85999999999999999 109.682 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.562 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -77.65 -24.99 49.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.477 -0.935 . . . . 1.9399999999999999 108.477 179.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 167.61 129.56 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.781 -0.822 . . . . 3.0600000000000001 108.781 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.585 ' CG2' ' CB ' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -111.87 121.51 64.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.176 -1.046 . . . . 0.47999999999999998 108.176 179.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 3.4 mtm -110.48 150.78 28.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.924 -1.11 . . . . 1.54 110.895 -178.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.586 HG12 ' CE2' ' A' ' 35' ' ' PHE . 51.5 t -119.0 159.42 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.411 -0.959 . . . . 1.29 108.411 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.54 ' N ' HG13 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -105.12 69.19 0.84 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.017 -1.052 . . . . 1.3400000000000001 109.57 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.89 -50.41 0.27 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.648 -1.263 . . . . 0.96999999999999997 110.231 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 39.7 t -80.71 150.89 29.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.988 -1.301 . . . . 1.25 110.011 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.47 -177.08 3.97 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.415 -0.803 . . . . 4.7199999999999998 109.262 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 3' ' ' VAL . . . -65.0 -120.55 0.01 OUTLIER Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.069 -1.212 . . . . 3.4399999999999999 110.069 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLY . 14.1 p -38.55 -44.73 0.99 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.653 -0.91 . . . . 2.6099999999999999 110.234 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -44.53 156.91 0.32 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.106 -0.996 . . . . 1.51 109.221 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 124' ' ' HIS . 35.9 Cg_endo -77.82 173.28 14.31 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.645 2.23 . . . . 1.52 110.183 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 5.4 m -122.11 135.91 54.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.068 -1.02 . . . . 0.79000000000000004 110.037 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.7 mm -110.35 107.96 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.276 -0.89 . . . . 1.3100000000000001 108.664 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 mp -87.76 122.74 39.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.184 -0.948 . . . . 1.01 109.632 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 12.7 m-70 -90.22 101.6 14.32 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.673 0.749 . . . . 1.4299999999999999 109.215 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.547 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -37.74 146.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.61 0.719 . . . . 3.2200000000000002 111.114 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.67 -5.63 56.49 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.678 -0.969 . . . . 0.94999999999999996 110.678 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -104.85 152.24 39.52 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.758 -1.436 . . . . 2.5899999999999999 110.214 -179.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.81 118.41 3.1 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.101 2.534 . . . . 0.54000000000000004 111.291 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.586 ' CE2' HG12 ' A' ' 18' ' ' VAL . 2.6 t80 -97.75 123.69 41.79 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.135 -1.431 . . . . 0.76000000000000001 107.135 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.8 m -107.37 136.16 47.63 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.515 -1.365 . . . . 1.23 110.813 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.664 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -141.21 123.59 15.79 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.938 -0.764 . . . . 2.4199999999999999 108.938 179.224 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 16' ' ' VAL . 25.2 tt0 -102.43 134.02 46.42 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.899 -1.148 . . . . 1.24 107.899 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.585 ' CB ' ' CG2' ' A' ' 16' ' ' VAL . . . -129.62 120.14 24.76 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 118.767 -1.173 . . . . 0.42999999999999999 110.683 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.558 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 15.8 mt -89.56 140.63 29.35 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 105.378 -2.082 . . . . 1.1299999999999999 105.378 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 27.3 p90 -155.2 139.2 16.38 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.046 -1.462 . . . . 0.42999999999999999 110.528 -178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.3 m-20 -84.54 108.96 17.58 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.987 -1.116 . . . . 1.1399999999999999 107.987 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -44.3 113.77 0.58 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.801 -0.814 . . . . 0.28000000000000003 108.801 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.459 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 7.2 p30 -83.5 10.3 9.25 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.073 -1.017 . . . . 0.57999999999999996 109.595 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.551 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 0.9 OUTLIER -168.28 158.11 9.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.382 -0.824 . . . . 0.73999999999999999 109.312 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -88.35 120.36 29.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.177 -0.952 . . . . 1.8899999999999999 109.537 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.513 ' O ' ' CA ' ' A' ' 79' ' ' PRO . 3.3 t -143.74 153.09 42.07 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.244 -0.91 . . . . 0.45000000000000001 109.313 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.639 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -98.61 -25.84 14.59 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.663 -1.236 . . . . 7.0099999999999998 107.663 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.6 p -111.3 138.33 47.91 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 122.134 0.968 . . . . 2.5299999999999998 109.766 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -142.21 154.23 44.64 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.837 -0.801 . . . . 0.71999999999999997 108.837 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.498 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 1.6 mtmt -145.29 141.06 28.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.009 -1.057 . . . . 1.27 111.038 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.552 ' CG2' ' O ' ' A' ' 69' ' ' ASP . 9.7 tt -94.69 152.05 3.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.227 -1.397 . . . . 0.95999999999999996 107.227 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -140.45 118.1 11.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.93 -1.106 . . . . 0.39000000000000001 110.15 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 107' ' ' THR . 2.2 mp -117.78 115.56 48.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.017 -1.052 . . . . 0.37 109.267 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 13.6 mttm -115.6 157.4 24.21 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.466 -0.938 . . . . 2.7200000000000002 108.466 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.52 123.95 26.09 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.692 -1.255 . . . . 0.66000000000000003 110.576 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -90.37 146.3 24.28 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.451 -0.944 . . . . 3.2599999999999998 108.451 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 61' ' ' LEU . 15.9 mt -113.18 48.27 1.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.027 -1.045 . . . . 1.8899999999999999 109.989 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.401 ' OD2' ' CG ' ' A' ' 102' ' ' GLU . 0.4 OUTLIER 58.0 14.99 2.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.482 -0.761 . . . . 1.45 109.866 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.75 -41.61 0.16 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.964 -1.254 . . . . 1.04 109.964 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 9.7 tp -106.53 111.32 23.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.204 -1.174 . . . . 1.0900000000000001 109.304 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.96 134.51 34.65 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.289 -0.882 . . . . 1.02 108.751 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 79.8 mt -124.89 166.46 20.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 122.011 0.91 . . . . 0.85999999999999999 109.596 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.568 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -115.23 108.83 17.1 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 106.426 -1.694 . . . . 1.21 106.426 177.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.641 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 2.5 t -73.61 113.72 25.31 Favored Pre-proline 0 C--N 1.297 -1.688 0 O-C-N 121.267 -0.895 . . . . 0.59999999999999998 111.027 -177.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.7 Cg_endo -83.41 -159.4 0.1 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.956 2.437 . . . . 0.81999999999999995 109.806 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.43 20.67 38.36 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.031 -1.228 . . . . 0.47999999999999998 110.031 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.587 HG22 ' CD1' ' A' ' 92' ' ' TRP . 34.0 pt -105.93 -165.93 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -1.177 . . . . 0.45000000000000001 109.09 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.6 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 3.1 t70 -105.41 106.44 16.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 1.24 110.083 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.498 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -86.74 47.56 1.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.361 -0.977 . . . . 1.45 108.361 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.474 ' OD1' ' HB2' ' A' ' 73' ' ' CYS . 17.9 t-20 176.72 85.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.609 -1.256 . . . . 2.6699999999999999 107.609 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.02 8.07 1.76 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.333 -0.854 . . . . 0.40999999999999998 112.057 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.474 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 2.1 m -65.13 -13.27 57.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.698 -1.251 . . . . 2.6400000000000001 109.485 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -82.27 -14.78 54.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.23 -0.919 . . . . 1.0600000000000001 109.864 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.54 ' CB ' HG13 ' A' ' 88' ' ' ILE . 35.0 m-85 -121.64 -14.15 8.22 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.205 -0.935 . . . . 0.65000000000000002 109.42 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.627 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 1.4 m -119.51 162.64 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.208 -0.932 . . . . 0.59999999999999998 108.602 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.598 ' HG3' ' CE2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -96.65 84.2 3.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.221 -0.924 . . . . 6.9199999999999999 111.136 -178.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.513 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 5.0 p -83.09 159.51 62.4 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.694 -1.254 . . . . 1.1399999999999999 107.944 178.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.639 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 23.7 Cg_endo -67.14 130.52 13.6 Favored 'Cis proline' 0 C--N 1.311 -1.422 0 C-N-CA 124.25 -1.146 . . . . 0.54000000000000004 112.281 2.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.595 HD23 ' CD2' ' A' ' 86' ' ' TYR . 14.7 mt -71.67 107.84 4.71 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.75 -1.204 . . . . 0.66000000000000003 107.75 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.69 136.11 24.54 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 CA-C-O 121.742 0.782 . . . . 0.52000000000000002 110.211 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.551 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 23.3 tttt -62.51 110.09 1.58 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.708 0.766 . . . . 4.0499999999999998 110.12 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 126.28 -16.76 6.69 Favored Glycine 0 N--CA 1.48 1.63 0 N-CA-C 110.185 -1.166 . . . . 0.16 110.185 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.558 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 3.3 tp-100 -101.95 156.48 17.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.066 -1.255 . . . . 3.4900000000000002 108.141 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.555 ' C ' ' CD1' ' A' ' 86' ' ' TYR . 1.2 tt0 -106.02 153.69 21.68 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.096 -1.076 . . . . 3.1600000000000001 108.096 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.598 ' CE2' ' HG3' ' A' ' 77' ' ' LYS . 23.4 m-85 -131.5 151.45 51.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.055 -1.028 . . . . 0.60999999999999999 110.218 -178.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.558 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -118.27 113.86 22.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.527 -0.733 . . . . 2.1899999999999999 110.063 -178.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.627 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 1.8 tt -115.59 119.41 61.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.181 -0.949 . . . . 0.58999999999999997 111.353 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -101.39 106.88 18.08 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 104.87 -2.27 . . . . 3.1299999999999999 104.87 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.6 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 32.2 t80 -119.97 141.23 49.87 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.869 -1.133 . . . . 0.75 112.544 -176.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.541 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -91.67 145.34 24.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.55 -1.648 . . . . 1.25 106.55 177.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.641 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 51.3 t90 -127.03 94.26 3.98 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.243 -0.911 . . . . 1.26 109.495 -177.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -57.42 104.88 0.19 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.66 -0.816 . . . . 2.8999999999999999 108.8 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.519 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 71.4 t -58.85 141.56 85.38 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 107.879 -1.156 . . . . 0.88 107.879 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.553 ' HD3' ' CG1' ' A' ' 65' ' ' VAL . 29.8 Cg_endo -71.58 124.66 10.48 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 C-N-CA 121.781 1.654 . . . . 0.55000000000000004 109.992 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.515 ' HA ' ' HG2' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -67.87 -2.75 7.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.534 -0.729 . . . . 4.6900000000000004 109.681 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.503 ' O ' ' C ' ' A' ' 98' ' ' ALA . 3.8 pt -88.23 -24.59 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 1.1299999999999999 109.318 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.547 ' O ' ' CD ' ' A' ' 31' ' ' ARG . . . -29.07 120.04 0.28 Allowed Pre-proline 0 N--CA 1.492 1.635 0 CA-C-N 116.054 -0.521 . . . . 1.04 110.76 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.59 ' O ' ' N ' ' A' ' 101' ' ' SER . 37.3 Cg_endo -86.09 133.29 4.07 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.565 2.176 . . . . 0.69999999999999996 108.688 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.556 ' N ' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -50.98 91.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.851 -1.156 . . . . 5.9100000000000001 107.913 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 99' ' ' PRO . 3.6 t -94.51 114.45 26.45 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.576 -0.702 . . . . 0.54000000000000004 109.465 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 11.4 pt-20 -38.85 -41.43 0.74 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.218 -0.66 . . . . 1.6000000000000001 109.218 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.429 ' N ' ' CG ' ' A' ' 102' ' ' GLU . 1.7 t-20 -134.67 140.73 46.23 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.497 -0.752 . . . . 3.0800000000000001 109.016 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.53 ' CG2' HD11 ' A' ' 127' ' ' ILE . 0.9 OUTLIER -133.47 146.74 31.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 121.344 -0.848 . . . . 1.0 108.99 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 t -126.53 114.81 39.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.815 -1.18 . . . . 1.24 107.815 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 38.9 t -97.5 137.94 23.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.293 -0.963 . . . . 0.94999999999999996 109.897 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 81.1 m -117.52 115.74 25.75 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.605 -0.684 . . . . 0.66000000000000003 109.617 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -94.79 128.57 45.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.466 -1.679 . . . . 0.48999999999999999 106.466 177.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.55 ' HG2' ' CG1' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -141.24 130.45 23.5 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.281 -1.512 . . . . 1.6799999999999999 112.378 -177.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.643 ' CD1' ' CE2' ' A' ' 41' ' ' PHE . 2.4 mt -102.53 139.49 38.06 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.165 -1.791 . . . . 1.22 106.165 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 116' ' ' VAL . 4.5 mp -137.07 114.73 13.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.746 -1.221 . . . . 0.58999999999999997 110.25 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.97 -139.66 6.52 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.358 -1.897 . . . . 0.73999999999999999 108.358 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.99 -0.0 27.29 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.192 -1.181 . . . . 2.0499999999999998 109.592 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -116.41 4.53 13.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 2.6499999999999999 110.479 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 142.42 -160.23 27.26 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.709 -1.357 . . . . 0.65000000000000002 109.709 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.55 ' CG1' ' HG2' ' A' ' 109' ' ' LYS . 72.1 t -85.12 110.48 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -1.156 . . . . 1.74 109.589 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 110' ' ' LEU . 77.6 mt -57.87 -39.16 77.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.5 110.56 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.516 ' O ' HG11 ' A' ' 116' ' ' VAL . . . -152.08 175.11 12.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.933 -1.104 . . . . 1.3 109.227 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 42.4 t -168.11 153.76 7.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.571 -1.33 . . . . 0.56999999999999995 110.018 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.13 149.79 29.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.05 -1.031 . . . . 0.54000000000000004 110.102 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 8' ' ' CYS . 4.3 mt -134.58 116.66 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.941 -1.133 . . . . 1.3200000000000001 107.941 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.465 ' CA ' HG11 ' A' ' 5' ' ' VAL . . . -105.71 121.1 43.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.908 -1.12 . . . . 1.48 110.264 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.28 -156.79 0.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.438 -0.789 . . . . 3.02 108.885 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 0.2 OUTLIER 46.54 30.41 1.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.003 -1.061 . . . . 2.9399999999999999 108.997 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -100.09 155.91 19.59 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.889 -1.148 . . . . 1.2 110.535 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 39.7 mttm -154.0 136.33 14.92 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.435 -1.32 . . . . 3.77 107.435 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.53 HD11 ' CG2' ' A' ' 104' ' ' VAL . 60.3 mt -107.68 134.71 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.327 -1.483 . . . . 0.70999999999999996 111.52 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.55 ' HA ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -116.15 177.02 4.84 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.797 -0.816 . . . . 4.2000000000000002 108.797 178.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.551 ' N ' ' HD2' ' A' ' 100' ' ' LYS . 24.6 t0 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.073 -0.965 . . . . 1.2 109.61 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.335 -0.617 . . . . 1.6200000000000001 109.335 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.474 ' HB2' ' HG2' ' A' ' 17' ' ' MET . 9.3 tt0 -78.18 140.56 38.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 2.3700000000000001 109.746 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.5 ' HA ' ' CA ' ' A' ' 23' ' ' GLY . 3.7 m -101.85 169.36 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.295 -0.878 . . . . 2.0 109.155 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.424 ' O ' HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -90.59 122.91 33.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 3.1099999999999999 110.806 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.454 HG12 HG23 ' A' ' 3' ' ' VAL . 29.6 m -153.47 149.56 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.015 -1.106 . . . . 0.95999999999999996 108.015 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.27 110.31 20.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.781 -1.199 . . . . 6.3399999999999999 110.569 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.32 134.49 39.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 2.8399999999999999 108.916 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.3 p -106.61 -2.87 21.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.131 -0.98 . . . . 1.3700000000000001 110.017 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 10' ' ' ASN . . . -73.81 -58.29 3.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.13 -0.981 . . . . 1.02 109.435 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER 167.2 50.86 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.85 -1.167 . . . . 3.4399999999999999 107.85 -178.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' A' ' 10' ' ' ASN . 3.9 t-20 63.8 15.83 9.34 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.017 -1.105 . . . . 2.7400000000000002 108.017 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.498 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -58.74 -62.1 2.12 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.501 -0.749 . . . . 1.28 109.266 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -59.19 128.27 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.39000000000000001 109.583 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.567 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 9.9 mmpt? -85.35 -13.98 47.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.461 -0.775 . . . . 1.3600000000000001 109.856 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.567 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.9 ttpt 156.96 127.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.06 -0.718 . . . . 2.21 109.06 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.617 ' CG2' ' CB ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -114.3 123.92 70.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.367 -0.833 . . . . 0.65000000000000002 108.949 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.474 ' HG2' ' HB2' ' A' ' 2' ' ' GLN . 2.8 mtm -115.76 147.84 40.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.13 -0.981 . . . . 1.1899999999999999 110.268 -179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.568 HG12 ' CE2' ' A' ' 35' ' ' PHE . 44.3 t -127.07 129.21 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.936 -0.764 . . . . 1.29 108.936 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -83.27 87.26 6.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 1.47 109.783 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.44 -68.07 0.22 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.531 -1.428 . . . . 0.95999999999999996 109.531 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . 6.5 m -76.95 -167.6 0.89 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.354 -1.086 . . . . 3.25 109.418 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -141.57 175.83 9.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.041 -1.037 . . . . 5.1900000000000004 109.813 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.5 ' CA ' ' HA ' ' A' ' 3' ' ' VAL . . . -114.09 150.44 18.6 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.364 -1.494 . . . . 3.3100000000000001 109.364 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER 72.71 1.5 4.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.042 -1.269 . . . . 2.3199999999999998 109.116 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.481 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 1.1 m-20 -135.43 176.01 3.18 Favored Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 108.267 -1.012 . . . . 1.6399999999999999 108.267 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 25' ' ' ASP . 34.4 Cg_endo -76.33 135.97 17.29 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.933 1.755 . . . . 0.80000000000000004 109.66 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -111.66 139.34 47.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.369 -0.832 . . . . 2.5 108.819 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.554 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 46.6 mm -112.11 115.78 50.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.167 -0.958 . . . . 0.91000000000000003 109.841 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.3 mt -103.93 118.13 50.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.505 -0.924 . . . . 1.2 108.505 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.528 ' HB2' ' CE ' ' A' ' 33' ' ' LYS . 17.4 m-70 -84.87 125.02 32.28 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.156 -0.965 . . . . 1.04 109.241 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.518 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 3.2 ptt180 -70.78 125.47 26.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.124 -0.985 . . . . 1.5700000000000001 109.84 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.56 -9.17 26.15 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.745 -1.342 . . . . 0.53000000000000003 109.745 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' CE ' ' HB2' ' A' ' 30' ' ' HIS . 1.6 ptpt -112.38 158.51 37.01 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.174 -1.192 . . . . 2.2400000000000002 109.647 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 33' ' ' LYS . 36.2 Cg_endo -78.01 136.38 14.7 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 C-N-CA 122.981 2.454 . . . . 0.42999999999999999 111.484 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CE2' HG12 ' A' ' 18' ' ' VAL . 2.5 t80 -117.67 116.88 27.94 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.673 -1.232 . . . . 1.0 107.673 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.1 m -96.93 137.16 36.45 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.95 -1.094 . . . . 1.5800000000000001 110.76 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.82 125.84 12.08 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.843 -0.799 . . . . 4.9800000000000004 108.843 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -100.23 125.32 46.38 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.723 -1.214 . . . . 1.4099999999999999 107.723 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.617 ' CB ' ' CG2' ' A' ' 16' ' ' VAL . . . -124.43 118.39 26.56 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.986 -1.086 . . . . 0.46999999999999997 110.809 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 12.3 mt -91.04 140.82 29.48 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.487 -1.671 . . . . 1.1299999999999999 106.487 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.621 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 25.1 p90 -156.68 141.24 16.8 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 120.898 -1.126 . . . . 0.34000000000000002 109.193 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 7.7 m-20 -84.81 111.48 19.66 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 118.938 -1.105 . . . . 1.3600000000000001 109.057 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.33 113.46 0.58 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.958 -0.756 . . . . 0.20999999999999999 108.958 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' C ' ' OD1' ' A' ' 44' ' ' ASN . 36.0 p30 -88.35 10.08 21.11 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.291 -0.88 . . . . 1.6399999999999999 109.382 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.588 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 1.5 pt20 -165.95 144.09 5.74 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.285 -0.884 . . . . 2.46 110.005 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -80.57 119.1 22.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -0.856 . . . . 1.76 108.998 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.478 HG22 ' HA3' ' A' ' 112' ' ' GLY . 0.1 OUTLIER -138.98 144.59 39.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.924 -1.11 . . . . 1.0900000000000001 109.849 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.659 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 20.0 mmmt -85.14 -9.37 57.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -0.888 . . . . 1.2 109.676 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 48' ' ' LYS . 9.7 p -151.01 139.75 20.76 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.762 0.791 . . . . 0.68000000000000005 109.42 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.534 ' HB3' ' CD1' ' A' ' 117' ' ' LEU . . . -129.9 156.1 44.95 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 121.72 -0.613 . . . . 1.05 109.384 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.537 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 0.1 OUTLIER -128.98 127.61 42.02 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.327 -0.858 . . . . 1.3300000000000001 111.174 -178.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.494 HG23 ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -101.57 127.58 54.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.834 -1.543 . . . . 1.8300000000000001 106.834 176.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.589 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -140.71 116.68 10.44 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.1 -1.0 . . . . 4.6600000000000001 108.43 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 107' ' ' THR . 4.2 mp -94.2 129.94 43.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 109.335 -0.617 . . . . 1.1399999999999999 109.335 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -115.0 138.17 51.16 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.327 -0.858 . . . . 1.3999999999999999 109.64 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.43 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . . . -119.63 128.17 53.61 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.492 -0.883 . . . . 1.3200000000000001 110.399 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.52 108.92 16.08 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.343 -0.984 . . . . 4.3899999999999997 108.343 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -77.87 -173.44 3.09 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.474 -0.766 . . . . 2.8399999999999999 110.141 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -52.57 -34.24 49.62 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.518 -0.739 . . . . 5.4199999999999999 110.371 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.67 1.06 0.8 Allowed Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.882 -1.628 . . . . 2.71 111.571 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.5 HD13 HG12 ' A' ' 63' ' ' ILE . 12.9 tp -113.39 107.69 16.2 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.528 -1.572 . . . . 3.96 109.353 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -96.07 127.5 42.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.915 -1.116 . . . . 6.0999999999999996 108.501 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.65 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -149.13 171.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 122.302 1.048 . . . . 5.7400000000000002 109.438 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.65 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -110.89 116.32 31.04 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 106.789 -1.559 . . . . 4.6500000000000004 106.789 177.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.635 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 15.6 t -66.94 110.31 4.83 Favored Pre-proline 0 C--N 1.295 -1.766 0 O-C-N 121.667 -0.645 . . . . 0.70999999999999996 110.594 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 42.2 Cg_endo -89.17 -157.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.719 2.946 . . . . 0.65000000000000002 109.99 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.433 ' C ' HG23 ' A' ' 68' ' ' ILE . . . 50.85 45.86 49.29 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.26 -1.136 . . . . 0.91000000000000003 110.26 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.573 ' CA ' ' OH ' ' A' ' 90' ' ' TYR . 2.5 pt -140.43 -138.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.07 -1.253 . . . . 1.6000000000000001 109.59 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.502 ' N ' ' OH ' ' A' ' 90' ' ' TYR . 1.1 t70 -117.21 105.34 12.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.923 -1.111 . . . . 1.6000000000000001 111.178 -178.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.537 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 11.0 p -92.44 49.92 1.55 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.366 -1.346 . . . . 1.1299999999999999 107.366 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 38.4 t30 177.55 81.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.231 -1.396 . . . . 0.73999999999999999 107.231 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.444 ' O ' HG23 ' A' ' 76' ' ' VAL . . . -65.58 -3.97 5.38 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.327 0.862 . . . . 1.28 113.327 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.485 ' HA ' HG23 ' A' ' 76' ' ' VAL . 9.7 t -65.9 -9.19 27.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 119.928 -1.732 . . . . 0.45000000000000001 109.352 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.489 ' O ' ' CD2' ' A' ' 74' ' ' HIS . 3.3 t60 -76.26 -30.88 58.01 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.037 -1.04 . . . . 5.4299999999999997 108.34 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CD1' ' O ' ' A' ' 89' ' ' LYS . 88.3 m-85 -105.4 -17.88 14.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.1 -1.0 . . . . 0.72999999999999998 110.321 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.626 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 2.5 m -115.0 169.71 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.406 -0.961 . . . . 0.58999999999999997 108.406 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.609 ' HG3' ' CE2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -95.61 91.32 6.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.16 -0.963 . . . . 5.1500000000000004 111.723 -177.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.48 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 20.1 p -84.16 151.89 60.76 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 107.636 -1.246 . . . . 0.48999999999999999 107.636 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.659 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.0 Cg_endo -69.84 132.68 23.1 Favored 'Cis proline' 0 C--N 1.314 -1.259 0 C-N-CA 124.281 -1.133 . . . . 0.26000000000000001 112.226 2.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.63 HD23 ' CD2' ' A' ' 86' ' ' TYR . 16.1 mt -74.91 104.24 5.44 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.514 -1.291 . . . . 0.88 107.514 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 73.2 t -71.66 139.03 20.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-O 121.559 0.695 . . . . 0.83999999999999997 109.919 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.588 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 14.5 ttpp -69.27 107.22 3.17 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.539 0.685 . . . . 3.54 109.688 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 131.8 -18.08 4.87 Favored Glycine 0 N--CA 1.481 1.641 0 C-N-CA 119.584 -1.294 . . . . 0.56000000000000005 110.249 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.59 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 5.3 tp60 -98.86 151.42 20.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.102 -1.234 . . . . 0.56000000000000005 108.306 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 1.9 tt0 -99.26 142.63 30.49 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.292 -1.373 . . . . 1.3400000000000001 107.292 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.63 ' CD2' HD23 ' A' ' 80' ' ' LEU . 32.9 m-85 -120.7 150.44 40.95 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.24 -0.913 . . . . 0.47999999999999998 110.295 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.536 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -115.63 115.06 25.77 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.415 -0.957 . . . . 2.1400000000000001 108.415 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.626 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 1.8 tt -108.2 116.54 51.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.031 -1.043 . . . . 0.29999999999999999 111.427 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.566 ' O ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -97.08 113.08 24.61 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 104.457 -2.423 . . . . 5.21 104.457 176.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.585 ' CZ ' ' O ' ' A' ' 91' ' ' THR . 12.8 t80 -130.84 138.91 50.08 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.365 -1.334 . . . . 1.0800000000000001 113.082 -175.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.585 ' O ' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -89.56 142.25 27.85 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 105.583 -2.006 . . . . 1.6100000000000001 105.583 176.582 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.635 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 21.1 t90 -123.75 89.01 3.01 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 120.571 -1.331 . . . . 1.3200000000000001 110.731 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -60.58 103.55 0.26 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.468 -0.938 . . . . 3.5600000000000001 108.468 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.57 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 40.5 t -62.88 142.34 97.4 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.812 -0.81 . . . . 0.59999999999999998 108.812 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.57 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 29.2 Cg_endo -71.17 127.55 13.63 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.764 1.642 . . . . 0.55000000000000004 109.389 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -69.19 3.25 2.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.506 -0.746 . . . . 4.8799999999999999 111.021 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 98' ' ' ALA . 12.5 pt -89.38 -26.29 5.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 O-C-N 120.708 -1.245 . . . . 0.97999999999999998 108.85 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.518 ' O ' ' CD ' ' A' ' 31' ' ' ARG . . . -39.38 116.62 1.09 Allowed Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 109.414 -0.587 . . . . 0.16 109.414 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.546 ' HD2' ' CD1' ' A' ' 58' ' ' LEU . 36.6 Cg_endo -85.4 137.88 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 123.244 2.63 . . . . 0.20000000000000001 109.139 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.51 ' HG2' ' HA ' ' A' ' 128' ' ' ARG . 5.8 mtmt -54.59 90.88 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.015 -1.053 . . . . 3.4399999999999999 108.732 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.579 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -98.84 129.27 45.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.585 -0.697 . . . . 2.4100000000000001 109.587 -179.031 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.5 ' HG3' ' N ' ' A' ' 103' ' ' ASN . 17.7 pt-20 -39.11 -48.19 1.66 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.47 -0.769 . . . . 1.1799999999999999 110.595 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.5 ' N ' ' HG3' ' A' ' 102' ' ' GLU . 4.2 m120 -132.89 145.8 51.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.989 -1.069 . . . . 2.3599999999999999 110.478 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.513 HG22 HG13 ' A' ' 127' ' ' ILE . 82.9 t -135.87 149.17 27.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.777 -0.823 . . . . 1.1599999999999999 108.777 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 98.2 t -121.31 117.8 53.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.045 -1.094 . . . . 1.1599999999999999 108.045 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.1 t -98.78 140.23 18.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 120.76 -1.212 . . . . 0.93999999999999995 109.965 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 27.0 m -126.7 118.79 25.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.68 -0.638 . . . . 2.0299999999999998 109.714 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.498 ' O ' ' CG1' ' A' ' 108' ' ' VAL . 0.4 OUTLIER -96.75 125.88 49.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.216 -1.402 . . . . 0.59999999999999998 107.216 177.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.565 ' HD2' ' CD1' ' A' ' 111' ' ' ILE . 0.4 OUTLIER -133.99 150.85 51.27 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 120.647 -1.283 . . . . 1.4199999999999999 111.435 -177.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.621 ' CD1' ' CZ ' ' A' ' 41' ' ' PHE . 13.4 mt -129.79 137.11 50.33 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.142 -1.429 . . . . 0.45000000000000001 107.142 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.565 ' CD1' ' HD2' ' A' ' 109' ' ' LYS . 4.5 mp -134.78 117.64 23.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.857 -1.152 . . . . 0.81999999999999995 110.205 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.478 ' HA3' HG22 ' A' ' 47' ' ' THR . . . -86.94 -120.02 1.27 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.003 -1.639 . . . . 0.16 109.003 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -123.49 -4.98 8.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -1.089 . . . . 2.6400000000000001 109.403 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.453 ' HB3' ' OE1' ' A' ' 45' ' ' GLN . 4.1 t30 -114.5 -5.91 12.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 5.5999999999999996 110.116 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.506 ' N ' ' OE1' ' A' ' 45' ' ' GLN . . . 156.98 -162.53 31.78 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.714 -1.354 . . . . 0.52000000000000002 109.714 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.557 ' CG1' ' HG2' ' A' ' 109' ' ' LYS . 3.8 t -82.88 109.36 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -1.133 . . . . 0.79000000000000004 109.719 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.534 ' CD1' ' HB3' ' A' ' 50' ' ' ALA . 6.4 mt -51.19 -38.62 53.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 1.8400000000000001 110.749 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.468 ' O ' HG11 ' A' ' 116' ' ' VAL . . . -155.32 -166.0 2.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.759 -1.213 . . . . 0.93000000000000005 109.401 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER 175.53 147.95 0.09 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.162 -0.962 . . . . 0.95999999999999996 109.529 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -147.05 146.35 29.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.958 -1.088 . . . . 0.58999999999999997 109.254 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.4 HD12 ' SG ' ' A' ' 119' ' ' CYS . 3.4 mp -133.75 136.11 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.128 -0.982 . . . . 2.75 109.418 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -112.76 132.75 55.09 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.185 -0.947 . . . . 0.88 109.109 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.4 p -116.37 57.22 0.77 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.128 -0.983 . . . . 3.29 109.383 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.85 60.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.628 -0.878 . . . . 2.3599999999999999 108.628 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.47 ' C ' ' HG3' ' A' ' 126' ' ' LYS . . . -130.57 164.06 23.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.804 -1.318 . . . . 1.1899999999999999 109.804 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 15.3 mtpt -152.07 145.11 24.52 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.964 -1.124 . . . . 2.8799999999999999 107.964 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.513 HG13 HG22 ' A' ' 104' ' ' VAL . 52.3 mt -106.39 140.89 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.407 -1.433 . . . . 0.80000000000000004 110.319 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.554 ' HB2' ' CG2' ' A' ' 28' ' ' ILE . 11.1 mtt180 -128.95 179.69 5.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.444 -0.785 . . . . 2.0699999999999998 109.275 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.5 t0 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.111 -0.947 . . . . 1.6399999999999999 109.649 -179.814 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.27 0.557 . . . . 3.25 109.552 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.526 ' CB ' ' HG2' ' A' ' 17' ' ' MET . 0.5 OUTLIER -73.77 154.49 39.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.162 -0.962 . . . . 2.3799999999999999 109.889 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.515 ' CG1' HG21 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -103.55 159.48 4.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.29 -0.881 . . . . 3.04 109.13 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -70.12 119.23 14.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.086 -1.009 . . . . 1.4099999999999999 109.837 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.6 140.16 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.383 -0.823 . . . . 2.3300000000000001 109.324 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.49 109.32 19.2 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.206 -0.934 . . . . 4.3099999999999996 109.385 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.426 ' CG ' ' HB ' ' A' ' 13' ' ' ILE . 1.4 m-20 -60.37 120.4 9.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 2.2400000000000002 108.943 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 p -95.59 23.12 6.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.03 -1.044 . . . . 0.34000000000000002 109.635 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 10' ' ' ASN . . . -96.52 -82.29 0.4 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.279 -0.888 . . . . 0.46999999999999997 109.829 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 0.8 OUTLIER 178.24 56.39 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.025 -0.67 . . . . 2.6600000000000001 109.396 -178.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 10' ' ' ASN . 3.3 m120 67.26 51.61 0.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 4.7599999999999998 109.137 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.484 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -113.33 -61.72 1.7 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 1.0800000000000001 109.897 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 1.1 mm -57.45 123.42 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.049 -1.032 . . . . 0.72999999999999998 109.939 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.606 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 4.6 mmpt? -71.77 -17.55 62.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.382 -0.824 . . . . 1.97 108.808 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.606 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 6.6 pttm 147.6 140.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.328 -1.36 . . . . 2.3500000000000001 107.328 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.572 ' CG2' ' CB ' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -115.27 128.91 72.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.271 -1.011 . . . . 0.5 108.271 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.526 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -125.37 145.33 50.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.124 -0.985 . . . . 1.0700000000000001 110.434 -178.201 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.515 HG21 ' CG1' ' A' ' 3' ' ' VAL . 50.2 t -98.24 165.63 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.403 -0.811 . . . . 1.79 108.918 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.467 ' N ' HG13 ' A' ' 18' ' ' VAL . 1.6 p-10 -47.29 -30.33 3.04 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.014 -1.054 . . . . 3.9300000000000002 108.919 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.405 ' N ' ' OD1' ' A' ' 19' ' ' ASP . . . 149.69 100.5 0.22 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.592 -1.29 . . . . 4.2199999999999998 110.741 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 22' ' ' HIS . 3.5 t -128.48 -51.52 1.27 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.185 -1.185 . . . . 3.6600000000000001 109.139 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.489 ' CB ' ' O ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER 166.52 -84.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 4.46 110.136 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 119.22 -107.45 1.38 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.571 -1.812 . . . . 1.51 108.571 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 23' ' ' GLY . 9.5 p -47.43 -40.99 19.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.97 -1.312 . . . . 2.3700000000000001 108.422 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -72.78 175.02 3.67 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 109.086 -0.709 . . . . 2.21 109.086 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 25' ' ' ASP . 34.8 Cg_endo -79.51 135.09 11.54 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.216 1.944 . . . . 1.3300000000000001 110.344 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.5 t -112.45 143.44 43.59 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.31 -0.996 . . . . 3.27 108.31 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.451 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 46.9 mm -108.57 118.18 55.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.104 -0.998 . . . . 1.1000000000000001 110.247 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 127' ' ' ILE . 23.0 mt -98.79 118.36 45.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.245 -1.02 . . . . 1.3799999999999999 108.245 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -95.43 122.43 38.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.946 . . . . 1.6100000000000001 110.163 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.512 ' HA ' HG11 ' A' ' 94' ' ' VAL . 16.6 ptt180 -66.1 151.52 46.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 2.3700000000000001 109.475 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.9 -17.32 57.07 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.902 -1.679 . . . . 0.67000000000000004 108.902 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.462 ' O ' HG22 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -107.45 148.68 37.65 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.282 -1.128 . . . . 2.0800000000000001 109.143 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 36.3 Cg_endo -78.44 122.41 5.57 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.7 2.267 . . . . 0.35999999999999999 111.147 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.429 ' CZ ' HG12 ' A' ' 18' ' ' VAL . 4.7 t80 -100.55 122.55 43.43 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.149 -1.056 . . . . 0.32000000000000001 108.149 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.499 ' O ' HG11 ' A' ' 18' ' ' VAL . 64.2 m -100.7 137.55 38.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.898 -1.126 . . . . 0.80000000000000004 110.752 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.34 128.09 16.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.483 -0.76 . . . . 3.8300000000000001 109.05 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 16' ' ' VAL . 2.3 mt-10 -105.07 129.58 53.46 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.547 -0.909 . . . . 1.3799999999999999 108.547 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.572 ' CB ' ' CG2' ' A' ' 16' ' ' VAL . . . -128.14 120.92 28.32 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.793 -1.192 . . . . 0.19 110.306 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.526 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 4.2 mt -91.16 140.95 29.32 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.332 -1.729 . . . . 0.97999999999999998 106.332 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.659 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 32.0 p90 -156.5 135.58 11.98 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.709 -1.196 . . . . 0.19 109.778 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.6 OUTLIER -83.35 112.81 20.25 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.351 -0.981 . . . . 1.1699999999999999 108.351 179.309 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -46.22 112.48 0.49 Allowed 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.672 -0.862 . . . . 0.28999999999999998 108.672 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 44' ' ' ASN . 2.3 p30 -84.93 10.94 10.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.112 -0.993 . . . . 0.89000000000000001 109.45 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.562 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 1.8 pt20 -167.93 145.38 4.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.459 -0.776 . . . . 0.73999999999999999 108.968 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 2.4 p30 -84.46 119.17 24.83 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.145 -0.972 . . . . 0.77000000000000002 109.36 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.489 ' O ' ' CA ' ' A' ' 79' ' ' PRO . 2.6 t -137.2 159.68 41.2 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.265 -0.897 . . . . 0.46000000000000002 109.249 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.583 ' N ' ' CD ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -100.49 -28.54 12.85 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.127 -1.435 . . . . 7.2699999999999996 107.127 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.465 ' OG1' ' OD1' ' A' ' 113' ' ' ASP . 34.2 p -111.51 138.9 47.43 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 122.146 0.974 . . . . 1.8700000000000001 109.522 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -142.88 152.66 42.34 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 108.85 -0.796 . . . . 1.05 108.85 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' HD2' ' HB ' ' A' ' 70' ' ' THR . 6.4 mtmt -142.59 141.07 31.91 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.18 -0.95 . . . . 0.65000000000000002 110.332 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.534 ' CG2' ' O ' ' A' ' 69' ' ' ASP . 11.0 tt -94.28 150.46 4.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.193 -1.41 . . . . 0.77000000000000002 107.193 177.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' OE1' HD12 ' A' ' 111' ' ' ILE . 1.8 mt-10 -140.15 116.27 10.47 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.079 -1.013 . . . . 1.1799999999999999 110.156 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 107' ' ' THR . 2.7 mp -112.97 114.08 45.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.074 -1.016 . . . . 0.46999999999999997 108.51 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -115.17 130.65 56.98 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.109 -0.994 . . . . 1.26 109.271 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -107.92 128.45 54.64 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.192 -0.942 . . . . 0.56000000000000005 110.528 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.458 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . 42.7 t -97.26 150.55 20.81 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.537 -0.912 . . . . 1.8300000000000001 108.537 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.467 HD13 ' CD1' ' A' ' 63' ' ' ILE . 35.8 mt -105.86 38.2 2.06 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.092 -1.005 . . . . 0.89000000000000001 109.961 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.44 12.24 5.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -0.872 . . . . 1.6899999999999999 109.456 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.26 -44.34 0.06 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.461 -1.456 . . . . 0.98999999999999999 109.461 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.92 111.31 23.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -1.168 . . . . 5.7300000000000004 108.997 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -79.82 133.43 36.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.021 -1.049 . . . . 2.04 109.83 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.552 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 98.0 mt -123.87 167.24 17.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.177 -0.952 . . . . 1.24 109.444 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.552 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 35.9 m-20 -114.63 115.24 26.81 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.754 -1.573 . . . . 1.03 106.754 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.627 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 2.8 t -83.36 115.17 57.86 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.946 . . . . 0.63 111.458 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 37.5 Cg_endo -85.04 -156.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 123.1 2.533 . . . . 0.23999999999999999 109.342 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.62 35.83 82.73 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.286 -1.126 . . . . 0.71999999999999997 110.286 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.594 ' CG2' ' CD1' ' A' ' 92' ' ' TRP . 18.2 pt -127.06 -156.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.157 -1.201 . . . . 0.46000000000000002 108.83 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.576 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 38.7 t0 -108.58 108.75 19.76 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.244 -0.91 . . . . 1.4099999999999999 109.464 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.467 ' HB ' ' HD2' ' A' ' 51' ' ' LYS . 1.4 p -88.07 46.56 1.4 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.628 -1.249 . . . . 1.4099999999999999 107.628 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 23.1 t30 175.49 83.54 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.645 -1.613 . . . . 1.8799999999999999 106.645 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 76' ' ' VAL . . . -66.24 1.6 1.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.53 -0.731 . . . . 0.67000000000000004 111.822 -177.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 20.2 m -61.92 -13.65 26.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.817 -1.177 . . . . 2.9900000000000002 109.674 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -81.84 -14.69 55.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.111 -0.993 . . . . 1.0 110.156 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.701 ' CE2' ' CD1' ' A' ' 90' ' ' TYR . 19.7 m-85 -122.54 -15.27 7.6 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.367 -0.833 . . . . 1.4399999999999999 109.739 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.621 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 3.1 m -122.15 169.05 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.35 -0.982 . . . . 0.98999999999999999 108.35 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.598 ' HG2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -100.76 87.59 3.37 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.221 -0.925 . . . . 3.1099999999999999 112.248 -178.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.529 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 20.4 p -87.62 157.44 52.43 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.445 -1.41 . . . . 0.97999999999999998 107.91 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.582 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 21.8 Cg_endo -65.08 125.19 5.16 Favored 'Cis proline' 0 C--N 1.314 -1.261 0 O-C-N 123.105 1.055 . . . . 0.68000000000000005 112.947 2.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.617 ' CD2' ' CD2' ' A' ' 86' ' ' TYR . 13.8 mt -70.75 117.06 11.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.531 -1.655 . . . . 1.6599999999999999 106.531 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 43.6 t -83.55 139.84 17.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 C-N-CA 119.606 -0.838 . . . . 0.93000000000000005 110.926 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.562 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 16.8 ttpt -66.48 108.51 2.42 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.644 0.735 . . . . 1.51 109.562 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.66 -19.14 5.93 Favored Glycine 0 C--N 1.298 -1.555 0 N-CA-C 109.519 -1.432 . . . . 0.41999999999999998 109.519 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.581 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 4.0 tp60 -97.91 152.06 19.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.169 -1.195 . . . . 0.71999999999999997 107.799 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -104.96 143.63 32.91 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 118.99 -1.084 . . . . 0.32000000000000001 108.511 179.388 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.617 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 25.9 m-85 -121.05 150.06 41.76 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.279 -0.888 . . . . 0.80000000000000004 109.606 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.526 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 8.8 p-10 -119.76 109.85 16.1 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.951 -1.129 . . . . 0.62 107.951 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.621 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 6.9 tt -106.43 122.12 59.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.007 0.908 . . . . 0.72999999999999998 111.839 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -101.85 112.58 25.25 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 104.637 -2.357 . . . . 1.4099999999999999 104.637 176.033 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.701 ' CD1' ' CE2' ' A' ' 75' ' ' PHE . 31.5 t80 -127.51 139.5 52.74 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.734 -1.229 . . . . 1.1000000000000001 112.405 -175.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.66 106.83 18.83 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.202 -1.407 . . . . 1.3100000000000001 107.202 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.627 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 29.9 t90 -82.2 94.32 7.26 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.494 0.664 . . . . 0.56999999999999995 109.832 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -67.71 109.82 3.49 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.487 -0.758 . . . . 2.8799999999999999 109.35 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.636 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 12.4 t -60.2 142.97 89.4 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.124 -1.065 . . . . 1.1899999999999999 108.124 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.636 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 23.7 Cg_endo -66.97 -11.84 33.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.508 2.139 . . . . 3.7999999999999998 111.755 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 0.0 OUTLIER 76.21 -7.23 1.86 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 4.0300000000000002 109.485 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.525 ' O ' ' C ' ' A' ' 98' ' ' ALA . 12.7 pt -93.5 -27.97 4.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 O-C-N 121.114 -0.991 . . . . 1.6399999999999999 108.444 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.525 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -32.84 117.6 0.43 Allowed Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 108.575 -0.898 . . . . 0.58999999999999997 108.575 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.594 ' O ' ' N ' ' A' ' 101' ' ' SER . 37.3 Cg_endo -83.86 138.94 8.36 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.747 2.298 . . . . 0.75 110.015 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.52 ' HE3' ' HG2' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -50.22 90.47 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.897 -1.149 . . . . 4.3200000000000003 107.897 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 99' ' ' PRO . 1.8 t -94.32 124.18 38.18 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.506 -0.746 . . . . 0.56000000000000005 109.271 -178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -43.13 -45.3 5.39 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.591 -0.892 . . . . 1.8500000000000001 108.591 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.418 ' N ' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -131.44 141.48 49.82 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.497 -0.752 . . . . 1.23 109.195 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.542 HG23 ' CD1' ' A' ' 127' ' ' ILE . 2.1 t -131.41 145.4 35.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.268 -0.895 . . . . 0.89000000000000001 109.497 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 57' ' ' SER . 73.4 t -126.27 114.72 39.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.878 -1.156 . . . . 0.82999999999999996 107.878 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.489 HG13 ' CG2' ' A' ' 54' ' ' ILE . 1.8 t -95.66 137.29 24.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.92 -1.112 . . . . 0.62 109.372 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.603 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 34.3 m -118.72 112.24 19.51 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.15 -0.969 . . . . 0.93000000000000005 109.584 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.426 HG11 ' HB2' ' A' ' 120' ' ' ALA . 0.5 OUTLIER -92.7 125.25 45.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 106.647 -1.612 . . . . 0.53000000000000003 106.647 178.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.64 ' CG ' ' CG1' ' A' ' 116' ' ' VAL . 9.0 ttmt -141.26 131.51 24.97 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.134 -1.427 . . . . 3.3399999999999999 112.117 -176.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.659 ' CD1' ' CZ ' ' A' ' 41' ' ' PHE . 9.0 mt -104.16 138.15 41.07 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.209 -1.404 . . . . 1.3300000000000001 107.209 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.526 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 3.2 mp -129.69 120.57 50.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.101 -1.0 . . . . 0.39000000000000001 109.922 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.416 ' HA3' HG22 ' A' ' 47' ' ' THR . . . -92.74 -145.95 17.92 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.754 -1.738 . . . . 0.85999999999999999 108.754 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.465 ' OD1' ' OG1' ' A' ' 49' ' ' THR . 0.1 OUTLIER -99.93 -1.5 37.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.128 -1.219 . . . . 1.24 109.941 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 114' ' ' ASN . 0.4 OUTLIER -114.68 -10.5 12.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.97 -1.081 . . . . 6.0599999999999996 110.247 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.458 ' O ' HG21 ' A' ' 111' ' ' ILE . . . 159.32 -148.0 16.2 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.521 -1.323 . . . . 0.34999999999999998 110.13 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.64 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 2.1 t -91.99 109.87 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -1.136 . . . . 0.28999999999999998 110.13 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.459 HD11 HD11 ' A' ' 80' ' ' LEU . 41.0 mt -52.85 -43.67 66.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.446 -0.784 . . . . 1.1100000000000001 109.782 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.459 ' O ' HG11 ' A' ' 116' ' ' VAL . . . -158.71 -178.1 7.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.093 -1.005 . . . . 0.68000000000000005 109.357 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.9 OUTLIER -166.36 156.07 11.75 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.044 -1.035 . . . . 0.77000000000000002 110.191 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.4 149.63 28.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.105 -0.997 . . . . 0.51000000000000001 109.833 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.2 mt -138.1 121.08 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.068 -1.02 . . . . 1.6000000000000001 109.794 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.27 140.82 30.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.995 -1.065 . . . . 1.48 108.923 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 55.1 p -125.02 171.81 9.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.134 -0.979 . . . . 2.75 109.873 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 61.55 29.5 18.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -0.811 . . . . 2.5699999999999998 109.513 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -98.93 162.85 20.27 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.728 -1.349 . . . . 1.26 109.728 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 11.2 mtmt -151.2 134.19 15.86 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.465 -1.021 . . . . 1.28 108.308 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.542 ' CD1' HG23 ' A' ' 104' ' ' VAL . 55.9 mt -99.22 141.5 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.692 -1.255 . . . . 0.89000000000000001 110.218 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.52 ' HG2' ' HE3' ' A' ' 100' ' ' LYS . 12.4 mtm180 -132.5 177.2 7.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.535 -0.728 . . . . 2.4100000000000001 109.299 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.049 -0.977 . . . . 2.3999999999999999 109.457 179.572 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 17' ' ' MET . 5.6 m-20 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.252 0.549 . . . . 3.46 109.573 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.53 ' CA ' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -65.25 156.65 31.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 3.6499999999999999 110.031 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.18 163.95 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.489 -0.757 . . . . 2.6499999999999999 109.096 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -71.74 119.02 15.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.103 -0.998 . . . . 2.1499999999999999 109.546 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.09 173.34 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.382 -0.824 . . . . 2.5600000000000001 109.156 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.32 108.56 13.38 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.262 -0.899 . . . . 6.8499999999999996 109.616 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -77.41 118.88 20.3 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.213 -0.929 . . . . 2.6000000000000001 108.81 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.1 p -98.65 13.54 31.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.004 -1.06 . . . . 1.3100000000000001 110.107 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 10' ' ' ASN . . . -93.65 -72.99 0.58 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.946 -1.096 . . . . 0.83999999999999997 109.425 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.472 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 19.8 t-20 172.5 63.48 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.762 -1.199 . . . . 5.0 107.762 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 11' ' ' ASN . 47.1 t-20 60.45 18.4 8.16 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.861 -1.163 . . . . 2.73 107.861 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.474 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 0.8 OUTLIER -57.79 -81.67 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.728 -0.607 . . . . 3.5899999999999999 109.57 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -56.43 125.73 12.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.32 -0.952 . . . . 0.55000000000000004 109.423 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.6 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 1.2 mmtt -75.57 -24.89 56.68 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.369 -0.832 . . . . 1.24 108.866 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.6 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 167.88 126.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.372 -0.973 . . . . 4.3700000000000001 108.372 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.615 ' CG2' ' CB ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -105.26 125.14 60.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.092 -1.077 . . . . 0.81000000000000005 108.092 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.537 ' HE2' ' CG ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -111.84 150.22 30.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.962 -1.086 . . . . 2.3500000000000001 110.811 -177.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.586 HG12 ' CE2' ' A' ' 35' ' ' PHE . 46.6 t -109.48 163.52 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.3 -1.0 . . . . 1.22 108.3 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -86.49 64.12 8.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.07 -1.018 . . . . 1.45 109.713 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 21' ' ' CYS . . . 163.02 -95.71 0.13 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.881 -1.288 . . . . 2.5600000000000001 109.881 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.414 ' C ' ' O ' ' A' ' 20' ' ' GLY . 93.5 m -42.39 155.11 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.339 -1.095 . . . . 1.8700000000000001 109.974 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.585 ' CG ' ' O ' ' A' ' 22' ' ' HIS . 13.9 p-80 -162.87 107.66 1.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.324 -0.86 . . . . 5.3399999999999999 110.103 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.59 -148.45 16.69 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.912 -1.275 . . . . 4.3799999999999999 109.912 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.0 t -87.4 21.82 2.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.338 -1.095 . . . . 2.5699999999999998 109.729 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.59 157.29 80.08 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.13 -0.982 . . . . 2.3300000000000001 109.313 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.8 158.84 31.47 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.743 2.295 . . . . 1.04 110.257 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.5 141.91 50.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 2.6699999999999999 109.421 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.548 HG23 ' CD2' ' A' ' 30' ' ' HIS . 51.0 mm -113.0 113.31 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.061 -1.024 . . . . 0.93000000000000005 109.065 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.499 HG12 ' CE1' ' A' ' 35' ' ' PHE . 32.5 mt -99.22 112.34 31.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.201 -0.937 . . . . 1.3300000000000001 109.031 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.548 ' CD2' HG23 ' A' ' 28' ' ' ILE . 47.3 m170 -88.35 105.16 17.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.057 -1.09 . . . . 3.1200000000000001 108.057 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.498 ' HA ' HG11 ' A' ' 94' ' ' VAL . 8.1 ptt180 -45.54 123.31 4.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.992 -1.068 . . . . 1.03 109.822 -178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.551 ' HA2' ' CD ' ' A' ' 96' ' ' LYS . . . 116.87 -11.85 15.13 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.058 -1.617 . . . . 0.41999999999999998 109.058 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -103.87 149.97 37.73 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.355 -1.085 . . . . 1.96 108.754 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 36.5 Cg_endo -79.44 121.66 4.83 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 122.379 2.053 . . . . 0.38 110.718 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.586 ' CE2' HG12 ' A' ' 18' ' ' VAL . 2.3 t80 -97.12 120.86 38.25 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.445 -1.317 . . . . 1.24 107.445 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.48 HG22 ' HE3' ' A' ' 89' ' ' LYS . 73.3 m -100.99 127.32 47.54 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.684 -1.26 . . . . 1.1899999999999999 110.68 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.655 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -138.19 124.12 20.08 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.96 -0.755 . . . . 1.8600000000000001 108.96 178.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 16' ' ' VAL . 38.6 tt0 -104.33 135.88 44.95 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.699 -1.223 . . . . 1.71 107.699 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.615 ' CB ' ' CG2' ' A' ' 16' ' ' VAL . . . -133.04 123.19 25.34 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.841 -1.143 . . . . 0.23999999999999999 110.562 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.571 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 8.7 mt -88.39 137.21 32.53 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.56 -2.015 . . . . 0.68000000000000005 105.56 177.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.639 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 34.8 p90 -152.12 134.81 15.46 Favored 'General case' 0 C--N 1.288 -2.107 0 C-N-CA 118.171 -1.412 . . . . 0.26000000000000001 110.168 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.8 OUTLIER -82.72 107.81 15.63 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.446 -0.946 . . . . 0.66000000000000003 108.446 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -45.67 114.36 0.75 Allowed 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.136 -0.69 . . . . 0.42999999999999999 109.136 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 44' ' ' ASN . 1.3 p30 -84.24 10.6 9.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.056 -1.027 . . . . 0.76000000000000001 109.23 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.58 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 8.4 pt20 -166.53 145.02 5.43 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.312 -0.868 . . . . 1.4399999999999999 109.253 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 9.4 p30 -83.93 110.04 18.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.82999999999999996 109.12 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.464 HG22 ' HA3' ' A' ' 112' ' ' GLY . 1.5 t -126.7 151.15 48.51 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.189 -0.944 . . . . 0.52000000000000002 109.795 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.747 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 1.1 mmmt -86.39 -20.61 27.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.332 -0.855 . . . . 0.83999999999999997 109.156 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 p -132.29 138.91 48.02 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.109 0.957 . . . . 1.4199999999999999 110.137 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -139.34 148.12 42.48 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.675 -1.232 . . . . 1.75 107.675 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.555 ' HD2' ' HA ' ' A' ' 70' ' ' THR . 1.0 OUTLIER -141.12 142.31 34.11 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.251 -0.906 . . . . 3.8900000000000001 110.339 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.461 ' HA ' HD21 ' A' ' 110' ' ' LEU . 5.3 tt -91.84 149.47 4.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 107.622 -1.251 . . . . 0.90000000000000002 107.622 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.442 ' OE2' ' N ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -145.01 117.24 8.41 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.598 -0.89 . . . . 4.8399999999999999 108.598 -177.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 107' ' ' THR . 3.4 mp -109.67 134.95 50.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.806 -1.184 . . . . 1.0700000000000001 110.596 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -125.17 131.65 53.18 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.161 -0.962 . . . . 2.46 108.952 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.25 146.96 34.75 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.71 -1.244 . . . . 1.1000000000000001 111.4 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.24 150.86 26.18 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.033 -1.099 . . . . 0.79000000000000004 108.033 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.48 HD13 ' HG2' ' A' ' 99' ' ' PRO . 44.4 mt -120.69 61.33 0.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.864 -1.148 . . . . 1.5700000000000001 110.486 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 58' ' ' LEU . 5.7 t0 41.71 26.72 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.593 -0.692 . . . . 1.1000000000000001 110.081 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 158.24 -49.35 0.42 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.597 -1.401 . . . . 0.40999999999999998 109.597 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.407 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 8.2 tp -97.93 113.03 24.76 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.394 -1.062 . . . . 1.3300000000000001 108.873 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -93.08 123.25 36.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.14 -0.975 . . . . 5.4699999999999998 109.636 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.611 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 12.8 mt -118.15 169.36 8.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 122.15 0.976 . . . . 0.72999999999999998 109.348 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.611 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 18.9 m-20 -108.52 134.56 51.13 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.131 -1.433 . . . . 0.67000000000000004 107.131 177.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.597 ' CG1' ' CZ2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -104.05 107.82 58.2 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.839 -1.163 . . . . 1.25 110.632 -178.44 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.3 Cg_endo -81.32 -154.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 123.151 2.567 . . . . 0.55000000000000004 109.914 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.85 34.09 86.11 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.333 -1.507 . . . . 0.89000000000000001 109.333 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.606 HG22 ' CE2' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -108.04 179.84 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.354 -1.086 . . . . 3.7000000000000002 109.378 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.592 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -86.01 -1.1 57.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.92 -1.112 . . . . 3.1499999999999999 109.318 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.555 ' HA ' ' HD2' ' A' ' 51' ' ' LYS . 29.3 p 30.19 36.36 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.678 0.752 . . . . 2.0800000000000001 109.921 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.561 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 14.7 t-20 174.56 90.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.685 -1.228 . . . . 1.74 107.685 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.609 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -75.29 2.05 12.12 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.589 -0.694 . . . . 0.71999999999999997 110.973 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.433 ' HA ' HG23 ' A' ' 76' ' ' VAL . 84.2 m -66.79 -9.42 36.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.015 -1.053 . . . . 2.6699999999999999 109.229 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.14 -17.42 35.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 1.3400000000000001 109.522 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 75' ' ' PHE . 2.8 m-85 -116.87 -12.01 10.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 1.22 109.111 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.622 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 1.7 m -120.99 165.73 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.362 -0.977 . . . . 0.58999999999999997 108.362 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.614 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -90.0 98.87 12.02 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.921 -1.112 . . . . 2.9300000000000002 110.864 -178.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.479 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 18.2 m -91.48 152.23 43.38 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.219 -0.926 . . . . 2.79 108.674 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.747 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.2 Cg_endo -70.13 139.26 54.62 Favored 'Cis proline' 0 C--N 1.312 -1.383 0 C-N-CA 124.117 -1.201 . . . . 0.40000000000000002 112.332 0.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.595 HD23 ' CE2' ' A' ' 86' ' ' TYR . 13.1 mt -77.86 112.14 14.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.625 -1.62 . . . . 1.1000000000000001 106.625 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 82' ' ' LYS . 10.9 t -82.92 144.95 9.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 121.841 0.829 . . . . 1.0700000000000001 110.946 -177.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.58 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 8.2 ttpt -68.53 117.42 10.26 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.703 0.763 . . . . 1.24 109.754 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 119.43 -11.08 11.41 Favored Glycine 0 C--N 1.296 -1.675 0 N-CA-C 109.514 -1.434 . . . . 0.26000000000000001 109.514 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.536 ' HG3' ' N ' ' A' ' 85' ' ' GLN . 4.6 tp60 -107.8 157.02 18.5 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.144 -1.058 . . . . 0.80000000000000004 108.144 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.536 ' N ' ' HG3' ' A' ' 84' ' ' GLN . 1.5 tt0 -109.93 144.29 38.65 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.049 -1.032 . . . . 2.3100000000000001 108.438 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.614 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 38.6 m-85 -125.75 145.95 49.98 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.201 -0.937 . . . . 0.89000000000000001 110.033 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.571 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -111.45 113.62 26.18 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.759 -0.83 . . . . 1.71 108.759 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.622 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 2.3 tt -109.87 117.36 54.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.058 -1.026 . . . . 0.5 111.199 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.48 ' HE3' HG22 ' A' ' 36' ' ' THR . 3.0 tttp -94.35 114.91 27.04 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.624 -2.362 . . . . 2.1800000000000002 104.624 176.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.606 ' CE2' HG22 ' A' ' 68' ' ' ILE . 27.8 t80 -126.09 139.64 53.22 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.113 -1.435 . . . . 0.83999999999999997 113.366 -175.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.496 ' O ' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -93.08 131.67 37.9 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 105.119 -2.178 . . . . 1.9199999999999999 105.119 175.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.597 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 29.9 t90 -109.92 96.81 6.48 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 121.351 -0.843 . . . . 1.05 109.826 -176.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -68.32 104.49 1.87 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.347 0.594 . . . . 3.1699999999999999 109.868 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.631 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 30.0 t -61.55 143.83 93.11 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.324 -0.991 . . . . 1.8400000000000001 108.324 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.631 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 23.4 Cg_endo -64.55 -6.33 11.87 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.377 2.052 . . . . 3.9700000000000002 112.182 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.551 ' CD ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER 67.98 -4.13 1.08 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.998 -1.064 . . . . 3.2599999999999998 110.425 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.528 ' O ' ' C ' ' A' ' 98' ' ' ALA . 16.2 pt -94.49 -26.52 4.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 O-C-N 120.789 -1.195 . . . . 1.8600000000000001 107.948 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -30.59 118.49 0.34 Allowed Pre-proline 0 N--CA 1.488 1.47 0 CA-C-N 115.813 -0.63 . . . . 0.5 109.376 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 101' ' ' SER . 35.8 Cg_endo -82.99 131.46 5.98 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.689 2.259 . . . . 0.59999999999999998 108.473 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.613 ' CG ' ' HA ' ' A' ' 128' ' ' ARG . 1.6 ttpt -48.33 91.03 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.334 -0.946 . . . . 2.6899999999999999 108.952 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 99' ' ' PRO . 1.2 t -94.16 116.91 29.38 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.842 -0.799 . . . . 0.82999999999999996 108.842 -179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 101' ' ' SER . 5.4 pt-20 -35.03 -47.5 0.37 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.805 -0.559 . . . . 1.4199999999999999 110.54 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -129.06 140.46 51.59 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.192 -0.942 . . . . 1.5600000000000001 109.154 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.52 ' CG2' ' CD1' ' A' ' 127' ' ' ILE . 0.9 OUTLIER -131.75 143.58 39.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.358 -0.839 . . . . 1.25 109.831 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 122' ' ' ALA . 11.8 t -124.6 117.1 49.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.791 -1.559 . . . . 1.52 106.791 178.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.15 141.68 14.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 C-N-CA 119.466 -0.893 . . . . 0.65000000000000002 110.594 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.599 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 51.7 m -116.15 138.27 51.41 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.387 -0.968 . . . . 1.78 108.387 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER -119.63 127.49 75.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 106.738 -1.579 . . . . 0.48999999999999999 106.738 178.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.561 ' HG2' ' CG1' ' A' ' 116' ' ' VAL . 3.9 ttmt -140.14 129.1 23.43 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.1 -1.44 . . . . 3.2599999999999998 111.693 -177.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.639 ' CD1' ' CE2' ' A' ' 41' ' ' PHE . 6.5 mt -103.17 138.7 39.63 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.98 -1.489 . . . . 0.62 106.98 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 116' ' ' VAL . 4.5 mp -133.25 115.87 24.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.967 -1.083 . . . . 0.52000000000000002 109.731 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.464 ' HA3' HG22 ' A' ' 47' ' ' THR . . . -87.87 -133.7 4.25 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.082 -1.607 . . . . 0.28000000000000003 109.082 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -110.53 -2.36 16.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -1.146 . . . . 2.9100000000000001 109.709 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.46 -0.09 12.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.073 -1.017 . . . . 2.79 110.257 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 151.37 -157.31 27.14 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.916 -1.274 . . . . 0.35999999999999999 109.916 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.561 ' CG1' ' HG2' ' A' ' 109' ' ' LYS . 21.3 t -86.48 110.54 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -1.14 . . . . 1.6499999999999999 109.626 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 50' ' ' ALA . 20.2 mt -58.03 -39.35 78.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.439 -0.788 . . . . 0.75 110.735 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.529 ' O ' HG11 ' A' ' 116' ' ' VAL . . . -150.43 177.2 10.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.721 -1.237 . . . . 1.23 109.534 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -170.04 148.07 3.35 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.875 -1.141 . . . . 0.85999999999999999 109.588 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -151.76 149.66 29.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.014 -1.054 . . . . 0.76000000000000001 109.743 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 85.0 mt -136.71 119.86 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.099 -1.001 . . . . 1.24 109.39 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.473 ' O ' ' CG1' ' A' ' 105' ' ' VAL . . . -88.36 150.88 22.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.857 -1.152 . . . . 0.67000000000000004 109.934 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.3 t -111.61 3.95 18.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.23 -0.919 . . . . 3.5699999999999998 110.424 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.421 ' CD2' ' C ' ' A' ' 124' ' ' HIS . 1.4 p-80 -133.46 173.81 11.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.889 -1.132 . . . . 8.0800000000000001 109.561 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 129.21 155.05 8.4 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.748 -1.215 . . . . 1.79 110.369 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 6.0 mtmp? -152.08 141.14 21.23 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.146 -1.427 . . . . 3.6499999999999999 107.146 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.52 ' CD1' ' CG2' ' A' ' 104' ' ' VAL . 81.6 mt -104.35 140.75 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.429 -1.42 . . . . 0.82999999999999996 111.147 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.613 ' HA ' ' CG ' ' A' ' 100' ' ' LYS . 4.4 mtt85 -127.85 174.82 8.83 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.274 -1.01 . . . . 4.5899999999999999 108.274 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 120.967 -1.083 . . . . 0.96999999999999997 109.527 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 17' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.39 -0.596 . . . . 1.75 109.39 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.546 ' HA ' ' CA ' ' A' ' 23' ' ' GLY . 1.3 m -106.29 165.48 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.98 109.609 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -87.1 119.19 27.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 1.59 109.509 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 m -150.88 157.04 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.73 109.224 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.04 108.57 14.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 3.47 109.383 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.418 ' CG ' ' HB ' ' A' ' 13' ' ' ILE . 2.3 m-20 -52.49 114.76 1.48 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.27 -0.894 . . . . 2.35 109.354 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -85.32 9.55 15.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.76 109.326 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.604 ' O ' ' ND2' ' A' ' 10' ' ' ASN . . . -90.55 -69.93 0.7 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.905 . . . . 0.61 109.702 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 9' ' ' ALA . 0.4 OUTLIER 171.74 57.67 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.461 -0.775 . . . . 2.4 109.252 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 64.83 13.66 8.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.126 -0.984 . . . . 2.2 108.924 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' O ' ' CE ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -63.17 -67.1 0.45 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.366 -0.834 . . . . 1.71 109.771 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -56.78 130.28 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.41 109.478 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 8.8 mmpt? -88.12 -13.95 40.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.325 -0.86 . . . . 1.13 109.454 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.2 ttpt 161.86 128.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 1.69 109.585 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.741 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -116.85 127.01 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.38 -0.825 . . . . 0.68 108.958 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.536 ' CB ' ' HA ' ' A' ' 2' ' ' GLN . 0.2 OUTLIER -122.53 156.67 33.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.059 -1.025 . . . . 0.91 110.191 -179.362 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.091 HG11 ' CE2' ' A' ' 35' ' ' PHE . 52.8 t -127.63 148.54 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.55 109.176 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.66 75.54 7.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 2.32 109.424 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.75 -69.75 0.14 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.89 -1.284 . . . . 1.23 109.89 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.7 t -67.88 168.1 12.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -1.191 . . . . 1.67 109.841 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -107.22 -9.3 16.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 3.26 109.68 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.546 ' CA ' ' HA ' ' A' ' 3' ' ' VAL . . . 103.37 -104.21 2.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.008 -1.237 . . . . 1.82 110.008 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' GLY . 9.3 t -41.71 -39.66 1.75 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.421 -1.047 . . . . 1.75 109.683 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.503 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -68.52 173.18 3.63 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 1.75 109.258 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 35.4 Cg_endo -77.67 152.62 29.47 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.715 2.277 . . . . 1.03 110.333 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.4 m -116.42 130.02 56.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 1.23 109.382 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.51 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 36.8 mm -106.06 102.57 14.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.072 -1.018 . . . . 0.56 108.81 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 mp -88.7 118.23 33.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.163 -0.961 . . . . 0.48 109.141 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.441 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 6.1 m80 -89.04 102.53 15.18 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.351 -0.843 . . . . 1.04 109.044 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 5.2 ptt180 -43.1 138.89 1.98 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.873 . . . . 1.36 110.064 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' CA ' ' HD2' ' A' ' 96' ' ' LYS . . . 97.61 -14.63 62.97 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.084 -1.206 . . . . 0.51 110.084 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.581 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -103.14 150.96 38.39 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.247 . . . . 1.72 109.812 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 36.5 Cg_endo -79.94 113.56 3.02 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.902 2.401 . . . . 0.46 111.138 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 1.091 ' CE2' HG11 ' A' ' 18' ' ' VAL . 5.8 t80 -99.4 122.1 42.04 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.428 -1.323 . . . . 0.63 107.428 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 1.015 ' C ' HD13 ' A' ' 37' ' ' LEU . 71.7 m -102.76 138.79 39.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.857 -1.152 . . . . 0.61 111.075 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.015 HD13 ' C ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -140.21 128.51 22.53 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.086 -0.709 . . . . 2.02 109.086 178.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.525 ' HG3' ' HA ' ' A' ' 89' ' ' LYS . 2.4 tt0 -104.97 126.26 51.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.835 -1.166 . . . . 1.34 108.076 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.741 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -124.72 122.8 38.51 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.733 -1.23 . . . . 0.32 110.668 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 7.9 mt -89.59 144.01 26.35 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.5 -1.667 . . . . 0.51 106.5 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.637 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 32.7 p90 -159.87 138.4 10.49 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.702 -1.249 . . . . 0.22 109.877 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.6 m-20 -85.05 113.59 21.58 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.346 -0.942 . . . . 1.15 108.698 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -44.71 113.28 0.53 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.046 -0.724 . . . . 0.21 109.046 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.55 ' ND2' ' OE1' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -81.62 7.75 11.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.237 -0.914 . . . . 1.12 109.554 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.55 ' OE1' ' ND2' ' A' ' 44' ' ' ASN . 1.1 pt20 -170.5 163.88 8.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.213 -0.929 . . . . 0.75 109.835 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 8.9 p30 -92.38 121.77 34.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 1.75 109.309 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.484 HG21 ' HA3' ' A' ' 112' ' ' GLY . 2.5 t -141.83 156.33 45.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.177 -0.952 . . . . 0.37 109.78 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.691 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -95.68 -14.5 23.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -0.847 . . . . 1.91 109.499 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.408 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 6.1 p -141.3 137.88 32.77 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.947 0.879 . . . . 0.74 109.862 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -129.62 152.69 48.87 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.482 -0.932 . . . . 0.41 108.482 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.552 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 1.3 mtmt -133.93 140.36 46.73 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.048 -1.061 . . . . 0.75 110.505 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.699 ' HA ' HD23 ' A' ' 110' ' ' LEU . 3.1 tt -94.39 149.01 4.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.617 -1.253 . . . . 0.54 107.617 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -137.24 115.06 11.37 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.216 -0.927 . . . . 1.48 109.758 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.841 HD12 ' N ' ' A' ' 54' ' ' ILE . 2.1 mp -113.99 117.79 56.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 120.971 -1.081 . . . . 0.36 108.948 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.471 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 21.0 mttt -119.71 131.16 55.33 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.18 -0.95 . . . . 1.25 109.396 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.62 133.37 52.16 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.173 -0.954 . . . . 0.53 110.424 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -98.49 151.32 20.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 1.64 109.085 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.815 HD11 HD12 ' A' ' 63' ' ' ILE . 34.3 mt -109.2 49.16 0.83 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.091 -1.005 . . . . 0.9 109.86 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 58' ' ' LEU . 20.7 t0 44.4 26.64 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.897 . . . . 1.46 109.305 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.91 -55.16 0.17 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.319 -1.513 . . . . 0.95 109.319 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 62' ' ' GLU . 1.2 tp -102.99 113.94 27.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -1.133 . . . . 2.07 109.141 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.58 ' N ' HD12 ' A' ' 61' ' ' LEU . 37.0 tt0 -81.62 133.6 35.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.955 . . . . 2.45 109.398 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.815 HD12 HD11 ' A' ' 58' ' ' LEU . 40.8 mt -126.66 168.69 19.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.008 0.908 . . . . 1.59 109.215 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.594 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 63.3 m-20 -111.87 141.85 44.98 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.732 -1.21 . . . . 1.85 107.732 178.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.056 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 6.2 t -108.32 105.39 56.55 Favored Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 121.03 -1.044 . . . . 0.45 110.472 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 37.3 Cg_endo -82.56 -156.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.475 2.784 . . . . 0.44 110.189 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.37 17.58 47.34 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.576 -1.41 . . . . 0.86 109.576 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.704 HG21 HD13 ' A' ' 54' ' ' ILE . 50.1 pt -104.67 -167.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -1.138 . . . . 0.62 109.432 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.598 ' O ' HG22 ' A' ' 52' ' ' ILE . 24.3 t0 -98.8 109.75 22.46 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.362 -0.836 . . . . 0.97 109.382 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.552 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 1.2 p -86.74 47.47 1.49 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.283 -0.886 . . . . 0.45 108.83 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 54.5 t-20 177.75 81.86 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.858 -1.164 . . . . 1.23 107.858 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.691 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -65.93 -5.57 9.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.572 -0.705 . . . . 0.32 111.822 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.574 ' HA ' HG22 ' A' ' 76' ' ' VAL . 1.3 t -64.39 -12.13 39.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.587 -1.321 . . . . 1.18 109.058 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.81 -23.19 55.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.051 -1.031 . . . . 1.09 109.845 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.436 ' HB2' HG13 ' A' ' 88' ' ' ILE . 79.4 m-85 -110.27 -24.49 10.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.52 109.098 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.762 ' CG2' HD21 ' A' ' 80' ' ' LEU . 1.2 m -107.66 162.6 5.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.122 -1.066 . . . . 0.35 108.122 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.633 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -88.54 93.82 9.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.931 -1.106 . . . . 2.17 111.222 -178.357 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.484 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 14.3 p -88.92 153.91 49.67 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 107.544 -1.28 . . . . 0.89 107.544 177.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.691 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 26.3 Cg_endo -69.92 134.8 31.22 Favored 'Cis proline' 0 C--N 1.311 -1.396 0 C-N-CA 124.206 -1.164 . . . . 0.32 112.346 2.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.843 HD23 ' CE2' ' A' ' 86' ' ' TYR . 7.3 mt -76.13 116.97 17.35 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.263 -1.384 . . . . 0.6 107.263 178.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.7 t -89.06 136.94 22.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 121.736 0.779 . . . . 0.43 110.543 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 2.6 ttmt -58.15 118.62 5.66 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.73 0.776 . . . . 1.45 110.269 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.51 -15.11 13.01 Favored Glycine 0 N--CA 1.479 1.549 0 C-N-CA 119.723 -1.227 . . . . 0.31 110.355 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.607 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 4.9 tp60 -102.43 156.68 17.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.042 -1.269 . . . . 1.05 108.044 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -109.26 149.28 29.66 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.107 -0.995 . . . . 1.1 108.502 179.29 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.843 ' CE2' HD23 ' A' ' 80' ' ' LEU . 32.4 m-85 -131.5 149.64 52.45 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.289 -0.882 . . . . 0.4 110.001 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.533 ' HB3' HD23 ' A' ' 40' ' ' LEU . 3.3 p30 -117.43 115.03 24.38 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.162 -1.051 . . . . 1.41 108.162 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.691 HD12 ' HB1' ' A' ' 72' ' ' ALA . 3.8 tt -106.62 120.74 58.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.121 -0.987 . . . . 0.26 111.153 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.525 ' HA ' ' HG3' ' A' ' 38' ' ' GLU . 69.0 tttt -103.09 101.55 11.53 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.099 -2.186 . . . . 2.39 105.099 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.596 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 20.0 t80 -118.45 140.16 50.29 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.19 -0.944 . . . . 0.44 111.535 -176.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.76 107.71 19.4 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.489 -1.3 . . . . 0.76 107.489 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.056 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 28.8 t90 -85.09 93.94 8.73 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.408 0.623 . . . . 0.59 109.628 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -61.51 108.85 1.03 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.395 -0.815 . . . . 1.85 109.6 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 33' ' ' LYS . 21.6 t -64.41 140.42 97.96 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.371 -0.831 . . . . 0.99 108.792 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.862 ' HG3' HG13 ' A' ' 65' ' ' VAL . 34.3 Cg_endo -74.98 140.19 25.21 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.206 1.937 . . . . 2.22 110.167 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.511 ' HD2' ' CA ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -77.48 4.54 10.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.323 -0.861 . . . . 2.59 109.724 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.497 HG12 ' HB2' ' A' ' 95' ' ' PRO . 9.2 pt -92.93 -28.0 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.043 -1.036 . . . . 0.55 109.649 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.574 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . . . -39.57 115.72 1.05 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 109.174 -0.676 . . . . 0.51 109.174 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 101' ' ' SER . 36.6 Cg_endo -83.02 139.54 9.62 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.753 2.302 . . . . 0.63 109.461 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.475 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 1.7 mtmt -50.36 90.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.498 -0.927 . . . . 2.91 108.498 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.721 ' HB3' HG23 ' A' ' 104' ' ' VAL . 2.0 t -96.24 120.47 36.59 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.47 -0.769 . . . . 0.8 109.244 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' A' ' 103' ' ' ASN . 11.8 pt-20 -41.02 -47.49 3.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.507 -0.746 . . . . 1.91 109.657 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.523 ' N ' ' CG ' ' A' ' 102' ' ' GLU . 0.8 OUTLIER -131.57 134.15 45.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 1.89 109.72 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 1.122 HG21 ' CD1' ' A' ' 127' ' ' ILE . 2.5 t -129.68 150.55 34.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.387 -0.821 . . . . 0.63 109.14 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.769 HG13 ' O ' ' A' ' 122' ' ' ALA . 74.2 t -126.62 119.03 52.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.409 -0.96 . . . . 0.63 108.409 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.56 138.93 20.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.093 -1.004 . . . . 0.38 109.617 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 32.9 m -120.39 115.68 23.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.392 -0.818 . . . . 0.37 109.831 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -95.92 127.39 48.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.62 -1.252 . . . . 0.36 107.62 178.558 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.733 ' HD2' HD11 ' A' ' 111' ' ' ILE . 1.4 ttmm -137.92 129.74 28.45 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.518 -1.364 . . . . 1.41 110.733 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.741 ' C ' HD12 ' A' ' 111' ' ' ILE . 14.0 mt -104.21 138.34 40.82 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.376 -1.342 . . . . 0.56 107.376 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.741 HD12 ' C ' ' A' ' 110' ' ' LEU . 4.1 mp -133.7 116.94 25.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.149 -0.97 . . . . 0.29 109.852 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.484 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -89.67 -126.34 2.98 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.112 -1.595 . . . . 0.54 109.112 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.17 -1.89 11.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -1.172 . . . . 1.32 109.565 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -115.22 -3.56 12.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 2.72 109.867 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 151.55 -148.8 20.26 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.756 -1.338 . . . . 0.34 109.756 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.593 ' CG1' ' CD ' ' A' ' 109' ' ' LYS . 2.0 t -90.06 110.21 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -1.176 . . . . 0.49 109.851 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 110' ' ' LEU . 53.2 mt -53.74 -39.59 65.43 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.386 -0.821 . . . . 0.34 109.981 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.512 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -156.87 -165.05 1.76 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.784 -1.197 . . . . 0.46 109.442 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.517 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 50.3 t -174.98 156.13 2.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.035 -1.04 . . . . 0.56 109.72 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -154.11 142.11 20.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.914 . . . . 0.39 109.409 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.44 HD12 ' HB3' ' A' ' 8' ' ' CYS . 26.0 mt -134.1 118.89 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.75 109.178 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.769 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -94.1 142.75 27.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.103 -0.998 . . . . 0.66 109.49 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -86.99 0.34 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.886 . . . . 2.06 109.592 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -49.12 115.8 1.44 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 2.56 109.667 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -159.6 149.81 19.78 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.297 -1.521 . . . . 0.42 109.297 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 13.8 mttt -152.6 136.0 15.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.42 -1.047 . . . . 1.98 108.524 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 1.122 ' CD1' HG21 ' A' ' 104' ' ' VAL . 75.6 mt -106.87 141.17 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.633 -1.292 . . . . 0.4 110.095 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.51 ' HB2' ' CG2' ' A' ' 28' ' ' ILE . 19.3 mtt180 -131.18 177.31 7.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.562 -0.711 . . . . 2.6 109.151 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.0 t70 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.05 -0.976 . . . . 1.72 109.422 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.546 ' CB ' ' HG2' ' A' ' 17' ' ' MET . 2.6 pt20 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.287 0.565 . . . . 0.63 109.77 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.62 ' CG2' HG23 ' A' ' 18' ' ' VAL . 1.4 m -104.78 143.36 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.342 -0.849 . . . . 0.77 109.258 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -71.25 117.91 13.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.77 110.1 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 m -142.72 154.13 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.552 -0.907 . . . . 0.3 108.552 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.46 107.69 17.45 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.121 -0.987 . . . . 2.05 109.127 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 2.2 p30 -59.63 135.86 57.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 3.69 109.154 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.81 -7.45 14.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.128 -0.983 . . . . 1.09 109.192 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 10' ' ' ASN . . . -67.54 -63.83 0.98 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.69 109.666 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER 166.64 49.88 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.438 -0.789 . . . . 0.89 109.152 -178.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m120 64.32 28.58 13.78 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.217 -1.031 . . . . 4.14 108.217 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.473 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -77.07 -70.99 0.43 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.646 -0.659 . . . . 1.11 109.407 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -55.09 122.76 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.55 109.798 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -66.67 -28.0 68.11 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.359 -0.838 . . . . 1.91 108.947 179.594 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.569 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 12.6 pttt 165.8 135.01 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.837 -1.171 . . . . 0.94 107.837 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.9 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -111.94 119.17 59.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 O-C-N 121.257 -0.902 . . . . 0.54 108.701 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.546 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 1.1 mtm -108.64 157.13 18.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.857 . . . . 0.32 110.483 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.868 HG11 ' CE2' ' A' ' 35' ' ' PHE . 48.4 t -124.11 141.52 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.468 -0.938 . . . . 0.31 108.468 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -85.19 82.36 8.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.015 -1.053 . . . . 0.57 109.493 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.48 -72.59 0.23 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.995 -1.242 . . . . 0.45 109.995 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -51.99 164.67 0.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -1.16 . . . . 1.7 110.322 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.59 -3.54 20.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.485 -0.759 . . . . 1.67 109.4 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 3' ' ' VAL . . . 95.27 -122.24 7.16 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.251 -1.54 . . . . 0.58 109.251 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' GLY . 17.8 t -40.69 -40.87 1.4 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.471 -1.017 . . . . 0.93 109.438 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.58 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -51.05 179.86 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 1.41 108.917 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.58 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 32.7 Cg_endo -76.13 142.43 24.55 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.226 1.951 . . . . 1.59 110.343 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.96 119.71 38.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.96 109.715 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.413 HG23 ' HG3' ' A' ' 128' ' ' ARG . 29.3 mm -111.81 107.91 24.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.007 -1.058 . . . . 0.57 108.991 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 mt -94.37 118.77 41.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.268 -0.895 . . . . 0.66 109.411 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.486 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 14.5 m-70 -91.19 114.92 27.58 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.124 -1.065 . . . . 0.98 108.124 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.529 ' HA ' HG11 ' A' ' 94' ' ' VAL . 12.1 ptt180 -57.36 158.64 5.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.838 -1.164 . . . . 1.14 109.924 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.505 ' HA2' ' CD ' ' A' ' 96' ' ' LYS . . . 87.86 -19.39 34.04 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.479 -1.449 . . . . 0.46 109.479 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.584 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -100.7 152.53 37.87 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.198 -1.178 . . . . 1.09 110.163 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.36 120.46 3.64 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.845 2.363 . . . . 0.46 110.785 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.868 ' CE2' HG11 ' A' ' 18' ' ' VAL . 4.3 t80 -96.76 121.31 38.47 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.868 -1.16 . . . . 0.42 107.868 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.906 ' C ' HD13 ' A' ' 37' ' ' LEU . 2.6 m -100.76 134.65 43.42 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.064 -1.022 . . . . 0.93 110.587 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.965 ' N ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -144.71 124.74 13.57 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.253 -1.017 . . . . 0.68 108.253 178.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.44 133.41 48.53 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.371 -0.974 . . . . 1.93 108.371 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.9 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -130.2 119.74 23.41 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.056 -1.058 . . . . 0.32 110.6 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.603 HD23 ' CB ' ' A' ' 87' ' ' ASP . 12.9 mt -89.71 141.57 28.49 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.154 -2.165 . . . . 0.7 105.154 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 110' ' ' LEU . 28.7 p90 -156.78 137.32 13.11 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.341 -1.343 . . . . 0.29 110.037 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.7 OUTLIER -82.45 112.43 19.38 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.327 -0.949 . . . . 0.52 108.584 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.873 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -44.46 115.54 0.87 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.564 -0.532 . . . . 0.13 109.564 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.568 ' C ' ' ND2' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -80.42 5.77 14.1 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.269 -0.894 . . . . 0.09 109.113 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.552 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 1.3 pt20 -169.5 170.33 8.32 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.34 -0.85 . . . . 0.53 109.357 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -101.18 121.07 41.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.87 108.927 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.575 HG21 HD11 ' A' ' 117' ' ' LEU . 1.2 t -137.88 146.08 42.93 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.234 -0.916 . . . . 0.27 109.867 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.68 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 10.0 mmmt -86.18 -12.76 48.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.416 -0.802 . . . . 0.44 109.578 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.6 p -141.92 149.65 40.44 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.831 -0.748 . . . . 0.44 109.418 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -145.07 156.64 44.04 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.247 -0.908 . . . . 0.37 109.55 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.561 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 0.9 OUTLIER -136.79 140.03 42.22 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.189 -0.944 . . . . 0.27 110.475 -179.313 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 69' ' ' ASP . 3.5 tt -92.94 153.04 3.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.177 -1.416 . . . . 0.74 107.177 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' CB ' ' HB3' ' A' ' 109' ' ' LYS . 2.4 tt0 -139.91 117.34 11.39 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.925 -1.109 . . . . 0.16 110.039 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.6 HD12 HD12 ' A' ' 68' ' ' ILE . 3.2 mp -119.37 116.32 50.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.027 -1.046 . . . . 0.2 109.458 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.701 ' HA ' HG23 ' A' ' 65' ' ' VAL . 2.6 mtmp? -115.98 157.37 24.7 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.197 -0.939 . . . . 1.91 108.712 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -134.22 123.7 24.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.819 -1.175 . . . . 0.35 110.305 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -93.63 150.04 20.74 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.852 -0.796 . . . . 0.69 108.852 179.181 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.563 HD11 ' CD1' ' A' ' 63' ' ' ILE . 15.4 mt -106.72 45.0 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.25 109.704 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.59 17.89 3.31 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.392 -0.818 . . . . 0.82 109.413 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.84 -45.6 0.07 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.806 -1.318 . . . . 0.35 109.806 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.423 ' HG ' HG13 ' A' ' 63' ' ' ILE . 5.1 tp -109.3 112.33 24.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.173 -1.192 . . . . 0.52 109.548 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -77.17 125.39 29.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.992 -1.068 . . . . 1.38 108.95 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.626 HG22 ' N ' ' A' ' 64' ' ' ASP . 43.8 mt -117.2 167.31 10.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 122.117 0.961 . . . . 0.42 109.812 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.626 ' N ' HG22 ' A' ' 63' ' ' ILE . 7.5 t70 -112.4 136.67 51.6 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.061 -1.829 . . . . 4.2 106.061 176.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.082 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 1.5 t -101.72 110.16 61.27 Favored Pre-proline 0 C--N 1.293 -1.868 0 C-N-CA 118.866 -1.134 . . . . 0.55 111.039 -177.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.5 Cg_endo -81.72 -163.18 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.98 2.453 . . . . 0.65 109.766 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.63 50.75 62.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.959 -1.256 . . . . 1.18 109.959 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.6 HD12 HD12 ' A' ' 54' ' ' ILE . 13.4 pt -139.88 -156.82 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -1.103 . . . . 0.66 109.035 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.649 ' O ' HG22 ' A' ' 52' ' ' ILE . 29.6 t70 -110.05 106.39 15.87 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.441 -0.787 . . . . 0.72 109.753 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.561 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -87.12 48.19 1.61 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.19 -0.944 . . . . 0.41 108.562 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 7.2 t30 178.41 79.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.462 -1.31 . . . . 2.22 107.462 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.44 -4.05 1.7 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.643 -0.661 . . . . 0.25 111.902 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.483 ' HA ' HG22 ' A' ' 76' ' ' VAL . 91.6 m -64.53 -10.58 26.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.539 -1.351 . . . . 3.01 109.481 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.71 -20.72 45.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.57 109.552 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CE2' ' CD1' ' A' ' 90' ' ' TYR . 79.4 m-85 -112.19 -20.88 11.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.275 -0.89 . . . . 0.35 109.289 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.802 ' CG2' HD21 ' A' ' 80' ' ' LEU . 2.1 m -112.35 166.25 6.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.616 -0.883 . . . . 0.34 108.616 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.662 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -91.9 94.8 9.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.001 -1.062 . . . . 1.54 111.305 -178.452 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.458 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 51.6 m -84.99 148.93 52.0 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 107.899 -1.149 . . . . 2.9 107.899 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.68 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 25.7 Cg_endo -71.1 136.01 39.43 Favored 'Cis proline' 0 C--N 1.312 -1.367 0 C-N-CA 124.207 -1.164 . . . . 0.16 112.664 1.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.802 HD21 ' CG2' ' A' ' 76' ' ' VAL . 16.5 mt -71.7 146.74 48.01 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.333 -2.099 . . . . 0.72 105.333 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.873 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 59.4 t -117.22 142.09 32.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 O-C-N 120.337 -1.477 . . . . 0.89 111.17 -177.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 6.2 ttmt -65.34 105.86 1.23 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.59 0.709 . . . . 0.56 109.905 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 122.72 -19.36 7.94 Favored Glycine 0 N--CA 1.48 1.583 0 C-N-CA 119.638 -1.268 . . . . 0.23 110.066 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.575 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 7.9 tp60 -95.41 159.48 14.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.075 -1.25 . . . . 0.44 107.804 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -110.49 148.43 32.09 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.878 -1.129 . . . . 0.46 108.371 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.725 ' CE2' HD23 ' A' ' 80' ' ' LEU . 28.6 m-85 -128.43 148.76 50.73 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.32 -0.863 . . . . 0.31 109.908 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.603 ' CB ' HD23 ' A' ' 40' ' ' LEU . 10.7 p-10 -118.69 113.93 21.94 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.605 -0.887 . . . . 0.98 108.605 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.612 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 2.4 tt -108.91 119.16 57.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.272 -0.893 . . . . 0.19 111.139 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -99.72 107.68 19.82 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 104.649 -2.352 . . . . 3.75 104.649 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.614 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 24.5 t80 -124.12 141.98 51.6 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.577 -1.249 . . . . 0.39 113.076 -175.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.586 ' O ' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.29 145.25 24.81 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 106.262 -1.755 . . . . 0.99 106.262 176.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.082 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 26.9 t90 -124.71 82.8 2.08 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.797 -1.19 . . . . 0.64 109.867 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -60.71 106.07 0.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.525 -0.734 . . . . 1.35 109.442 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.648 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 22.1 t -55.99 144.72 57.35 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.157 -1.053 . . . . 1.22 108.157 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.648 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 24.0 Cg_endo -64.36 -7.48 14.22 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.211 1.941 . . . . 3.7 112.192 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.505 ' CD ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER 75.38 -10.74 1.19 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.154 -0.966 . . . . 1.78 109.88 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.513 ' O ' ' C ' ' A' ' 98' ' ' ALA . 19.9 pt -91.11 -28.42 4.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 108.1 -1.074 . . . . 0.5 108.1 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.549 ' HB1' HD13 ' A' ' 127' ' ' ILE . . . -37.3 113.65 0.65 Allowed Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 107.926 -1.138 . . . . 0.65 107.926 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.3 177.83 8.3 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 122.769 2.313 . . . . 1.32 110.459 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 4.5 mtmt -82.19 68.74 8.72 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.573 -1.269 . . . . 0.65 107.573 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.696 ' HB3' HG23 ' A' ' 104' ' ' VAL . 4.0 t -70.86 118.85 14.16 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.495 -0.753 . . . . 0.51 109.615 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 1.1 pt-20 -41.16 -47.36 3.25 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.671 -0.863 . . . . 1.99 108.671 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 3.5 t-20 -130.72 141.62 50.39 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.051 -0.722 . . . . 2.95 109.051 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 1.013 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.9 OUTLIER -131.93 142.65 42.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.101 -1.0 . . . . 0.56 109.467 179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 2.7 t -118.27 117.63 55.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.671 -1.233 . . . . 0.92 107.671 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 2.2 t -101.89 135.92 36.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 120.768 -1.207 . . . . 0.31 110.186 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 94.2 m -116.25 116.59 28.05 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.246 -0.909 . . . . 0.36 109.974 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -94.42 132.23 39.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 106.834 -1.543 . . . . 0.16 106.834 177.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.956 ' CD ' HD11 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -142.03 129.67 21.51 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.327 -1.483 . . . . 0.92 112.112 -177.618 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.694 ' C ' HD12 ' A' ' 111' ' ' ILE . 9.1 mt -103.31 137.97 40.71 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.552 -1.647 . . . . 0.26 106.552 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.956 HD11 ' CD ' ' A' ' 109' ' ' LYS . 4.2 mp -134.11 116.29 22.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.961 -1.087 . . . . 0.21 110.162 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.447 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -87.07 -135.62 4.48 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.943 -1.663 . . . . 0.25 108.943 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.65 -3.53 17.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -1.16 . . . . 0.83 109.403 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -112.85 -7.42 13.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 4.3 110.277 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 111' ' ' ILE . . . 156.97 -147.02 14.73 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.274 -1.441 . . . . 0.25 110.483 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.642 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 2.0 t -92.57 107.64 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.433 -1.039 . . . . 0.19 109.731 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 47' ' ' THR . 29.2 mt -56.02 -42.71 76.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.485 -0.759 . . . . 0.2 110.488 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.469 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -149.07 -177.01 5.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.909 -1.119 . . . . 0.4 109.247 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -170.68 150.24 3.29 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.184 -1.006 . . . . 0.62 109.913 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.401 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -150.81 146.82 26.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.219 -0.926 . . . . 0.22 109.626 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 52.4 mt -133.23 116.73 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.957 . . . . 0.27 108.936 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.03 142.35 27.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.074 -1.016 . . . . 0.21 109.31 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.0 p -102.7 -87.68 0.41 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.43 109.59 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -45.66 116.5 1.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 1.69 109.011 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -166.62 144.59 9.22 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.795 -1.322 . . . . 0.16 109.795 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 125' ' ' GLY . 1.8 mtmp? -150.55 135.75 17.79 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.075 -1.083 . . . . 1.84 108.075 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 1.013 ' CD1' HG21 ' A' ' 104' ' ' VAL . 82.3 mt -106.69 143.03 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.639 -1.288 . . . . 0.44 110.62 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.517 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 22.4 mtm180 -129.59 177.45 7.21 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.955 -0.757 . . . . 2.67 108.955 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.516 ' HB2' ' HD3' ' A' ' 100' ' ' LYS . 20.5 t70 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.987 -1.006 . . . . 0.8 109.636 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.522 ' HG2' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.33 0.586 . . . . 2.42 109.501 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.522 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 33.8 m -105.53 165.53 3.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.192 -0.942 . . . . 0.67 109.371 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -90.39 122.76 33.55 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.315 -0.866 . . . . 1.74 109.944 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 m -148.13 156.47 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.413 -0.804 . . . . 0.46 109.079 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -120.08 105.53 11.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.172 -0.955 . . . . 2.64 108.958 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.49 ' OD2' ' HB ' ' A' ' 13' ' ' ILE . 1.1 m-20 -54.99 141.13 35.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 2.3 109.788 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -112.66 -12.12 13.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.269 -0.894 . . . . 1.05 108.71 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.455 ' HB2' ' C ' ' A' ' 118' ' ' ALA . . . -60.38 -79.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.949 0.88 . . . . 0.17 109.581 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 59.7 t-20 -179.16 37.73 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.594 -0.891 . . . . 2.96 108.594 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 20.1 t-20 76.08 30.12 0.73 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.411 -0.959 . . . . 1.57 108.411 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.445 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 60.8 mm-40 -76.77 -62.34 1.67 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.491 -0.756 . . . . 1.33 109.903 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -61.63 121.73 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.931 -1.105 . . . . 0.66 109.94 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -66.9 -30.41 70.55 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.245 -1.02 . . . . 1.76 108.245 178.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 164.62 131.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.32 -0.622 . . . . 1.95 109.32 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.553 ' HB ' ' CB ' ' A' ' 39' ' ' ALA . 2.1 p -120.75 125.91 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.962 -1.086 . . . . 1.85 108.705 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.426 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -109.6 159.28 17.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.375 -0.828 . . . . 0.47 110.879 -178.55 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.018 HG22 ' HB3' ' A' ' 37' ' ' LEU . 92.5 t -120.8 147.65 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.947 -0.76 . . . . 0.29 108.947 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.48 57.89 0.94 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.244 -0.91 . . . . 3.22 109.46 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.41 27.71 0.07 OUTLIER Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.309 -1.424 . . . . 2.84 110.871 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 m -140.42 -167.26 2.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.864 -1.374 . . . . 1.94 109.812 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 25' ' ' ASP . 2.9 m80 -128.94 -8.9 4.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.994 . . . . 3.99 110.265 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 107.72 -132.76 11.29 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.728 -1.349 . . . . 1.57 109.728 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -42.54 -38.43 1.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -1.12 . . . . 1.0 109.662 -179.668 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -52.13 170.53 0.23 Allowed Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 121.254 -0.904 . . . . 1.42 108.693 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 25' ' ' ASP . 31.6 Cg_endo -75.48 153.59 39.63 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.413 2.075 . . . . 0.57 110.184 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.2 m -112.79 136.39 52.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.57 109.281 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.464 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 29.1 mm -111.35 107.7 23.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.049 -1.032 . . . . 0.49 109.216 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.431 ' HB ' HG12 ' A' ' 127' ' ' ILE . 2.4 mt -88.99 121.62 39.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.29 -0.881 . . . . 0.6 108.979 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 32.2 m-70 -84.87 133.91 34.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.464 -0.773 . . . . 1.02 109.971 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.563 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 6.0 mtm180 -57.6 140.09 51.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.533 -0.729 . . . . 1.89 110.409 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 94' ' ' VAL . . . 67.19 1.58 14.46 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.528 -0.844 . . . . 0.92 111.274 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -88.71 149.76 44.61 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 120.755 -1.438 . . . . 0.99 109.78 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.477 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 36.6 Cg_endo -81.12 113.74 2.75 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.971 2.447 . . . . 0.66 111.031 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.713 ' CE2' HG11 ' A' ' 18' ' ' VAL . 2.0 t80 -97.61 115.22 27.47 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.345 -1.354 . . . . 0.87 107.345 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.784 ' C ' HD13 ' A' ' 37' ' ' LEU . 29.9 m -107.72 129.2 55.05 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.974 -1.079 . . . . 0.71 111.168 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.018 ' HB3' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -143.63 126.26 15.99 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.903 -0.777 . . . . 1.31 108.903 179.045 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.534 ' O ' HG23 ' A' ' 16' ' ' VAL . 12.6 tt0 -94.64 134.44 37.22 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.016 -1.105 . . . . 1.55 108.016 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.553 ' CB ' ' HB ' ' A' ' 16' ' ' VAL . . . -129.5 126.06 37.76 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.868 -1.145 . . . . 0.59 110.48 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 87' ' ' ASP . 5.1 mt -93.92 144.84 25.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.467 -1.679 . . . . 0.77 106.467 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.62 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 33.1 p90 -161.69 139.28 8.85 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.757 -1.177 . . . . 0.39 109.517 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.2 m-20 -86.67 114.47 23.4 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.083 -1.047 . . . . 3.45 109.179 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.15 112.55 0.54 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.111 -0.7 . . . . 0.36 109.111 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.609 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -82.66 10.27 7.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.063 -1.023 . . . . 0.4 109.477 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.58 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 4.6 pt20 -167.23 147.28 5.38 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.418 -0.801 . . . . 0.4 109.052 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 2.8 p-10 -84.21 114.17 21.62 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.061 -1.024 . . . . 2.69 109.06 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.484 HG21 ' HA3' ' A' ' 112' ' ' GLY . 1.7 t -131.55 155.12 48.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.332 -0.855 . . . . 0.1 109.855 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.702 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 9.3 mmmt -92.16 -10.58 38.28 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.263 -0.898 . . . . 0.57 109.982 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.8 p -147.41 139.44 24.32 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.265 -0.897 . . . . 0.36 110.098 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -128.51 153.56 47.05 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.48 -0.762 . . . . 0.23 109.13 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -133.32 136.38 45.38 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.374 -0.931 . . . . 0.44 110.745 -178.882 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 69' ' ' ASP . 4.9 tt -90.26 151.95 3.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.363 -1.347 . . . . 0.2 107.363 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' LYS . 2.7 mt-10 -138.54 116.28 11.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.026 -1.046 . . . . 0.62 110.291 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.641 ' N ' HD12 ' A' ' 54' ' ' ILE . 3.3 mp -117.53 112.77 40.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.742 -1.223 . . . . 0.23 109.396 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 40.3 mtmt -111.75 152.4 27.85 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.034 -1.098 . . . . 2.17 108.034 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -122.59 156.35 34.43 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.209 -1.396 . . . . 0.93 110.737 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.0 OUTLIER -117.06 150.48 38.58 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.796 -0.816 . . . . 0.83 108.796 179.631 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 57' ' ' SER . 12.7 mt -115.92 43.49 2.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.946 -1.096 . . . . 0.42 109.267 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 57.3 t0 51.16 21.95 1.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 1.17 108.953 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.44 -53.96 0.17 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.976 -1.65 . . . . 0.16 108.976 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 mp -102.67 116.1 31.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.346 -1.09 . . . . 4.36 108.945 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.7 mt-10 -91.76 120.78 32.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.035 -1.041 . . . . 3.31 109.519 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.594 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 49.2 mt -104.83 169.58 2.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 122.135 0.969 . . . . 0.41 110.011 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.594 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 43.4 m-20 -109.4 138.33 45.92 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.583 -1.636 . . . . 0.66 106.583 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.984 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 1.6 t -106.68 107.4 60.16 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.791 -1.193 . . . . 0.39 111.406 -177.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.7 Cg_endo -82.83 -158.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 123.236 2.624 . . . . 0.15 109.752 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.87 45.82 93.15 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.31 -1.116 . . . . 0.78 110.31 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.547 HG22 ' CD1' ' A' ' 92' ' ' TRP . 32.3 pt -136.21 -156.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.163 -1.198 . . . . 0.48 108.951 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.601 ' O ' HG22 ' A' ' 52' ' ' ILE . 31.4 t70 -107.97 105.74 15.66 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.251 -0.906 . . . . 0.93 109.473 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.507 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -87.35 48.06 1.59 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.316 -0.994 . . . . 0.38 108.316 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 26.2 t-20 178.08 77.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.691 -1.226 . . . . 1.33 107.691 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.636 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -61.96 -5.67 2.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.18 112.009 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.566 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -63.94 -12.49 37.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.384 -1.448 . . . . 0.27 108.987 179.661 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -75.53 -22.77 56.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.069 -1.02 . . . . 1.39 110.156 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.509 ' HB2' HG13 ' A' ' 88' ' ' ILE . 58.7 m-85 -109.42 -30.75 7.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.57 108.79 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.715 ' CG2' HD21 ' A' ' 80' ' ' LEU . 2.1 m -99.23 165.82 2.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.086 -1.079 . . . . 0.27 108.086 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.612 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -91.28 91.23 8.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.14 -0.975 . . . . 1.35 111.411 -178.241 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.498 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 11.5 p -89.14 153.59 49.02 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 107.541 -1.281 . . . . 0.32 107.541 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.702 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 23.2 Cg_endo -68.53 130.16 14.67 Favored 'Cis proline' 0 C--N 1.313 -1.339 0 C-N-CA 124.474 -1.053 . . . . 0.43 112.785 2.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.877 HD23 ' CE2' ' A' ' 86' ' ' TYR . 11.1 mt -74.13 115.69 13.91 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.962 -1.495 . . . . 0.47 106.962 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.9 t -83.45 141.25 15.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 C-N-CA 119.084 -1.047 . . . . 0.43 110.125 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.58 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 3.7 tttt -64.99 116.9 6.89 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.851 0.834 . . . . 1.98 110.195 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.06 -11.39 14.85 Favored Glycine 0 N--CA 1.479 1.505 0 N-CA-C 109.43 -1.468 . . . . 0.42 109.43 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.565 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 37.5 tp60 -100.72 156.54 17.28 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.668 -1.234 . . . . 2.31 107.668 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -109.3 149.99 28.64 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.363 -0.977 . . . . 1.2 108.363 179.508 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.877 ' CE2' HD23 ' A' ' 80' ' ' LEU . 36.6 m-85 -132.07 149.35 52.43 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.145 -0.972 . . . . 0.54 110.258 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.576 ' HB3' HD23 ' A' ' 40' ' ' LEU . 9.7 p-10 -117.94 113.69 22.08 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.555 -0.905 . . . . 0.67 108.555 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.636 HD12 ' HB1' ' A' ' 72' ' ' ALA . 7.4 tt -108.15 124.83 64.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.195 -0.941 . . . . 0.43 111.626 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.451 ' HD3' ' OE1' ' A' ' 38' ' ' GLU . 5.2 tptt -100.49 105.0 16.41 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.353 -2.091 . . . . 3.7 105.353 176.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.594 ' CE2' ' O ' ' A' ' 91' ' ' THR . 27.5 t80 -119.8 141.86 49.11 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 118.579 -1.249 . . . . 0.45 113.143 -176.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.594 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -94.38 144.18 25.77 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.482 -1.673 . . . . 1.02 106.482 177.064 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.984 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 22.2 t90 -122.74 89.48 3.12 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.798 -1.189 . . . . 0.58 111.162 -177.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -62.39 107.74 0.98 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.239 -0.913 . . . . 2.41 108.655 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.784 HG13 ' HD2' ' A' ' 95' ' ' PRO . 53.8 t -74.9 144.42 79.67 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.474 -0.766 . . . . 1.19 109.149 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.784 ' HD2' HG13 ' A' ' 94' ' ' VAL . 29.8 Cg_endo -70.77 136.15 29.68 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.897 1.731 . . . . 0.84 109.573 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.14 4.81 3.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.483 -0.761 . . . . 2.37 111.299 -178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 98' ' ' ALA . 13.2 pt -89.9 -25.93 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.673 -1.267 . . . . 0.98 109.047 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.563 ' O ' ' CD ' ' A' ' 31' ' ' ARG . . . -36.17 117.54 0.67 Allowed Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 109.396 -0.594 . . . . 0.53 109.396 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -83.01 167.0 14.47 Favored 'Trans proline' 0 C--N 1.298 -2.097 0 C-N-CA 122.595 2.197 . . . . 0.87 109.221 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.549 ' CD ' ' HA ' ' A' ' 128' ' ' ARG . 6.2 mmtp -79.31 77.86 5.82 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.682 -1.229 . . . . 4.83 107.682 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.494 ' HB2' HD22 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -80.8 118.55 22.42 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.951 -0.759 . . . . 0.49 108.951 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 0.7 OUTLIER -37.32 -50.63 1.04 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.604 -0.685 . . . . 2.75 109.911 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.526 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 24.5 m120 -129.96 139.0 51.15 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.077 -1.014 . . . . 2.85 110.058 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.648 HG21 ' CD1' ' A' ' 127' ' ' ILE . 74.0 t -129.88 149.35 33.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.326 -0.859 . . . . 0.61 109.405 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.528 ' HB ' ' CB ' ' A' ' 57' ' ' SER . 1.0 OUTLIER -124.13 122.45 64.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.988 -1.116 . . . . 1.08 107.988 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 20.1 t -103.94 144.09 14.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.239 -0.913 . . . . 0.44 109.779 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 36.9 m -123.67 114.45 19.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.366 -0.834 . . . . 0.2 109.676 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -95.24 127.52 47.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.289 -1.375 . . . . 0.31 107.289 178.597 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.873 ' CD ' HD11 ' A' ' 111' ' ' ILE . 8.5 ttmt -142.58 127.05 17.82 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.387 -1.446 . . . . 2.34 111.468 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.638 ' C ' HD12 ' A' ' 111' ' ' ILE . 1.4 mp -103.46 137.37 41.64 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.472 -1.307 . . . . 1.99 107.472 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.873 HD11 ' CD ' ' A' ' 109' ' ' LYS . 4.2 mp -131.09 121.54 49.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.41 -0.806 . . . . 0.37 109.856 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.484 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -80.92 -129.88 0.96 Allowed Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.455 -1.858 . . . . 0.45 108.455 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.34 -3.57 11.92 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.284 -1.127 . . . . 0.77 109.12 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.401 ' O ' ' CG ' ' A' ' 114' ' ' ASN . 1.3 t30 -116.77 -10.96 10.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.242 -0.911 . . . . 3.7 110.708 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 111' ' ' ILE . . . 168.35 -158.47 31.2 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.467 -1.349 . . . . 0.3 110.573 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.632 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -87.74 109.84 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -1.107 . . . . 0.35 110.162 -179.385 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 112' ' ' GLY . 85.1 mt -53.95 -43.11 69.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 0.52 108.999 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.478 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -155.46 -162.53 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.095 -1.003 . . . . 0.51 109.465 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -178.59 155.24 0.82 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.208 -0.933 . . . . 0.74 109.158 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.06 143.97 23.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.011 -1.056 . . . . 0.31 109.925 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.0 mt -133.17 116.92 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.106 -0.996 . . . . 0.56 108.41 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.1 146.62 24.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.993 -1.067 . . . . 0.25 110.517 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 124' ' ' HIS . 88.3 m -116.65 162.65 17.31 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.148 -0.686 . . . . 2.57 109.148 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.519 ' N ' HG22 ' A' ' 123' ' ' THR . 5.0 t-160 54.03 75.05 0.29 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 2.12 109.93 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -131.7 161.62 23.73 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.717 -1.753 . . . . 0.48 108.717 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 125' ' ' GLY . 46.3 mttt -152.85 139.52 18.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.219 -1.166 . . . . 1.7 109.255 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.648 ' CD1' HG21 ' A' ' 104' ' ' VAL . 64.2 mt -106.55 139.83 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.621 -1.3 . . . . 0.32 109.677 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.549 ' HA ' ' CD ' ' A' ' 100' ' ' LYS . 22.0 mtt180 -132.92 178.53 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.383 -0.823 . . . . 3.62 109.307 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.995 -1.002 . . . . 2.78 109.449 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 9.4 pt20 . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.266 -0.642 . . . . 1.21 109.266 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 21' ' ' CYS . 28.2 m -104.76 160.72 5.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.307 -0.87 . . . . 0.63 108.903 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.82 118.19 30.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.991 -1.068 . . . . 0.83 110.139 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 m -142.17 157.51 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.329 -0.989 . . . . 0.36 108.329 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 109.17 17.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.058 -1.026 . . . . 4.4 109.596 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 16.9 p-10 -45.06 132.51 7.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 3.73 109.805 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -108.7 -2.9 18.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.805 . . . . 0.33 109.505 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.541 ' N ' ' HB3' ' A' ' 119' ' ' CYS . . . -75.33 -74.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.6 109.668 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.434 ' CG ' ' O ' ' A' ' 9' ' ' ALA . 7.4 m-20 178.49 55.64 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.557 -0.905 . . . . 2.42 108.557 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.404 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 1.3 t30 65.28 42.85 3.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.446 -0.946 . . . . 3.15 108.446 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.555 ' HG2' ' ND2' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -98.9 -63.18 1.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -0.852 . . . . 1.83 110.485 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 15' ' ' LYS . 1.2 mt -60.25 128.05 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.951 -1.093 . . . . 0.6 110.417 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -81.86 -15.64 53.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.31 -0.869 . . . . 0.77 109.358 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 156.98 141.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.15 -1.056 . . . . 2.86 108.15 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.792 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -121.99 126.27 74.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.876 -0.787 . . . . 0.39 108.876 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.494 ' HE2' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -112.41 156.45 22.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.005 -1.06 . . . . 1.21 110.213 -179.258 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 36' ' ' THR . 2.4 t -133.26 143.36 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.302 -0.874 . . . . 0.8 108.718 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.64 100.58 11.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.99 . . . . 3.18 109.639 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.47 -56.15 0.52 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.753 -1.339 . . . . 0.39 109.753 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.409 ' HB2' HG12 ' A' ' 3' ' ' VAL . 66.8 m -59.65 -167.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -1.128 . . . . 2.29 109.232 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -144.31 15.3 1.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.136 -0.977 . . . . 1.98 109.834 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 77.55 145.92 2.42 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.74 -1.344 . . . . 3.7 109.74 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER 38.14 46.72 0.88 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.595 -0.944 . . . . 3.69 110.321 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.453 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER -156.75 170.9 8.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 1.68 109.322 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 34.9 Cg_endo -77.71 148.04 25.3 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.707 2.271 . . . . 0.88 111.027 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 87.3 m -116.76 134.27 54.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.383 -0.823 . . . . 0.83 109.255 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.473 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 37.6 mm -101.15 104.08 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.77 -1.206 . . . . 0.61 108.519 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.408 ' HB ' HG12 ' A' ' 127' ' ' ILE . 3.4 mt -88.44 119.14 35.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.568 -0.853 . . . . 0.34 109.469 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -95.34 106.56 18.62 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.028 -1.101 . . . . 0.89 108.028 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 9.2 ptt180 -52.03 154.65 2.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.977 -1.077 . . . . 1.79 110.004 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.88 -10.69 64.49 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.392 -1.483 . . . . 0.45 109.392 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -108.79 154.61 41.68 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.279 -1.13 . . . . 1.27 109.565 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.426 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 34.4 Cg_endo -79.84 114.45 3.18 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.812 2.342 . . . . 0.31 110.884 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -96.37 132.91 41.4 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.55 -1.278 . . . . 0.66 107.55 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 18' ' ' VAL . 91.8 m -113.39 140.79 47.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.675 -1.265 . . . . 0.42 110.879 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -146.55 122.44 10.65 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.86 -0.792 . . . . 3.47 108.86 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 3.0 tt0 -101.08 127.82 47.42 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.72 -1.215 . . . . 2.14 107.72 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.792 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -126.6 122.98 36.6 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.746 -1.221 . . . . 0.17 110.413 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.545 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 20.2 mt -89.69 142.61 27.52 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.606 -1.627 . . . . 0.28 106.606 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.644 ' CE1' ' CD1' ' A' ' 110' ' ' LEU . 35.3 p90 -157.85 137.67 12.25 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.823 -1.173 . . . . 0.25 109.669 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.5 m-20 -84.73 111.58 19.72 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.239 -0.985 . . . . 1.53 108.928 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -47.84 114.22 0.87 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.298 -0.63 . . . . 0.22 109.298 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -91.87 14.07 16.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 3.51 108.944 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.642 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 1.8 pt20 -164.78 138.98 5.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.436 -0.79 . . . . 1.09 109.022 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 6.1 p30 -81.51 123.63 28.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.126 -0.984 . . . . 3.22 109.355 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.6 t -145.13 153.94 41.93 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.225 -0.922 . . . . 0.71 109.382 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.684 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 3.2 mmmt -89.43 -12.75 39.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 1.4 109.724 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.0 p -147.2 136.7 22.79 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.354 -0.938 . . . . 1.33 110.189 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -127.57 155.79 43.26 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.477 -0.934 . . . . 0.56 108.477 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.541 ' CD ' ' HB ' ' A' ' 70' ' ' THR . 0.3 OUTLIER -134.55 145.06 48.36 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.422 -0.799 . . . . 1.9 110.37 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 69' ' ' ASP . 5.6 tt -95.22 154.46 3.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.012 -1.055 . . . . 0.81 108.917 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 0.9 OUTLIER -141.04 114.14 8.54 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.538 -0.912 . . . . 1.24 108.538 -179.123 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.77 HD13 HG21 ' A' ' 68' ' ' ILE . 2.5 mp -113.99 130.81 67.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.95 -1.093 . . . . 0.82 109.097 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -126.05 134.03 51.54 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.161 -0.962 . . . . 1.39 108.716 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -122.28 131.5 53.95 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.607 -1.237 . . . . 0.53 111.16 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.24 148.21 23.33 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.206 -1.035 . . . . 0.53 108.206 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.721 HD13 ' CG ' ' A' ' 99' ' ' PRO . 17.2 mt -109.26 56.97 0.61 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.134 -0.979 . . . . 0.8 109.668 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 58' ' ' LEU . 3.4 t70 41.47 27.95 0.06 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.649 -0.657 . . . . 1.53 109.726 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 174.23 -49.89 0.14 Allowed Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.754 -1.212 . . . . 1.1 110.093 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.517 ' HG ' HG13 ' A' ' 63' ' ' ILE . 3.8 tp -108.43 112.73 25.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.021 -1.282 . . . . 0.76 110.069 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.492 ' N ' HD12 ' A' ' 61' ' ' LEU . 1.9 tt0 -79.14 124.58 28.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.127 -0.983 . . . . 1.45 108.975 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.683 ' CD1' HD11 ' A' ' 58' ' ' LEU . 71.4 mt -121.21 165.95 16.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.991 0.9 . . . . 0.56 110.203 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.677 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -112.44 108.71 17.95 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 105.881 -1.896 . . . . 1.36 105.881 176.475 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.086 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 10.3 t -71.34 114.13 25.25 Favored Pre-proline 0 C--N 1.298 -1.663 0 O-C-N 121.501 -0.749 . . . . 0.81 111.904 -177.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 37.6 Cg_endo -86.56 -157.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 123.278 2.652 . . . . 0.67 109.241 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.27 36.13 61.85 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.247 -0.978 . . . . 0.96 110.825 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.77 HG21 HD13 ' A' ' 54' ' ' ILE . 9.0 pt -120.72 -157.66 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.957 -1.319 . . . . 0.52 108.849 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.735 ' O ' HG22 ' A' ' 52' ' ' ILE . 47.9 t0 -108.29 107.69 18.39 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.381 -0.824 . . . . 0.51 109.367 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.541 ' HB ' ' CD ' ' A' ' 51' ' ' LYS . 64.4 p -86.8 45.08 1.22 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.052 -1.03 . . . . 0.76 108.443 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 58.2 t30 175.32 83.6 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.4 -1.333 . . . . 1.05 107.4 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.855 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -72.33 4.35 3.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.464 -0.772 . . . . 0.39 113.016 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.559 ' HA ' HG22 ' A' ' 76' ' ' VAL . 2.2 t -64.89 -13.91 58.1 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.189 -1.569 . . . . 0.53 108.675 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -75.05 -23.98 58.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.222 -0.923 . . . . 1.82 109.728 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.528 ' CB ' HG13 ' A' ' 88' ' ' ILE . 74.1 m-85 -109.34 -16.54 14.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.86 109.203 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.814 ' CG2' HD21 ' A' ' 80' ' ' LEU . 2.3 m -117.7 166.78 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.246 -1.02 . . . . 0.51 108.246 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.649 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -92.25 90.69 7.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.995 -1.065 . . . . 2.32 111.536 -178.352 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.469 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 17.5 p -84.28 151.11 59.08 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 107.077 -1.453 . . . . 0.6 107.077 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.684 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.6 Cg_endo -70.11 132.55 23.09 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 124.416 -1.077 . . . . 0.86 112.806 2.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.814 HD21 ' CG2' ' A' ' 76' ' ' VAL . 12.8 mt -75.95 113.87 13.94 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.555 -1.646 . . . . 0.66 106.555 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.638 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 55.1 t -79.45 143.31 12.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 C-N-CA 119.53 -0.868 . . . . 0.81 110.204 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.642 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 11.4 ttpt -71.5 99.8 2.1 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.824 0.821 . . . . 1.15 110.127 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 136.5 -15.97 3.85 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 109.621 -1.392 . . . . 0.42 109.621 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.574 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 26.9 tp60 -97.88 156.02 16.79 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.837 -1.172 . . . . 1.19 107.837 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -106.94 142.84 35.93 Favored 'General case' 0 C--N 1.294 -1.848 0 O-C-N 120.936 -1.102 . . . . 0.93 108.08 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.649 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 21.0 m-85 -122.96 150.65 42.7 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.469 -0.769 . . . . 0.57 110.559 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.545 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 3.9 p30 -116.7 113.92 23.29 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.171 -1.048 . . . . 0.31 108.171 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.855 HD12 ' HB1' ' A' ' 72' ' ' ALA . 4.8 tt -106.93 120.05 57.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.032 -1.043 . . . . 0.27 111.793 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.504 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 5.0 tttp -98.36 104.44 16.48 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 104.574 -2.38 . . . . 1.83 104.574 175.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 20.9 t80 -119.13 137.06 53.85 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.045 -1.062 . . . . 0.54 112.004 -176.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.59 98.07 10.56 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.656 -1.609 . . . . 0.43 106.656 177.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.086 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 33.6 t90 -72.18 97.02 1.88 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.822 -0.627 . . . . 0.42 109.797 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.26 105.16 0.46 Allowed 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.565 -0.854 . . . . 2.21 108.742 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.662 HG13 ' HD2' ' A' ' 95' ' ' PRO . 64.5 t -65.49 143.19 98.61 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.445 -0.784 . . . . 0.69 109.156 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.869 ' HG3' HG13 ' A' ' 65' ' ' VAL . 30.1 Cg_endo -72.52 129.2 14.41 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.136 1.89 . . . . 0.56 109.726 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -1.27 4.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.573 -0.704 . . . . 2.69 110.182 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 98' ' ' ALA . 9.5 pt -90.2 -27.52 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.834 -1.166 . . . . 0.57 110.084 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.519 ' O ' ' CD ' ' A' ' 31' ' ' ARG . . . -34.83 118.8 0.57 Allowed Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 109.428 -0.582 . . . . 0.23 109.428 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.721 ' CG ' HD13 ' A' ' 58' ' ' LEU . 36.8 Cg_endo -85.02 139.95 7.54 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.852 2.368 . . . . 0.32 109.696 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.48 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 7.4 mtmt -52.76 89.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.994 -1.113 . . . . 0.73 107.994 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 99' ' ' PRO . 3.4 t -93.71 122.46 36.19 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.439 -0.788 . . . . 0.37 109.151 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 8.3 pt-20 -41.39 -44.54 2.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.523 -0.736 . . . . 1.07 109.456 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 14.5 t30 -132.17 140.49 48.76 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.521 -0.737 . . . . 1.33 109.722 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.972 HG21 ' CD1' ' A' ' 127' ' ' ILE . 1.0 OUTLIER -130.69 143.92 39.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.338 -0.851 . . . . 0.84 109.191 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 2.9 t -118.87 118.7 58.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.217 -1.031 . . . . 1.04 108.217 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.8 t -104.61 140.78 21.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.731 -1.231 . . . . 0.44 110.646 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 89.8 m -122.1 127.07 49.71 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.008 -0.738 . . . . 0.5 109.008 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -104.79 132.89 50.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 107.853 -1.166 . . . . 0.39 107.853 178.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.886 ' CD ' HD11 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -141.56 128.63 20.81 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.419 -1.426 . . . . 1.24 111.79 -178.397 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 52' ' ' ILE . 13.3 mt -104.55 141.79 35.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.151 -1.425 . . . . 0.14 107.151 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.886 HD11 ' CD ' ' A' ' 109' ' ' LYS . 4.4 mp -135.57 121.86 32.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.218 -0.926 . . . . 0.22 110.039 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.44 ' N ' ' HG ' ' A' ' 117' ' ' LEU . . . -99.71 -144.53 16.43 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.788 -1.725 . . . . 0.57 108.788 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.6 -0.28 46.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -1.173 . . . . 1.53 109.747 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.81 -4.15 13.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 2.06 110.372 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 144.27 -147.63 18.98 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.886 -1.286 . . . . 0.25 109.886 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.634 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 2.1 t -86.82 108.98 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -1.166 . . . . 0.12 109.878 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.607 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 22.1 mt -56.46 -35.12 67.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.51 109.84 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.508 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -163.03 179.31 7.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.716 -1.24 . . . . 0.36 109.515 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.541 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 14.5 t -165.08 157.61 15.94 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.319 -0.863 . . . . 0.4 109.314 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.465 ' HB2' HD12 ' A' ' 13' ' ' ILE . . . -152.92 147.06 25.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.035 -1.041 . . . . 0.46 109.483 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 65.7 mt -134.0 120.9 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.52 109.554 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -92.8 147.53 22.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.144 -0.972 . . . . 0.66 109.697 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -78.47 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.79 109.837 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -56.91 -177.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 3.02 109.353 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . 141.51 138.86 3.58 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.869 -1.292 . . . . 0.48 109.869 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 7.8 mtmt -151.09 134.86 16.47 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.455 -1.026 . . . . 1.25 108.614 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.972 ' CD1' HG21 ' A' ' 104' ' ' VAL . 58.6 mt -105.8 140.39 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.822 -1.174 . . . . 0.53 110.485 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.48 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -133.5 173.5 11.43 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.74 -0.837 . . . . 2.75 108.74 178.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.028 -1.045 . . . . 1.16 109.513 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.52 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 1.3 tt0 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.211 -0.663 . . . . 2.16 109.211 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 22' ' ' HIS . 2.4 m -109.54 168.8 3.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.339 -0.851 . . . . 1.88 110.184 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -80.16 128.63 33.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.412 -0.805 . . . . 1.1 110.952 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.7 m -147.49 159.3 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.703 -1.221 . . . . 0.45 107.703 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.68 108.62 15.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.805 -1.184 . . . . 1.91 109.462 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 120' ' ' ALA . 24.8 m-20 -52.76 130.29 32.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.9 109.106 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.4 3.96 38.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.37 109.49 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 10' ' ' ASN . . . -81.52 -57.5 3.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.277 -0.889 . . . . 0.63 109.21 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER 161.64 -31.26 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.244 -1.021 . . . . 3.44 108.244 -178.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 1.0 OUTLIER 159.61 39.51 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.255 -1.017 . . . . 2.3 108.255 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.481 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 77.1 mm-40 -90.82 -52.75 4.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 2.7 110.386 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.524 HG12 ' HB1' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -73.97 131.8 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.702 -1.249 . . . . 0.57 110.082 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 39.2 mmtt -85.95 -22.59 27.31 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.849 -1.167 . . . . 0.94 107.849 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.1 ttpt 160.9 128.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.211 -0.662 . . . . 1.91 109.211 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 38' ' ' GLU . 1.5 p -119.31 122.77 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.044 -1.035 . . . . 1.59 109.086 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.52 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -105.23 158.69 16.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.261 -0.899 . . . . 1.47 110.41 -178.536 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.066 HG11 ' CE1' ' A' ' 35' ' ' PHE . 24.7 t -127.9 115.69 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.873 . . . . 0.47 108.66 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -68.15 89.82 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 3.48 109.749 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.38 -63.54 0.26 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.404 -1.478 . . . . 0.7 109.404 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.6 t -90.18 154.08 20.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -1.133 . . . . 0.67 109.243 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.632 ' O ' HG12 ' A' ' 3' ' ' VAL . 12.2 m80 -94.01 -169.16 2.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 2.7 109.789 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.588 ' CA ' ' HA ' ' A' ' 3' ' ' VAL . . . -108.09 154.82 16.44 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.361 -1.496 . . . . 3.91 109.361 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.0 6.18 4.55 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.161 -1.199 . . . . 1.7 109.079 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -128.57 158.5 71.69 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 108.497 -0.927 . . . . 2.75 108.497 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.78 147.36 21.65 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.708 2.272 . . . . 0.83 110.368 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.2 m -115.69 154.42 29.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.95 109.7 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.542 HG23 ' HG3' ' A' ' 128' ' ' ARG . 45.9 mm -111.95 113.16 43.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.353 -0.842 . . . . 0.47 109.206 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.517 ' HB ' HG12 ' A' ' 127' ' ' ILE . 10.1 mt -94.94 120.89 44.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.249 -0.907 . . . . 0.76 108.931 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.502 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 3.9 m-70 -87.43 133.97 33.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.35 -0.844 . . . . 1.88 109.639 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.513 ' HA ' HG11 ' A' ' 94' ' ' VAL . 9.2 mtm180 -54.81 135.06 48.07 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.159 -0.963 . . . . 1.73 108.922 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.514 ' N ' ' HB ' ' A' ' 94' ' ' VAL . . . 69.26 20.47 75.12 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.397 -0.906 . . . . 0.84 111.041 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.046 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -109.64 137.76 20.45 Favored Pre-proline 0 N--CA 1.482 1.175 0 O-C-N 120.594 -1.533 . . . . 3.45 108.305 179.472 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.5 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 33.9 Cg_endo -74.18 115.56 4.36 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.844 2.363 . . . . 0.45 112.089 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 1.066 ' CE1' HG11 ' A' ' 18' ' ' VAL . 1.5 t80 -98.97 111.74 24.05 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.166 -1.05 . . . . 1.06 108.166 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.912 ' O ' HG13 ' A' ' 18' ' ' VAL . 96.2 m -88.04 128.71 35.4 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.087 -1.008 . . . . 0.95 109.944 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.43 HD13 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -140.66 123.68 16.49 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.475 -0.765 . . . . 3.62 109.238 179.474 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 16' ' ' VAL . 4.5 tt0 -105.28 126.78 52.48 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.642 -1.244 . . . . 0.92 107.642 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.563 ' CB ' ' HB ' ' A' ' 16' ' ' VAL . . . -129.42 132.08 46.92 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.676 -1.265 . . . . 0.47 110.975 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 5.4 mt -94.85 144.39 25.69 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.092 -1.447 . . . . 0.33 107.092 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.702 ' CE2' HD11 ' A' ' 110' ' ' LEU . 35.2 p90 -159.36 136.53 9.68 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.785 -1.166 . . . . 0.28 109.864 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.4 m-20 -84.2 112.25 20.1 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.292 -0.963 . . . . 1.39 108.611 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -45.19 110.88 0.27 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.759 -0.83 . . . . 0.26 108.759 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.642 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -80.03 4.65 16.4 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.154 -0.966 . . . . 1.37 109.5 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 4.3 pt20 -164.84 156.75 15.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.028 -1.045 . . . . 1.16 109.676 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 7.2 p30 -84.79 121.67 28.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 2.34 109.271 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.694 HG21 HD11 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -141.46 139.26 33.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.056 -1.028 . . . . 0.79 110.287 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.707 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 3.2 mmmm -80.92 -10.87 59.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.384 -0.822 . . . . 1.34 109.477 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 47' ' ' THR . 12.7 p -147.03 137.86 23.78 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.985 0.897 . . . . 0.49 109.714 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -126.3 149.81 48.89 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.815 -0.809 . . . . 0.35 108.815 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.564 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 2.2 mtmt -129.28 136.2 49.76 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.114 -1.034 . . . . 0.21 110.401 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 69' ' ' ASP . 12.2 tt -92.17 151.28 3.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 107.085 -1.45 . . . . 0.41 107.085 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -142.13 115.38 8.89 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.089 -1.007 . . . . 0.56 109.468 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 54' ' ' ILE . 2.3 mp -112.63 111.41 36.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.044 -1.035 . . . . 0.18 109.13 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -106.57 160.57 15.33 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.263 -1.014 . . . . 0.73 108.263 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -134.67 150.63 50.66 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.494 -1.379 . . . . 1.06 110.829 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 4.6 m -116.26 151.56 35.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.875 -1.157 . . . . 2.61 107.875 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.625 HD12 ' HG ' ' A' ' 61' ' ' LEU . 10.9 mt -123.66 60.1 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.648 -1.282 . . . . 0.81 110.312 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' ' 103' ' ' ASN . 0.4 OUTLIER 44.01 24.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.554 -0.716 . . . . 0.83 110.005 179.441 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 162.85 -47.23 0.33 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.01 -1.236 . . . . 0.31 110.01 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.625 ' HG ' HD12 ' A' ' 58' ' ' LEU . 12.3 tp -107.67 117.63 34.61 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.117 -1.225 . . . . 0.64 109.051 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.6 mt-10 -100.8 128.26 46.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 3.91 109.937 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.71 HG23 ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -117.1 178.05 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 122.419 1.104 . . . . 1.29 110.04 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.71 ' N ' HG23 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -110.49 143.03 41.44 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.8 -1.185 . . . . 3.72 107.8 178.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.131 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 2.9 t -110.87 104.27 55.87 Favored Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 120.977 -1.077 . . . . 0.26 111.523 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.523 ' O ' HG23 ' A' ' 68' ' ' ILE . 36.4 Cg_endo -81.81 -154.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.4 2.733 . . . . 0.2 109.639 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.91 29.39 64.81 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.792 -1.323 . . . . 0.54 109.792 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.689 HG21 HD13 ' A' ' 54' ' ' ILE . 9.3 pt -120.44 -162.13 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.153 -1.204 . . . . 0.34 109.195 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.718 ' O ' HG22 ' A' ' 52' ' ' ILE . 16.6 t70 -103.55 107.05 17.73 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.445 -0.784 . . . . 0.84 109.062 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.564 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 1.0 OUTLIER -85.76 44.55 1.12 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.268 -0.895 . . . . 0.15 108.682 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 49.2 t30 -177.63 69.65 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.532 -1.285 . . . . 0.96 107.532 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.515 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -56.4 -11.2 1.14 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.563 -0.71 . . . . 0.15 111.868 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.558 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -61.23 -15.18 31.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.534 -1.354 . . . . 0.31 109.379 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.22 -25.06 60.59 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.082 -1.011 . . . . 0.84 109.917 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.518 ' HB2' HG13 ' A' ' 88' ' ' ILE . 78.3 m-85 -102.54 -35.9 8.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.203 -0.936 . . . . 0.45 109.189 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.982 HG23 HD21 ' A' ' 80' ' ' LEU . 2.0 m -96.02 166.07 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.134 -1.061 . . . . 0.17 108.134 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.637 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -88.24 93.1 9.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.945 -1.097 . . . . 0.68 110.692 -178.585 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.511 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 11.9 p -90.06 154.04 47.15 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 107.682 -1.229 . . . . 0.17 107.682 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.707 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 26.3 Cg_endo -68.7 133.56 24.26 Favored 'Cis proline' 0 C--N 1.312 -1.359 0 C-N-CA 124.223 -1.157 . . . . 0.16 112.513 2.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.982 HD21 HG23 ' A' ' 76' ' ' VAL . 13.1 mt -76.86 112.42 13.44 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.782 -1.562 . . . . 0.82 106.782 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.8 t -80.77 136.79 22.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 C-N-CA 119.707 -0.797 . . . . 0.23 110.114 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 25.0 tttm -60.54 110.42 1.27 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.648 0.737 . . . . 3.13 110.253 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 126.71 -16.46 6.54 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 110.264 -1.134 . . . . 0.39 110.264 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.583 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 13.6 tp60 -97.99 157.39 16.14 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.125 -1.22 . . . . 0.52 108.162 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -110.68 143.13 41.63 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.074 -1.084 . . . . 1.08 108.074 179.006 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.637 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 19.0 m-85 -125.94 152.83 45.12 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.409 -0.807 . . . . 0.2 110.438 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.45 ' OD1' ' C ' ' A' ' 87' ' ' ASP . 24.0 t0 -119.49 113.18 20.35 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.882 -1.155 . . . . 4.07 107.882 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.624 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 9.1 tt -106.71 126.75 62.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.361 -0.936 . . . . 0.39 111.506 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.501 ' HA ' ' HG3' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -100.59 119.89 39.21 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 105.124 -2.176 . . . . 2.04 105.124 176.477 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.544 ' OH ' ' N ' ' A' ' 69' ' ' ASP . 34.4 t80 -138.03 140.74 40.24 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.051 -1.46 . . . . 0.51 112.698 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.501 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -92.74 138.96 31.04 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.512 -1.662 . . . . 0.79 106.512 177.058 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.131 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 26.4 t90 -120.27 82.73 1.94 Allowed 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.949 -1.094 . . . . 0.7 109.472 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -61.28 108.51 0.93 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.591 -0.693 . . . . 1.55 109.958 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.046 HG23 ' O ' ' A' ' 33' ' ' LYS . 33.9 t -47.39 144.04 4.87 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.134 -1.062 . . . . 1.19 108.134 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.718 ' HG3' HG13 ' A' ' 65' ' ' VAL . 26.7 Cg_endo -68.67 -8.7 24.03 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.854 2.369 . . . . 3.72 113.038 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 0.9 OUTLIER 77.84 -17.82 0.54 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.913 -1.117 . . . . 3.32 110.665 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.523 ' O ' ' C ' ' A' ' 98' ' ' ALA . 11.8 pt -88.11 -25.62 5.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 120.704 -1.247 . . . . 0.7 108.335 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.854 ' HB1' HD13 ' A' ' 127' ' ' ILE . . . -33.84 116.77 0.48 Allowed Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.92 -0.771 . . . . 0.57 108.92 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.606 ' O ' ' N ' ' A' ' 101' ' ' SER . 36.0 Cg_endo -83.6 129.41 4.93 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.674 2.249 . . . . 0.77 109.165 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -46.93 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.457 -0.942 . . . . 3.88 108.457 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -103.38 124.42 48.67 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.167 -0.679 . . . . 1.65 109.167 -178.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 101' ' ' SER . 6.4 pt-20 -41.65 -46.38 3.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.443 -0.786 . . . . 0.83 110.022 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.41 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 1.9 t30 -129.36 140.68 51.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.901 -1.124 . . . . 0.81 110.223 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.757 HG21 ' CD1' ' A' ' 127' ' ' ILE . 2.7 t -133.1 147.22 31.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.531 -0.731 . . . . 0.2 109.377 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 57' ' ' SER . 2.7 t -123.31 118.85 55.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.516 -1.29 . . . . 0.53 107.516 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.1 t -100.92 142.49 15.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.281 -0.887 . . . . 0.3 110.039 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 24.1 m -122.52 117.15 25.24 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.607 -0.683 . . . . 0.35 109.358 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -94.9 129.12 45.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 107.001 -1.481 . . . . 0.34 107.001 178.561 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.915 ' CD ' HD11 ' A' ' 111' ' ' ILE . 0.7 OUTLIER -140.08 130.79 25.8 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.363 -1.461 . . . . 1.05 112.05 -177.119 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.702 HD11 ' CE2' ' A' ' 41' ' ' PHE . 14.1 mt -101.79 143.01 32.23 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.945 -1.502 . . . . 0.35 106.945 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.915 HD11 ' CD ' ' A' ' 109' ' ' LYS . 4.2 mp -136.4 116.89 17.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 120.823 -1.173 . . . . 0.43 111.065 -177.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.43 -169.71 41.96 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.202 -1.959 . . . . 0.96 108.202 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.58 1.67 25.15 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.035 -1.274 . . . . 1.05 109.709 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.37 -6.51 12.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.197 -0.939 . . . . 4.71 110.702 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.91 -153.12 24.91 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.537 -1.316 . . . . 0.51 110.209 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.623 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -85.08 110.03 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.382 -1.069 . . . . 0.36 109.606 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.694 HD11 HG21 ' A' ' 47' ' ' THR . 26.7 mt -58.66 -39.89 81.92 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.206 -0.934 . . . . 0.23 109.816 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.524 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -154.87 -162.64 1.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.989 -1.07 . . . . 0.16 109.468 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.489 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 53.4 t 178.88 154.6 0.42 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.029 -1.045 . . . . 0.32 109.499 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.27 152.31 32.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.03 -1.044 . . . . 0.28 109.695 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 53.5 mt -134.99 140.2 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.2 -0.937 . . . . 0.85 109.083 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.19 119.46 38.9 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.456 -1.402 . . . . 0.73 108.571 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 51.3 p -70.12 -33.24 71.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -0.839 . . . . 2.11 110.498 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -120.97 154.89 35.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.95 -1.094 . . . . 1.35 110.098 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 126' ' ' LYS . . . 166.1 155.3 8.71 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.476 -1.449 . . . . 0.55 109.476 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.437 ' CG ' ' O ' ' A' ' 125' ' ' GLY . 30.6 mttt -154.88 138.09 15.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -1.197 . . . . 1.81 108.563 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.854 HD13 ' HB1' ' A' ' 98' ' ' ALA . 67.0 mt -104.17 140.7 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.508 -1.37 . . . . 0.44 109.769 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.542 ' HG3' HG23 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -124.86 154.21 41.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.465 -0.772 . . . . 5.07 109.824 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.41 ' HB3' ' HG3' ' A' ' 100' ' ' LYS . 2.9 p30 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 118.0 -1.0 . . . . 4.68 109.563 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.358 0.599 . . . . 2.82 109.483 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.483 ' CG1' ' HB3' ' A' ' 21' ' ' CYS . 3.0 m -99.16 167.24 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.68 109.307 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 51.9 t0 -92.53 124.21 36.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.87 110.211 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.3 m -146.27 148.93 16.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.464 -0.939 . . . . 0.25 108.464 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.23 110.33 21.5 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.095 -1.003 . . . . 2.85 109.609 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -53.91 142.92 22.89 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.335 -0.853 . . . . 3.54 109.374 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.92 -14.17 11.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.344 -0.847 . . . . 0.96 108.963 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.94 -65.65 0.67 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.868 0.842 . . . . 0.24 109.199 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.47 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 3.4 t-20 173.98 59.23 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.134 -1.061 . . . . 4.45 108.134 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.6 t30 53.12 21.37 2.12 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.972 -1.08 . . . . 1.76 108.087 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.496 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 19.7 mm-40 -64.67 -61.27 2.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.582 -0.699 . . . . 3.52 109.363 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER -58.95 127.35 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.35 109.459 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.565 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 11.4 mmpt? -77.13 -19.83 56.4 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.242 -0.911 . . . . 0.53 108.899 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.567 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.8 OUTLIER 156.59 128.54 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.882 -0.784 . . . . 2.38 108.882 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.73 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -108.33 123.18 63.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.377 -0.972 . . . . 0.6 108.377 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.48 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 1.3 mtm -117.03 148.05 41.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.049 -1.032 . . . . 1.89 110.796 -178.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.488 HG12 ' OD1' ' A' ' 19' ' ' ASP . 31.6 t -103.9 158.03 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.385 -0.968 . . . . 0.83 108.385 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.488 ' OD1' HG12 ' A' ' 18' ' ' VAL . 8.8 p-10 -44.12 -31.28 0.92 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.092 -1.005 . . . . 4.11 109.802 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.92 97.45 0.12 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.57 -1.3 . . . . 2.51 110.27 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -108.48 -66.78 1.02 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -1.135 . . . . 3.43 108.913 179.266 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.489 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER 168.93 -27.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.833 . . . . 4.31 109.66 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 101.13 -135.71 12.31 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.957 -1.257 . . . . 1.61 109.957 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 23' ' ' GLY . 29.1 t -40.4 -34.68 0.36 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.534 -0.98 . . . . 1.51 109.988 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.439 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -67.12 164.92 31.55 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 2.25 109.42 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 25' ' ' ASP . 34.3 Cg_endo -78.03 162.18 29.21 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.692 2.261 . . . . 2.17 109.844 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.6 m -116.62 153.51 32.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.909 . . . . 0.94 109.371 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.515 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 47.8 mm -107.37 109.13 27.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.911 -1.118 . . . . 0.47 108.872 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.467 HG23 HG21 ' A' ' 94' ' ' VAL . 1.9 mt -91.19 119.31 38.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.444 -0.785 . . . . 0.41 109.357 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.415 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 19.0 m80 -84.41 114.57 22.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.368 -0.832 . . . . 1.17 110.122 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.718 ' HG3' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -48.12 148.41 1.79 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.566 -0.709 . . . . 1.99 111.127 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.73 -22.55 4.03 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.923 -0.871 . . . . 0.93 110.923 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -93.01 155.18 41.53 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.77 -1.43 . . . . 2.94 109.745 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.465 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 36.4 Cg_endo -79.11 162.21 26.06 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.863 2.376 . . . . 1.4 110.689 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 92' ' ' TRP . 2.5 t80 -135.08 122.14 21.33 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.172 -1.048 . . . . 0.64 108.172 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 2.9 m -96.36 128.2 43.06 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.77 -1.207 . . . . 0.98 110.427 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.41 123.44 15.47 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.359 -0.838 . . . . 3.4 108.767 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 89' ' ' LYS . 5.6 mt-10 -96.96 126.9 42.43 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.31 -0.996 . . . . 2.4 108.31 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.73 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -123.97 118.96 28.2 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.875 -1.13 . . . . 0.37 110.386 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 5.9 mt -92.76 141.9 27.94 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.505 -1.665 . . . . 0.33 106.505 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.621 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 27.8 p90 -158.23 142.13 15.58 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 120.695 -1.253 . . . . 0.21 109.751 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.8 m-20 -87.06 110.88 20.39 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.408 -0.917 . . . . 0.61 108.728 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -46.3 114.1 0.74 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.61 -0.681 . . . . 0.13 109.398 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.425 ' OD1' ' C ' ' A' ' 44' ' ' ASN . 4.0 p30 -85.31 9.76 14.47 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.191 -0.943 . . . . 0.29 109.425 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.565 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -166.24 149.16 7.17 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.297 -0.877 . . . . 0.62 109.412 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -86.27 106.16 17.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.057 -1.027 . . . . 2.06 108.963 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.88 154.32 38.47 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.293 -0.879 . . . . 0.4 109.787 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.724 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 11.0 mmmt -89.22 -12.44 40.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.53 109.755 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 p -146.47 137.35 24.17 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.156 0.979 . . . . 0.53 110.195 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -127.93 149.17 50.44 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.357 -1.349 . . . . 0.51 107.357 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.587 ' HD2' ' CB ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -135.27 140.58 45.31 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.646 -0.822 . . . . 2.04 110.492 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.576 HG23 ' O ' ' A' ' 52' ' ' ILE . 7.0 tt -109.6 124.66 66.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.271 -0.893 . . . . 1.38 108.836 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 11.4 pt-20 -129.79 117.71 20.66 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.478 -1.304 . . . . 2.04 107.478 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.756 ' H ' HD12 ' A' ' 54' ' ' ILE . 3.8 mp -93.14 136.24 25.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 121.448 -0.782 . . . . 0.6 109.146 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 64' ' ' ASP . 49.8 mttt -119.05 131.9 55.99 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.225 -1.028 . . . . 0.61 108.225 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -116.33 154.38 30.3 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 120.7 -1.25 . . . . 0.77 111.608 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.804 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -120.14 150.75 40.13 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.71 -1.219 . . . . 0.51 107.71 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.844 HD13 ' CD ' ' A' ' 99' ' ' PRO . 3.4 mt -132.55 75.02 1.61 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.823 -1.173 . . . . 2.0 110.428 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER 40.51 25.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.596 -0.69 . . . . 1.73 110.274 179.511 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 152.35 -29.52 0.87 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.387 -1.387 . . . . 1.54 110.443 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.85 HD23 ' HG3' ' A' ' 99' ' ' PRO . 4.9 tp -110.3 110.02 20.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.848 -1.384 . . . . 2.43 110.112 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 2.0 tt0 -112.75 119.85 39.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.201 -0.937 . . . . 1.53 108.887 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.616 HG13 ' N ' ' A' ' 64' ' ' ASP . 2.2 tp -126.32 164.44 26.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 122.171 0.986 . . . . 5.42 109.65 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.616 ' N ' HG13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -83.38 110.15 17.91 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 105.64 -1.985 . . . . 1.59 105.64 177.056 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.1 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 3.0 t -66.5 113.68 13.89 Favored Pre-proline 0 C--N 1.293 -1.867 0 O-C-N 121.322 -0.862 . . . . 0.72 110.786 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.477 ' O ' HG23 ' A' ' 68' ' ' ILE . 37.5 Cg_endo -81.91 -165.7 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 123.121 2.547 . . . . 0.72 109.757 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 93' ' ' ASN . . . 58.0 56.83 23.03 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.796 -1.322 . . . . 1.38 109.796 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.563 HD13 ' O ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -149.12 -155.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.216 -1.167 . . . . 0.84 109.002 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.532 ' N ' ' OH ' ' A' ' 90' ' ' TYR . 38.6 t0 -114.18 112.13 22.67 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.096 -0.642 . . . . 0.73 109.575 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.587 ' CB ' ' HD2' ' A' ' 51' ' ' LYS . 21.2 p -90.39 42.41 1.1 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.645 -1.242 . . . . 0.71 107.645 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.62 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 21.1 t-20 176.94 88.33 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.497 -1.298 . . . . 2.03 107.497 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.923 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -76.45 7.35 4.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.45 112.613 -176.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.552 ' HA ' HG22 ' A' ' 76' ' ' VAL . 1.6 t -65.82 -12.99 58.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.225 -1.547 . . . . 0.23 108.837 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -78.56 -21.02 49.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.056 -1.027 . . . . 0.54 109.819 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.421 ' HB2' HG13 ' A' ' 88' ' ' ILE . 72.1 m-85 -108.74 -20.93 12.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 0.22 108.681 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.882 HG23 HD21 ' A' ' 80' ' ' LEU . 2.0 m -113.94 165.58 8.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.687 -1.227 . . . . 0.24 107.687 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.614 ' HG2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -92.54 93.05 8.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.983 -1.073 . . . . 1.72 111.202 -178.6 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.479 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 15.7 p -86.69 153.06 55.12 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 107.316 -1.364 . . . . 0.14 107.316 177.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.724 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.5 Cg_endo -69.52 132.13 21.04 Favored 'Cis proline' 0 C--N 1.311 -1.401 0 C-N-CA 124.363 -1.099 . . . . 0.25 112.778 2.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.882 HD21 HG23 ' A' ' 76' ' ' VAL . 11.1 mt -77.12 111.11 12.38 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.777 -1.564 . . . . 0.99 106.777 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 85.6 t -78.32 144.31 11.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 121.715 0.769 . . . . 0.35 110.782 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.565 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 14.2 ttpt -67.17 110.95 3.67 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.799 0.809 . . . . 0.67 109.858 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 124.12 -12.24 8.1 Favored Glycine 0 C--N 1.298 -1.578 0 N-CA-C 109.479 -1.448 . . . . 0.23 109.479 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.63 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 6.8 tp60 -103.28 151.6 22.5 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.839 -1.171 . . . . 0.28 107.839 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 1.2 tt0 -103.97 144.98 30.82 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.92 -1.141 . . . . 1.63 107.92 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.63 ' CE1' ' HG3' ' A' ' 84' ' ' GLN . 38.9 m-85 -125.67 143.56 50.98 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.008 -1.057 . . . . 0.3 110.212 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.29 115.7 30.49 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.845 -0.798 . . . . 2.82 108.845 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.923 HD12 ' HB1' ' A' ' 72' ' ' ALA . 3.4 tt -111.06 119.1 58.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.109 -0.995 . . . . 0.22 111.406 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.421 ' HA ' ' CG ' ' A' ' 38' ' ' GLU . 0.9 OUTLIER -94.39 119.35 33.0 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 104.662 -2.347 . . . . 2.17 104.662 175.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.607 ' CE2' ' O ' ' A' ' 91' ' ' THR . 24.0 t80 -132.7 143.04 49.36 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 117.539 -1.664 . . . . 0.62 113.982 -175.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.607 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -92.44 144.33 25.47 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 105.742 -1.947 . . . . 1.04 105.742 176.456 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.1 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 22.7 t90 -127.39 97.69 4.99 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.667 -1.271 . . . . 0.71 110.724 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 2.9 m-80 -61.75 103.08 0.31 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.646 -0.872 . . . . 1.88 108.646 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.731 HG13 ' HD2' ' A' ' 95' ' ' PRO . 88.3 t -59.23 144.02 83.96 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.325 -0.859 . . . . 0.95 108.747 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.952 ' HG3' HG13 ' A' ' 65' ' ' VAL . 29.4 Cg_endo -71.23 121.37 7.73 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.0 1.8 . . . . 1.15 110.165 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.486 ' HA ' ' HG2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -66.56 -0.98 3.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.818 -0.551 . . . . 3.02 110.971 -178.656 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.498 ' O ' ' C ' ' A' ' 98' ' ' ALA . 9.4 pt -92.41 -25.09 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.706 -1.246 . . . . 1.06 109.29 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.718 ' HB3' ' HG3' ' A' ' 31' ' ' ARG . . . -28.62 122.45 0.26 Allowed Pre-proline 0 N--CA 1.491 1.613 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.782 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.85 ' HG3' HD23 ' A' ' 61' ' ' LEU . 36.8 Cg_endo -87.01 115.57 1.19 Allowed 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.377 2.052 . . . . 1.03 107.995 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.518 ' CD ' ' HA ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -38.42 92.44 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.742 0.782 . . . . 4.1 108.946 -179.327 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 99' ' ' PRO . 1.4 t -102.76 115.03 29.79 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.33 -0.619 . . . . 0.62 109.33 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.472 ' O ' ' HE2' ' A' ' 126' ' ' LYS . 0.1 OUTLIER -41.15 -36.28 0.71 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.684 -0.635 . . . . 3.84 109.573 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 11.4 t-20 -128.48 138.36 52.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 2.32 110.097 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 1.026 HG21 HG13 ' A' ' 127' ' ' ILE . 20.2 t -135.79 150.54 28.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.573 -0.704 . . . . 1.39 109.896 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.539 HG23 ' OG ' ' A' ' 57' ' ' SER . 2.9 t -123.33 117.62 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.229 -1.026 . . . . 0.83 108.229 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.31 142.22 15.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 120.966 -1.084 . . . . 0.45 110.195 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 34.3 m -125.9 117.05 22.49 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.802 -0.561 . . . . 0.38 109.586 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER -96.78 125.79 49.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 106.945 -1.502 . . . . 0.31 106.945 178.338 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.854 ' HD2' HD11 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -135.41 137.03 41.86 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.552 -1.342 . . . . 1.02 111.504 -177.702 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.856 ' C ' HD12 ' A' ' 111' ' ' ILE . 10.0 mt -113.87 139.97 48.73 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.66 -1.607 . . . . 0.37 106.66 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.856 HD12 ' C ' ' A' ' 110' ' ' LEU . 3.7 mp -134.17 115.99 21.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 120.707 -1.245 . . . . 0.29 110.769 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.08 -150.85 16.26 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.364 -1.894 . . . . 0.62 108.364 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -96.65 -0.6 48.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.082 -1.246 . . . . 1.22 109.551 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.98 -2.52 12.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.095 -1.003 . . . . 4.25 110.401 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.28 -164.65 29.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.847 -1.301 . . . . 0.28 109.847 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.568 ' CG1' ' CD ' ' A' ' 109' ' ' LYS . 1.8 t -77.97 112.02 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -1.128 . . . . 0.39 109.671 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.93 -38.67 76.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 0.38 110.014 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.539 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -157.07 -171.05 3.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.001 -1.062 . . . . 0.36 109.128 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -177.44 151.24 0.75 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.263 -0.898 . . . . 0.47 109.393 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -149.63 153.2 36.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.045 . . . . 0.39 109.771 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.5 mt -134.81 138.91 48.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.371 -0.831 . . . . 0.89 108.783 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.07 133.62 34.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.84 -1.162 . . . . 0.91 109.732 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -68.41 0.34 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.466 -0.771 . . . . 2.49 109.928 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -128.76 142.07 51.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.9 . . . . 4.66 110.322 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -156.83 175.32 34.4 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.895 -1.682 . . . . 0.4 108.895 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' A' ' 102' ' ' GLU . 31.0 ttmt -153.07 138.44 17.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -1.14 . . . . 2.62 108.45 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 1.026 HG13 HG21 ' A' ' 104' ' ' VAL . 62.0 mt -106.61 140.31 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.427 -1.421 . . . . 0.32 109.738 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.518 ' HA ' ' CD ' ' A' ' 100' ' ' LYS . 10.4 mtt180 -132.42 174.93 9.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.401 -0.812 . . . . 2.02 108.948 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.2 t0 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.005 -1.06 . . . . 2.57 109.702 -179.759 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.531 ' CB ' ' HG2' ' A' ' 17' ' ' MET . 1.5 pt20 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.39 0.614 . . . . 1.73 109.991 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.586 HG21 HG23 ' A' ' 18' ' ' VAL . 2.3 m -105.58 162.97 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.33 -0.857 . . . . 0.2 109.121 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.32 126.28 38.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 3.36 109.141 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 121' ' ' ILE . 27.6 m -143.69 162.64 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.874 -0.787 . . . . 0.75 108.874 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -112.82 104.42 12.43 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.151 -1.055 . . . . 4.21 108.151 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -45.14 113.04 0.51 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.406 -0.809 . . . . 1.21 110.18 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.507 ' HB3' HG13 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -83.84 -7.47 59.44 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.636 -0.875 . . . . 0.91 108.636 179.225 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.536 ' N ' ' HB3' ' A' ' 119' ' ' CYS . . . -88.54 -79.52 0.31 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.371 -0.83 . . . . 0.97 109.5 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 178.83 61.13 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.761 -0.776 . . . . 1.36 109.682 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 57.93 17.98 4.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.293 -0.879 . . . . 0.96 109.362 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.412 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -67.83 -66.81 0.52 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.355 -0.841 . . . . 1.41 109.606 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.695 HD13 ' HB1' ' A' ' 39' ' ' ALA . 0.9 OUTLIER -56.23 120.0 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.0 -1.063 . . . . 0.61 109.769 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.596 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -61.0 -29.08 69.49 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.443 -0.786 . . . . 2.02 109.452 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.596 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 6.9 pttt 168.07 131.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.579 -0.897 . . . . 0.84 108.579 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.104 HG23 ' HB2' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -108.18 130.79 60.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.054 -1.091 . . . . 0.43 108.054 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.531 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 8.2 mtm -122.63 153.22 39.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.074 -1.016 . . . . 0.65 111.012 -177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.075 HG11 ' CE2' ' A' ' 35' ' ' PHE . 2.5 t -127.0 128.36 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.577 -0.898 . . . . 0.62 108.577 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.79 -17.39 35.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.149 -0.969 . . . . 2.45 110.496 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 21' ' ' CYS . . . -88.33 -94.68 1.01 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.646 -1.381 . . . . 1.13 109.646 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' O ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -47.53 173.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.213 -1.169 . . . . 0.69 108.975 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.493 ' NE2' ' CB ' ' A' ' 25' ' ' ASP . 5.5 p80 -139.48 3.34 2.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.927 -1.108 . . . . 4.38 110.594 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.13 -157.51 27.91 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.054 -1.545 . . . . 1.21 110.951 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.468 ' O ' ' C ' ' A' ' 25' ' ' ASP . 5.0 t -41.35 -36.27 0.79 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.613 -0.934 . . . . 2.75 110.553 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.493 ' CB ' ' NE2' ' A' ' 22' ' ' HIS . 0.7 OUTLIER -39.92 157.18 0.15 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.5 -0.75 . . . . 2.12 109.607 -179.648 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.82 138.88 19.22 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.957 2.438 . . . . 0.83 110.746 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -116.25 132.66 56.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.446 -0.784 . . . . 0.93 109.331 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 46.6 mm -101.97 109.31 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.019 -1.051 . . . . 0.65 108.616 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.3 mt -92.53 113.43 27.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.212 -0.93 . . . . 0.62 109.391 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.505 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -89.63 105.97 18.15 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.468 -1.308 . . . . 1.4 107.468 178.736 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.769 ' HA ' HG11 ' A' ' 94' ' ' VAL . 2.6 ptt180 -45.26 152.55 0.27 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.055 -1.028 . . . . 1.08 110.051 -178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.453 ' HA2' ' HD3' ' A' ' 96' ' ' LYS . . . 94.58 -15.88 62.36 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.57 -1.412 . . . . 0.42 109.57 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.505 ' HE2' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -102.3 152.51 38.3 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.178 -1.189 . . . . 2.11 109.445 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -81.3 119.85 3.53 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.886 2.391 . . . . 0.5 110.825 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 1.075 ' CE2' HG11 ' A' ' 18' ' ' VAL . 5.2 t80 -97.83 116.81 30.78 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.945 -1.502 . . . . 0.69 106.945 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.94 ' C ' HD13 ' A' ' 37' ' ' LEU . 28.3 m -96.21 131.03 43.12 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.15 -0.969 . . . . 0.69 110.838 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.94 HD13 ' C ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -134.64 141.63 46.64 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.696 -0.854 . . . . 0.41 108.696 178.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 0.7 OUTLIER -121.66 127.09 50.42 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.293 -1.003 . . . . 1.16 108.293 -179.621 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 1.104 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -132.75 121.51 23.16 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.597 -1.314 . . . . 0.33 110.513 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.578 HD23 ' HB3' ' A' ' 87' ' ' ASP . 2.3 mt -88.28 145.03 26.08 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 105.488 -2.041 . . . . 0.9 105.488 177.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.659 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 28.2 p90 -157.15 141.93 16.84 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.143 -1.423 . . . . 0.27 110.38 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 26.8 m-20 -85.51 111.01 19.61 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.202 -0.936 . . . . 1.36 108.79 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -46.82 114.8 0.9 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.703 -0.623 . . . . 0.29 109.329 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.453 ' OD1' HD23 ' A' ' 117' ' ' LEU . 38.8 p30 -83.66 7.85 16.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.096 -1.003 . . . . 1.92 109.847 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.53 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 3.5 pt20 -168.39 162.02 12.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.068 -1.02 . . . . 0.85 109.685 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 10.7 p-10 -89.1 120.55 30.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.215 -0.928 . . . . 2.75 109.245 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -141.6 141.74 33.46 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.57 110.17 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.677 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 8.0 mmmt -84.12 -11.45 56.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.54 -0.725 . . . . 0.75 109.688 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.2 p -144.75 138.1 26.94 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.977 0.894 . . . . 0.55 109.729 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -126.57 153.23 45.52 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.691 -0.855 . . . . 0.37 108.691 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 0.5 OUTLIER -132.09 136.92 47.52 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.959 -1.088 . . . . 0.4 110.833 -179.035 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.696 HG22 ' O ' ' A' ' 69' ' ' ASP . 4.5 tt -93.61 148.95 4.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.527 -1.286 . . . . 0.69 107.527 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.413 ' N ' HG12 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -139.07 116.8 11.47 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.146 -0.972 . . . . 0.77 109.142 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.795 HD13 HG21 ' A' ' 68' ' ' ILE . 2.8 mp -116.12 116.84 53.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 119.256 -0.978 . . . . 0.3 109.259 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.475 ' HA ' HG23 ' A' ' 65' ' ' VAL . 26.6 mtmt -114.87 159.45 20.65 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.181 -0.95 . . . . 0.87 108.993 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.59 122.56 22.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.884 -1.135 . . . . 0.29 110.482 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -93.21 150.85 20.2 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.777 -0.823 . . . . 2.7 108.777 179.261 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.823 HD11 HD11 ' A' ' 63' ' ' ILE . 20.4 mt -103.29 38.78 1.7 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.193 -0.942 . . . . 1.05 109.491 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 4.3 t0 72.58 5.46 5.24 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.512 -0.743 . . . . 2.06 109.324 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.06 -35.68 0.03 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.911 -1.275 . . . . 1.65 109.911 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 61' ' ' LEU . 7.0 mp -114.05 113.41 24.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.988 -1.301 . . . . 4.8 109.664 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 17.0 tt0 -77.78 137.05 38.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.967 -1.083 . . . . 1.71 109.936 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.823 HD11 HD11 ' A' ' 58' ' ' LEU . 74.0 mt -123.01 169.54 14.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-O 121.687 0.756 . . . . 1.2 109.079 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.686 ' N ' HG22 ' A' ' 63' ' ' ILE . 3.6 m-20 -114.18 129.59 56.62 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.198 -1.408 . . . . 2.18 107.198 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.066 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 2.7 t -103.26 112.67 65.86 Favored Pre-proline 0 C--N 1.303 -1.451 0 O-C-N 120.848 -1.157 . . . . 0.33 111.418 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.565 ' O ' HG23 ' A' ' 68' ' ' ILE . 36.3 Cg_endo -82.71 -154.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.261 2.641 . . . . 0.43 109.522 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.23 31.86 74.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.641 -1.384 . . . . 0.93 109.641 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.795 HG21 HD13 ' A' ' 54' ' ' ILE . 17.8 pt -125.79 -165.33 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.315 -1.109 . . . . 0.4 108.968 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.696 ' O ' HG22 ' A' ' 52' ' ' ILE . 38.7 t0 -103.05 112.32 25.1 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.221 -0.924 . . . . 1.47 109.495 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.515 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 10.3 p -87.11 45.46 1.27 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.492 -0.929 . . . . 0.35 108.492 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 23.8 t30 -179.85 74.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.429 -1.322 . . . . 0.92 107.429 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.617 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -59.5 -5.84 0.93 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.629 -0.669 . . . . 0.19 112.1 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.589 ' HA ' HG22 ' A' ' 76' ' ' VAL . 1.3 t -62.71 -14.34 43.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.43 -1.419 . . . . 0.2 108.621 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -25.81 63.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.964 . . . . 0.92 109.858 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.482 ' HB2' HG13 ' A' ' 88' ' ' ILE . 68.2 m-85 -111.62 -23.8 10.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.838 . . . . 0.27 109.896 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.851 ' CG2' HD21 ' A' ' 80' ' ' LEU . 1.5 m -104.42 171.69 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.047 -1.094 . . . . 0.25 108.047 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.592 ' HG3' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -94.27 92.43 7.21 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.156 -0.965 . . . . 1.32 110.82 -178.257 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.486 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 15.3 p -90.12 149.62 41.82 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 107.579 -1.267 . . . . 0.21 107.579 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.677 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.7 Cg_endo -70.17 133.86 27.98 Favored 'Cis proline' 0 C--N 1.312 -1.367 0 C-N-CA 124.171 -1.179 . . . . 0.17 112.906 2.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.851 HD21 ' CG2' ' A' ' 76' ' ' VAL . 14.0 mt -75.54 112.89 12.34 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.832 -1.544 . . . . 0.25 106.832 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 45.8 t -80.85 138.91 18.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 CA-C-O 121.668 0.746 . . . . 0.52 110.679 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.53 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 34.9 tttt -64.24 112.43 3.04 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.666 0.746 . . . . 2.12 109.326 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.87 -14.25 9.73 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 109.927 -1.269 . . . . 0.39 109.927 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.617 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 33.8 tp60 -101.17 153.12 19.87 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.83 -1.174 . . . . 2.38 107.83 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 1.4 tt0 -102.61 155.52 18.24 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.811 -1.181 . . . . 1.91 107.811 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.648 ' CE2' HD23 ' A' ' 80' ' ' LEU . 63.3 m-85 -134.81 151.8 51.23 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.065 -1.022 . . . . 0.34 109.981 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.578 ' HB3' HD23 ' A' ' 40' ' ' LEU . 4.5 p-10 -120.62 113.43 20.23 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.253 -0.905 . . . . 0.65 109.624 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.717 ' HB ' HG12 ' A' ' 76' ' ' VAL . 5.4 tt -110.78 121.59 63.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.271 -0.893 . . . . 0.28 111.705 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -104.11 109.75 21.66 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 104.741 -2.318 . . . . 2.75 104.741 175.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.632 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 39.7 t80 -125.42 142.33 51.56 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.83 -1.169 . . . . 0.42 113.174 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.632 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.2 144.14 25.93 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.625 -1.62 . . . . 0.89 106.625 176.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.066 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 24.7 t90 -118.83 87.79 2.8 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.896 -1.128 . . . . 0.68 110.328 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -64.19 104.12 0.7 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.471 0.653 . . . . 1.59 109.351 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.879 HG12 ' H ' ' A' ' 96' ' ' LYS . 52.2 t -56.14 143.56 63.1 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.524 -0.735 . . . . 1.8 109.312 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.7 ' HD2' HG13 ' A' ' 94' ' ' VAL . 25.0 Cg_endo -64.92 -3.35 6.86 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.835 2.356 . . . . 3.93 111.992 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.879 ' H ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER 66.81 1.38 2.22 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.982 -1.074 . . . . 3.25 109.515 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.519 ' O ' ' C ' ' A' ' 98' ' ' ALA . 10.0 pt -100.45 -30.16 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 120.96 -1.087 . . . . 0.54 108.399 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.574 ' HB1' HD13 ' A' ' 127' ' ' ILE . . . -33.15 117.93 0.44 Allowed Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.637 -0.875 . . . . 0.48 108.637 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 98' ' ' ALA . 32.7 Cg_endo -79.18 174.5 11.97 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.541 2.161 . . . . 0.99 110.19 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.516 ' HE3' ' HG2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -80.84 72.32 7.82 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.513 -0.921 . . . . 4.05 108.513 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.867 ' OG ' HG23 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -81.84 103.85 11.8 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.595 -0.891 . . . . 2.22 108.595 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.54 ' HG3' ' N ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -41.3 -30.17 0.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.34 -0.85 . . . . 5.03 109.565 -179.161 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.54 ' N ' ' HG3' ' A' ' 102' ' ' GLU . 0.6 OUTLIER -132.96 132.01 41.46 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.152 -0.967 . . . . 2.44 109.542 179.219 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.904 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.9 OUTLIER -132.05 144.59 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.342 -0.849 . . . . 0.85 109.978 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 122' ' ' ALA . 31.8 t -119.79 113.83 42.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.468 -1.308 . . . . 0.46 107.468 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.58 137.6 23.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 120.721 -1.237 . . . . 0.34 110.361 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 81.5 m -118.59 125.27 49.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.811 -0.556 . . . . 0.55 109.76 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -102.42 129.9 53.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.322 -1.362 . . . . 0.33 107.322 178.2 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.55 ' HG2' ' CG1' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -141.04 131.15 24.74 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.078 -1.639 . . . . 1.81 112.296 -178.082 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.659 ' CD1' ' CE2' ' A' ' 41' ' ' PHE . 16.2 mt -104.36 139.62 39.06 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.671 -1.603 . . . . 0.35 106.671 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.615 HD12 ' C ' ' A' ' 110' ' ' LEU . 5.1 mp -138.66 112.06 7.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 120.66 -1.275 . . . . 0.39 110.289 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.75 -150.19 7.81 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.481 -1.847 . . . . 0.56 108.481 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.28 -1.74 50.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.219 -1.165 . . . . 1.68 109.759 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -115.04 -0.36 13.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -0.956 . . . . 2.49 110.714 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.62 -169.61 27.78 Favored Glycine 0 N--CA 1.496 2.662 0 C-N-CA 119.525 -1.322 . . . . 0.54 110.305 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.55 ' CG1' ' HG2' ' A' ' 109' ' ' LYS . 44.4 t -77.5 111.2 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.296 -1.12 . . . . 1.07 109.867 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.453 HD23 ' OD1' ' A' ' 44' ' ' ASN . 28.3 mt -60.35 -41.37 93.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.32 109.874 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.645 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -151.75 176.15 11.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.967 -1.083 . . . . 0.69 109.526 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.536 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 42.8 t -164.13 154.05 14.53 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.042 -1.036 . . . . 0.57 109.007 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -150.44 154.95 38.62 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.837 -1.164 . . . . 0.32 110.353 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.507 HG13 ' HB3' ' A' ' 8' ' ' CYS . 72.4 mt -130.87 140.37 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.318 -0.864 . . . . 1.01 109.003 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.801 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -120.1 145.79 46.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.45 -1.406 . . . . 0.57 109.033 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.92 170.45 15.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.084 -1.01 . . . . 2.7 109.731 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 9.0 m80 64.34 40.52 6.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -0.848 . . . . 4.0 109.801 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -111.13 162.78 12.37 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.273 -1.531 . . . . 0.58 109.273 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.408 ' HB3' HD13 ' A' ' 28' ' ' ILE . 15.7 tttt -149.56 137.34 20.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -1.179 . . . . 4.31 108.615 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.904 ' CD1' HG21 ' A' ' 104' ' ' VAL . 61.2 mt -105.53 139.74 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.604 -1.31 . . . . 0.37 110.255 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.516 ' HG2' ' HE3' ' A' ' 100' ' ' LYS . 1.4 mtm180 -133.76 162.87 30.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.467 -0.77 . . . . 4.74 109.216 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.061 -0.971 . . . . 4.93 109.201 179.559 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.407 -0.59 . . . . 2.66 109.407 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 3.0 m -105.49 169.03 2.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.226 -0.922 . . . . 1.15 109.337 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -75.77 122.67 24.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 1.77 110.851 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -150.41 157.42 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.987 -1.116 . . . . 2.35 107.987 178.426 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -117.42 110.26 17.79 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.083 -1.011 . . . . 3.37 109.715 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.487 ' OD2' ' HB ' ' A' ' 13' ' ' ILE . 0.8 OUTLIER -49.65 152.49 1.42 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.482 -0.761 . . . . 1.62 109.909 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.469 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.1 OUTLIER -128.47 27.24 5.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.264 -0.898 . . . . 2.67 108.791 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.58 ' O ' ' ND2' ' A' ' 10' ' ' ASN . . . -116.25 -76.56 0.57 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.394 -0.816 . . . . 0.68 109.773 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.58 ' ND2' ' O ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER 174.21 68.6 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.069 -0.715 . . . . 1.17 109.069 -178.819 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 55.08 35.59 25.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.194 -0.941 . . . . 2.67 108.874 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.5 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -87.3 -79.2 0.28 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.456 -0.777 . . . . 1.18 109.805 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.528 ' CD1' ' HB1' ' A' ' 118' ' ' ALA . 0.7 OUTLIER -46.36 127.64 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.53 109.682 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.572 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -77.65 -24.99 49.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.477 -0.935 . . . . 1.17 108.477 179.422 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 167.61 129.56 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.781 -0.822 . . . . 1.94 108.781 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.81 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -111.87 121.51 64.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.176 -1.046 . . . . 0.48 108.176 179.553 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 3.4 mtm -110.48 150.78 28.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.924 -1.11 . . . . 1.33 110.895 -178.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.641 HG11 ' CE2' ' A' ' 35' ' ' PHE . 51.5 t -119.0 159.42 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.411 -0.959 . . . . 0.6 108.411 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.489 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -105.12 69.19 0.84 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.017 -1.052 . . . . 1.32 109.57 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.89 -50.41 0.27 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.648 -1.263 . . . . 0.97 110.231 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 39.7 t -80.71 150.89 29.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.988 -1.301 . . . . 1.25 110.011 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.47 -177.08 3.97 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.415 -0.803 . . . . 3.31 109.262 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 3' ' ' VAL . . . -65.0 -120.55 0.01 OUTLIER Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.069 -1.212 . . . . 1.92 110.069 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLY . 14.1 p -38.55 -44.73 0.99 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.653 -0.91 . . . . 1.27 110.234 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -44.53 156.91 0.32 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.106 -0.996 . . . . 1.51 109.221 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 124' ' ' HIS . 35.9 Cg_endo -77.82 173.28 14.31 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.645 2.23 . . . . 1.34 110.183 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.453 ' O ' HD13 ' A' ' 28' ' ' ILE . 5.4 m -122.11 135.91 54.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.068 -1.02 . . . . 0.79 110.037 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 27' ' ' CYS . 7.7 mm -110.35 107.96 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.276 -0.89 . . . . 1.14 108.664 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.409 HG23 HG21 ' A' ' 94' ' ' VAL . 1.4 mp -87.76 122.74 39.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.184 -0.948 . . . . 0.76 109.632 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 7.1 m80 -90.22 101.6 14.32 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.673 0.749 . . . . 1.19 109.215 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.833 ' HG3' ' HB3' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -37.74 146.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.61 0.719 . . . . 1.79 111.114 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.67 -5.63 56.49 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.678 -0.969 . . . . 0.87 110.678 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -104.85 152.24 39.52 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.758 -1.436 . . . . 1.73 110.214 -179.532 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.81 118.41 3.1 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.101 2.534 . . . . 0.46 111.291 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.641 ' CE2' HG11 ' A' ' 18' ' ' VAL . 2.6 t80 -97.75 123.69 41.79 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.135 -1.431 . . . . 0.65 107.135 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.732 ' C ' HD13 ' A' ' 37' ' ' LEU . 61.8 m -107.37 136.16 47.63 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.515 -1.365 . . . . 0.35 110.813 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.947 ' N ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -141.21 123.59 15.79 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.938 -0.764 . . . . 0.78 108.938 179.224 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -102.43 134.02 46.42 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.899 -1.148 . . . . 0.89 107.899 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.81 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -129.62 120.14 24.76 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 118.767 -1.173 . . . . 0.42 110.683 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.563 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 15.8 mt -89.56 140.63 29.35 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 105.378 -2.082 . . . . 0.79 105.378 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 27.3 p90 -155.2 139.2 16.38 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.046 -1.462 . . . . 0.39 110.528 -178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.3 m-20 -84.54 108.96 17.58 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.987 -1.116 . . . . 1.14 107.987 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -44.3 113.77 0.58 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.801 -0.814 . . . . 0.17 108.801 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.583 ' ND2' ' OE1' ' A' ' 45' ' ' GLN . 0.9 OUTLIER -83.5 10.3 9.25 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.073 -1.017 . . . . 0.58 109.595 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.583 ' OE1' ' ND2' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -168.28 158.11 9.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.382 -0.824 . . . . 0.74 109.312 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -88.35 120.36 29.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.177 -0.952 . . . . 1.71 109.537 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.513 ' O ' ' CA ' ' A' ' 79' ' ' PRO . 3.3 t -143.74 153.09 42.07 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.244 -0.91 . . . . 0.37 109.313 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.673 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -98.61 -25.84 14.59 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.663 -1.236 . . . . 6.51 107.663 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.408 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 24.6 p -111.3 138.33 47.91 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 122.134 0.968 . . . . 1.4 109.766 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -142.21 154.23 44.64 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.837 -0.801 . . . . 0.47 108.837 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.516 ' HD2' ' CB ' ' A' ' 70' ' ' THR . 1.6 mtmt -145.29 141.06 28.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.009 -1.057 . . . . 0.4 111.038 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 69' ' ' ASP . 9.7 tt -94.69 152.05 3.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.227 -1.397 . . . . 0.45 107.227 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -140.45 118.1 11.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.93 -1.106 . . . . 0.39 110.15 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.781 HD12 ' N ' ' A' ' 54' ' ' ILE . 2.2 mp -117.78 115.56 48.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.017 -1.052 . . . . 0.29 109.267 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 13.6 mttm -115.6 157.4 24.21 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.466 -0.938 . . . . 2.09 108.466 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.52 123.95 26.09 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.692 -1.255 . . . . 0.35 110.576 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 16.0 m -90.37 146.3 24.28 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.451 -0.944 . . . . 2.9 108.451 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.874 HD11 ' CD1' ' A' ' 63' ' ' ILE . 15.9 mt -113.18 48.27 1.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.027 -1.045 . . . . 0.61 109.989 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.401 ' OD2' ' CG ' ' A' ' 102' ' ' GLU . 0.4 OUTLIER 58.0 14.99 2.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.482 -0.761 . . . . 1.04 109.866 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.75 -41.61 0.16 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.964 -1.254 . . . . 1.03 109.964 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 58' ' ' LEU . 9.7 tp -106.53 111.32 23.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.204 -1.174 . . . . 0.84 109.304 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 30.4 tt0 -83.96 134.51 34.65 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.289 -0.882 . . . . 0.7 108.751 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.874 ' CD1' HD11 ' A' ' 58' ' ' LEU . 79.8 mt -124.89 166.46 20.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 122.011 0.91 . . . . 0.75 109.596 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.645 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -115.23 108.83 17.1 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 106.426 -1.694 . . . . 1.21 106.426 177.233 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.108 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 2.5 t -73.61 113.72 25.31 Favored Pre-proline 0 C--N 1.297 -1.688 0 O-C-N 121.267 -0.895 . . . . 0.4 111.027 -177.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.511 ' O ' HG23 ' A' ' 68' ' ' ILE . 36.7 Cg_endo -83.41 -159.4 0.1 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.956 2.437 . . . . 0.72 109.806 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.43 20.67 38.36 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.031 -1.228 . . . . 0.41 110.031 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.762 HG22 ' CD1' ' A' ' 92' ' ' TRP . 34.0 pt -105.93 -165.93 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -1.177 . . . . 0.33 109.09 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.67 ' O ' HG22 ' A' ' 52' ' ' ILE . 3.1 t70 -105.41 106.44 16.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 1.24 110.083 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.516 ' CB ' ' HD2' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -86.74 47.56 1.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.361 -0.977 . . . . 0.39 108.361 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 73' ' ' CYS . 17.9 t-20 176.72 85.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.609 -1.256 . . . . 1.62 107.609 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.654 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -73.02 8.07 1.76 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.333 -0.854 . . . . 0.35 112.057 -177.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.486 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 2.1 m -65.13 -13.27 57.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.698 -1.251 . . . . 2.14 109.485 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -82.27 -14.78 54.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.23 -0.919 . . . . 0.74 109.864 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.54 ' CB ' HG13 ' A' ' 88' ' ' ILE . 35.0 m-85 -121.64 -14.15 8.22 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.205 -0.935 . . . . 0.65 109.42 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.702 HG12 ' HB ' ' A' ' 88' ' ' ILE . 1.4 m -119.51 162.64 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.208 -0.932 . . . . 0.38 108.602 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.621 ' HG3' ' CD2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -96.65 84.2 3.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.221 -0.924 . . . . 5.77 111.136 -178.688 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.525 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 5.0 p -83.09 159.51 62.4 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.694 -1.254 . . . . 0.83 107.944 178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.673 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 23.7 Cg_endo -67.14 130.52 13.6 Favored 'Cis proline' 0 C--N 1.311 -1.422 0 C-N-CA 124.25 -1.146 . . . . 0.54 112.281 2.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.628 HD23 ' CE2' ' A' ' 86' ' ' TYR . 14.7 mt -71.67 107.84 4.71 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.75 -1.204 . . . . 0.51 107.75 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 61.0 t -78.69 136.11 24.54 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 CA-C-O 121.742 0.782 . . . . 0.3 110.211 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 23.3 tttt -62.51 110.09 1.58 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.708 0.766 . . . . 2.66 110.12 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 126.28 -16.76 6.69 Favored Glycine 0 N--CA 1.48 1.63 0 N-CA-C 110.185 -1.166 . . . . 0.15 110.185 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.575 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 3.3 tp-100 -101.95 156.48 17.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.066 -1.255 . . . . 2.13 108.141 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.555 ' C ' ' CD1' ' A' ' 86' ' ' TYR . 1.2 tt0 -106.02 153.69 21.68 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.096 -1.076 . . . . 1.99 108.096 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.628 ' CE2' HD23 ' A' ' 80' ' ' LEU . 23.4 m-85 -131.5 151.45 51.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.055 -1.028 . . . . 0.52 110.218 -178.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.563 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -118.27 113.86 22.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.527 -0.733 . . . . 2.19 110.063 -178.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.702 ' HB ' HG12 ' A' ' 76' ' ' VAL . 1.8 tt -115.59 119.41 61.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.181 -0.949 . . . . 0.48 111.353 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -101.39 106.88 18.08 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 104.87 -2.27 . . . . 2.31 104.87 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.627 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 32.2 t80 -119.97 141.23 49.87 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.869 -1.133 . . . . 0.38 112.544 -176.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.541 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -91.67 145.34 24.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.55 -1.648 . . . . 0.82 106.55 177.17 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.108 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 51.3 t90 -127.03 94.26 3.98 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.243 -0.911 . . . . 0.89 109.495 -177.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -57.42 104.88 0.19 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.66 -0.816 . . . . 2.13 108.8 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.717 HG22 ' CZ3' ' A' ' 92' ' ' TRP . 71.4 t -58.85 141.56 85.38 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 107.879 -1.156 . . . . 0.62 107.879 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.944 ' HG3' HG13 ' A' ' 65' ' ' VAL . 29.8 Cg_endo -71.58 124.66 10.48 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 C-N-CA 121.781 1.654 . . . . 0.5 109.992 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.531 ' HA ' ' HG2' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -67.87 -2.75 7.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.534 -0.729 . . . . 3.01 109.681 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 95' ' ' PRO . 3.8 pt -88.23 -24.59 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.54 109.318 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.833 ' HB3' ' HG3' ' A' ' 31' ' ' ARG . . . -29.07 120.04 0.28 Allowed Pre-proline 0 N--CA 1.492 1.635 0 CA-C-N 116.054 -0.521 . . . . 0.74 110.76 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.609 ' HG2' HD13 ' A' ' 58' ' ' LEU . 37.3 Cg_endo -86.09 133.29 4.07 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.565 2.176 . . . . 0.56 108.688 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.557 ' HD2' ' N ' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -50.98 91.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.851 -1.156 . . . . 5.4 107.913 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.604 ' HB3' HG23 ' A' ' 104' ' ' VAL . 3.6 t -94.51 114.45 26.45 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.576 -0.702 . . . . 0.46 109.465 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 11.4 pt-20 -38.85 -41.43 0.74 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.218 -0.66 . . . . 1.6 109.218 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.429 ' N ' ' CG ' ' A' ' 102' ' ' GLU . 1.7 t-20 -134.67 140.73 46.23 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.497 -0.752 . . . . 3.06 109.016 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.981 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.9 OUTLIER -133.47 146.74 31.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 121.344 -0.848 . . . . 0.64 108.99 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 t -126.53 114.81 39.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.815 -1.18 . . . . 0.67 107.815 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 38.9 t -97.5 137.94 23.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.293 -0.963 . . . . 0.5 109.897 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 81.1 m -117.52 115.74 25.75 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.605 -0.684 . . . . 0.37 109.617 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -94.79 128.57 45.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.466 -1.679 . . . . 0.45 106.466 177.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.558 ' HG2' ' CG1' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -141.24 130.45 23.5 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.281 -1.512 . . . . 0.95 112.378 -177.052 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.4 mt -102.53 139.49 38.06 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.165 -1.791 . . . . 0.8 106.165 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.573 HD12 ' C ' ' A' ' 110' ' ' LEU . 4.5 mp -137.07 114.73 13.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.746 -1.221 . . . . 0.45 110.25 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.475 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -87.97 -139.66 6.52 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.358 -1.897 . . . . 0.74 108.358 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.99 -0.0 27.29 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.192 -1.181 . . . . 2.05 109.592 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -116.41 4.53 13.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 2.08 110.479 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 142.42 -160.23 27.26 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.709 -1.357 . . . . 0.55 109.709 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.558 ' CG1' ' HG2' ' A' ' 109' ' ' LYS . 72.1 t -85.12 110.48 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -1.156 . . . . 1.1 109.589 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.567 HD13 ' CD1' ' A' ' 80' ' ' LEU . 77.6 mt -57.87 -39.16 77.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.5 110.56 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.544 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -152.08 175.11 12.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.933 -1.104 . . . . 0.88 109.227 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 42.4 t -168.11 153.76 7.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.571 -1.33 . . . . 0.49 110.018 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.13 149.79 29.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.05 -1.031 . . . . 0.45 110.102 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.447 HD12 ' SG ' ' A' ' 8' ' ' CYS . 4.3 mt -134.58 116.66 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.941 -1.133 . . . . 0.71 107.941 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.553 ' HB2' HG13 ' A' ' 5' ' ' VAL . . . -105.71 121.1 43.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.908 -1.12 . . . . 1.48 110.264 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.28 -156.79 0.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.438 -0.789 . . . . 2.43 108.885 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 0.2 OUTLIER 46.54 30.41 1.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.003 -1.061 . . . . 2.18 108.997 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -100.09 155.91 19.59 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.889 -1.148 . . . . 0.29 110.535 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 39.7 mttm -154.0 136.33 14.92 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.435 -1.32 . . . . 2.97 107.435 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.981 ' CD1' HG21 ' A' ' 104' ' ' VAL . 60.3 mt -107.68 134.71 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.327 -1.483 . . . . 0.26 111.52 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.543 ' CD ' ' N ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -116.15 177.02 4.84 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.797 -0.816 . . . . 3.14 108.797 178.141 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.557 ' N ' ' HD2' ' A' ' 100' ' ' LYS . 24.6 t0 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.073 -0.965 . . . . 1.2 109.61 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.478 ' HB2' ' HG2' ' A' ' 17' ' ' MET . 42.1 tt0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.18 0.515 . . . . 1.53 109.746 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.531 HG23 HG13 ' A' ' 5' ' ' VAL . 3.7 m -101.85 169.36 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.295 -0.878 . . . . 1.29 109.155 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.403 ' C ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -90.59 122.91 33.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 3.11 110.806 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 3' ' ' VAL . 29.6 m -153.47 149.56 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.015 -1.106 . . . . 0.51 108.015 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.27 110.31 20.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.781 -1.199 . . . . 5.09 110.569 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.32 134.49 39.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 2.84 108.916 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.47 ' HB3' HD13 ' A' ' 121' ' ' ILE . 4.3 p -106.61 -2.87 21.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.131 -0.98 . . . . 1.37 110.017 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 10' ' ' ASN . . . -73.81 -58.29 3.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.13 -0.981 . . . . 1.02 109.435 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 0.2 OUTLIER 167.2 50.86 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.85 -1.167 . . . . 3.44 107.85 -178.71 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 10' ' ' ASN . 52.9 t30 63.8 15.83 9.34 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.017 -1.105 . . . . 2.05 108.017 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.525 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -58.74 -62.1 2.12 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.501 -0.749 . . . . 1.28 109.266 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -59.19 128.27 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.37 109.583 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.567 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 9.9 mmpt? -85.35 -13.98 47.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.461 -0.775 . . . . 0.6 109.856 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.567 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.9 ttpt 156.96 127.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.06 -0.718 . . . . 1.38 109.06 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.711 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -114.3 123.92 70.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.367 -0.833 . . . . 0.53 108.949 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.478 ' HG2' ' HB2' ' A' ' 2' ' ' GLN . 2.8 mtm -115.76 147.84 40.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.13 -0.981 . . . . 0.83 110.268 -179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.013 HG11 ' CE2' ' A' ' 35' ' ' PHE . 44.3 t -127.07 129.21 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.936 -0.764 . . . . 0.56 108.936 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -83.27 87.26 6.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 1.42 109.783 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.44 -68.07 0.22 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.531 -1.428 . . . . 0.96 109.531 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.5 m -76.95 -167.6 0.89 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.354 -1.086 . . . . 3.25 109.418 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.57 175.83 9.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.041 -1.037 . . . . 4.52 109.813 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 3' ' ' VAL . . . -114.09 150.44 18.6 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.364 -1.494 . . . . 3.31 109.364 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER 72.71 1.5 4.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.042 -1.269 . . . . 2.05 109.116 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.482 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 1.1 m-20 -135.43 176.01 3.18 Favored Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 108.267 -1.012 . . . . 1.61 108.267 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 34.4 Cg_endo -76.33 135.97 17.29 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.933 1.755 . . . . 0.75 109.66 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.66 139.34 47.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.369 -0.832 . . . . 2.49 108.819 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.627 HG23 ' HG3' ' A' ' 128' ' ' ARG . 46.6 mm -112.11 115.78 50.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.167 -0.958 . . . . 0.91 109.841 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.3 mt -103.93 118.13 50.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.505 -0.924 . . . . 0.85 108.505 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.537 ' HB2' ' CE ' ' A' ' 33' ' ' LYS . 14.0 m80 -84.87 125.02 32.28 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.156 -0.965 . . . . 1.04 109.241 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.579 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 3.2 ptt180 -70.78 125.47 26.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.124 -0.985 . . . . 1.29 109.84 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.56 -9.17 26.15 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.745 -1.342 . . . . 0.3 109.745 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.537 ' CE ' ' HB2' ' A' ' 30' ' ' HIS . 1.6 ptpt -112.38 158.51 37.01 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.174 -1.192 . . . . 1.76 109.647 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 33' ' ' LYS . 36.2 Cg_endo -78.01 136.38 14.7 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 C-N-CA 122.981 2.454 . . . . 0.39 111.484 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 1.013 ' CE2' HG11 ' A' ' 18' ' ' VAL . 2.5 t80 -117.67 116.88 27.94 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.673 -1.232 . . . . 0.74 107.673 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.783 ' O ' HG13 ' A' ' 18' ' ' VAL . 23.1 m -96.93 137.16 36.45 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.95 -1.094 . . . . 0.93 110.76 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.498 ' HB3' HG22 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -147.82 125.84 12.08 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.843 -0.799 . . . . 4.01 108.843 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -100.23 125.32 46.38 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.723 -1.214 . . . . 1.41 107.723 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.711 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -124.43 118.39 26.56 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.986 -1.086 . . . . 0.45 110.809 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 12.3 mt -91.04 140.82 29.48 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.487 -1.671 . . . . 0.62 106.487 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.621 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 25.1 p90 -156.68 141.24 16.8 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 120.898 -1.126 . . . . 0.24 109.193 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 7.7 m-20 -84.81 111.48 19.66 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 118.938 -1.105 . . . . 1.36 109.057 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -45.33 113.46 0.58 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.958 -0.756 . . . . 0.13 108.958 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.409 ' OD1' ' C ' ' A' ' 44' ' ' ASN . 36.0 p30 -88.35 10.08 21.11 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.291 -0.88 . . . . 1.49 109.382 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.615 HE21 HD23 ' A' ' 117' ' ' LEU . 1.5 pt20 -165.95 144.09 5.74 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.285 -0.884 . . . . 1.91 110.005 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.4 p-10 -80.57 119.1 22.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -0.856 . . . . 1.3 108.998 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.54 HG21 ' HA3' ' A' ' 112' ' ' GLY . 0.1 OUTLIER -138.98 144.59 39.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.924 -1.11 . . . . 0.35 109.849 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.69 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 20.0 mmmt -85.14 -9.37 57.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -0.888 . . . . 0.66 109.676 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 48' ' ' LYS . 9.7 p -151.01 139.75 20.76 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.762 0.791 . . . . 0.41 109.42 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -129.9 156.1 44.95 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 121.72 -0.613 . . . . 0.3 109.384 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.552 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 0.1 OUTLIER -128.98 127.61 42.02 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.327 -0.858 . . . . 0.58 111.174 -178.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.757 ' HA ' HD23 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -101.57 127.58 54.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.834 -1.543 . . . . 1.21 106.834 176.441 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.589 ' CD ' ' N ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -140.71 116.68 10.44 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.1 -1.0 . . . . 4.66 108.43 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.792 HD12 HD13 ' A' ' 68' ' ' ILE . 4.2 mp -94.2 129.94 43.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 109.335 -0.617 . . . . 0.86 109.335 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -115.0 138.17 51.16 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.327 -0.858 . . . . 0.96 109.64 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -119.63 128.17 53.61 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.492 -0.883 . . . . 0.51 110.399 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.52 108.92 16.08 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.343 -0.984 . . . . 3.59 108.343 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.827 HD23 ' N ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -77.87 -173.44 3.09 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.474 -0.766 . . . . 2.51 110.141 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -52.57 -34.24 49.62 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.518 -0.739 . . . . 5.42 110.371 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.67 1.06 0.8 Allowed Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.882 -1.628 . . . . 2.71 111.571 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.499 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 12.9 tp -113.39 107.69 16.2 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.528 -1.572 . . . . 3.13 109.353 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.456 ' O ' ' OE2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -96.07 127.5 42.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.915 -1.116 . . . . 6.1 108.501 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.65 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -149.13 171.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 122.302 1.048 . . . . 4.53 109.438 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.65 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -110.89 116.32 31.04 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 106.789 -1.559 . . . . 4.65 106.789 177.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.119 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 15.6 t -66.94 110.31 4.83 Favored Pre-proline 0 C--N 1.295 -1.766 0 O-C-N 121.667 -0.645 . . . . 0.45 110.594 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.684 ' O ' HG23 ' A' ' 68' ' ' ILE . 42.2 Cg_endo -89.17 -157.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.719 2.946 . . . . 0.51 109.99 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 50.85 45.86 49.29 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.26 -1.136 . . . . 0.91 110.26 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.792 HD13 HD12 ' A' ' 54' ' ' ILE . 2.5 pt -140.43 -138.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.07 -1.253 . . . . 1.16 109.59 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.502 ' N ' ' OH ' ' A' ' 90' ' ' TYR . 1.1 t70 -117.21 105.34 12.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.923 -1.111 . . . . 1.6 111.178 -178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.552 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 11.0 p -92.44 49.92 1.55 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.366 -1.346 . . . . 0.74 107.366 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 38.4 t30 177.55 81.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.231 -1.396 . . . . 0.74 107.231 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.589 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . . . -65.58 -3.97 5.38 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.327 0.862 . . . . 0.41 113.327 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.481 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 9.7 t -65.9 -9.19 27.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 119.928 -1.732 . . . . 0.45 109.352 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -76.26 -30.88 58.01 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.037 -1.04 . . . . 5.2 108.34 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CD1' ' O ' ' A' ' 89' ' ' LYS . 88.3 m-85 -105.4 -17.88 14.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.1 -1.0 . . . . 0.73 110.321 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.746 ' CG2' HD21 ' A' ' 80' ' ' LEU . 2.5 m -115.0 169.71 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.406 -0.961 . . . . 0.51 108.406 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.624 ' HG3' ' CD2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -95.61 91.32 6.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.16 -0.963 . . . . 4.59 111.723 -177.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.485 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 20.1 p -84.16 151.89 60.76 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 107.636 -1.246 . . . . 0.41 107.636 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.69 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.0 Cg_endo -69.84 132.68 23.1 Favored 'Cis proline' 0 C--N 1.314 -1.259 0 C-N-CA 124.281 -1.133 . . . . 0.24 112.226 2.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.746 HD21 ' CG2' ' A' ' 76' ' ' VAL . 16.1 mt -74.91 104.24 5.44 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.514 -1.291 . . . . 0.49 107.514 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.527 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 73.2 t -71.66 139.03 20.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-O 121.559 0.695 . . . . 0.57 109.919 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.596 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 14.5 ttpp -69.27 107.22 3.17 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.539 0.685 . . . . 2.45 109.688 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 131.8 -18.08 4.87 Favored Glycine 0 N--CA 1.481 1.641 0 C-N-CA 119.584 -1.294 . . . . 0.43 110.249 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.609 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 5.3 tp60 -98.86 151.42 20.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.102 -1.234 . . . . 0.44 108.306 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 1.9 tt0 -99.26 142.63 30.49 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.292 -1.373 . . . . 0.79 107.292 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.716 ' CE2' HD23 ' A' ' 80' ' ' LEU . 32.9 m-85 -120.7 150.44 40.95 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.24 -0.913 . . . . 0.39 110.295 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.536 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -115.63 115.06 25.77 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.415 -0.957 . . . . 2.14 108.415 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.63 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 1.8 tt -108.2 116.54 51.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.031 -1.043 . . . . 0.24 111.427 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.566 ' O ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -97.08 113.08 24.61 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 104.457 -2.423 . . . . 4.15 104.457 176.035 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.585 ' CZ ' ' O ' ' A' ' 91' ' ' THR . 12.8 t80 -130.84 138.91 50.08 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.365 -1.334 . . . . 0.77 113.082 -175.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.585 ' O ' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -89.56 142.25 27.85 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 105.583 -2.006 . . . . 0.89 105.583 176.582 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.119 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 21.1 t90 -123.75 89.01 3.01 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 120.571 -1.331 . . . . 0.74 110.731 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -60.58 103.55 0.26 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.468 -0.938 . . . . 2.76 108.468 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.577 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 40.5 t -62.88 142.34 97.4 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.812 -0.81 . . . . 0.38 108.812 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.673 ' HG3' HG13 ' A' ' 65' ' ' VAL . 29.2 Cg_endo -71.17 127.55 13.63 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.764 1.642 . . . . 0.55 109.389 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -69.19 3.25 2.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.506 -0.746 . . . . 3.61 111.021 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 98' ' ' ALA . 12.5 pt -89.38 -26.29 5.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 O-C-N 120.708 -1.245 . . . . 0.42 108.85 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.579 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . . . -39.38 116.62 1.09 Allowed Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 109.414 -0.587 . . . . 0.14 109.414 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.555 ' HD2' ' CD1' ' A' ' 58' ' ' LEU . 36.6 Cg_endo -85.4 137.88 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 123.244 2.63 . . . . 0.18 109.139 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.516 ' HG2' ' HA ' ' A' ' 128' ' ' ARG . 5.8 mtmt -54.59 90.88 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.015 -1.053 . . . . 1.54 108.732 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.602 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -98.84 129.27 45.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.585 -0.697 . . . . 0.87 109.587 -179.031 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 103' ' ' ASN . 17.7 pt-20 -39.11 -48.19 1.66 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.47 -0.769 . . . . 1.18 110.595 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.521 ' N ' ' HG3' ' A' ' 102' ' ' GLU . 4.2 m120 -132.89 145.8 51.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.989 -1.069 . . . . 1.82 110.478 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.766 HG21 HD12 ' A' ' 127' ' ' ILE . 82.9 t -135.87 149.17 27.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.777 -0.823 . . . . 0.59 108.777 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 122' ' ' ALA . 98.2 t -121.31 117.8 53.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.045 -1.094 . . . . 0.47 108.045 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.1 t -98.78 140.23 18.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 120.76 -1.212 . . . . 0.56 109.965 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 27.0 m -126.7 118.79 25.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.68 -0.638 . . . . 0.5 109.714 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER -96.75 125.88 49.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.216 -1.402 . . . . 0.48 107.216 177.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.948 ' HD2' HD11 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -133.99 150.85 51.27 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 120.647 -1.283 . . . . 1.12 111.435 -177.433 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.757 HD23 ' HA ' ' A' ' 52' ' ' ILE . 13.4 mt -129.79 137.11 50.33 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.142 -1.429 . . . . 0.35 107.142 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.948 HD11 ' HD2' ' A' ' 109' ' ' LYS . 4.5 mp -134.78 117.64 23.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.857 -1.152 . . . . 0.32 110.205 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.54 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -86.94 -120.02 1.27 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.003 -1.639 . . . . 0.16 109.003 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -123.49 -4.98 8.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -1.089 . . . . 2.64 109.403 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.437 ' HB3' ' OE1' ' A' ' 45' ' ' GLN . 4.1 t30 -114.5 -5.91 12.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 4.31 110.116 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.506 ' N ' ' OE1' ' A' ' 45' ' ' GLN . . . 156.98 -162.53 31.78 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.714 -1.354 . . . . 0.44 109.714 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 118' ' ' ALA . 3.8 t -82.88 109.36 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -1.133 . . . . 0.53 109.719 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.615 HD23 HE21 ' A' ' 45' ' ' GLN . 6.4 mt -51.19 -38.62 53.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.76 110.749 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.594 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -155.32 -166.0 2.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.759 -1.213 . . . . 0.35 109.401 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER 175.53 147.95 0.09 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.162 -0.962 . . . . 0.95 109.529 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.646 ' C ' HD12 ' A' ' 121' ' ' ILE . . . -147.05 146.35 29.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.958 -1.088 . . . . 0.52 109.254 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.646 HD12 ' C ' ' A' ' 120' ' ' ALA . 3.4 mp -133.75 136.11 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.128 -0.982 . . . . 1.97 109.418 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -112.76 132.75 55.09 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.185 -0.947 . . . . 0.64 109.109 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.4 p -116.37 57.22 0.77 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.128 -0.983 . . . . 3.29 109.383 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.85 60.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.628 -0.878 . . . . 1.14 108.628 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.485 ' C ' ' HG3' ' A' ' 126' ' ' LYS . . . -130.57 164.06 23.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.804 -1.318 . . . . 0.48 109.804 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.485 ' HG3' ' C ' ' A' ' 125' ' ' GLY . 15.3 mtpt -152.07 145.11 24.52 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.964 -1.124 . . . . 1.28 107.964 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.766 HD12 HG21 ' A' ' 104' ' ' VAL . 52.3 mt -106.39 140.89 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.407 -1.433 . . . . 0.37 110.319 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.627 ' HG3' HG23 ' A' ' 28' ' ' ILE . 11.1 mtt180 -128.95 179.69 5.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.444 -0.785 . . . . 1.54 109.275 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.5 t0 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.111 -0.947 . . . . 1.64 109.649 -179.814 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.541 ' CB ' ' HG2' ' A' ' 17' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.324 0.583 . . . . 2.09 109.889 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.474 ' O ' HG22 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -103.55 159.48 4.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.29 -0.881 . . . . 1.87 109.13 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -70.12 119.23 14.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.086 -1.009 . . . . 1.41 109.837 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.663 HG21 HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -139.6 140.16 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.383 -0.823 . . . . 1.64 109.324 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.49 109.32 19.2 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.206 -0.934 . . . . 3.36 109.385 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.438 ' CG ' ' HB ' ' A' ' 13' ' ' ILE . 1.4 m-20 -60.37 120.4 9.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 2.24 108.943 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 8' ' ' CYS . 1.6 p -95.59 23.12 6.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.03 -1.044 . . . . 0.34 109.635 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 10' ' ' ASN . . . -96.52 -82.29 0.4 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.279 -0.888 . . . . 0.36 109.829 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 0.8 OUTLIER 178.24 56.39 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.025 -0.67 . . . . 1.71 109.396 -178.759 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 10' ' ' ASN . 3.3 m120 67.26 51.61 0.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 4.76 109.137 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.508 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -113.33 -61.72 1.7 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 1.08 109.897 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.659 HG22 ' H ' ' A' ' 15' ' ' LYS . 1.1 mm -57.45 123.42 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.049 -1.032 . . . . 0.48 109.939 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.606 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 4.6 mmpt? -71.77 -17.55 62.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.382 -0.824 . . . . 1.33 108.808 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.659 ' H ' HG22 ' A' ' 13' ' ' ILE . 6.6 pttm 147.6 140.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.328 -1.36 . . . . 1.18 107.328 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.803 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -115.27 128.91 72.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.271 -1.011 . . . . 0.41 108.271 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.541 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -125.37 145.33 50.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.124 -0.985 . . . . 0.76 110.434 -178.201 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 19' ' ' ASP . 50.2 t -98.24 165.63 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.403 -0.811 . . . . 1.02 108.918 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.553 ' N ' HG12 ' A' ' 18' ' ' VAL . 1.6 p-10 -47.29 -30.33 3.04 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.014 -1.054 . . . . 3.93 108.919 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.405 ' N ' ' OD1' ' A' ' 19' ' ' ASP . . . 149.69 100.5 0.22 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.592 -1.29 . . . . 2.79 110.741 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 22' ' ' HIS . 3.5 t -128.48 -51.52 1.27 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.185 -1.185 . . . . 3.66 109.139 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.489 ' CB ' ' O ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER 166.52 -84.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 4.24 110.136 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 119.22 -107.45 1.38 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.571 -1.812 . . . . 1.23 108.571 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 23' ' ' GLY . 9.5 p -47.43 -40.99 19.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.97 -1.312 . . . . 1.44 108.422 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.494 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -72.78 175.02 3.67 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 109.086 -0.709 . . . . 2.21 109.086 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 25' ' ' ASP . 34.8 Cg_endo -79.51 135.09 11.54 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.216 1.944 . . . . 1.33 110.344 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.5 t -112.45 143.44 43.59 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.31 -0.996 . . . . 2.68 108.31 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.513 HG23 ' HG3' ' A' ' 128' ' ' ARG . 46.9 mm -108.57 118.18 55.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.104 -0.998 . . . . 0.76 110.247 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 127' ' ' ILE . 23.0 mt -98.79 118.36 45.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.245 -1.02 . . . . 0.84 108.245 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -95.43 122.43 38.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.946 . . . . 1.11 110.163 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.549 ' HA ' HG11 ' A' ' 94' ' ' VAL . 16.6 ptt180 -66.1 151.52 46.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 1.61 109.475 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.9 -17.32 57.07 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.902 -1.679 . . . . 0.59 108.902 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.443 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -107.45 148.68 37.65 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.282 -1.128 . . . . 1.26 109.143 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 36.3 Cg_endo -78.44 122.41 5.57 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.7 2.267 . . . . 0.31 111.147 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -100.55 122.55 43.43 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.149 -1.056 . . . . 0.32 108.149 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.476 ' O ' HG13 ' A' ' 18' ' ' VAL . 64.2 m -100.7 137.55 38.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.898 -1.126 . . . . 0.67 110.752 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -145.34 128.09 16.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.483 -0.76 . . . . 2.69 109.05 179.402 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -105.07 129.58 53.46 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.547 -0.909 . . . . 1.38 108.547 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.803 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -128.14 120.92 28.32 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.793 -1.192 . . . . 0.13 110.306 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.547 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 4.2 mt -91.16 140.95 29.32 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.332 -1.729 . . . . 0.59 106.332 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.659 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 32.0 p90 -156.5 135.58 11.98 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.709 -1.196 . . . . 0.17 109.778 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.6 OUTLIER -83.35 112.81 20.25 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.351 -0.981 . . . . 1.17 108.351 179.309 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -46.22 112.48 0.49 Allowed 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.672 -0.862 . . . . 0.25 108.672 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 44' ' ' ASN . 2.3 p30 -84.93 10.94 10.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.112 -0.993 . . . . 0.89 109.45 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.562 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 1.8 pt20 -167.93 145.38 4.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.459 -0.776 . . . . 0.74 108.968 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 2.4 p30 -84.46 119.17 24.83 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.145 -0.972 . . . . 0.77 109.36 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.489 ' O ' ' CA ' ' A' ' 79' ' ' PRO . 2.6 t -137.2 159.68 41.2 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.265 -0.897 . . . . 0.33 109.249 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.62 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -100.49 -28.54 12.85 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.127 -1.435 . . . . 6.83 107.127 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.465 ' OG1' ' OD1' ' A' ' 113' ' ' ASP . 34.2 p -111.51 138.9 47.43 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 122.146 0.974 . . . . 1.67 109.522 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -142.88 152.66 42.34 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 108.85 -0.796 . . . . 0.74 108.85 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HD2' ' HB ' ' A' ' 70' ' ' THR . 6.4 mtmt -142.59 141.07 31.91 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.18 -0.95 . . . . 0.43 110.332 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 69' ' ' ASP . 11.0 tt -94.28 150.46 4.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.193 -1.41 . . . . 0.53 107.193 177.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -140.15 116.27 10.47 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.079 -1.013 . . . . 1.18 110.156 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.779 HD13 HG21 ' A' ' 68' ' ' ILE . 2.7 mp -112.97 114.08 45.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.074 -1.016 . . . . 0.3 108.51 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -115.17 130.65 56.98 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.109 -0.994 . . . . 0.61 109.271 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -107.92 128.45 54.64 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.192 -0.942 . . . . 0.29 110.528 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.483 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . 42.7 t -97.26 150.55 20.81 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.537 -0.912 . . . . 1.59 108.537 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 63' ' ' ILE . 35.8 mt -105.86 38.2 2.06 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.092 -1.005 . . . . 0.6 109.961 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.44 12.24 5.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -0.872 . . . . 1.69 109.456 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.26 -44.34 0.06 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.461 -1.456 . . . . 0.88 109.461 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.92 111.31 23.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -1.168 . . . . 4.03 108.997 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -79.82 133.43 36.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.021 -1.049 . . . . 2.04 109.83 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.683 HD11 HD11 ' A' ' 58' ' ' LEU . 98.0 mt -123.87 167.24 17.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.177 -0.952 . . . . 0.8 109.444 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.669 ' N ' HG22 ' A' ' 63' ' ' ILE . 35.9 m-20 -114.63 115.24 26.81 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.754 -1.573 . . . . 1.03 106.754 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.045 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 2.8 t -83.36 115.17 57.86 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.946 . . . . 0.34 111.458 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.528 ' O ' HG23 ' A' ' 68' ' ' ILE . 37.5 Cg_endo -85.04 -156.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 123.1 2.533 . . . . 0.22 109.342 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.62 35.83 82.73 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.286 -1.126 . . . . 0.72 110.286 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.779 HG21 HD13 ' A' ' 54' ' ' ILE . 18.2 pt -127.06 -156.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.157 -1.201 . . . . 0.3 108.83 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.733 ' O ' HG22 ' A' ' 52' ' ' ILE . 38.7 t0 -108.58 108.75 19.76 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.244 -0.91 . . . . 1.41 109.464 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 51' ' ' LYS . 1.4 p -88.07 46.56 1.4 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.628 -1.249 . . . . 0.42 107.628 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 14.6 t-20 175.49 83.54 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.645 -1.613 . . . . 1.39 106.645 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.521 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -66.24 1.6 1.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.53 -0.731 . . . . 0.67 111.822 -177.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 20.2 m -61.92 -13.65 26.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.817 -1.177 . . . . 2.37 109.674 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -81.84 -14.69 55.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.111 -0.993 . . . . 0.86 110.156 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.701 ' CE2' ' CD1' ' A' ' 90' ' ' TYR . 19.7 m-85 -122.54 -15.27 7.6 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.367 -0.833 . . . . 1.11 109.739 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.622 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 3.1 m -122.15 169.05 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.35 -0.982 . . . . 0.75 108.35 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.614 ' HG2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -100.76 87.59 3.37 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.221 -0.925 . . . . 1.81 112.248 -178.054 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.54 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 20.4 p -87.62 157.44 52.43 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.445 -1.41 . . . . 0.88 107.91 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.62 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 21.8 Cg_endo -65.08 125.19 5.16 Favored 'Cis proline' 0 C--N 1.314 -1.261 0 O-C-N 123.105 1.055 . . . . 0.54 112.947 2.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.875 HD23 ' CE2' ' A' ' 86' ' ' TYR . 13.8 mt -70.75 117.06 11.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.531 -1.655 . . . . 0.61 106.531 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 43.6 t -83.55 139.84 17.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 C-N-CA 119.606 -0.838 . . . . 0.56 110.926 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.562 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 16.8 ttpt -66.48 108.51 2.42 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.644 0.735 . . . . 0.84 109.562 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.66 -19.14 5.93 Favored Glycine 0 C--N 1.298 -1.555 0 N-CA-C 109.519 -1.432 . . . . 0.36 109.519 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.601 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 4.0 tp60 -97.91 152.06 19.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.169 -1.195 . . . . 0.61 107.799 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -104.96 143.63 32.91 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 118.99 -1.084 . . . . 0.28 108.511 179.388 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.875 ' CE2' HD23 ' A' ' 80' ' ' LEU . 25.9 m-85 -121.05 150.06 41.76 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.279 -0.888 . . . . 0.76 109.606 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.547 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 8.8 p-10 -119.76 109.85 16.1 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.951 -1.129 . . . . 0.62 107.951 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.622 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 6.9 tt -106.43 122.12 59.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.007 0.908 . . . . 0.36 111.839 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -101.85 112.58 25.25 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 104.637 -2.357 . . . . 1.0 104.637 176.033 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.701 ' CD1' ' CE2' ' A' ' 75' ' ' PHE . 31.5 t80 -127.51 139.5 52.74 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.734 -1.229 . . . . 0.47 112.405 -175.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.66 106.83 18.83 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.202 -1.407 . . . . 0.54 107.202 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.045 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 29.9 t90 -82.2 94.32 7.26 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.494 0.664 . . . . 0.49 109.832 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -67.71 109.82 3.49 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.487 -0.758 . . . . 2.88 109.35 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.649 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 12.4 t -60.2 142.97 89.4 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.124 -1.065 . . . . 1.11 108.124 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.649 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 23.7 Cg_endo -66.97 -11.84 33.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.508 2.139 . . . . 3.8 111.755 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 0.0 OUTLIER 76.21 -7.23 1.86 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 2.98 109.485 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.525 ' O ' ' C ' ' A' ' 98' ' ' ALA . 12.7 pt -93.5 -27.97 4.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 O-C-N 121.114 -0.991 . . . . 0.55 108.444 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.525 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -32.84 117.6 0.43 Allowed Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 108.575 -0.898 . . . . 0.51 108.575 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.594 ' O ' ' N ' ' A' ' 101' ' ' SER . 37.3 Cg_endo -83.86 138.94 8.36 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.747 2.298 . . . . 0.69 110.015 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.531 ' HE3' ' HG2' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -50.22 90.47 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.897 -1.149 . . . . 3.28 107.897 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.655 ' HB3' HG23 ' A' ' 104' ' ' VAL . 1.8 t -94.32 124.18 38.18 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.506 -0.746 . . . . 0.56 109.271 -178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -43.13 -45.3 5.39 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.591 -0.892 . . . . 1.75 108.591 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.429 ' N ' ' HG2' ' A' ' 102' ' ' GLU . 0.6 OUTLIER -131.44 141.48 49.82 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.497 -0.752 . . . . 0.93 109.195 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.897 HG21 ' CD1' ' A' ' 127' ' ' ILE . 2.1 t -131.41 145.4 35.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.268 -0.895 . . . . 0.68 109.497 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 57' ' ' SER . 73.4 t -126.27 114.72 39.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.878 -1.156 . . . . 0.32 107.878 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.496 HG12 ' CG2' ' A' ' 54' ' ' ILE . 1.8 t -95.66 137.29 24.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.92 -1.112 . . . . 0.39 109.372 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.608 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 34.3 m -118.72 112.24 19.51 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.15 -0.969 . . . . 0.44 109.584 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -92.7 125.25 45.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 106.647 -1.612 . . . . 0.53 106.647 178.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.8 ' CD ' HD11 ' A' ' 111' ' ' ILE . 9.0 ttmt -141.26 131.51 24.97 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.134 -1.427 . . . . 2.07 112.117 -176.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.872 ' C ' HD12 ' A' ' 111' ' ' ILE . 9.0 mt -104.16 138.15 41.07 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.209 -1.404 . . . . 0.78 107.209 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.872 HD12 ' C ' ' A' ' 110' ' ' LEU . 3.2 mp -129.69 120.57 50.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.101 -1.0 . . . . 0.28 109.922 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.446 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -92.74 -145.95 17.92 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.754 -1.738 . . . . 0.86 108.754 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.465 ' OD1' ' OG1' ' A' ' 49' ' ' THR . 0.1 OUTLIER -99.93 -1.5 37.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.128 -1.219 . . . . 1.24 109.941 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 114' ' ' ASN . 0.6 OUTLIER -114.68 -10.5 12.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.97 -1.081 . . . . 4.67 110.247 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 111' ' ' ILE . . . 159.32 -148.0 16.2 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.521 -1.323 . . . . 0.3 110.13 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.64 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 2.1 t -91.99 109.87 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -1.136 . . . . 0.25 110.13 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 110' ' ' LEU . 41.0 mt -52.85 -43.67 66.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.446 -0.784 . . . . 0.27 109.782 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.481 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -158.71 -178.1 7.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.093 -1.005 . . . . 0.68 109.357 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.9 OUTLIER -166.36 156.07 11.75 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.044 -1.035 . . . . 0.62 110.191 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.4 149.63 28.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.105 -0.997 . . . . 0.47 109.833 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.2 mt -138.1 121.08 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.068 -1.02 . . . . 0.84 109.794 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.27 140.82 30.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.995 -1.065 . . . . 0.91 108.923 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 55.1 p -125.02 171.81 9.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.134 -0.979 . . . . 2.75 109.873 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 61.55 29.5 18.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -0.811 . . . . 2.56 109.513 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -98.93 162.85 20.27 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.728 -1.349 . . . . 0.41 109.728 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 11.2 mtmt -151.2 134.19 15.86 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.465 -1.021 . . . . 0.68 108.308 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.897 ' CD1' HG21 ' A' ' 104' ' ' VAL . 55.9 mt -99.22 141.5 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.692 -1.255 . . . . 0.73 110.218 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.531 ' HG2' ' HE3' ' A' ' 100' ' ' LYS . 12.4 mtm180 -132.5 177.2 7.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.535 -0.728 . . . . 2.13 109.299 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.049 -0.977 . . . . 2.4 109.457 179.572 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.549 ' CA ' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.514 0.673 . . . . 2.72 110.031 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.18 163.95 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.489 -0.757 . . . . 1.86 109.096 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -71.74 119.02 15.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.103 -0.998 . . . . 2.15 109.546 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.09 173.34 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.382 -0.824 . . . . 1.47 109.156 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.32 108.56 13.38 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.262 -0.899 . . . . 5.63 109.616 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -77.41 118.88 20.3 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.213 -0.929 . . . . 2.6 108.81 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.1 p -98.65 13.54 31.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.004 -1.06 . . . . 1.01 110.107 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 12' ' ' GLU . . . -93.65 -72.99 0.58 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.946 -1.096 . . . . 0.84 109.425 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 10' ' ' ASN . 19.8 t-20 172.5 63.48 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.762 -1.199 . . . . 5.0 107.762 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 11' ' ' ASN . 47.1 t-20 60.45 18.4 8.16 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.861 -1.163 . . . . 1.86 107.861 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -57.79 -81.67 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.728 -0.607 . . . . 3.59 109.57 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.605 HD13 ' HB1' ' A' ' 39' ' ' ALA . 0.9 OUTLIER -56.43 125.73 12.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.32 -0.952 . . . . 0.49 109.423 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.612 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 1.2 mmtt -75.57 -24.89 56.68 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.369 -0.832 . . . . 0.85 108.866 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.89 ' HD3' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER 167.88 126.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.372 -0.973 . . . . 2.59 108.372 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.958 HG23 ' CB ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -105.26 125.14 60.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.092 -1.077 . . . . 0.5 108.092 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.549 ' HG2' ' CA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -111.84 150.22 30.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.962 -1.086 . . . . 1.07 110.811 -177.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 19' ' ' ASP . 46.6 t -109.48 163.52 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.3 -1.0 . . . . 0.81 108.3 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.515 ' N ' HG12 ' A' ' 18' ' ' VAL . 4.7 t0 -86.49 64.12 8.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.07 -1.018 . . . . 1.44 109.713 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 21' ' ' CYS . . . 163.02 -95.71 0.13 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.881 -1.288 . . . . 2.56 109.881 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.414 ' C ' ' O ' ' A' ' 20' ' ' GLY . 93.5 m -42.39 155.11 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.339 -1.095 . . . . 1.52 109.974 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.585 ' CG ' ' O ' ' A' ' 22' ' ' HIS . 13.9 p-80 -162.87 107.66 1.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.324 -0.86 . . . . 4.19 110.103 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.59 -148.45 16.69 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.912 -1.275 . . . . 3.03 109.912 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.0 t -87.4 21.82 2.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.338 -1.095 . . . . 2.02 109.729 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.59 157.29 80.08 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.13 -0.982 . . . . 2.33 109.313 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.8 158.84 31.47 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.743 2.295 . . . . 0.97 110.257 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.5 141.91 50.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 2.67 109.421 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.691 HG22 ' CD2' ' A' ' 30' ' ' HIS . 51.0 mm -113.0 113.31 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.061 -1.024 . . . . 0.81 109.065 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.522 HG12 ' CE1' ' A' ' 35' ' ' PHE . 32.5 mt -99.22 112.34 31.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.201 -0.937 . . . . 0.69 109.031 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.691 ' CD2' HG22 ' A' ' 28' ' ' ILE . 47.3 m170 -88.35 105.16 17.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.057 -1.09 . . . . 1.95 108.057 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.48 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 8.1 ptt180 -45.54 123.31 4.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.992 -1.068 . . . . 0.72 109.822 -178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.577 ' HA2' ' CD ' ' A' ' 96' ' ' LYS . . . 116.87 -11.85 15.13 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.058 -1.617 . . . . 0.17 109.058 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -103.87 149.97 37.73 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.355 -1.085 . . . . 1.35 108.754 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 36.5 Cg_endo -79.44 121.66 4.83 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 122.379 2.053 . . . . 0.38 110.718 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.522 ' CE1' HG12 ' A' ' 29' ' ' ILE . 2.3 t80 -97.12 120.86 38.25 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.445 -1.317 . . . . 1.01 107.445 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.663 ' C ' HD13 ' A' ' 37' ' ' LEU . 73.3 m -100.99 127.32 47.54 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.684 -1.26 . . . . 0.59 110.68 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.949 ' N ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -138.19 124.12 20.08 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.96 -0.755 . . . . 0.67 108.96 178.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -104.33 135.88 44.95 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.699 -1.223 . . . . 1.71 107.699 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.958 ' CB ' HG23 ' A' ' 16' ' ' VAL . . . -133.04 123.19 25.34 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.841 -1.143 . . . . 0.1 110.562 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.89 HD12 ' HD3' ' A' ' 15' ' ' LYS . 8.7 mt -88.39 137.21 32.53 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.56 -2.015 . . . . 0.23 105.56 177.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 110' ' ' LEU . 34.8 p90 -152.12 134.81 15.46 Favored 'General case' 0 C--N 1.288 -2.107 0 C-N-CA 118.171 -1.412 . . . . 0.22 110.168 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.8 OUTLIER -82.72 107.81 15.63 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.446 -0.946 . . . . 0.66 108.446 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -45.67 114.36 0.75 Allowed 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.136 -0.69 . . . . 0.36 109.136 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 44' ' ' ASN . 1.3 p30 -84.24 10.6 9.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.056 -1.027 . . . . 0.76 109.23 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.578 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 8.4 pt20 -166.53 145.02 5.43 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.312 -0.868 . . . . 0.83 109.253 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 9.4 p30 -83.93 110.04 18.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.76 109.12 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.614 HG21 HD11 ' A' ' 117' ' ' LEU . 1.5 t -126.7 151.15 48.51 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.189 -0.944 . . . . 0.32 109.795 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.783 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 1.1 mmmt -86.39 -20.61 27.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.332 -0.855 . . . . 0.39 109.156 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 p -132.29 138.91 48.02 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.109 0.957 . . . . 0.25 110.137 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -139.34 148.12 42.48 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.675 -1.232 . . . . 0.59 107.675 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HD2' ' HA ' ' A' ' 70' ' ' THR . 1.0 OUTLIER -141.12 142.31 34.11 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.251 -0.906 . . . . 2.02 110.339 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.669 ' HA ' HD23 ' A' ' 110' ' ' LEU . 5.3 tt -91.84 149.47 4.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 107.622 -1.251 . . . . 0.6 107.622 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.442 ' OE2' ' N ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -145.01 117.24 8.41 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.598 -0.89 . . . . 4.84 108.598 -177.477 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.772 HD12 HD13 ' A' ' 68' ' ' ILE . 3.4 mp -109.67 134.95 50.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.806 -1.184 . . . . 0.6 110.596 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -125.17 131.65 53.18 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.161 -0.962 . . . . 1.87 108.952 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.25 146.96 34.75 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.71 -1.244 . . . . 0.82 111.4 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.423 ' O ' HD23 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -107.24 150.86 26.18 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.033 -1.099 . . . . 0.72 108.033 178.736 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 63' ' ' ILE . 44.4 mt -120.69 61.33 0.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.864 -1.148 . . . . 0.69 110.486 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 58' ' ' LEU . 5.7 t0 41.71 26.72 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.593 -0.692 . . . . 1.1 110.081 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 158.24 -49.35 0.42 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.597 -1.401 . . . . 0.34 109.597 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.491 ' HG ' HD12 ' A' ' 58' ' ' LEU . 8.2 tp -97.93 113.03 24.76 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.394 -1.062 . . . . 0.78 108.873 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -93.08 123.25 36.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.14 -0.975 . . . . 5.47 109.636 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.65 HD12 HD11 ' A' ' 58' ' ' LEU . 12.8 mt -118.15 169.36 8.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 122.15 0.976 . . . . 0.54 109.348 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.611 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 18.9 m-20 -108.52 134.56 51.13 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.131 -1.433 . . . . 0.62 107.131 177.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.96 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -104.05 107.82 58.2 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.839 -1.163 . . . . 0.86 110.632 -178.44 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.3 Cg_endo -81.32 -154.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 123.151 2.567 . . . . 0.55 109.914 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.85 34.09 86.11 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.333 -1.507 . . . . 0.89 109.333 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.772 HD13 HD12 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -108.04 179.84 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.354 -1.086 . . . . 2.59 109.378 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.599 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -86.01 -1.1 57.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.92 -1.112 . . . . 3.15 109.318 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.573 ' HA ' ' HD2' ' A' ' 51' ' ' LYS . 29.3 p 30.19 36.36 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.678 0.752 . . . . 0.64 109.921 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 14.7 t-20 174.56 90.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.685 -1.228 . . . . 1.35 107.685 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.857 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -75.29 2.05 12.12 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.589 -0.694 . . . . 0.53 110.973 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.461 ' HA ' HG22 ' A' ' 76' ' ' VAL . 84.2 m -66.79 -9.42 36.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.015 -1.053 . . . . 2.67 109.229 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.14 -17.42 35.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.9 109.522 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 75' ' ' PHE . 2.8 m-85 -116.87 -12.01 10.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 0.82 109.111 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.88 HG23 HD21 ' A' ' 80' ' ' LEU . 1.7 m -120.99 165.73 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.362 -0.977 . . . . 0.48 108.362 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.634 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -90.0 98.87 12.02 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.921 -1.112 . . . . 2.31 110.864 -178.903 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.492 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 18.2 m -91.48 152.23 43.38 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.219 -0.926 . . . . 2.79 108.674 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.783 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.2 Cg_endo -70.13 139.26 54.62 Favored 'Cis proline' 0 C--N 1.312 -1.383 0 C-N-CA 124.117 -1.201 . . . . 0.4 112.332 0.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.88 HD21 HG23 ' A' ' 76' ' ' VAL . 13.1 mt -77.86 112.14 14.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.625 -1.62 . . . . 0.9 106.625 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 10.9 t -82.92 144.95 9.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 121.841 0.829 . . . . 0.62 110.946 -177.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.578 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 8.2 ttpt -68.53 117.42 10.26 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.703 0.763 . . . . 0.7 109.754 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 119.43 -11.08 11.41 Favored Glycine 0 C--N 1.296 -1.675 0 N-CA-C 109.514 -1.434 . . . . 0.24 109.514 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.527 ' HG3' ' N ' ' A' ' 85' ' ' GLN . 4.6 tp60 -107.8 157.02 18.5 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.144 -1.058 . . . . 0.55 108.144 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.527 ' N ' ' HG3' ' A' ' 84' ' ' GLN . 1.5 tt0 -109.93 144.29 38.65 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.049 -1.032 . . . . 1.44 108.438 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.634 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 38.6 m-85 -125.75 145.95 49.98 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.201 -0.937 . . . . 0.35 110.033 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.569 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -111.45 113.62 26.18 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.759 -0.83 . . . . 1.71 108.759 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.857 HD12 ' HB1' ' A' ' 72' ' ' ALA . 2.3 tt -109.87 117.36 54.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.058 -1.026 . . . . 0.38 111.199 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -94.35 114.91 27.04 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.624 -2.362 . . . . 1.34 104.624 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 27.8 t80 -126.09 139.64 53.22 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.113 -1.435 . . . . 0.56 113.366 -175.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.496 ' O ' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -93.08 131.67 37.9 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 105.119 -2.178 . . . . 0.64 105.119 175.735 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.96 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 29.9 t90 -109.92 96.81 6.48 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 121.351 -0.843 . . . . 0.77 109.826 -176.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -68.32 104.49 1.87 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.347 0.594 . . . . 2.43 109.868 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.642 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 30.0 t -61.55 143.83 93.11 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.324 -0.991 . . . . 1.64 108.324 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.723 ' HD3' HG12 ' A' ' 65' ' ' VAL . 23.4 Cg_endo -64.55 -6.33 11.87 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.377 2.052 . . . . 3.97 112.182 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.577 ' CD ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER 67.98 -4.13 1.08 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.998 -1.064 . . . . 1.48 110.425 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.528 ' O ' ' C ' ' A' ' 98' ' ' ALA . 16.2 pt -94.49 -26.52 4.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 O-C-N 120.789 -1.195 . . . . 0.55 107.948 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -30.59 118.49 0.34 Allowed Pre-proline 0 N--CA 1.488 1.47 0 CA-C-N 115.813 -0.63 . . . . 0.5 109.376 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.617 ' HG2' HD13 ' A' ' 58' ' ' LEU . 35.8 Cg_endo -82.99 131.46 5.98 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.689 2.259 . . . . 0.54 108.473 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.609 ' CG ' ' HA ' ' A' ' 128' ' ' ARG . 1.6 ttpt -48.33 91.03 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.334 -0.946 . . . . 1.4 108.952 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 99' ' ' PRO . 1.2 t -94.16 116.91 29.38 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.842 -0.799 . . . . 0.37 108.842 -179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 101' ' ' SER . 5.4 pt-20 -35.03 -47.5 0.37 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.805 -0.559 . . . . 1.42 110.54 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -129.06 140.46 51.59 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.192 -0.942 . . . . 1.45 109.154 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.988 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.9 OUTLIER -131.75 143.58 39.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.358 -0.839 . . . . 1.0 109.831 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.873 HG13 ' O ' ' A' ' 122' ' ' ALA . 11.8 t -124.6 117.1 49.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.791 -1.559 . . . . 0.9 106.791 178.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.15 141.68 14.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 C-N-CA 119.466 -0.893 . . . . 0.46 110.594 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.607 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 51.7 m -116.15 138.27 51.41 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.387 -0.968 . . . . 1.02 108.387 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER -119.63 127.49 75.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 106.738 -1.579 . . . . 0.38 106.738 178.762 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.625 ' HD2' HD11 ' A' ' 111' ' ' ILE . 3.9 ttmt -140.14 129.1 23.43 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.1 -1.44 . . . . 2.41 111.693 -177.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.669 HD23 ' HA ' ' A' ' 52' ' ' ILE . 6.5 mt -103.17 138.7 39.63 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.98 -1.489 . . . . 0.39 106.98 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.625 HD11 ' HD2' ' A' ' 109' ' ' LYS . 4.5 mp -133.25 115.87 24.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.967 -1.083 . . . . 0.38 109.731 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.469 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -87.87 -133.7 4.25 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.082 -1.607 . . . . 0.28 109.082 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -110.53 -2.36 16.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -1.146 . . . . 2.91 109.709 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.46 -0.09 12.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.073 -1.017 . . . . 1.86 110.257 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 151.37 -157.31 27.14 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.916 -1.274 . . . . 0.33 109.916 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 118' ' ' ALA . 21.3 t -86.48 110.54 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -1.14 . . . . 0.86 109.626 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.614 HD11 HG21 ' A' ' 47' ' ' THR . 20.2 mt -58.03 -39.35 78.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.439 -0.788 . . . . 0.38 110.735 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.583 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -150.43 177.2 10.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.721 -1.237 . . . . 0.64 109.534 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -170.04 148.07 3.35 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.875 -1.141 . . . . 0.63 109.588 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -151.76 149.66 29.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.014 -1.054 . . . . 0.51 109.743 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 85.0 mt -136.71 119.86 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.099 -1.001 . . . . 0.63 109.39 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.873 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -88.36 150.88 22.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.857 -1.152 . . . . 0.55 109.934 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.3 t -111.61 3.95 18.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.23 -0.919 . . . . 2.76 110.424 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.46 173.81 11.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.889 -1.132 . . . . 8.08 109.561 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 129.21 155.05 8.4 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.748 -1.215 . . . . 1.09 110.369 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 6.0 mtmp? -152.08 141.14 21.23 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.146 -1.427 . . . . 2.79 107.146 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.988 ' CD1' HG21 ' A' ' 104' ' ' VAL . 81.6 mt -104.35 140.75 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.429 -1.42 . . . . 0.58 111.147 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.609 ' HA ' ' CG ' ' A' ' 100' ' ' LYS . 4.4 mtt85 -127.85 174.82 8.83 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.274 -1.01 . . . . 3.14 108.274 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 120.967 -1.083 . . . . 0.97 109.527 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.258 0.551 . . . . 1.96 109.525 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -77.64 152.72 33.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 1.75 109.39 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.546 ' HA ' ' CA ' ' A' ' 23' ' ' GLY . 1.3 m -106.29 165.48 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.98 109.609 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -87.1 119.19 27.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 1.59 109.509 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 m -150.88 157.04 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.73 109.224 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.04 108.57 14.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 3.47 109.383 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.418 ' CG ' ' HB ' ' A' ' 13' ' ' ILE . 2.3 m-20 -52.49 114.76 1.48 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.27 -0.894 . . . . 2.35 109.354 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -85.32 9.55 15.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.76 109.326 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.604 ' O ' ' ND2' ' A' ' 10' ' ' ASN . . . -90.55 -69.93 0.7 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.905 . . . . 0.61 109.702 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 9' ' ' ALA . 0.4 OUTLIER 171.74 57.67 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.461 -0.775 . . . . 2.4 109.252 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 64.83 13.66 8.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.126 -0.984 . . . . 2.2 108.924 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' O ' ' CE ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -63.17 -67.1 0.45 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.366 -0.834 . . . . 1.71 109.771 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -56.78 130.28 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.41 109.478 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 8.8 mmpt? -88.12 -13.95 40.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.325 -0.86 . . . . 1.13 109.454 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.2 ttpt 161.86 128.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 1.69 109.585 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.741 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -116.85 127.01 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.38 -0.825 . . . . 0.68 108.958 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.536 ' CB ' ' HA ' ' A' ' 2' ' ' GLN . 0.2 OUTLIER -122.53 156.67 33.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.059 -1.025 . . . . 0.91 110.191 -179.362 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.091 HG11 ' CE2' ' A' ' 35' ' ' PHE . 52.8 t -127.63 148.54 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.55 109.176 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.66 75.54 7.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 2.32 109.424 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.75 -69.75 0.14 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.89 -1.284 . . . . 1.23 109.89 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.7 t -67.88 168.1 12.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -1.191 . . . . 1.67 109.841 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -107.22 -9.3 16.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 3.26 109.68 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.546 ' CA ' ' HA ' ' A' ' 3' ' ' VAL . . . 103.37 -104.21 2.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.008 -1.237 . . . . 1.82 110.008 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' GLY . 9.3 t -41.71 -39.66 1.75 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.421 -1.047 . . . . 1.75 109.683 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.503 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -68.52 173.18 3.63 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 1.75 109.258 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 35.4 Cg_endo -77.67 152.62 29.47 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.715 2.277 . . . . 1.03 110.333 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.4 m -116.42 130.02 56.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 1.23 109.382 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.51 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 36.8 mm -106.06 102.57 14.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.072 -1.018 . . . . 0.56 108.81 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 mp -88.7 118.23 33.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.163 -0.961 . . . . 0.48 109.141 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.441 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 6.1 m80 -89.04 102.53 15.18 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.351 -0.843 . . . . 1.04 109.044 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 5.2 ptt180 -43.1 138.89 1.98 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.873 . . . . 1.36 110.064 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' CA ' ' HD2' ' A' ' 96' ' ' LYS . . . 97.61 -14.63 62.97 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.084 -1.206 . . . . 0.51 110.084 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.581 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -103.14 150.96 38.39 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.247 . . . . 1.72 109.812 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 36.5 Cg_endo -79.94 113.56 3.02 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.902 2.401 . . . . 0.46 111.138 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 1.091 ' CE2' HG11 ' A' ' 18' ' ' VAL . 5.8 t80 -99.4 122.1 42.04 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.428 -1.323 . . . . 0.63 107.428 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 1.015 ' C ' HD13 ' A' ' 37' ' ' LEU . 71.7 m -102.76 138.79 39.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.857 -1.152 . . . . 0.61 111.075 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.015 HD13 ' C ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -140.21 128.51 22.53 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.086 -0.709 . . . . 2.02 109.086 178.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.525 ' HG3' ' HA ' ' A' ' 89' ' ' LYS . 2.4 tt0 -104.97 126.26 51.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.835 -1.166 . . . . 1.34 108.076 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.741 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -124.72 122.8 38.51 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.733 -1.23 . . . . 0.32 110.668 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 7.9 mt -89.59 144.01 26.35 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.5 -1.667 . . . . 0.51 106.5 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.637 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 32.7 p90 -159.87 138.4 10.49 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.702 -1.249 . . . . 0.22 109.877 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.6 m-20 -85.05 113.59 21.58 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.346 -0.942 . . . . 1.15 108.698 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -44.71 113.28 0.53 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.046 -0.724 . . . . 0.21 109.046 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.55 ' ND2' ' OE1' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -81.62 7.75 11.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.237 -0.914 . . . . 1.12 109.554 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.55 ' OE1' ' ND2' ' A' ' 44' ' ' ASN . 1.1 pt20 -170.5 163.88 8.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.213 -0.929 . . . . 0.75 109.835 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 8.9 p30 -92.38 121.77 34.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 1.75 109.309 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.484 HG21 ' HA3' ' A' ' 112' ' ' GLY . 2.5 t -141.83 156.33 45.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.177 -0.952 . . . . 0.37 109.78 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.691 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -95.68 -14.5 23.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -0.847 . . . . 1.91 109.499 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.408 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 6.1 p -141.3 137.88 32.77 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.947 0.879 . . . . 0.74 109.862 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -129.62 152.69 48.87 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.482 -0.932 . . . . 0.41 108.482 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.552 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 1.3 mtmt -133.93 140.36 46.73 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.048 -1.061 . . . . 0.75 110.505 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.699 ' HA ' HD23 ' A' ' 110' ' ' LEU . 3.1 tt -94.39 149.01 4.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.617 -1.253 . . . . 0.54 107.617 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -137.24 115.06 11.37 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.216 -0.927 . . . . 1.48 109.758 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.841 HD12 ' N ' ' A' ' 54' ' ' ILE . 2.1 mp -113.99 117.79 56.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 120.971 -1.081 . . . . 0.36 108.948 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.471 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 21.0 mttt -119.71 131.16 55.33 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.18 -0.95 . . . . 1.25 109.396 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.62 133.37 52.16 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.173 -0.954 . . . . 0.53 110.424 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -98.49 151.32 20.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 1.64 109.085 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.815 HD11 HD12 ' A' ' 63' ' ' ILE . 34.3 mt -109.2 49.16 0.83 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.091 -1.005 . . . . 0.9 109.86 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 58' ' ' LEU . 20.7 t0 44.4 26.64 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.897 . . . . 1.46 109.305 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.91 -55.16 0.17 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.319 -1.513 . . . . 0.95 109.319 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 62' ' ' GLU . 1.2 tp -102.99 113.94 27.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -1.133 . . . . 2.07 109.141 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.58 ' N ' HD12 ' A' ' 61' ' ' LEU . 37.0 tt0 -81.62 133.6 35.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.955 . . . . 2.45 109.398 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.815 HD12 HD11 ' A' ' 58' ' ' LEU . 40.8 mt -126.66 168.69 19.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.008 0.908 . . . . 1.59 109.215 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.594 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 63.3 m-20 -111.87 141.85 44.98 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.732 -1.21 . . . . 1.85 107.732 178.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.056 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 6.2 t -108.32 105.39 56.55 Favored Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 121.03 -1.044 . . . . 0.45 110.472 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 37.3 Cg_endo -82.56 -156.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.475 2.784 . . . . 0.44 110.189 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.37 17.58 47.34 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.576 -1.41 . . . . 0.86 109.576 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.704 HG21 HD13 ' A' ' 54' ' ' ILE . 50.1 pt -104.67 -167.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -1.138 . . . . 0.62 109.432 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.598 ' O ' HG22 ' A' ' 52' ' ' ILE . 24.3 t0 -98.8 109.75 22.46 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.362 -0.836 . . . . 0.97 109.382 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.552 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 1.2 p -86.74 47.47 1.49 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.283 -0.886 . . . . 0.45 108.83 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 54.5 t-20 177.75 81.86 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.858 -1.164 . . . . 1.23 107.858 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.691 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -65.93 -5.57 9.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.572 -0.705 . . . . 0.32 111.822 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.574 ' HA ' HG22 ' A' ' 76' ' ' VAL . 1.3 t -64.39 -12.13 39.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.587 -1.321 . . . . 1.18 109.058 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.81 -23.19 55.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.051 -1.031 . . . . 1.09 109.845 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.436 ' HB2' HG13 ' A' ' 88' ' ' ILE . 79.4 m-85 -110.27 -24.49 10.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.52 109.098 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.762 ' CG2' HD21 ' A' ' 80' ' ' LEU . 1.2 m -107.66 162.6 5.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.122 -1.066 . . . . 0.35 108.122 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.633 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -88.54 93.82 9.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.931 -1.106 . . . . 2.17 111.222 -178.357 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.484 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 14.3 p -88.92 153.91 49.67 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 107.544 -1.28 . . . . 0.89 107.544 177.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.691 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 26.3 Cg_endo -69.92 134.8 31.22 Favored 'Cis proline' 0 C--N 1.311 -1.396 0 C-N-CA 124.206 -1.164 . . . . 0.32 112.346 2.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.843 HD23 ' CE2' ' A' ' 86' ' ' TYR . 7.3 mt -76.13 116.97 17.35 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.263 -1.384 . . . . 0.6 107.263 178.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.7 t -89.06 136.94 22.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 121.736 0.779 . . . . 0.43 110.543 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 2.6 ttmt -58.15 118.62 5.66 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.73 0.776 . . . . 1.45 110.269 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.51 -15.11 13.01 Favored Glycine 0 N--CA 1.479 1.549 0 C-N-CA 119.723 -1.227 . . . . 0.31 110.355 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.607 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 4.9 tp60 -102.43 156.68 17.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.042 -1.269 . . . . 1.05 108.044 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -109.26 149.28 29.66 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.107 -0.995 . . . . 1.1 108.502 179.29 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.843 ' CE2' HD23 ' A' ' 80' ' ' LEU . 32.4 m-85 -131.5 149.64 52.45 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.289 -0.882 . . . . 0.4 110.001 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.533 ' HB3' HD23 ' A' ' 40' ' ' LEU . 3.3 p30 -117.43 115.03 24.38 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.162 -1.051 . . . . 1.41 108.162 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.691 HD12 ' HB1' ' A' ' 72' ' ' ALA . 3.8 tt -106.62 120.74 58.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.121 -0.987 . . . . 0.26 111.153 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.525 ' HA ' ' HG3' ' A' ' 38' ' ' GLU . 69.0 tttt -103.09 101.55 11.53 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.099 -2.186 . . . . 2.39 105.099 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.596 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 20.0 t80 -118.45 140.16 50.29 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.19 -0.944 . . . . 0.44 111.535 -176.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.76 107.71 19.4 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.489 -1.3 . . . . 0.76 107.489 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.056 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 28.8 t90 -85.09 93.94 8.73 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.408 0.623 . . . . 0.59 109.628 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -61.51 108.85 1.03 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.395 -0.815 . . . . 1.85 109.6 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 33' ' ' LYS . 21.6 t -64.41 140.42 97.96 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.371 -0.831 . . . . 0.99 108.792 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.862 ' HG3' HG13 ' A' ' 65' ' ' VAL . 34.3 Cg_endo -74.98 140.19 25.21 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.206 1.937 . . . . 2.22 110.167 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.511 ' HD2' ' CA ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -77.48 4.54 10.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.323 -0.861 . . . . 2.59 109.724 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.497 HG12 ' HB2' ' A' ' 95' ' ' PRO . 9.2 pt -92.93 -28.0 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.043 -1.036 . . . . 0.55 109.649 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.574 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . . . -39.57 115.72 1.05 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 109.174 -0.676 . . . . 0.51 109.174 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 101' ' ' SER . 36.6 Cg_endo -83.02 139.54 9.62 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.753 2.302 . . . . 0.63 109.461 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.475 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 1.7 mtmt -50.36 90.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.498 -0.927 . . . . 2.91 108.498 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.721 ' HB3' HG23 ' A' ' 104' ' ' VAL . 2.0 t -96.24 120.47 36.59 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.47 -0.769 . . . . 0.8 109.244 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' A' ' 103' ' ' ASN . 11.8 pt-20 -41.02 -47.49 3.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.507 -0.746 . . . . 1.91 109.657 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.523 ' N ' ' CG ' ' A' ' 102' ' ' GLU . 0.8 OUTLIER -131.57 134.15 45.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 1.89 109.72 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 1.122 HG21 ' CD1' ' A' ' 127' ' ' ILE . 2.5 t -129.68 150.55 34.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.387 -0.821 . . . . 0.63 109.14 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.769 HG13 ' O ' ' A' ' 122' ' ' ALA . 74.2 t -126.62 119.03 52.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.409 -0.96 . . . . 0.63 108.409 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.56 138.93 20.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.093 -1.004 . . . . 0.38 109.617 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 32.9 m -120.39 115.68 23.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.392 -0.818 . . . . 0.37 109.831 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -95.92 127.39 48.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.62 -1.252 . . . . 0.36 107.62 178.558 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.733 ' HD2' HD11 ' A' ' 111' ' ' ILE . 1.4 ttmm -137.92 129.74 28.45 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.518 -1.364 . . . . 1.41 110.733 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.741 ' C ' HD12 ' A' ' 111' ' ' ILE . 14.0 mt -104.21 138.34 40.82 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.376 -1.342 . . . . 0.56 107.376 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.741 HD12 ' C ' ' A' ' 110' ' ' LEU . 4.1 mp -133.7 116.94 25.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.149 -0.97 . . . . 0.29 109.852 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.484 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -89.67 -126.34 2.98 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.112 -1.595 . . . . 0.54 109.112 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.17 -1.89 11.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -1.172 . . . . 1.32 109.565 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -115.22 -3.56 12.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 2.72 109.867 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 151.55 -148.8 20.26 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.756 -1.338 . . . . 0.34 109.756 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.593 ' CG1' ' CD ' ' A' ' 109' ' ' LYS . 2.0 t -90.06 110.21 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -1.176 . . . . 0.49 109.851 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 110' ' ' LEU . 53.2 mt -53.74 -39.59 65.43 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.386 -0.821 . . . . 0.34 109.981 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.512 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -156.87 -165.05 1.76 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.784 -1.197 . . . . 0.46 109.442 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.517 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 50.3 t -174.98 156.13 2.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.035 -1.04 . . . . 0.56 109.72 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -154.11 142.11 20.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.914 . . . . 0.39 109.409 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.44 HD12 ' HB3' ' A' ' 8' ' ' CYS . 26.0 mt -134.1 118.89 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.75 109.178 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.769 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -94.1 142.75 27.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.103 -0.998 . . . . 0.66 109.49 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -86.99 0.34 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.886 . . . . 2.06 109.592 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -49.12 115.8 1.44 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 2.56 109.667 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -159.6 149.81 19.78 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.297 -1.521 . . . . 0.42 109.297 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 13.8 mttt -152.6 136.0 15.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.42 -1.047 . . . . 1.98 108.524 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 1.122 ' CD1' HG21 ' A' ' 104' ' ' VAL . 75.6 mt -106.87 141.17 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.633 -1.292 . . . . 0.4 110.095 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.51 ' HB2' ' CG2' ' A' ' 28' ' ' ILE . 19.3 mtt180 -131.18 177.31 7.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.562 -0.711 . . . . 2.6 109.151 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.0 t70 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.05 -0.976 . . . . 1.72 109.422 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.445 -0.576 . . . . 2.25 109.445 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.546 ' CB ' ' HG2' ' A' ' 17' ' ' MET . 2.6 pt20 -91.46 154.89 18.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.319 -0.863 . . . . 0.63 109.77 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.62 ' CG2' HG23 ' A' ' 18' ' ' VAL . 1.4 m -104.78 143.36 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.342 -0.849 . . . . 0.77 109.258 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -71.25 117.91 13.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.77 110.1 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 m -142.72 154.13 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.552 -0.907 . . . . 0.3 108.552 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.46 107.69 17.45 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.121 -0.987 . . . . 2.05 109.127 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 2.2 p30 -59.63 135.86 57.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 3.69 109.154 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.81 -7.45 14.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.128 -0.983 . . . . 1.09 109.192 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 10' ' ' ASN . . . -67.54 -63.83 0.98 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.69 109.666 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER 166.64 49.88 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.438 -0.789 . . . . 0.89 109.152 -178.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m120 64.32 28.58 13.78 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.217 -1.031 . . . . 4.14 108.217 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.473 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -77.07 -70.99 0.43 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.646 -0.659 . . . . 1.11 109.407 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -55.09 122.76 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.55 109.798 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -66.67 -28.0 68.11 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.359 -0.838 . . . . 1.91 108.947 179.594 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.569 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 12.6 pttt 165.8 135.01 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.837 -1.171 . . . . 0.94 107.837 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.9 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -111.94 119.17 59.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 O-C-N 121.257 -0.902 . . . . 0.54 108.701 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.546 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 1.1 mtm -108.64 157.13 18.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.857 . . . . 0.32 110.483 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.868 HG11 ' CE2' ' A' ' 35' ' ' PHE . 48.4 t -124.11 141.52 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.468 -0.938 . . . . 0.31 108.468 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -85.19 82.36 8.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.015 -1.053 . . . . 0.57 109.493 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.48 -72.59 0.23 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.995 -1.242 . . . . 0.45 109.995 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -51.99 164.67 0.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -1.16 . . . . 1.7 110.322 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.59 -3.54 20.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.485 -0.759 . . . . 1.67 109.4 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 3' ' ' VAL . . . 95.27 -122.24 7.16 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.251 -1.54 . . . . 0.58 109.251 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' GLY . 17.8 t -40.69 -40.87 1.4 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.471 -1.017 . . . . 0.93 109.438 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.58 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -51.05 179.86 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 1.41 108.917 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.58 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 32.7 Cg_endo -76.13 142.43 24.55 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.226 1.951 . . . . 1.59 110.343 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.96 119.71 38.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.96 109.715 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.413 HG23 ' HG3' ' A' ' 128' ' ' ARG . 29.3 mm -111.81 107.91 24.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.007 -1.058 . . . . 0.57 108.991 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 mt -94.37 118.77 41.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.268 -0.895 . . . . 0.66 109.411 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.486 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 14.5 m-70 -91.19 114.92 27.58 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.124 -1.065 . . . . 0.98 108.124 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.529 ' HA ' HG11 ' A' ' 94' ' ' VAL . 12.1 ptt180 -57.36 158.64 5.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.838 -1.164 . . . . 1.14 109.924 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.505 ' HA2' ' CD ' ' A' ' 96' ' ' LYS . . . 87.86 -19.39 34.04 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.479 -1.449 . . . . 0.46 109.479 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.584 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -100.7 152.53 37.87 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.198 -1.178 . . . . 1.09 110.163 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.36 120.46 3.64 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.845 2.363 . . . . 0.46 110.785 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.868 ' CE2' HG11 ' A' ' 18' ' ' VAL . 4.3 t80 -96.76 121.31 38.47 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.868 -1.16 . . . . 0.42 107.868 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.906 ' C ' HD13 ' A' ' 37' ' ' LEU . 2.6 m -100.76 134.65 43.42 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.064 -1.022 . . . . 0.93 110.587 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.965 ' N ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -144.71 124.74 13.57 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.253 -1.017 . . . . 0.68 108.253 178.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.44 133.41 48.53 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.371 -0.974 . . . . 1.93 108.371 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.9 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -130.2 119.74 23.41 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.056 -1.058 . . . . 0.32 110.6 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.603 HD23 ' CB ' ' A' ' 87' ' ' ASP . 12.9 mt -89.71 141.57 28.49 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.154 -2.165 . . . . 0.7 105.154 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 110' ' ' LEU . 28.7 p90 -156.78 137.32 13.11 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.341 -1.343 . . . . 0.29 110.037 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.7 OUTLIER -82.45 112.43 19.38 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.327 -0.949 . . . . 0.52 108.584 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.873 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -44.46 115.54 0.87 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.564 -0.532 . . . . 0.13 109.564 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.568 ' C ' ' ND2' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -80.42 5.77 14.1 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.269 -0.894 . . . . 0.09 109.113 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.552 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 1.3 pt20 -169.5 170.33 8.32 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.34 -0.85 . . . . 0.53 109.357 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -101.18 121.07 41.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.87 108.927 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.575 HG21 HD11 ' A' ' 117' ' ' LEU . 1.2 t -137.88 146.08 42.93 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.234 -0.916 . . . . 0.27 109.867 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.68 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 10.0 mmmt -86.18 -12.76 48.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.416 -0.802 . . . . 0.44 109.578 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.6 p -141.92 149.65 40.44 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.831 -0.748 . . . . 0.44 109.418 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -145.07 156.64 44.04 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.247 -0.908 . . . . 0.37 109.55 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.561 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 0.9 OUTLIER -136.79 140.03 42.22 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.189 -0.944 . . . . 0.27 110.475 -179.313 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 69' ' ' ASP . 3.5 tt -92.94 153.04 3.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.177 -1.416 . . . . 0.74 107.177 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' CB ' ' HB3' ' A' ' 109' ' ' LYS . 2.4 tt0 -139.91 117.34 11.39 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.925 -1.109 . . . . 0.16 110.039 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.6 HD12 HD12 ' A' ' 68' ' ' ILE . 3.2 mp -119.37 116.32 50.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.027 -1.046 . . . . 0.2 109.458 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.701 ' HA ' HG23 ' A' ' 65' ' ' VAL . 2.6 mtmp? -115.98 157.37 24.7 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.197 -0.939 . . . . 1.91 108.712 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -134.22 123.7 24.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.819 -1.175 . . . . 0.35 110.305 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -93.63 150.04 20.74 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.852 -0.796 . . . . 0.69 108.852 179.181 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.563 HD11 ' CD1' ' A' ' 63' ' ' ILE . 15.4 mt -106.72 45.0 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.25 109.704 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.59 17.89 3.31 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.392 -0.818 . . . . 0.82 109.413 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.84 -45.6 0.07 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.806 -1.318 . . . . 0.35 109.806 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.423 ' HG ' HG13 ' A' ' 63' ' ' ILE . 5.1 tp -109.3 112.33 24.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.173 -1.192 . . . . 0.52 109.548 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -77.17 125.39 29.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.992 -1.068 . . . . 1.38 108.95 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.626 HG22 ' N ' ' A' ' 64' ' ' ASP . 43.8 mt -117.2 167.31 10.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 122.117 0.961 . . . . 0.42 109.812 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.626 ' N ' HG22 ' A' ' 63' ' ' ILE . 7.5 t70 -112.4 136.67 51.6 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.061 -1.829 . . . . 4.2 106.061 176.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.082 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 1.5 t -101.72 110.16 61.27 Favored Pre-proline 0 C--N 1.293 -1.868 0 C-N-CA 118.866 -1.134 . . . . 0.55 111.039 -177.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.5 Cg_endo -81.72 -163.18 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.98 2.453 . . . . 0.65 109.766 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.63 50.75 62.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.959 -1.256 . . . . 1.18 109.959 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.6 HD12 HD12 ' A' ' 54' ' ' ILE . 13.4 pt -139.88 -156.82 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -1.103 . . . . 0.66 109.035 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.649 ' O ' HG22 ' A' ' 52' ' ' ILE . 29.6 t70 -110.05 106.39 15.87 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.441 -0.787 . . . . 0.72 109.753 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.561 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -87.12 48.19 1.61 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.19 -0.944 . . . . 0.41 108.562 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 7.2 t30 178.41 79.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.462 -1.31 . . . . 2.22 107.462 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.44 -4.05 1.7 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.643 -0.661 . . . . 0.25 111.902 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.483 ' HA ' HG22 ' A' ' 76' ' ' VAL . 91.6 m -64.53 -10.58 26.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.539 -1.351 . . . . 3.01 109.481 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.71 -20.72 45.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.57 109.552 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CE2' ' CD1' ' A' ' 90' ' ' TYR . 79.4 m-85 -112.19 -20.88 11.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.275 -0.89 . . . . 0.35 109.289 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.802 ' CG2' HD21 ' A' ' 80' ' ' LEU . 2.1 m -112.35 166.25 6.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.616 -0.883 . . . . 0.34 108.616 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.662 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -91.9 94.8 9.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.001 -1.062 . . . . 1.54 111.305 -178.452 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.458 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 51.6 m -84.99 148.93 52.0 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 107.899 -1.149 . . . . 2.9 107.899 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.68 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 25.7 Cg_endo -71.1 136.01 39.43 Favored 'Cis proline' 0 C--N 1.312 -1.367 0 C-N-CA 124.207 -1.164 . . . . 0.16 112.664 1.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.802 HD21 ' CG2' ' A' ' 76' ' ' VAL . 16.5 mt -71.7 146.74 48.01 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.333 -2.099 . . . . 0.72 105.333 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.873 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 59.4 t -117.22 142.09 32.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 O-C-N 120.337 -1.477 . . . . 0.89 111.17 -177.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 6.2 ttmt -65.34 105.86 1.23 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.59 0.709 . . . . 0.56 109.905 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 122.72 -19.36 7.94 Favored Glycine 0 N--CA 1.48 1.583 0 C-N-CA 119.638 -1.268 . . . . 0.23 110.066 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.575 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 7.9 tp60 -95.41 159.48 14.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.075 -1.25 . . . . 0.44 107.804 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -110.49 148.43 32.09 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.878 -1.129 . . . . 0.46 108.371 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.725 ' CE2' HD23 ' A' ' 80' ' ' LEU . 28.6 m-85 -128.43 148.76 50.73 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.32 -0.863 . . . . 0.31 109.908 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.603 ' CB ' HD23 ' A' ' 40' ' ' LEU . 10.7 p-10 -118.69 113.93 21.94 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.605 -0.887 . . . . 0.98 108.605 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.612 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 2.4 tt -108.91 119.16 57.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.272 -0.893 . . . . 0.19 111.139 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -99.72 107.68 19.82 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 104.649 -2.352 . . . . 3.75 104.649 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.614 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 24.5 t80 -124.12 141.98 51.6 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.577 -1.249 . . . . 0.39 113.076 -175.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.586 ' O ' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.29 145.25 24.81 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 106.262 -1.755 . . . . 0.99 106.262 176.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.082 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 26.9 t90 -124.71 82.8 2.08 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.797 -1.19 . . . . 0.64 109.867 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -60.71 106.07 0.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.525 -0.734 . . . . 1.35 109.442 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.648 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 22.1 t -55.99 144.72 57.35 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.157 -1.053 . . . . 1.22 108.157 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.648 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 24.0 Cg_endo -64.36 -7.48 14.22 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.211 1.941 . . . . 3.7 112.192 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.505 ' CD ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER 75.38 -10.74 1.19 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.154 -0.966 . . . . 1.78 109.88 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.513 ' O ' ' C ' ' A' ' 98' ' ' ALA . 19.9 pt -91.11 -28.42 4.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 108.1 -1.074 . . . . 0.5 108.1 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.549 ' HB1' HD13 ' A' ' 127' ' ' ILE . . . -37.3 113.65 0.65 Allowed Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 107.926 -1.138 . . . . 0.65 107.926 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.3 177.83 8.3 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 122.769 2.313 . . . . 1.32 110.459 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 4.5 mtmt -82.19 68.74 8.72 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.573 -1.269 . . . . 0.65 107.573 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.696 ' HB3' HG23 ' A' ' 104' ' ' VAL . 4.0 t -70.86 118.85 14.16 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.495 -0.753 . . . . 0.51 109.615 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 1.1 pt-20 -41.16 -47.36 3.25 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.671 -0.863 . . . . 1.99 108.671 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 3.5 t-20 -130.72 141.62 50.39 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.051 -0.722 . . . . 2.95 109.051 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 1.013 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.9 OUTLIER -131.93 142.65 42.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.101 -1.0 . . . . 0.56 109.467 179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 2.7 t -118.27 117.63 55.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.671 -1.233 . . . . 0.92 107.671 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 2.2 t -101.89 135.92 36.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 120.768 -1.207 . . . . 0.31 110.186 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 94.2 m -116.25 116.59 28.05 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.246 -0.909 . . . . 0.36 109.974 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -94.42 132.23 39.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 106.834 -1.543 . . . . 0.16 106.834 177.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.956 ' CD ' HD11 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -142.03 129.67 21.51 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.327 -1.483 . . . . 0.92 112.112 -177.618 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.694 ' C ' HD12 ' A' ' 111' ' ' ILE . 9.1 mt -103.31 137.97 40.71 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.552 -1.647 . . . . 0.26 106.552 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.956 HD11 ' CD ' ' A' ' 109' ' ' LYS . 4.2 mp -134.11 116.29 22.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.961 -1.087 . . . . 0.21 110.162 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.447 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -87.07 -135.62 4.48 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.943 -1.663 . . . . 0.25 108.943 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.65 -3.53 17.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -1.16 . . . . 0.83 109.403 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -112.85 -7.42 13.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 4.3 110.277 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 111' ' ' ILE . . . 156.97 -147.02 14.73 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.274 -1.441 . . . . 0.25 110.483 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.642 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 2.0 t -92.57 107.64 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.433 -1.039 . . . . 0.19 109.731 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 47' ' ' THR . 29.2 mt -56.02 -42.71 76.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.485 -0.759 . . . . 0.2 110.488 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.469 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -149.07 -177.01 5.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.909 -1.119 . . . . 0.4 109.247 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -170.68 150.24 3.29 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.184 -1.006 . . . . 0.62 109.913 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.401 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -150.81 146.82 26.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.219 -0.926 . . . . 0.22 109.626 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 52.4 mt -133.23 116.73 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.957 . . . . 0.27 108.936 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.03 142.35 27.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.074 -1.016 . . . . 0.21 109.31 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.0 p -102.7 -87.68 0.41 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.43 109.59 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -45.66 116.5 1.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 1.69 109.011 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -166.62 144.59 9.22 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.795 -1.322 . . . . 0.16 109.795 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 125' ' ' GLY . 1.8 mtmp? -150.55 135.75 17.79 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.075 -1.083 . . . . 1.84 108.075 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 1.013 ' CD1' HG21 ' A' ' 104' ' ' VAL . 82.3 mt -106.69 143.03 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.639 -1.288 . . . . 0.44 110.62 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.517 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 22.4 mtm180 -129.59 177.45 7.21 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.955 -0.757 . . . . 2.67 108.955 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.516 ' HB2' ' HD3' ' A' ' 100' ' ' LYS . 20.5 t70 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.987 -1.006 . . . . 0.8 109.636 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.142 0.496 . . . . 3.2 109.733 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.522 ' HG2' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -82.85 142.27 31.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 2.42 109.501 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.522 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 33.8 m -105.53 165.53 3.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.192 -0.942 . . . . 0.67 109.371 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -90.39 122.76 33.55 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.315 -0.866 . . . . 1.74 109.944 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 m -148.13 156.47 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.413 -0.804 . . . . 0.46 109.079 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -120.08 105.53 11.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.172 -0.955 . . . . 2.64 108.958 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' OD2' ' HB ' ' A' ' 13' ' ' ILE . 1.1 m-20 -54.99 141.13 35.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 2.3 109.788 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -112.66 -12.12 13.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.269 -0.894 . . . . 1.05 108.71 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.455 ' HB2' ' C ' ' A' ' 118' ' ' ALA . . . -60.38 -79.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.949 0.88 . . . . 0.17 109.581 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 59.7 t-20 -179.16 37.73 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.594 -0.891 . . . . 2.96 108.594 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 20.1 t-20 76.08 30.12 0.73 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.411 -0.959 . . . . 1.57 108.411 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.445 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 60.8 mm-40 -76.77 -62.34 1.67 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.491 -0.756 . . . . 1.33 109.903 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -61.63 121.73 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.931 -1.105 . . . . 0.66 109.94 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -66.9 -30.41 70.55 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.245 -1.02 . . . . 1.76 108.245 178.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 164.62 131.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.32 -0.622 . . . . 1.95 109.32 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.553 ' HB ' ' CB ' ' A' ' 39' ' ' ALA . 2.1 p -120.75 125.91 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.962 -1.086 . . . . 1.85 108.705 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.426 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -109.6 159.28 17.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.375 -0.828 . . . . 0.47 110.879 -178.55 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.018 HG22 ' HB3' ' A' ' 37' ' ' LEU . 92.5 t -120.8 147.65 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.947 -0.76 . . . . 0.29 108.947 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.48 57.89 0.94 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.244 -0.91 . . . . 3.22 109.46 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.41 27.71 0.07 OUTLIER Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.309 -1.424 . . . . 2.84 110.871 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 m -140.42 -167.26 2.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.864 -1.374 . . . . 1.94 109.812 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 25' ' ' ASP . 2.9 m80 -128.94 -8.9 4.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.994 . . . . 3.99 110.265 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 107.72 -132.76 11.29 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.728 -1.349 . . . . 1.57 109.728 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -42.54 -38.43 1.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -1.12 . . . . 1.0 109.662 -179.668 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -52.13 170.53 0.23 Allowed Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 121.254 -0.904 . . . . 1.42 108.693 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 25' ' ' ASP . 31.6 Cg_endo -75.48 153.59 39.63 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.413 2.075 . . . . 0.57 110.184 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.2 m -112.79 136.39 52.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.57 109.281 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.464 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 29.1 mm -111.35 107.7 23.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.049 -1.032 . . . . 0.49 109.216 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.431 ' HB ' HG12 ' A' ' 127' ' ' ILE . 2.4 mt -88.99 121.62 39.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.29 -0.881 . . . . 0.6 108.979 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 32.2 m-70 -84.87 133.91 34.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.464 -0.773 . . . . 1.02 109.971 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.563 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 6.0 mtm180 -57.6 140.09 51.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.533 -0.729 . . . . 1.89 110.409 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 94' ' ' VAL . . . 67.19 1.58 14.46 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.528 -0.844 . . . . 0.92 111.274 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -88.71 149.76 44.61 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 120.755 -1.438 . . . . 0.99 109.78 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.477 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 36.6 Cg_endo -81.12 113.74 2.75 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.971 2.447 . . . . 0.66 111.031 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.713 ' CE2' HG11 ' A' ' 18' ' ' VAL . 2.0 t80 -97.61 115.22 27.47 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.345 -1.354 . . . . 0.87 107.345 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.784 ' C ' HD13 ' A' ' 37' ' ' LEU . 29.9 m -107.72 129.2 55.05 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.974 -1.079 . . . . 0.71 111.168 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.018 ' HB3' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -143.63 126.26 15.99 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.903 -0.777 . . . . 1.31 108.903 179.045 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.534 ' O ' HG23 ' A' ' 16' ' ' VAL . 12.6 tt0 -94.64 134.44 37.22 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.016 -1.105 . . . . 1.55 108.016 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.553 ' CB ' ' HB ' ' A' ' 16' ' ' VAL . . . -129.5 126.06 37.76 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.868 -1.145 . . . . 0.59 110.48 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 87' ' ' ASP . 5.1 mt -93.92 144.84 25.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.467 -1.679 . . . . 0.77 106.467 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.62 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 33.1 p90 -161.69 139.28 8.85 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.757 -1.177 . . . . 0.39 109.517 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.2 m-20 -86.67 114.47 23.4 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.083 -1.047 . . . . 3.45 109.179 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.15 112.55 0.54 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.111 -0.7 . . . . 0.36 109.111 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.609 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -82.66 10.27 7.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.063 -1.023 . . . . 0.4 109.477 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.58 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 4.6 pt20 -167.23 147.28 5.38 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.418 -0.801 . . . . 0.4 109.052 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 2.8 p-10 -84.21 114.17 21.62 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.061 -1.024 . . . . 2.69 109.06 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.484 HG21 ' HA3' ' A' ' 112' ' ' GLY . 1.7 t -131.55 155.12 48.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.332 -0.855 . . . . 0.1 109.855 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.702 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 9.3 mmmt -92.16 -10.58 38.28 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.263 -0.898 . . . . 0.57 109.982 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.8 p -147.41 139.44 24.32 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.265 -0.897 . . . . 0.36 110.098 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -128.51 153.56 47.05 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.48 -0.762 . . . . 0.23 109.13 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -133.32 136.38 45.38 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.374 -0.931 . . . . 0.44 110.745 -178.882 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 69' ' ' ASP . 4.9 tt -90.26 151.95 3.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.363 -1.347 . . . . 0.2 107.363 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' LYS . 2.7 mt-10 -138.54 116.28 11.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.026 -1.046 . . . . 0.62 110.291 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.641 ' N ' HD12 ' A' ' 54' ' ' ILE . 3.3 mp -117.53 112.77 40.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.742 -1.223 . . . . 0.23 109.396 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 40.3 mtmt -111.75 152.4 27.85 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.034 -1.098 . . . . 2.17 108.034 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -122.59 156.35 34.43 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.209 -1.396 . . . . 0.93 110.737 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.0 OUTLIER -117.06 150.48 38.58 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.796 -0.816 . . . . 0.83 108.796 179.631 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 57' ' ' SER . 12.7 mt -115.92 43.49 2.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.946 -1.096 . . . . 0.42 109.267 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 57.3 t0 51.16 21.95 1.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 1.17 108.953 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.44 -53.96 0.17 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.976 -1.65 . . . . 0.16 108.976 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 mp -102.67 116.1 31.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.346 -1.09 . . . . 4.36 108.945 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.7 mt-10 -91.76 120.78 32.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.035 -1.041 . . . . 3.31 109.519 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.594 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 49.2 mt -104.83 169.58 2.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 122.135 0.969 . . . . 0.41 110.011 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.594 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 43.4 m-20 -109.4 138.33 45.92 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.583 -1.636 . . . . 0.66 106.583 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.984 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 1.6 t -106.68 107.4 60.16 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.791 -1.193 . . . . 0.39 111.406 -177.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.7 Cg_endo -82.83 -158.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 123.236 2.624 . . . . 0.15 109.752 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.87 45.82 93.15 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.31 -1.116 . . . . 0.78 110.31 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.547 HG22 ' CD1' ' A' ' 92' ' ' TRP . 32.3 pt -136.21 -156.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.163 -1.198 . . . . 0.48 108.951 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.601 ' O ' HG22 ' A' ' 52' ' ' ILE . 31.4 t70 -107.97 105.74 15.66 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.251 -0.906 . . . . 0.93 109.473 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.507 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -87.35 48.06 1.59 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.316 -0.994 . . . . 0.38 108.316 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 26.2 t-20 178.08 77.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.691 -1.226 . . . . 1.33 107.691 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.636 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -61.96 -5.67 2.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.18 112.009 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.566 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -63.94 -12.49 37.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.384 -1.448 . . . . 0.27 108.987 179.661 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -75.53 -22.77 56.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.069 -1.02 . . . . 1.39 110.156 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.509 ' HB2' HG13 ' A' ' 88' ' ' ILE . 58.7 m-85 -109.42 -30.75 7.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.57 108.79 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.715 ' CG2' HD21 ' A' ' 80' ' ' LEU . 2.1 m -99.23 165.82 2.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.086 -1.079 . . . . 0.27 108.086 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.612 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -91.28 91.23 8.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.14 -0.975 . . . . 1.35 111.411 -178.241 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.498 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 11.5 p -89.14 153.59 49.02 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 107.541 -1.281 . . . . 0.32 107.541 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.702 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 23.2 Cg_endo -68.53 130.16 14.67 Favored 'Cis proline' 0 C--N 1.313 -1.339 0 C-N-CA 124.474 -1.053 . . . . 0.43 112.785 2.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.877 HD23 ' CE2' ' A' ' 86' ' ' TYR . 11.1 mt -74.13 115.69 13.91 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.962 -1.495 . . . . 0.47 106.962 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.9 t -83.45 141.25 15.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 C-N-CA 119.084 -1.047 . . . . 0.43 110.125 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.58 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 3.7 tttt -64.99 116.9 6.89 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.851 0.834 . . . . 1.98 110.195 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.06 -11.39 14.85 Favored Glycine 0 N--CA 1.479 1.505 0 N-CA-C 109.43 -1.468 . . . . 0.42 109.43 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.565 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 37.5 tp60 -100.72 156.54 17.28 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.668 -1.234 . . . . 2.31 107.668 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -109.3 149.99 28.64 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.363 -0.977 . . . . 1.2 108.363 179.508 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.877 ' CE2' HD23 ' A' ' 80' ' ' LEU . 36.6 m-85 -132.07 149.35 52.43 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.145 -0.972 . . . . 0.54 110.258 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.576 ' HB3' HD23 ' A' ' 40' ' ' LEU . 9.7 p-10 -117.94 113.69 22.08 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.555 -0.905 . . . . 0.67 108.555 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.636 HD12 ' HB1' ' A' ' 72' ' ' ALA . 7.4 tt -108.15 124.83 64.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.195 -0.941 . . . . 0.43 111.626 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.451 ' HD3' ' OE1' ' A' ' 38' ' ' GLU . 5.2 tptt -100.49 105.0 16.41 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.353 -2.091 . . . . 3.7 105.353 176.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.594 ' CE2' ' O ' ' A' ' 91' ' ' THR . 27.5 t80 -119.8 141.86 49.11 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 118.579 -1.249 . . . . 0.45 113.143 -176.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.594 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -94.38 144.18 25.77 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.482 -1.673 . . . . 1.02 106.482 177.064 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.984 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 22.2 t90 -122.74 89.48 3.12 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.798 -1.189 . . . . 0.58 111.162 -177.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -62.39 107.74 0.98 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.239 -0.913 . . . . 2.41 108.655 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.784 HG13 ' HD2' ' A' ' 95' ' ' PRO . 53.8 t -74.9 144.42 79.67 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.474 -0.766 . . . . 1.19 109.149 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.784 ' HD2' HG13 ' A' ' 94' ' ' VAL . 29.8 Cg_endo -70.77 136.15 29.68 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.897 1.731 . . . . 0.84 109.573 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.14 4.81 3.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.483 -0.761 . . . . 2.37 111.299 -178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 98' ' ' ALA . 13.2 pt -89.9 -25.93 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.673 -1.267 . . . . 0.98 109.047 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.563 ' O ' ' CD ' ' A' ' 31' ' ' ARG . . . -36.17 117.54 0.67 Allowed Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 109.396 -0.594 . . . . 0.53 109.396 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -83.01 167.0 14.47 Favored 'Trans proline' 0 C--N 1.298 -2.097 0 C-N-CA 122.595 2.197 . . . . 0.87 109.221 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.549 ' CD ' ' HA ' ' A' ' 128' ' ' ARG . 6.2 mmtp -79.31 77.86 5.82 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.682 -1.229 . . . . 4.83 107.682 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.494 ' HB2' HD22 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -80.8 118.55 22.42 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.951 -0.759 . . . . 0.49 108.951 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 0.7 OUTLIER -37.32 -50.63 1.04 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.604 -0.685 . . . . 2.75 109.911 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.526 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 24.5 m120 -129.96 139.0 51.15 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.077 -1.014 . . . . 2.85 110.058 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.648 HG21 ' CD1' ' A' ' 127' ' ' ILE . 74.0 t -129.88 149.35 33.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.326 -0.859 . . . . 0.61 109.405 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.528 ' HB ' ' CB ' ' A' ' 57' ' ' SER . 1.0 OUTLIER -124.13 122.45 64.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.988 -1.116 . . . . 1.08 107.988 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 20.1 t -103.94 144.09 14.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.239 -0.913 . . . . 0.44 109.779 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 36.9 m -123.67 114.45 19.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.366 -0.834 . . . . 0.2 109.676 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -95.24 127.52 47.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.289 -1.375 . . . . 0.31 107.289 178.597 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.873 ' CD ' HD11 ' A' ' 111' ' ' ILE . 8.5 ttmt -142.58 127.05 17.82 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.387 -1.446 . . . . 2.34 111.468 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.638 ' C ' HD12 ' A' ' 111' ' ' ILE . 1.4 mp -103.46 137.37 41.64 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.472 -1.307 . . . . 1.99 107.472 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.873 HD11 ' CD ' ' A' ' 109' ' ' LYS . 4.2 mp -131.09 121.54 49.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.41 -0.806 . . . . 0.37 109.856 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.484 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -80.92 -129.88 0.96 Allowed Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.455 -1.858 . . . . 0.45 108.455 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.34 -3.57 11.92 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.284 -1.127 . . . . 0.77 109.12 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.401 ' O ' ' CG ' ' A' ' 114' ' ' ASN . 1.3 t30 -116.77 -10.96 10.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.242 -0.911 . . . . 3.7 110.708 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 111' ' ' ILE . . . 168.35 -158.47 31.2 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.467 -1.349 . . . . 0.3 110.573 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.632 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -87.74 109.84 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -1.107 . . . . 0.35 110.162 -179.385 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 112' ' ' GLY . 85.1 mt -53.95 -43.11 69.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 0.52 108.999 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.478 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -155.46 -162.53 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.095 -1.003 . . . . 0.51 109.465 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -178.59 155.24 0.82 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.208 -0.933 . . . . 0.74 109.158 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.06 143.97 23.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.011 -1.056 . . . . 0.31 109.925 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.0 mt -133.17 116.92 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.106 -0.996 . . . . 0.56 108.41 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.1 146.62 24.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.993 -1.067 . . . . 0.25 110.517 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 124' ' ' HIS . 88.3 m -116.65 162.65 17.31 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.148 -0.686 . . . . 2.57 109.148 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.519 ' N ' HG22 ' A' ' 123' ' ' THR . 5.0 t-160 54.03 75.05 0.29 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 2.12 109.93 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -131.7 161.62 23.73 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.717 -1.753 . . . . 0.48 108.717 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 125' ' ' GLY . 46.3 mttt -152.85 139.52 18.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.219 -1.166 . . . . 1.7 109.255 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.648 ' CD1' HG21 ' A' ' 104' ' ' VAL . 64.2 mt -106.55 139.83 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.621 -1.3 . . . . 0.32 109.677 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.549 ' HA ' ' CD ' ' A' ' 100' ' ' LYS . 22.0 mtt180 -132.92 178.53 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.383 -0.823 . . . . 3.62 109.307 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.995 -1.002 . . . . 2.78 109.449 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.278 0.561 . . . . 1.34 109.502 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 9.4 pt20 -95.89 152.49 18.45 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.322 -0.861 . . . . 1.21 109.266 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 21' ' ' CYS . 28.2 m -104.76 160.72 5.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.307 -0.87 . . . . 0.63 108.903 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.82 118.19 30.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.991 -1.068 . . . . 0.83 110.139 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 m -142.17 157.51 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.329 -0.989 . . . . 0.36 108.329 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 109.17 17.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.058 -1.026 . . . . 4.4 109.596 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 16.9 p-10 -45.06 132.51 7.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 3.73 109.805 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -108.7 -2.9 18.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.805 . . . . 0.33 109.505 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.541 ' N ' ' HB3' ' A' ' 119' ' ' CYS . . . -75.33 -74.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.6 109.668 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.434 ' CG ' ' O ' ' A' ' 9' ' ' ALA . 7.4 m-20 178.49 55.64 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.557 -0.905 . . . . 2.42 108.557 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.404 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 1.3 t30 65.28 42.85 3.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.446 -0.946 . . . . 3.15 108.446 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.555 ' HG2' ' ND2' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -98.9 -63.18 1.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -0.852 . . . . 1.83 110.485 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 15' ' ' LYS . 1.2 mt -60.25 128.05 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.951 -1.093 . . . . 0.6 110.417 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -81.86 -15.64 53.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.31 -0.869 . . . . 0.77 109.358 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 156.98 141.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.15 -1.056 . . . . 2.86 108.15 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.792 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -121.99 126.27 74.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.876 -0.787 . . . . 0.39 108.876 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.494 ' HE2' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -112.41 156.45 22.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.005 -1.06 . . . . 1.21 110.213 -179.258 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 36' ' ' THR . 2.4 t -133.26 143.36 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.302 -0.874 . . . . 0.8 108.718 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.64 100.58 11.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.99 . . . . 3.18 109.639 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.47 -56.15 0.52 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.753 -1.339 . . . . 0.39 109.753 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.409 ' HB2' HG12 ' A' ' 3' ' ' VAL . 66.8 m -59.65 -167.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -1.128 . . . . 2.29 109.232 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -144.31 15.3 1.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.136 -0.977 . . . . 1.98 109.834 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 77.55 145.92 2.42 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.74 -1.344 . . . . 3.7 109.74 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER 38.14 46.72 0.88 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.595 -0.944 . . . . 3.69 110.321 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.453 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER -156.75 170.9 8.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 1.68 109.322 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 34.9 Cg_endo -77.71 148.04 25.3 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.707 2.271 . . . . 0.88 111.027 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 87.3 m -116.76 134.27 54.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.383 -0.823 . . . . 0.83 109.255 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.473 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 37.6 mm -101.15 104.08 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.77 -1.206 . . . . 0.61 108.519 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.408 ' HB ' HG12 ' A' ' 127' ' ' ILE . 3.4 mt -88.44 119.14 35.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.568 -0.853 . . . . 0.34 109.469 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -95.34 106.56 18.62 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.028 -1.101 . . . . 0.89 108.028 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 9.2 ptt180 -52.03 154.65 2.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.977 -1.077 . . . . 1.79 110.004 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.88 -10.69 64.49 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.392 -1.483 . . . . 0.45 109.392 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -108.79 154.61 41.68 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.279 -1.13 . . . . 1.27 109.565 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.426 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 34.4 Cg_endo -79.84 114.45 3.18 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.812 2.342 . . . . 0.31 110.884 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -96.37 132.91 41.4 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.55 -1.278 . . . . 0.66 107.55 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 18' ' ' VAL . 91.8 m -113.39 140.79 47.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.675 -1.265 . . . . 0.42 110.879 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -146.55 122.44 10.65 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.86 -0.792 . . . . 3.47 108.86 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 3.0 tt0 -101.08 127.82 47.42 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.72 -1.215 . . . . 2.14 107.72 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.792 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -126.6 122.98 36.6 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.746 -1.221 . . . . 0.17 110.413 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.545 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 20.2 mt -89.69 142.61 27.52 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.606 -1.627 . . . . 0.28 106.606 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.644 ' CE1' ' CD1' ' A' ' 110' ' ' LEU . 35.3 p90 -157.85 137.67 12.25 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.823 -1.173 . . . . 0.25 109.669 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.5 m-20 -84.73 111.58 19.72 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.239 -0.985 . . . . 1.53 108.928 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -47.84 114.22 0.87 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.298 -0.63 . . . . 0.22 109.298 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -91.87 14.07 16.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 3.51 108.944 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.642 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 1.8 pt20 -164.78 138.98 5.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.436 -0.79 . . . . 1.09 109.022 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 6.1 p30 -81.51 123.63 28.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.126 -0.984 . . . . 3.22 109.355 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.6 t -145.13 153.94 41.93 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.225 -0.922 . . . . 0.71 109.382 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.684 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 3.2 mmmt -89.43 -12.75 39.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 1.4 109.724 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.0 p -147.2 136.7 22.79 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.354 -0.938 . . . . 1.33 110.189 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -127.57 155.79 43.26 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.477 -0.934 . . . . 0.56 108.477 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.541 ' CD ' ' HB ' ' A' ' 70' ' ' THR . 0.3 OUTLIER -134.55 145.06 48.36 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.422 -0.799 . . . . 1.9 110.37 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 69' ' ' ASP . 5.6 tt -95.22 154.46 3.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.012 -1.055 . . . . 0.81 108.917 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 0.9 OUTLIER -141.04 114.14 8.54 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.538 -0.912 . . . . 1.24 108.538 -179.123 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.77 HD13 HG21 ' A' ' 68' ' ' ILE . 2.5 mp -113.99 130.81 67.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.95 -1.093 . . . . 0.82 109.097 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -126.05 134.03 51.54 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.161 -0.962 . . . . 1.39 108.716 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -122.28 131.5 53.95 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.607 -1.237 . . . . 0.53 111.16 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.24 148.21 23.33 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.206 -1.035 . . . . 0.53 108.206 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.721 HD13 ' CG ' ' A' ' 99' ' ' PRO . 17.2 mt -109.26 56.97 0.61 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.134 -0.979 . . . . 0.8 109.668 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 58' ' ' LEU . 3.4 t70 41.47 27.95 0.06 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.649 -0.657 . . . . 1.53 109.726 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 174.23 -49.89 0.14 Allowed Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.754 -1.212 . . . . 1.1 110.093 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.517 ' HG ' HG13 ' A' ' 63' ' ' ILE . 3.8 tp -108.43 112.73 25.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.021 -1.282 . . . . 0.76 110.069 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.492 ' N ' HD12 ' A' ' 61' ' ' LEU . 1.9 tt0 -79.14 124.58 28.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.127 -0.983 . . . . 1.45 108.975 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.683 ' CD1' HD11 ' A' ' 58' ' ' LEU . 71.4 mt -121.21 165.95 16.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.991 0.9 . . . . 0.56 110.203 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.677 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -112.44 108.71 17.95 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 105.881 -1.896 . . . . 1.36 105.881 176.475 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.086 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 10.3 t -71.34 114.13 25.25 Favored Pre-proline 0 C--N 1.298 -1.663 0 O-C-N 121.501 -0.749 . . . . 0.81 111.904 -177.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 37.6 Cg_endo -86.56 -157.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 123.278 2.652 . . . . 0.67 109.241 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.27 36.13 61.85 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.247 -0.978 . . . . 0.96 110.825 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.77 HG21 HD13 ' A' ' 54' ' ' ILE . 9.0 pt -120.72 -157.66 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.957 -1.319 . . . . 0.52 108.849 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.735 ' O ' HG22 ' A' ' 52' ' ' ILE . 47.9 t0 -108.29 107.69 18.39 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.381 -0.824 . . . . 0.51 109.367 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.541 ' HB ' ' CD ' ' A' ' 51' ' ' LYS . 64.4 p -86.8 45.08 1.22 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.052 -1.03 . . . . 0.76 108.443 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 58.2 t30 175.32 83.6 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.4 -1.333 . . . . 1.05 107.4 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.855 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -72.33 4.35 3.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.464 -0.772 . . . . 0.39 113.016 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.559 ' HA ' HG22 ' A' ' 76' ' ' VAL . 2.2 t -64.89 -13.91 58.1 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.189 -1.569 . . . . 0.53 108.675 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -75.05 -23.98 58.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.222 -0.923 . . . . 1.82 109.728 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.528 ' CB ' HG13 ' A' ' 88' ' ' ILE . 74.1 m-85 -109.34 -16.54 14.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.86 109.203 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.814 ' CG2' HD21 ' A' ' 80' ' ' LEU . 2.3 m -117.7 166.78 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.246 -1.02 . . . . 0.51 108.246 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.649 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -92.25 90.69 7.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.995 -1.065 . . . . 2.32 111.536 -178.352 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.469 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 17.5 p -84.28 151.11 59.08 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 107.077 -1.453 . . . . 0.6 107.077 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.684 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.6 Cg_endo -70.11 132.55 23.09 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 124.416 -1.077 . . . . 0.86 112.806 2.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.814 HD21 ' CG2' ' A' ' 76' ' ' VAL . 12.8 mt -75.95 113.87 13.94 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.555 -1.646 . . . . 0.66 106.555 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.638 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 55.1 t -79.45 143.31 12.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 C-N-CA 119.53 -0.868 . . . . 0.81 110.204 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.642 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 11.4 ttpt -71.5 99.8 2.1 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.824 0.821 . . . . 1.15 110.127 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 136.5 -15.97 3.85 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 109.621 -1.392 . . . . 0.42 109.621 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.574 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 26.9 tp60 -97.88 156.02 16.79 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.837 -1.172 . . . . 1.19 107.837 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -106.94 142.84 35.93 Favored 'General case' 0 C--N 1.294 -1.848 0 O-C-N 120.936 -1.102 . . . . 0.93 108.08 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.649 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 21.0 m-85 -122.96 150.65 42.7 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.469 -0.769 . . . . 0.57 110.559 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.545 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 3.9 p30 -116.7 113.92 23.29 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.171 -1.048 . . . . 0.31 108.171 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.855 HD12 ' HB1' ' A' ' 72' ' ' ALA . 4.8 tt -106.93 120.05 57.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.032 -1.043 . . . . 0.27 111.793 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.504 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 5.0 tttp -98.36 104.44 16.48 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 104.574 -2.38 . . . . 1.83 104.574 175.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 20.9 t80 -119.13 137.06 53.85 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.045 -1.062 . . . . 0.54 112.004 -176.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.59 98.07 10.56 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.656 -1.609 . . . . 0.43 106.656 177.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.086 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 33.6 t90 -72.18 97.02 1.88 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.822 -0.627 . . . . 0.42 109.797 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.26 105.16 0.46 Allowed 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.565 -0.854 . . . . 2.21 108.742 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.662 HG13 ' HD2' ' A' ' 95' ' ' PRO . 64.5 t -65.49 143.19 98.61 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.445 -0.784 . . . . 0.69 109.156 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.869 ' HG3' HG13 ' A' ' 65' ' ' VAL . 30.1 Cg_endo -72.52 129.2 14.41 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.136 1.89 . . . . 0.56 109.726 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -1.27 4.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.573 -0.704 . . . . 2.69 110.182 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 98' ' ' ALA . 9.5 pt -90.2 -27.52 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.834 -1.166 . . . . 0.57 110.084 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.519 ' O ' ' CD ' ' A' ' 31' ' ' ARG . . . -34.83 118.8 0.57 Allowed Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 109.428 -0.582 . . . . 0.23 109.428 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.721 ' CG ' HD13 ' A' ' 58' ' ' LEU . 36.8 Cg_endo -85.02 139.95 7.54 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.852 2.368 . . . . 0.32 109.696 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.48 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 7.4 mtmt -52.76 89.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.994 -1.113 . . . . 0.73 107.994 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 99' ' ' PRO . 3.4 t -93.71 122.46 36.19 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.439 -0.788 . . . . 0.37 109.151 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 8.3 pt-20 -41.39 -44.54 2.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.523 -0.736 . . . . 1.07 109.456 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 14.5 t30 -132.17 140.49 48.76 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.521 -0.737 . . . . 1.33 109.722 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.972 HG21 ' CD1' ' A' ' 127' ' ' ILE . 1.0 OUTLIER -130.69 143.92 39.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.338 -0.851 . . . . 0.84 109.191 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 2.9 t -118.87 118.7 58.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.217 -1.031 . . . . 1.04 108.217 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.8 t -104.61 140.78 21.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.731 -1.231 . . . . 0.44 110.646 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 89.8 m -122.1 127.07 49.71 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.008 -0.738 . . . . 0.5 109.008 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -104.79 132.89 50.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 107.853 -1.166 . . . . 0.39 107.853 178.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.886 ' CD ' HD11 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -141.56 128.63 20.81 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.419 -1.426 . . . . 1.24 111.79 -178.397 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 52' ' ' ILE . 13.3 mt -104.55 141.79 35.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.151 -1.425 . . . . 0.14 107.151 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.886 HD11 ' CD ' ' A' ' 109' ' ' LYS . 4.4 mp -135.57 121.86 32.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.218 -0.926 . . . . 0.22 110.039 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.44 ' N ' ' HG ' ' A' ' 117' ' ' LEU . . . -99.71 -144.53 16.43 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.788 -1.725 . . . . 0.57 108.788 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.6 -0.28 46.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -1.173 . . . . 1.53 109.747 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.81 -4.15 13.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 2.06 110.372 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 144.27 -147.63 18.98 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.886 -1.286 . . . . 0.25 109.886 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.634 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 2.1 t -86.82 108.98 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -1.166 . . . . 0.12 109.878 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.607 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 22.1 mt -56.46 -35.12 67.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.51 109.84 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.508 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -163.03 179.31 7.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.716 -1.24 . . . . 0.36 109.515 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.541 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 14.5 t -165.08 157.61 15.94 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.319 -0.863 . . . . 0.4 109.314 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.465 ' HB2' HD12 ' A' ' 13' ' ' ILE . . . -152.92 147.06 25.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.035 -1.041 . . . . 0.46 109.483 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 65.7 mt -134.0 120.9 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.52 109.554 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -92.8 147.53 22.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.144 -0.972 . . . . 0.66 109.697 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -78.47 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.79 109.837 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -56.91 -177.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 3.02 109.353 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . 141.51 138.86 3.58 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.869 -1.292 . . . . 0.48 109.869 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 7.8 mtmt -151.09 134.86 16.47 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.455 -1.026 . . . . 1.25 108.614 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.972 ' CD1' HG21 ' A' ' 104' ' ' VAL . 58.6 mt -105.8 140.39 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.822 -1.174 . . . . 0.53 110.485 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.48 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -133.5 173.5 11.43 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.74 -0.837 . . . . 2.75 108.74 178.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.028 -1.045 . . . . 1.16 109.513 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.418 -0.586 . . . . 0.88 109.418 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.52 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 1.3 tt0 -69.46 141.31 54.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.219 -0.926 . . . . 2.16 109.211 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 22' ' ' HIS . 2.4 m -109.54 168.8 3.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.339 -0.851 . . . . 1.88 110.184 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -80.16 128.63 33.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.412 -0.805 . . . . 1.1 110.952 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.7 m -147.49 159.3 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.703 -1.221 . . . . 0.45 107.703 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.68 108.62 15.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.805 -1.184 . . . . 1.91 109.462 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 120' ' ' ALA . 24.8 m-20 -52.76 130.29 32.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.9 109.106 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.4 3.96 38.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.37 109.49 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 10' ' ' ASN . . . -81.52 -57.5 3.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.277 -0.889 . . . . 0.63 109.21 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER 161.64 -31.26 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.244 -1.021 . . . . 3.44 108.244 -178.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 1.0 OUTLIER 159.61 39.51 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.255 -1.017 . . . . 2.3 108.255 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.481 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 77.1 mm-40 -90.82 -52.75 4.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 2.7 110.386 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.524 HG12 ' HB1' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -73.97 131.8 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.702 -1.249 . . . . 0.57 110.082 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 39.2 mmtt -85.95 -22.59 27.31 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.849 -1.167 . . . . 0.94 107.849 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.1 ttpt 160.9 128.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.211 -0.662 . . . . 1.91 109.211 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 38' ' ' GLU . 1.5 p -119.31 122.77 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.044 -1.035 . . . . 1.59 109.086 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.52 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -105.23 158.69 16.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.261 -0.899 . . . . 1.47 110.41 -178.536 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.066 HG11 ' CE1' ' A' ' 35' ' ' PHE . 24.7 t -127.9 115.69 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.873 . . . . 0.47 108.66 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -68.15 89.82 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 3.48 109.749 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.38 -63.54 0.26 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.404 -1.478 . . . . 0.7 109.404 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.6 t -90.18 154.08 20.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -1.133 . . . . 0.67 109.243 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.632 ' O ' HG12 ' A' ' 3' ' ' VAL . 12.2 m80 -94.01 -169.16 2.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 2.7 109.789 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.588 ' CA ' ' HA ' ' A' ' 3' ' ' VAL . . . -108.09 154.82 16.44 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.361 -1.496 . . . . 3.91 109.361 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.0 6.18 4.55 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.161 -1.199 . . . . 1.7 109.079 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -128.57 158.5 71.69 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 108.497 -0.927 . . . . 2.75 108.497 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.78 147.36 21.65 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.708 2.272 . . . . 0.83 110.368 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.2 m -115.69 154.42 29.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.95 109.7 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.542 HG23 ' HG3' ' A' ' 128' ' ' ARG . 45.9 mm -111.95 113.16 43.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.353 -0.842 . . . . 0.47 109.206 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.517 ' HB ' HG12 ' A' ' 127' ' ' ILE . 10.1 mt -94.94 120.89 44.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.249 -0.907 . . . . 0.76 108.931 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.502 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 3.9 m-70 -87.43 133.97 33.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.35 -0.844 . . . . 1.88 109.639 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.513 ' HA ' HG11 ' A' ' 94' ' ' VAL . 9.2 mtm180 -54.81 135.06 48.07 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.159 -0.963 . . . . 1.73 108.922 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.514 ' N ' ' HB ' ' A' ' 94' ' ' VAL . . . 69.26 20.47 75.12 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.397 -0.906 . . . . 0.84 111.041 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.046 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -109.64 137.76 20.45 Favored Pre-proline 0 N--CA 1.482 1.175 0 O-C-N 120.594 -1.533 . . . . 3.45 108.305 179.472 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.5 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 33.9 Cg_endo -74.18 115.56 4.36 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.844 2.363 . . . . 0.45 112.089 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 1.066 ' CE1' HG11 ' A' ' 18' ' ' VAL . 1.5 t80 -98.97 111.74 24.05 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.166 -1.05 . . . . 1.06 108.166 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.912 ' O ' HG13 ' A' ' 18' ' ' VAL . 96.2 m -88.04 128.71 35.4 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.087 -1.008 . . . . 0.95 109.944 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.43 HD13 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -140.66 123.68 16.49 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.475 -0.765 . . . . 3.62 109.238 179.474 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 16' ' ' VAL . 4.5 tt0 -105.28 126.78 52.48 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.642 -1.244 . . . . 0.92 107.642 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.563 ' CB ' ' HB ' ' A' ' 16' ' ' VAL . . . -129.42 132.08 46.92 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.676 -1.265 . . . . 0.47 110.975 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 5.4 mt -94.85 144.39 25.69 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.092 -1.447 . . . . 0.33 107.092 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.702 ' CE2' HD11 ' A' ' 110' ' ' LEU . 35.2 p90 -159.36 136.53 9.68 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.785 -1.166 . . . . 0.28 109.864 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.4 m-20 -84.2 112.25 20.1 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.292 -0.963 . . . . 1.39 108.611 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -45.19 110.88 0.27 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.759 -0.83 . . . . 0.26 108.759 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.642 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -80.03 4.65 16.4 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.154 -0.966 . . . . 1.37 109.5 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 4.3 pt20 -164.84 156.75 15.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.028 -1.045 . . . . 1.16 109.676 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 7.2 p30 -84.79 121.67 28.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 2.34 109.271 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.694 HG21 HD11 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -141.46 139.26 33.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.056 -1.028 . . . . 0.79 110.287 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.707 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 3.2 mmmm -80.92 -10.87 59.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.384 -0.822 . . . . 1.34 109.477 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 47' ' ' THR . 12.7 p -147.03 137.86 23.78 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.985 0.897 . . . . 0.49 109.714 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -126.3 149.81 48.89 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.815 -0.809 . . . . 0.35 108.815 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.564 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 2.2 mtmt -129.28 136.2 49.76 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.114 -1.034 . . . . 0.21 110.401 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 69' ' ' ASP . 12.2 tt -92.17 151.28 3.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 107.085 -1.45 . . . . 0.41 107.085 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -142.13 115.38 8.89 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.089 -1.007 . . . . 0.56 109.468 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 54' ' ' ILE . 2.3 mp -112.63 111.41 36.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.044 -1.035 . . . . 0.18 109.13 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -106.57 160.57 15.33 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.263 -1.014 . . . . 0.73 108.263 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -134.67 150.63 50.66 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.494 -1.379 . . . . 1.06 110.829 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 4.6 m -116.26 151.56 35.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.875 -1.157 . . . . 2.61 107.875 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.625 HD12 ' HG ' ' A' ' 61' ' ' LEU . 10.9 mt -123.66 60.1 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.648 -1.282 . . . . 0.81 110.312 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' ' 103' ' ' ASN . 0.4 OUTLIER 44.01 24.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.554 -0.716 . . . . 0.83 110.005 179.441 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 162.85 -47.23 0.33 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.01 -1.236 . . . . 0.31 110.01 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.625 ' HG ' HD12 ' A' ' 58' ' ' LEU . 12.3 tp -107.67 117.63 34.61 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.117 -1.225 . . . . 0.64 109.051 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.6 mt-10 -100.8 128.26 46.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 3.91 109.937 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.71 HG23 ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -117.1 178.05 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 122.419 1.104 . . . . 1.29 110.04 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.71 ' N ' HG23 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -110.49 143.03 41.44 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.8 -1.185 . . . . 3.72 107.8 178.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.131 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 2.9 t -110.87 104.27 55.87 Favored Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 120.977 -1.077 . . . . 0.26 111.523 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.523 ' O ' HG23 ' A' ' 68' ' ' ILE . 36.4 Cg_endo -81.81 -154.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.4 2.733 . . . . 0.2 109.639 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.91 29.39 64.81 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.792 -1.323 . . . . 0.54 109.792 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.689 HG21 HD13 ' A' ' 54' ' ' ILE . 9.3 pt -120.44 -162.13 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.153 -1.204 . . . . 0.34 109.195 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.718 ' O ' HG22 ' A' ' 52' ' ' ILE . 16.6 t70 -103.55 107.05 17.73 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.445 -0.784 . . . . 0.84 109.062 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.564 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 1.0 OUTLIER -85.76 44.55 1.12 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.268 -0.895 . . . . 0.15 108.682 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 49.2 t30 -177.63 69.65 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.532 -1.285 . . . . 0.96 107.532 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.515 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -56.4 -11.2 1.14 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.563 -0.71 . . . . 0.15 111.868 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.558 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -61.23 -15.18 31.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.534 -1.354 . . . . 0.31 109.379 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.22 -25.06 60.59 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.082 -1.011 . . . . 0.84 109.917 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.518 ' HB2' HG13 ' A' ' 88' ' ' ILE . 78.3 m-85 -102.54 -35.9 8.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.203 -0.936 . . . . 0.45 109.189 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.982 HG23 HD21 ' A' ' 80' ' ' LEU . 2.0 m -96.02 166.07 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.134 -1.061 . . . . 0.17 108.134 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.637 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -88.24 93.1 9.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.945 -1.097 . . . . 0.68 110.692 -178.585 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.511 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 11.9 p -90.06 154.04 47.15 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 107.682 -1.229 . . . . 0.17 107.682 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.707 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 26.3 Cg_endo -68.7 133.56 24.26 Favored 'Cis proline' 0 C--N 1.312 -1.359 0 C-N-CA 124.223 -1.157 . . . . 0.16 112.513 2.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.982 HD21 HG23 ' A' ' 76' ' ' VAL . 13.1 mt -76.86 112.42 13.44 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.782 -1.562 . . . . 0.82 106.782 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.8 t -80.77 136.79 22.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 C-N-CA 119.707 -0.797 . . . . 0.23 110.114 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 25.0 tttm -60.54 110.42 1.27 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.648 0.737 . . . . 3.13 110.253 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 126.71 -16.46 6.54 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 110.264 -1.134 . . . . 0.39 110.264 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.583 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 13.6 tp60 -97.99 157.39 16.14 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.125 -1.22 . . . . 0.52 108.162 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -110.68 143.13 41.63 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.074 -1.084 . . . . 1.08 108.074 179.006 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.637 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 19.0 m-85 -125.94 152.83 45.12 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.409 -0.807 . . . . 0.2 110.438 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.45 ' OD1' ' C ' ' A' ' 87' ' ' ASP . 24.0 t0 -119.49 113.18 20.35 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.882 -1.155 . . . . 4.07 107.882 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.624 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 9.1 tt -106.71 126.75 62.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.361 -0.936 . . . . 0.39 111.506 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.501 ' HA ' ' HG3' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -100.59 119.89 39.21 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 105.124 -2.176 . . . . 2.04 105.124 176.477 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.544 ' OH ' ' N ' ' A' ' 69' ' ' ASP . 34.4 t80 -138.03 140.74 40.24 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.051 -1.46 . . . . 0.51 112.698 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.501 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -92.74 138.96 31.04 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.512 -1.662 . . . . 0.79 106.512 177.058 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.131 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 26.4 t90 -120.27 82.73 1.94 Allowed 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.949 -1.094 . . . . 0.7 109.472 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -61.28 108.51 0.93 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.591 -0.693 . . . . 1.55 109.958 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.046 HG23 ' O ' ' A' ' 33' ' ' LYS . 33.9 t -47.39 144.04 4.87 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.134 -1.062 . . . . 1.19 108.134 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.718 ' HG3' HG13 ' A' ' 65' ' ' VAL . 26.7 Cg_endo -68.67 -8.7 24.03 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.854 2.369 . . . . 3.72 113.038 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 0.9 OUTLIER 77.84 -17.82 0.54 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.913 -1.117 . . . . 3.32 110.665 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.523 ' O ' ' C ' ' A' ' 98' ' ' ALA . 11.8 pt -88.11 -25.62 5.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 120.704 -1.247 . . . . 0.7 108.335 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.854 ' HB1' HD13 ' A' ' 127' ' ' ILE . . . -33.84 116.77 0.48 Allowed Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.92 -0.771 . . . . 0.57 108.92 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.606 ' O ' ' N ' ' A' ' 101' ' ' SER . 36.0 Cg_endo -83.6 129.41 4.93 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.674 2.249 . . . . 0.77 109.165 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -46.93 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.457 -0.942 . . . . 3.88 108.457 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -103.38 124.42 48.67 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.167 -0.679 . . . . 1.65 109.167 -178.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 101' ' ' SER . 6.4 pt-20 -41.65 -46.38 3.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.443 -0.786 . . . . 0.83 110.022 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.41 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 1.9 t30 -129.36 140.68 51.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.901 -1.124 . . . . 0.81 110.223 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.757 HG21 ' CD1' ' A' ' 127' ' ' ILE . 2.7 t -133.1 147.22 31.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.531 -0.731 . . . . 0.2 109.377 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 57' ' ' SER . 2.7 t -123.31 118.85 55.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.516 -1.29 . . . . 0.53 107.516 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.1 t -100.92 142.49 15.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.281 -0.887 . . . . 0.3 110.039 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 24.1 m -122.52 117.15 25.24 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.607 -0.683 . . . . 0.35 109.358 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -94.9 129.12 45.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 107.001 -1.481 . . . . 0.34 107.001 178.561 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.915 ' CD ' HD11 ' A' ' 111' ' ' ILE . 0.7 OUTLIER -140.08 130.79 25.8 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.363 -1.461 . . . . 1.05 112.05 -177.119 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.702 HD11 ' CE2' ' A' ' 41' ' ' PHE . 14.1 mt -101.79 143.01 32.23 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.945 -1.502 . . . . 0.35 106.945 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.915 HD11 ' CD ' ' A' ' 109' ' ' LYS . 4.2 mp -136.4 116.89 17.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 120.823 -1.173 . . . . 0.43 111.065 -177.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.43 -169.71 41.96 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.202 -1.959 . . . . 0.96 108.202 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.58 1.67 25.15 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.035 -1.274 . . . . 1.05 109.709 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.37 -6.51 12.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.197 -0.939 . . . . 4.71 110.702 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.91 -153.12 24.91 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.537 -1.316 . . . . 0.51 110.209 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.623 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -85.08 110.03 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.382 -1.069 . . . . 0.36 109.606 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.694 HD11 HG21 ' A' ' 47' ' ' THR . 26.7 mt -58.66 -39.89 81.92 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.206 -0.934 . . . . 0.23 109.816 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.524 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -154.87 -162.64 1.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.989 -1.07 . . . . 0.16 109.468 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.489 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 53.4 t 178.88 154.6 0.42 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.029 -1.045 . . . . 0.32 109.499 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.27 152.31 32.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.03 -1.044 . . . . 0.28 109.695 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 53.5 mt -134.99 140.2 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.2 -0.937 . . . . 0.85 109.083 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.19 119.46 38.9 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.456 -1.402 . . . . 0.73 108.571 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 51.3 p -70.12 -33.24 71.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -0.839 . . . . 2.11 110.498 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -120.97 154.89 35.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.95 -1.094 . . . . 1.35 110.098 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 126' ' ' LYS . . . 166.1 155.3 8.71 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.476 -1.449 . . . . 0.55 109.476 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.437 ' CG ' ' O ' ' A' ' 125' ' ' GLY . 30.6 mttt -154.88 138.09 15.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -1.197 . . . . 1.81 108.563 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.854 HD13 ' HB1' ' A' ' 98' ' ' ALA . 67.0 mt -104.17 140.7 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.508 -1.37 . . . . 0.44 109.769 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.542 ' HG3' HG23 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -124.86 154.21 41.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.465 -0.772 . . . . 5.07 109.824 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.41 ' HB3' ' HG3' ' A' ' 100' ' ' LYS . 2.9 p30 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 118.0 -1.0 . . . . 4.68 109.563 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.334 0.588 . . . . 2.55 109.492 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 0.0 OUTLIER -66.55 159.69 26.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 2.82 109.483 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.483 ' CG1' ' HB3' ' A' ' 21' ' ' CYS . 3.0 m -99.16 167.24 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.68 109.307 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 51.9 t0 -92.53 124.21 36.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.87 110.211 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.3 m -146.27 148.93 16.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.464 -0.939 . . . . 0.25 108.464 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.23 110.33 21.5 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.095 -1.003 . . . . 2.85 109.609 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -53.91 142.92 22.89 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.335 -0.853 . . . . 3.54 109.374 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.92 -14.17 11.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.344 -0.847 . . . . 0.96 108.963 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.94 -65.65 0.67 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.868 0.842 . . . . 0.24 109.199 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.47 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 3.4 t-20 173.98 59.23 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.134 -1.061 . . . . 4.45 108.134 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.6 t30 53.12 21.37 2.12 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.972 -1.08 . . . . 1.76 108.087 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.496 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 19.7 mm-40 -64.67 -61.27 2.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.582 -0.699 . . . . 3.52 109.363 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER -58.95 127.35 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.35 109.459 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.565 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 11.4 mmpt? -77.13 -19.83 56.4 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.242 -0.911 . . . . 0.53 108.899 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.567 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.8 OUTLIER 156.59 128.54 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.882 -0.784 . . . . 2.38 108.882 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.73 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -108.33 123.18 63.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.377 -0.972 . . . . 0.6 108.377 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.48 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 1.3 mtm -117.03 148.05 41.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.049 -1.032 . . . . 1.89 110.796 -178.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.488 HG12 ' OD1' ' A' ' 19' ' ' ASP . 31.6 t -103.9 158.03 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.385 -0.968 . . . . 0.83 108.385 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.488 ' OD1' HG12 ' A' ' 18' ' ' VAL . 8.8 p-10 -44.12 -31.28 0.92 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.092 -1.005 . . . . 4.11 109.802 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.92 97.45 0.12 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.57 -1.3 . . . . 2.51 110.27 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -108.48 -66.78 1.02 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -1.135 . . . . 3.43 108.913 179.266 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.489 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER 168.93 -27.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.833 . . . . 4.31 109.66 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 101.13 -135.71 12.31 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.957 -1.257 . . . . 1.61 109.957 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 23' ' ' GLY . 29.1 t -40.4 -34.68 0.36 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.534 -0.98 . . . . 1.51 109.988 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.439 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -67.12 164.92 31.55 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 2.25 109.42 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 25' ' ' ASP . 34.3 Cg_endo -78.03 162.18 29.21 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.692 2.261 . . . . 2.17 109.844 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.6 m -116.62 153.51 32.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.909 . . . . 0.94 109.371 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.515 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 47.8 mm -107.37 109.13 27.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.911 -1.118 . . . . 0.47 108.872 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.467 HG23 HG21 ' A' ' 94' ' ' VAL . 1.9 mt -91.19 119.31 38.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.444 -0.785 . . . . 0.41 109.357 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.415 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 19.0 m80 -84.41 114.57 22.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.368 -0.832 . . . . 1.17 110.122 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.718 ' HG3' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -48.12 148.41 1.79 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.566 -0.709 . . . . 1.99 111.127 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.73 -22.55 4.03 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.923 -0.871 . . . . 0.93 110.923 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -93.01 155.18 41.53 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.77 -1.43 . . . . 2.94 109.745 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.465 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 36.4 Cg_endo -79.11 162.21 26.06 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.863 2.376 . . . . 1.4 110.689 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 92' ' ' TRP . 2.5 t80 -135.08 122.14 21.33 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.172 -1.048 . . . . 0.64 108.172 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 2.9 m -96.36 128.2 43.06 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.77 -1.207 . . . . 0.98 110.427 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.41 123.44 15.47 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.359 -0.838 . . . . 3.4 108.767 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 89' ' ' LYS . 5.6 mt-10 -96.96 126.9 42.43 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.31 -0.996 . . . . 2.4 108.31 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.73 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -123.97 118.96 28.2 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.875 -1.13 . . . . 0.37 110.386 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 5.9 mt -92.76 141.9 27.94 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.505 -1.665 . . . . 0.33 106.505 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.621 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 27.8 p90 -158.23 142.13 15.58 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 120.695 -1.253 . . . . 0.21 109.751 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.8 m-20 -87.06 110.88 20.39 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.408 -0.917 . . . . 0.61 108.728 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -46.3 114.1 0.74 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.61 -0.681 . . . . 0.13 109.398 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.425 ' OD1' ' C ' ' A' ' 44' ' ' ASN . 4.0 p30 -85.31 9.76 14.47 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.191 -0.943 . . . . 0.29 109.425 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.565 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -166.24 149.16 7.17 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.297 -0.877 . . . . 0.62 109.412 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -86.27 106.16 17.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.057 -1.027 . . . . 2.06 108.963 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.88 154.32 38.47 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.293 -0.879 . . . . 0.4 109.787 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.724 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 11.0 mmmt -89.22 -12.44 40.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.53 109.755 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 p -146.47 137.35 24.17 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.156 0.979 . . . . 0.53 110.195 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -127.93 149.17 50.44 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.357 -1.349 . . . . 0.51 107.357 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.587 ' HD2' ' CB ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -135.27 140.58 45.31 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.646 -0.822 . . . . 2.04 110.492 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.576 HG23 ' O ' ' A' ' 52' ' ' ILE . 7.0 tt -109.6 124.66 66.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.271 -0.893 . . . . 1.38 108.836 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 11.4 pt-20 -129.79 117.71 20.66 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.478 -1.304 . . . . 2.04 107.478 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.756 ' H ' HD12 ' A' ' 54' ' ' ILE . 3.8 mp -93.14 136.24 25.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 121.448 -0.782 . . . . 0.6 109.146 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 64' ' ' ASP . 49.8 mttt -119.05 131.9 55.99 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.225 -1.028 . . . . 0.61 108.225 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -116.33 154.38 30.3 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 120.7 -1.25 . . . . 0.77 111.608 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.804 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -120.14 150.75 40.13 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.71 -1.219 . . . . 0.51 107.71 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.844 HD13 ' CD ' ' A' ' 99' ' ' PRO . 3.4 mt -132.55 75.02 1.61 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.823 -1.173 . . . . 2.0 110.428 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER 40.51 25.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.596 -0.69 . . . . 1.73 110.274 179.511 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 152.35 -29.52 0.87 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.387 -1.387 . . . . 1.54 110.443 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.85 HD23 ' HG3' ' A' ' 99' ' ' PRO . 4.9 tp -110.3 110.02 20.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.848 -1.384 . . . . 2.43 110.112 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 2.0 tt0 -112.75 119.85 39.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.201 -0.937 . . . . 1.53 108.887 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.616 HG13 ' N ' ' A' ' 64' ' ' ASP . 2.2 tp -126.32 164.44 26.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 122.171 0.986 . . . . 5.42 109.65 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.616 ' N ' HG13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -83.38 110.15 17.91 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 105.64 -1.985 . . . . 1.59 105.64 177.056 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.1 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 3.0 t -66.5 113.68 13.89 Favored Pre-proline 0 C--N 1.293 -1.867 0 O-C-N 121.322 -0.862 . . . . 0.72 110.786 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.477 ' O ' HG23 ' A' ' 68' ' ' ILE . 37.5 Cg_endo -81.91 -165.7 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 123.121 2.547 . . . . 0.72 109.757 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 93' ' ' ASN . . . 58.0 56.83 23.03 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.796 -1.322 . . . . 1.38 109.796 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.563 HD13 ' O ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -149.12 -155.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.216 -1.167 . . . . 0.84 109.002 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.532 ' N ' ' OH ' ' A' ' 90' ' ' TYR . 38.6 t0 -114.18 112.13 22.67 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.096 -0.642 . . . . 0.73 109.575 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.587 ' CB ' ' HD2' ' A' ' 51' ' ' LYS . 21.2 p -90.39 42.41 1.1 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.645 -1.242 . . . . 0.71 107.645 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.62 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 21.1 t-20 176.94 88.33 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.497 -1.298 . . . . 2.03 107.497 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.923 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -76.45 7.35 4.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.45 112.613 -176.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.552 ' HA ' HG22 ' A' ' 76' ' ' VAL . 1.6 t -65.82 -12.99 58.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.225 -1.547 . . . . 0.23 108.837 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -78.56 -21.02 49.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.056 -1.027 . . . . 0.54 109.819 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.421 ' HB2' HG13 ' A' ' 88' ' ' ILE . 72.1 m-85 -108.74 -20.93 12.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 0.22 108.681 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.882 HG23 HD21 ' A' ' 80' ' ' LEU . 2.0 m -113.94 165.58 8.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.687 -1.227 . . . . 0.24 107.687 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.614 ' HG2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -92.54 93.05 8.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.983 -1.073 . . . . 1.72 111.202 -178.6 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.479 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 15.7 p -86.69 153.06 55.12 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 107.316 -1.364 . . . . 0.14 107.316 177.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.724 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.5 Cg_endo -69.52 132.13 21.04 Favored 'Cis proline' 0 C--N 1.311 -1.401 0 C-N-CA 124.363 -1.099 . . . . 0.25 112.778 2.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.882 HD21 HG23 ' A' ' 76' ' ' VAL . 11.1 mt -77.12 111.11 12.38 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.777 -1.564 . . . . 0.99 106.777 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 85.6 t -78.32 144.31 11.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 121.715 0.769 . . . . 0.35 110.782 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.565 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 14.2 ttpt -67.17 110.95 3.67 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.799 0.809 . . . . 0.67 109.858 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 124.12 -12.24 8.1 Favored Glycine 0 C--N 1.298 -1.578 0 N-CA-C 109.479 -1.448 . . . . 0.23 109.479 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.63 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 6.8 tp60 -103.28 151.6 22.5 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.839 -1.171 . . . . 0.28 107.839 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 1.2 tt0 -103.97 144.98 30.82 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.92 -1.141 . . . . 1.63 107.92 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.63 ' CE1' ' HG3' ' A' ' 84' ' ' GLN . 38.9 m-85 -125.67 143.56 50.98 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.008 -1.057 . . . . 0.3 110.212 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.29 115.7 30.49 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.845 -0.798 . . . . 2.82 108.845 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.923 HD12 ' HB1' ' A' ' 72' ' ' ALA . 3.4 tt -111.06 119.1 58.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.109 -0.995 . . . . 0.22 111.406 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.421 ' HA ' ' CG ' ' A' ' 38' ' ' GLU . 0.9 OUTLIER -94.39 119.35 33.0 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 104.662 -2.347 . . . . 2.17 104.662 175.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.607 ' CE2' ' O ' ' A' ' 91' ' ' THR . 24.0 t80 -132.7 143.04 49.36 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 117.539 -1.664 . . . . 0.62 113.982 -175.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.607 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -92.44 144.33 25.47 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 105.742 -1.947 . . . . 1.04 105.742 176.456 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.1 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 22.7 t90 -127.39 97.69 4.99 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.667 -1.271 . . . . 0.71 110.724 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 2.9 m-80 -61.75 103.08 0.31 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.646 -0.872 . . . . 1.88 108.646 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.731 HG13 ' HD2' ' A' ' 95' ' ' PRO . 88.3 t -59.23 144.02 83.96 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.325 -0.859 . . . . 0.95 108.747 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.952 ' HG3' HG13 ' A' ' 65' ' ' VAL . 29.4 Cg_endo -71.23 121.37 7.73 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.0 1.8 . . . . 1.15 110.165 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.486 ' HA ' ' HG2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -66.56 -0.98 3.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.818 -0.551 . . . . 3.02 110.971 -178.656 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.498 ' O ' ' C ' ' A' ' 98' ' ' ALA . 9.4 pt -92.41 -25.09 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.706 -1.246 . . . . 1.06 109.29 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.718 ' HB3' ' HG3' ' A' ' 31' ' ' ARG . . . -28.62 122.45 0.26 Allowed Pre-proline 0 N--CA 1.491 1.613 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.782 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.85 ' HG3' HD23 ' A' ' 61' ' ' LEU . 36.8 Cg_endo -87.01 115.57 1.19 Allowed 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.377 2.052 . . . . 1.03 107.995 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.518 ' CD ' ' HA ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -38.42 92.44 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.742 0.782 . . . . 4.1 108.946 -179.327 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 99' ' ' PRO . 1.4 t -102.76 115.03 29.79 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.33 -0.619 . . . . 0.62 109.33 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.472 ' O ' ' HE2' ' A' ' 126' ' ' LYS . 0.1 OUTLIER -41.15 -36.28 0.71 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.684 -0.635 . . . . 3.84 109.573 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 11.4 t-20 -128.48 138.36 52.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 2.32 110.097 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 1.026 HG21 HG13 ' A' ' 127' ' ' ILE . 20.2 t -135.79 150.54 28.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.573 -0.704 . . . . 1.39 109.896 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.539 HG23 ' OG ' ' A' ' 57' ' ' SER . 2.9 t -123.33 117.62 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.229 -1.026 . . . . 0.83 108.229 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.31 142.22 15.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 120.966 -1.084 . . . . 0.45 110.195 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 34.3 m -125.9 117.05 22.49 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.802 -0.561 . . . . 0.38 109.586 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER -96.78 125.79 49.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 106.945 -1.502 . . . . 0.31 106.945 178.338 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.854 ' HD2' HD11 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -135.41 137.03 41.86 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.552 -1.342 . . . . 1.02 111.504 -177.702 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.856 ' C ' HD12 ' A' ' 111' ' ' ILE . 10.0 mt -113.87 139.97 48.73 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.66 -1.607 . . . . 0.37 106.66 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.856 HD12 ' C ' ' A' ' 110' ' ' LEU . 3.7 mp -134.17 115.99 21.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 120.707 -1.245 . . . . 0.29 110.769 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.08 -150.85 16.26 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.364 -1.894 . . . . 0.62 108.364 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -96.65 -0.6 48.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.082 -1.246 . . . . 1.22 109.551 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.98 -2.52 12.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.095 -1.003 . . . . 4.25 110.401 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.28 -164.65 29.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.847 -1.301 . . . . 0.28 109.847 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.568 ' CG1' ' CD ' ' A' ' 109' ' ' LYS . 1.8 t -77.97 112.02 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -1.128 . . . . 0.39 109.671 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.93 -38.67 76.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 0.38 110.014 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.539 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -157.07 -171.05 3.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.001 -1.062 . . . . 0.36 109.128 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -177.44 151.24 0.75 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.263 -0.898 . . . . 0.47 109.393 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -149.63 153.2 36.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.045 . . . . 0.39 109.771 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.5 mt -134.81 138.91 48.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.371 -0.831 . . . . 0.89 108.783 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.07 133.62 34.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.84 -1.162 . . . . 0.91 109.732 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -68.41 0.34 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.466 -0.771 . . . . 2.49 109.928 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -128.76 142.07 51.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.9 . . . . 4.66 110.322 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -156.83 175.32 34.4 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.895 -1.682 . . . . 0.4 108.895 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' A' ' 102' ' ' GLU . 31.0 ttmt -153.07 138.44 17.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -1.14 . . . . 2.62 108.45 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 1.026 HG13 HG21 ' A' ' 104' ' ' VAL . 62.0 mt -106.61 140.31 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.427 -1.421 . . . . 0.32 109.738 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.518 ' HA ' ' CD ' ' A' ' 100' ' ' LYS . 10.4 mtt180 -132.42 174.93 9.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.401 -0.812 . . . . 2.02 108.948 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.2 t0 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.005 -1.06 . . . . 2.57 109.702 -179.759 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 17' ' ' MET . 4.3 m-20 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.203 -0.665 . . . . 2.58 109.203 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.531 ' CB ' ' HG2' ' A' ' 17' ' ' MET . 1.5 pt20 -109.08 154.33 22.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.166 -0.959 . . . . 1.73 109.991 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.586 HG21 HG23 ' A' ' 18' ' ' VAL . 2.3 m -105.58 162.97 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.33 -0.857 . . . . 0.2 109.121 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.32 126.28 38.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 3.36 109.141 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 121' ' ' ILE . 27.6 m -143.69 162.64 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.874 -0.787 . . . . 0.75 108.874 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -112.82 104.42 12.43 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.151 -1.055 . . . . 4.21 108.151 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -45.14 113.04 0.51 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.406 -0.809 . . . . 1.21 110.18 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.507 ' HB3' HG13 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -83.84 -7.47 59.44 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.636 -0.875 . . . . 0.91 108.636 179.225 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.536 ' N ' ' HB3' ' A' ' 119' ' ' CYS . . . -88.54 -79.52 0.31 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.371 -0.83 . . . . 0.97 109.5 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 178.83 61.13 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.761 -0.776 . . . . 1.36 109.682 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 57.93 17.98 4.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.293 -0.879 . . . . 0.96 109.362 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.412 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -67.83 -66.81 0.52 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.355 -0.841 . . . . 1.41 109.606 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.695 HD13 ' HB1' ' A' ' 39' ' ' ALA . 0.9 OUTLIER -56.23 120.0 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.0 -1.063 . . . . 0.61 109.769 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.596 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -61.0 -29.08 69.49 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.443 -0.786 . . . . 2.02 109.452 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.596 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 6.9 pttt 168.07 131.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.579 -0.897 . . . . 0.84 108.579 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.104 HG23 ' HB2' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -108.18 130.79 60.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.054 -1.091 . . . . 0.43 108.054 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.531 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 8.2 mtm -122.63 153.22 39.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.074 -1.016 . . . . 0.65 111.012 -177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.075 HG11 ' CE2' ' A' ' 35' ' ' PHE . 2.5 t -127.0 128.36 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.577 -0.898 . . . . 0.62 108.577 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.79 -17.39 35.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.149 -0.969 . . . . 2.45 110.496 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 21' ' ' CYS . . . -88.33 -94.68 1.01 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.646 -1.381 . . . . 1.13 109.646 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' O ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -47.53 173.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.213 -1.169 . . . . 0.69 108.975 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.493 ' NE2' ' CB ' ' A' ' 25' ' ' ASP . 5.5 p80 -139.48 3.34 2.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.927 -1.108 . . . . 4.38 110.594 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.13 -157.51 27.91 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.054 -1.545 . . . . 1.21 110.951 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.468 ' O ' ' C ' ' A' ' 25' ' ' ASP . 5.0 t -41.35 -36.27 0.79 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.613 -0.934 . . . . 2.75 110.553 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.493 ' CB ' ' NE2' ' A' ' 22' ' ' HIS . 0.7 OUTLIER -39.92 157.18 0.15 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.5 -0.75 . . . . 2.12 109.607 -179.648 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.82 138.88 19.22 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.957 2.438 . . . . 0.83 110.746 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -116.25 132.66 56.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.446 -0.784 . . . . 0.93 109.331 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 46.6 mm -101.97 109.31 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.019 -1.051 . . . . 0.65 108.616 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.3 mt -92.53 113.43 27.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.212 -0.93 . . . . 0.62 109.391 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.505 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -89.63 105.97 18.15 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.468 -1.308 . . . . 1.4 107.468 178.736 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.769 ' HA ' HG11 ' A' ' 94' ' ' VAL . 2.6 ptt180 -45.26 152.55 0.27 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.055 -1.028 . . . . 1.08 110.051 -178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.453 ' HA2' ' HD3' ' A' ' 96' ' ' LYS . . . 94.58 -15.88 62.36 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.57 -1.412 . . . . 0.42 109.57 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.505 ' HE2' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -102.3 152.51 38.3 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.178 -1.189 . . . . 2.11 109.445 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -81.3 119.85 3.53 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.886 2.391 . . . . 0.5 110.825 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 1.075 ' CE2' HG11 ' A' ' 18' ' ' VAL . 5.2 t80 -97.83 116.81 30.78 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.945 -1.502 . . . . 0.69 106.945 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.94 ' C ' HD13 ' A' ' 37' ' ' LEU . 28.3 m -96.21 131.03 43.12 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.15 -0.969 . . . . 0.69 110.838 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.94 HD13 ' C ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -134.64 141.63 46.64 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.696 -0.854 . . . . 0.41 108.696 178.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 0.7 OUTLIER -121.66 127.09 50.42 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.293 -1.003 . . . . 1.16 108.293 -179.621 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 1.104 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -132.75 121.51 23.16 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.597 -1.314 . . . . 0.33 110.513 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.578 HD23 ' HB3' ' A' ' 87' ' ' ASP . 2.3 mt -88.28 145.03 26.08 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 105.488 -2.041 . . . . 0.9 105.488 177.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.659 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 28.2 p90 -157.15 141.93 16.84 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.143 -1.423 . . . . 0.27 110.38 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 26.8 m-20 -85.51 111.01 19.61 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.202 -0.936 . . . . 1.36 108.79 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -46.82 114.8 0.9 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.703 -0.623 . . . . 0.29 109.329 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.453 ' OD1' HD23 ' A' ' 117' ' ' LEU . 38.8 p30 -83.66 7.85 16.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.096 -1.003 . . . . 1.92 109.847 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.53 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 3.5 pt20 -168.39 162.02 12.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.068 -1.02 . . . . 0.85 109.685 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 10.7 p-10 -89.1 120.55 30.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.215 -0.928 . . . . 2.75 109.245 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -141.6 141.74 33.46 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.57 110.17 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.677 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 8.0 mmmt -84.12 -11.45 56.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.54 -0.725 . . . . 0.75 109.688 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.2 p -144.75 138.1 26.94 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.977 0.894 . . . . 0.55 109.729 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -126.57 153.23 45.52 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.691 -0.855 . . . . 0.37 108.691 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 0.5 OUTLIER -132.09 136.92 47.52 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.959 -1.088 . . . . 0.4 110.833 -179.035 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.696 HG22 ' O ' ' A' ' 69' ' ' ASP . 4.5 tt -93.61 148.95 4.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.527 -1.286 . . . . 0.69 107.527 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.413 ' N ' HG12 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -139.07 116.8 11.47 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.146 -0.972 . . . . 0.77 109.142 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.795 HD13 HG21 ' A' ' 68' ' ' ILE . 2.8 mp -116.12 116.84 53.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 119.256 -0.978 . . . . 0.3 109.259 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.475 ' HA ' HG23 ' A' ' 65' ' ' VAL . 26.6 mtmt -114.87 159.45 20.65 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.181 -0.95 . . . . 0.87 108.993 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.59 122.56 22.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.884 -1.135 . . . . 0.29 110.482 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -93.21 150.85 20.2 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.777 -0.823 . . . . 2.7 108.777 179.261 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.823 HD11 HD11 ' A' ' 63' ' ' ILE . 20.4 mt -103.29 38.78 1.7 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.193 -0.942 . . . . 1.05 109.491 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 4.3 t0 72.58 5.46 5.24 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.512 -0.743 . . . . 2.06 109.324 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.06 -35.68 0.03 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.911 -1.275 . . . . 1.65 109.911 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 61' ' ' LEU . 7.0 mp -114.05 113.41 24.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.988 -1.301 . . . . 4.8 109.664 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 17.0 tt0 -77.78 137.05 38.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.967 -1.083 . . . . 1.71 109.936 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.823 HD11 HD11 ' A' ' 58' ' ' LEU . 74.0 mt -123.01 169.54 14.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-O 121.687 0.756 . . . . 1.2 109.079 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.686 ' N ' HG22 ' A' ' 63' ' ' ILE . 3.6 m-20 -114.18 129.59 56.62 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.198 -1.408 . . . . 2.18 107.198 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.066 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 2.7 t -103.26 112.67 65.86 Favored Pre-proline 0 C--N 1.303 -1.451 0 O-C-N 120.848 -1.157 . . . . 0.33 111.418 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.565 ' O ' HG23 ' A' ' 68' ' ' ILE . 36.3 Cg_endo -82.71 -154.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.261 2.641 . . . . 0.43 109.522 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.23 31.86 74.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.641 -1.384 . . . . 0.93 109.641 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.795 HG21 HD13 ' A' ' 54' ' ' ILE . 17.8 pt -125.79 -165.33 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.315 -1.109 . . . . 0.4 108.968 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.696 ' O ' HG22 ' A' ' 52' ' ' ILE . 38.7 t0 -103.05 112.32 25.1 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.221 -0.924 . . . . 1.47 109.495 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.515 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 10.3 p -87.11 45.46 1.27 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.492 -0.929 . . . . 0.35 108.492 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 23.8 t30 -179.85 74.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.429 -1.322 . . . . 0.92 107.429 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.617 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -59.5 -5.84 0.93 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.629 -0.669 . . . . 0.19 112.1 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.589 ' HA ' HG22 ' A' ' 76' ' ' VAL . 1.3 t -62.71 -14.34 43.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.43 -1.419 . . . . 0.2 108.621 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -25.81 63.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.964 . . . . 0.92 109.858 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.482 ' HB2' HG13 ' A' ' 88' ' ' ILE . 68.2 m-85 -111.62 -23.8 10.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.838 . . . . 0.27 109.896 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.851 ' CG2' HD21 ' A' ' 80' ' ' LEU . 1.5 m -104.42 171.69 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.047 -1.094 . . . . 0.25 108.047 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.592 ' HG3' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -94.27 92.43 7.21 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.156 -0.965 . . . . 1.32 110.82 -178.257 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.486 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 15.3 p -90.12 149.62 41.82 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 107.579 -1.267 . . . . 0.21 107.579 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.677 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.7 Cg_endo -70.17 133.86 27.98 Favored 'Cis proline' 0 C--N 1.312 -1.367 0 C-N-CA 124.171 -1.179 . . . . 0.17 112.906 2.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.851 HD21 ' CG2' ' A' ' 76' ' ' VAL . 14.0 mt -75.54 112.89 12.34 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.832 -1.544 . . . . 0.25 106.832 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 45.8 t -80.85 138.91 18.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 CA-C-O 121.668 0.746 . . . . 0.52 110.679 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.53 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 34.9 tttt -64.24 112.43 3.04 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.666 0.746 . . . . 2.12 109.326 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.87 -14.25 9.73 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 109.927 -1.269 . . . . 0.39 109.927 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.617 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 33.8 tp60 -101.17 153.12 19.87 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.83 -1.174 . . . . 2.38 107.83 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 1.4 tt0 -102.61 155.52 18.24 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.811 -1.181 . . . . 1.91 107.811 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.648 ' CE2' HD23 ' A' ' 80' ' ' LEU . 63.3 m-85 -134.81 151.8 51.23 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.065 -1.022 . . . . 0.34 109.981 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.578 ' HB3' HD23 ' A' ' 40' ' ' LEU . 4.5 p-10 -120.62 113.43 20.23 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.253 -0.905 . . . . 0.65 109.624 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.717 ' HB ' HG12 ' A' ' 76' ' ' VAL . 5.4 tt -110.78 121.59 63.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.271 -0.893 . . . . 0.28 111.705 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -104.11 109.75 21.66 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 104.741 -2.318 . . . . 2.75 104.741 175.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.632 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 39.7 t80 -125.42 142.33 51.56 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.83 -1.169 . . . . 0.42 113.174 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.632 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.2 144.14 25.93 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.625 -1.62 . . . . 0.89 106.625 176.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.066 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 24.7 t90 -118.83 87.79 2.8 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.896 -1.128 . . . . 0.68 110.328 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -64.19 104.12 0.7 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.471 0.653 . . . . 1.59 109.351 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.879 HG12 ' H ' ' A' ' 96' ' ' LYS . 52.2 t -56.14 143.56 63.1 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.524 -0.735 . . . . 1.8 109.312 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.7 ' HD2' HG13 ' A' ' 94' ' ' VAL . 25.0 Cg_endo -64.92 -3.35 6.86 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.835 2.356 . . . . 3.93 111.992 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.879 ' H ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER 66.81 1.38 2.22 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.982 -1.074 . . . . 3.25 109.515 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.519 ' O ' ' C ' ' A' ' 98' ' ' ALA . 10.0 pt -100.45 -30.16 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 120.96 -1.087 . . . . 0.54 108.399 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.574 ' HB1' HD13 ' A' ' 127' ' ' ILE . . . -33.15 117.93 0.44 Allowed Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.637 -0.875 . . . . 0.48 108.637 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 98' ' ' ALA . 32.7 Cg_endo -79.18 174.5 11.97 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.541 2.161 . . . . 0.99 110.19 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.516 ' HE3' ' HG2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -80.84 72.32 7.82 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.513 -0.921 . . . . 4.05 108.513 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.867 ' OG ' HG23 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -81.84 103.85 11.8 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.595 -0.891 . . . . 2.22 108.595 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.54 ' HG3' ' N ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -41.3 -30.17 0.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.34 -0.85 . . . . 5.03 109.565 -179.161 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.54 ' N ' ' HG3' ' A' ' 102' ' ' GLU . 0.6 OUTLIER -132.96 132.01 41.46 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.152 -0.967 . . . . 2.44 109.542 179.219 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.904 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.9 OUTLIER -132.05 144.59 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.342 -0.849 . . . . 0.85 109.978 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 122' ' ' ALA . 31.8 t -119.79 113.83 42.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.468 -1.308 . . . . 0.46 107.468 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.58 137.6 23.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 120.721 -1.237 . . . . 0.34 110.361 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 81.5 m -118.59 125.27 49.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.811 -0.556 . . . . 0.55 109.76 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -102.42 129.9 53.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.322 -1.362 . . . . 0.33 107.322 178.2 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.55 ' HG2' ' CG1' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -141.04 131.15 24.74 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.078 -1.639 . . . . 1.81 112.296 -178.082 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.659 ' CD1' ' CE2' ' A' ' 41' ' ' PHE . 16.2 mt -104.36 139.62 39.06 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.671 -1.603 . . . . 0.35 106.671 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.615 HD12 ' C ' ' A' ' 110' ' ' LEU . 5.1 mp -138.66 112.06 7.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 120.66 -1.275 . . . . 0.39 110.289 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.75 -150.19 7.81 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.481 -1.847 . . . . 0.56 108.481 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.28 -1.74 50.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.219 -1.165 . . . . 1.68 109.759 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -115.04 -0.36 13.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -0.956 . . . . 2.49 110.714 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.62 -169.61 27.78 Favored Glycine 0 N--CA 1.496 2.662 0 C-N-CA 119.525 -1.322 . . . . 0.54 110.305 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.55 ' CG1' ' HG2' ' A' ' 109' ' ' LYS . 44.4 t -77.5 111.2 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.296 -1.12 . . . . 1.07 109.867 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.453 HD23 ' OD1' ' A' ' 44' ' ' ASN . 28.3 mt -60.35 -41.37 93.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.32 109.874 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.645 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -151.75 176.15 11.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.967 -1.083 . . . . 0.69 109.526 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.536 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 42.8 t -164.13 154.05 14.53 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.042 -1.036 . . . . 0.57 109.007 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -150.44 154.95 38.62 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.837 -1.164 . . . . 0.32 110.353 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.507 HG13 ' HB3' ' A' ' 8' ' ' CYS . 72.4 mt -130.87 140.37 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.318 -0.864 . . . . 1.01 109.003 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.801 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -120.1 145.79 46.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.45 -1.406 . . . . 0.57 109.033 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.92 170.45 15.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.084 -1.01 . . . . 2.7 109.731 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 9.0 m80 64.34 40.52 6.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -0.848 . . . . 4.0 109.801 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -111.13 162.78 12.37 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.273 -1.531 . . . . 0.58 109.273 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.408 ' HB3' HD13 ' A' ' 28' ' ' ILE . 15.7 tttt -149.56 137.34 20.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -1.179 . . . . 4.31 108.615 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.904 ' CD1' HG21 ' A' ' 104' ' ' VAL . 61.2 mt -105.53 139.74 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.604 -1.31 . . . . 0.37 110.255 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.516 ' HG2' ' HE3' ' A' ' 100' ' ' LYS . 1.4 mtm180 -133.76 162.87 30.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.467 -0.77 . . . . 4.74 109.216 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.061 -0.971 . . . . 4.93 109.201 179.559 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.438 -0.579 . . . . 2.99 109.438 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -71.81 135.26 46.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.228 -0.92 . . . . 2.66 109.407 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 3.0 m -105.49 169.03 2.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.226 -0.922 . . . . 1.15 109.337 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -75.77 122.67 24.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 1.77 110.851 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -150.41 157.42 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.987 -1.116 . . . . 2.35 107.987 178.426 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -117.42 110.26 17.79 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.083 -1.011 . . . . 3.37 109.715 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.487 ' OD2' ' HB ' ' A' ' 13' ' ' ILE . 0.8 OUTLIER -49.65 152.49 1.42 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.482 -0.761 . . . . 1.62 109.909 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.469 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.1 OUTLIER -128.47 27.24 5.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.264 -0.898 . . . . 2.67 108.791 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.58 ' O ' ' ND2' ' A' ' 10' ' ' ASN . . . -116.25 -76.56 0.57 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.394 -0.816 . . . . 0.68 109.773 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.58 ' ND2' ' O ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER 174.21 68.6 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.069 -0.715 . . . . 1.17 109.069 -178.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 55.08 35.59 25.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.194 -0.941 . . . . 2.67 108.874 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.5 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -87.3 -79.2 0.28 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.456 -0.777 . . . . 1.18 109.805 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.528 ' CD1' ' HB1' ' A' ' 118' ' ' ALA . 0.7 OUTLIER -46.36 127.64 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.53 109.682 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.572 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -77.65 -24.99 49.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.477 -0.935 . . . . 1.17 108.477 179.422 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 167.61 129.56 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.781 -0.822 . . . . 1.94 108.781 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.81 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -111.87 121.51 64.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.176 -1.046 . . . . 0.48 108.176 179.553 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 3.4 mtm -110.48 150.78 28.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.924 -1.11 . . . . 1.33 110.895 -178.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.641 HG11 ' CE2' ' A' ' 35' ' ' PHE . 51.5 t -119.0 159.42 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.411 -0.959 . . . . 0.6 108.411 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.489 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -105.12 69.19 0.84 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.017 -1.052 . . . . 1.32 109.57 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.89 -50.41 0.27 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.648 -1.263 . . . . 0.97 110.231 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 39.7 t -80.71 150.89 29.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.988 -1.301 . . . . 1.25 110.011 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.47 -177.08 3.97 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.415 -0.803 . . . . 3.31 109.262 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 3' ' ' VAL . . . -65.0 -120.55 0.01 OUTLIER Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.069 -1.212 . . . . 1.92 110.069 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLY . 14.1 p -38.55 -44.73 0.99 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.653 -0.91 . . . . 1.27 110.234 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -44.53 156.91 0.32 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.106 -0.996 . . . . 1.51 109.221 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 124' ' ' HIS . 35.9 Cg_endo -77.82 173.28 14.31 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.645 2.23 . . . . 1.34 110.183 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.453 ' O ' HD13 ' A' ' 28' ' ' ILE . 5.4 m -122.11 135.91 54.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.068 -1.02 . . . . 0.79 110.037 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 27' ' ' CYS . 7.7 mm -110.35 107.96 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.276 -0.89 . . . . 1.14 108.664 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.409 HG23 HG21 ' A' ' 94' ' ' VAL . 1.4 mp -87.76 122.74 39.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.184 -0.948 . . . . 0.76 109.632 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 7.1 m80 -90.22 101.6 14.32 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.673 0.749 . . . . 1.19 109.215 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.833 ' HG3' ' HB3' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -37.74 146.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.61 0.719 . . . . 1.79 111.114 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.67 -5.63 56.49 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.678 -0.969 . . . . 0.87 110.678 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -104.85 152.24 39.52 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.758 -1.436 . . . . 1.73 110.214 -179.532 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.81 118.41 3.1 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.101 2.534 . . . . 0.46 111.291 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.641 ' CE2' HG11 ' A' ' 18' ' ' VAL . 2.6 t80 -97.75 123.69 41.79 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.135 -1.431 . . . . 0.65 107.135 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.732 ' C ' HD13 ' A' ' 37' ' ' LEU . 61.8 m -107.37 136.16 47.63 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.515 -1.365 . . . . 0.35 110.813 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.947 ' N ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -141.21 123.59 15.79 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.938 -0.764 . . . . 0.78 108.938 179.224 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -102.43 134.02 46.42 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.899 -1.148 . . . . 0.89 107.899 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.81 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -129.62 120.14 24.76 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 118.767 -1.173 . . . . 0.42 110.683 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.563 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 15.8 mt -89.56 140.63 29.35 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 105.378 -2.082 . . . . 0.79 105.378 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 27.3 p90 -155.2 139.2 16.38 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.046 -1.462 . . . . 0.39 110.528 -178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.3 m-20 -84.54 108.96 17.58 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.987 -1.116 . . . . 1.14 107.987 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -44.3 113.77 0.58 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.801 -0.814 . . . . 0.17 108.801 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.583 ' ND2' ' OE1' ' A' ' 45' ' ' GLN . 0.9 OUTLIER -83.5 10.3 9.25 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.073 -1.017 . . . . 0.58 109.595 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.583 ' OE1' ' ND2' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -168.28 158.11 9.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.382 -0.824 . . . . 0.74 109.312 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -88.35 120.36 29.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.177 -0.952 . . . . 1.71 109.537 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.513 ' O ' ' CA ' ' A' ' 79' ' ' PRO . 3.3 t -143.74 153.09 42.07 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.244 -0.91 . . . . 0.37 109.313 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.673 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -98.61 -25.84 14.59 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.663 -1.236 . . . . 6.51 107.663 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.408 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 24.6 p -111.3 138.33 47.91 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 122.134 0.968 . . . . 1.4 109.766 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -142.21 154.23 44.64 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.837 -0.801 . . . . 0.47 108.837 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.516 ' HD2' ' CB ' ' A' ' 70' ' ' THR . 1.6 mtmt -145.29 141.06 28.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.009 -1.057 . . . . 0.4 111.038 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 69' ' ' ASP . 9.7 tt -94.69 152.05 3.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.227 -1.397 . . . . 0.45 107.227 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -140.45 118.1 11.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.93 -1.106 . . . . 0.39 110.15 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.781 HD12 ' N ' ' A' ' 54' ' ' ILE . 2.2 mp -117.78 115.56 48.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.017 -1.052 . . . . 0.29 109.267 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 13.6 mttm -115.6 157.4 24.21 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.466 -0.938 . . . . 2.09 108.466 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.52 123.95 26.09 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.692 -1.255 . . . . 0.35 110.576 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 16.0 m -90.37 146.3 24.28 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.451 -0.944 . . . . 2.9 108.451 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.874 HD11 ' CD1' ' A' ' 63' ' ' ILE . 15.9 mt -113.18 48.27 1.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.027 -1.045 . . . . 0.61 109.989 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.401 ' OD2' ' CG ' ' A' ' 102' ' ' GLU . 0.4 OUTLIER 58.0 14.99 2.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.482 -0.761 . . . . 1.04 109.866 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.75 -41.61 0.16 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.964 -1.254 . . . . 1.03 109.964 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 58' ' ' LEU . 9.7 tp -106.53 111.32 23.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.204 -1.174 . . . . 0.84 109.304 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 30.4 tt0 -83.96 134.51 34.65 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.289 -0.882 . . . . 0.7 108.751 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.874 ' CD1' HD11 ' A' ' 58' ' ' LEU . 79.8 mt -124.89 166.46 20.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 122.011 0.91 . . . . 0.75 109.596 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.645 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -115.23 108.83 17.1 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 106.426 -1.694 . . . . 1.21 106.426 177.233 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.108 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 2.5 t -73.61 113.72 25.31 Favored Pre-proline 0 C--N 1.297 -1.688 0 O-C-N 121.267 -0.895 . . . . 0.4 111.027 -177.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.511 ' O ' HG23 ' A' ' 68' ' ' ILE . 36.7 Cg_endo -83.41 -159.4 0.1 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.956 2.437 . . . . 0.72 109.806 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.43 20.67 38.36 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.031 -1.228 . . . . 0.41 110.031 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.762 HG22 ' CD1' ' A' ' 92' ' ' TRP . 34.0 pt -105.93 -165.93 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -1.177 . . . . 0.33 109.09 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.67 ' O ' HG22 ' A' ' 52' ' ' ILE . 3.1 t70 -105.41 106.44 16.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 1.24 110.083 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.516 ' CB ' ' HD2' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -86.74 47.56 1.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.361 -0.977 . . . . 0.39 108.361 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 73' ' ' CYS . 17.9 t-20 176.72 85.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.609 -1.256 . . . . 1.62 107.609 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.654 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -73.02 8.07 1.76 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.333 -0.854 . . . . 0.35 112.057 -177.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.486 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 2.1 m -65.13 -13.27 57.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.698 -1.251 . . . . 2.14 109.485 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -82.27 -14.78 54.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.23 -0.919 . . . . 0.74 109.864 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.54 ' CB ' HG13 ' A' ' 88' ' ' ILE . 35.0 m-85 -121.64 -14.15 8.22 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.205 -0.935 . . . . 0.65 109.42 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.702 HG12 ' HB ' ' A' ' 88' ' ' ILE . 1.4 m -119.51 162.64 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.208 -0.932 . . . . 0.38 108.602 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.621 ' HG3' ' CD2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -96.65 84.2 3.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.221 -0.924 . . . . 5.77 111.136 -178.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.525 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 5.0 p -83.09 159.51 62.4 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.694 -1.254 . . . . 0.83 107.944 178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.673 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 23.7 Cg_endo -67.14 130.52 13.6 Favored 'Cis proline' 0 C--N 1.311 -1.422 0 C-N-CA 124.25 -1.146 . . . . 0.54 112.281 2.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.628 HD23 ' CE2' ' A' ' 86' ' ' TYR . 14.7 mt -71.67 107.84 4.71 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.75 -1.204 . . . . 0.51 107.75 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 61.0 t -78.69 136.11 24.54 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 CA-C-O 121.742 0.782 . . . . 0.3 110.211 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 23.3 tttt -62.51 110.09 1.58 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.708 0.766 . . . . 2.66 110.12 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 126.28 -16.76 6.69 Favored Glycine 0 N--CA 1.48 1.63 0 N-CA-C 110.185 -1.166 . . . . 0.15 110.185 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.575 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 3.3 tp-100 -101.95 156.48 17.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.066 -1.255 . . . . 2.13 108.141 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.555 ' C ' ' CD1' ' A' ' 86' ' ' TYR . 1.2 tt0 -106.02 153.69 21.68 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.096 -1.076 . . . . 1.99 108.096 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.628 ' CE2' HD23 ' A' ' 80' ' ' LEU . 23.4 m-85 -131.5 151.45 51.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.055 -1.028 . . . . 0.52 110.218 -178.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.563 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -118.27 113.86 22.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.527 -0.733 . . . . 2.19 110.063 -178.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.702 ' HB ' HG12 ' A' ' 76' ' ' VAL . 1.8 tt -115.59 119.41 61.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.181 -0.949 . . . . 0.48 111.353 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -101.39 106.88 18.08 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 104.87 -2.27 . . . . 2.31 104.87 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.627 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 32.2 t80 -119.97 141.23 49.87 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.869 -1.133 . . . . 0.38 112.544 -176.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.541 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -91.67 145.34 24.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.55 -1.648 . . . . 0.82 106.55 177.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.108 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 51.3 t90 -127.03 94.26 3.98 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.243 -0.911 . . . . 0.89 109.495 -177.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -57.42 104.88 0.19 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.66 -0.816 . . . . 2.13 108.8 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.717 HG22 ' CZ3' ' A' ' 92' ' ' TRP . 71.4 t -58.85 141.56 85.38 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 107.879 -1.156 . . . . 0.62 107.879 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.944 ' HG3' HG13 ' A' ' 65' ' ' VAL . 29.8 Cg_endo -71.58 124.66 10.48 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 C-N-CA 121.781 1.654 . . . . 0.5 109.992 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.531 ' HA ' ' HG2' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -67.87 -2.75 7.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.534 -0.729 . . . . 3.01 109.681 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 95' ' ' PRO . 3.8 pt -88.23 -24.59 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.54 109.318 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.833 ' HB3' ' HG3' ' A' ' 31' ' ' ARG . . . -29.07 120.04 0.28 Allowed Pre-proline 0 N--CA 1.492 1.635 0 CA-C-N 116.054 -0.521 . . . . 0.74 110.76 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.609 ' HG2' HD13 ' A' ' 58' ' ' LEU . 37.3 Cg_endo -86.09 133.29 4.07 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.565 2.176 . . . . 0.56 108.688 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.557 ' HD2' ' N ' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -50.98 91.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.851 -1.156 . . . . 5.4 107.913 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.604 ' HB3' HG23 ' A' ' 104' ' ' VAL . 3.6 t -94.51 114.45 26.45 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.576 -0.702 . . . . 0.46 109.465 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 11.4 pt-20 -38.85 -41.43 0.74 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.218 -0.66 . . . . 1.6 109.218 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.429 ' N ' ' CG ' ' A' ' 102' ' ' GLU . 1.7 t-20 -134.67 140.73 46.23 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.497 -0.752 . . . . 3.06 109.016 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.981 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.9 OUTLIER -133.47 146.74 31.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 121.344 -0.848 . . . . 0.64 108.99 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 t -126.53 114.81 39.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.815 -1.18 . . . . 0.67 107.815 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 38.9 t -97.5 137.94 23.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.293 -0.963 . . . . 0.5 109.897 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 81.1 m -117.52 115.74 25.75 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.605 -0.684 . . . . 0.37 109.617 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -94.79 128.57 45.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.466 -1.679 . . . . 0.45 106.466 177.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.558 ' HG2' ' CG1' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -141.24 130.45 23.5 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.281 -1.512 . . . . 0.95 112.378 -177.052 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.4 mt -102.53 139.49 38.06 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.165 -1.791 . . . . 0.8 106.165 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.573 HD12 ' C ' ' A' ' 110' ' ' LEU . 4.5 mp -137.07 114.73 13.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.746 -1.221 . . . . 0.45 110.25 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.475 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -87.97 -139.66 6.52 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.358 -1.897 . . . . 0.74 108.358 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.99 -0.0 27.29 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.192 -1.181 . . . . 2.05 109.592 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -116.41 4.53 13.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 2.08 110.479 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 142.42 -160.23 27.26 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.709 -1.357 . . . . 0.55 109.709 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.558 ' CG1' ' HG2' ' A' ' 109' ' ' LYS . 72.1 t -85.12 110.48 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -1.156 . . . . 1.1 109.589 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.567 HD13 ' CD1' ' A' ' 80' ' ' LEU . 77.6 mt -57.87 -39.16 77.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.5 110.56 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.544 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -152.08 175.11 12.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.933 -1.104 . . . . 0.88 109.227 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 42.4 t -168.11 153.76 7.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.571 -1.33 . . . . 0.49 110.018 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.13 149.79 29.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.05 -1.031 . . . . 0.45 110.102 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.447 HD12 ' SG ' ' A' ' 8' ' ' CYS . 4.3 mt -134.58 116.66 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.941 -1.133 . . . . 0.71 107.941 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.553 ' HB2' HG13 ' A' ' 5' ' ' VAL . . . -105.71 121.1 43.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.908 -1.12 . . . . 1.48 110.264 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.28 -156.79 0.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.438 -0.789 . . . . 2.43 108.885 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 0.2 OUTLIER 46.54 30.41 1.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.003 -1.061 . . . . 2.18 108.997 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -100.09 155.91 19.59 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.889 -1.148 . . . . 0.29 110.535 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 39.7 mttm -154.0 136.33 14.92 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.435 -1.32 . . . . 2.97 107.435 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.981 ' CD1' HG21 ' A' ' 104' ' ' VAL . 60.3 mt -107.68 134.71 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.327 -1.483 . . . . 0.26 111.52 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.543 ' CD ' ' N ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -116.15 177.02 4.84 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.797 -0.816 . . . . 3.14 108.797 178.141 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.557 ' N ' ' HD2' ' A' ' 100' ' ' LYS . 24.6 t0 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.073 -0.965 . . . . 1.2 109.61 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.335 -0.617 . . . . 1.22 109.335 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.478 ' HB2' ' HG2' ' A' ' 17' ' ' MET . 42.1 tt0 -78.18 140.56 38.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 1.53 109.746 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.531 HG23 HG13 ' A' ' 5' ' ' VAL . 3.7 m -101.85 169.36 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.295 -0.878 . . . . 1.29 109.155 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.403 ' C ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -90.59 122.91 33.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 3.11 110.806 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 3' ' ' VAL . 29.6 m -153.47 149.56 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.015 -1.106 . . . . 0.51 108.015 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.27 110.31 20.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.781 -1.199 . . . . 5.09 110.569 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.32 134.49 39.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 2.84 108.916 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.47 ' HB3' HD13 ' A' ' 121' ' ' ILE . 4.3 p -106.61 -2.87 21.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.131 -0.98 . . . . 1.37 110.017 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 10' ' ' ASN . . . -73.81 -58.29 3.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.13 -0.981 . . . . 1.02 109.435 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 0.2 OUTLIER 167.2 50.86 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.85 -1.167 . . . . 3.44 107.85 -178.71 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 10' ' ' ASN . 52.9 t30 63.8 15.83 9.34 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.017 -1.105 . . . . 2.05 108.017 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.525 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -58.74 -62.1 2.12 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.501 -0.749 . . . . 1.28 109.266 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -59.19 128.27 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.37 109.583 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.567 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 9.9 mmpt? -85.35 -13.98 47.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.461 -0.775 . . . . 0.6 109.856 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.567 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.9 ttpt 156.96 127.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.06 -0.718 . . . . 1.38 109.06 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.711 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -114.3 123.92 70.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.367 -0.833 . . . . 0.53 108.949 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.478 ' HG2' ' HB2' ' A' ' 2' ' ' GLN . 2.8 mtm -115.76 147.84 40.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.13 -0.981 . . . . 0.83 110.268 -179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.013 HG11 ' CE2' ' A' ' 35' ' ' PHE . 44.3 t -127.07 129.21 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.936 -0.764 . . . . 0.56 108.936 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -83.27 87.26 6.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 1.42 109.783 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.44 -68.07 0.22 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.531 -1.428 . . . . 0.96 109.531 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.5 m -76.95 -167.6 0.89 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.354 -1.086 . . . . 3.25 109.418 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.57 175.83 9.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.041 -1.037 . . . . 4.52 109.813 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 3' ' ' VAL . . . -114.09 150.44 18.6 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.364 -1.494 . . . . 3.31 109.364 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER 72.71 1.5 4.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.042 -1.269 . . . . 2.05 109.116 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.482 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 1.1 m-20 -135.43 176.01 3.18 Favored Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 108.267 -1.012 . . . . 1.61 108.267 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 34.4 Cg_endo -76.33 135.97 17.29 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.933 1.755 . . . . 0.75 109.66 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.66 139.34 47.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.369 -0.832 . . . . 2.49 108.819 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.627 HG23 ' HG3' ' A' ' 128' ' ' ARG . 46.6 mm -112.11 115.78 50.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.167 -0.958 . . . . 0.91 109.841 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.3 mt -103.93 118.13 50.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.505 -0.924 . . . . 0.85 108.505 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.537 ' HB2' ' CE ' ' A' ' 33' ' ' LYS . 14.0 m80 -84.87 125.02 32.28 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.156 -0.965 . . . . 1.04 109.241 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.579 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 3.2 ptt180 -70.78 125.47 26.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.124 -0.985 . . . . 1.29 109.84 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.56 -9.17 26.15 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.745 -1.342 . . . . 0.3 109.745 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.537 ' CE ' ' HB2' ' A' ' 30' ' ' HIS . 1.6 ptpt -112.38 158.51 37.01 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.174 -1.192 . . . . 1.76 109.647 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 33' ' ' LYS . 36.2 Cg_endo -78.01 136.38 14.7 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 C-N-CA 122.981 2.454 . . . . 0.39 111.484 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 1.013 ' CE2' HG11 ' A' ' 18' ' ' VAL . 2.5 t80 -117.67 116.88 27.94 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.673 -1.232 . . . . 0.74 107.673 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.783 ' O ' HG13 ' A' ' 18' ' ' VAL . 23.1 m -96.93 137.16 36.45 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.95 -1.094 . . . . 0.93 110.76 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.498 ' HB3' HG22 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -147.82 125.84 12.08 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.843 -0.799 . . . . 4.01 108.843 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -100.23 125.32 46.38 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.723 -1.214 . . . . 1.41 107.723 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.711 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -124.43 118.39 26.56 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.986 -1.086 . . . . 0.45 110.809 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 12.3 mt -91.04 140.82 29.48 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.487 -1.671 . . . . 0.62 106.487 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.621 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 25.1 p90 -156.68 141.24 16.8 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 120.898 -1.126 . . . . 0.24 109.193 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 7.7 m-20 -84.81 111.48 19.66 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 118.938 -1.105 . . . . 1.36 109.057 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -45.33 113.46 0.58 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.958 -0.756 . . . . 0.13 108.958 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' OD1' ' C ' ' A' ' 44' ' ' ASN . 36.0 p30 -88.35 10.08 21.11 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.291 -0.88 . . . . 1.49 109.382 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.615 HE21 HD23 ' A' ' 117' ' ' LEU . 1.5 pt20 -165.95 144.09 5.74 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.285 -0.884 . . . . 1.91 110.005 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.4 p-10 -80.57 119.1 22.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -0.856 . . . . 1.3 108.998 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.54 HG21 ' HA3' ' A' ' 112' ' ' GLY . 0.1 OUTLIER -138.98 144.59 39.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.924 -1.11 . . . . 0.35 109.849 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.69 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 20.0 mmmt -85.14 -9.37 57.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -0.888 . . . . 0.66 109.676 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 48' ' ' LYS . 9.7 p -151.01 139.75 20.76 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.762 0.791 . . . . 0.41 109.42 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -129.9 156.1 44.95 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 121.72 -0.613 . . . . 0.3 109.384 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.552 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 0.1 OUTLIER -128.98 127.61 42.02 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.327 -0.858 . . . . 0.58 111.174 -178.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.757 ' HA ' HD23 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -101.57 127.58 54.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.834 -1.543 . . . . 1.21 106.834 176.441 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.589 ' CD ' ' N ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -140.71 116.68 10.44 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.1 -1.0 . . . . 4.66 108.43 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.792 HD12 HD13 ' A' ' 68' ' ' ILE . 4.2 mp -94.2 129.94 43.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 109.335 -0.617 . . . . 0.86 109.335 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -115.0 138.17 51.16 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.327 -0.858 . . . . 0.96 109.64 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -119.63 128.17 53.61 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.492 -0.883 . . . . 0.51 110.399 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.52 108.92 16.08 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.343 -0.984 . . . . 3.59 108.343 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.827 HD23 ' N ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -77.87 -173.44 3.09 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.474 -0.766 . . . . 2.51 110.141 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -52.57 -34.24 49.62 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.518 -0.739 . . . . 5.42 110.371 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.67 1.06 0.8 Allowed Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.882 -1.628 . . . . 2.71 111.571 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.499 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 12.9 tp -113.39 107.69 16.2 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.528 -1.572 . . . . 3.13 109.353 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.456 ' O ' ' OE2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -96.07 127.5 42.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.915 -1.116 . . . . 6.1 108.501 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.65 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -149.13 171.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 122.302 1.048 . . . . 4.53 109.438 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.65 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -110.89 116.32 31.04 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 106.789 -1.559 . . . . 4.65 106.789 177.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.119 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 15.6 t -66.94 110.31 4.83 Favored Pre-proline 0 C--N 1.295 -1.766 0 O-C-N 121.667 -0.645 . . . . 0.45 110.594 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.684 ' O ' HG23 ' A' ' 68' ' ' ILE . 42.2 Cg_endo -89.17 -157.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.719 2.946 . . . . 0.51 109.99 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 50.85 45.86 49.29 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.26 -1.136 . . . . 0.91 110.26 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.792 HD13 HD12 ' A' ' 54' ' ' ILE . 2.5 pt -140.43 -138.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.07 -1.253 . . . . 1.16 109.59 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.502 ' N ' ' OH ' ' A' ' 90' ' ' TYR . 1.1 t70 -117.21 105.34 12.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.923 -1.111 . . . . 1.6 111.178 -178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.552 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 11.0 p -92.44 49.92 1.55 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.366 -1.346 . . . . 0.74 107.366 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 38.4 t30 177.55 81.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.231 -1.396 . . . . 0.74 107.231 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.589 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . . . -65.58 -3.97 5.38 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.327 0.862 . . . . 0.41 113.327 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.481 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 9.7 t -65.9 -9.19 27.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 119.928 -1.732 . . . . 0.45 109.352 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -76.26 -30.88 58.01 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.037 -1.04 . . . . 5.2 108.34 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CD1' ' O ' ' A' ' 89' ' ' LYS . 88.3 m-85 -105.4 -17.88 14.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.1 -1.0 . . . . 0.73 110.321 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.746 ' CG2' HD21 ' A' ' 80' ' ' LEU . 2.5 m -115.0 169.71 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.406 -0.961 . . . . 0.51 108.406 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.624 ' HG3' ' CD2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -95.61 91.32 6.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.16 -0.963 . . . . 4.59 111.723 -177.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.485 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 20.1 p -84.16 151.89 60.76 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 107.636 -1.246 . . . . 0.41 107.636 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.69 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.0 Cg_endo -69.84 132.68 23.1 Favored 'Cis proline' 0 C--N 1.314 -1.259 0 C-N-CA 124.281 -1.133 . . . . 0.24 112.226 2.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.746 HD21 ' CG2' ' A' ' 76' ' ' VAL . 16.1 mt -74.91 104.24 5.44 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.514 -1.291 . . . . 0.49 107.514 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.527 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 73.2 t -71.66 139.03 20.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-O 121.559 0.695 . . . . 0.57 109.919 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.596 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 14.5 ttpp -69.27 107.22 3.17 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.539 0.685 . . . . 2.45 109.688 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 131.8 -18.08 4.87 Favored Glycine 0 N--CA 1.481 1.641 0 C-N-CA 119.584 -1.294 . . . . 0.43 110.249 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.609 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 5.3 tp60 -98.86 151.42 20.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.102 -1.234 . . . . 0.44 108.306 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 1.9 tt0 -99.26 142.63 30.49 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.292 -1.373 . . . . 0.79 107.292 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.716 ' CE2' HD23 ' A' ' 80' ' ' LEU . 32.9 m-85 -120.7 150.44 40.95 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.24 -0.913 . . . . 0.39 110.295 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.536 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -115.63 115.06 25.77 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.415 -0.957 . . . . 2.14 108.415 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.63 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 1.8 tt -108.2 116.54 51.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.031 -1.043 . . . . 0.24 111.427 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.566 ' O ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -97.08 113.08 24.61 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 104.457 -2.423 . . . . 4.15 104.457 176.035 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.585 ' CZ ' ' O ' ' A' ' 91' ' ' THR . 12.8 t80 -130.84 138.91 50.08 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.365 -1.334 . . . . 0.77 113.082 -175.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.585 ' O ' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -89.56 142.25 27.85 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 105.583 -2.006 . . . . 0.89 105.583 176.582 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.119 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 21.1 t90 -123.75 89.01 3.01 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 120.571 -1.331 . . . . 0.74 110.731 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -60.58 103.55 0.26 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.468 -0.938 . . . . 2.76 108.468 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.577 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 40.5 t -62.88 142.34 97.4 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.812 -0.81 . . . . 0.38 108.812 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.673 ' HG3' HG13 ' A' ' 65' ' ' VAL . 29.2 Cg_endo -71.17 127.55 13.63 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.764 1.642 . . . . 0.55 109.389 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -69.19 3.25 2.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.506 -0.746 . . . . 3.61 111.021 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 98' ' ' ALA . 12.5 pt -89.38 -26.29 5.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 O-C-N 120.708 -1.245 . . . . 0.42 108.85 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.579 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . . . -39.38 116.62 1.09 Allowed Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 109.414 -0.587 . . . . 0.14 109.414 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.555 ' HD2' ' CD1' ' A' ' 58' ' ' LEU . 36.6 Cg_endo -85.4 137.88 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 123.244 2.63 . . . . 0.18 109.139 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.516 ' HG2' ' HA ' ' A' ' 128' ' ' ARG . 5.8 mtmt -54.59 90.88 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.015 -1.053 . . . . 1.54 108.732 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.602 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -98.84 129.27 45.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.585 -0.697 . . . . 0.87 109.587 -179.031 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 103' ' ' ASN . 17.7 pt-20 -39.11 -48.19 1.66 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.47 -0.769 . . . . 1.18 110.595 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.521 ' N ' ' HG3' ' A' ' 102' ' ' GLU . 4.2 m120 -132.89 145.8 51.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.989 -1.069 . . . . 1.82 110.478 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.766 HG21 HD12 ' A' ' 127' ' ' ILE . 82.9 t -135.87 149.17 27.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.777 -0.823 . . . . 0.59 108.777 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 122' ' ' ALA . 98.2 t -121.31 117.8 53.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.045 -1.094 . . . . 0.47 108.045 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.1 t -98.78 140.23 18.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 120.76 -1.212 . . . . 0.56 109.965 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 27.0 m -126.7 118.79 25.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.68 -0.638 . . . . 0.5 109.714 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER -96.75 125.88 49.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.216 -1.402 . . . . 0.48 107.216 177.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.948 ' HD2' HD11 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -133.99 150.85 51.27 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 120.647 -1.283 . . . . 1.12 111.435 -177.433 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.757 HD23 ' HA ' ' A' ' 52' ' ' ILE . 13.4 mt -129.79 137.11 50.33 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.142 -1.429 . . . . 0.35 107.142 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.948 HD11 ' HD2' ' A' ' 109' ' ' LYS . 4.5 mp -134.78 117.64 23.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.857 -1.152 . . . . 0.32 110.205 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.54 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -86.94 -120.02 1.27 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.003 -1.639 . . . . 0.16 109.003 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -123.49 -4.98 8.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -1.089 . . . . 2.64 109.403 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.437 ' HB3' ' OE1' ' A' ' 45' ' ' GLN . 4.1 t30 -114.5 -5.91 12.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 4.31 110.116 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.506 ' N ' ' OE1' ' A' ' 45' ' ' GLN . . . 156.98 -162.53 31.78 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.714 -1.354 . . . . 0.44 109.714 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 118' ' ' ALA . 3.8 t -82.88 109.36 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -1.133 . . . . 0.53 109.719 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.615 HD23 HE21 ' A' ' 45' ' ' GLN . 6.4 mt -51.19 -38.62 53.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.76 110.749 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.594 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -155.32 -166.0 2.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.759 -1.213 . . . . 0.35 109.401 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER 175.53 147.95 0.09 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.162 -0.962 . . . . 0.95 109.529 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.646 ' C ' HD12 ' A' ' 121' ' ' ILE . . . -147.05 146.35 29.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.958 -1.088 . . . . 0.52 109.254 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.646 HD12 ' C ' ' A' ' 120' ' ' ALA . 3.4 mp -133.75 136.11 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.128 -0.982 . . . . 1.97 109.418 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -112.76 132.75 55.09 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.185 -0.947 . . . . 0.64 109.109 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.4 p -116.37 57.22 0.77 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.128 -0.983 . . . . 3.29 109.383 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.85 60.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.628 -0.878 . . . . 1.14 108.628 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.485 ' C ' ' HG3' ' A' ' 126' ' ' LYS . . . -130.57 164.06 23.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.804 -1.318 . . . . 0.48 109.804 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.485 ' HG3' ' C ' ' A' ' 125' ' ' GLY . 15.3 mtpt -152.07 145.11 24.52 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.964 -1.124 . . . . 1.28 107.964 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.766 HD12 HG21 ' A' ' 104' ' ' VAL . 52.3 mt -106.39 140.89 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.407 -1.433 . . . . 0.37 110.319 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.627 ' HG3' HG23 ' A' ' 28' ' ' ILE . 11.1 mtt180 -128.95 179.69 5.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.444 -0.785 . . . . 1.54 109.275 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.5 t0 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.111 -0.947 . . . . 1.64 109.649 -179.814 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.27 0.557 . . . . 2.46 109.552 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.541 ' CB ' ' HG2' ' A' ' 17' ' ' MET . 0.5 OUTLIER -73.77 154.49 39.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.162 -0.962 . . . . 2.09 109.889 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.474 ' O ' HG22 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -103.55 159.48 4.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.29 -0.881 . . . . 1.87 109.13 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -70.12 119.23 14.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.086 -1.009 . . . . 1.41 109.837 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.663 HG21 HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -139.6 140.16 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.383 -0.823 . . . . 1.64 109.324 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.49 109.32 19.2 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.206 -0.934 . . . . 3.36 109.385 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.438 ' CG ' ' HB ' ' A' ' 13' ' ' ILE . 1.4 m-20 -60.37 120.4 9.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 2.24 108.943 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 8' ' ' CYS . 1.6 p -95.59 23.12 6.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.03 -1.044 . . . . 0.34 109.635 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 10' ' ' ASN . . . -96.52 -82.29 0.4 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.279 -0.888 . . . . 0.36 109.829 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 0.8 OUTLIER 178.24 56.39 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.025 -0.67 . . . . 1.71 109.396 -178.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 10' ' ' ASN . 3.3 m120 67.26 51.61 0.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 4.76 109.137 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.508 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -113.33 -61.72 1.7 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 1.08 109.897 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.659 HG22 ' H ' ' A' ' 15' ' ' LYS . 1.1 mm -57.45 123.42 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.049 -1.032 . . . . 0.48 109.939 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.606 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 4.6 mmpt? -71.77 -17.55 62.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.382 -0.824 . . . . 1.33 108.808 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.659 ' H ' HG22 ' A' ' 13' ' ' ILE . 6.6 pttm 147.6 140.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.328 -1.36 . . . . 1.18 107.328 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.803 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -115.27 128.91 72.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.271 -1.011 . . . . 0.41 108.271 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.541 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -125.37 145.33 50.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.124 -0.985 . . . . 0.76 110.434 -178.201 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 19' ' ' ASP . 50.2 t -98.24 165.63 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.403 -0.811 . . . . 1.02 108.918 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.553 ' N ' HG12 ' A' ' 18' ' ' VAL . 1.6 p-10 -47.29 -30.33 3.04 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.014 -1.054 . . . . 3.93 108.919 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.405 ' N ' ' OD1' ' A' ' 19' ' ' ASP . . . 149.69 100.5 0.22 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.592 -1.29 . . . . 2.79 110.741 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 22' ' ' HIS . 3.5 t -128.48 -51.52 1.27 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.185 -1.185 . . . . 3.66 109.139 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.489 ' CB ' ' O ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER 166.52 -84.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 4.24 110.136 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 119.22 -107.45 1.38 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.571 -1.812 . . . . 1.23 108.571 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 23' ' ' GLY . 9.5 p -47.43 -40.99 19.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.97 -1.312 . . . . 1.44 108.422 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.494 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -72.78 175.02 3.67 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 109.086 -0.709 . . . . 2.21 109.086 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 25' ' ' ASP . 34.8 Cg_endo -79.51 135.09 11.54 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.216 1.944 . . . . 1.33 110.344 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.5 t -112.45 143.44 43.59 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.31 -0.996 . . . . 2.68 108.31 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.513 HG23 ' HG3' ' A' ' 128' ' ' ARG . 46.9 mm -108.57 118.18 55.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.104 -0.998 . . . . 0.76 110.247 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 127' ' ' ILE . 23.0 mt -98.79 118.36 45.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.245 -1.02 . . . . 0.84 108.245 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -95.43 122.43 38.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.946 . . . . 1.11 110.163 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.549 ' HA ' HG11 ' A' ' 94' ' ' VAL . 16.6 ptt180 -66.1 151.52 46.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 1.61 109.475 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.9 -17.32 57.07 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.902 -1.679 . . . . 0.59 108.902 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -107.45 148.68 37.65 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.282 -1.128 . . . . 1.26 109.143 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 36.3 Cg_endo -78.44 122.41 5.57 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.7 2.267 . . . . 0.31 111.147 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -100.55 122.55 43.43 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.149 -1.056 . . . . 0.32 108.149 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.476 ' O ' HG13 ' A' ' 18' ' ' VAL . 64.2 m -100.7 137.55 38.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.898 -1.126 . . . . 0.67 110.752 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -145.34 128.09 16.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.483 -0.76 . . . . 2.69 109.05 179.402 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -105.07 129.58 53.46 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.547 -0.909 . . . . 1.38 108.547 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.803 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -128.14 120.92 28.32 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.793 -1.192 . . . . 0.13 110.306 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.547 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 4.2 mt -91.16 140.95 29.32 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.332 -1.729 . . . . 0.59 106.332 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.659 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 32.0 p90 -156.5 135.58 11.98 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.709 -1.196 . . . . 0.17 109.778 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.6 OUTLIER -83.35 112.81 20.25 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.351 -0.981 . . . . 1.17 108.351 179.309 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -46.22 112.48 0.49 Allowed 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.672 -0.862 . . . . 0.25 108.672 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 44' ' ' ASN . 2.3 p30 -84.93 10.94 10.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.112 -0.993 . . . . 0.89 109.45 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.562 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 1.8 pt20 -167.93 145.38 4.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.459 -0.776 . . . . 0.74 108.968 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 2.4 p30 -84.46 119.17 24.83 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.145 -0.972 . . . . 0.77 109.36 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.489 ' O ' ' CA ' ' A' ' 79' ' ' PRO . 2.6 t -137.2 159.68 41.2 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.265 -0.897 . . . . 0.33 109.249 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.62 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -100.49 -28.54 12.85 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.127 -1.435 . . . . 6.83 107.127 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.465 ' OG1' ' OD1' ' A' ' 113' ' ' ASP . 34.2 p -111.51 138.9 47.43 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 122.146 0.974 . . . . 1.67 109.522 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -142.88 152.66 42.34 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 108.85 -0.796 . . . . 0.74 108.85 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HD2' ' HB ' ' A' ' 70' ' ' THR . 6.4 mtmt -142.59 141.07 31.91 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.18 -0.95 . . . . 0.43 110.332 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 69' ' ' ASP . 11.0 tt -94.28 150.46 4.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.193 -1.41 . . . . 0.53 107.193 177.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -140.15 116.27 10.47 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.079 -1.013 . . . . 1.18 110.156 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.779 HD13 HG21 ' A' ' 68' ' ' ILE . 2.7 mp -112.97 114.08 45.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.074 -1.016 . . . . 0.3 108.51 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -115.17 130.65 56.98 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.109 -0.994 . . . . 0.61 109.271 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -107.92 128.45 54.64 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.192 -0.942 . . . . 0.29 110.528 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.483 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . 42.7 t -97.26 150.55 20.81 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.537 -0.912 . . . . 1.59 108.537 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 63' ' ' ILE . 35.8 mt -105.86 38.2 2.06 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.092 -1.005 . . . . 0.6 109.961 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.44 12.24 5.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -0.872 . . . . 1.69 109.456 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.26 -44.34 0.06 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.461 -1.456 . . . . 0.88 109.461 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.92 111.31 23.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -1.168 . . . . 4.03 108.997 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -79.82 133.43 36.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.021 -1.049 . . . . 2.04 109.83 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.683 HD11 HD11 ' A' ' 58' ' ' LEU . 98.0 mt -123.87 167.24 17.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.177 -0.952 . . . . 0.8 109.444 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.669 ' N ' HG22 ' A' ' 63' ' ' ILE . 35.9 m-20 -114.63 115.24 26.81 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.754 -1.573 . . . . 1.03 106.754 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.045 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 2.8 t -83.36 115.17 57.86 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.946 . . . . 0.34 111.458 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.528 ' O ' HG23 ' A' ' 68' ' ' ILE . 37.5 Cg_endo -85.04 -156.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 123.1 2.533 . . . . 0.22 109.342 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.62 35.83 82.73 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.286 -1.126 . . . . 0.72 110.286 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.779 HG21 HD13 ' A' ' 54' ' ' ILE . 18.2 pt -127.06 -156.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.157 -1.201 . . . . 0.3 108.83 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.733 ' O ' HG22 ' A' ' 52' ' ' ILE . 38.7 t0 -108.58 108.75 19.76 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.244 -0.91 . . . . 1.41 109.464 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 51' ' ' LYS . 1.4 p -88.07 46.56 1.4 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.628 -1.249 . . . . 0.42 107.628 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 14.6 t-20 175.49 83.54 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.645 -1.613 . . . . 1.39 106.645 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.521 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -66.24 1.6 1.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.53 -0.731 . . . . 0.67 111.822 -177.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 20.2 m -61.92 -13.65 26.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.817 -1.177 . . . . 2.37 109.674 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -81.84 -14.69 55.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.111 -0.993 . . . . 0.86 110.156 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.701 ' CE2' ' CD1' ' A' ' 90' ' ' TYR . 19.7 m-85 -122.54 -15.27 7.6 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.367 -0.833 . . . . 1.11 109.739 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.622 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 3.1 m -122.15 169.05 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.35 -0.982 . . . . 0.75 108.35 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.614 ' HG2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -100.76 87.59 3.37 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.221 -0.925 . . . . 1.81 112.248 -178.054 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.54 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 20.4 p -87.62 157.44 52.43 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.445 -1.41 . . . . 0.88 107.91 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.62 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 21.8 Cg_endo -65.08 125.19 5.16 Favored 'Cis proline' 0 C--N 1.314 -1.261 0 O-C-N 123.105 1.055 . . . . 0.54 112.947 2.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.875 HD23 ' CE2' ' A' ' 86' ' ' TYR . 13.8 mt -70.75 117.06 11.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.531 -1.655 . . . . 0.61 106.531 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 43.6 t -83.55 139.84 17.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 C-N-CA 119.606 -0.838 . . . . 0.56 110.926 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.562 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 16.8 ttpt -66.48 108.51 2.42 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.644 0.735 . . . . 0.84 109.562 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.66 -19.14 5.93 Favored Glycine 0 C--N 1.298 -1.555 0 N-CA-C 109.519 -1.432 . . . . 0.36 109.519 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.601 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 4.0 tp60 -97.91 152.06 19.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.169 -1.195 . . . . 0.61 107.799 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -104.96 143.63 32.91 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 118.99 -1.084 . . . . 0.28 108.511 179.388 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.875 ' CE2' HD23 ' A' ' 80' ' ' LEU . 25.9 m-85 -121.05 150.06 41.76 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.279 -0.888 . . . . 0.76 109.606 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.547 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 8.8 p-10 -119.76 109.85 16.1 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.951 -1.129 . . . . 0.62 107.951 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.622 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 6.9 tt -106.43 122.12 59.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.007 0.908 . . . . 0.36 111.839 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -101.85 112.58 25.25 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 104.637 -2.357 . . . . 1.0 104.637 176.033 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.701 ' CD1' ' CE2' ' A' ' 75' ' ' PHE . 31.5 t80 -127.51 139.5 52.74 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.734 -1.229 . . . . 0.47 112.405 -175.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.66 106.83 18.83 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.202 -1.407 . . . . 0.54 107.202 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.045 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 29.9 t90 -82.2 94.32 7.26 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.494 0.664 . . . . 0.49 109.832 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -67.71 109.82 3.49 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.487 -0.758 . . . . 2.88 109.35 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.649 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 12.4 t -60.2 142.97 89.4 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.124 -1.065 . . . . 1.11 108.124 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.649 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 23.7 Cg_endo -66.97 -11.84 33.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.508 2.139 . . . . 3.8 111.755 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 0.0 OUTLIER 76.21 -7.23 1.86 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 2.98 109.485 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.525 ' O ' ' C ' ' A' ' 98' ' ' ALA . 12.7 pt -93.5 -27.97 4.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 O-C-N 121.114 -0.991 . . . . 0.55 108.444 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.525 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -32.84 117.6 0.43 Allowed Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 108.575 -0.898 . . . . 0.51 108.575 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.594 ' O ' ' N ' ' A' ' 101' ' ' SER . 37.3 Cg_endo -83.86 138.94 8.36 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.747 2.298 . . . . 0.69 110.015 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.531 ' HE3' ' HG2' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -50.22 90.47 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.897 -1.149 . . . . 3.28 107.897 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.655 ' HB3' HG23 ' A' ' 104' ' ' VAL . 1.8 t -94.32 124.18 38.18 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.506 -0.746 . . . . 0.56 109.271 -178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -43.13 -45.3 5.39 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.591 -0.892 . . . . 1.75 108.591 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.429 ' N ' ' HG2' ' A' ' 102' ' ' GLU . 0.6 OUTLIER -131.44 141.48 49.82 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.497 -0.752 . . . . 0.93 109.195 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.897 HG21 ' CD1' ' A' ' 127' ' ' ILE . 2.1 t -131.41 145.4 35.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.268 -0.895 . . . . 0.68 109.497 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 57' ' ' SER . 73.4 t -126.27 114.72 39.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.878 -1.156 . . . . 0.32 107.878 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.496 HG12 ' CG2' ' A' ' 54' ' ' ILE . 1.8 t -95.66 137.29 24.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.92 -1.112 . . . . 0.39 109.372 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.608 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 34.3 m -118.72 112.24 19.51 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.15 -0.969 . . . . 0.44 109.584 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -92.7 125.25 45.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 106.647 -1.612 . . . . 0.53 106.647 178.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.8 ' CD ' HD11 ' A' ' 111' ' ' ILE . 9.0 ttmt -141.26 131.51 24.97 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.134 -1.427 . . . . 2.07 112.117 -176.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.872 ' C ' HD12 ' A' ' 111' ' ' ILE . 9.0 mt -104.16 138.15 41.07 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.209 -1.404 . . . . 0.78 107.209 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.872 HD12 ' C ' ' A' ' 110' ' ' LEU . 3.2 mp -129.69 120.57 50.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.101 -1.0 . . . . 0.28 109.922 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.446 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -92.74 -145.95 17.92 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.754 -1.738 . . . . 0.86 108.754 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.465 ' OD1' ' OG1' ' A' ' 49' ' ' THR . 0.1 OUTLIER -99.93 -1.5 37.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.128 -1.219 . . . . 1.24 109.941 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 114' ' ' ASN . 0.6 OUTLIER -114.68 -10.5 12.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.97 -1.081 . . . . 4.67 110.247 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 111' ' ' ILE . . . 159.32 -148.0 16.2 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.521 -1.323 . . . . 0.3 110.13 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.64 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 2.1 t -91.99 109.87 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -1.136 . . . . 0.25 110.13 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 110' ' ' LEU . 41.0 mt -52.85 -43.67 66.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.446 -0.784 . . . . 0.27 109.782 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.481 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -158.71 -178.1 7.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.093 -1.005 . . . . 0.68 109.357 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.9 OUTLIER -166.36 156.07 11.75 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.044 -1.035 . . . . 0.62 110.191 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.4 149.63 28.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.105 -0.997 . . . . 0.47 109.833 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.2 mt -138.1 121.08 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.068 -1.02 . . . . 0.84 109.794 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.27 140.82 30.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.995 -1.065 . . . . 0.91 108.923 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 55.1 p -125.02 171.81 9.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.134 -0.979 . . . . 2.75 109.873 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 61.55 29.5 18.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -0.811 . . . . 2.56 109.513 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -98.93 162.85 20.27 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.728 -1.349 . . . . 0.41 109.728 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 11.2 mtmt -151.2 134.19 15.86 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.465 -1.021 . . . . 0.68 108.308 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.897 ' CD1' HG21 ' A' ' 104' ' ' VAL . 55.9 mt -99.22 141.5 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.692 -1.255 . . . . 0.73 110.218 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.531 ' HG2' ' HE3' ' A' ' 100' ' ' LYS . 12.4 mtm180 -132.5 177.2 7.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.535 -0.728 . . . . 2.13 109.299 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.049 -0.977 . . . . 2.4 109.457 179.572 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 17' ' ' MET . 5.6 m-20 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.252 0.549 . . . . 2.96 109.573 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.549 ' CA ' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -65.25 156.65 31.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 2.72 110.031 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.18 163.95 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.489 -0.757 . . . . 1.86 109.096 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -71.74 119.02 15.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.103 -0.998 . . . . 2.15 109.546 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.09 173.34 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.382 -0.824 . . . . 1.47 109.156 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.32 108.56 13.38 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.262 -0.899 . . . . 5.63 109.616 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -77.41 118.88 20.3 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.213 -0.929 . . . . 2.6 108.81 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.1 p -98.65 13.54 31.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.004 -1.06 . . . . 1.01 110.107 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 12' ' ' GLU . . . -93.65 -72.99 0.58 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.946 -1.096 . . . . 0.84 109.425 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 10' ' ' ASN . 19.8 t-20 172.5 63.48 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.762 -1.199 . . . . 5.0 107.762 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 11' ' ' ASN . 47.1 t-20 60.45 18.4 8.16 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.861 -1.163 . . . . 1.86 107.861 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -57.79 -81.67 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.728 -0.607 . . . . 3.59 109.57 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.605 HD13 ' HB1' ' A' ' 39' ' ' ALA . 0.9 OUTLIER -56.43 125.73 12.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.32 -0.952 . . . . 0.49 109.423 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.612 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 1.2 mmtt -75.57 -24.89 56.68 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.369 -0.832 . . . . 0.85 108.866 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.89 ' HD3' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER 167.88 126.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.372 -0.973 . . . . 2.59 108.372 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.958 HG23 ' CB ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -105.26 125.14 60.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.092 -1.077 . . . . 0.5 108.092 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.549 ' HG2' ' CA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -111.84 150.22 30.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.962 -1.086 . . . . 1.07 110.811 -177.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 19' ' ' ASP . 46.6 t -109.48 163.52 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.3 -1.0 . . . . 0.81 108.3 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.515 ' N ' HG12 ' A' ' 18' ' ' VAL . 4.7 t0 -86.49 64.12 8.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.07 -1.018 . . . . 1.44 109.713 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 21' ' ' CYS . . . 163.02 -95.71 0.13 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.881 -1.288 . . . . 2.56 109.881 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.414 ' C ' ' O ' ' A' ' 20' ' ' GLY . 93.5 m -42.39 155.11 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.339 -1.095 . . . . 1.52 109.974 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.585 ' CG ' ' O ' ' A' ' 22' ' ' HIS . 13.9 p-80 -162.87 107.66 1.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.324 -0.86 . . . . 4.19 110.103 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.59 -148.45 16.69 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.912 -1.275 . . . . 3.03 109.912 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.0 t -87.4 21.82 2.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.338 -1.095 . . . . 2.02 109.729 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.59 157.29 80.08 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.13 -0.982 . . . . 2.33 109.313 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.8 158.84 31.47 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.743 2.295 . . . . 0.97 110.257 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.5 141.91 50.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 2.67 109.421 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.691 HG22 ' CD2' ' A' ' 30' ' ' HIS . 51.0 mm -113.0 113.31 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.061 -1.024 . . . . 0.81 109.065 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.522 HG12 ' CE1' ' A' ' 35' ' ' PHE . 32.5 mt -99.22 112.34 31.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.201 -0.937 . . . . 0.69 109.031 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.691 ' CD2' HG22 ' A' ' 28' ' ' ILE . 47.3 m170 -88.35 105.16 17.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.057 -1.09 . . . . 1.95 108.057 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.48 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 8.1 ptt180 -45.54 123.31 4.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.992 -1.068 . . . . 0.72 109.822 -178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.577 ' HA2' ' CD ' ' A' ' 96' ' ' LYS . . . 116.87 -11.85 15.13 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.058 -1.617 . . . . 0.17 109.058 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -103.87 149.97 37.73 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.355 -1.085 . . . . 1.35 108.754 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 36.5 Cg_endo -79.44 121.66 4.83 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 122.379 2.053 . . . . 0.38 110.718 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.522 ' CE1' HG12 ' A' ' 29' ' ' ILE . 2.3 t80 -97.12 120.86 38.25 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.445 -1.317 . . . . 1.01 107.445 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.663 ' C ' HD13 ' A' ' 37' ' ' LEU . 73.3 m -100.99 127.32 47.54 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.684 -1.26 . . . . 0.59 110.68 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.949 ' N ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -138.19 124.12 20.08 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.96 -0.755 . . . . 0.67 108.96 178.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -104.33 135.88 44.95 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.699 -1.223 . . . . 1.71 107.699 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.958 ' CB ' HG23 ' A' ' 16' ' ' VAL . . . -133.04 123.19 25.34 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.841 -1.143 . . . . 0.1 110.562 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.89 HD12 ' HD3' ' A' ' 15' ' ' LYS . 8.7 mt -88.39 137.21 32.53 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.56 -2.015 . . . . 0.23 105.56 177.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 110' ' ' LEU . 34.8 p90 -152.12 134.81 15.46 Favored 'General case' 0 C--N 1.288 -2.107 0 C-N-CA 118.171 -1.412 . . . . 0.22 110.168 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.8 OUTLIER -82.72 107.81 15.63 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.446 -0.946 . . . . 0.66 108.446 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -45.67 114.36 0.75 Allowed 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.136 -0.69 . . . . 0.36 109.136 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 44' ' ' ASN . 1.3 p30 -84.24 10.6 9.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.056 -1.027 . . . . 0.76 109.23 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.578 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 8.4 pt20 -166.53 145.02 5.43 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.312 -0.868 . . . . 0.83 109.253 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 9.4 p30 -83.93 110.04 18.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.76 109.12 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.614 HG21 HD11 ' A' ' 117' ' ' LEU . 1.5 t -126.7 151.15 48.51 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.189 -0.944 . . . . 0.32 109.795 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.783 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 1.1 mmmt -86.39 -20.61 27.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.332 -0.855 . . . . 0.39 109.156 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 p -132.29 138.91 48.02 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.109 0.957 . . . . 0.25 110.137 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -139.34 148.12 42.48 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.675 -1.232 . . . . 0.59 107.675 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HD2' ' HA ' ' A' ' 70' ' ' THR . 1.0 OUTLIER -141.12 142.31 34.11 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.251 -0.906 . . . . 2.02 110.339 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.669 ' HA ' HD23 ' A' ' 110' ' ' LEU . 5.3 tt -91.84 149.47 4.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 107.622 -1.251 . . . . 0.6 107.622 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.442 ' OE2' ' N ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -145.01 117.24 8.41 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.598 -0.89 . . . . 4.84 108.598 -177.477 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.772 HD12 HD13 ' A' ' 68' ' ' ILE . 3.4 mp -109.67 134.95 50.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.806 -1.184 . . . . 0.6 110.596 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -125.17 131.65 53.18 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.161 -0.962 . . . . 1.87 108.952 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.25 146.96 34.75 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.71 -1.244 . . . . 0.82 111.4 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.423 ' O ' HD23 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -107.24 150.86 26.18 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.033 -1.099 . . . . 0.72 108.033 178.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 63' ' ' ILE . 44.4 mt -120.69 61.33 0.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.864 -1.148 . . . . 0.69 110.486 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 58' ' ' LEU . 5.7 t0 41.71 26.72 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.593 -0.692 . . . . 1.1 110.081 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 158.24 -49.35 0.42 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.597 -1.401 . . . . 0.34 109.597 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.491 ' HG ' HD12 ' A' ' 58' ' ' LEU . 8.2 tp -97.93 113.03 24.76 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.394 -1.062 . . . . 0.78 108.873 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -93.08 123.25 36.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.14 -0.975 . . . . 5.47 109.636 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.65 HD12 HD11 ' A' ' 58' ' ' LEU . 12.8 mt -118.15 169.36 8.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 122.15 0.976 . . . . 0.54 109.348 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.611 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 18.9 m-20 -108.52 134.56 51.13 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.131 -1.433 . . . . 0.62 107.131 177.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.96 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -104.05 107.82 58.2 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.839 -1.163 . . . . 0.86 110.632 -178.44 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.3 Cg_endo -81.32 -154.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 123.151 2.567 . . . . 0.55 109.914 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.85 34.09 86.11 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.333 -1.507 . . . . 0.89 109.333 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.772 HD13 HD12 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -108.04 179.84 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.354 -1.086 . . . . 2.59 109.378 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.599 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -86.01 -1.1 57.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.92 -1.112 . . . . 3.15 109.318 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.573 ' HA ' ' HD2' ' A' ' 51' ' ' LYS . 29.3 p 30.19 36.36 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.678 0.752 . . . . 0.64 109.921 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 14.7 t-20 174.56 90.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.685 -1.228 . . . . 1.35 107.685 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.857 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -75.29 2.05 12.12 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.589 -0.694 . . . . 0.53 110.973 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.461 ' HA ' HG22 ' A' ' 76' ' ' VAL . 84.2 m -66.79 -9.42 36.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.015 -1.053 . . . . 2.67 109.229 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.14 -17.42 35.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.9 109.522 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 75' ' ' PHE . 2.8 m-85 -116.87 -12.01 10.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 0.82 109.111 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.88 HG23 HD21 ' A' ' 80' ' ' LEU . 1.7 m -120.99 165.73 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.362 -0.977 . . . . 0.48 108.362 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.634 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -90.0 98.87 12.02 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.921 -1.112 . . . . 2.31 110.864 -178.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.492 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 18.2 m -91.48 152.23 43.38 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.219 -0.926 . . . . 2.79 108.674 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.783 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.2 Cg_endo -70.13 139.26 54.62 Favored 'Cis proline' 0 C--N 1.312 -1.383 0 C-N-CA 124.117 -1.201 . . . . 0.4 112.332 0.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.88 HD21 HG23 ' A' ' 76' ' ' VAL . 13.1 mt -77.86 112.14 14.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.625 -1.62 . . . . 0.9 106.625 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 10.9 t -82.92 144.95 9.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 121.841 0.829 . . . . 0.62 110.946 -177.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.578 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 8.2 ttpt -68.53 117.42 10.26 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.703 0.763 . . . . 0.7 109.754 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 119.43 -11.08 11.41 Favored Glycine 0 C--N 1.296 -1.675 0 N-CA-C 109.514 -1.434 . . . . 0.24 109.514 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.527 ' HG3' ' N ' ' A' ' 85' ' ' GLN . 4.6 tp60 -107.8 157.02 18.5 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.144 -1.058 . . . . 0.55 108.144 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.527 ' N ' ' HG3' ' A' ' 84' ' ' GLN . 1.5 tt0 -109.93 144.29 38.65 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.049 -1.032 . . . . 1.44 108.438 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.634 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 38.6 m-85 -125.75 145.95 49.98 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.201 -0.937 . . . . 0.35 110.033 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.569 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -111.45 113.62 26.18 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.759 -0.83 . . . . 1.71 108.759 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.857 HD12 ' HB1' ' A' ' 72' ' ' ALA . 2.3 tt -109.87 117.36 54.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.058 -1.026 . . . . 0.38 111.199 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -94.35 114.91 27.04 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.624 -2.362 . . . . 1.34 104.624 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 27.8 t80 -126.09 139.64 53.22 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.113 -1.435 . . . . 0.56 113.366 -175.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.496 ' O ' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -93.08 131.67 37.9 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 105.119 -2.178 . . . . 0.64 105.119 175.735 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.96 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 29.9 t90 -109.92 96.81 6.48 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 121.351 -0.843 . . . . 0.77 109.826 -176.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -68.32 104.49 1.87 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.347 0.594 . . . . 2.43 109.868 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.642 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 30.0 t -61.55 143.83 93.11 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.324 -0.991 . . . . 1.64 108.324 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.723 ' HD3' HG12 ' A' ' 65' ' ' VAL . 23.4 Cg_endo -64.55 -6.33 11.87 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.377 2.052 . . . . 3.97 112.182 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.577 ' CD ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER 67.98 -4.13 1.08 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.998 -1.064 . . . . 1.48 110.425 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.528 ' O ' ' C ' ' A' ' 98' ' ' ALA . 16.2 pt -94.49 -26.52 4.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 O-C-N 120.789 -1.195 . . . . 0.55 107.948 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -30.59 118.49 0.34 Allowed Pre-proline 0 N--CA 1.488 1.47 0 CA-C-N 115.813 -0.63 . . . . 0.5 109.376 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.617 ' HG2' HD13 ' A' ' 58' ' ' LEU . 35.8 Cg_endo -82.99 131.46 5.98 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.689 2.259 . . . . 0.54 108.473 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.609 ' CG ' ' HA ' ' A' ' 128' ' ' ARG . 1.6 ttpt -48.33 91.03 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.334 -0.946 . . . . 1.4 108.952 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 99' ' ' PRO . 1.2 t -94.16 116.91 29.38 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.842 -0.799 . . . . 0.37 108.842 -179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 101' ' ' SER . 5.4 pt-20 -35.03 -47.5 0.37 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.805 -0.559 . . . . 1.42 110.54 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -129.06 140.46 51.59 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.192 -0.942 . . . . 1.45 109.154 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.988 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.9 OUTLIER -131.75 143.58 39.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.358 -0.839 . . . . 1.0 109.831 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.873 HG13 ' O ' ' A' ' 122' ' ' ALA . 11.8 t -124.6 117.1 49.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.791 -1.559 . . . . 0.9 106.791 178.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.15 141.68 14.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 C-N-CA 119.466 -0.893 . . . . 0.46 110.594 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.607 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 51.7 m -116.15 138.27 51.41 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.387 -0.968 . . . . 1.02 108.387 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER -119.63 127.49 75.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 106.738 -1.579 . . . . 0.38 106.738 178.762 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.625 ' HD2' HD11 ' A' ' 111' ' ' ILE . 3.9 ttmt -140.14 129.1 23.43 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.1 -1.44 . . . . 2.41 111.693 -177.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.669 HD23 ' HA ' ' A' ' 52' ' ' ILE . 6.5 mt -103.17 138.7 39.63 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.98 -1.489 . . . . 0.39 106.98 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.625 HD11 ' HD2' ' A' ' 109' ' ' LYS . 4.5 mp -133.25 115.87 24.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.967 -1.083 . . . . 0.38 109.731 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.469 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -87.87 -133.7 4.25 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.082 -1.607 . . . . 0.28 109.082 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -110.53 -2.36 16.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -1.146 . . . . 2.91 109.709 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.46 -0.09 12.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.073 -1.017 . . . . 1.86 110.257 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 151.37 -157.31 27.14 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.916 -1.274 . . . . 0.33 109.916 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 118' ' ' ALA . 21.3 t -86.48 110.54 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -1.14 . . . . 0.86 109.626 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.614 HD11 HG21 ' A' ' 47' ' ' THR . 20.2 mt -58.03 -39.35 78.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.439 -0.788 . . . . 0.38 110.735 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.583 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -150.43 177.2 10.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.721 -1.237 . . . . 0.64 109.534 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -170.04 148.07 3.35 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.875 -1.141 . . . . 0.63 109.588 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -151.76 149.66 29.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.014 -1.054 . . . . 0.51 109.743 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 85.0 mt -136.71 119.86 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.099 -1.001 . . . . 0.63 109.39 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.873 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -88.36 150.88 22.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.857 -1.152 . . . . 0.55 109.934 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.3 t -111.61 3.95 18.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.23 -0.919 . . . . 2.76 110.424 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.46 173.81 11.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.889 -1.132 . . . . 8.08 109.561 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 129.21 155.05 8.4 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.748 -1.215 . . . . 1.09 110.369 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 6.0 mtmp? -152.08 141.14 21.23 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.146 -1.427 . . . . 2.79 107.146 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.988 ' CD1' HG21 ' A' ' 104' ' ' VAL . 81.6 mt -104.35 140.75 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.429 -1.42 . . . . 0.58 111.147 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.609 ' HA ' ' CG ' ' A' ' 100' ' ' LYS . 4.4 mtt85 -127.85 174.82 8.83 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.274 -1.01 . . . . 3.14 108.274 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 120.967 -1.083 . . . . 0.97 109.527 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 17' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.39 -0.596 . . . . 1.75 109.39 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.546 ' HA ' ' CA ' ' A' ' 23' ' ' GLY . 1.3 m -106.29 165.48 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.97999999999999998 109.609 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -87.1 119.19 27.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 1.5900000000000001 109.509 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 m -150.88 157.04 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.72999999999999998 109.224 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.04 108.57 14.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 3.4700000000000002 109.383 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.418 ' CG ' ' HB ' ' A' ' 13' ' ' ILE . 2.3 m-20 -52.49 114.76 1.48 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.27 -0.894 . . . . 2.3500000000000001 109.354 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -85.32 9.55 15.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.76000000000000001 109.326 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.517 ' N ' ' HB3' ' A' ' 119' ' ' CYS . . . -90.55 -69.93 0.7 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.905 . . . . 0.60999999999999999 109.702 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 9' ' ' ALA . 0.8 OUTLIER 171.74 57.67 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.461 -0.775 . . . . 2.3999999999999999 109.252 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 64.83 13.66 8.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.126 -0.984 . . . . 2.2000000000000002 108.924 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' O ' ' CE ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -63.17 -67.1 0.45 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.366 -0.834 . . . . 1.71 109.771 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -56.78 130.28 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.40999999999999998 109.478 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 8.8 mmpt? -88.12 -13.95 40.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.325 -0.86 . . . . 1.1299999999999999 109.454 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.2 ttpt 161.86 128.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 1.6899999999999999 109.585 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.741 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -116.85 127.01 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.38 -0.825 . . . . 0.68000000000000005 108.958 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.536 ' CB ' ' HA ' ' A' ' 2' ' ' GLN . 0.2 OUTLIER -122.53 156.67 33.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.059 -1.025 . . . . 0.91000000000000003 110.191 -179.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.091 HG11 ' CE2' ' A' ' 35' ' ' PHE . 52.8 t -127.63 148.54 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.55000000000000004 109.176 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.66 75.54 7.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 2.3199999999999998 109.424 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.75 -69.75 0.14 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.89 -1.284 . . . . 1.23 109.89 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.7 t -67.88 168.1 12.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -1.191 . . . . 1.6699999999999999 109.841 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -107.22 -9.3 16.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 3.2599999999999998 109.68 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.546 ' CA ' ' HA ' ' A' ' 3' ' ' VAL . . . 103.37 -104.21 2.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.008 -1.237 . . . . 1.8200000000000001 110.008 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' GLY . 9.3 t -41.71 -39.66 1.75 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.421 -1.047 . . . . 1.75 109.683 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.503 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -68.52 173.18 3.63 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 1.75 109.258 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 35.4 Cg_endo -77.67 152.62 29.47 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.715 2.277 . . . . 1.03 110.333 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.4 m -116.42 130.02 56.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 1.23 109.382 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.51 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 36.8 mm -106.06 102.57 14.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.072 -1.018 . . . . 0.56000000000000005 108.81 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 mp -88.7 118.23 33.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.163 -0.961 . . . . 0.47999999999999998 109.141 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.452 ' CD2' ' N ' ' A' ' 30' ' ' HIS . 8.2 m-70 -89.04 102.53 15.18 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.351 -0.843 . . . . 1.04 109.044 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 5.2 ptt180 -43.1 138.89 1.98 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.873 . . . . 1.3600000000000001 110.064 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' CA ' ' HD2' ' A' ' 96' ' ' LYS . . . 97.61 -14.63 62.97 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.084 -1.206 . . . . 0.51000000000000001 110.084 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.581 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -103.14 150.96 38.39 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.247 . . . . 1.72 109.812 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 36.5 Cg_endo -79.94 113.56 3.02 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.902 2.401 . . . . 0.46000000000000002 111.138 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 1.091 ' CE2' HG11 ' A' ' 18' ' ' VAL . 5.8 t80 -99.4 122.1 42.04 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.428 -1.323 . . . . 0.63 107.428 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 1.015 ' C ' HD13 ' A' ' 37' ' ' LEU . 71.7 m -102.76 138.79 39.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.857 -1.152 . . . . 0.60999999999999999 111.075 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.015 HD13 ' C ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -140.21 128.51 22.53 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.086 -0.709 . . . . 2.02 109.086 178.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.525 ' HG3' ' HA ' ' A' ' 89' ' ' LYS . 2.4 tt0 -104.97 126.26 51.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.835 -1.166 . . . . 1.3400000000000001 108.076 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.741 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -124.72 122.8 38.51 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.733 -1.23 . . . . 0.32000000000000001 110.668 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 7.9 mt -89.59 144.01 26.35 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.5 -1.667 . . . . 0.51000000000000001 106.5 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.637 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 32.7 p90 -159.87 138.4 10.49 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.702 -1.249 . . . . 0.22 109.877 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.6 m-20 -85.05 113.59 21.58 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.346 -0.942 . . . . 1.1499999999999999 108.698 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -44.71 113.28 0.53 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.046 -0.724 . . . . 0.20999999999999999 109.046 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 117' ' ' LEU . 4.9 p30 -81.62 7.75 11.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.237 -0.914 . . . . 1.1200000000000001 109.554 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 1.1 pt20 -170.5 163.88 8.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.213 -0.929 . . . . 0.75 109.835 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 8.9 p30 -92.38 121.77 34.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 1.75 109.309 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.484 HG21 ' HA3' ' A' ' 112' ' ' GLY . 2.5 t -141.83 156.33 45.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.177 -0.952 . . . . 0.37 109.78 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.691 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -95.68 -14.5 23.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -0.847 . . . . 1.9099999999999999 109.499 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.408 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 6.1 p -141.3 137.88 32.77 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.947 0.879 . . . . 0.73999999999999999 109.862 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -129.62 152.69 48.87 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.482 -0.932 . . . . 0.40999999999999998 108.482 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.552 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 1.3 mtmt -133.93 140.36 46.73 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.048 -1.061 . . . . 0.75 110.505 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.699 ' HA ' HD23 ' A' ' 110' ' ' LEU . 3.1 tt -94.39 149.01 4.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.617 -1.253 . . . . 0.54000000000000004 107.617 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -137.24 115.06 11.37 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.216 -0.927 . . . . 1.48 109.758 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.841 HD12 ' N ' ' A' ' 54' ' ' ILE . 2.1 mp -113.99 117.79 56.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 120.971 -1.081 . . . . 0.35999999999999999 108.948 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.471 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 21.0 mttt -119.71 131.16 55.33 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.18 -0.95 . . . . 1.25 109.396 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.62 133.37 52.16 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.173 -0.954 . . . . 0.53000000000000003 110.424 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -98.49 151.32 20.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 1.6399999999999999 109.085 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.815 HD11 HD12 ' A' ' 63' ' ' ILE . 34.3 mt -109.2 49.16 0.83 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.091 -1.005 . . . . 0.90000000000000002 109.86 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 58' ' ' LEU . 20.7 t0 44.4 26.64 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.897 . . . . 1.46 109.305 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.91 -55.16 0.17 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.319 -1.513 . . . . 0.94999999999999996 109.319 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 62' ' ' GLU . 1.2 tp -102.99 113.94 27.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -1.133 . . . . 2.0699999999999998 109.141 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.58 ' N ' HD12 ' A' ' 61' ' ' LEU . 37.0 tt0 -81.62 133.6 35.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.955 . . . . 2.4500000000000002 109.398 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.815 HD12 HD11 ' A' ' 58' ' ' LEU . 40.8 mt -126.66 168.69 19.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.008 0.908 . . . . 1.5900000000000001 109.215 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.594 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 63.3 m-20 -111.87 141.85 44.98 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.732 -1.21 . . . . 1.8500000000000001 107.732 178.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.056 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 6.2 t -108.32 105.39 56.55 Favored Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 121.03 -1.044 . . . . 0.45000000000000001 110.472 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 37.3 Cg_endo -82.56 -156.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.475 2.784 . . . . 0.44 110.189 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.37 17.58 47.34 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.576 -1.41 . . . . 0.85999999999999999 109.576 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.704 HG21 HD13 ' A' ' 54' ' ' ILE . 50.1 pt -104.67 -167.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -1.138 . . . . 0.62 109.432 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.598 ' O ' HG22 ' A' ' 52' ' ' ILE . 24.3 t0 -98.8 109.75 22.46 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.362 -0.836 . . . . 0.96999999999999997 109.382 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.552 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 1.2 p -86.74 47.47 1.49 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.283 -0.886 . . . . 0.45000000000000001 108.83 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 54.5 t-20 177.75 81.86 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.858 -1.164 . . . . 1.23 107.858 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.691 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -65.93 -5.57 9.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.572 -0.705 . . . . 0.32000000000000001 111.822 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.574 ' HA ' HG22 ' A' ' 76' ' ' VAL . 1.3 t -64.39 -12.13 39.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.587 -1.321 . . . . 1.1799999999999999 109.058 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.81 -23.19 55.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.051 -1.031 . . . . 1.0900000000000001 109.845 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.436 ' HB2' HG13 ' A' ' 88' ' ' ILE . 79.4 m-85 -110.27 -24.49 10.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.52000000000000002 109.098 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.762 ' CG2' HD21 ' A' ' 80' ' ' LEU . 1.2 m -107.66 162.6 5.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.122 -1.066 . . . . 0.34999999999999998 108.122 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.633 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -88.54 93.82 9.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.931 -1.106 . . . . 2.1699999999999999 111.222 -178.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.484 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 14.3 p -88.92 153.91 49.67 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 107.544 -1.28 . . . . 0.89000000000000001 107.544 177.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.691 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 26.3 Cg_endo -69.92 134.8 31.22 Favored 'Cis proline' 0 C--N 1.311 -1.396 0 C-N-CA 124.206 -1.164 . . . . 0.32000000000000001 112.346 2.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.843 HD23 ' CE2' ' A' ' 86' ' ' TYR . 7.3 mt -76.13 116.97 17.35 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.263 -1.384 . . . . 0.59999999999999998 107.263 178.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.7 t -89.06 136.94 22.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 121.736 0.779 . . . . 0.42999999999999999 110.543 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 2.6 ttmt -58.15 118.62 5.66 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.73 0.776 . . . . 1.45 110.269 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.51 -15.11 13.01 Favored Glycine 0 N--CA 1.479 1.549 0 C-N-CA 119.723 -1.227 . . . . 0.31 110.355 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.607 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 4.9 tp60 -102.43 156.68 17.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.042 -1.269 . . . . 1.05 108.044 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -109.26 149.28 29.66 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.107 -0.995 . . . . 1.1000000000000001 108.502 179.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.843 ' CE2' HD23 ' A' ' 80' ' ' LEU . 32.4 m-85 -131.5 149.64 52.45 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.289 -0.882 . . . . 0.40000000000000002 110.001 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.533 ' HB3' HD23 ' A' ' 40' ' ' LEU . 3.3 p30 -117.43 115.03 24.38 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.162 -1.051 . . . . 1.4099999999999999 108.162 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.691 HD12 ' HB1' ' A' ' 72' ' ' ALA . 3.8 tt -106.62 120.74 58.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.121 -0.987 . . . . 0.26000000000000001 111.153 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.525 ' HA ' ' HG3' ' A' ' 38' ' ' GLU . 69.0 tttt -103.09 101.55 11.53 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.099 -2.186 . . . . 2.3900000000000001 105.099 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.596 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 20.0 t80 -118.45 140.16 50.29 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.19 -0.944 . . . . 0.44 111.535 -176.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.76 107.71 19.4 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.489 -1.3 . . . . 0.76000000000000001 107.489 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.056 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 28.8 t90 -85.09 93.94 8.73 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.408 0.623 . . . . 0.58999999999999997 109.628 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -61.51 108.85 1.03 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.395 -0.815 . . . . 1.8500000000000001 109.6 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 33' ' ' LYS . 21.6 t -64.41 140.42 97.96 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.371 -0.831 . . . . 0.98999999999999999 108.792 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.862 ' HG3' HG13 ' A' ' 65' ' ' VAL . 34.3 Cg_endo -74.98 140.19 25.21 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.206 1.937 . . . . 2.2200000000000002 110.167 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.511 ' HD2' ' CA ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -77.48 4.54 10.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.323 -0.861 . . . . 2.5899999999999999 109.724 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.497 HG12 ' HB2' ' A' ' 95' ' ' PRO . 9.2 pt -92.93 -28.0 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.043 -1.036 . . . . 0.55000000000000004 109.649 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.574 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . . . -39.57 115.72 1.05 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 109.174 -0.676 . . . . 0.51000000000000001 109.174 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 101' ' ' SER . 36.6 Cg_endo -83.02 139.54 9.62 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.753 2.302 . . . . 0.63 109.461 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.475 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 1.7 mtmt -50.36 90.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.498 -0.927 . . . . 2.9100000000000001 108.498 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.721 ' HB3' HG23 ' A' ' 104' ' ' VAL . 2.0 t -96.24 120.47 36.59 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.47 -0.769 . . . . 0.80000000000000004 109.244 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' A' ' 103' ' ' ASN . 11.8 pt-20 -41.02 -47.49 3.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.507 -0.746 . . . . 1.9099999999999999 109.657 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.523 ' N ' ' CG ' ' A' ' 102' ' ' GLU . 0.8 OUTLIER -131.57 134.15 45.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 1.8899999999999999 109.72 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 1.122 HG21 ' CD1' ' A' ' 127' ' ' ILE . 2.5 t -129.68 150.55 34.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.387 -0.821 . . . . 0.63 109.14 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.769 HG13 ' O ' ' A' ' 122' ' ' ALA . 74.2 t -126.62 119.03 52.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.409 -0.96 . . . . 0.63 108.409 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.56 138.93 20.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.093 -1.004 . . . . 0.38 109.617 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 32.9 m -120.39 115.68 23.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.392 -0.818 . . . . 0.37 109.831 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 108' ' ' VAL . 0.7 OUTLIER -95.92 127.39 48.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.62 -1.252 . . . . 0.35999999999999999 107.62 178.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.733 ' HD2' HD11 ' A' ' 111' ' ' ILE . 1.4 ttmm -137.92 129.74 28.45 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.518 -1.364 . . . . 1.4099999999999999 110.733 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.741 ' C ' HD12 ' A' ' 111' ' ' ILE . 14.0 mt -104.21 138.34 40.82 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.376 -1.342 . . . . 0.56000000000000005 107.376 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.741 HD12 ' C ' ' A' ' 110' ' ' LEU . 4.1 mp -133.7 116.94 25.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.149 -0.97 . . . . 0.28999999999999998 109.852 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.484 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -89.67 -126.34 2.98 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.112 -1.595 . . . . 0.54000000000000004 109.112 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.17 -1.89 11.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -1.172 . . . . 1.3200000000000001 109.565 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -115.22 -3.56 12.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 2.7200000000000002 109.867 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 151.55 -148.8 20.26 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.756 -1.338 . . . . 0.34000000000000002 109.756 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.593 ' CG1' ' CD ' ' A' ' 109' ' ' LYS . 2.0 t -90.06 110.21 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -1.176 . . . . 0.48999999999999999 109.851 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 110' ' ' LEU . 53.2 mt -53.74 -39.59 65.43 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.386 -0.821 . . . . 0.34000000000000002 109.981 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.512 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -156.87 -165.05 1.76 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.784 -1.197 . . . . 0.46000000000000002 109.442 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.517 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 50.3 t -174.98 156.13 2.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.035 -1.04 . . . . 0.56000000000000005 109.72 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -154.11 142.11 20.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.914 . . . . 0.39000000000000001 109.409 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.44 HD12 ' HB3' ' A' ' 8' ' ' CYS . 26.0 mt -134.1 118.89 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.75 109.178 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.769 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -94.1 142.75 27.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.103 -0.998 . . . . 0.66000000000000003 109.49 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -86.99 0.34 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.886 . . . . 2.0600000000000001 109.592 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -49.12 115.8 1.44 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 2.5600000000000001 109.667 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -159.6 149.81 19.78 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.297 -1.521 . . . . 0.41999999999999998 109.297 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 13.8 mttt -152.6 136.0 15.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.42 -1.047 . . . . 1.98 108.524 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 1.122 ' CD1' HG21 ' A' ' 104' ' ' VAL . 75.6 mt -106.87 141.17 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.633 -1.292 . . . . 0.40000000000000002 110.095 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.51 ' HB2' ' CG2' ' A' ' 28' ' ' ILE . 19.3 mtt180 -131.18 177.31 7.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.562 -0.711 . . . . 2.6000000000000001 109.151 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.0 t70 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.05 -0.976 . . . . 1.72 109.422 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.546 ' CB ' ' HG2' ' A' ' 17' ' ' MET . 2.6 pt20 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.287 0.565 . . . . 0.63 109.77 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.62 ' CG2' HG23 ' A' ' 18' ' ' VAL . 1.4 m -104.78 143.36 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.342 -0.849 . . . . 0.77000000000000002 109.258 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -71.25 117.91 13.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.77000000000000002 110.1 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 m -142.72 154.13 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.552 -0.907 . . . . 0.29999999999999999 108.552 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.46 107.69 17.45 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.121 -0.987 . . . . 2.0499999999999998 109.127 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 2.2 p30 -59.63 135.86 57.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 3.6899999999999999 109.154 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.81 -7.45 14.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.128 -0.983 . . . . 1.0900000000000001 109.192 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 10' ' ' ASN . . . -67.54 -63.83 0.98 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.68999999999999995 109.666 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER 166.64 49.88 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.438 -0.789 . . . . 0.89000000000000001 109.152 -178.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m120 64.32 28.58 13.78 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.217 -1.031 . . . . 4.1399999999999997 108.217 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.473 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -77.07 -70.99 0.43 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.646 -0.659 . . . . 1.1100000000000001 109.407 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -55.09 122.76 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.55000000000000004 109.798 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -66.67 -28.0 68.11 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.359 -0.838 . . . . 1.9099999999999999 108.947 179.594 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.569 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 12.6 pttt 165.8 135.01 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.837 -1.171 . . . . 0.93999999999999995 107.837 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.9 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -111.94 119.17 59.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 O-C-N 121.257 -0.902 . . . . 0.54000000000000004 108.701 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.546 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 1.1 mtm -108.64 157.13 18.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.857 . . . . 0.32000000000000001 110.483 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.868 HG11 ' CE2' ' A' ' 35' ' ' PHE . 48.4 t -124.11 141.52 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.468 -0.938 . . . . 0.31 108.468 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -85.19 82.36 8.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.015 -1.053 . . . . 0.56999999999999995 109.493 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.48 -72.59 0.23 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.995 -1.242 . . . . 0.45000000000000001 109.995 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -51.99 164.67 0.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -1.16 . . . . 1.7 110.322 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.59 -3.54 20.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.485 -0.759 . . . . 1.6699999999999999 109.4 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 3' ' ' VAL . . . 95.27 -122.24 7.16 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.251 -1.54 . . . . 0.57999999999999996 109.251 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' GLY . 17.8 t -40.69 -40.87 1.4 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.471 -1.017 . . . . 0.93000000000000005 109.438 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.58 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -51.05 179.86 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 1.4099999999999999 108.917 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.58 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 32.7 Cg_endo -76.13 142.43 24.55 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.226 1.951 . . . . 1.5900000000000001 110.343 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.96 119.71 38.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.95999999999999996 109.715 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.413 HG23 ' HG3' ' A' ' 128' ' ' ARG . 29.3 mm -111.81 107.91 24.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.007 -1.058 . . . . 0.56999999999999995 108.991 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 mt -94.37 118.77 41.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.268 -0.895 . . . . 0.66000000000000003 109.411 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.486 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 14.5 m-70 -91.19 114.92 27.58 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.124 -1.065 . . . . 0.97999999999999998 108.124 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.529 ' HA ' HG11 ' A' ' 94' ' ' VAL . 12.1 ptt180 -57.36 158.64 5.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.838 -1.164 . . . . 1.1399999999999999 109.924 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.505 ' HA2' ' CD ' ' A' ' 96' ' ' LYS . . . 87.86 -19.39 34.04 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.479 -1.449 . . . . 0.46000000000000002 109.479 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.584 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -100.7 152.53 37.87 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.198 -1.178 . . . . 1.0900000000000001 110.163 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.36 120.46 3.64 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.845 2.363 . . . . 0.46000000000000002 110.785 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.868 ' CE2' HG11 ' A' ' 18' ' ' VAL . 4.3 t80 -96.76 121.31 38.47 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.868 -1.16 . . . . 0.41999999999999998 107.868 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.906 ' C ' HD13 ' A' ' 37' ' ' LEU . 2.6 m -100.76 134.65 43.42 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.064 -1.022 . . . . 0.93000000000000005 110.587 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.965 HD13 ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -144.71 124.74 13.57 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.253 -1.017 . . . . 0.68000000000000005 108.253 178.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.44 133.41 48.53 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.371 -0.974 . . . . 1.9299999999999999 108.371 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.9 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -130.2 119.74 23.41 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.056 -1.058 . . . . 0.32000000000000001 110.6 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.603 HD23 ' CB ' ' A' ' 87' ' ' ASP . 12.9 mt -89.71 141.57 28.49 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.154 -2.165 . . . . 0.69999999999999996 105.154 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 110' ' ' LEU . 28.7 p90 -156.78 137.32 13.11 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.341 -1.343 . . . . 0.28999999999999998 110.037 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.7 OUTLIER -82.45 112.43 19.38 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.327 -0.949 . . . . 0.52000000000000002 108.584 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.873 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -44.46 115.54 0.87 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.564 -0.532 . . . . 0.13 109.564 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.465 ' C ' ' HG3' ' A' ' 82' ' ' LYS . 4.7 p30 -80.42 5.77 14.1 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.269 -0.894 . . . . 0.089999999999999997 109.113 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.552 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 1.3 pt20 -169.5 170.33 8.32 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.34 -0.85 . . . . 0.53000000000000003 109.357 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -101.18 121.07 41.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.87 108.927 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.575 HG21 HD11 ' A' ' 117' ' ' LEU . 1.2 t -137.88 146.08 42.93 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.234 -0.916 . . . . 0.27000000000000002 109.867 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.68 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 10.0 mmmt -86.18 -12.76 48.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.416 -0.802 . . . . 0.44 109.578 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.6 p -141.92 149.65 40.44 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.831 -0.748 . . . . 0.44 109.418 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -145.07 156.64 44.04 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.247 -0.908 . . . . 0.37 109.55 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.561 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 0.9 OUTLIER -136.79 140.03 42.22 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.189 -0.944 . . . . 0.27000000000000002 110.475 -179.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 69' ' ' ASP . 3.5 tt -92.94 153.04 3.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.177 -1.416 . . . . 0.73999999999999999 107.177 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' CB ' ' HB3' ' A' ' 109' ' ' LYS . 2.4 tt0 -139.91 117.34 11.39 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.925 -1.109 . . . . 0.16 110.039 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.6 HD12 HD12 ' A' ' 68' ' ' ILE . 3.2 mp -119.37 116.32 50.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.027 -1.046 . . . . 0.20000000000000001 109.458 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.701 ' HA ' HG23 ' A' ' 65' ' ' VAL . 2.6 mtmp? -115.98 157.37 24.7 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.197 -0.939 . . . . 1.9099999999999999 108.712 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -134.22 123.7 24.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.819 -1.175 . . . . 0.34999999999999998 110.305 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -93.63 150.04 20.74 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.852 -0.796 . . . . 0.68999999999999995 108.852 179.181 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.563 HD11 ' CD1' ' A' ' 63' ' ' ILE . 15.4 mt -106.72 45.0 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.25 109.704 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.59 17.89 3.31 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.392 -0.818 . . . . 0.81999999999999995 109.413 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.84 -45.6 0.07 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.806 -1.318 . . . . 0.34999999999999998 109.806 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.423 ' HG ' HG13 ' A' ' 63' ' ' ILE . 5.1 tp -109.3 112.33 24.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.173 -1.192 . . . . 0.52000000000000002 109.548 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -77.17 125.39 29.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.992 -1.068 . . . . 1.3799999999999999 108.95 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.626 HG22 ' N ' ' A' ' 64' ' ' ASP . 43.8 mt -117.2 167.31 10.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 122.117 0.961 . . . . 0.41999999999999998 109.812 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.626 ' N ' HG22 ' A' ' 63' ' ' ILE . 7.5 t70 -112.4 136.67 51.6 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.061 -1.829 . . . . 4.2000000000000002 106.061 176.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.082 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 1.5 t -101.72 110.16 61.27 Favored Pre-proline 0 C--N 1.293 -1.868 0 C-N-CA 118.866 -1.134 . . . . 0.55000000000000004 111.039 -177.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.5 Cg_endo -81.72 -163.18 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.98 2.453 . . . . 0.65000000000000002 109.766 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.63 50.75 62.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.959 -1.256 . . . . 1.1799999999999999 109.959 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.6 HD12 HD12 ' A' ' 54' ' ' ILE . 13.4 pt -139.88 -156.82 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -1.103 . . . . 0.66000000000000003 109.035 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.649 ' O ' HG22 ' A' ' 52' ' ' ILE . 29.6 t70 -110.05 106.39 15.87 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.441 -0.787 . . . . 0.71999999999999997 109.753 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.561 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -87.12 48.19 1.61 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.19 -0.944 . . . . 0.40999999999999998 108.562 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 9.9 t-20 178.41 79.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.462 -1.31 . . . . 2.2200000000000002 107.462 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.44 -4.05 1.7 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.643 -0.661 . . . . 0.25 111.902 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.483 ' HA ' HG22 ' A' ' 76' ' ' VAL . 91.6 m -64.53 -10.58 26.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.539 -1.351 . . . . 3.0099999999999998 109.481 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.71 -20.72 45.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.56999999999999995 109.552 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CE2' ' CD1' ' A' ' 90' ' ' TYR . 79.4 m-85 -112.19 -20.88 11.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.275 -0.89 . . . . 0.34999999999999998 109.289 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.802 ' CG2' HD21 ' A' ' 80' ' ' LEU . 2.1 m -112.35 166.25 6.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.616 -0.883 . . . . 0.34000000000000002 108.616 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.662 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -91.9 94.8 9.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.001 -1.062 . . . . 1.54 111.305 -178.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.458 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 51.6 m -84.99 148.93 52.0 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 107.899 -1.149 . . . . 2.8999999999999999 107.899 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.68 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 25.7 Cg_endo -71.1 136.01 39.43 Favored 'Cis proline' 0 C--N 1.312 -1.367 0 C-N-CA 124.207 -1.164 . . . . 0.16 112.664 1.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.802 HD21 ' CG2' ' A' ' 76' ' ' VAL . 16.5 mt -71.7 146.74 48.01 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.333 -2.099 . . . . 0.71999999999999997 105.333 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.873 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 59.4 t -117.22 142.09 32.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 O-C-N 120.337 -1.477 . . . . 0.89000000000000001 111.17 -177.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 6.2 ttmt -65.34 105.86 1.23 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.59 0.709 . . . . 0.56000000000000005 109.905 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 122.72 -19.36 7.94 Favored Glycine 0 N--CA 1.48 1.583 0 C-N-CA 119.638 -1.268 . . . . 0.23000000000000001 110.066 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.575 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 7.9 tp60 -95.41 159.48 14.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.075 -1.25 . . . . 0.44 107.804 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -110.49 148.43 32.09 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.878 -1.129 . . . . 0.46000000000000002 108.371 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.725 ' CE2' HD23 ' A' ' 80' ' ' LEU . 28.6 m-85 -128.43 148.76 50.73 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.32 -0.863 . . . . 0.31 109.908 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.603 ' CB ' HD23 ' A' ' 40' ' ' LEU . 10.7 p-10 -118.69 113.93 21.94 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.605 -0.887 . . . . 0.97999999999999998 108.605 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.612 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 2.4 tt -108.91 119.16 57.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.272 -0.893 . . . . 0.19 111.139 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -99.72 107.68 19.82 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 104.649 -2.352 . . . . 3.75 104.649 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.614 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 24.5 t80 -124.12 141.98 51.6 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.577 -1.249 . . . . 0.39000000000000001 113.076 -175.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.586 ' O ' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.29 145.25 24.81 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 106.262 -1.755 . . . . 0.98999999999999999 106.262 176.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.082 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 26.9 t90 -124.71 82.8 2.08 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.797 -1.19 . . . . 0.64000000000000001 109.867 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -60.71 106.07 0.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.525 -0.734 . . . . 1.3500000000000001 109.442 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.648 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 22.1 t -55.99 144.72 57.35 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.157 -1.053 . . . . 1.22 108.157 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.648 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 24.0 Cg_endo -64.36 -7.48 14.22 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.211 1.941 . . . . 3.7000000000000002 112.192 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.505 ' CD ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER 75.38 -10.74 1.19 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.154 -0.966 . . . . 1.78 109.88 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.513 ' O ' ' C ' ' A' ' 98' ' ' ALA . 19.9 pt -91.11 -28.42 4.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 108.1 -1.074 . . . . 0.5 108.1 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.549 ' HB1' HD13 ' A' ' 127' ' ' ILE . . . -37.3 113.65 0.65 Allowed Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 107.926 -1.138 . . . . 0.65000000000000002 107.926 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.3 177.83 8.3 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 122.769 2.313 . . . . 1.3200000000000001 110.459 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 4.5 mtmt -82.19 68.74 8.72 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.573 -1.269 . . . . 0.65000000000000002 107.573 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.696 ' HB3' HG23 ' A' ' 104' ' ' VAL . 4.0 t -70.86 118.85 14.16 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.495 -0.753 . . . . 0.51000000000000001 109.615 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 1.1 pt-20 -41.16 -47.36 3.25 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.671 -0.863 . . . . 1.99 108.671 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 3.5 t-20 -130.72 141.62 50.39 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.051 -0.722 . . . . 2.9500000000000002 109.051 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 1.013 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.9 OUTLIER -131.93 142.65 42.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.101 -1.0 . . . . 0.56000000000000005 109.467 179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 2.7 t -118.27 117.63 55.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.671 -1.233 . . . . 0.92000000000000004 107.671 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 2.2 t -101.89 135.92 36.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 120.768 -1.207 . . . . 0.31 110.186 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 94.2 m -116.25 116.59 28.05 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.246 -0.909 . . . . 0.35999999999999999 109.974 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -94.42 132.23 39.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 106.834 -1.543 . . . . 0.16 106.834 177.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.956 ' CD ' HD11 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -142.03 129.67 21.51 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.327 -1.483 . . . . 0.92000000000000004 112.112 -177.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.694 ' C ' HD12 ' A' ' 111' ' ' ILE . 9.1 mt -103.31 137.97 40.71 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.552 -1.647 . . . . 0.26000000000000001 106.552 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.956 HD11 ' CD ' ' A' ' 109' ' ' LYS . 4.2 mp -134.11 116.29 22.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.961 -1.087 . . . . 0.20999999999999999 110.162 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.447 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -87.07 -135.62 4.48 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.943 -1.663 . . . . 0.25 108.943 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.65 -3.53 17.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -1.16 . . . . 0.82999999999999996 109.403 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -112.85 -7.42 13.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 4.2999999999999998 110.277 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 111' ' ' ILE . . . 156.97 -147.02 14.73 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.274 -1.441 . . . . 0.25 110.483 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.642 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 2.0 t -92.57 107.64 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.433 -1.039 . . . . 0.19 109.731 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 47' ' ' THR . 29.2 mt -56.02 -42.71 76.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.485 -0.759 . . . . 0.20000000000000001 110.488 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.469 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -149.07 -177.01 5.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.909 -1.119 . . . . 0.40000000000000002 109.247 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -170.68 150.24 3.29 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.184 -1.006 . . . . 0.62 109.913 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.401 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -150.81 146.82 26.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.219 -0.926 . . . . 0.22 109.626 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 52.4 mt -133.23 116.73 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.957 . . . . 0.27000000000000002 108.936 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.03 142.35 27.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.074 -1.016 . . . . 0.20999999999999999 109.31 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.0 p -102.7 -87.68 0.41 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.42999999999999999 109.59 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -45.66 116.5 1.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 1.6899999999999999 109.011 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -166.62 144.59 9.22 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.795 -1.322 . . . . 0.16 109.795 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 125' ' ' GLY . 1.8 mtmp? -150.55 135.75 17.79 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.075 -1.083 . . . . 1.8400000000000001 108.075 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 1.013 ' CD1' HG21 ' A' ' 104' ' ' VAL . 82.3 mt -106.69 143.03 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.639 -1.288 . . . . 0.44 110.62 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.517 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 22.4 mtm180 -129.59 177.45 7.21 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.955 -0.757 . . . . 2.6699999999999999 108.955 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.516 ' HB2' ' HD3' ' A' ' 100' ' ' LYS . 20.5 t70 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.987 -1.006 . . . . 0.80000000000000004 109.636 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.522 ' HG2' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.33 0.586 . . . . 2.4199999999999999 109.501 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.522 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 33.8 m -105.53 165.53 3.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.192 -0.942 . . . . 0.67000000000000004 109.371 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -90.39 122.76 33.55 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.315 -0.866 . . . . 1.74 109.944 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 m -148.13 156.47 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.413 -0.804 . . . . 0.46000000000000002 109.079 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -120.08 105.53 11.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.172 -0.955 . . . . 2.6400000000000001 108.958 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.49 ' OD2' ' HB ' ' A' ' 13' ' ' ILE . 1.1 m-20 -54.99 141.13 35.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 2.2999999999999998 109.788 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -112.66 -12.12 13.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.269 -0.894 . . . . 1.05 108.71 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.455 ' HB2' ' C ' ' A' ' 118' ' ' ALA . . . -60.38 -79.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.949 0.88 . . . . 0.17000000000000001 109.581 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 59.7 t-20 -179.16 37.73 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.594 -0.891 . . . . 2.96 108.594 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 20.1 t-20 76.08 30.12 0.73 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.411 -0.959 . . . . 1.5700000000000001 108.411 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.445 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 60.8 mm-40 -76.77 -62.34 1.67 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.491 -0.756 . . . . 1.3300000000000001 109.903 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -61.63 121.73 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.931 -1.105 . . . . 0.66000000000000003 109.94 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -66.9 -30.41 70.55 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.245 -1.02 . . . . 1.76 108.245 178.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 164.62 131.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.32 -0.622 . . . . 1.95 109.32 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.553 ' HB ' ' CB ' ' A' ' 39' ' ' ALA . 2.1 p -120.75 125.91 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.962 -1.086 . . . . 1.8500000000000001 108.705 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.426 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -109.6 159.28 17.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.375 -0.828 . . . . 0.46999999999999997 110.879 -178.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.018 HG22 ' HB3' ' A' ' 37' ' ' LEU . 92.5 t -120.8 147.65 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.947 -0.76 . . . . 0.28999999999999998 108.947 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.48 57.89 0.94 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.244 -0.91 . . . . 3.2200000000000002 109.46 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.41 27.71 0.07 OUTLIER Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.309 -1.424 . . . . 2.8399999999999999 110.871 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 m -140.42 -167.26 2.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.864 -1.374 . . . . 1.9399999999999999 109.812 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 25' ' ' ASP . 4.2 m-70 -128.94 -8.9 4.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.994 . . . . 3.9900000000000002 110.265 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 107.72 -132.76 11.29 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.728 -1.349 . . . . 1.5700000000000001 109.728 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -42.54 -38.43 1.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -1.12 . . . . 1.0 109.662 -179.668 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -52.13 170.53 0.23 Allowed Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 121.254 -0.904 . . . . 1.4199999999999999 108.693 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 25' ' ' ASP . 31.6 Cg_endo -75.48 153.59 39.63 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.413 2.075 . . . . 0.56999999999999995 110.184 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.2 m -112.79 136.39 52.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.56999999999999995 109.281 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.464 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 29.1 mm -111.35 107.7 23.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.049 -1.032 . . . . 0.48999999999999999 109.216 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.431 ' HB ' HG12 ' A' ' 127' ' ' ILE . 2.4 mt -88.99 121.62 39.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.29 -0.881 . . . . 0.59999999999999998 108.979 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 32.2 m-70 -84.87 133.91 34.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.464 -0.773 . . . . 1.02 109.971 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.563 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 6.0 mtm180 -57.6 140.09 51.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.533 -0.729 . . . . 1.8899999999999999 110.409 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 94' ' ' VAL . . . 67.19 1.58 14.46 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.528 -0.844 . . . . 0.92000000000000004 111.274 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -88.71 149.76 44.61 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 120.755 -1.438 . . . . 0.98999999999999999 109.78 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.477 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 36.6 Cg_endo -81.12 113.74 2.75 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.971 2.447 . . . . 0.66000000000000003 111.031 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.713 ' CE2' HG11 ' A' ' 18' ' ' VAL . 2.0 t80 -97.61 115.22 27.47 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.345 -1.354 . . . . 0.87 107.345 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.784 ' C ' HD13 ' A' ' 37' ' ' LEU . 29.9 m -107.72 129.2 55.05 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.974 -1.079 . . . . 0.70999999999999996 111.168 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.018 ' HB3' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -143.63 126.26 15.99 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.903 -0.777 . . . . 1.3100000000000001 108.903 179.045 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.534 ' O ' HG23 ' A' ' 16' ' ' VAL . 12.6 tt0 -94.64 134.44 37.22 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.016 -1.105 . . . . 1.55 108.016 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.553 ' CB ' ' HB ' ' A' ' 16' ' ' VAL . . . -129.5 126.06 37.76 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.868 -1.145 . . . . 0.58999999999999997 110.48 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 87' ' ' ASP . 5.1 mt -93.92 144.84 25.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.467 -1.679 . . . . 0.77000000000000002 106.467 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.62 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 33.1 p90 -161.69 139.28 8.85 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.757 -1.177 . . . . 0.39000000000000001 109.517 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.2 m-20 -86.67 114.47 23.4 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.083 -1.047 . . . . 3.4500000000000002 109.179 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.15 112.55 0.54 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.111 -0.7 . . . . 0.35999999999999999 109.111 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 44' ' ' ASN . 3.0 p30 -82.66 10.27 7.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.063 -1.023 . . . . 0.40000000000000002 109.477 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.58 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 4.6 pt20 -167.23 147.28 5.38 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.418 -0.801 . . . . 0.40000000000000002 109.052 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 2.8 p-10 -84.21 114.17 21.62 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.061 -1.024 . . . . 2.6899999999999999 109.06 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.484 HG21 ' HA3' ' A' ' 112' ' ' GLY . 1.7 t -131.55 155.12 48.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.332 -0.855 . . . . 0.10000000000000001 109.855 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.702 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 9.3 mmmt -92.16 -10.58 38.28 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.263 -0.898 . . . . 0.56999999999999995 109.982 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.8 p -147.41 139.44 24.32 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.265 -0.897 . . . . 0.35999999999999999 110.098 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -128.51 153.56 47.05 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.48 -0.762 . . . . 0.23000000000000001 109.13 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -133.32 136.38 45.38 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.374 -0.931 . . . . 0.44 110.745 -178.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 69' ' ' ASP . 4.9 tt -90.26 151.95 3.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.363 -1.347 . . . . 0.20000000000000001 107.363 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' LYS . 2.7 mt-10 -138.54 116.28 11.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.026 -1.046 . . . . 0.62 110.291 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.641 ' N ' HD12 ' A' ' 54' ' ' ILE . 3.3 mp -117.53 112.77 40.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.742 -1.223 . . . . 0.23000000000000001 109.396 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 40.3 mtmt -111.75 152.4 27.85 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.034 -1.098 . . . . 2.1699999999999999 108.034 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -122.59 156.35 34.43 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.209 -1.396 . . . . 0.93000000000000005 110.737 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.0 OUTLIER -117.06 150.48 38.58 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.796 -0.816 . . . . 0.82999999999999996 108.796 179.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 57' ' ' SER . 12.7 mt -115.92 43.49 2.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.946 -1.096 . . . . 0.41999999999999998 109.267 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 57.3 t0 51.16 21.95 1.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 1.1699999999999999 108.953 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.44 -53.96 0.17 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.976 -1.65 . . . . 0.16 108.976 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 mp -102.67 116.1 31.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.346 -1.09 . . . . 4.3600000000000003 108.945 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.7 mt-10 -91.76 120.78 32.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.035 -1.041 . . . . 3.3100000000000001 109.519 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.594 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 49.2 mt -104.83 169.58 2.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 122.135 0.969 . . . . 0.40999999999999998 110.011 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.594 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 43.4 m-20 -109.4 138.33 45.92 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.583 -1.636 . . . . 0.66000000000000003 106.583 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.984 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 1.6 t -106.68 107.4 60.16 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.791 -1.193 . . . . 0.39000000000000001 111.406 -177.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.7 Cg_endo -82.83 -158.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 123.236 2.624 . . . . 0.14999999999999999 109.752 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.87 45.82 93.15 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.31 -1.116 . . . . 0.78000000000000003 110.31 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.547 HG22 ' CD1' ' A' ' 92' ' ' TRP . 32.3 pt -136.21 -156.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.163 -1.198 . . . . 0.47999999999999998 108.951 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.601 ' O ' HG22 ' A' ' 52' ' ' ILE . 31.4 t70 -107.97 105.74 15.66 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.251 -0.906 . . . . 0.93000000000000005 109.473 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.507 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -87.35 48.06 1.59 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.316 -0.994 . . . . 0.38 108.316 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 26.2 t-20 178.08 77.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.691 -1.226 . . . . 1.3300000000000001 107.691 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.636 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -61.96 -5.67 2.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.17999999999999999 112.009 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.566 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -63.94 -12.49 37.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.384 -1.448 . . . . 0.27000000000000002 108.987 179.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -75.53 -22.77 56.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.069 -1.02 . . . . 1.3899999999999999 110.156 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.509 ' HB2' HG13 ' A' ' 88' ' ' ILE . 58.7 m-85 -109.42 -30.75 7.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.56999999999999995 108.79 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.715 ' CG2' HD21 ' A' ' 80' ' ' LEU . 2.1 m -99.23 165.82 2.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.086 -1.079 . . . . 0.27000000000000002 108.086 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.612 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -91.28 91.23 8.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.14 -0.975 . . . . 1.3500000000000001 111.411 -178.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.498 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 11.5 p -89.14 153.59 49.02 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 107.541 -1.281 . . . . 0.32000000000000001 107.541 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.702 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 23.2 Cg_endo -68.53 130.16 14.67 Favored 'Cis proline' 0 C--N 1.313 -1.339 0 C-N-CA 124.474 -1.053 . . . . 0.42999999999999999 112.785 2.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.877 HD23 ' CE2' ' A' ' 86' ' ' TYR . 11.1 mt -74.13 115.69 13.91 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.962 -1.495 . . . . 0.46999999999999997 106.962 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.9 t -83.45 141.25 15.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 C-N-CA 119.084 -1.047 . . . . 0.42999999999999999 110.125 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.58 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 3.7 tttt -64.99 116.9 6.89 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.851 0.834 . . . . 1.98 110.195 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.06 -11.39 14.85 Favored Glycine 0 N--CA 1.479 1.505 0 N-CA-C 109.43 -1.468 . . . . 0.41999999999999998 109.43 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.565 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 4.2 tp-100 -100.72 156.54 17.28 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.668 -1.234 . . . . 2.3100000000000001 107.668 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -109.3 149.99 28.64 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.363 -0.977 . . . . 1.2 108.363 179.508 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.877 ' CE2' HD23 ' A' ' 80' ' ' LEU . 36.6 m-85 -132.07 149.35 52.43 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.145 -0.972 . . . . 0.54000000000000004 110.258 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.576 ' HB3' HD23 ' A' ' 40' ' ' LEU . 9.7 p-10 -117.94 113.69 22.08 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.555 -0.905 . . . . 0.67000000000000004 108.555 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.636 HD12 ' HB1' ' A' ' 72' ' ' ALA . 7.4 tt -108.15 124.83 64.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.195 -0.941 . . . . 0.42999999999999999 111.626 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.451 ' HD3' ' OE1' ' A' ' 38' ' ' GLU . 5.2 tptt -100.49 105.0 16.41 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.353 -2.091 . . . . 3.7000000000000002 105.353 176.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.594 ' CE2' ' O ' ' A' ' 91' ' ' THR . 27.5 t80 -119.8 141.86 49.11 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 118.579 -1.249 . . . . 0.45000000000000001 113.143 -176.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.594 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -94.38 144.18 25.77 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.482 -1.673 . . . . 1.02 106.482 177.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.984 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 22.2 t90 -122.74 89.48 3.12 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.798 -1.189 . . . . 0.57999999999999996 111.162 -177.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -62.39 107.74 0.98 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.239 -0.913 . . . . 2.4100000000000001 108.655 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.784 HG13 ' HD2' ' A' ' 95' ' ' PRO . 53.8 t -74.9 144.42 79.67 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.474 -0.766 . . . . 1.1899999999999999 109.149 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.784 ' HD2' HG13 ' A' ' 94' ' ' VAL . 29.8 Cg_endo -70.77 136.15 29.68 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.897 1.731 . . . . 0.83999999999999997 109.573 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.14 4.81 3.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.483 -0.761 . . . . 2.3700000000000001 111.299 -178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 98' ' ' ALA . 13.2 pt -89.9 -25.93 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.673 -1.267 . . . . 0.97999999999999998 109.047 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.563 ' O ' ' CD ' ' A' ' 31' ' ' ARG . . . -36.17 117.54 0.67 Allowed Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 109.396 -0.594 . . . . 0.53000000000000003 109.396 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -83.01 167.0 14.47 Favored 'Trans proline' 0 C--N 1.298 -2.097 0 C-N-CA 122.595 2.197 . . . . 0.87 109.221 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.549 ' CD ' ' HA ' ' A' ' 128' ' ' ARG . 6.2 mmtp -79.31 77.86 5.82 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.682 -1.229 . . . . 4.8300000000000001 107.682 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.494 ' HB2' HD22 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -80.8 118.55 22.42 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.951 -0.759 . . . . 0.48999999999999999 108.951 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 0.7 OUTLIER -37.32 -50.63 1.04 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.604 -0.685 . . . . 2.75 109.911 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.526 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 24.5 m120 -129.96 139.0 51.15 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.077 -1.014 . . . . 2.8500000000000001 110.058 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.648 HG21 ' CD1' ' A' ' 127' ' ' ILE . 74.0 t -129.88 149.35 33.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.326 -0.859 . . . . 0.60999999999999999 109.405 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.528 ' HB ' ' CB ' ' A' ' 57' ' ' SER . 1.0 OUTLIER -124.13 122.45 64.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.988 -1.116 . . . . 1.0800000000000001 107.988 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 20.1 t -103.94 144.09 14.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.239 -0.913 . . . . 0.44 109.779 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 36.9 m -123.67 114.45 19.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.366 -0.834 . . . . 0.20000000000000001 109.676 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -95.24 127.52 47.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.289 -1.375 . . . . 0.31 107.289 178.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.873 ' CD ' HD11 ' A' ' 111' ' ' ILE . 8.5 ttmt -142.58 127.05 17.82 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.387 -1.446 . . . . 2.3399999999999999 111.468 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.638 ' C ' HD12 ' A' ' 111' ' ' ILE . 1.4 mp -103.46 137.37 41.64 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.472 -1.307 . . . . 1.99 107.472 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.873 HD11 ' CD ' ' A' ' 109' ' ' LYS . 4.2 mp -131.09 121.54 49.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.41 -0.806 . . . . 0.37 109.856 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.484 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -80.92 -129.88 0.96 Allowed Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.455 -1.858 . . . . 0.45000000000000001 108.455 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.34 -3.57 11.92 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.284 -1.127 . . . . 0.77000000000000002 109.12 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.401 ' O ' ' CG ' ' A' ' 114' ' ' ASN . 1.3 t30 -116.77 -10.96 10.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.242 -0.911 . . . . 3.7000000000000002 110.708 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 111' ' ' ILE . . . 168.35 -158.47 31.2 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.467 -1.349 . . . . 0.29999999999999999 110.573 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.632 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -87.74 109.84 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -1.107 . . . . 0.34999999999999998 110.162 -179.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 112' ' ' GLY . 85.1 mt -53.95 -43.11 69.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 0.52000000000000002 108.999 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.478 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -155.46 -162.53 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.095 -1.003 . . . . 0.51000000000000001 109.465 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -178.59 155.24 0.82 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.208 -0.933 . . . . 0.73999999999999999 109.158 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.06 143.97 23.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.011 -1.056 . . . . 0.31 109.925 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.0 mt -133.17 116.92 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.106 -0.996 . . . . 0.56000000000000005 108.41 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.1 146.62 24.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.993 -1.067 . . . . 0.25 110.517 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 124' ' ' HIS . 88.3 m -116.65 162.65 17.31 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.148 -0.686 . . . . 2.5699999999999998 109.148 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.519 ' N ' HG22 ' A' ' 123' ' ' THR . 5.0 t-160 54.03 75.05 0.29 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 2.1200000000000001 109.93 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -131.7 161.62 23.73 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.717 -1.753 . . . . 0.47999999999999998 108.717 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 125' ' ' GLY . 46.3 mttt -152.85 139.52 18.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.219 -1.166 . . . . 1.7 109.255 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.648 ' CD1' HG21 ' A' ' 104' ' ' VAL . 64.2 mt -106.55 139.83 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.621 -1.3 . . . . 0.32000000000000001 109.677 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.549 ' HA ' ' CD ' ' A' ' 100' ' ' LYS . 22.0 mtt180 -132.92 178.53 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.383 -0.823 . . . . 3.6200000000000001 109.307 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.995 -1.002 . . . . 2.7799999999999998 109.449 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 9.4 pt20 . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.266 -0.642 . . . . 1.21 109.266 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 21' ' ' CYS . 28.2 m -104.76 160.72 5.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.307 -0.87 . . . . 0.63 108.903 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.82 118.19 30.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.991 -1.068 . . . . 0.82999999999999996 110.139 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 m -142.17 157.51 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.329 -0.989 . . . . 0.35999999999999999 108.329 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 109.17 17.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.058 -1.026 . . . . 4.4000000000000004 109.596 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 16.9 p-10 -45.06 132.51 7.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 3.73 109.805 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -108.7 -2.9 18.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.805 . . . . 0.33000000000000002 109.505 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.541 ' N ' ' HB3' ' A' ' 119' ' ' CYS . . . -75.33 -74.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.59999999999999998 109.668 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.434 ' CG ' ' O ' ' A' ' 9' ' ' ALA . 7.4 m-20 178.49 55.64 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.557 -0.905 . . . . 2.4199999999999999 108.557 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.404 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 1.3 t30 65.28 42.85 3.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.446 -0.946 . . . . 3.1499999999999999 108.446 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.488 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -98.9 -63.18 1.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -0.852 . . . . 1.8300000000000001 110.485 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 15' ' ' LYS . 1.2 mt -60.25 128.05 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.951 -1.093 . . . . 0.59999999999999998 110.417 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -81.86 -15.64 53.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.31 -0.869 . . . . 0.77000000000000002 109.358 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 156.98 141.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.15 -1.056 . . . . 2.8599999999999999 108.15 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.792 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -121.99 126.27 74.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.876 -0.787 . . . . 0.39000000000000001 108.876 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.494 ' HE2' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -112.41 156.45 22.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.005 -1.06 . . . . 1.21 110.213 -179.258 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 36' ' ' THR . 2.4 t -133.26 143.36 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.302 -0.874 . . . . 0.80000000000000004 108.718 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.64 100.58 11.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.99 . . . . 3.1800000000000002 109.639 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.47 -56.15 0.52 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.753 -1.339 . . . . 0.39000000000000001 109.753 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.409 ' HB2' HG12 ' A' ' 3' ' ' VAL . 66.8 m -59.65 -167.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -1.128 . . . . 2.29 109.232 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -144.31 15.3 1.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.136 -0.977 . . . . 1.98 109.834 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 77.55 145.92 2.42 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.74 -1.344 . . . . 3.7000000000000002 109.74 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER 38.14 46.72 0.88 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.595 -0.944 . . . . 3.6899999999999999 110.321 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.453 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER -156.75 170.9 8.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 1.6799999999999999 109.322 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 34.9 Cg_endo -77.71 148.04 25.3 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.707 2.271 . . . . 0.88 111.027 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 87.3 m -116.76 134.27 54.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.383 -0.823 . . . . 0.82999999999999996 109.255 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.473 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 37.6 mm -101.15 104.08 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.77 -1.206 . . . . 0.60999999999999999 108.519 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.408 ' HB ' HG12 ' A' ' 127' ' ' ILE . 3.4 mt -88.44 119.14 35.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.568 -0.853 . . . . 0.34000000000000002 109.469 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -95.34 106.56 18.62 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.028 -1.101 . . . . 0.89000000000000001 108.028 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 9.2 ptt180 -52.03 154.65 2.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.977 -1.077 . . . . 1.79 110.004 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.88 -10.69 64.49 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.392 -1.483 . . . . 0.45000000000000001 109.392 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -108.79 154.61 41.68 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.279 -1.13 . . . . 1.27 109.565 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.426 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 34.4 Cg_endo -79.84 114.45 3.18 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.812 2.342 . . . . 0.31 110.884 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -96.37 132.91 41.4 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.55 -1.278 . . . . 0.66000000000000003 107.55 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 18' ' ' VAL . 91.8 m -113.39 140.79 47.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.675 -1.265 . . . . 0.41999999999999998 110.879 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -146.55 122.44 10.65 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.86 -0.792 . . . . 3.4700000000000002 108.86 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 3.0 tt0 -101.08 127.82 47.42 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.72 -1.215 . . . . 2.1400000000000001 107.72 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.792 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -126.6 122.98 36.6 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.746 -1.221 . . . . 0.17000000000000001 110.413 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.545 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 20.2 mt -89.69 142.61 27.52 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.606 -1.627 . . . . 0.28000000000000003 106.606 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.644 ' CE1' ' CD1' ' A' ' 110' ' ' LEU . 35.3 p90 -157.85 137.67 12.25 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.823 -1.173 . . . . 0.25 109.669 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.5 m-20 -84.73 111.58 19.72 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.239 -0.985 . . . . 1.53 108.928 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -47.84 114.22 0.87 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.298 -0.63 . . . . 0.22 109.298 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 117' ' ' LEU . 0.6 OUTLIER -91.87 14.07 16.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 3.5099999999999998 108.944 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.642 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 1.8 pt20 -164.78 138.98 5.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.436 -0.79 . . . . 1.0900000000000001 109.022 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -81.51 123.63 28.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.126 -0.984 . . . . 3.2200000000000002 109.355 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.6 t -145.13 153.94 41.93 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.225 -0.922 . . . . 0.70999999999999996 109.382 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.684 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 3.2 mmmt -89.43 -12.75 39.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 1.3999999999999999 109.724 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.0 p -147.2 136.7 22.79 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.354 -0.938 . . . . 1.3300000000000001 110.189 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -127.57 155.79 43.26 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.477 -0.934 . . . . 0.56000000000000005 108.477 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.541 ' CD ' ' HB ' ' A' ' 70' ' ' THR . 0.3 OUTLIER -134.55 145.06 48.36 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.422 -0.799 . . . . 1.8999999999999999 110.37 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 69' ' ' ASP . 5.6 tt -95.22 154.46 3.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.012 -1.055 . . . . 0.81000000000000005 108.917 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 0.9 OUTLIER -141.04 114.14 8.54 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.538 -0.912 . . . . 1.24 108.538 -179.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.77 HD13 HG21 ' A' ' 68' ' ' ILE . 2.5 mp -113.99 130.81 67.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.95 -1.093 . . . . 0.81999999999999995 109.097 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -126.05 134.03 51.54 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.161 -0.962 . . . . 1.3899999999999999 108.716 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -122.28 131.5 53.95 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.607 -1.237 . . . . 0.53000000000000003 111.16 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.24 148.21 23.33 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.206 -1.035 . . . . 0.53000000000000003 108.206 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.721 HD13 ' CG ' ' A' ' 99' ' ' PRO . 17.2 mt -109.26 56.97 0.61 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.134 -0.979 . . . . 0.80000000000000004 109.668 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 58' ' ' LEU . 3.4 t70 41.47 27.95 0.06 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.649 -0.657 . . . . 1.53 109.726 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 174.23 -49.89 0.14 Allowed Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.754 -1.212 . . . . 1.1000000000000001 110.093 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.517 ' HG ' HG13 ' A' ' 63' ' ' ILE . 3.8 tp -108.43 112.73 25.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.021 -1.282 . . . . 0.76000000000000001 110.069 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.492 ' N ' HD12 ' A' ' 61' ' ' LEU . 1.9 tt0 -79.14 124.58 28.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.127 -0.983 . . . . 1.45 108.975 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.683 ' CD1' HD11 ' A' ' 58' ' ' LEU . 71.4 mt -121.21 165.95 16.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.991 0.9 . . . . 0.56000000000000005 110.203 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.677 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -112.44 108.71 17.95 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 105.881 -1.896 . . . . 1.3600000000000001 105.881 176.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.086 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 10.3 t -71.34 114.13 25.25 Favored Pre-proline 0 C--N 1.298 -1.663 0 O-C-N 121.501 -0.749 . . . . 0.81000000000000005 111.904 -177.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 37.6 Cg_endo -86.56 -157.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 123.278 2.652 . . . . 0.67000000000000004 109.241 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.27 36.13 61.85 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.247 -0.978 . . . . 0.95999999999999996 110.825 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.77 HG21 HD13 ' A' ' 54' ' ' ILE . 9.0 pt -120.72 -157.66 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.957 -1.319 . . . . 0.52000000000000002 108.849 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.735 ' O ' HG22 ' A' ' 52' ' ' ILE . 47.9 t0 -108.29 107.69 18.39 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.381 -0.824 . . . . 0.51000000000000001 109.367 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.541 ' HB ' ' CD ' ' A' ' 51' ' ' LYS . 64.4 p -86.8 45.08 1.22 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.052 -1.03 . . . . 0.76000000000000001 108.443 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 58.2 t30 175.32 83.6 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.4 -1.333 . . . . 1.05 107.4 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.855 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -72.33 4.35 3.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.464 -0.772 . . . . 0.39000000000000001 113.016 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.559 ' HA ' HG22 ' A' ' 76' ' ' VAL . 2.2 t -64.89 -13.91 58.1 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.189 -1.569 . . . . 0.53000000000000003 108.675 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -75.05 -23.98 58.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.222 -0.923 . . . . 1.8200000000000001 109.728 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.528 ' CB ' HG13 ' A' ' 88' ' ' ILE . 74.1 m-85 -109.34 -16.54 14.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.85999999999999999 109.203 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.814 ' CG2' HD21 ' A' ' 80' ' ' LEU . 2.3 m -117.7 166.78 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.246 -1.02 . . . . 0.51000000000000001 108.246 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.649 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -92.25 90.69 7.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.995 -1.065 . . . . 2.3199999999999998 111.536 -178.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.469 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 17.5 p -84.28 151.11 59.08 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 107.077 -1.453 . . . . 0.59999999999999998 107.077 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.684 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.6 Cg_endo -70.11 132.55 23.09 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 124.416 -1.077 . . . . 0.85999999999999999 112.806 2.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.814 HD21 ' CG2' ' A' ' 76' ' ' VAL . 12.8 mt -75.95 113.87 13.94 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.555 -1.646 . . . . 0.66000000000000003 106.555 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.638 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 55.1 t -79.45 143.31 12.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 C-N-CA 119.53 -0.868 . . . . 0.81000000000000005 110.204 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.642 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 11.4 ttpt -71.5 99.8 2.1 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.824 0.821 . . . . 1.1499999999999999 110.127 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 136.5 -15.97 3.85 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 109.621 -1.392 . . . . 0.41999999999999998 109.621 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.574 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 26.9 tp60 -97.88 156.02 16.79 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.837 -1.172 . . . . 1.1899999999999999 107.837 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -106.94 142.84 35.93 Favored 'General case' 0 C--N 1.294 -1.848 0 O-C-N 120.936 -1.102 . . . . 0.93000000000000005 108.08 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.649 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 21.0 m-85 -122.96 150.65 42.7 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.469 -0.769 . . . . 0.56999999999999995 110.559 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.545 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 3.9 p30 -116.7 113.92 23.29 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.171 -1.048 . . . . 0.31 108.171 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.855 HD12 ' HB1' ' A' ' 72' ' ' ALA . 4.8 tt -106.93 120.05 57.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.032 -1.043 . . . . 0.27000000000000002 111.793 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.504 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 5.0 tttp -98.36 104.44 16.48 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 104.574 -2.38 . . . . 1.8300000000000001 104.574 175.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 20.9 t80 -119.13 137.06 53.85 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.045 -1.062 . . . . 0.54000000000000004 112.004 -176.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.59 98.07 10.56 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.656 -1.609 . . . . 0.42999999999999999 106.656 177.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.086 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 33.6 t90 -72.18 97.02 1.88 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.822 -0.627 . . . . 0.41999999999999998 109.797 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.26 105.16 0.46 Allowed 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.565 -0.854 . . . . 2.21 108.742 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.662 HG13 ' HD2' ' A' ' 95' ' ' PRO . 64.5 t -65.49 143.19 98.61 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.445 -0.784 . . . . 0.68999999999999995 109.156 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.869 ' HG3' HG13 ' A' ' 65' ' ' VAL . 30.1 Cg_endo -72.52 129.2 14.41 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.136 1.89 . . . . 0.56000000000000005 109.726 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -1.27 4.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.573 -0.704 . . . . 2.6899999999999999 110.182 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 98' ' ' ALA . 9.5 pt -90.2 -27.52 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.834 -1.166 . . . . 0.56999999999999995 110.084 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.519 ' O ' ' CD ' ' A' ' 31' ' ' ARG . . . -34.83 118.8 0.57 Allowed Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 109.428 -0.582 . . . . 0.23000000000000001 109.428 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.721 ' CG ' HD13 ' A' ' 58' ' ' LEU . 36.8 Cg_endo -85.02 139.95 7.54 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.852 2.368 . . . . 0.32000000000000001 109.696 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.48 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 7.4 mtmt -52.76 89.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.994 -1.113 . . . . 0.72999999999999998 107.994 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 99' ' ' PRO . 3.4 t -93.71 122.46 36.19 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.439 -0.788 . . . . 0.37 109.151 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 8.3 pt-20 -41.39 -44.54 2.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.523 -0.736 . . . . 1.0700000000000001 109.456 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 14.5 t30 -132.17 140.49 48.76 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.521 -0.737 . . . . 1.3300000000000001 109.722 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.972 HG21 ' CD1' ' A' ' 127' ' ' ILE . 1.0 OUTLIER -130.69 143.92 39.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.338 -0.851 . . . . 0.83999999999999997 109.191 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 2.9 t -118.87 118.7 58.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.217 -1.031 . . . . 1.04 108.217 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.8 t -104.61 140.78 21.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.731 -1.231 . . . . 0.44 110.646 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 89.8 m -122.1 127.07 49.71 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.008 -0.738 . . . . 0.5 109.008 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -104.79 132.89 50.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 107.853 -1.166 . . . . 0.39000000000000001 107.853 178.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.886 ' CD ' HD11 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -141.56 128.63 20.81 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.419 -1.426 . . . . 1.24 111.79 -178.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 52' ' ' ILE . 13.3 mt -104.55 141.79 35.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.151 -1.425 . . . . 0.14000000000000001 107.151 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.886 HD11 ' CD ' ' A' ' 109' ' ' LYS . 4.4 mp -135.57 121.86 32.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.218 -0.926 . . . . 0.22 110.039 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.44 ' N ' ' HG ' ' A' ' 117' ' ' LEU . . . -99.71 -144.53 16.43 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.788 -1.725 . . . . 0.56999999999999995 108.788 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.6 -0.28 46.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -1.173 . . . . 1.53 109.747 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.81 -4.15 13.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 2.0600000000000001 110.372 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 144.27 -147.63 18.98 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.886 -1.286 . . . . 0.25 109.886 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.634 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 2.1 t -86.82 108.98 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -1.166 . . . . 0.12 109.878 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.468 ' O ' ' OD1' ' A' ' 44' ' ' ASN . 22.1 mt -56.46 -35.12 67.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.51000000000000001 109.84 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.508 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -163.03 179.31 7.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.716 -1.24 . . . . 0.35999999999999999 109.515 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.541 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 14.5 t -165.08 157.61 15.94 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.319 -0.863 . . . . 0.40000000000000002 109.314 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.465 ' HB2' HD12 ' A' ' 13' ' ' ILE . . . -152.92 147.06 25.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.035 -1.041 . . . . 0.46000000000000002 109.483 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 65.7 mt -134.0 120.9 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.52000000000000002 109.554 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -92.8 147.53 22.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.144 -0.972 . . . . 0.66000000000000003 109.697 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -78.47 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.79000000000000004 109.837 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -56.91 -177.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 3.02 109.353 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . 141.51 138.86 3.58 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.869 -1.292 . . . . 0.47999999999999998 109.869 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 7.8 mtmt -151.09 134.86 16.47 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.455 -1.026 . . . . 1.25 108.614 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.972 ' CD1' HG21 ' A' ' 104' ' ' VAL . 58.6 mt -105.8 140.39 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.822 -1.174 . . . . 0.53000000000000003 110.485 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.48 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -133.5 173.5 11.43 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.74 -0.837 . . . . 2.75 108.74 178.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.028 -1.045 . . . . 1.1599999999999999 109.513 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.52 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.211 -0.663 . . . . 2.1600000000000001 109.211 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 22' ' ' HIS . 2.4 m -109.54 168.8 3.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.339 -0.851 . . . . 1.8799999999999999 110.184 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -80.16 128.63 33.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.412 -0.805 . . . . 1.1000000000000001 110.952 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.7 m -147.49 159.3 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.703 -1.221 . . . . 0.45000000000000001 107.703 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.68 108.62 15.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.805 -1.184 . . . . 1.9099999999999999 109.462 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 120' ' ' ALA . 24.8 m-20 -52.76 130.29 32.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.90000000000000002 109.106 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.4 3.96 38.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.37 109.49 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 10' ' ' ASN . . . -81.52 -57.5 3.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.277 -0.889 . . . . 0.63 109.21 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER 161.64 -31.26 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.244 -1.021 . . . . 3.4399999999999999 108.244 -178.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 0.3 OUTLIER 159.61 39.51 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.255 -1.017 . . . . 2.2999999999999998 108.255 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.481 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 77.1 mm-40 -90.82 -52.75 4.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 2.7000000000000002 110.386 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.524 HG12 ' HB1' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -73.97 131.8 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.702 -1.249 . . . . 0.56999999999999995 110.082 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 39.2 mmtt -85.95 -22.59 27.31 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.849 -1.167 . . . . 0.93999999999999995 107.849 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.1 ttpt 160.9 128.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.211 -0.662 . . . . 1.9099999999999999 109.211 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 38' ' ' GLU . 1.5 p -119.31 122.77 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.044 -1.035 . . . . 1.5900000000000001 109.086 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.52 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -105.23 158.69 16.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.261 -0.899 . . . . 1.47 110.41 -178.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.066 HG11 ' CE1' ' A' ' 35' ' ' PHE . 24.7 t -127.9 115.69 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.873 . . . . 0.46999999999999997 108.66 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -68.15 89.82 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 3.48 109.749 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.38 -63.54 0.26 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.404 -1.478 . . . . 0.69999999999999996 109.404 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.6 t -90.18 154.08 20.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -1.133 . . . . 0.67000000000000004 109.243 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.632 ' O ' HG12 ' A' ' 3' ' ' VAL . 12.2 m80 -94.01 -169.16 2.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 2.7000000000000002 109.789 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.588 ' CA ' ' HA ' ' A' ' 3' ' ' VAL . . . -108.09 154.82 16.44 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.361 -1.496 . . . . 3.9100000000000001 109.361 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.0 6.18 4.55 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.161 -1.199 . . . . 1.7 109.079 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -128.57 158.5 71.69 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 108.497 -0.927 . . . . 2.75 108.497 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.78 147.36 21.65 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.708 2.272 . . . . 0.82999999999999996 110.368 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.2 m -115.69 154.42 29.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.94999999999999996 109.7 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.542 HG23 ' HG3' ' A' ' 128' ' ' ARG . 45.9 mm -111.95 113.16 43.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.353 -0.842 . . . . 0.46999999999999997 109.206 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.517 ' HB ' HG12 ' A' ' 127' ' ' ILE . 10.1 mt -94.94 120.89 44.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.249 -0.907 . . . . 0.76000000000000001 108.931 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.502 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 3.9 m-70 -87.43 133.97 33.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.35 -0.844 . . . . 1.8799999999999999 109.639 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.513 ' HA ' HG11 ' A' ' 94' ' ' VAL . 9.2 mtm180 -54.81 135.06 48.07 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.159 -0.963 . . . . 1.73 108.922 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.514 ' N ' ' HB ' ' A' ' 94' ' ' VAL . . . 69.26 20.47 75.12 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.397 -0.906 . . . . 0.83999999999999997 111.041 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.046 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -109.64 137.76 20.45 Favored Pre-proline 0 N--CA 1.482 1.175 0 O-C-N 120.594 -1.533 . . . . 3.4500000000000002 108.305 179.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.5 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 33.9 Cg_endo -74.18 115.56 4.36 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.844 2.363 . . . . 0.45000000000000001 112.089 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 1.066 ' CE1' HG11 ' A' ' 18' ' ' VAL . 1.5 t80 -98.97 111.74 24.05 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.166 -1.05 . . . . 1.0600000000000001 108.166 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.912 ' O ' HG13 ' A' ' 18' ' ' VAL . 96.2 m -88.04 128.71 35.4 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.087 -1.008 . . . . 0.94999999999999996 109.944 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.43 HD13 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -140.66 123.68 16.49 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.475 -0.765 . . . . 3.6200000000000001 109.238 179.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 16' ' ' VAL . 4.5 tt0 -105.28 126.78 52.48 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.642 -1.244 . . . . 0.92000000000000004 107.642 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.563 ' CB ' ' HB ' ' A' ' 16' ' ' VAL . . . -129.42 132.08 46.92 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.676 -1.265 . . . . 0.46999999999999997 110.975 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 5.4 mt -94.85 144.39 25.69 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.092 -1.447 . . . . 0.33000000000000002 107.092 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.702 ' CE2' HD11 ' A' ' 110' ' ' LEU . 35.2 p90 -159.36 136.53 9.68 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.785 -1.166 . . . . 0.28000000000000003 109.864 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.4 m-20 -84.2 112.25 20.1 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.292 -0.963 . . . . 1.3899999999999999 108.611 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -45.19 110.88 0.27 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.759 -0.83 . . . . 0.26000000000000001 108.759 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -80.03 4.65 16.4 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.154 -0.966 . . . . 1.3700000000000001 109.5 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 4.3 pt20 -164.84 156.75 15.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.028 -1.045 . . . . 1.1599999999999999 109.676 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.463 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 1.9 p-10 -84.79 121.67 28.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 2.3399999999999999 109.271 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.694 HG21 HD11 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -141.46 139.26 33.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.056 -1.028 . . . . 0.79000000000000004 110.287 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.707 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 3.2 mmmm -80.92 -10.87 59.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.384 -0.822 . . . . 1.3400000000000001 109.477 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 47' ' ' THR . 12.7 p -147.03 137.86 23.78 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.985 0.897 . . . . 0.48999999999999999 109.714 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -126.3 149.81 48.89 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.815 -0.809 . . . . 0.34999999999999998 108.815 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.564 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 2.2 mtmt -129.28 136.2 49.76 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.114 -1.034 . . . . 0.20999999999999999 110.401 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 69' ' ' ASP . 12.2 tt -92.17 151.28 3.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 107.085 -1.45 . . . . 0.40999999999999998 107.085 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -142.13 115.38 8.89 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.089 -1.007 . . . . 0.56000000000000005 109.468 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 54' ' ' ILE . 2.3 mp -112.63 111.41 36.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.044 -1.035 . . . . 0.17999999999999999 109.13 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -106.57 160.57 15.33 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.263 -1.014 . . . . 0.72999999999999998 108.263 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -134.67 150.63 50.66 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.494 -1.379 . . . . 1.0600000000000001 110.829 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 4.6 m -116.26 151.56 35.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.875 -1.157 . . . . 2.6099999999999999 107.875 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.625 HD12 ' HG ' ' A' ' 61' ' ' LEU . 10.9 mt -123.66 60.1 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.648 -1.282 . . . . 0.81000000000000005 110.312 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' ' 103' ' ' ASN . 0.4 OUTLIER 44.01 24.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.554 -0.716 . . . . 0.82999999999999996 110.005 179.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 162.85 -47.23 0.33 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.01 -1.236 . . . . 0.31 110.01 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.625 ' HG ' HD12 ' A' ' 58' ' ' LEU . 12.3 tp -107.67 117.63 34.61 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.117 -1.225 . . . . 0.64000000000000001 109.051 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.6 mt-10 -100.8 128.26 46.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 3.9100000000000001 109.937 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.71 HG23 ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -117.1 178.05 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 122.419 1.104 . . . . 1.29 110.04 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.71 ' N ' HG23 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -110.49 143.03 41.44 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.8 -1.185 . . . . 3.7200000000000002 107.8 178.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.131 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 2.9 t -110.87 104.27 55.87 Favored Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 120.977 -1.077 . . . . 0.26000000000000001 111.523 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.523 ' O ' HG23 ' A' ' 68' ' ' ILE . 36.4 Cg_endo -81.81 -154.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.4 2.733 . . . . 0.20000000000000001 109.639 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.91 29.39 64.81 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.792 -1.323 . . . . 0.54000000000000004 109.792 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.689 HG21 HD13 ' A' ' 54' ' ' ILE . 9.3 pt -120.44 -162.13 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.153 -1.204 . . . . 0.34000000000000002 109.195 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.718 ' O ' HG22 ' A' ' 52' ' ' ILE . 16.6 t70 -103.55 107.05 17.73 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.445 -0.784 . . . . 0.83999999999999997 109.062 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.564 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 1.0 OUTLIER -85.76 44.55 1.12 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.268 -0.895 . . . . 0.14999999999999999 108.682 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 49.2 t30 -177.63 69.65 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.532 -1.285 . . . . 0.95999999999999996 107.532 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.515 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -56.4 -11.2 1.14 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.563 -0.71 . . . . 0.14999999999999999 111.868 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.558 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -61.23 -15.18 31.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.534 -1.354 . . . . 0.31 109.379 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.22 -25.06 60.59 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.082 -1.011 . . . . 0.83999999999999997 109.917 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.518 ' HB2' HG13 ' A' ' 88' ' ' ILE . 78.3 m-85 -102.54 -35.9 8.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.203 -0.936 . . . . 0.45000000000000001 109.189 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.982 HG23 HD21 ' A' ' 80' ' ' LEU . 2.0 m -96.02 166.07 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.134 -1.061 . . . . 0.17000000000000001 108.134 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.637 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -88.24 93.1 9.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.945 -1.097 . . . . 0.68000000000000005 110.692 -178.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.511 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 11.9 p -90.06 154.04 47.15 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 107.682 -1.229 . . . . 0.17000000000000001 107.682 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.707 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 26.3 Cg_endo -68.7 133.56 24.26 Favored 'Cis proline' 0 C--N 1.312 -1.359 0 C-N-CA 124.223 -1.157 . . . . 0.16 112.513 2.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.982 HD21 HG23 ' A' ' 76' ' ' VAL . 13.1 mt -76.86 112.42 13.44 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.782 -1.562 . . . . 0.81999999999999995 106.782 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.8 t -80.77 136.79 22.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 C-N-CA 119.707 -0.797 . . . . 0.23000000000000001 110.114 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 25.0 tttm -60.54 110.42 1.27 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.648 0.737 . . . . 3.1299999999999999 110.253 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 126.71 -16.46 6.54 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 110.264 -1.134 . . . . 0.39000000000000001 110.264 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.583 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 13.6 tp60 -97.99 157.39 16.14 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.125 -1.22 . . . . 0.52000000000000002 108.162 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -110.68 143.13 41.63 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.074 -1.084 . . . . 1.0800000000000001 108.074 179.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.637 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 19.0 m-85 -125.94 152.83 45.12 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.409 -0.807 . . . . 0.20000000000000001 110.438 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.45 ' C ' ' OD1' ' A' ' 87' ' ' ASP . 24.0 t0 -119.49 113.18 20.35 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.882 -1.155 . . . . 4.0700000000000003 107.882 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.624 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 9.1 tt -106.71 126.75 62.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.361 -0.936 . . . . 0.39000000000000001 111.506 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.501 ' HA ' ' HG3' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -100.59 119.89 39.21 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 105.124 -2.176 . . . . 2.04 105.124 176.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.544 ' OH ' ' N ' ' A' ' 69' ' ' ASP . 34.4 t80 -138.03 140.74 40.24 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.051 -1.46 . . . . 0.51000000000000001 112.698 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.501 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -92.74 138.96 31.04 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.512 -1.662 . . . . 0.79000000000000004 106.512 177.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.131 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 26.4 t90 -120.27 82.73 1.94 Allowed 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.949 -1.094 . . . . 0.69999999999999996 109.472 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -61.28 108.51 0.93 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.591 -0.693 . . . . 1.55 109.958 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.046 HG23 ' O ' ' A' ' 33' ' ' LYS . 33.9 t -47.39 144.04 4.87 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.134 -1.062 . . . . 1.1899999999999999 108.134 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.718 ' HG3' HG13 ' A' ' 65' ' ' VAL . 26.7 Cg_endo -68.67 -8.7 24.03 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.854 2.369 . . . . 3.7200000000000002 113.038 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 0.9 OUTLIER 77.84 -17.82 0.54 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.913 -1.117 . . . . 3.3199999999999998 110.665 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.523 ' O ' ' C ' ' A' ' 98' ' ' ALA . 11.8 pt -88.11 -25.62 5.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 120.704 -1.247 . . . . 0.69999999999999996 108.335 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.854 ' HB1' HD13 ' A' ' 127' ' ' ILE . . . -33.84 116.77 0.48 Allowed Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.92 -0.771 . . . . 0.56999999999999995 108.92 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.606 ' O ' ' N ' ' A' ' 101' ' ' SER . 36.0 Cg_endo -83.6 129.41 4.93 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.674 2.249 . . . . 0.77000000000000002 109.165 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -46.93 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.457 -0.942 . . . . 3.8799999999999999 108.457 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -103.38 124.42 48.67 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.167 -0.679 . . . . 1.6499999999999999 109.167 -178.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 101' ' ' SER . 6.4 pt-20 -41.65 -46.38 3.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.443 -0.786 . . . . 0.82999999999999996 110.022 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.41 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 1.9 t30 -129.36 140.68 51.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.901 -1.124 . . . . 0.81000000000000005 110.223 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.757 HG21 ' CD1' ' A' ' 127' ' ' ILE . 2.7 t -133.1 147.22 31.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.531 -0.731 . . . . 0.20000000000000001 109.377 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 57' ' ' SER . 2.7 t -123.31 118.85 55.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.516 -1.29 . . . . 0.53000000000000003 107.516 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.1 t -100.92 142.49 15.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.281 -0.887 . . . . 0.29999999999999999 110.039 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 24.1 m -122.52 117.15 25.24 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.607 -0.683 . . . . 0.34999999999999998 109.358 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -94.9 129.12 45.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 107.001 -1.481 . . . . 0.34000000000000002 107.001 178.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.915 ' CD ' HD11 ' A' ' 111' ' ' ILE . 0.7 OUTLIER -140.08 130.79 25.8 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.363 -1.461 . . . . 1.05 112.05 -177.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.702 HD11 ' CE2' ' A' ' 41' ' ' PHE . 14.1 mt -101.79 143.01 32.23 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.945 -1.502 . . . . 0.34999999999999998 106.945 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.915 HD11 ' CD ' ' A' ' 109' ' ' LYS . 4.2 mp -136.4 116.89 17.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 120.823 -1.173 . . . . 0.42999999999999999 111.065 -177.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.43 -169.71 41.96 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.202 -1.959 . . . . 0.95999999999999996 108.202 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.58 1.67 25.15 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.035 -1.274 . . . . 1.05 109.709 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.37 -6.51 12.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.197 -0.939 . . . . 4.71 110.702 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.91 -153.12 24.91 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.537 -1.316 . . . . 0.51000000000000001 110.209 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.623 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -85.08 110.03 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.382 -1.069 . . . . 0.35999999999999999 109.606 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.694 HD11 HG21 ' A' ' 47' ' ' THR . 26.7 mt -58.66 -39.89 81.92 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.206 -0.934 . . . . 0.23000000000000001 109.816 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.524 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -154.87 -162.64 1.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.989 -1.07 . . . . 0.16 109.468 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.489 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 53.4 t 178.88 154.6 0.42 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.029 -1.045 . . . . 0.32000000000000001 109.499 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.27 152.31 32.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.03 -1.044 . . . . 0.28000000000000003 109.695 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 53.5 mt -134.99 140.2 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.2 -0.937 . . . . 0.84999999999999998 109.083 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.19 119.46 38.9 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.456 -1.402 . . . . 0.72999999999999998 108.571 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 51.3 p -70.12 -33.24 71.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -0.839 . . . . 2.1099999999999999 110.498 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -120.97 154.89 35.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.95 -1.094 . . . . 1.3500000000000001 110.098 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 126' ' ' LYS . . . 166.1 155.3 8.71 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.476 -1.449 . . . . 0.55000000000000004 109.476 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 125' ' ' GLY . 30.6 mttt -154.88 138.09 15.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -1.197 . . . . 1.8100000000000001 108.563 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.854 HD13 ' HB1' ' A' ' 98' ' ' ALA . 67.0 mt -104.17 140.7 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.508 -1.37 . . . . 0.44 109.769 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.542 ' HG3' HG23 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -124.86 154.21 41.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.465 -0.772 . . . . 5.0700000000000003 109.824 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.41 ' HB3' ' HG3' ' A' ' 100' ' ' LYS . 2.9 p30 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 118.0 -1.0 . . . . 4.6799999999999997 109.563 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.358 0.599 . . . . 2.8199999999999998 109.483 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.483 ' CG1' ' HB3' ' A' ' 21' ' ' CYS . 3.0 m -99.16 167.24 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.68000000000000005 109.307 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 51.9 t0 -92.53 124.21 36.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.87 110.211 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.3 m -146.27 148.93 16.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.464 -0.939 . . . . 0.25 108.464 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.23 110.33 21.5 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.095 -1.003 . . . . 2.8500000000000001 109.609 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -53.91 142.92 22.89 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.335 -0.853 . . . . 3.54 109.374 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.92 -14.17 11.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.344 -0.847 . . . . 0.95999999999999996 108.963 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.94 -65.65 0.67 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.868 0.842 . . . . 0.23999999999999999 109.199 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.47 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 3.4 t-20 173.98 59.23 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.134 -1.061 . . . . 4.4500000000000002 108.134 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 53.12 21.37 2.12 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.972 -1.08 . . . . 1.76 108.087 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.496 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 19.7 mm-40 -64.67 -61.27 2.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.582 -0.699 . . . . 3.52 109.363 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER -58.95 127.35 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.34999999999999998 109.459 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.565 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 11.4 mmpt? -77.13 -19.83 56.4 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.242 -0.911 . . . . 0.53000000000000003 108.899 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.567 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.8 OUTLIER 156.59 128.54 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.882 -0.784 . . . . 2.3799999999999999 108.882 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.73 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -108.33 123.18 63.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.377 -0.972 . . . . 0.59999999999999998 108.377 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.48 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 1.3 mtm -117.03 148.05 41.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.049 -1.032 . . . . 1.8899999999999999 110.796 -178.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.488 HG12 ' OD1' ' A' ' 19' ' ' ASP . 31.6 t -103.9 158.03 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.385 -0.968 . . . . 0.82999999999999996 108.385 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.488 ' OD1' HG12 ' A' ' 18' ' ' VAL . 8.8 p-10 -44.12 -31.28 0.92 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.092 -1.005 . . . . 4.1100000000000003 109.802 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.92 97.45 0.12 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.57 -1.3 . . . . 2.5099999999999998 110.27 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -108.48 -66.78 1.02 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -1.135 . . . . 3.4300000000000002 108.913 179.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.489 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER 168.93 -27.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.833 . . . . 4.3099999999999996 109.66 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 101.13 -135.71 12.31 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.957 -1.257 . . . . 1.6100000000000001 109.957 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 23' ' ' GLY . 29.1 t -40.4 -34.68 0.36 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.534 -0.98 . . . . 1.51 109.988 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.439 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -67.12 164.92 31.55 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 2.25 109.42 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 25' ' ' ASP . 34.3 Cg_endo -78.03 162.18 29.21 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.692 2.261 . . . . 2.1699999999999999 109.844 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.6 m -116.62 153.51 32.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.909 . . . . 0.93999999999999995 109.371 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.515 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 47.8 mm -107.37 109.13 27.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.911 -1.118 . . . . 0.46999999999999997 108.872 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.467 HG23 HG21 ' A' ' 94' ' ' VAL . 1.9 mt -91.19 119.31 38.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.444 -0.785 . . . . 0.40999999999999998 109.357 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.415 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 24.6 m-70 -84.41 114.57 22.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.368 -0.832 . . . . 1.1699999999999999 110.122 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.718 ' HG3' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -48.12 148.41 1.79 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.566 -0.709 . . . . 1.99 111.127 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.73 -22.55 4.03 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.923 -0.871 . . . . 0.93000000000000005 110.923 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -93.01 155.18 41.53 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.77 -1.43 . . . . 2.9399999999999999 109.745 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.465 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 36.4 Cg_endo -79.11 162.21 26.06 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.863 2.376 . . . . 1.3999999999999999 110.689 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 92' ' ' TRP . 2.5 t80 -135.08 122.14 21.33 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.172 -1.048 . . . . 0.64000000000000001 108.172 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 2.9 m -96.36 128.2 43.06 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.77 -1.207 . . . . 0.97999999999999998 110.427 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.41 123.44 15.47 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.359 -0.838 . . . . 3.3999999999999999 108.767 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 89' ' ' LYS . 5.6 mt-10 -96.96 126.9 42.43 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.31 -0.996 . . . . 2.3999999999999999 108.31 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.73 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -123.97 118.96 28.2 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.875 -1.13 . . . . 0.37 110.386 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 5.9 mt -92.76 141.9 27.94 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.505 -1.665 . . . . 0.33000000000000002 106.505 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.621 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 27.8 p90 -158.23 142.13 15.58 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 120.695 -1.253 . . . . 0.20999999999999999 109.751 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.8 m-20 -87.06 110.88 20.39 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.408 -0.917 . . . . 0.60999999999999999 108.728 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -46.3 114.1 0.74 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.61 -0.681 . . . . 0.13 109.398 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.425 ' OD1' ' C ' ' A' ' 44' ' ' ASN . 4.0 p30 -85.31 9.76 14.47 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.191 -0.943 . . . . 0.28999999999999998 109.425 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.565 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 6.0 pt20 -166.24 149.16 7.17 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.297 -0.877 . . . . 0.62 109.412 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -86.27 106.16 17.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.057 -1.027 . . . . 2.0600000000000001 108.963 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.88 154.32 38.47 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.293 -0.879 . . . . 0.40000000000000002 109.787 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.724 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 11.0 mmmt -89.22 -12.44 40.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.53000000000000003 109.755 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 p -146.47 137.35 24.17 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.156 0.979 . . . . 0.53000000000000003 110.195 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -127.93 149.17 50.44 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.357 -1.349 . . . . 0.51000000000000001 107.357 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.587 ' HD2' ' CB ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -135.27 140.58 45.31 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.646 -0.822 . . . . 2.04 110.492 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.576 ' O ' HG23 ' A' ' 52' ' ' ILE . 7.0 tt -109.6 124.66 66.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.271 -0.893 . . . . 1.3799999999999999 108.836 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 11.4 pt-20 -129.79 117.71 20.66 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.478 -1.304 . . . . 2.04 107.478 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.756 ' H ' HD12 ' A' ' 54' ' ' ILE . 3.8 mp -93.14 136.24 25.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 121.448 -0.782 . . . . 0.59999999999999998 109.146 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 64' ' ' ASP . 49.8 mttt -119.05 131.9 55.99 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.225 -1.028 . . . . 0.60999999999999999 108.225 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -116.33 154.38 30.3 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 120.7 -1.25 . . . . 0.77000000000000002 111.608 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.804 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -120.14 150.75 40.13 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.71 -1.219 . . . . 0.51000000000000001 107.71 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.844 HD13 ' CD ' ' A' ' 99' ' ' PRO . 3.4 mt -132.55 75.02 1.61 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.823 -1.173 . . . . 2.0 110.428 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER 40.51 25.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.596 -0.69 . . . . 1.73 110.274 179.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 152.35 -29.52 0.87 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.387 -1.387 . . . . 1.54 110.443 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.85 HD23 ' HG3' ' A' ' 99' ' ' PRO . 4.9 tp -110.3 110.02 20.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.848 -1.384 . . . . 2.4300000000000002 110.112 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 2.0 tt0 -112.75 119.85 39.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.201 -0.937 . . . . 1.53 108.887 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.616 HG13 ' N ' ' A' ' 64' ' ' ASP . 2.2 tp -126.32 164.44 26.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 122.171 0.986 . . . . 5.4199999999999999 109.65 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.616 ' N ' HG13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -83.38 110.15 17.91 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 105.64 -1.985 . . . . 1.5900000000000001 105.64 177.056 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.1 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 3.0 t -66.5 113.68 13.89 Favored Pre-proline 0 C--N 1.293 -1.867 0 O-C-N 121.322 -0.862 . . . . 0.71999999999999997 110.786 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.477 ' O ' HG23 ' A' ' 68' ' ' ILE . 37.5 Cg_endo -81.91 -165.7 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 123.121 2.547 . . . . 0.71999999999999997 109.757 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 93' ' ' ASN . . . 58.0 56.83 23.03 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.796 -1.322 . . . . 1.3799999999999999 109.796 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.563 HD13 ' O ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -149.12 -155.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.216 -1.167 . . . . 0.83999999999999997 109.002 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.532 ' N ' ' OH ' ' A' ' 90' ' ' TYR . 38.6 t0 -114.18 112.13 22.67 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.096 -0.642 . . . . 0.72999999999999998 109.575 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.587 ' CB ' ' HD2' ' A' ' 51' ' ' LYS . 21.2 p -90.39 42.41 1.1 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.645 -1.242 . . . . 0.70999999999999996 107.645 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.62 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 8.3 t30 176.94 88.33 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.497 -1.298 . . . . 2.0299999999999998 107.497 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.923 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -76.45 7.35 4.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.45000000000000001 112.613 -176.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.552 ' HA ' HG22 ' A' ' 76' ' ' VAL . 1.6 t -65.82 -12.99 58.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.225 -1.547 . . . . 0.23000000000000001 108.837 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -78.56 -21.02 49.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.056 -1.027 . . . . 0.54000000000000004 109.819 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.421 ' HB2' HG13 ' A' ' 88' ' ' ILE . 72.1 m-85 -108.74 -20.93 12.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 0.22 108.681 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.882 HG23 HD21 ' A' ' 80' ' ' LEU . 2.0 m -113.94 165.58 8.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.687 -1.227 . . . . 0.23999999999999999 107.687 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.614 ' HG2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -92.54 93.05 8.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.983 -1.073 . . . . 1.72 111.202 -178.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.479 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 15.7 p -86.69 153.06 55.12 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 107.316 -1.364 . . . . 0.14000000000000001 107.316 177.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.724 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.5 Cg_endo -69.52 132.13 21.04 Favored 'Cis proline' 0 C--N 1.311 -1.401 0 C-N-CA 124.363 -1.099 . . . . 0.25 112.778 2.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.882 HD21 HG23 ' A' ' 76' ' ' VAL . 11.1 mt -77.12 111.11 12.38 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.777 -1.564 . . . . 0.98999999999999999 106.777 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 85.6 t -78.32 144.31 11.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 121.715 0.769 . . . . 0.34999999999999998 110.782 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.565 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 14.2 ttpt -67.17 110.95 3.67 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.799 0.809 . . . . 0.67000000000000004 109.858 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 124.12 -12.24 8.1 Favored Glycine 0 C--N 1.298 -1.578 0 N-CA-C 109.479 -1.448 . . . . 0.23000000000000001 109.479 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.63 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 6.8 tp60 -103.28 151.6 22.5 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.839 -1.171 . . . . 0.28000000000000003 107.839 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -103.97 144.98 30.82 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.92 -1.141 . . . . 1.6299999999999999 107.92 179.037 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.63 ' CE1' ' HG3' ' A' ' 84' ' ' GLN . 38.9 m-85 -125.67 143.56 50.98 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.008 -1.057 . . . . 0.29999999999999999 110.212 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.29 115.7 30.49 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.845 -0.798 . . . . 2.8199999999999998 108.845 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.923 HD12 ' HB1' ' A' ' 72' ' ' ALA . 3.4 tt -111.06 119.1 58.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.109 -0.995 . . . . 0.22 111.406 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.421 ' HA ' ' CG ' ' A' ' 38' ' ' GLU . 0.9 OUTLIER -94.39 119.35 33.0 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 104.662 -2.347 . . . . 2.1699999999999999 104.662 175.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.607 ' CE2' ' O ' ' A' ' 91' ' ' THR . 24.0 t80 -132.7 143.04 49.36 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 117.539 -1.664 . . . . 0.62 113.982 -175.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.607 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -92.44 144.33 25.47 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 105.742 -1.947 . . . . 1.04 105.742 176.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.1 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 22.7 t90 -127.39 97.69 4.99 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.667 -1.271 . . . . 0.70999999999999996 110.724 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 2.9 m-80 -61.75 103.08 0.31 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.646 -0.872 . . . . 1.8799999999999999 108.646 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.731 HG13 ' HD2' ' A' ' 95' ' ' PRO . 88.3 t -59.23 144.02 83.96 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.325 -0.859 . . . . 0.94999999999999996 108.747 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.952 ' HG3' HG13 ' A' ' 65' ' ' VAL . 29.4 Cg_endo -71.23 121.37 7.73 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.0 1.8 . . . . 1.1499999999999999 110.165 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.486 ' HA ' ' HG2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -66.56 -0.98 3.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.818 -0.551 . . . . 3.02 110.971 -178.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.498 ' O ' ' C ' ' A' ' 98' ' ' ALA . 9.4 pt -92.41 -25.09 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.706 -1.246 . . . . 1.0600000000000001 109.29 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.718 ' HB3' ' HG3' ' A' ' 31' ' ' ARG . . . -28.62 122.45 0.26 Allowed Pre-proline 0 N--CA 1.491 1.613 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.782 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.85 ' HG3' HD23 ' A' ' 61' ' ' LEU . 36.8 Cg_endo -87.01 115.57 1.19 Allowed 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.377 2.052 . . . . 1.03 107.995 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.518 ' CD ' ' HA ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -38.42 92.44 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.742 0.782 . . . . 4.0999999999999996 108.946 -179.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 99' ' ' PRO . 1.4 t -102.76 115.03 29.79 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.33 -0.619 . . . . 0.62 109.33 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.472 ' O ' ' HE2' ' A' ' 126' ' ' LYS . 0.1 OUTLIER -41.15 -36.28 0.71 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.684 -0.635 . . . . 3.8399999999999999 109.573 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 1.5 t30 -128.48 138.36 52.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 2.3199999999999998 110.097 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 1.026 HG21 HG13 ' A' ' 127' ' ' ILE . 20.2 t -135.79 150.54 28.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.573 -0.704 . . . . 1.3899999999999999 109.896 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.539 HG23 ' OG ' ' A' ' 57' ' ' SER . 2.9 t -123.33 117.62 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.229 -1.026 . . . . 0.82999999999999996 108.229 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.31 142.22 15.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 120.966 -1.084 . . . . 0.45000000000000001 110.195 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 34.3 m -125.9 117.05 22.49 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.802 -0.561 . . . . 0.38 109.586 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER -96.78 125.79 49.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 106.945 -1.502 . . . . 0.31 106.945 178.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.854 ' HD2' HD11 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -135.41 137.03 41.86 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.552 -1.342 . . . . 1.02 111.504 -177.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.856 ' C ' HD12 ' A' ' 111' ' ' ILE . 10.0 mt -113.87 139.97 48.73 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.66 -1.607 . . . . 0.37 106.66 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.856 HD12 ' C ' ' A' ' 110' ' ' LEU . 3.7 mp -134.17 115.99 21.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 120.707 -1.245 . . . . 0.28999999999999998 110.769 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.08 -150.85 16.26 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.364 -1.894 . . . . 0.62 108.364 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -96.65 -0.6 48.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.082 -1.246 . . . . 1.22 109.551 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.98 -2.52 12.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.095 -1.003 . . . . 4.25 110.401 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.28 -164.65 29.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.847 -1.301 . . . . 0.28000000000000003 109.847 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.568 ' CG1' ' CD ' ' A' ' 109' ' ' LYS . 1.8 t -77.97 112.02 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -1.128 . . . . 0.39000000000000001 109.671 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.93 -38.67 76.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 0.38 110.014 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.539 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -157.07 -171.05 3.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.001 -1.062 . . . . 0.35999999999999999 109.128 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -177.44 151.24 0.75 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.263 -0.898 . . . . 0.46999999999999997 109.393 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -149.63 153.2 36.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.045 . . . . 0.39000000000000001 109.771 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.5 mt -134.81 138.91 48.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.371 -0.831 . . . . 0.89000000000000001 108.783 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.07 133.62 34.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.84 -1.162 . . . . 0.91000000000000003 109.732 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -68.41 0.34 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.466 -0.771 . . . . 2.4900000000000002 109.928 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -128.76 142.07 51.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.9 . . . . 4.6600000000000001 110.322 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -156.83 175.32 34.4 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.895 -1.682 . . . . 0.40000000000000002 108.895 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' A' ' 102' ' ' GLU . 31.0 ttmt -153.07 138.44 17.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -1.14 . . . . 2.6200000000000001 108.45 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 1.026 HG13 HG21 ' A' ' 104' ' ' VAL . 62.0 mt -106.61 140.31 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.427 -1.421 . . . . 0.32000000000000001 109.738 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.518 ' HA ' ' CD ' ' A' ' 100' ' ' LYS . 10.4 mtt180 -132.42 174.93 9.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.401 -0.812 . . . . 2.02 108.948 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.2 t0 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.005 -1.06 . . . . 2.5699999999999998 109.702 -179.759 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.531 ' CB ' ' HG2' ' A' ' 17' ' ' MET . 1.5 pt20 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.39 0.614 . . . . 1.73 109.991 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.586 HG21 HG23 ' A' ' 18' ' ' VAL . 2.3 m -105.58 162.97 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.33 -0.857 . . . . 0.20000000000000001 109.121 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.32 126.28 38.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 3.3599999999999999 109.141 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 121' ' ' ILE . 27.6 m -143.69 162.64 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.874 -0.787 . . . . 0.75 108.874 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -112.82 104.42 12.43 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.151 -1.055 . . . . 4.21 108.151 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -45.14 113.04 0.51 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.406 -0.809 . . . . 1.21 110.18 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.507 ' HB3' HG13 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -83.84 -7.47 59.44 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.636 -0.875 . . . . 0.91000000000000003 108.636 179.225 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.536 ' N ' ' HB3' ' A' ' 119' ' ' CYS . . . -88.54 -79.52 0.31 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.371 -0.83 . . . . 0.96999999999999997 109.5 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 178.83 61.13 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.761 -0.776 . . . . 1.3600000000000001 109.682 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 57.93 17.98 4.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.293 -0.879 . . . . 0.95999999999999996 109.362 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.412 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -67.83 -66.81 0.52 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.355 -0.841 . . . . 1.4099999999999999 109.606 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.695 HD13 ' HB1' ' A' ' 39' ' ' ALA . 0.9 OUTLIER -56.23 120.0 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.0 -1.063 . . . . 0.60999999999999999 109.769 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.596 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -61.0 -29.08 69.49 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.443 -0.786 . . . . 2.02 109.452 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.596 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 6.9 pttt 168.07 131.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.579 -0.897 . . . . 0.83999999999999997 108.579 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.104 HG23 ' HB2' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -108.18 130.79 60.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.054 -1.091 . . . . 0.42999999999999999 108.054 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.531 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 8.2 mtm -122.63 153.22 39.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.074 -1.016 . . . . 0.65000000000000002 111.012 -177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.075 HG11 ' CE2' ' A' ' 35' ' ' PHE . 2.5 t -127.0 128.36 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.577 -0.898 . . . . 0.62 108.577 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.79 -17.39 35.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.149 -0.969 . . . . 2.4500000000000002 110.496 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 21' ' ' CYS . . . -88.33 -94.68 1.01 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.646 -1.381 . . . . 1.1299999999999999 109.646 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' O ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -47.53 173.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.213 -1.169 . . . . 0.68999999999999995 108.975 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.493 ' NE2' ' CB ' ' A' ' 25' ' ' ASP . 5.5 p80 -139.48 3.34 2.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.927 -1.108 . . . . 4.3799999999999999 110.594 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.13 -157.51 27.91 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.054 -1.545 . . . . 1.21 110.951 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.468 ' O ' ' C ' ' A' ' 25' ' ' ASP . 5.0 t -41.35 -36.27 0.79 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.613 -0.934 . . . . 2.75 110.553 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.493 ' CB ' ' NE2' ' A' ' 22' ' ' HIS . 0.7 OUTLIER -39.92 157.18 0.15 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.5 -0.75 . . . . 2.1200000000000001 109.607 -179.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.82 138.88 19.22 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.957 2.438 . . . . 0.82999999999999996 110.746 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -116.25 132.66 56.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.446 -0.784 . . . . 0.93000000000000005 109.331 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.571 HG22 ' CD2' ' A' ' 30' ' ' HIS . 46.6 mm -101.97 109.31 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.019 -1.051 . . . . 0.65000000000000002 108.616 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.3 mt -92.53 113.43 27.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.212 -0.93 . . . . 0.62 109.391 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.571 ' CD2' HG22 ' A' ' 28' ' ' ILE . 5.7 m170 -89.63 105.97 18.15 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.468 -1.308 . . . . 1.3999999999999999 107.468 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.769 ' HA ' HG11 ' A' ' 94' ' ' VAL . 2.6 ptt180 -45.26 152.55 0.27 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.055 -1.028 . . . . 1.0800000000000001 110.051 -178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.453 ' HA2' ' HD3' ' A' ' 96' ' ' LYS . . . 94.58 -15.88 62.36 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.57 -1.412 . . . . 0.41999999999999998 109.57 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.505 ' HE2' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -102.3 152.51 38.3 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.178 -1.189 . . . . 2.1099999999999999 109.445 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -81.3 119.85 3.53 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.886 2.391 . . . . 0.5 110.825 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 1.075 ' CE2' HG11 ' A' ' 18' ' ' VAL . 5.2 t80 -97.83 116.81 30.78 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.945 -1.502 . . . . 0.68999999999999995 106.945 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.94 ' C ' HD13 ' A' ' 37' ' ' LEU . 28.3 m -96.21 131.03 43.12 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.15 -0.969 . . . . 0.68999999999999995 110.838 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.94 HD13 ' C ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -134.64 141.63 46.64 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.696 -0.854 . . . . 0.40999999999999998 108.696 178.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 0.7 OUTLIER -121.66 127.09 50.42 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.293 -1.003 . . . . 1.1599999999999999 108.293 -179.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 1.104 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -132.75 121.51 23.16 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.597 -1.314 . . . . 0.33000000000000002 110.513 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.578 HD23 ' HB3' ' A' ' 87' ' ' ASP . 2.3 mt -88.28 145.03 26.08 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 105.488 -2.041 . . . . 0.90000000000000002 105.488 177.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.659 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 28.2 p90 -157.15 141.93 16.84 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.143 -1.423 . . . . 0.27000000000000002 110.38 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 26.8 m-20 -85.51 111.01 19.61 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.202 -0.936 . . . . 1.3600000000000001 108.79 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -46.82 114.8 0.9 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.703 -0.623 . . . . 0.28999999999999998 109.329 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.453 ' OD1' HD23 ' A' ' 117' ' ' LEU . 38.8 p30 -83.66 7.85 16.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.096 -1.003 . . . . 1.9199999999999999 109.847 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.53 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 3.5 pt20 -168.39 162.02 12.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.068 -1.02 . . . . 0.84999999999999998 109.685 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 10.7 p-10 -89.1 120.55 30.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.215 -0.928 . . . . 2.75 109.245 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -141.6 141.74 33.46 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.56999999999999995 110.17 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.677 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 8.0 mmmt -84.12 -11.45 56.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.54 -0.725 . . . . 0.75 109.688 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.2 p -144.75 138.1 26.94 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.977 0.894 . . . . 0.55000000000000004 109.729 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -126.57 153.23 45.52 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.691 -0.855 . . . . 0.37 108.691 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 0.5 OUTLIER -132.09 136.92 47.52 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.959 -1.088 . . . . 0.40000000000000002 110.833 -179.035 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.696 HG22 ' O ' ' A' ' 69' ' ' ASP . 4.5 tt -93.61 148.95 4.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.527 -1.286 . . . . 0.68999999999999995 107.527 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.413 ' N ' HG12 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -139.07 116.8 11.47 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.146 -0.972 . . . . 0.77000000000000002 109.142 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.795 HD13 HG21 ' A' ' 68' ' ' ILE . 2.8 mp -116.12 116.84 53.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 119.256 -0.978 . . . . 0.29999999999999999 109.259 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.475 ' HA ' HG23 ' A' ' 65' ' ' VAL . 26.6 mtmt -114.87 159.45 20.65 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.181 -0.95 . . . . 0.87 108.993 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.59 122.56 22.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.884 -1.135 . . . . 0.28999999999999998 110.482 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -93.21 150.85 20.2 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.777 -0.823 . . . . 2.7000000000000002 108.777 179.261 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.823 HD11 HD11 ' A' ' 63' ' ' ILE . 20.4 mt -103.29 38.78 1.7 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.193 -0.942 . . . . 1.05 109.491 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 4.3 t0 72.58 5.46 5.24 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.512 -0.743 . . . . 2.0600000000000001 109.324 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.06 -35.68 0.03 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.911 -1.275 . . . . 1.6499999999999999 109.911 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 61' ' ' LEU . 7.0 mp -114.05 113.41 24.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.988 -1.301 . . . . 4.7999999999999998 109.664 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 17.0 tt0 -77.78 137.05 38.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.967 -1.083 . . . . 1.71 109.936 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.823 HD11 HD11 ' A' ' 58' ' ' LEU . 74.0 mt -123.01 169.54 14.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-O 121.687 0.756 . . . . 1.2 109.079 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.686 ' N ' HG22 ' A' ' 63' ' ' ILE . 3.6 m-20 -114.18 129.59 56.62 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.198 -1.408 . . . . 2.1800000000000002 107.198 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.066 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 2.7 t -103.26 112.67 65.86 Favored Pre-proline 0 C--N 1.303 -1.451 0 O-C-N 120.848 -1.157 . . . . 0.33000000000000002 111.418 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.565 ' O ' HG23 ' A' ' 68' ' ' ILE . 36.3 Cg_endo -82.71 -154.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.261 2.641 . . . . 0.42999999999999999 109.522 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.23 31.86 74.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.641 -1.384 . . . . 0.93000000000000005 109.641 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.795 HG21 HD13 ' A' ' 54' ' ' ILE . 17.8 pt -125.79 -165.33 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.315 -1.109 . . . . 0.40000000000000002 108.968 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.696 ' O ' HG22 ' A' ' 52' ' ' ILE . 38.7 t0 -103.05 112.32 25.1 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.221 -0.924 . . . . 1.47 109.495 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.515 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 10.3 p -87.11 45.46 1.27 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.492 -0.929 . . . . 0.34999999999999998 108.492 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 23.8 t30 -179.85 74.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.429 -1.322 . . . . 0.92000000000000004 107.429 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.617 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -59.5 -5.84 0.93 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.629 -0.669 . . . . 0.19 112.1 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.589 ' HA ' HG22 ' A' ' 76' ' ' VAL . 1.3 t -62.71 -14.34 43.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.43 -1.419 . . . . 0.20000000000000001 108.621 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -25.81 63.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.964 . . . . 0.92000000000000004 109.858 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.482 ' HB2' HG13 ' A' ' 88' ' ' ILE . 68.2 m-85 -111.62 -23.8 10.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.838 . . . . 0.27000000000000002 109.896 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.851 ' CG2' HD21 ' A' ' 80' ' ' LEU . 1.5 m -104.42 171.69 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.047 -1.094 . . . . 0.25 108.047 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.592 ' HG3' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -94.27 92.43 7.21 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.156 -0.965 . . . . 1.3200000000000001 110.82 -178.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.486 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 15.3 p -90.12 149.62 41.82 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 107.579 -1.267 . . . . 0.20999999999999999 107.579 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.677 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.7 Cg_endo -70.17 133.86 27.98 Favored 'Cis proline' 0 C--N 1.312 -1.367 0 C-N-CA 124.171 -1.179 . . . . 0.17000000000000001 112.906 2.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.851 HD21 ' CG2' ' A' ' 76' ' ' VAL . 14.0 mt -75.54 112.89 12.34 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.832 -1.544 . . . . 0.25 106.832 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 45.8 t -80.85 138.91 18.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 CA-C-O 121.668 0.746 . . . . 0.52000000000000002 110.679 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.53 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 34.9 tttt -64.24 112.43 3.04 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.666 0.746 . . . . 2.1200000000000001 109.326 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.87 -14.25 9.73 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 109.927 -1.269 . . . . 0.39000000000000001 109.927 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.617 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 2.9 tp-100 -101.17 153.12 19.87 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.83 -1.174 . . . . 2.3799999999999999 107.83 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -102.61 155.52 18.24 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.811 -1.181 . . . . 1.9099999999999999 107.811 178.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.648 ' CE2' HD23 ' A' ' 80' ' ' LEU . 63.3 m-85 -134.81 151.8 51.23 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.065 -1.022 . . . . 0.34000000000000002 109.981 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.578 ' HB3' HD23 ' A' ' 40' ' ' LEU . 4.5 p-10 -120.62 113.43 20.23 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.253 -0.905 . . . . 0.65000000000000002 109.624 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.717 ' HB ' HG12 ' A' ' 76' ' ' VAL . 5.4 tt -110.78 121.59 63.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.271 -0.893 . . . . 0.28000000000000003 111.705 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -104.11 109.75 21.66 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 104.741 -2.318 . . . . 2.75 104.741 175.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.632 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 39.7 t80 -125.42 142.33 51.56 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.83 -1.169 . . . . 0.41999999999999998 113.174 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.632 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.2 144.14 25.93 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.625 -1.62 . . . . 0.89000000000000001 106.625 176.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.066 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 24.7 t90 -118.83 87.79 2.8 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.896 -1.128 . . . . 0.68000000000000005 110.328 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -64.19 104.12 0.7 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.471 0.653 . . . . 1.5900000000000001 109.351 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.879 HG12 ' H ' ' A' ' 96' ' ' LYS . 52.2 t -56.14 143.56 63.1 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.524 -0.735 . . . . 1.8 109.312 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.7 ' HD2' HG13 ' A' ' 94' ' ' VAL . 25.0 Cg_endo -64.92 -3.35 6.86 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.835 2.356 . . . . 3.9300000000000002 111.992 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.879 ' H ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER 66.81 1.38 2.22 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.982 -1.074 . . . . 3.25 109.515 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.519 ' O ' ' C ' ' A' ' 98' ' ' ALA . 10.0 pt -100.45 -30.16 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 120.96 -1.087 . . . . 0.54000000000000004 108.399 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.574 ' HB1' HD13 ' A' ' 127' ' ' ILE . . . -33.15 117.93 0.44 Allowed Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.637 -0.875 . . . . 0.47999999999999998 108.637 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 98' ' ' ALA . 32.7 Cg_endo -79.18 174.5 11.97 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.541 2.161 . . . . 0.98999999999999999 110.19 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.516 ' HE3' ' HG2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -80.84 72.32 7.82 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.513 -0.921 . . . . 4.0499999999999998 108.513 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.867 ' OG ' HG23 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -81.84 103.85 11.8 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.595 -0.891 . . . . 2.2200000000000002 108.595 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.54 ' HG3' ' N ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -41.3 -30.17 0.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.34 -0.85 . . . . 5.0300000000000002 109.565 -179.161 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.54 ' N ' ' HG3' ' A' ' 102' ' ' GLU . 0.6 OUTLIER -132.96 132.01 41.46 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.152 -0.967 . . . . 2.4399999999999999 109.542 179.219 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.904 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.9 OUTLIER -132.05 144.59 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.342 -0.849 . . . . 0.84999999999999998 109.978 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 122' ' ' ALA . 31.8 t -119.79 113.83 42.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.468 -1.308 . . . . 0.46000000000000002 107.468 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.58 137.6 23.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 120.721 -1.237 . . . . 0.34000000000000002 110.361 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 81.5 m -118.59 125.27 49.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.811 -0.556 . . . . 0.55000000000000004 109.76 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -102.42 129.9 53.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.322 -1.362 . . . . 0.33000000000000002 107.322 178.2 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.55 ' HG2' ' CG1' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -141.04 131.15 24.74 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.078 -1.639 . . . . 1.8100000000000001 112.296 -178.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.659 ' CD1' ' CE2' ' A' ' 41' ' ' PHE . 16.2 mt -104.36 139.62 39.06 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.671 -1.603 . . . . 0.34999999999999998 106.671 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.615 HD12 ' C ' ' A' ' 110' ' ' LEU . 5.1 mp -138.66 112.06 7.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 120.66 -1.275 . . . . 0.39000000000000001 110.289 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.75 -150.19 7.81 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.481 -1.847 . . . . 0.56000000000000005 108.481 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.28 -1.74 50.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.219 -1.165 . . . . 1.6799999999999999 109.759 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -115.04 -0.36 13.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -0.956 . . . . 2.4900000000000002 110.714 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.62 -169.61 27.78 Favored Glycine 0 N--CA 1.496 2.662 0 C-N-CA 119.525 -1.322 . . . . 0.54000000000000004 110.305 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.55 ' CG1' ' HG2' ' A' ' 109' ' ' LYS . 44.4 t -77.5 111.2 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.296 -1.12 . . . . 1.0700000000000001 109.867 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.453 HD23 ' OD1' ' A' ' 44' ' ' ASN . 28.3 mt -60.35 -41.37 93.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.32000000000000001 109.874 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.645 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -151.75 176.15 11.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.967 -1.083 . . . . 0.68999999999999995 109.526 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.536 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 42.8 t -164.13 154.05 14.53 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.042 -1.036 . . . . 0.56999999999999995 109.007 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -150.44 154.95 38.62 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.837 -1.164 . . . . 0.32000000000000001 110.353 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.507 HG13 ' HB3' ' A' ' 8' ' ' CYS . 72.4 mt -130.87 140.37 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.318 -0.864 . . . . 1.01 109.003 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.801 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -120.1 145.79 46.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.45 -1.406 . . . . 0.56999999999999995 109.033 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.92 170.45 15.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.084 -1.01 . . . . 2.7000000000000002 109.731 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 9.0 m80 64.34 40.52 6.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -0.848 . . . . 4.0 109.801 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -111.13 162.78 12.37 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.273 -1.531 . . . . 0.57999999999999996 109.273 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.408 ' HB3' HD13 ' A' ' 28' ' ' ILE . 15.7 tttt -149.56 137.34 20.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -1.179 . . . . 4.3099999999999996 108.615 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.904 ' CD1' HG21 ' A' ' 104' ' ' VAL . 61.2 mt -105.53 139.74 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.604 -1.31 . . . . 0.37 110.255 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.516 ' HG2' ' HE3' ' A' ' 100' ' ' LYS . 1.4 mtm180 -133.76 162.87 30.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.467 -0.77 . . . . 4.7400000000000002 109.216 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.061 -0.971 . . . . 4.9299999999999997 109.201 179.559 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.407 -0.59 . . . . 2.6600000000000001 109.407 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 3.0 m -105.49 169.03 2.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.226 -0.922 . . . . 1.1499999999999999 109.337 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -75.77 122.67 24.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 1.77 110.851 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -150.41 157.42 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.987 -1.116 . . . . 2.3500000000000001 107.987 178.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -117.42 110.26 17.79 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.083 -1.011 . . . . 3.3700000000000001 109.715 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.487 ' OD2' ' HB ' ' A' ' 13' ' ' ILE . 0.8 OUTLIER -49.65 152.49 1.42 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.482 -0.761 . . . . 1.6200000000000001 109.909 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.469 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.1 OUTLIER -128.47 27.24 5.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.264 -0.898 . . . . 2.6699999999999999 108.791 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.43 ' O ' ' OD1' ' A' ' 10' ' ' ASN . . . -116.25 -76.56 0.57 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.394 -0.816 . . . . 0.68000000000000005 109.773 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER 174.21 68.6 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.069 -0.715 . . . . 1.1699999999999999 109.069 -178.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 55.08 35.59 25.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.194 -0.941 . . . . 2.6699999999999999 108.874 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.5 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -87.3 -79.2 0.28 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.456 -0.777 . . . . 1.1799999999999999 109.805 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.528 ' CD1' ' HB1' ' A' ' 118' ' ' ALA . 0.7 OUTLIER -46.36 127.64 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.53000000000000003 109.682 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.572 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -77.65 -24.99 49.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.477 -0.935 . . . . 1.1699999999999999 108.477 179.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 167.61 129.56 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.781 -0.822 . . . . 1.9399999999999999 108.781 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.81 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -111.87 121.51 64.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.176 -1.046 . . . . 0.47999999999999998 108.176 179.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 3.4 mtm -110.48 150.78 28.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.924 -1.11 . . . . 1.3300000000000001 110.895 -178.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.641 HG11 ' CE2' ' A' ' 35' ' ' PHE . 51.5 t -119.0 159.42 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.411 -0.959 . . . . 0.59999999999999998 108.411 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.489 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -105.12 69.19 0.84 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.017 -1.052 . . . . 1.3200000000000001 109.57 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.89 -50.41 0.27 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.648 -1.263 . . . . 0.96999999999999997 110.231 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 39.7 t -80.71 150.89 29.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.988 -1.301 . . . . 1.25 110.011 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.47 -177.08 3.97 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.415 -0.803 . . . . 3.3100000000000001 109.262 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 3' ' ' VAL . . . -65.0 -120.55 0.01 OUTLIER Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.069 -1.212 . . . . 1.9199999999999999 110.069 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLY . 14.1 p -38.55 -44.73 0.99 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.653 -0.91 . . . . 1.27 110.234 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -44.53 156.91 0.32 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.106 -0.996 . . . . 1.51 109.221 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 124' ' ' HIS . 35.9 Cg_endo -77.82 173.28 14.31 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.645 2.23 . . . . 1.3400000000000001 110.183 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.453 ' O ' HD13 ' A' ' 28' ' ' ILE . 5.4 m -122.11 135.91 54.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.068 -1.02 . . . . 0.79000000000000004 110.037 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 27' ' ' CYS . 7.7 mm -110.35 107.96 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.276 -0.89 . . . . 1.1399999999999999 108.664 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.409 HG23 HG21 ' A' ' 94' ' ' VAL . 1.4 mp -87.76 122.74 39.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.184 -0.948 . . . . 0.76000000000000001 109.632 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 12.7 m-70 -90.22 101.6 14.32 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.673 0.749 . . . . 1.1899999999999999 109.215 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.833 ' HG3' ' HB3' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -37.74 146.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.61 0.719 . . . . 1.79 111.114 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.67 -5.63 56.49 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.678 -0.969 . . . . 0.87 110.678 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -104.85 152.24 39.52 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.758 -1.436 . . . . 1.73 110.214 -179.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.81 118.41 3.1 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.101 2.534 . . . . 0.46000000000000002 111.291 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.641 ' CE2' HG11 ' A' ' 18' ' ' VAL . 2.6 t80 -97.75 123.69 41.79 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.135 -1.431 . . . . 0.65000000000000002 107.135 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.732 ' C ' HD13 ' A' ' 37' ' ' LEU . 61.8 m -107.37 136.16 47.63 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.515 -1.365 . . . . 0.34999999999999998 110.813 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.947 HD13 ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -141.21 123.59 15.79 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.938 -0.764 . . . . 0.78000000000000003 108.938 179.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -102.43 134.02 46.42 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.899 -1.148 . . . . 0.89000000000000001 107.899 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.81 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -129.62 120.14 24.76 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 118.767 -1.173 . . . . 0.41999999999999998 110.683 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.563 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 15.8 mt -89.56 140.63 29.35 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 105.378 -2.082 . . . . 0.79000000000000004 105.378 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 27.3 p90 -155.2 139.2 16.38 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.046 -1.462 . . . . 0.39000000000000001 110.528 -178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.3 m-20 -84.54 108.96 17.58 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.987 -1.116 . . . . 1.1399999999999999 107.987 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -44.3 113.77 0.58 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.801 -0.814 . . . . 0.17000000000000001 108.801 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.477 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 7.2 p30 -83.5 10.3 9.25 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.073 -1.017 . . . . 0.57999999999999996 109.595 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.547 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 0.9 OUTLIER -168.28 158.11 9.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.382 -0.824 . . . . 0.73999999999999999 109.312 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -88.35 120.36 29.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.177 -0.952 . . . . 1.71 109.537 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.513 ' O ' ' CA ' ' A' ' 79' ' ' PRO . 3.3 t -143.74 153.09 42.07 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.244 -0.91 . . . . 0.37 109.313 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.673 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -98.61 -25.84 14.59 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.663 -1.236 . . . . 6.5099999999999998 107.663 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.408 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 24.6 p -111.3 138.33 47.91 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 122.134 0.968 . . . . 1.3999999999999999 109.766 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -142.21 154.23 44.64 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.837 -0.801 . . . . 0.46999999999999997 108.837 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.516 ' HD2' ' CB ' ' A' ' 70' ' ' THR . 1.6 mtmt -145.29 141.06 28.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.009 -1.057 . . . . 0.40000000000000002 111.038 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 69' ' ' ASP . 9.7 tt -94.69 152.05 3.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.227 -1.397 . . . . 0.45000000000000001 107.227 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -140.45 118.1 11.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.93 -1.106 . . . . 0.39000000000000001 110.15 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.781 HD12 ' N ' ' A' ' 54' ' ' ILE . 2.2 mp -117.78 115.56 48.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.017 -1.052 . . . . 0.28999999999999998 109.267 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 13.6 mttm -115.6 157.4 24.21 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.466 -0.938 . . . . 2.0899999999999999 108.466 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.52 123.95 26.09 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.692 -1.255 . . . . 0.34999999999999998 110.576 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 16.0 m -90.37 146.3 24.28 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.451 -0.944 . . . . 2.8999999999999999 108.451 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.874 HD11 ' CD1' ' A' ' 63' ' ' ILE . 15.9 mt -113.18 48.27 1.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.027 -1.045 . . . . 0.60999999999999999 109.989 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.401 ' OD2' ' CG ' ' A' ' 102' ' ' GLU . 0.4 OUTLIER 58.0 14.99 2.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.482 -0.761 . . . . 1.04 109.866 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.75 -41.61 0.16 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.964 -1.254 . . . . 1.03 109.964 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 58' ' ' LEU . 9.7 tp -106.53 111.32 23.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.204 -1.174 . . . . 0.83999999999999997 109.304 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 30.4 tt0 -83.96 134.51 34.65 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.289 -0.882 . . . . 0.69999999999999996 108.751 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.874 ' CD1' HD11 ' A' ' 58' ' ' LEU . 79.8 mt -124.89 166.46 20.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 122.011 0.91 . . . . 0.75 109.596 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.645 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -115.23 108.83 17.1 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 106.426 -1.694 . . . . 1.21 106.426 177.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.108 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 2.5 t -73.61 113.72 25.31 Favored Pre-proline 0 C--N 1.297 -1.688 0 O-C-N 121.267 -0.895 . . . . 0.40000000000000002 111.027 -177.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.511 ' O ' HG23 ' A' ' 68' ' ' ILE . 36.7 Cg_endo -83.41 -159.4 0.1 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.956 2.437 . . . . 0.71999999999999997 109.806 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.43 20.67 38.36 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.031 -1.228 . . . . 0.40999999999999998 110.031 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.762 HG22 ' CD1' ' A' ' 92' ' ' TRP . 34.0 pt -105.93 -165.93 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -1.177 . . . . 0.33000000000000002 109.09 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.67 ' O ' HG22 ' A' ' 52' ' ' ILE . 3.1 t70 -105.41 106.44 16.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 1.24 110.083 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.516 ' CB ' ' HD2' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -86.74 47.56 1.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.361 -0.977 . . . . 0.39000000000000001 108.361 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 73' ' ' CYS . 17.9 t-20 176.72 85.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.609 -1.256 . . . . 1.6200000000000001 107.609 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.654 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -73.02 8.07 1.76 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.333 -0.854 . . . . 0.34999999999999998 112.057 -177.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.486 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 2.1 m -65.13 -13.27 57.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.698 -1.251 . . . . 2.1400000000000001 109.485 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -82.27 -14.78 54.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.23 -0.919 . . . . 0.73999999999999999 109.864 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.54 ' CB ' HG13 ' A' ' 88' ' ' ILE . 35.0 m-85 -121.64 -14.15 8.22 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.205 -0.935 . . . . 0.65000000000000002 109.42 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.702 HG12 ' HB ' ' A' ' 88' ' ' ILE . 1.4 m -119.51 162.64 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.208 -0.932 . . . . 0.38 108.602 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.621 ' HG3' ' CD2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -96.65 84.2 3.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.221 -0.924 . . . . 5.7699999999999996 111.136 -178.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.525 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 5.0 p -83.09 159.51 62.4 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.694 -1.254 . . . . 0.82999999999999996 107.944 178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.673 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 23.7 Cg_endo -67.14 130.52 13.6 Favored 'Cis proline' 0 C--N 1.311 -1.422 0 C-N-CA 124.25 -1.146 . . . . 0.54000000000000004 112.281 2.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.628 HD23 ' CE2' ' A' ' 86' ' ' TYR . 14.7 mt -71.67 107.84 4.71 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.75 -1.204 . . . . 0.51000000000000001 107.75 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 61.0 t -78.69 136.11 24.54 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 CA-C-O 121.742 0.782 . . . . 0.29999999999999999 110.211 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 23.3 tttt -62.51 110.09 1.58 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.708 0.766 . . . . 2.6600000000000001 110.12 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 126.28 -16.76 6.69 Favored Glycine 0 N--CA 1.48 1.63 0 N-CA-C 110.185 -1.166 . . . . 0.14999999999999999 110.185 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.575 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 3.3 tp-100 -101.95 156.48 17.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.066 -1.255 . . . . 2.1299999999999999 108.141 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.555 ' C ' ' CD1' ' A' ' 86' ' ' TYR . 1.2 tt0 -106.02 153.69 21.68 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.096 -1.076 . . . . 1.99 108.096 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.628 ' CE2' HD23 ' A' ' 80' ' ' LEU . 23.4 m-85 -131.5 151.45 51.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.055 -1.028 . . . . 0.52000000000000002 110.218 -178.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.563 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -118.27 113.86 22.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.527 -0.733 . . . . 2.1899999999999999 110.063 -178.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.702 ' HB ' HG12 ' A' ' 76' ' ' VAL . 1.8 tt -115.59 119.41 61.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.181 -0.949 . . . . 0.47999999999999998 111.353 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -101.39 106.88 18.08 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 104.87 -2.27 . . . . 2.3100000000000001 104.87 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.627 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 32.2 t80 -119.97 141.23 49.87 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.869 -1.133 . . . . 0.38 112.544 -176.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.541 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -91.67 145.34 24.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.55 -1.648 . . . . 0.81999999999999995 106.55 177.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.108 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 51.3 t90 -127.03 94.26 3.98 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.243 -0.911 . . . . 0.89000000000000001 109.495 -177.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -57.42 104.88 0.19 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.66 -0.816 . . . . 2.1299999999999999 108.8 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.717 HG22 ' CZ3' ' A' ' 92' ' ' TRP . 71.4 t -58.85 141.56 85.38 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 107.879 -1.156 . . . . 0.62 107.879 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.944 ' HG3' HG13 ' A' ' 65' ' ' VAL . 29.8 Cg_endo -71.58 124.66 10.48 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 C-N-CA 121.781 1.654 . . . . 0.5 109.992 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.531 ' HA ' ' HG2' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -67.87 -2.75 7.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.534 -0.729 . . . . 3.0099999999999998 109.681 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 95' ' ' PRO . 3.8 pt -88.23 -24.59 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.54000000000000004 109.318 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.833 ' HB3' ' HG3' ' A' ' 31' ' ' ARG . . . -29.07 120.04 0.28 Allowed Pre-proline 0 N--CA 1.492 1.635 0 CA-C-N 116.054 -0.521 . . . . 0.73999999999999999 110.76 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.609 ' HG2' HD13 ' A' ' 58' ' ' LEU . 37.3 Cg_endo -86.09 133.29 4.07 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.565 2.176 . . . . 0.56000000000000005 108.688 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.557 ' HD2' ' N ' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -50.98 91.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.851 -1.156 . . . . 5.4000000000000004 107.913 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.604 ' HB3' HG23 ' A' ' 104' ' ' VAL . 3.6 t -94.51 114.45 26.45 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.576 -0.702 . . . . 0.46000000000000002 109.465 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 11.4 pt-20 -38.85 -41.43 0.74 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.218 -0.66 . . . . 1.6000000000000001 109.218 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.429 ' N ' ' CG ' ' A' ' 102' ' ' GLU . 1.7 t-20 -134.67 140.73 46.23 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.497 -0.752 . . . . 3.0600000000000001 109.016 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.981 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.9 OUTLIER -133.47 146.74 31.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 121.344 -0.848 . . . . 0.64000000000000001 108.99 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 t -126.53 114.81 39.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.815 -1.18 . . . . 0.67000000000000004 107.815 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 38.9 t -97.5 137.94 23.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.293 -0.963 . . . . 0.5 109.897 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 81.1 m -117.52 115.74 25.75 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.605 -0.684 . . . . 0.37 109.617 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -94.79 128.57 45.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.466 -1.679 . . . . 0.45000000000000001 106.466 177.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.558 ' HG2' ' CG1' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -141.24 130.45 23.5 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.281 -1.512 . . . . 0.94999999999999996 112.378 -177.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.4 mt -102.53 139.49 38.06 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.165 -1.791 . . . . 0.80000000000000004 106.165 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.573 HD12 ' C ' ' A' ' 110' ' ' LEU . 4.5 mp -137.07 114.73 13.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.746 -1.221 . . . . 0.45000000000000001 110.25 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.475 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -87.97 -139.66 6.52 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.358 -1.897 . . . . 0.73999999999999999 108.358 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.99 -0.0 27.29 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.192 -1.181 . . . . 2.0499999999999998 109.592 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -116.41 4.53 13.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 2.0800000000000001 110.479 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 142.42 -160.23 27.26 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.709 -1.357 . . . . 0.55000000000000004 109.709 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.558 ' CG1' ' HG2' ' A' ' 109' ' ' LYS . 72.1 t -85.12 110.48 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -1.156 . . . . 1.1000000000000001 109.589 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.567 HD13 ' CD1' ' A' ' 80' ' ' LEU . 77.6 mt -57.87 -39.16 77.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.5 110.56 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.544 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -152.08 175.11 12.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.933 -1.104 . . . . 0.88 109.227 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 42.4 t -168.11 153.76 7.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.571 -1.33 . . . . 0.48999999999999999 110.018 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.13 149.79 29.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.05 -1.031 . . . . 0.45000000000000001 110.102 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.447 HD12 ' SG ' ' A' ' 8' ' ' CYS . 4.3 mt -134.58 116.66 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.941 -1.133 . . . . 0.70999999999999996 107.941 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.553 ' HB2' HG13 ' A' ' 5' ' ' VAL . . . -105.71 121.1 43.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.908 -1.12 . . . . 1.48 110.264 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.28 -156.79 0.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.438 -0.789 . . . . 2.4300000000000002 108.885 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 0.2 OUTLIER 46.54 30.41 1.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.003 -1.061 . . . . 2.1800000000000002 108.997 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -100.09 155.91 19.59 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.889 -1.148 . . . . 0.28999999999999998 110.535 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 39.7 mttm -154.0 136.33 14.92 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.435 -1.32 . . . . 2.9700000000000002 107.435 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.981 ' CD1' HG21 ' A' ' 104' ' ' VAL . 60.3 mt -107.68 134.71 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.327 -1.483 . . . . 0.26000000000000001 111.52 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.543 ' HA ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -116.15 177.02 4.84 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.797 -0.816 . . . . 3.1400000000000001 108.797 178.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.557 ' N ' ' HD2' ' A' ' 100' ' ' LYS . 24.6 t0 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.073 -0.965 . . . . 1.2 109.61 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.478 ' HB2' ' HG2' ' A' ' 17' ' ' MET . 9.3 tt0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.18 0.515 . . . . 1.53 109.746 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.531 HG23 HG13 ' A' ' 5' ' ' VAL . 3.7 m -101.85 169.36 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.295 -0.878 . . . . 1.29 109.155 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.403 ' C ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -90.59 122.91 33.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 3.1099999999999999 110.806 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 3' ' ' VAL . 29.6 m -153.47 149.56 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.015 -1.106 . . . . 0.51000000000000001 108.015 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.27 110.31 20.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.781 -1.199 . . . . 5.0899999999999999 110.569 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.32 134.49 39.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 2.8399999999999999 108.916 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.47 ' HB3' HD13 ' A' ' 121' ' ' ILE . 4.3 p -106.61 -2.87 21.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.131 -0.98 . . . . 1.3700000000000001 110.017 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 10' ' ' ASN . . . -73.81 -58.29 3.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.13 -0.981 . . . . 1.02 109.435 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 0.2 OUTLIER 167.2 50.86 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.85 -1.167 . . . . 3.4399999999999999 107.85 -178.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 10' ' ' ASN . 3.9 t-20 63.8 15.83 9.34 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.017 -1.105 . . . . 2.0499999999999998 108.017 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.525 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -58.74 -62.1 2.12 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.501 -0.749 . . . . 1.28 109.266 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -59.19 128.27 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.37 109.583 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.567 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 9.9 mmpt? -85.35 -13.98 47.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.461 -0.775 . . . . 0.59999999999999998 109.856 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.567 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.9 ttpt 156.96 127.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.06 -0.718 . . . . 1.3799999999999999 109.06 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.711 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -114.3 123.92 70.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.367 -0.833 . . . . 0.53000000000000003 108.949 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.478 ' HG2' ' HB2' ' A' ' 2' ' ' GLN . 2.8 mtm -115.76 147.84 40.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.13 -0.981 . . . . 0.82999999999999996 110.268 -179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.013 HG11 ' CE2' ' A' ' 35' ' ' PHE . 44.3 t -127.07 129.21 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.936 -0.764 . . . . 0.56000000000000005 108.936 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -83.27 87.26 6.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 1.4199999999999999 109.783 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.44 -68.07 0.22 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.531 -1.428 . . . . 0.95999999999999996 109.531 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.5 m -76.95 -167.6 0.89 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.354 -1.086 . . . . 3.25 109.418 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -141.57 175.83 9.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.041 -1.037 . . . . 4.5199999999999996 109.813 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 3' ' ' VAL . . . -114.09 150.44 18.6 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.364 -1.494 . . . . 3.3100000000000001 109.364 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER 72.71 1.5 4.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.042 -1.269 . . . . 2.0499999999999998 109.116 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.482 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 1.1 m-20 -135.43 176.01 3.18 Favored Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 108.267 -1.012 . . . . 1.6100000000000001 108.267 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 34.4 Cg_endo -76.33 135.97 17.29 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.933 1.755 . . . . 0.75 109.66 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.66 139.34 47.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.369 -0.832 . . . . 2.4900000000000002 108.819 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.627 HG23 ' HG3' ' A' ' 128' ' ' ARG . 46.6 mm -112.11 115.78 50.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.167 -0.958 . . . . 0.91000000000000003 109.841 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.3 mt -103.93 118.13 50.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.505 -0.924 . . . . 0.84999999999999998 108.505 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.537 ' HB2' ' CE ' ' A' ' 33' ' ' LYS . 17.4 m-70 -84.87 125.02 32.28 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.156 -0.965 . . . . 1.04 109.241 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.579 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 3.2 ptt180 -70.78 125.47 26.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.124 -0.985 . . . . 1.29 109.84 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.56 -9.17 26.15 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.745 -1.342 . . . . 0.29999999999999999 109.745 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.537 ' CE ' ' HB2' ' A' ' 30' ' ' HIS . 1.6 ptpt -112.38 158.51 37.01 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.174 -1.192 . . . . 1.76 109.647 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 33' ' ' LYS . 36.2 Cg_endo -78.01 136.38 14.7 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 C-N-CA 122.981 2.454 . . . . 0.39000000000000001 111.484 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 1.013 ' CE2' HG11 ' A' ' 18' ' ' VAL . 2.5 t80 -117.67 116.88 27.94 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.673 -1.232 . . . . 0.73999999999999999 107.673 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.783 ' O ' HG13 ' A' ' 18' ' ' VAL . 23.1 m -96.93 137.16 36.45 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.95 -1.094 . . . . 0.93000000000000005 110.76 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.498 ' HB3' HG22 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -147.82 125.84 12.08 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.843 -0.799 . . . . 4.0099999999999998 108.843 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -100.23 125.32 46.38 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.723 -1.214 . . . . 1.4099999999999999 107.723 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.711 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -124.43 118.39 26.56 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.986 -1.086 . . . . 0.45000000000000001 110.809 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 12.3 mt -91.04 140.82 29.48 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.487 -1.671 . . . . 0.62 106.487 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.621 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 25.1 p90 -156.68 141.24 16.8 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 120.898 -1.126 . . . . 0.23999999999999999 109.193 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 7.7 m-20 -84.81 111.48 19.66 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 118.938 -1.105 . . . . 1.3600000000000001 109.057 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -45.33 113.46 0.58 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.958 -0.756 . . . . 0.13 108.958 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.409 ' OD1' ' C ' ' A' ' 44' ' ' ASN . 36.0 p30 -88.35 10.08 21.11 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.291 -0.88 . . . . 1.49 109.382 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.615 HE21 HD23 ' A' ' 117' ' ' LEU . 1.5 pt20 -165.95 144.09 5.74 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.285 -0.884 . . . . 1.9099999999999999 110.005 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -80.57 119.1 22.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -0.856 . . . . 1.3 108.998 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.54 HG21 ' HA3' ' A' ' 112' ' ' GLY . 0.1 OUTLIER -138.98 144.59 39.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.924 -1.11 . . . . 0.34999999999999998 109.849 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.69 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 20.0 mmmt -85.14 -9.37 57.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -0.888 . . . . 0.66000000000000003 109.676 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 48' ' ' LYS . 9.7 p -151.01 139.75 20.76 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.762 0.791 . . . . 0.40999999999999998 109.42 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -129.9 156.1 44.95 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 121.72 -0.613 . . . . 0.29999999999999999 109.384 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.552 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 0.1 OUTLIER -128.98 127.61 42.02 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.327 -0.858 . . . . 0.57999999999999996 111.174 -178.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.757 ' HA ' HD23 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -101.57 127.58 54.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.834 -1.543 . . . . 1.21 106.834 176.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.589 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -140.71 116.68 10.44 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.1 -1.0 . . . . 4.6600000000000001 108.43 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.792 HD12 HD13 ' A' ' 68' ' ' ILE . 4.2 mp -94.2 129.94 43.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 109.335 -0.617 . . . . 0.85999999999999999 109.335 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -115.0 138.17 51.16 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.327 -0.858 . . . . 0.95999999999999996 109.64 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -119.63 128.17 53.61 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.492 -0.883 . . . . 0.51000000000000001 110.399 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.52 108.92 16.08 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.343 -0.984 . . . . 3.5899999999999999 108.343 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.827 HD23 ' N ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -77.87 -173.44 3.09 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.474 -0.766 . . . . 2.5099999999999998 110.141 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -52.57 -34.24 49.62 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.518 -0.739 . . . . 5.4199999999999999 110.371 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.67 1.06 0.8 Allowed Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.882 -1.628 . . . . 2.71 111.571 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.499 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 12.9 tp -113.39 107.69 16.2 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.528 -1.572 . . . . 3.1299999999999999 109.353 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -96.07 127.5 42.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.915 -1.116 . . . . 6.0999999999999996 108.501 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.65 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -149.13 171.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 122.302 1.048 . . . . 4.5300000000000002 109.438 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.65 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -110.89 116.32 31.04 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 106.789 -1.559 . . . . 4.6500000000000004 106.789 177.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.119 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 15.6 t -66.94 110.31 4.83 Favored Pre-proline 0 C--N 1.295 -1.766 0 O-C-N 121.667 -0.645 . . . . 0.45000000000000001 110.594 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.684 ' O ' HG23 ' A' ' 68' ' ' ILE . 42.2 Cg_endo -89.17 -157.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.719 2.946 . . . . 0.51000000000000001 109.99 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 50.85 45.86 49.29 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.26 -1.136 . . . . 0.91000000000000003 110.26 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.792 HD13 HD12 ' A' ' 54' ' ' ILE . 2.5 pt -140.43 -138.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.07 -1.253 . . . . 1.1599999999999999 109.59 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.502 ' N ' ' OH ' ' A' ' 90' ' ' TYR . 1.1 t70 -117.21 105.34 12.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.923 -1.111 . . . . 1.6000000000000001 111.178 -178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.552 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 11.0 p -92.44 49.92 1.55 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.366 -1.346 . . . . 0.73999999999999999 107.366 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 38.4 t30 177.55 81.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.231 -1.396 . . . . 0.73999999999999999 107.231 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.589 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . . . -65.58 -3.97 5.38 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.327 0.862 . . . . 0.40999999999999998 113.327 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.481 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 9.7 t -65.9 -9.19 27.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 119.928 -1.732 . . . . 0.45000000000000001 109.352 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.489 ' CD2' ' O ' ' A' ' 74' ' ' HIS . 3.3 t60 -76.26 -30.88 58.01 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.037 -1.04 . . . . 5.2000000000000002 108.34 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CD1' ' O ' ' A' ' 89' ' ' LYS . 88.3 m-85 -105.4 -17.88 14.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.1 -1.0 . . . . 0.72999999999999998 110.321 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.746 ' CG2' HD21 ' A' ' 80' ' ' LEU . 2.5 m -115.0 169.71 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.406 -0.961 . . . . 0.51000000000000001 108.406 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.624 ' HG3' ' CD2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -95.61 91.32 6.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.16 -0.963 . . . . 4.5899999999999999 111.723 -177.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.485 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 20.1 p -84.16 151.89 60.76 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 107.636 -1.246 . . . . 0.40999999999999998 107.636 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.69 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.0 Cg_endo -69.84 132.68 23.1 Favored 'Cis proline' 0 C--N 1.314 -1.259 0 C-N-CA 124.281 -1.133 . . . . 0.23999999999999999 112.226 2.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.746 HD21 ' CG2' ' A' ' 76' ' ' VAL . 16.1 mt -74.91 104.24 5.44 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.514 -1.291 . . . . 0.48999999999999999 107.514 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.527 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 73.2 t -71.66 139.03 20.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-O 121.559 0.695 . . . . 0.56999999999999995 109.919 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.596 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 14.5 ttpp -69.27 107.22 3.17 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.539 0.685 . . . . 2.4500000000000002 109.688 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 131.8 -18.08 4.87 Favored Glycine 0 N--CA 1.481 1.641 0 C-N-CA 119.584 -1.294 . . . . 0.42999999999999999 110.249 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.609 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 5.3 tp60 -98.86 151.42 20.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.102 -1.234 . . . . 0.44 108.306 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 1.9 tt0 -99.26 142.63 30.49 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.292 -1.373 . . . . 0.79000000000000004 107.292 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.716 ' CE2' HD23 ' A' ' 80' ' ' LEU . 32.9 m-85 -120.7 150.44 40.95 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.24 -0.913 . . . . 0.39000000000000001 110.295 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.536 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -115.63 115.06 25.77 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.415 -0.957 . . . . 2.1400000000000001 108.415 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.63 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 1.8 tt -108.2 116.54 51.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.031 -1.043 . . . . 0.23999999999999999 111.427 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.566 ' O ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -97.08 113.08 24.61 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 104.457 -2.423 . . . . 4.1500000000000004 104.457 176.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.585 ' CZ ' ' O ' ' A' ' 91' ' ' THR . 12.8 t80 -130.84 138.91 50.08 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.365 -1.334 . . . . 0.77000000000000002 113.082 -175.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.585 ' O ' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -89.56 142.25 27.85 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 105.583 -2.006 . . . . 0.89000000000000001 105.583 176.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.119 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 21.1 t90 -123.75 89.01 3.01 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 120.571 -1.331 . . . . 0.73999999999999999 110.731 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -60.58 103.55 0.26 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.468 -0.938 . . . . 2.7599999999999998 108.468 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.577 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 40.5 t -62.88 142.34 97.4 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.812 -0.81 . . . . 0.38 108.812 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.673 ' HG3' HG13 ' A' ' 65' ' ' VAL . 29.2 Cg_endo -71.17 127.55 13.63 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.764 1.642 . . . . 0.55000000000000004 109.389 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -69.19 3.25 2.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.506 -0.746 . . . . 3.6099999999999999 111.021 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 98' ' ' ALA . 12.5 pt -89.38 -26.29 5.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 O-C-N 120.708 -1.245 . . . . 0.41999999999999998 108.85 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.579 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . . . -39.38 116.62 1.09 Allowed Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 109.414 -0.587 . . . . 0.14000000000000001 109.414 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.555 ' HD2' ' CD1' ' A' ' 58' ' ' LEU . 36.6 Cg_endo -85.4 137.88 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 123.244 2.63 . . . . 0.17999999999999999 109.139 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.516 ' HG2' ' HA ' ' A' ' 128' ' ' ARG . 5.8 mtmt -54.59 90.88 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.015 -1.053 . . . . 1.54 108.732 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.602 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -98.84 129.27 45.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.585 -0.697 . . . . 0.87 109.587 -179.031 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 103' ' ' ASN . 17.7 pt-20 -39.11 -48.19 1.66 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.47 -0.769 . . . . 1.1799999999999999 110.595 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.521 ' N ' ' HG3' ' A' ' 102' ' ' GLU . 4.2 m120 -132.89 145.8 51.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.989 -1.069 . . . . 1.8200000000000001 110.478 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.766 HG21 HD12 ' A' ' 127' ' ' ILE . 82.9 t -135.87 149.17 27.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.777 -0.823 . . . . 0.58999999999999997 108.777 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 122' ' ' ALA . 98.2 t -121.31 117.8 53.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.045 -1.094 . . . . 0.46999999999999997 108.045 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.1 t -98.78 140.23 18.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 120.76 -1.212 . . . . 0.56000000000000005 109.965 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 27.0 m -126.7 118.79 25.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.68 -0.638 . . . . 0.5 109.714 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER -96.75 125.88 49.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.216 -1.402 . . . . 0.47999999999999998 107.216 177.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.948 ' HD2' HD11 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -133.99 150.85 51.27 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 120.647 -1.283 . . . . 1.1200000000000001 111.435 -177.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.757 HD23 ' HA ' ' A' ' 52' ' ' ILE . 13.4 mt -129.79 137.11 50.33 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.142 -1.429 . . . . 0.34999999999999998 107.142 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.948 HD11 ' HD2' ' A' ' 109' ' ' LYS . 4.5 mp -134.78 117.64 23.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.857 -1.152 . . . . 0.32000000000000001 110.205 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.54 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -86.94 -120.02 1.27 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.003 -1.639 . . . . 0.16 109.003 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -123.49 -4.98 8.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -1.089 . . . . 2.6400000000000001 109.403 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.437 ' HB3' ' OE1' ' A' ' 45' ' ' GLN . 4.1 t30 -114.5 -5.91 12.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 4.3099999999999996 110.116 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.506 ' N ' ' OE1' ' A' ' 45' ' ' GLN . . . 156.98 -162.53 31.78 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.714 -1.354 . . . . 0.44 109.714 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 118' ' ' ALA . 3.8 t -82.88 109.36 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -1.133 . . . . 0.53000000000000003 109.719 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.615 HD23 HE21 ' A' ' 45' ' ' GLN . 6.4 mt -51.19 -38.62 53.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.76000000000000001 110.749 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.594 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -155.32 -166.0 2.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.759 -1.213 . . . . 0.34999999999999998 109.401 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER 175.53 147.95 0.09 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.162 -0.962 . . . . 0.94999999999999996 109.529 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.646 ' C ' HD12 ' A' ' 121' ' ' ILE . . . -147.05 146.35 29.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.958 -1.088 . . . . 0.52000000000000002 109.254 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.646 HD12 ' C ' ' A' ' 120' ' ' ALA . 3.4 mp -133.75 136.11 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.128 -0.982 . . . . 1.97 109.418 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -112.76 132.75 55.09 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.185 -0.947 . . . . 0.64000000000000001 109.109 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.4 p -116.37 57.22 0.77 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.128 -0.983 . . . . 3.29 109.383 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.85 60.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.628 -0.878 . . . . 1.1399999999999999 108.628 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.485 ' C ' ' HG3' ' A' ' 126' ' ' LYS . . . -130.57 164.06 23.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.804 -1.318 . . . . 0.47999999999999998 109.804 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.485 ' HG3' ' C ' ' A' ' 125' ' ' GLY . 15.3 mtpt -152.07 145.11 24.52 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.964 -1.124 . . . . 1.28 107.964 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.766 HD12 HG21 ' A' ' 104' ' ' VAL . 52.3 mt -106.39 140.89 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.407 -1.433 . . . . 0.37 110.319 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.627 ' HG3' HG23 ' A' ' 28' ' ' ILE . 11.1 mtt180 -128.95 179.69 5.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.444 -0.785 . . . . 1.54 109.275 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.5 t0 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.111 -0.947 . . . . 1.6399999999999999 109.649 -179.814 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.541 ' CB ' ' HG2' ' A' ' 17' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.324 0.583 . . . . 2.0899999999999999 109.889 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.474 ' O ' HG22 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -103.55 159.48 4.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.29 -0.881 . . . . 1.8700000000000001 109.13 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -70.12 119.23 14.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.086 -1.009 . . . . 1.4099999999999999 109.837 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.663 HG21 HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -139.6 140.16 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.383 -0.823 . . . . 1.6399999999999999 109.324 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.49 109.32 19.2 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.206 -0.934 . . . . 3.3599999999999999 109.385 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.438 ' CG ' ' HB ' ' A' ' 13' ' ' ILE . 1.4 m-20 -60.37 120.4 9.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 2.2400000000000002 108.943 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 p -95.59 23.12 6.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.03 -1.044 . . . . 0.34000000000000002 109.635 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 10' ' ' ASN . . . -96.52 -82.29 0.4 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.279 -0.888 . . . . 0.35999999999999999 109.829 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 0.8 OUTLIER 178.24 56.39 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.025 -0.67 . . . . 1.71 109.396 -178.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 10' ' ' ASN . 3.3 m120 67.26 51.61 0.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 4.7599999999999998 109.137 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.508 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -113.33 -61.72 1.7 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 1.0800000000000001 109.897 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.659 HG22 ' H ' ' A' ' 15' ' ' LYS . 1.1 mm -57.45 123.42 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.049 -1.032 . . . . 0.47999999999999998 109.939 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.606 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 4.6 mmpt? -71.77 -17.55 62.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.382 -0.824 . . . . 1.3300000000000001 108.808 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.659 ' H ' HG22 ' A' ' 13' ' ' ILE . 6.6 pttm 147.6 140.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.328 -1.36 . . . . 1.1799999999999999 107.328 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.803 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -115.27 128.91 72.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.271 -1.011 . . . . 0.40999999999999998 108.271 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.541 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -125.37 145.33 50.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.124 -0.985 . . . . 0.76000000000000001 110.434 -178.201 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 19' ' ' ASP . 50.2 t -98.24 165.63 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.403 -0.811 . . . . 1.02 108.918 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.553 ' N ' HG12 ' A' ' 18' ' ' VAL . 1.6 p-10 -47.29 -30.33 3.04 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.014 -1.054 . . . . 3.9300000000000002 108.919 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.405 ' N ' ' OD1' ' A' ' 19' ' ' ASP . . . 149.69 100.5 0.22 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.592 -1.29 . . . . 2.79 110.741 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 22' ' ' HIS . 3.5 t -128.48 -51.52 1.27 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.185 -1.185 . . . . 3.6600000000000001 109.139 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.489 ' CB ' ' O ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER 166.52 -84.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 4.2400000000000002 110.136 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 119.22 -107.45 1.38 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.571 -1.812 . . . . 1.23 108.571 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 23' ' ' GLY . 9.5 p -47.43 -40.99 19.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.97 -1.312 . . . . 1.4399999999999999 108.422 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.494 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -72.78 175.02 3.67 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 109.086 -0.709 . . . . 2.21 109.086 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 25' ' ' ASP . 34.8 Cg_endo -79.51 135.09 11.54 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.216 1.944 . . . . 1.3300000000000001 110.344 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.5 t -112.45 143.44 43.59 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.31 -0.996 . . . . 2.6800000000000002 108.31 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.513 HG23 ' HG3' ' A' ' 128' ' ' ARG . 46.9 mm -108.57 118.18 55.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.104 -0.998 . . . . 0.76000000000000001 110.247 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 127' ' ' ILE . 23.0 mt -98.79 118.36 45.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.245 -1.02 . . . . 0.83999999999999997 108.245 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -95.43 122.43 38.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.946 . . . . 1.1100000000000001 110.163 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.549 ' HA ' HG11 ' A' ' 94' ' ' VAL . 16.6 ptt180 -66.1 151.52 46.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 1.6100000000000001 109.475 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.9 -17.32 57.07 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.902 -1.679 . . . . 0.58999999999999997 108.902 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.443 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -107.45 148.68 37.65 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.282 -1.128 . . . . 1.26 109.143 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 36.3 Cg_endo -78.44 122.41 5.57 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.7 2.267 . . . . 0.31 111.147 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -100.55 122.55 43.43 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.149 -1.056 . . . . 0.32000000000000001 108.149 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.476 ' O ' HG13 ' A' ' 18' ' ' VAL . 64.2 m -100.7 137.55 38.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.898 -1.126 . . . . 0.67000000000000004 110.752 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -145.34 128.09 16.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.483 -0.76 . . . . 2.6899999999999999 109.05 179.402 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -105.07 129.58 53.46 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.547 -0.909 . . . . 1.3799999999999999 108.547 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.803 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -128.14 120.92 28.32 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.793 -1.192 . . . . 0.13 110.306 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.547 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 4.2 mt -91.16 140.95 29.32 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.332 -1.729 . . . . 0.58999999999999997 106.332 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.659 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 32.0 p90 -156.5 135.58 11.98 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.709 -1.196 . . . . 0.17000000000000001 109.778 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.6 OUTLIER -83.35 112.81 20.25 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.351 -0.981 . . . . 1.1699999999999999 108.351 179.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -46.22 112.48 0.49 Allowed 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.672 -0.862 . . . . 0.25 108.672 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 44' ' ' ASN . 2.3 p30 -84.93 10.94 10.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.112 -0.993 . . . . 0.89000000000000001 109.45 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.562 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 1.8 pt20 -167.93 145.38 4.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.459 -0.776 . . . . 0.73999999999999999 108.968 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 2.4 p30 -84.46 119.17 24.83 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.145 -0.972 . . . . 0.77000000000000002 109.36 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.489 ' O ' ' CA ' ' A' ' 79' ' ' PRO . 2.6 t -137.2 159.68 41.2 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.265 -0.897 . . . . 0.33000000000000002 109.249 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.62 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -100.49 -28.54 12.85 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.127 -1.435 . . . . 6.8300000000000001 107.127 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.465 ' OG1' ' OD1' ' A' ' 113' ' ' ASP . 34.2 p -111.51 138.9 47.43 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 122.146 0.974 . . . . 1.6699999999999999 109.522 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -142.88 152.66 42.34 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 108.85 -0.796 . . . . 0.73999999999999999 108.85 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HD2' ' HB ' ' A' ' 70' ' ' THR . 6.4 mtmt -142.59 141.07 31.91 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.18 -0.95 . . . . 0.42999999999999999 110.332 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 69' ' ' ASP . 11.0 tt -94.28 150.46 4.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.193 -1.41 . . . . 0.53000000000000003 107.193 177.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -140.15 116.27 10.47 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.079 -1.013 . . . . 1.1799999999999999 110.156 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.779 HD13 HG21 ' A' ' 68' ' ' ILE . 2.7 mp -112.97 114.08 45.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.074 -1.016 . . . . 0.29999999999999999 108.51 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -115.17 130.65 56.98 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.109 -0.994 . . . . 0.60999999999999999 109.271 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -107.92 128.45 54.64 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.192 -0.942 . . . . 0.28999999999999998 110.528 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.483 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . 42.7 t -97.26 150.55 20.81 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.537 -0.912 . . . . 1.5900000000000001 108.537 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 63' ' ' ILE . 35.8 mt -105.86 38.2 2.06 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.092 -1.005 . . . . 0.59999999999999998 109.961 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.44 12.24 5.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -0.872 . . . . 1.6899999999999999 109.456 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.26 -44.34 0.06 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.461 -1.456 . . . . 0.88 109.461 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.92 111.31 23.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -1.168 . . . . 4.0300000000000002 108.997 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -79.82 133.43 36.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.021 -1.049 . . . . 2.04 109.83 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.683 HD11 HD11 ' A' ' 58' ' ' LEU . 98.0 mt -123.87 167.24 17.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.177 -0.952 . . . . 0.80000000000000004 109.444 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.669 ' N ' HG22 ' A' ' 63' ' ' ILE . 35.9 m-20 -114.63 115.24 26.81 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.754 -1.573 . . . . 1.03 106.754 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.045 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 2.8 t -83.36 115.17 57.86 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.946 . . . . 0.34000000000000002 111.458 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.528 ' O ' HG23 ' A' ' 68' ' ' ILE . 37.5 Cg_endo -85.04 -156.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 123.1 2.533 . . . . 0.22 109.342 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.62 35.83 82.73 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.286 -1.126 . . . . 0.71999999999999997 110.286 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.779 HG21 HD13 ' A' ' 54' ' ' ILE . 18.2 pt -127.06 -156.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.157 -1.201 . . . . 0.29999999999999999 108.83 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.733 ' O ' HG22 ' A' ' 52' ' ' ILE . 38.7 t0 -108.58 108.75 19.76 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.244 -0.91 . . . . 1.4099999999999999 109.464 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 51' ' ' LYS . 1.4 p -88.07 46.56 1.4 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.628 -1.249 . . . . 0.41999999999999998 107.628 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 23.1 t30 175.49 83.54 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.645 -1.613 . . . . 1.3899999999999999 106.645 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.521 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -66.24 1.6 1.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.53 -0.731 . . . . 0.67000000000000004 111.822 -177.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 20.2 m -61.92 -13.65 26.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.817 -1.177 . . . . 2.3700000000000001 109.674 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -81.84 -14.69 55.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.111 -0.993 . . . . 0.85999999999999999 110.156 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.701 ' CE2' ' CD1' ' A' ' 90' ' ' TYR . 19.7 m-85 -122.54 -15.27 7.6 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.367 -0.833 . . . . 1.1100000000000001 109.739 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.622 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 3.1 m -122.15 169.05 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.35 -0.982 . . . . 0.75 108.35 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.614 ' HG2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -100.76 87.59 3.37 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.221 -0.925 . . . . 1.8100000000000001 112.248 -178.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.54 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 20.4 p -87.62 157.44 52.43 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.445 -1.41 . . . . 0.88 107.91 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.62 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 21.8 Cg_endo -65.08 125.19 5.16 Favored 'Cis proline' 0 C--N 1.314 -1.261 0 O-C-N 123.105 1.055 . . . . 0.54000000000000004 112.947 2.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.875 HD23 ' CE2' ' A' ' 86' ' ' TYR . 13.8 mt -70.75 117.06 11.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.531 -1.655 . . . . 0.60999999999999999 106.531 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 43.6 t -83.55 139.84 17.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 C-N-CA 119.606 -0.838 . . . . 0.56000000000000005 110.926 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.562 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 16.8 ttpt -66.48 108.51 2.42 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.644 0.735 . . . . 0.83999999999999997 109.562 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.66 -19.14 5.93 Favored Glycine 0 C--N 1.298 -1.555 0 N-CA-C 109.519 -1.432 . . . . 0.35999999999999999 109.519 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.601 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 4.0 tp60 -97.91 152.06 19.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.169 -1.195 . . . . 0.60999999999999999 107.799 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -104.96 143.63 32.91 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 118.99 -1.084 . . . . 0.28000000000000003 108.511 179.388 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.875 ' CE2' HD23 ' A' ' 80' ' ' LEU . 25.9 m-85 -121.05 150.06 41.76 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.279 -0.888 . . . . 0.76000000000000001 109.606 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.547 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 8.8 p-10 -119.76 109.85 16.1 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.951 -1.129 . . . . 0.62 107.951 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.622 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 6.9 tt -106.43 122.12 59.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.007 0.908 . . . . 0.35999999999999999 111.839 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -101.85 112.58 25.25 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 104.637 -2.357 . . . . 1.0 104.637 176.033 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.701 ' CD1' ' CE2' ' A' ' 75' ' ' PHE . 31.5 t80 -127.51 139.5 52.74 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.734 -1.229 . . . . 0.46999999999999997 112.405 -175.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.66 106.83 18.83 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.202 -1.407 . . . . 0.54000000000000004 107.202 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.045 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 29.9 t90 -82.2 94.32 7.26 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.494 0.664 . . . . 0.48999999999999999 109.832 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -67.71 109.82 3.49 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.487 -0.758 . . . . 2.8799999999999999 109.35 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.649 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 12.4 t -60.2 142.97 89.4 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.124 -1.065 . . . . 1.1100000000000001 108.124 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.649 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 23.7 Cg_endo -66.97 -11.84 33.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.508 2.139 . . . . 3.7999999999999998 111.755 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 0.0 OUTLIER 76.21 -7.23 1.86 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 2.98 109.485 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.525 ' O ' ' C ' ' A' ' 98' ' ' ALA . 12.7 pt -93.5 -27.97 4.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 O-C-N 121.114 -0.991 . . . . 0.55000000000000004 108.444 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.525 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -32.84 117.6 0.43 Allowed Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 108.575 -0.898 . . . . 0.51000000000000001 108.575 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.594 ' O ' ' N ' ' A' ' 101' ' ' SER . 37.3 Cg_endo -83.86 138.94 8.36 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.747 2.298 . . . . 0.68999999999999995 110.015 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.531 ' HE3' ' HG2' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -50.22 90.47 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.897 -1.149 . . . . 3.2799999999999998 107.897 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.655 ' HB3' HG23 ' A' ' 104' ' ' VAL . 1.8 t -94.32 124.18 38.18 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.506 -0.746 . . . . 0.56000000000000005 109.271 -178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -43.13 -45.3 5.39 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.591 -0.892 . . . . 1.75 108.591 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.429 ' N ' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -131.44 141.48 49.82 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.497 -0.752 . . . . 0.93000000000000005 109.195 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.897 HG21 ' CD1' ' A' ' 127' ' ' ILE . 2.1 t -131.41 145.4 35.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.268 -0.895 . . . . 0.68000000000000005 109.497 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 57' ' ' SER . 73.4 t -126.27 114.72 39.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.878 -1.156 . . . . 0.32000000000000001 107.878 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.496 HG12 ' CG2' ' A' ' 54' ' ' ILE . 1.8 t -95.66 137.29 24.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.92 -1.112 . . . . 0.39000000000000001 109.372 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.608 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 34.3 m -118.72 112.24 19.51 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.15 -0.969 . . . . 0.44 109.584 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -92.7 125.25 45.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 106.647 -1.612 . . . . 0.53000000000000003 106.647 178.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.8 ' CD ' HD11 ' A' ' 111' ' ' ILE . 9.0 ttmt -141.26 131.51 24.97 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.134 -1.427 . . . . 2.0699999999999998 112.117 -176.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.872 ' C ' HD12 ' A' ' 111' ' ' ILE . 9.0 mt -104.16 138.15 41.07 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.209 -1.404 . . . . 0.78000000000000003 107.209 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.872 HD12 ' C ' ' A' ' 110' ' ' LEU . 3.2 mp -129.69 120.57 50.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.101 -1.0 . . . . 0.28000000000000003 109.922 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.446 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -92.74 -145.95 17.92 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.754 -1.738 . . . . 0.85999999999999999 108.754 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.465 ' OD1' ' OG1' ' A' ' 49' ' ' THR . 0.1 OUTLIER -99.93 -1.5 37.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.128 -1.219 . . . . 1.24 109.941 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 114' ' ' ASN . 0.4 OUTLIER -114.68 -10.5 12.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.97 -1.081 . . . . 4.6699999999999999 110.247 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 111' ' ' ILE . . . 159.32 -148.0 16.2 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.521 -1.323 . . . . 0.29999999999999999 110.13 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.64 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 2.1 t -91.99 109.87 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -1.136 . . . . 0.25 110.13 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 110' ' ' LEU . 41.0 mt -52.85 -43.67 66.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.446 -0.784 . . . . 0.27000000000000002 109.782 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.481 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -158.71 -178.1 7.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.093 -1.005 . . . . 0.68000000000000005 109.357 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.9 OUTLIER -166.36 156.07 11.75 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.044 -1.035 . . . . 0.62 110.191 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.4 149.63 28.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.105 -0.997 . . . . 0.46999999999999997 109.833 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.2 mt -138.1 121.08 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.068 -1.02 . . . . 0.83999999999999997 109.794 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.27 140.82 30.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.995 -1.065 . . . . 0.91000000000000003 108.923 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 55.1 p -125.02 171.81 9.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.134 -0.979 . . . . 2.75 109.873 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 61.55 29.5 18.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -0.811 . . . . 2.5600000000000001 109.513 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -98.93 162.85 20.27 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.728 -1.349 . . . . 0.40999999999999998 109.728 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 11.2 mtmt -151.2 134.19 15.86 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.465 -1.021 . . . . 0.68000000000000005 108.308 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.897 ' CD1' HG21 ' A' ' 104' ' ' VAL . 55.9 mt -99.22 141.5 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.692 -1.255 . . . . 0.72999999999999998 110.218 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.531 ' HG2' ' HE3' ' A' ' 100' ' ' LYS . 12.4 mtm180 -132.5 177.2 7.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.535 -0.728 . . . . 2.1299999999999999 109.299 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.049 -0.977 . . . . 2.3999999999999999 109.457 179.572 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.549 ' CA ' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.514 0.673 . . . . 2.7200000000000002 110.031 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.18 163.95 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.489 -0.757 . . . . 1.8600000000000001 109.096 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -71.74 119.02 15.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.103 -0.998 . . . . 2.1499999999999999 109.546 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.09 173.34 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.382 -0.824 . . . . 1.47 109.156 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.32 108.56 13.38 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.262 -0.899 . . . . 5.6299999999999999 109.616 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -77.41 118.88 20.3 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.213 -0.929 . . . . 2.6000000000000001 108.81 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.1 p -98.65 13.54 31.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.004 -1.06 . . . . 1.01 110.107 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 12' ' ' GLU . . . -93.65 -72.99 0.58 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.946 -1.096 . . . . 0.83999999999999997 109.425 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.472 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 19.8 t-20 172.5 63.48 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.762 -1.199 . . . . 5.0 107.762 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 11' ' ' ASN . 47.1 t-20 60.45 18.4 8.16 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.861 -1.163 . . . . 1.8600000000000001 107.861 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -57.79 -81.67 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.728 -0.607 . . . . 3.5899999999999999 109.57 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.605 HD13 ' HB1' ' A' ' 39' ' ' ALA . 0.9 OUTLIER -56.43 125.73 12.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.32 -0.952 . . . . 0.48999999999999999 109.423 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.612 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 1.2 mmtt -75.57 -24.89 56.68 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.369 -0.832 . . . . 0.84999999999999998 108.866 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.89 ' HD3' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER 167.88 126.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.372 -0.973 . . . . 2.5899999999999999 108.372 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.958 HG23 ' CB ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -105.26 125.14 60.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.092 -1.077 . . . . 0.5 108.092 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.549 ' HG2' ' CA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -111.84 150.22 30.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.962 -1.086 . . . . 1.0700000000000001 110.811 -177.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 19' ' ' ASP . 46.6 t -109.48 163.52 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.3 -1.0 . . . . 0.81000000000000005 108.3 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.515 ' N ' HG12 ' A' ' 18' ' ' VAL . 4.7 t0 -86.49 64.12 8.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.07 -1.018 . . . . 1.4399999999999999 109.713 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 21' ' ' CYS . . . 163.02 -95.71 0.13 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.881 -1.288 . . . . 2.5600000000000001 109.881 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.414 ' C ' ' O ' ' A' ' 20' ' ' GLY . 93.5 m -42.39 155.11 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.339 -1.095 . . . . 1.52 109.974 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.585 ' CG ' ' O ' ' A' ' 22' ' ' HIS . 13.9 p-80 -162.87 107.66 1.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.324 -0.86 . . . . 4.1900000000000004 110.103 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.59 -148.45 16.69 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.912 -1.275 . . . . 3.0299999999999998 109.912 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.0 t -87.4 21.82 2.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.338 -1.095 . . . . 2.02 109.729 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.59 157.29 80.08 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.13 -0.982 . . . . 2.3300000000000001 109.313 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.8 158.84 31.47 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.743 2.295 . . . . 0.96999999999999997 110.257 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.5 141.91 50.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 2.6699999999999999 109.421 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.691 HG22 ' CD2' ' A' ' 30' ' ' HIS . 51.0 mm -113.0 113.31 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.061 -1.024 . . . . 0.81000000000000005 109.065 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.522 HG12 ' CE1' ' A' ' 35' ' ' PHE . 32.5 mt -99.22 112.34 31.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.201 -0.937 . . . . 0.68999999999999995 109.031 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.691 ' CD2' HG22 ' A' ' 28' ' ' ILE . 47.3 m170 -88.35 105.16 17.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.057 -1.09 . . . . 1.95 108.057 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.48 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 8.1 ptt180 -45.54 123.31 4.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.992 -1.068 . . . . 0.71999999999999997 109.822 -178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.577 ' HA2' ' CD ' ' A' ' 96' ' ' LYS . . . 116.87 -11.85 15.13 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.058 -1.617 . . . . 0.17000000000000001 109.058 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -103.87 149.97 37.73 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.355 -1.085 . . . . 1.3500000000000001 108.754 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 36.5 Cg_endo -79.44 121.66 4.83 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 122.379 2.053 . . . . 0.38 110.718 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.522 ' CE1' HG12 ' A' ' 29' ' ' ILE . 2.3 t80 -97.12 120.86 38.25 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.445 -1.317 . . . . 1.01 107.445 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.663 ' C ' HD13 ' A' ' 37' ' ' LEU . 73.3 m -100.99 127.32 47.54 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.684 -1.26 . . . . 0.58999999999999997 110.68 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.949 HD13 ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -138.19 124.12 20.08 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.96 -0.755 . . . . 0.67000000000000004 108.96 178.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -104.33 135.88 44.95 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.699 -1.223 . . . . 1.71 107.699 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.958 ' CB ' HG23 ' A' ' 16' ' ' VAL . . . -133.04 123.19 25.34 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.841 -1.143 . . . . 0.10000000000000001 110.562 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.89 HD12 ' HD3' ' A' ' 15' ' ' LYS . 8.7 mt -88.39 137.21 32.53 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.56 -2.015 . . . . 0.23000000000000001 105.56 177.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 110' ' ' LEU . 34.8 p90 -152.12 134.81 15.46 Favored 'General case' 0 C--N 1.288 -2.107 0 C-N-CA 118.171 -1.412 . . . . 0.22 110.168 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.8 OUTLIER -82.72 107.81 15.63 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.446 -0.946 . . . . 0.66000000000000003 108.446 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -45.67 114.36 0.75 Allowed 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.136 -0.69 . . . . 0.35999999999999999 109.136 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 44' ' ' ASN . 1.3 p30 -84.24 10.6 9.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.056 -1.027 . . . . 0.76000000000000001 109.23 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.578 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 8.4 pt20 -166.53 145.02 5.43 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.312 -0.868 . . . . 0.82999999999999996 109.253 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 9.4 p30 -83.93 110.04 18.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.76000000000000001 109.12 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.614 HG21 HD11 ' A' ' 117' ' ' LEU . 1.5 t -126.7 151.15 48.51 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.189 -0.944 . . . . 0.32000000000000001 109.795 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.783 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 1.1 mmmt -86.39 -20.61 27.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.332 -0.855 . . . . 0.39000000000000001 109.156 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 p -132.29 138.91 48.02 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.109 0.957 . . . . 0.25 110.137 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -139.34 148.12 42.48 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.675 -1.232 . . . . 0.58999999999999997 107.675 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HD2' ' HA ' ' A' ' 70' ' ' THR . 1.0 OUTLIER -141.12 142.31 34.11 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.251 -0.906 . . . . 2.02 110.339 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.669 ' HA ' HD23 ' A' ' 110' ' ' LEU . 5.3 tt -91.84 149.47 4.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 107.622 -1.251 . . . . 0.59999999999999998 107.622 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.442 ' OE2' ' N ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -145.01 117.24 8.41 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.598 -0.89 . . . . 4.8399999999999999 108.598 -177.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.772 HD12 HD13 ' A' ' 68' ' ' ILE . 3.4 mp -109.67 134.95 50.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.806 -1.184 . . . . 0.59999999999999998 110.596 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -125.17 131.65 53.18 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.161 -0.962 . . . . 1.8700000000000001 108.952 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.25 146.96 34.75 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.71 -1.244 . . . . 0.81999999999999995 111.4 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.423 ' O ' HD23 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -107.24 150.86 26.18 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.033 -1.099 . . . . 0.71999999999999997 108.033 178.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 63' ' ' ILE . 44.4 mt -120.69 61.33 0.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.864 -1.148 . . . . 0.68999999999999995 110.486 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 58' ' ' LEU . 5.7 t0 41.71 26.72 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.593 -0.692 . . . . 1.1000000000000001 110.081 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 158.24 -49.35 0.42 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.597 -1.401 . . . . 0.34000000000000002 109.597 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.491 ' HG ' HD12 ' A' ' 58' ' ' LEU . 8.2 tp -97.93 113.03 24.76 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.394 -1.062 . . . . 0.78000000000000003 108.873 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -93.08 123.25 36.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.14 -0.975 . . . . 5.4699999999999998 109.636 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.65 HD12 HD11 ' A' ' 58' ' ' LEU . 12.8 mt -118.15 169.36 8.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 122.15 0.976 . . . . 0.54000000000000004 109.348 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.611 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 18.9 m-20 -108.52 134.56 51.13 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.131 -1.433 . . . . 0.62 107.131 177.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.96 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -104.05 107.82 58.2 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.839 -1.163 . . . . 0.85999999999999999 110.632 -178.44 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.3 Cg_endo -81.32 -154.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 123.151 2.567 . . . . 0.55000000000000004 109.914 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.85 34.09 86.11 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.333 -1.507 . . . . 0.89000000000000001 109.333 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.772 HD13 HD12 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -108.04 179.84 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.354 -1.086 . . . . 2.5899999999999999 109.378 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.599 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -86.01 -1.1 57.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.92 -1.112 . . . . 3.1499999999999999 109.318 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.573 ' HA ' ' HD2' ' A' ' 51' ' ' LYS . 29.3 p 30.19 36.36 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.678 0.752 . . . . 0.64000000000000001 109.921 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 14.7 t-20 174.56 90.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.685 -1.228 . . . . 1.3500000000000001 107.685 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.857 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -75.29 2.05 12.12 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.589 -0.694 . . . . 0.53000000000000003 110.973 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.461 ' HA ' HG22 ' A' ' 76' ' ' VAL . 84.2 m -66.79 -9.42 36.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.015 -1.053 . . . . 2.6699999999999999 109.229 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.14 -17.42 35.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.90000000000000002 109.522 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 75' ' ' PHE . 2.8 m-85 -116.87 -12.01 10.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 0.81999999999999995 109.111 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.88 HG23 HD21 ' A' ' 80' ' ' LEU . 1.7 m -120.99 165.73 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.362 -0.977 . . . . 0.47999999999999998 108.362 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.634 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -90.0 98.87 12.02 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.921 -1.112 . . . . 2.3100000000000001 110.864 -178.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.492 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 18.2 m -91.48 152.23 43.38 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.219 -0.926 . . . . 2.79 108.674 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.783 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.2 Cg_endo -70.13 139.26 54.62 Favored 'Cis proline' 0 C--N 1.312 -1.383 0 C-N-CA 124.117 -1.201 . . . . 0.40000000000000002 112.332 0.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.88 HD21 HG23 ' A' ' 76' ' ' VAL . 13.1 mt -77.86 112.14 14.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.625 -1.62 . . . . 0.90000000000000002 106.625 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 10.9 t -82.92 144.95 9.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 121.841 0.829 . . . . 0.62 110.946 -177.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.578 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 8.2 ttpt -68.53 117.42 10.26 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.703 0.763 . . . . 0.69999999999999996 109.754 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 119.43 -11.08 11.41 Favored Glycine 0 C--N 1.296 -1.675 0 N-CA-C 109.514 -1.434 . . . . 0.23999999999999999 109.514 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.527 ' HG3' ' N ' ' A' ' 85' ' ' GLN . 4.6 tp60 -107.8 157.02 18.5 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.144 -1.058 . . . . 0.55000000000000004 108.144 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.527 ' N ' ' HG3' ' A' ' 84' ' ' GLN . 1.5 tt0 -109.93 144.29 38.65 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.049 -1.032 . . . . 1.4399999999999999 108.438 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.634 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 38.6 m-85 -125.75 145.95 49.98 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.201 -0.937 . . . . 0.34999999999999998 110.033 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.569 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -111.45 113.62 26.18 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.759 -0.83 . . . . 1.71 108.759 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.857 HD12 ' HB1' ' A' ' 72' ' ' ALA . 2.3 tt -109.87 117.36 54.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.058 -1.026 . . . . 0.38 111.199 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -94.35 114.91 27.04 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.624 -2.362 . . . . 1.3400000000000001 104.624 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 27.8 t80 -126.09 139.64 53.22 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.113 -1.435 . . . . 0.56000000000000005 113.366 -175.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.496 ' O ' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -93.08 131.67 37.9 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 105.119 -2.178 . . . . 0.64000000000000001 105.119 175.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.96 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 29.9 t90 -109.92 96.81 6.48 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 121.351 -0.843 . . . . 0.77000000000000002 109.826 -176.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -68.32 104.49 1.87 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.347 0.594 . . . . 2.4300000000000002 109.868 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.642 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 30.0 t -61.55 143.83 93.11 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.324 -0.991 . . . . 1.6399999999999999 108.324 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.723 ' HD3' HG12 ' A' ' 65' ' ' VAL . 23.4 Cg_endo -64.55 -6.33 11.87 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.377 2.052 . . . . 3.9700000000000002 112.182 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.577 ' CD ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER 67.98 -4.13 1.08 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.998 -1.064 . . . . 1.48 110.425 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.528 ' O ' ' C ' ' A' ' 98' ' ' ALA . 16.2 pt -94.49 -26.52 4.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 O-C-N 120.789 -1.195 . . . . 0.55000000000000004 107.948 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -30.59 118.49 0.34 Allowed Pre-proline 0 N--CA 1.488 1.47 0 CA-C-N 115.813 -0.63 . . . . 0.5 109.376 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.617 ' HG2' HD13 ' A' ' 58' ' ' LEU . 35.8 Cg_endo -82.99 131.46 5.98 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.689 2.259 . . . . 0.54000000000000004 108.473 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.609 ' CG ' ' HA ' ' A' ' 128' ' ' ARG . 1.6 ttpt -48.33 91.03 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.334 -0.946 . . . . 1.3999999999999999 108.952 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 99' ' ' PRO . 1.2 t -94.16 116.91 29.38 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.842 -0.799 . . . . 0.37 108.842 -179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 101' ' ' SER . 5.4 pt-20 -35.03 -47.5 0.37 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.805 -0.559 . . . . 1.4199999999999999 110.54 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -129.06 140.46 51.59 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.192 -0.942 . . . . 1.45 109.154 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.988 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.9 OUTLIER -131.75 143.58 39.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.358 -0.839 . . . . 1.0 109.831 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.873 HG13 ' O ' ' A' ' 122' ' ' ALA . 11.8 t -124.6 117.1 49.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.791 -1.559 . . . . 0.90000000000000002 106.791 178.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.15 141.68 14.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 C-N-CA 119.466 -0.893 . . . . 0.46000000000000002 110.594 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.607 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 51.7 m -116.15 138.27 51.41 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.387 -0.968 . . . . 1.02 108.387 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER -119.63 127.49 75.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 106.738 -1.579 . . . . 0.38 106.738 178.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.625 ' HD2' HD11 ' A' ' 111' ' ' ILE . 3.9 ttmt -140.14 129.1 23.43 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.1 -1.44 . . . . 2.4100000000000001 111.693 -177.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.669 HD23 ' HA ' ' A' ' 52' ' ' ILE . 6.5 mt -103.17 138.7 39.63 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.98 -1.489 . . . . 0.39000000000000001 106.98 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.625 HD11 ' HD2' ' A' ' 109' ' ' LYS . 4.5 mp -133.25 115.87 24.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.967 -1.083 . . . . 0.38 109.731 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.469 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -87.87 -133.7 4.25 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.082 -1.607 . . . . 0.28000000000000003 109.082 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -110.53 -2.36 16.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -1.146 . . . . 2.9100000000000001 109.709 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.46 -0.09 12.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.073 -1.017 . . . . 1.8600000000000001 110.257 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 151.37 -157.31 27.14 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.916 -1.274 . . . . 0.33000000000000002 109.916 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 118' ' ' ALA . 21.3 t -86.48 110.54 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -1.14 . . . . 0.85999999999999999 109.626 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.614 HD11 HG21 ' A' ' 47' ' ' THR . 20.2 mt -58.03 -39.35 78.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.439 -0.788 . . . . 0.38 110.735 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.583 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -150.43 177.2 10.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.721 -1.237 . . . . 0.64000000000000001 109.534 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -170.04 148.07 3.35 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.875 -1.141 . . . . 0.63 109.588 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -151.76 149.66 29.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.014 -1.054 . . . . 0.51000000000000001 109.743 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 85.0 mt -136.71 119.86 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.099 -1.001 . . . . 0.63 109.39 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.873 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -88.36 150.88 22.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.857 -1.152 . . . . 0.55000000000000004 109.934 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.3 t -111.61 3.95 18.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.23 -0.919 . . . . 2.7599999999999998 110.424 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.421 ' CD2' ' C ' ' A' ' 124' ' ' HIS . 1.4 p-80 -133.46 173.81 11.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.889 -1.132 . . . . 8.0800000000000001 109.561 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 129.21 155.05 8.4 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.748 -1.215 . . . . 1.0900000000000001 110.369 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 6.0 mtmp? -152.08 141.14 21.23 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.146 -1.427 . . . . 2.79 107.146 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.988 ' CD1' HG21 ' A' ' 104' ' ' VAL . 81.6 mt -104.35 140.75 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.429 -1.42 . . . . 0.57999999999999996 111.147 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.609 ' HA ' ' CG ' ' A' ' 100' ' ' LYS . 4.4 mtt85 -127.85 174.82 8.83 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.274 -1.01 . . . . 3.1400000000000001 108.274 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 120.967 -1.083 . . . . 0.96999999999999997 109.527 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.258 0.551 . . . . 1.96 109.525 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -77.64 152.72 33.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 1.75 109.39 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.546 ' HA ' ' CA ' ' A' ' 23' ' ' GLY . 1.3 m -106.29 165.48 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.97999999999999998 109.609 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -87.1 119.19 27.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 1.5900000000000001 109.509 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 m -150.88 157.04 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.72999999999999998 109.224 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.04 108.57 14.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 3.4700000000000002 109.383 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.418 ' CG ' ' HB ' ' A' ' 13' ' ' ILE . 2.3 m-20 -52.49 114.76 1.48 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.27 -0.894 . . . . 2.3500000000000001 109.354 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -85.32 9.55 15.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.76000000000000001 109.326 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.517 ' N ' ' HB3' ' A' ' 119' ' ' CYS . . . -90.55 -69.93 0.7 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.905 . . . . 0.60999999999999999 109.702 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 9' ' ' ALA . 0.8 OUTLIER 171.74 57.67 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.461 -0.775 . . . . 2.3999999999999999 109.252 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 64.83 13.66 8.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.126 -0.984 . . . . 2.2000000000000002 108.924 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' O ' ' CE ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -63.17 -67.1 0.45 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.366 -0.834 . . . . 1.71 109.771 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -56.78 130.28 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.40999999999999998 109.478 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 8.8 mmpt? -88.12 -13.95 40.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.325 -0.86 . . . . 1.1299999999999999 109.454 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.2 ttpt 161.86 128.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 1.6899999999999999 109.585 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.741 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -116.85 127.01 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.38 -0.825 . . . . 0.68000000000000005 108.958 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.536 ' CB ' ' HA ' ' A' ' 2' ' ' GLN . 0.2 OUTLIER -122.53 156.67 33.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.059 -1.025 . . . . 0.91000000000000003 110.191 -179.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.091 HG11 ' CE2' ' A' ' 35' ' ' PHE . 52.8 t -127.63 148.54 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.55000000000000004 109.176 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.66 75.54 7.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 2.3199999999999998 109.424 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.75 -69.75 0.14 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.89 -1.284 . . . . 1.23 109.89 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.7 t -67.88 168.1 12.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -1.191 . . . . 1.6699999999999999 109.841 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -107.22 -9.3 16.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 3.2599999999999998 109.68 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.546 ' CA ' ' HA ' ' A' ' 3' ' ' VAL . . . 103.37 -104.21 2.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.008 -1.237 . . . . 1.8200000000000001 110.008 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' GLY . 9.3 t -41.71 -39.66 1.75 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.421 -1.047 . . . . 1.75 109.683 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.503 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -68.52 173.18 3.63 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 1.75 109.258 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 35.4 Cg_endo -77.67 152.62 29.47 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.715 2.277 . . . . 1.03 110.333 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.4 m -116.42 130.02 56.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 1.23 109.382 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.51 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 36.8 mm -106.06 102.57 14.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.072 -1.018 . . . . 0.56000000000000005 108.81 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 mp -88.7 118.23 33.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.163 -0.961 . . . . 0.47999999999999998 109.141 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.452 ' CD2' ' N ' ' A' ' 30' ' ' HIS . 8.2 m-70 -89.04 102.53 15.18 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.351 -0.843 . . . . 1.04 109.044 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 5.2 ptt180 -43.1 138.89 1.98 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.873 . . . . 1.3600000000000001 110.064 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' CA ' ' HD2' ' A' ' 96' ' ' LYS . . . 97.61 -14.63 62.97 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.084 -1.206 . . . . 0.51000000000000001 110.084 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.581 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -103.14 150.96 38.39 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.247 . . . . 1.72 109.812 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 36.5 Cg_endo -79.94 113.56 3.02 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.902 2.401 . . . . 0.46000000000000002 111.138 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 1.091 ' CE2' HG11 ' A' ' 18' ' ' VAL . 5.8 t80 -99.4 122.1 42.04 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.428 -1.323 . . . . 0.63 107.428 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 1.015 ' C ' HD13 ' A' ' 37' ' ' LEU . 71.7 m -102.76 138.79 39.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.857 -1.152 . . . . 0.60999999999999999 111.075 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.015 HD13 ' C ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -140.21 128.51 22.53 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.086 -0.709 . . . . 2.02 109.086 178.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.525 ' HG3' ' HA ' ' A' ' 89' ' ' LYS . 2.4 tt0 -104.97 126.26 51.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.835 -1.166 . . . . 1.3400000000000001 108.076 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.741 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -124.72 122.8 38.51 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.733 -1.23 . . . . 0.32000000000000001 110.668 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 7.9 mt -89.59 144.01 26.35 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.5 -1.667 . . . . 0.51000000000000001 106.5 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.637 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 32.7 p90 -159.87 138.4 10.49 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.702 -1.249 . . . . 0.22 109.877 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.6 m-20 -85.05 113.59 21.58 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.346 -0.942 . . . . 1.1499999999999999 108.698 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -44.71 113.28 0.53 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.046 -0.724 . . . . 0.20999999999999999 109.046 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 117' ' ' LEU . 4.9 p30 -81.62 7.75 11.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.237 -0.914 . . . . 1.1200000000000001 109.554 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 1.1 pt20 -170.5 163.88 8.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.213 -0.929 . . . . 0.75 109.835 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 8.9 p30 -92.38 121.77 34.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 1.75 109.309 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.484 HG21 ' HA3' ' A' ' 112' ' ' GLY . 2.5 t -141.83 156.33 45.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.177 -0.952 . . . . 0.37 109.78 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.691 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -95.68 -14.5 23.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -0.847 . . . . 1.9099999999999999 109.499 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.408 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 6.1 p -141.3 137.88 32.77 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.947 0.879 . . . . 0.73999999999999999 109.862 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -129.62 152.69 48.87 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.482 -0.932 . . . . 0.40999999999999998 108.482 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.552 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 1.3 mtmt -133.93 140.36 46.73 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.048 -1.061 . . . . 0.75 110.505 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.699 ' HA ' HD23 ' A' ' 110' ' ' LEU . 3.1 tt -94.39 149.01 4.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.617 -1.253 . . . . 0.54000000000000004 107.617 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -137.24 115.06 11.37 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.216 -0.927 . . . . 1.48 109.758 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.841 HD12 ' N ' ' A' ' 54' ' ' ILE . 2.1 mp -113.99 117.79 56.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 120.971 -1.081 . . . . 0.35999999999999999 108.948 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.471 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 21.0 mttt -119.71 131.16 55.33 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.18 -0.95 . . . . 1.25 109.396 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.62 133.37 52.16 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.173 -0.954 . . . . 0.53000000000000003 110.424 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -98.49 151.32 20.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 1.6399999999999999 109.085 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.815 HD11 HD12 ' A' ' 63' ' ' ILE . 34.3 mt -109.2 49.16 0.83 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.091 -1.005 . . . . 0.90000000000000002 109.86 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 58' ' ' LEU . 20.7 t0 44.4 26.64 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.897 . . . . 1.46 109.305 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.91 -55.16 0.17 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.319 -1.513 . . . . 0.94999999999999996 109.319 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 62' ' ' GLU . 1.2 tp -102.99 113.94 27.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -1.133 . . . . 2.0699999999999998 109.141 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.58 ' N ' HD12 ' A' ' 61' ' ' LEU . 37.0 tt0 -81.62 133.6 35.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.955 . . . . 2.4500000000000002 109.398 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.815 HD12 HD11 ' A' ' 58' ' ' LEU . 40.8 mt -126.66 168.69 19.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.008 0.908 . . . . 1.5900000000000001 109.215 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.594 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 63.3 m-20 -111.87 141.85 44.98 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.732 -1.21 . . . . 1.8500000000000001 107.732 178.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.056 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 6.2 t -108.32 105.39 56.55 Favored Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 121.03 -1.044 . . . . 0.45000000000000001 110.472 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 37.3 Cg_endo -82.56 -156.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.475 2.784 . . . . 0.44 110.189 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.37 17.58 47.34 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.576 -1.41 . . . . 0.85999999999999999 109.576 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.704 HG21 HD13 ' A' ' 54' ' ' ILE . 50.1 pt -104.67 -167.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -1.138 . . . . 0.62 109.432 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.598 ' O ' HG22 ' A' ' 52' ' ' ILE . 24.3 t0 -98.8 109.75 22.46 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.362 -0.836 . . . . 0.96999999999999997 109.382 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.552 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 1.2 p -86.74 47.47 1.49 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.283 -0.886 . . . . 0.45000000000000001 108.83 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 54.5 t-20 177.75 81.86 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.858 -1.164 . . . . 1.23 107.858 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.691 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -65.93 -5.57 9.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.572 -0.705 . . . . 0.32000000000000001 111.822 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.574 ' HA ' HG22 ' A' ' 76' ' ' VAL . 1.3 t -64.39 -12.13 39.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.587 -1.321 . . . . 1.1799999999999999 109.058 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.81 -23.19 55.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.051 -1.031 . . . . 1.0900000000000001 109.845 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.436 ' HB2' HG13 ' A' ' 88' ' ' ILE . 79.4 m-85 -110.27 -24.49 10.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.52000000000000002 109.098 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.762 ' CG2' HD21 ' A' ' 80' ' ' LEU . 1.2 m -107.66 162.6 5.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.122 -1.066 . . . . 0.34999999999999998 108.122 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.633 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -88.54 93.82 9.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.931 -1.106 . . . . 2.1699999999999999 111.222 -178.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.484 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 14.3 p -88.92 153.91 49.67 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 107.544 -1.28 . . . . 0.89000000000000001 107.544 177.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.691 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 26.3 Cg_endo -69.92 134.8 31.22 Favored 'Cis proline' 0 C--N 1.311 -1.396 0 C-N-CA 124.206 -1.164 . . . . 0.32000000000000001 112.346 2.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.843 HD23 ' CE2' ' A' ' 86' ' ' TYR . 7.3 mt -76.13 116.97 17.35 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.263 -1.384 . . . . 0.59999999999999998 107.263 178.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.7 t -89.06 136.94 22.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 121.736 0.779 . . . . 0.42999999999999999 110.543 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 2.6 ttmt -58.15 118.62 5.66 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.73 0.776 . . . . 1.45 110.269 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.51 -15.11 13.01 Favored Glycine 0 N--CA 1.479 1.549 0 C-N-CA 119.723 -1.227 . . . . 0.31 110.355 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.607 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 4.9 tp60 -102.43 156.68 17.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.042 -1.269 . . . . 1.05 108.044 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -109.26 149.28 29.66 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.107 -0.995 . . . . 1.1000000000000001 108.502 179.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.843 ' CE2' HD23 ' A' ' 80' ' ' LEU . 32.4 m-85 -131.5 149.64 52.45 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.289 -0.882 . . . . 0.40000000000000002 110.001 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.533 ' HB3' HD23 ' A' ' 40' ' ' LEU . 3.3 p30 -117.43 115.03 24.38 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.162 -1.051 . . . . 1.4099999999999999 108.162 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.691 HD12 ' HB1' ' A' ' 72' ' ' ALA . 3.8 tt -106.62 120.74 58.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.121 -0.987 . . . . 0.26000000000000001 111.153 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.525 ' HA ' ' HG3' ' A' ' 38' ' ' GLU . 69.0 tttt -103.09 101.55 11.53 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.099 -2.186 . . . . 2.3900000000000001 105.099 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.596 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 20.0 t80 -118.45 140.16 50.29 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.19 -0.944 . . . . 0.44 111.535 -176.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.76 107.71 19.4 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.489 -1.3 . . . . 0.76000000000000001 107.489 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.056 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 28.8 t90 -85.09 93.94 8.73 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.408 0.623 . . . . 0.58999999999999997 109.628 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -61.51 108.85 1.03 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.395 -0.815 . . . . 1.8500000000000001 109.6 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 33' ' ' LYS . 21.6 t -64.41 140.42 97.96 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.371 -0.831 . . . . 0.98999999999999999 108.792 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.862 ' HG3' HG13 ' A' ' 65' ' ' VAL . 34.3 Cg_endo -74.98 140.19 25.21 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.206 1.937 . . . . 2.2200000000000002 110.167 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.511 ' HD2' ' CA ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -77.48 4.54 10.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.323 -0.861 . . . . 2.5899999999999999 109.724 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.497 HG12 ' HB2' ' A' ' 95' ' ' PRO . 9.2 pt -92.93 -28.0 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.043 -1.036 . . . . 0.55000000000000004 109.649 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.574 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . . . -39.57 115.72 1.05 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 109.174 -0.676 . . . . 0.51000000000000001 109.174 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 101' ' ' SER . 36.6 Cg_endo -83.02 139.54 9.62 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.753 2.302 . . . . 0.63 109.461 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.475 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 1.7 mtmt -50.36 90.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.498 -0.927 . . . . 2.9100000000000001 108.498 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.721 ' HB3' HG23 ' A' ' 104' ' ' VAL . 2.0 t -96.24 120.47 36.59 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.47 -0.769 . . . . 0.80000000000000004 109.244 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' A' ' 103' ' ' ASN . 11.8 pt-20 -41.02 -47.49 3.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.507 -0.746 . . . . 1.9099999999999999 109.657 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.523 ' N ' ' CG ' ' A' ' 102' ' ' GLU . 0.8 OUTLIER -131.57 134.15 45.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 1.8899999999999999 109.72 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 1.122 HG21 ' CD1' ' A' ' 127' ' ' ILE . 2.5 t -129.68 150.55 34.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.387 -0.821 . . . . 0.63 109.14 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.769 HG13 ' O ' ' A' ' 122' ' ' ALA . 74.2 t -126.62 119.03 52.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.409 -0.96 . . . . 0.63 108.409 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.56 138.93 20.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.093 -1.004 . . . . 0.38 109.617 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 32.9 m -120.39 115.68 23.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.392 -0.818 . . . . 0.37 109.831 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 108' ' ' VAL . 0.7 OUTLIER -95.92 127.39 48.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.62 -1.252 . . . . 0.35999999999999999 107.62 178.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.733 ' HD2' HD11 ' A' ' 111' ' ' ILE . 1.4 ttmm -137.92 129.74 28.45 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.518 -1.364 . . . . 1.4099999999999999 110.733 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.741 ' C ' HD12 ' A' ' 111' ' ' ILE . 14.0 mt -104.21 138.34 40.82 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.376 -1.342 . . . . 0.56000000000000005 107.376 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.741 HD12 ' C ' ' A' ' 110' ' ' LEU . 4.1 mp -133.7 116.94 25.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.149 -0.97 . . . . 0.28999999999999998 109.852 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.484 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -89.67 -126.34 2.98 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.112 -1.595 . . . . 0.54000000000000004 109.112 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.17 -1.89 11.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -1.172 . . . . 1.3200000000000001 109.565 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -115.22 -3.56 12.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 2.7200000000000002 109.867 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 151.55 -148.8 20.26 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.756 -1.338 . . . . 0.34000000000000002 109.756 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.593 ' CG1' ' CD ' ' A' ' 109' ' ' LYS . 2.0 t -90.06 110.21 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -1.176 . . . . 0.48999999999999999 109.851 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 110' ' ' LEU . 53.2 mt -53.74 -39.59 65.43 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.386 -0.821 . . . . 0.34000000000000002 109.981 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.512 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -156.87 -165.05 1.76 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.784 -1.197 . . . . 0.46000000000000002 109.442 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.517 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 50.3 t -174.98 156.13 2.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.035 -1.04 . . . . 0.56000000000000005 109.72 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -154.11 142.11 20.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.914 . . . . 0.39000000000000001 109.409 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.44 HD12 ' HB3' ' A' ' 8' ' ' CYS . 26.0 mt -134.1 118.89 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.75 109.178 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.769 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -94.1 142.75 27.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.103 -0.998 . . . . 0.66000000000000003 109.49 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -86.99 0.34 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.886 . . . . 2.0600000000000001 109.592 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -49.12 115.8 1.44 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 2.5600000000000001 109.667 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -159.6 149.81 19.78 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.297 -1.521 . . . . 0.41999999999999998 109.297 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 13.8 mttt -152.6 136.0 15.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.42 -1.047 . . . . 1.98 108.524 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 1.122 ' CD1' HG21 ' A' ' 104' ' ' VAL . 75.6 mt -106.87 141.17 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.633 -1.292 . . . . 0.40000000000000002 110.095 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.51 ' HB2' ' CG2' ' A' ' 28' ' ' ILE . 19.3 mtt180 -131.18 177.31 7.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.562 -0.711 . . . . 2.6000000000000001 109.151 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.0 t70 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.05 -0.976 . . . . 1.72 109.422 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.445 -0.576 . . . . 2.25 109.445 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.546 ' CB ' ' HG2' ' A' ' 17' ' ' MET . 2.6 pt20 -91.46 154.89 18.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.319 -0.863 . . . . 0.63 109.77 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.62 ' CG2' HG23 ' A' ' 18' ' ' VAL . 1.4 m -104.78 143.36 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.342 -0.849 . . . . 0.77000000000000002 109.258 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -71.25 117.91 13.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.77000000000000002 110.1 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 m -142.72 154.13 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.552 -0.907 . . . . 0.29999999999999999 108.552 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.46 107.69 17.45 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.121 -0.987 . . . . 2.0499999999999998 109.127 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 2.2 p30 -59.63 135.86 57.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 3.6899999999999999 109.154 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.81 -7.45 14.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.128 -0.983 . . . . 1.0900000000000001 109.192 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 10' ' ' ASN . . . -67.54 -63.83 0.98 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.68999999999999995 109.666 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER 166.64 49.88 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.438 -0.789 . . . . 0.89000000000000001 109.152 -178.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m120 64.32 28.58 13.78 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.217 -1.031 . . . . 4.1399999999999997 108.217 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.473 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -77.07 -70.99 0.43 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.646 -0.659 . . . . 1.1100000000000001 109.407 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -55.09 122.76 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.55000000000000004 109.798 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -66.67 -28.0 68.11 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.359 -0.838 . . . . 1.9099999999999999 108.947 179.594 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.569 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 12.6 pttt 165.8 135.01 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.837 -1.171 . . . . 0.93999999999999995 107.837 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.9 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -111.94 119.17 59.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 O-C-N 121.257 -0.902 . . . . 0.54000000000000004 108.701 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.546 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 1.1 mtm -108.64 157.13 18.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.857 . . . . 0.32000000000000001 110.483 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.868 HG11 ' CE2' ' A' ' 35' ' ' PHE . 48.4 t -124.11 141.52 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.468 -0.938 . . . . 0.31 108.468 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -85.19 82.36 8.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.015 -1.053 . . . . 0.56999999999999995 109.493 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.48 -72.59 0.23 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.995 -1.242 . . . . 0.45000000000000001 109.995 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -51.99 164.67 0.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -1.16 . . . . 1.7 110.322 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.59 -3.54 20.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.485 -0.759 . . . . 1.6699999999999999 109.4 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 3' ' ' VAL . . . 95.27 -122.24 7.16 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.251 -1.54 . . . . 0.57999999999999996 109.251 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' GLY . 17.8 t -40.69 -40.87 1.4 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.471 -1.017 . . . . 0.93000000000000005 109.438 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.58 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -51.05 179.86 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 1.4099999999999999 108.917 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.58 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 32.7 Cg_endo -76.13 142.43 24.55 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.226 1.951 . . . . 1.5900000000000001 110.343 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.96 119.71 38.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.95999999999999996 109.715 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.413 HG23 ' HG3' ' A' ' 128' ' ' ARG . 29.3 mm -111.81 107.91 24.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.007 -1.058 . . . . 0.56999999999999995 108.991 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 mt -94.37 118.77 41.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.268 -0.895 . . . . 0.66000000000000003 109.411 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.486 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 14.5 m-70 -91.19 114.92 27.58 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.124 -1.065 . . . . 0.97999999999999998 108.124 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.529 ' HA ' HG11 ' A' ' 94' ' ' VAL . 12.1 ptt180 -57.36 158.64 5.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.838 -1.164 . . . . 1.1399999999999999 109.924 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.505 ' HA2' ' CD ' ' A' ' 96' ' ' LYS . . . 87.86 -19.39 34.04 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.479 -1.449 . . . . 0.46000000000000002 109.479 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.584 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -100.7 152.53 37.87 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.198 -1.178 . . . . 1.0900000000000001 110.163 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.36 120.46 3.64 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.845 2.363 . . . . 0.46000000000000002 110.785 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.868 ' CE2' HG11 ' A' ' 18' ' ' VAL . 4.3 t80 -96.76 121.31 38.47 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.868 -1.16 . . . . 0.41999999999999998 107.868 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.906 ' C ' HD13 ' A' ' 37' ' ' LEU . 2.6 m -100.76 134.65 43.42 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.064 -1.022 . . . . 0.93000000000000005 110.587 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.965 HD13 ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -144.71 124.74 13.57 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.253 -1.017 . . . . 0.68000000000000005 108.253 178.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.44 133.41 48.53 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.371 -0.974 . . . . 1.9299999999999999 108.371 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.9 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -130.2 119.74 23.41 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.056 -1.058 . . . . 0.32000000000000001 110.6 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.603 HD23 ' CB ' ' A' ' 87' ' ' ASP . 12.9 mt -89.71 141.57 28.49 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.154 -2.165 . . . . 0.69999999999999996 105.154 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 110' ' ' LEU . 28.7 p90 -156.78 137.32 13.11 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.341 -1.343 . . . . 0.28999999999999998 110.037 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.7 OUTLIER -82.45 112.43 19.38 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.327 -0.949 . . . . 0.52000000000000002 108.584 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.873 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -44.46 115.54 0.87 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.564 -0.532 . . . . 0.13 109.564 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.465 ' C ' ' HG3' ' A' ' 82' ' ' LYS . 4.7 p30 -80.42 5.77 14.1 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.269 -0.894 . . . . 0.089999999999999997 109.113 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.552 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 1.3 pt20 -169.5 170.33 8.32 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.34 -0.85 . . . . 0.53000000000000003 109.357 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -101.18 121.07 41.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.87 108.927 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.575 HG21 HD11 ' A' ' 117' ' ' LEU . 1.2 t -137.88 146.08 42.93 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.234 -0.916 . . . . 0.27000000000000002 109.867 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.68 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 10.0 mmmt -86.18 -12.76 48.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.416 -0.802 . . . . 0.44 109.578 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.6 p -141.92 149.65 40.44 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.831 -0.748 . . . . 0.44 109.418 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -145.07 156.64 44.04 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.247 -0.908 . . . . 0.37 109.55 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.561 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 0.9 OUTLIER -136.79 140.03 42.22 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.189 -0.944 . . . . 0.27000000000000002 110.475 -179.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 69' ' ' ASP . 3.5 tt -92.94 153.04 3.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.177 -1.416 . . . . 0.73999999999999999 107.177 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' CB ' ' HB3' ' A' ' 109' ' ' LYS . 2.4 tt0 -139.91 117.34 11.39 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.925 -1.109 . . . . 0.16 110.039 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.6 HD12 HD12 ' A' ' 68' ' ' ILE . 3.2 mp -119.37 116.32 50.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.027 -1.046 . . . . 0.20000000000000001 109.458 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.701 ' HA ' HG23 ' A' ' 65' ' ' VAL . 2.6 mtmp? -115.98 157.37 24.7 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.197 -0.939 . . . . 1.9099999999999999 108.712 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -134.22 123.7 24.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.819 -1.175 . . . . 0.34999999999999998 110.305 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -93.63 150.04 20.74 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.852 -0.796 . . . . 0.68999999999999995 108.852 179.181 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.563 HD11 ' CD1' ' A' ' 63' ' ' ILE . 15.4 mt -106.72 45.0 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.25 109.704 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.59 17.89 3.31 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.392 -0.818 . . . . 0.81999999999999995 109.413 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.84 -45.6 0.07 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.806 -1.318 . . . . 0.34999999999999998 109.806 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.423 ' HG ' HG13 ' A' ' 63' ' ' ILE . 5.1 tp -109.3 112.33 24.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.173 -1.192 . . . . 0.52000000000000002 109.548 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -77.17 125.39 29.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.992 -1.068 . . . . 1.3799999999999999 108.95 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.626 HG22 ' N ' ' A' ' 64' ' ' ASP . 43.8 mt -117.2 167.31 10.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 122.117 0.961 . . . . 0.41999999999999998 109.812 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.626 ' N ' HG22 ' A' ' 63' ' ' ILE . 7.5 t70 -112.4 136.67 51.6 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.061 -1.829 . . . . 4.2000000000000002 106.061 176.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.082 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 1.5 t -101.72 110.16 61.27 Favored Pre-proline 0 C--N 1.293 -1.868 0 C-N-CA 118.866 -1.134 . . . . 0.55000000000000004 111.039 -177.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.5 Cg_endo -81.72 -163.18 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.98 2.453 . . . . 0.65000000000000002 109.766 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.63 50.75 62.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.959 -1.256 . . . . 1.1799999999999999 109.959 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.6 HD12 HD12 ' A' ' 54' ' ' ILE . 13.4 pt -139.88 -156.82 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -1.103 . . . . 0.66000000000000003 109.035 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.649 ' O ' HG22 ' A' ' 52' ' ' ILE . 29.6 t70 -110.05 106.39 15.87 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.441 -0.787 . . . . 0.71999999999999997 109.753 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.561 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -87.12 48.19 1.61 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.19 -0.944 . . . . 0.40999999999999998 108.562 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 9.9 t-20 178.41 79.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.462 -1.31 . . . . 2.2200000000000002 107.462 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.44 -4.05 1.7 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.643 -0.661 . . . . 0.25 111.902 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.483 ' HA ' HG22 ' A' ' 76' ' ' VAL . 91.6 m -64.53 -10.58 26.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.539 -1.351 . . . . 3.0099999999999998 109.481 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.71 -20.72 45.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.56999999999999995 109.552 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CE2' ' CD1' ' A' ' 90' ' ' TYR . 79.4 m-85 -112.19 -20.88 11.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.275 -0.89 . . . . 0.34999999999999998 109.289 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.802 ' CG2' HD21 ' A' ' 80' ' ' LEU . 2.1 m -112.35 166.25 6.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.616 -0.883 . . . . 0.34000000000000002 108.616 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.662 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -91.9 94.8 9.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.001 -1.062 . . . . 1.54 111.305 -178.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.458 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 51.6 m -84.99 148.93 52.0 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 107.899 -1.149 . . . . 2.8999999999999999 107.899 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.68 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 25.7 Cg_endo -71.1 136.01 39.43 Favored 'Cis proline' 0 C--N 1.312 -1.367 0 C-N-CA 124.207 -1.164 . . . . 0.16 112.664 1.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.802 HD21 ' CG2' ' A' ' 76' ' ' VAL . 16.5 mt -71.7 146.74 48.01 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.333 -2.099 . . . . 0.71999999999999997 105.333 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.873 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 59.4 t -117.22 142.09 32.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 O-C-N 120.337 -1.477 . . . . 0.89000000000000001 111.17 -177.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 6.2 ttmt -65.34 105.86 1.23 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.59 0.709 . . . . 0.56000000000000005 109.905 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 122.72 -19.36 7.94 Favored Glycine 0 N--CA 1.48 1.583 0 C-N-CA 119.638 -1.268 . . . . 0.23000000000000001 110.066 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.575 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 7.9 tp60 -95.41 159.48 14.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.075 -1.25 . . . . 0.44 107.804 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -110.49 148.43 32.09 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.878 -1.129 . . . . 0.46000000000000002 108.371 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.725 ' CE2' HD23 ' A' ' 80' ' ' LEU . 28.6 m-85 -128.43 148.76 50.73 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.32 -0.863 . . . . 0.31 109.908 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.603 ' CB ' HD23 ' A' ' 40' ' ' LEU . 10.7 p-10 -118.69 113.93 21.94 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.605 -0.887 . . . . 0.97999999999999998 108.605 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.612 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 2.4 tt -108.91 119.16 57.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.272 -0.893 . . . . 0.19 111.139 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -99.72 107.68 19.82 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 104.649 -2.352 . . . . 3.75 104.649 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.614 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 24.5 t80 -124.12 141.98 51.6 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.577 -1.249 . . . . 0.39000000000000001 113.076 -175.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.586 ' O ' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.29 145.25 24.81 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 106.262 -1.755 . . . . 0.98999999999999999 106.262 176.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.082 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 26.9 t90 -124.71 82.8 2.08 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.797 -1.19 . . . . 0.64000000000000001 109.867 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -60.71 106.07 0.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.525 -0.734 . . . . 1.3500000000000001 109.442 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.648 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 22.1 t -55.99 144.72 57.35 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.157 -1.053 . . . . 1.22 108.157 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.648 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 24.0 Cg_endo -64.36 -7.48 14.22 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.211 1.941 . . . . 3.7000000000000002 112.192 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.505 ' CD ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER 75.38 -10.74 1.19 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.154 -0.966 . . . . 1.78 109.88 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.513 ' O ' ' C ' ' A' ' 98' ' ' ALA . 19.9 pt -91.11 -28.42 4.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 108.1 -1.074 . . . . 0.5 108.1 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.549 ' HB1' HD13 ' A' ' 127' ' ' ILE . . . -37.3 113.65 0.65 Allowed Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 107.926 -1.138 . . . . 0.65000000000000002 107.926 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.3 177.83 8.3 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 122.769 2.313 . . . . 1.3200000000000001 110.459 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 4.5 mtmt -82.19 68.74 8.72 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.573 -1.269 . . . . 0.65000000000000002 107.573 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.696 ' HB3' HG23 ' A' ' 104' ' ' VAL . 4.0 t -70.86 118.85 14.16 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.495 -0.753 . . . . 0.51000000000000001 109.615 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 1.1 pt-20 -41.16 -47.36 3.25 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.671 -0.863 . . . . 1.99 108.671 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 3.5 t-20 -130.72 141.62 50.39 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.051 -0.722 . . . . 2.9500000000000002 109.051 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 1.013 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.9 OUTLIER -131.93 142.65 42.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.101 -1.0 . . . . 0.56000000000000005 109.467 179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 2.7 t -118.27 117.63 55.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.671 -1.233 . . . . 0.92000000000000004 107.671 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 2.2 t -101.89 135.92 36.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 120.768 -1.207 . . . . 0.31 110.186 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 94.2 m -116.25 116.59 28.05 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.246 -0.909 . . . . 0.35999999999999999 109.974 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -94.42 132.23 39.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 106.834 -1.543 . . . . 0.16 106.834 177.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.956 ' CD ' HD11 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -142.03 129.67 21.51 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.327 -1.483 . . . . 0.92000000000000004 112.112 -177.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.694 ' C ' HD12 ' A' ' 111' ' ' ILE . 9.1 mt -103.31 137.97 40.71 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.552 -1.647 . . . . 0.26000000000000001 106.552 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.956 HD11 ' CD ' ' A' ' 109' ' ' LYS . 4.2 mp -134.11 116.29 22.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.961 -1.087 . . . . 0.20999999999999999 110.162 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.447 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -87.07 -135.62 4.48 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.943 -1.663 . . . . 0.25 108.943 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.65 -3.53 17.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -1.16 . . . . 0.82999999999999996 109.403 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -112.85 -7.42 13.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 4.2999999999999998 110.277 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 111' ' ' ILE . . . 156.97 -147.02 14.73 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.274 -1.441 . . . . 0.25 110.483 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.642 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 2.0 t -92.57 107.64 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.433 -1.039 . . . . 0.19 109.731 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 47' ' ' THR . 29.2 mt -56.02 -42.71 76.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.485 -0.759 . . . . 0.20000000000000001 110.488 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.469 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -149.07 -177.01 5.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.909 -1.119 . . . . 0.40000000000000002 109.247 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -170.68 150.24 3.29 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.184 -1.006 . . . . 0.62 109.913 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.401 ' N ' ' SG ' ' A' ' 119' ' ' CYS . . . -150.81 146.82 26.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.219 -0.926 . . . . 0.22 109.626 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 52.4 mt -133.23 116.73 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.957 . . . . 0.27000000000000002 108.936 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.03 142.35 27.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.074 -1.016 . . . . 0.20999999999999999 109.31 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.0 p -102.7 -87.68 0.41 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.42999999999999999 109.59 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -45.66 116.5 1.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 1.6899999999999999 109.011 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -166.62 144.59 9.22 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.795 -1.322 . . . . 0.16 109.795 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 125' ' ' GLY . 1.8 mtmp? -150.55 135.75 17.79 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.075 -1.083 . . . . 1.8400000000000001 108.075 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 1.013 ' CD1' HG21 ' A' ' 104' ' ' VAL . 82.3 mt -106.69 143.03 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.639 -1.288 . . . . 0.44 110.62 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.517 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 22.4 mtm180 -129.59 177.45 7.21 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.955 -0.757 . . . . 2.6699999999999999 108.955 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.516 ' HB2' ' HD3' ' A' ' 100' ' ' LYS . 20.5 t70 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.987 -1.006 . . . . 0.80000000000000004 109.636 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.142 0.496 . . . . 3.2000000000000002 109.733 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.522 ' HG2' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -82.85 142.27 31.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 2.4199999999999999 109.501 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.522 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 33.8 m -105.53 165.53 3.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.192 -0.942 . . . . 0.67000000000000004 109.371 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -90.39 122.76 33.55 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.315 -0.866 . . . . 1.74 109.944 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 m -148.13 156.47 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.413 -0.804 . . . . 0.46000000000000002 109.079 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -120.08 105.53 11.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.172 -0.955 . . . . 2.6400000000000001 108.958 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' OD2' ' HB ' ' A' ' 13' ' ' ILE . 1.1 m-20 -54.99 141.13 35.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 2.2999999999999998 109.788 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -112.66 -12.12 13.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.269 -0.894 . . . . 1.05 108.71 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.455 ' HB2' ' C ' ' A' ' 118' ' ' ALA . . . -60.38 -79.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.949 0.88 . . . . 0.17000000000000001 109.581 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 59.7 t-20 -179.16 37.73 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.594 -0.891 . . . . 2.96 108.594 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 20.1 t-20 76.08 30.12 0.73 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.411 -0.959 . . . . 1.5700000000000001 108.411 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.445 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 60.8 mm-40 -76.77 -62.34 1.67 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.491 -0.756 . . . . 1.3300000000000001 109.903 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -61.63 121.73 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.931 -1.105 . . . . 0.66000000000000003 109.94 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -66.9 -30.41 70.55 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.245 -1.02 . . . . 1.76 108.245 178.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 164.62 131.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.32 -0.622 . . . . 1.95 109.32 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.553 ' HB ' ' CB ' ' A' ' 39' ' ' ALA . 2.1 p -120.75 125.91 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.962 -1.086 . . . . 1.8500000000000001 108.705 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.426 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -109.6 159.28 17.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.375 -0.828 . . . . 0.46999999999999997 110.879 -178.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.018 HG22 ' HB3' ' A' ' 37' ' ' LEU . 92.5 t -120.8 147.65 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.947 -0.76 . . . . 0.28999999999999998 108.947 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.48 57.89 0.94 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.244 -0.91 . . . . 3.2200000000000002 109.46 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.41 27.71 0.07 OUTLIER Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.309 -1.424 . . . . 2.8399999999999999 110.871 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 m -140.42 -167.26 2.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.864 -1.374 . . . . 1.9399999999999999 109.812 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 25' ' ' ASP . 4.2 m-70 -128.94 -8.9 4.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.994 . . . . 3.9900000000000002 110.265 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 107.72 -132.76 11.29 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.728 -1.349 . . . . 1.5700000000000001 109.728 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -42.54 -38.43 1.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -1.12 . . . . 1.0 109.662 -179.668 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -52.13 170.53 0.23 Allowed Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 121.254 -0.904 . . . . 1.4199999999999999 108.693 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 25' ' ' ASP . 31.6 Cg_endo -75.48 153.59 39.63 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.413 2.075 . . . . 0.56999999999999995 110.184 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.2 m -112.79 136.39 52.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.56999999999999995 109.281 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.464 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 29.1 mm -111.35 107.7 23.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.049 -1.032 . . . . 0.48999999999999999 109.216 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.431 ' HB ' HG12 ' A' ' 127' ' ' ILE . 2.4 mt -88.99 121.62 39.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.29 -0.881 . . . . 0.59999999999999998 108.979 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 32.2 m-70 -84.87 133.91 34.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.464 -0.773 . . . . 1.02 109.971 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.563 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 6.0 mtm180 -57.6 140.09 51.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.533 -0.729 . . . . 1.8899999999999999 110.409 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 94' ' ' VAL . . . 67.19 1.58 14.46 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.528 -0.844 . . . . 0.92000000000000004 111.274 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -88.71 149.76 44.61 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 120.755 -1.438 . . . . 0.98999999999999999 109.78 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.477 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 36.6 Cg_endo -81.12 113.74 2.75 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.971 2.447 . . . . 0.66000000000000003 111.031 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.713 ' CE2' HG11 ' A' ' 18' ' ' VAL . 2.0 t80 -97.61 115.22 27.47 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.345 -1.354 . . . . 0.87 107.345 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.784 ' C ' HD13 ' A' ' 37' ' ' LEU . 29.9 m -107.72 129.2 55.05 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.974 -1.079 . . . . 0.70999999999999996 111.168 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.018 ' HB3' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -143.63 126.26 15.99 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.903 -0.777 . . . . 1.3100000000000001 108.903 179.045 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.534 ' O ' HG23 ' A' ' 16' ' ' VAL . 12.6 tt0 -94.64 134.44 37.22 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.016 -1.105 . . . . 1.55 108.016 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.553 ' CB ' ' HB ' ' A' ' 16' ' ' VAL . . . -129.5 126.06 37.76 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.868 -1.145 . . . . 0.58999999999999997 110.48 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 87' ' ' ASP . 5.1 mt -93.92 144.84 25.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.467 -1.679 . . . . 0.77000000000000002 106.467 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.62 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 33.1 p90 -161.69 139.28 8.85 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.757 -1.177 . . . . 0.39000000000000001 109.517 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.2 m-20 -86.67 114.47 23.4 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.083 -1.047 . . . . 3.4500000000000002 109.179 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.15 112.55 0.54 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.111 -0.7 . . . . 0.35999999999999999 109.111 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 44' ' ' ASN . 3.0 p30 -82.66 10.27 7.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.063 -1.023 . . . . 0.40000000000000002 109.477 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.58 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 4.6 pt20 -167.23 147.28 5.38 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.418 -0.801 . . . . 0.40000000000000002 109.052 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 2.8 p-10 -84.21 114.17 21.62 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.061 -1.024 . . . . 2.6899999999999999 109.06 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.484 HG21 ' HA3' ' A' ' 112' ' ' GLY . 1.7 t -131.55 155.12 48.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.332 -0.855 . . . . 0.10000000000000001 109.855 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.702 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 9.3 mmmt -92.16 -10.58 38.28 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.263 -0.898 . . . . 0.56999999999999995 109.982 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.8 p -147.41 139.44 24.32 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.265 -0.897 . . . . 0.35999999999999999 110.098 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -128.51 153.56 47.05 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.48 -0.762 . . . . 0.23000000000000001 109.13 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -133.32 136.38 45.38 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.374 -0.931 . . . . 0.44 110.745 -178.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 69' ' ' ASP . 4.9 tt -90.26 151.95 3.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.363 -1.347 . . . . 0.20000000000000001 107.363 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' LYS . 2.7 mt-10 -138.54 116.28 11.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.026 -1.046 . . . . 0.62 110.291 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.641 ' N ' HD12 ' A' ' 54' ' ' ILE . 3.3 mp -117.53 112.77 40.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.742 -1.223 . . . . 0.23000000000000001 109.396 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 40.3 mtmt -111.75 152.4 27.85 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.034 -1.098 . . . . 2.1699999999999999 108.034 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -122.59 156.35 34.43 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.209 -1.396 . . . . 0.93000000000000005 110.737 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.0 OUTLIER -117.06 150.48 38.58 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.796 -0.816 . . . . 0.82999999999999996 108.796 179.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 57' ' ' SER . 12.7 mt -115.92 43.49 2.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.946 -1.096 . . . . 0.41999999999999998 109.267 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 57.3 t0 51.16 21.95 1.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 1.1699999999999999 108.953 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.44 -53.96 0.17 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.976 -1.65 . . . . 0.16 108.976 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 mp -102.67 116.1 31.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.346 -1.09 . . . . 4.3600000000000003 108.945 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.7 mt-10 -91.76 120.78 32.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.035 -1.041 . . . . 3.3100000000000001 109.519 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.594 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 49.2 mt -104.83 169.58 2.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 122.135 0.969 . . . . 0.40999999999999998 110.011 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.594 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 43.4 m-20 -109.4 138.33 45.92 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.583 -1.636 . . . . 0.66000000000000003 106.583 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.984 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 1.6 t -106.68 107.4 60.16 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.791 -1.193 . . . . 0.39000000000000001 111.406 -177.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.7 Cg_endo -82.83 -158.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 123.236 2.624 . . . . 0.14999999999999999 109.752 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.87 45.82 93.15 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.31 -1.116 . . . . 0.78000000000000003 110.31 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.547 HG22 ' CD1' ' A' ' 92' ' ' TRP . 32.3 pt -136.21 -156.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.163 -1.198 . . . . 0.47999999999999998 108.951 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.601 ' O ' HG22 ' A' ' 52' ' ' ILE . 31.4 t70 -107.97 105.74 15.66 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.251 -0.906 . . . . 0.93000000000000005 109.473 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.507 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -87.35 48.06 1.59 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.316 -0.994 . . . . 0.38 108.316 179.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 26.2 t-20 178.08 77.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.691 -1.226 . . . . 1.3300000000000001 107.691 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.636 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -61.96 -5.67 2.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.17999999999999999 112.009 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.566 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -63.94 -12.49 37.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.384 -1.448 . . . . 0.27000000000000002 108.987 179.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -75.53 -22.77 56.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.069 -1.02 . . . . 1.3899999999999999 110.156 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.509 ' HB2' HG13 ' A' ' 88' ' ' ILE . 58.7 m-85 -109.42 -30.75 7.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.56999999999999995 108.79 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.715 ' CG2' HD21 ' A' ' 80' ' ' LEU . 2.1 m -99.23 165.82 2.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.086 -1.079 . . . . 0.27000000000000002 108.086 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.612 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -91.28 91.23 8.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.14 -0.975 . . . . 1.3500000000000001 111.411 -178.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.498 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 11.5 p -89.14 153.59 49.02 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 107.541 -1.281 . . . . 0.32000000000000001 107.541 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.702 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 23.2 Cg_endo -68.53 130.16 14.67 Favored 'Cis proline' 0 C--N 1.313 -1.339 0 C-N-CA 124.474 -1.053 . . . . 0.42999999999999999 112.785 2.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.877 HD23 ' CE2' ' A' ' 86' ' ' TYR . 11.1 mt -74.13 115.69 13.91 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.962 -1.495 . . . . 0.46999999999999997 106.962 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.9 t -83.45 141.25 15.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 C-N-CA 119.084 -1.047 . . . . 0.42999999999999999 110.125 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.58 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 3.7 tttt -64.99 116.9 6.89 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.851 0.834 . . . . 1.98 110.195 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.06 -11.39 14.85 Favored Glycine 0 N--CA 1.479 1.505 0 N-CA-C 109.43 -1.468 . . . . 0.41999999999999998 109.43 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.565 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 4.2 tp-100 -100.72 156.54 17.28 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.668 -1.234 . . . . 2.3100000000000001 107.668 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -109.3 149.99 28.64 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.363 -0.977 . . . . 1.2 108.363 179.508 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.877 ' CE2' HD23 ' A' ' 80' ' ' LEU . 36.6 m-85 -132.07 149.35 52.43 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.145 -0.972 . . . . 0.54000000000000004 110.258 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.576 ' HB3' HD23 ' A' ' 40' ' ' LEU . 9.7 p-10 -117.94 113.69 22.08 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.555 -0.905 . . . . 0.67000000000000004 108.555 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.636 HD12 ' HB1' ' A' ' 72' ' ' ALA . 7.4 tt -108.15 124.83 64.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.195 -0.941 . . . . 0.42999999999999999 111.626 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.451 ' HD3' ' OE1' ' A' ' 38' ' ' GLU . 5.2 tptt -100.49 105.0 16.41 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.353 -2.091 . . . . 3.7000000000000002 105.353 176.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.594 ' CE2' ' O ' ' A' ' 91' ' ' THR . 27.5 t80 -119.8 141.86 49.11 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 118.579 -1.249 . . . . 0.45000000000000001 113.143 -176.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.594 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -94.38 144.18 25.77 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.482 -1.673 . . . . 1.02 106.482 177.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.984 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 22.2 t90 -122.74 89.48 3.12 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.798 -1.189 . . . . 0.57999999999999996 111.162 -177.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -62.39 107.74 0.98 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.239 -0.913 . . . . 2.4100000000000001 108.655 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.784 HG13 ' HD2' ' A' ' 95' ' ' PRO . 53.8 t -74.9 144.42 79.67 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.474 -0.766 . . . . 1.1899999999999999 109.149 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.784 ' HD2' HG13 ' A' ' 94' ' ' VAL . 29.8 Cg_endo -70.77 136.15 29.68 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.897 1.731 . . . . 0.83999999999999997 109.573 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.14 4.81 3.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.483 -0.761 . . . . 2.3700000000000001 111.299 -178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 98' ' ' ALA . 13.2 pt -89.9 -25.93 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.673 -1.267 . . . . 0.97999999999999998 109.047 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.563 ' O ' ' CD ' ' A' ' 31' ' ' ARG . . . -36.17 117.54 0.67 Allowed Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 109.396 -0.594 . . . . 0.53000000000000003 109.396 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -83.01 167.0 14.47 Favored 'Trans proline' 0 C--N 1.298 -2.097 0 C-N-CA 122.595 2.197 . . . . 0.87 109.221 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.549 ' CD ' ' HA ' ' A' ' 128' ' ' ARG . 6.2 mmtp -79.31 77.86 5.82 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.682 -1.229 . . . . 4.8300000000000001 107.682 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.494 ' HB2' HD22 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -80.8 118.55 22.42 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.951 -0.759 . . . . 0.48999999999999999 108.951 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 0.7 OUTLIER -37.32 -50.63 1.04 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.604 -0.685 . . . . 2.75 109.911 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.526 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 24.5 m120 -129.96 139.0 51.15 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.077 -1.014 . . . . 2.8500000000000001 110.058 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.648 HG21 ' CD1' ' A' ' 127' ' ' ILE . 74.0 t -129.88 149.35 33.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.326 -0.859 . . . . 0.60999999999999999 109.405 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.528 ' HB ' ' CB ' ' A' ' 57' ' ' SER . 1.0 OUTLIER -124.13 122.45 64.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.988 -1.116 . . . . 1.0800000000000001 107.988 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 20.1 t -103.94 144.09 14.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.239 -0.913 . . . . 0.44 109.779 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 36.9 m -123.67 114.45 19.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.366 -0.834 . . . . 0.20000000000000001 109.676 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -95.24 127.52 47.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.289 -1.375 . . . . 0.31 107.289 178.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.873 ' CD ' HD11 ' A' ' 111' ' ' ILE . 8.5 ttmt -142.58 127.05 17.82 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.387 -1.446 . . . . 2.3399999999999999 111.468 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.638 ' C ' HD12 ' A' ' 111' ' ' ILE . 1.4 mp -103.46 137.37 41.64 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.472 -1.307 . . . . 1.99 107.472 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.873 HD11 ' CD ' ' A' ' 109' ' ' LYS . 4.2 mp -131.09 121.54 49.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.41 -0.806 . . . . 0.37 109.856 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.484 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -80.92 -129.88 0.96 Allowed Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.455 -1.858 . . . . 0.45000000000000001 108.455 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.34 -3.57 11.92 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.284 -1.127 . . . . 0.77000000000000002 109.12 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.401 ' O ' ' CG ' ' A' ' 114' ' ' ASN . 1.3 t30 -116.77 -10.96 10.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.242 -0.911 . . . . 3.7000000000000002 110.708 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 111' ' ' ILE . . . 168.35 -158.47 31.2 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.467 -1.349 . . . . 0.29999999999999999 110.573 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.632 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -87.74 109.84 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -1.107 . . . . 0.34999999999999998 110.162 -179.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 112' ' ' GLY . 85.1 mt -53.95 -43.11 69.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 0.52000000000000002 108.999 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.478 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -155.46 -162.53 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.095 -1.003 . . . . 0.51000000000000001 109.465 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -178.59 155.24 0.82 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.208 -0.933 . . . . 0.73999999999999999 109.158 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.06 143.97 23.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.011 -1.056 . . . . 0.31 109.925 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.0 mt -133.17 116.92 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.106 -0.996 . . . . 0.56000000000000005 108.41 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.1 146.62 24.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.993 -1.067 . . . . 0.25 110.517 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 124' ' ' HIS . 88.3 m -116.65 162.65 17.31 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.148 -0.686 . . . . 2.5699999999999998 109.148 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.519 ' N ' HG22 ' A' ' 123' ' ' THR . 5.0 t-160 54.03 75.05 0.29 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 2.1200000000000001 109.93 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -131.7 161.62 23.73 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.717 -1.753 . . . . 0.47999999999999998 108.717 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 125' ' ' GLY . 46.3 mttt -152.85 139.52 18.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.219 -1.166 . . . . 1.7 109.255 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.648 ' CD1' HG21 ' A' ' 104' ' ' VAL . 64.2 mt -106.55 139.83 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.621 -1.3 . . . . 0.32000000000000001 109.677 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.549 ' HA ' ' CD ' ' A' ' 100' ' ' LYS . 22.0 mtt180 -132.92 178.53 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.383 -0.823 . . . . 3.6200000000000001 109.307 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.995 -1.002 . . . . 2.7799999999999998 109.449 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.278 0.561 . . . . 1.3400000000000001 109.502 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 9.4 pt20 -95.89 152.49 18.45 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.322 -0.861 . . . . 1.21 109.266 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 21' ' ' CYS . 28.2 m -104.76 160.72 5.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.307 -0.87 . . . . 0.63 108.903 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -92.82 118.19 30.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.991 -1.068 . . . . 0.82999999999999996 110.139 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 m -142.17 157.51 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.329 -0.989 . . . . 0.35999999999999999 108.329 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 109.17 17.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.058 -1.026 . . . . 4.4000000000000004 109.596 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 16.9 p-10 -45.06 132.51 7.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 3.73 109.805 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -108.7 -2.9 18.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.805 . . . . 0.33000000000000002 109.505 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.541 ' N ' ' HB3' ' A' ' 119' ' ' CYS . . . -75.33 -74.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.59999999999999998 109.668 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.434 ' CG ' ' O ' ' A' ' 9' ' ' ALA . 7.4 m-20 178.49 55.64 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.557 -0.905 . . . . 2.4199999999999999 108.557 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.404 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 1.3 t30 65.28 42.85 3.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.446 -0.946 . . . . 3.1499999999999999 108.446 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.488 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -98.9 -63.18 1.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -0.852 . . . . 1.8300000000000001 110.485 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 15' ' ' LYS . 1.2 mt -60.25 128.05 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.951 -1.093 . . . . 0.59999999999999998 110.417 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -81.86 -15.64 53.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.31 -0.869 . . . . 0.77000000000000002 109.358 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 156.98 141.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.15 -1.056 . . . . 2.8599999999999999 108.15 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.792 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -121.99 126.27 74.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.876 -0.787 . . . . 0.39000000000000001 108.876 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.494 ' HE2' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -112.41 156.45 22.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.005 -1.06 . . . . 1.21 110.213 -179.258 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 36' ' ' THR . 2.4 t -133.26 143.36 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.302 -0.874 . . . . 0.80000000000000004 108.718 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.64 100.58 11.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.99 . . . . 3.1800000000000002 109.639 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.47 -56.15 0.52 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.753 -1.339 . . . . 0.39000000000000001 109.753 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.409 ' HB2' HG12 ' A' ' 3' ' ' VAL . 66.8 m -59.65 -167.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.282 -1.128 . . . . 2.29 109.232 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -144.31 15.3 1.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.136 -0.977 . . . . 1.98 109.834 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 77.55 145.92 2.42 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.74 -1.344 . . . . 3.7000000000000002 109.74 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER 38.14 46.72 0.88 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.595 -0.944 . . . . 3.6899999999999999 110.321 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.453 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER -156.75 170.9 8.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 1.6799999999999999 109.322 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 34.9 Cg_endo -77.71 148.04 25.3 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.707 2.271 . . . . 0.88 111.027 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 87.3 m -116.76 134.27 54.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.383 -0.823 . . . . 0.82999999999999996 109.255 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.473 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 37.6 mm -101.15 104.08 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.77 -1.206 . . . . 0.60999999999999999 108.519 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.408 ' HB ' HG12 ' A' ' 127' ' ' ILE . 3.4 mt -88.44 119.14 35.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.568 -0.853 . . . . 0.34000000000000002 109.469 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -95.34 106.56 18.62 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.028 -1.101 . . . . 0.89000000000000001 108.028 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 98' ' ' ALA . 9.2 ptt180 -52.03 154.65 2.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.977 -1.077 . . . . 1.79 110.004 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.88 -10.69 64.49 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.392 -1.483 . . . . 0.45000000000000001 109.392 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -108.79 154.61 41.68 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.279 -1.13 . . . . 1.27 109.565 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.426 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 34.4 Cg_endo -79.84 114.45 3.18 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.812 2.342 . . . . 0.31 110.884 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -96.37 132.91 41.4 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.55 -1.278 . . . . 0.66000000000000003 107.55 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 18' ' ' VAL . 91.8 m -113.39 140.79 47.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.675 -1.265 . . . . 0.41999999999999998 110.879 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -146.55 122.44 10.65 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.86 -0.792 . . . . 3.4700000000000002 108.86 178.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 3.0 tt0 -101.08 127.82 47.42 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.72 -1.215 . . . . 2.1400000000000001 107.72 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.792 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -126.6 122.98 36.6 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.746 -1.221 . . . . 0.17000000000000001 110.413 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.545 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 20.2 mt -89.69 142.61 27.52 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.606 -1.627 . . . . 0.28000000000000003 106.606 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.644 ' CE1' ' CD1' ' A' ' 110' ' ' LEU . 35.3 p90 -157.85 137.67 12.25 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.823 -1.173 . . . . 0.25 109.669 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.5 m-20 -84.73 111.58 19.72 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.239 -0.985 . . . . 1.53 108.928 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -47.84 114.22 0.87 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.298 -0.63 . . . . 0.22 109.298 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 117' ' ' LEU . 0.6 OUTLIER -91.87 14.07 16.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 3.5099999999999998 108.944 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.642 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 1.8 pt20 -164.78 138.98 5.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.436 -0.79 . . . . 1.0900000000000001 109.022 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -81.51 123.63 28.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.126 -0.984 . . . . 3.2200000000000002 109.355 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.6 t -145.13 153.94 41.93 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.225 -0.922 . . . . 0.70999999999999996 109.382 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.684 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 3.2 mmmt -89.43 -12.75 39.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 1.3999999999999999 109.724 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.0 p -147.2 136.7 22.79 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.354 -0.938 . . . . 1.3300000000000001 110.189 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -127.57 155.79 43.26 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.477 -0.934 . . . . 0.56000000000000005 108.477 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.541 ' CD ' ' HB ' ' A' ' 70' ' ' THR . 0.3 OUTLIER -134.55 145.06 48.36 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.422 -0.799 . . . . 1.8999999999999999 110.37 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 69' ' ' ASP . 5.6 tt -95.22 154.46 3.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.012 -1.055 . . . . 0.81000000000000005 108.917 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 0.9 OUTLIER -141.04 114.14 8.54 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.538 -0.912 . . . . 1.24 108.538 -179.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.77 HD13 HG21 ' A' ' 68' ' ' ILE . 2.5 mp -113.99 130.81 67.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.95 -1.093 . . . . 0.81999999999999995 109.097 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -126.05 134.03 51.54 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.161 -0.962 . . . . 1.3899999999999999 108.716 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -122.28 131.5 53.95 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.607 -1.237 . . . . 0.53000000000000003 111.16 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.24 148.21 23.33 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.206 -1.035 . . . . 0.53000000000000003 108.206 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.721 HD13 ' CG ' ' A' ' 99' ' ' PRO . 17.2 mt -109.26 56.97 0.61 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.134 -0.979 . . . . 0.80000000000000004 109.668 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 58' ' ' LEU . 3.4 t70 41.47 27.95 0.06 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.649 -0.657 . . . . 1.53 109.726 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 174.23 -49.89 0.14 Allowed Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.754 -1.212 . . . . 1.1000000000000001 110.093 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.517 ' HG ' HG13 ' A' ' 63' ' ' ILE . 3.8 tp -108.43 112.73 25.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.021 -1.282 . . . . 0.76000000000000001 110.069 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.492 ' N ' HD12 ' A' ' 61' ' ' LEU . 1.9 tt0 -79.14 124.58 28.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.127 -0.983 . . . . 1.45 108.975 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.683 ' CD1' HD11 ' A' ' 58' ' ' LEU . 71.4 mt -121.21 165.95 16.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.991 0.9 . . . . 0.56000000000000005 110.203 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.677 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.9 OUTLIER -112.44 108.71 17.95 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 105.881 -1.896 . . . . 1.3600000000000001 105.881 176.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.086 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 10.3 t -71.34 114.13 25.25 Favored Pre-proline 0 C--N 1.298 -1.663 0 O-C-N 121.501 -0.749 . . . . 0.81000000000000005 111.904 -177.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 37.6 Cg_endo -86.56 -157.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 123.278 2.652 . . . . 0.67000000000000004 109.241 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.27 36.13 61.85 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.247 -0.978 . . . . 0.95999999999999996 110.825 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.77 HG21 HD13 ' A' ' 54' ' ' ILE . 9.0 pt -120.72 -157.66 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.957 -1.319 . . . . 0.52000000000000002 108.849 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.735 ' O ' HG22 ' A' ' 52' ' ' ILE . 47.9 t0 -108.29 107.69 18.39 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.381 -0.824 . . . . 0.51000000000000001 109.367 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.541 ' HB ' ' CD ' ' A' ' 51' ' ' LYS . 64.4 p -86.8 45.08 1.22 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.052 -1.03 . . . . 0.76000000000000001 108.443 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 58.2 t30 175.32 83.6 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.4 -1.333 . . . . 1.05 107.4 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.855 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -72.33 4.35 3.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.464 -0.772 . . . . 0.39000000000000001 113.016 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.559 ' HA ' HG22 ' A' ' 76' ' ' VAL . 2.2 t -64.89 -13.91 58.1 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.189 -1.569 . . . . 0.53000000000000003 108.675 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -75.05 -23.98 58.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.222 -0.923 . . . . 1.8200000000000001 109.728 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.528 ' CB ' HG13 ' A' ' 88' ' ' ILE . 74.1 m-85 -109.34 -16.54 14.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.85999999999999999 109.203 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.814 ' CG2' HD21 ' A' ' 80' ' ' LEU . 2.3 m -117.7 166.78 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.246 -1.02 . . . . 0.51000000000000001 108.246 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.649 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -92.25 90.69 7.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.995 -1.065 . . . . 2.3199999999999998 111.536 -178.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.469 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 17.5 p -84.28 151.11 59.08 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 107.077 -1.453 . . . . 0.59999999999999998 107.077 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.684 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.6 Cg_endo -70.11 132.55 23.09 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 124.416 -1.077 . . . . 0.85999999999999999 112.806 2.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.814 HD21 ' CG2' ' A' ' 76' ' ' VAL . 12.8 mt -75.95 113.87 13.94 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.555 -1.646 . . . . 0.66000000000000003 106.555 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.638 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 55.1 t -79.45 143.31 12.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 C-N-CA 119.53 -0.868 . . . . 0.81000000000000005 110.204 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.642 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 11.4 ttpt -71.5 99.8 2.1 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.824 0.821 . . . . 1.1499999999999999 110.127 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 136.5 -15.97 3.85 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 109.621 -1.392 . . . . 0.41999999999999998 109.621 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.574 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 26.9 tp60 -97.88 156.02 16.79 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.837 -1.172 . . . . 1.1899999999999999 107.837 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.7 OUTLIER -106.94 142.84 35.93 Favored 'General case' 0 C--N 1.294 -1.848 0 O-C-N 120.936 -1.102 . . . . 0.93000000000000005 108.08 179.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.649 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 21.0 m-85 -122.96 150.65 42.7 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.469 -0.769 . . . . 0.56999999999999995 110.559 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.545 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 3.9 p30 -116.7 113.92 23.29 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.171 -1.048 . . . . 0.31 108.171 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.855 HD12 ' HB1' ' A' ' 72' ' ' ALA . 4.8 tt -106.93 120.05 57.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.032 -1.043 . . . . 0.27000000000000002 111.793 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.504 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 5.0 tttp -98.36 104.44 16.48 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 104.574 -2.38 . . . . 1.8300000000000001 104.574 175.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 20.9 t80 -119.13 137.06 53.85 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.045 -1.062 . . . . 0.54000000000000004 112.004 -176.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.59 98.07 10.56 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.656 -1.609 . . . . 0.42999999999999999 106.656 177.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.086 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 33.6 t90 -72.18 97.02 1.88 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.822 -0.627 . . . . 0.41999999999999998 109.797 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.26 105.16 0.46 Allowed 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.565 -0.854 . . . . 2.21 108.742 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.662 HG13 ' HD2' ' A' ' 95' ' ' PRO . 64.5 t -65.49 143.19 98.61 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.445 -0.784 . . . . 0.68999999999999995 109.156 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.869 ' HG3' HG13 ' A' ' 65' ' ' VAL . 30.1 Cg_endo -72.52 129.2 14.41 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.136 1.89 . . . . 0.56000000000000005 109.726 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -1.27 4.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.573 -0.704 . . . . 2.6899999999999999 110.182 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 98' ' ' ALA . 9.5 pt -90.2 -27.52 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.834 -1.166 . . . . 0.56999999999999995 110.084 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.519 ' O ' ' CD ' ' A' ' 31' ' ' ARG . . . -34.83 118.8 0.57 Allowed Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 109.428 -0.582 . . . . 0.23000000000000001 109.428 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.721 ' CG ' HD13 ' A' ' 58' ' ' LEU . 36.8 Cg_endo -85.02 139.95 7.54 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.852 2.368 . . . . 0.32000000000000001 109.696 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.48 ' HD2' ' HA ' ' A' ' 128' ' ' ARG . 7.4 mtmt -52.76 89.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.994 -1.113 . . . . 0.72999999999999998 107.994 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 99' ' ' PRO . 3.4 t -93.71 122.46 36.19 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.439 -0.788 . . . . 0.37 109.151 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 8.3 pt-20 -41.39 -44.54 2.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.523 -0.736 . . . . 1.0700000000000001 109.456 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 14.5 t30 -132.17 140.49 48.76 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.521 -0.737 . . . . 1.3300000000000001 109.722 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.972 HG21 ' CD1' ' A' ' 127' ' ' ILE . 1.0 OUTLIER -130.69 143.92 39.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.338 -0.851 . . . . 0.83999999999999997 109.191 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 2.9 t -118.87 118.7 58.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.217 -1.031 . . . . 1.04 108.217 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.8 t -104.61 140.78 21.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.731 -1.231 . . . . 0.44 110.646 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 89.8 m -122.1 127.07 49.71 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.008 -0.738 . . . . 0.5 109.008 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -104.79 132.89 50.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 107.853 -1.166 . . . . 0.39000000000000001 107.853 178.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.886 ' CD ' HD11 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -141.56 128.63 20.81 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.419 -1.426 . . . . 1.24 111.79 -178.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 52' ' ' ILE . 13.3 mt -104.55 141.79 35.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.151 -1.425 . . . . 0.14000000000000001 107.151 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.886 HD11 ' CD ' ' A' ' 109' ' ' LYS . 4.4 mp -135.57 121.86 32.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.218 -0.926 . . . . 0.22 110.039 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.44 ' N ' ' HG ' ' A' ' 117' ' ' LEU . . . -99.71 -144.53 16.43 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.788 -1.725 . . . . 0.56999999999999995 108.788 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.6 -0.28 46.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -1.173 . . . . 1.53 109.747 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.81 -4.15 13.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 2.0600000000000001 110.372 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 144.27 -147.63 18.98 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.886 -1.286 . . . . 0.25 109.886 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.634 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 2.1 t -86.82 108.98 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -1.166 . . . . 0.12 109.878 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.468 ' O ' ' OD1' ' A' ' 44' ' ' ASN . 22.1 mt -56.46 -35.12 67.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.51000000000000001 109.84 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.508 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -163.03 179.31 7.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.716 -1.24 . . . . 0.35999999999999999 109.515 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.541 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 14.5 t -165.08 157.61 15.94 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.319 -0.863 . . . . 0.40000000000000002 109.314 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.465 ' HB2' HD12 ' A' ' 13' ' ' ILE . . . -152.92 147.06 25.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.035 -1.041 . . . . 0.46000000000000002 109.483 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 65.7 mt -134.0 120.9 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.52000000000000002 109.554 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -92.8 147.53 22.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.144 -0.972 . . . . 0.66000000000000003 109.697 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -78.47 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.79000000000000004 109.837 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -56.91 -177.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 3.02 109.353 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . 141.51 138.86 3.58 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.869 -1.292 . . . . 0.47999999999999998 109.869 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 7.8 mtmt -151.09 134.86 16.47 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.455 -1.026 . . . . 1.25 108.614 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.972 ' CD1' HG21 ' A' ' 104' ' ' VAL . 58.6 mt -105.8 140.39 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.822 -1.174 . . . . 0.53000000000000003 110.485 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.48 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -133.5 173.5 11.43 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.74 -0.837 . . . . 2.75 108.74 178.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.028 -1.045 . . . . 1.1599999999999999 109.513 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.418 -0.586 . . . . 0.88 109.418 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.52 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 0.0 OUTLIER -69.46 141.31 54.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.219 -0.926 . . . . 2.1600000000000001 109.211 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 22' ' ' HIS . 2.4 m -109.54 168.8 3.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.339 -0.851 . . . . 1.8799999999999999 110.184 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -80.16 128.63 33.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.412 -0.805 . . . . 1.1000000000000001 110.952 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.7 m -147.49 159.3 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.703 -1.221 . . . . 0.45000000000000001 107.703 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.68 108.62 15.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.805 -1.184 . . . . 1.9099999999999999 109.462 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 120' ' ' ALA . 24.8 m-20 -52.76 130.29 32.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.90000000000000002 109.106 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.4 3.96 38.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.37 109.49 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.539 ' O ' ' CB ' ' A' ' 10' ' ' ASN . . . -81.52 -57.5 3.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.277 -0.889 . . . . 0.63 109.21 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER 161.64 -31.26 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.244 -1.021 . . . . 3.4399999999999999 108.244 -178.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' ASN . 0.3 OUTLIER 159.61 39.51 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.255 -1.017 . . . . 2.2999999999999998 108.255 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.481 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 77.1 mm-40 -90.82 -52.75 4.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 2.7000000000000002 110.386 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.524 HG12 ' HB1' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -73.97 131.8 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.702 -1.249 . . . . 0.56999999999999995 110.082 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 39.2 mmtt -85.95 -22.59 27.31 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.849 -1.167 . . . . 0.93999999999999995 107.849 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.1 ttpt 160.9 128.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.211 -0.662 . . . . 1.9099999999999999 109.211 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 38' ' ' GLU . 1.5 p -119.31 122.77 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.044 -1.035 . . . . 1.5900000000000001 109.086 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.52 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -105.23 158.69 16.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.261 -0.899 . . . . 1.47 110.41 -178.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.066 HG11 ' CE1' ' A' ' 35' ' ' PHE . 24.7 t -127.9 115.69 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.873 . . . . 0.46999999999999997 108.66 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -68.15 89.82 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 3.48 109.749 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.38 -63.54 0.26 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.404 -1.478 . . . . 0.69999999999999996 109.404 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.6 t -90.18 154.08 20.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -1.133 . . . . 0.67000000000000004 109.243 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.632 ' O ' HG12 ' A' ' 3' ' ' VAL . 12.2 m80 -94.01 -169.16 2.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 2.7000000000000002 109.789 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.588 ' CA ' ' HA ' ' A' ' 3' ' ' VAL . . . -108.09 154.82 16.44 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.361 -1.496 . . . . 3.9100000000000001 109.361 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.0 6.18 4.55 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.161 -1.199 . . . . 1.7 109.079 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -128.57 158.5 71.69 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 108.497 -0.927 . . . . 2.75 108.497 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.78 147.36 21.65 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.708 2.272 . . . . 0.82999999999999996 110.368 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.2 m -115.69 154.42 29.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.94999999999999996 109.7 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.542 HG23 ' HG3' ' A' ' 128' ' ' ARG . 45.9 mm -111.95 113.16 43.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.353 -0.842 . . . . 0.46999999999999997 109.206 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.517 ' HB ' HG12 ' A' ' 127' ' ' ILE . 10.1 mt -94.94 120.89 44.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.249 -0.907 . . . . 0.76000000000000001 108.931 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.502 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 3.9 m-70 -87.43 133.97 33.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.35 -0.844 . . . . 1.8799999999999999 109.639 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.513 ' HA ' HG11 ' A' ' 94' ' ' VAL . 9.2 mtm180 -54.81 135.06 48.07 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.159 -0.963 . . . . 1.73 108.922 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.514 ' N ' ' HB ' ' A' ' 94' ' ' VAL . . . 69.26 20.47 75.12 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.397 -0.906 . . . . 0.83999999999999997 111.041 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.046 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -109.64 137.76 20.45 Favored Pre-proline 0 N--CA 1.482 1.175 0 O-C-N 120.594 -1.533 . . . . 3.4500000000000002 108.305 179.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.5 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 33.9 Cg_endo -74.18 115.56 4.36 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.844 2.363 . . . . 0.45000000000000001 112.089 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 1.066 ' CE1' HG11 ' A' ' 18' ' ' VAL . 1.5 t80 -98.97 111.74 24.05 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.166 -1.05 . . . . 1.0600000000000001 108.166 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.912 ' O ' HG13 ' A' ' 18' ' ' VAL . 96.2 m -88.04 128.71 35.4 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.087 -1.008 . . . . 0.94999999999999996 109.944 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.43 HD13 HG21 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -140.66 123.68 16.49 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.475 -0.765 . . . . 3.6200000000000001 109.238 179.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 16' ' ' VAL . 4.5 tt0 -105.28 126.78 52.48 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.642 -1.244 . . . . 0.92000000000000004 107.642 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.563 ' CB ' ' HB ' ' A' ' 16' ' ' VAL . . . -129.42 132.08 46.92 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.676 -1.265 . . . . 0.46999999999999997 110.975 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 5.4 mt -94.85 144.39 25.69 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.092 -1.447 . . . . 0.33000000000000002 107.092 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.702 ' CE2' HD11 ' A' ' 110' ' ' LEU . 35.2 p90 -159.36 136.53 9.68 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.785 -1.166 . . . . 0.28000000000000003 109.864 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.4 m-20 -84.2 112.25 20.1 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.292 -0.963 . . . . 1.3899999999999999 108.611 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -45.19 110.88 0.27 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.759 -0.83 . . . . 0.26000000000000001 108.759 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -80.03 4.65 16.4 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.154 -0.966 . . . . 1.3700000000000001 109.5 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 4.3 pt20 -164.84 156.75 15.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.028 -1.045 . . . . 1.1599999999999999 109.676 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.463 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 1.9 p-10 -84.79 121.67 28.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 2.3399999999999999 109.271 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.694 HG21 HD11 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -141.46 139.26 33.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.056 -1.028 . . . . 0.79000000000000004 110.287 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.707 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 3.2 mmmm -80.92 -10.87 59.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.384 -0.822 . . . . 1.3400000000000001 109.477 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 47' ' ' THR . 12.7 p -147.03 137.86 23.78 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.985 0.897 . . . . 0.48999999999999999 109.714 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -126.3 149.81 48.89 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.815 -0.809 . . . . 0.34999999999999998 108.815 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.564 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 2.2 mtmt -129.28 136.2 49.76 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.114 -1.034 . . . . 0.20999999999999999 110.401 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 69' ' ' ASP . 12.2 tt -92.17 151.28 3.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 107.085 -1.45 . . . . 0.40999999999999998 107.085 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -142.13 115.38 8.89 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.089 -1.007 . . . . 0.56000000000000005 109.468 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 54' ' ' ILE . 2.3 mp -112.63 111.41 36.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.044 -1.035 . . . . 0.17999999999999999 109.13 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -106.57 160.57 15.33 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.263 -1.014 . . . . 0.72999999999999998 108.263 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -134.67 150.63 50.66 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.494 -1.379 . . . . 1.0600000000000001 110.829 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 4.6 m -116.26 151.56 35.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.875 -1.157 . . . . 2.6099999999999999 107.875 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.625 HD12 ' HG ' ' A' ' 61' ' ' LEU . 10.9 mt -123.66 60.1 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.648 -1.282 . . . . 0.81000000000000005 110.312 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' ' 103' ' ' ASN . 0.4 OUTLIER 44.01 24.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.554 -0.716 . . . . 0.82999999999999996 110.005 179.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 162.85 -47.23 0.33 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.01 -1.236 . . . . 0.31 110.01 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.625 ' HG ' HD12 ' A' ' 58' ' ' LEU . 12.3 tp -107.67 117.63 34.61 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.117 -1.225 . . . . 0.64000000000000001 109.051 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.6 mt-10 -100.8 128.26 46.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 3.9100000000000001 109.937 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.71 HG23 ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -117.1 178.05 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 122.419 1.104 . . . . 1.29 110.04 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.71 ' N ' HG23 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -110.49 143.03 41.44 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.8 -1.185 . . . . 3.7200000000000002 107.8 178.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.131 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 2.9 t -110.87 104.27 55.87 Favored Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 120.977 -1.077 . . . . 0.26000000000000001 111.523 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.523 ' O ' HG23 ' A' ' 68' ' ' ILE . 36.4 Cg_endo -81.81 -154.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.4 2.733 . . . . 0.20000000000000001 109.639 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.91 29.39 64.81 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.792 -1.323 . . . . 0.54000000000000004 109.792 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.689 HG21 HD13 ' A' ' 54' ' ' ILE . 9.3 pt -120.44 -162.13 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.153 -1.204 . . . . 0.34000000000000002 109.195 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.718 ' O ' HG22 ' A' ' 52' ' ' ILE . 16.6 t70 -103.55 107.05 17.73 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.445 -0.784 . . . . 0.83999999999999997 109.062 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.564 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 1.0 OUTLIER -85.76 44.55 1.12 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.268 -0.895 . . . . 0.14999999999999999 108.682 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 49.2 t30 -177.63 69.65 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.532 -1.285 . . . . 0.95999999999999996 107.532 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.515 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -56.4 -11.2 1.14 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.563 -0.71 . . . . 0.14999999999999999 111.868 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.558 ' HA ' HG22 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -61.23 -15.18 31.92 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.534 -1.354 . . . . 0.31 109.379 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.22 -25.06 60.59 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.082 -1.011 . . . . 0.83999999999999997 109.917 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.518 ' HB2' HG13 ' A' ' 88' ' ' ILE . 78.3 m-85 -102.54 -35.9 8.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.203 -0.936 . . . . 0.45000000000000001 109.189 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.982 HG23 HD21 ' A' ' 80' ' ' LEU . 2.0 m -96.02 166.07 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.134 -1.061 . . . . 0.17000000000000001 108.134 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.637 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -88.24 93.1 9.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.945 -1.097 . . . . 0.68000000000000005 110.692 -178.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.511 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 11.9 p -90.06 154.04 47.15 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 107.682 -1.229 . . . . 0.17000000000000001 107.682 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.707 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 26.3 Cg_endo -68.7 133.56 24.26 Favored 'Cis proline' 0 C--N 1.312 -1.359 0 C-N-CA 124.223 -1.157 . . . . 0.16 112.513 2.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.982 HD21 HG23 ' A' ' 76' ' ' VAL . 13.1 mt -76.86 112.42 13.44 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.782 -1.562 . . . . 0.81999999999999995 106.782 178.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.8 t -80.77 136.79 22.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 C-N-CA 119.707 -0.797 . . . . 0.23000000000000001 110.114 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 45' ' ' GLN . 25.0 tttm -60.54 110.42 1.27 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.648 0.737 . . . . 3.1299999999999999 110.253 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 126.71 -16.46 6.54 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 110.264 -1.134 . . . . 0.39000000000000001 110.264 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.583 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 13.6 tp60 -97.99 157.39 16.14 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.125 -1.22 . . . . 0.52000000000000002 108.162 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -110.68 143.13 41.63 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.074 -1.084 . . . . 1.0800000000000001 108.074 179.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.637 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 19.0 m-85 -125.94 152.83 45.12 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.409 -0.807 . . . . 0.20000000000000001 110.438 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.45 ' C ' ' OD1' ' A' ' 87' ' ' ASP . 24.0 t0 -119.49 113.18 20.35 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.882 -1.155 . . . . 4.0700000000000003 107.882 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.624 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 9.1 tt -106.71 126.75 62.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.361 -0.936 . . . . 0.39000000000000001 111.506 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.501 ' HA ' ' HG3' ' A' ' 38' ' ' GLU . 0.7 OUTLIER -100.59 119.89 39.21 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 105.124 -2.176 . . . . 2.04 105.124 176.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.544 ' OH ' ' N ' ' A' ' 69' ' ' ASP . 34.4 t80 -138.03 140.74 40.24 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.051 -1.46 . . . . 0.51000000000000001 112.698 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.501 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -92.74 138.96 31.04 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.512 -1.662 . . . . 0.79000000000000004 106.512 177.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.131 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 26.4 t90 -120.27 82.73 1.94 Allowed 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.949 -1.094 . . . . 0.69999999999999996 109.472 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -61.28 108.51 0.93 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.591 -0.693 . . . . 1.55 109.958 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.046 HG23 ' O ' ' A' ' 33' ' ' LYS . 33.9 t -47.39 144.04 4.87 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.134 -1.062 . . . . 1.1899999999999999 108.134 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.718 ' HG3' HG13 ' A' ' 65' ' ' VAL . 26.7 Cg_endo -68.67 -8.7 24.03 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.854 2.369 . . . . 3.7200000000000002 113.038 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 0.9 OUTLIER 77.84 -17.82 0.54 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.913 -1.117 . . . . 3.3199999999999998 110.665 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.523 ' O ' ' C ' ' A' ' 98' ' ' ALA . 11.8 pt -88.11 -25.62 5.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 120.704 -1.247 . . . . 0.69999999999999996 108.335 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.854 ' HB1' HD13 ' A' ' 127' ' ' ILE . . . -33.84 116.77 0.48 Allowed Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.92 -0.771 . . . . 0.56999999999999995 108.92 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.606 ' O ' ' N ' ' A' ' 101' ' ' SER . 36.0 Cg_endo -83.6 129.41 4.93 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.674 2.249 . . . . 0.77000000000000002 109.165 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -46.93 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.457 -0.942 . . . . 3.8799999999999999 108.457 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -103.38 124.42 48.67 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.167 -0.679 . . . . 1.6499999999999999 109.167 -178.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 101' ' ' SER . 6.4 pt-20 -41.65 -46.38 3.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.443 -0.786 . . . . 0.82999999999999996 110.022 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.41 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 1.9 t30 -129.36 140.68 51.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.901 -1.124 . . . . 0.81000000000000005 110.223 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.757 HG21 ' CD1' ' A' ' 127' ' ' ILE . 2.7 t -133.1 147.22 31.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.531 -0.731 . . . . 0.20000000000000001 109.377 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 57' ' ' SER . 2.7 t -123.31 118.85 55.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.516 -1.29 . . . . 0.53000000000000003 107.516 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.1 t -100.92 142.49 15.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.281 -0.887 . . . . 0.29999999999999999 110.039 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 24.1 m -122.52 117.15 25.24 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.607 -0.683 . . . . 0.34999999999999998 109.358 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -94.9 129.12 45.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 107.001 -1.481 . . . . 0.34000000000000002 107.001 178.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.915 ' CD ' HD11 ' A' ' 111' ' ' ILE . 0.7 OUTLIER -140.08 130.79 25.8 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.363 -1.461 . . . . 1.05 112.05 -177.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.702 HD11 ' CE2' ' A' ' 41' ' ' PHE . 14.1 mt -101.79 143.01 32.23 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.945 -1.502 . . . . 0.34999999999999998 106.945 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.915 HD11 ' CD ' ' A' ' 109' ' ' LYS . 4.2 mp -136.4 116.89 17.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 120.823 -1.173 . . . . 0.42999999999999999 111.065 -177.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.43 -169.71 41.96 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.202 -1.959 . . . . 0.95999999999999996 108.202 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.58 1.67 25.15 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.035 -1.274 . . . . 1.05 109.709 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.37 -6.51 12.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.197 -0.939 . . . . 4.71 110.702 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.91 -153.12 24.91 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.537 -1.316 . . . . 0.51000000000000001 110.209 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.623 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -85.08 110.03 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.382 -1.069 . . . . 0.35999999999999999 109.606 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.694 HD11 HG21 ' A' ' 47' ' ' THR . 26.7 mt -58.66 -39.89 81.92 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.206 -0.934 . . . . 0.23000000000000001 109.816 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.524 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -154.87 -162.64 1.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.989 -1.07 . . . . 0.16 109.468 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.489 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 53.4 t 178.88 154.6 0.42 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.029 -1.045 . . . . 0.32000000000000001 109.499 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.27 152.31 32.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.03 -1.044 . . . . 0.28000000000000003 109.695 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 53.5 mt -134.99 140.2 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.2 -0.937 . . . . 0.84999999999999998 109.083 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.19 119.46 38.9 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.456 -1.402 . . . . 0.72999999999999998 108.571 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 51.3 p -70.12 -33.24 71.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -0.839 . . . . 2.1099999999999999 110.498 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -120.97 154.89 35.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.95 -1.094 . . . . 1.3500000000000001 110.098 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 126' ' ' LYS . . . 166.1 155.3 8.71 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.476 -1.449 . . . . 0.55000000000000004 109.476 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 125' ' ' GLY . 30.6 mttt -154.88 138.09 15.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -1.197 . . . . 1.8100000000000001 108.563 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.854 HD13 ' HB1' ' A' ' 98' ' ' ALA . 67.0 mt -104.17 140.7 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.508 -1.37 . . . . 0.44 109.769 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.542 ' HG3' HG23 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -124.86 154.21 41.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.465 -0.772 . . . . 5.0700000000000003 109.824 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.41 ' HB3' ' HG3' ' A' ' 100' ' ' LYS . 2.9 p30 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 118.0 -1.0 . . . . 4.6799999999999997 109.563 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.334 0.588 . . . . 2.5499999999999998 109.492 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 17' ' ' MET . 0.0 OUTLIER -66.55 159.69 26.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 2.8199999999999998 109.483 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.483 ' CG1' ' HB3' ' A' ' 21' ' ' CYS . 3.0 m -99.16 167.24 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.68000000000000005 109.307 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 4' ' ' ASP . 51.9 t0 -92.53 124.21 36.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.87 110.211 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.3 m -146.27 148.93 16.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.464 -0.939 . . . . 0.25 108.464 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.23 110.33 21.5 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.095 -1.003 . . . . 2.8500000000000001 109.609 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -53.91 142.92 22.89 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.335 -0.853 . . . . 3.54 109.374 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.92 -14.17 11.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.344 -0.847 . . . . 0.95999999999999996 108.963 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.94 -65.65 0.67 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.868 0.842 . . . . 0.23999999999999999 109.199 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.47 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 3.4 t-20 173.98 59.23 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.134 -1.061 . . . . 4.4500000000000002 108.134 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 53.12 21.37 2.12 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.972 -1.08 . . . . 1.76 108.087 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.496 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 19.7 mm-40 -64.67 -61.27 2.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.582 -0.699 . . . . 3.52 109.363 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER -58.95 127.35 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.34999999999999998 109.459 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.565 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 11.4 mmpt? -77.13 -19.83 56.4 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.242 -0.911 . . . . 0.53000000000000003 108.899 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.567 ' H ' HG22 ' A' ' 13' ' ' ILE . 0.8 OUTLIER 156.59 128.54 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.882 -0.784 . . . . 2.3799999999999999 108.882 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.73 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -108.33 123.18 63.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.377 -0.972 . . . . 0.59999999999999998 108.377 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.48 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 1.3 mtm -117.03 148.05 41.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.049 -1.032 . . . . 1.8899999999999999 110.796 -178.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.488 HG12 ' OD1' ' A' ' 19' ' ' ASP . 31.6 t -103.9 158.03 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.385 -0.968 . . . . 0.82999999999999996 108.385 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.488 ' OD1' HG12 ' A' ' 18' ' ' VAL . 8.8 p-10 -44.12 -31.28 0.92 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.092 -1.005 . . . . 4.1100000000000003 109.802 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.92 97.45 0.12 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.57 -1.3 . . . . 2.5099999999999998 110.27 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -108.48 -66.78 1.02 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -1.135 . . . . 3.4300000000000002 108.913 179.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.489 ' N ' ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER 168.93 -27.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.833 . . . . 4.3099999999999996 109.66 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 101.13 -135.71 12.31 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.957 -1.257 . . . . 1.6100000000000001 109.957 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 23' ' ' GLY . 29.1 t -40.4 -34.68 0.36 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.534 -0.98 . . . . 1.51 109.988 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.439 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -67.12 164.92 31.55 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 2.25 109.42 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 25' ' ' ASP . 34.3 Cg_endo -78.03 162.18 29.21 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.692 2.261 . . . . 2.1699999999999999 109.844 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.6 m -116.62 153.51 32.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.909 . . . . 0.93999999999999995 109.371 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.515 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 47.8 mm -107.37 109.13 27.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.911 -1.118 . . . . 0.46999999999999997 108.872 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.467 HG23 HG21 ' A' ' 94' ' ' VAL . 1.9 mt -91.19 119.31 38.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.444 -0.785 . . . . 0.40999999999999998 109.357 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.415 ' HB2' ' HD2' ' A' ' 33' ' ' LYS . 24.6 m-70 -84.41 114.57 22.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.368 -0.832 . . . . 1.1699999999999999 110.122 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.718 ' HG3' ' HB3' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -48.12 148.41 1.79 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.566 -0.709 . . . . 1.99 111.127 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.73 -22.55 4.03 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.923 -0.871 . . . . 0.93000000000000005 110.923 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -93.01 155.18 41.53 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.77 -1.43 . . . . 2.9399999999999999 109.745 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.465 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 36.4 Cg_endo -79.11 162.21 26.06 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.863 2.376 . . . . 1.3999999999999999 110.689 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 92' ' ' TRP . 2.5 t80 -135.08 122.14 21.33 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.172 -1.048 . . . . 0.64000000000000001 108.172 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 2.9 m -96.36 128.2 43.06 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.77 -1.207 . . . . 0.97999999999999998 110.427 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.41 123.44 15.47 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.359 -0.838 . . . . 3.3999999999999999 108.767 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 89' ' ' LYS . 5.6 mt-10 -96.96 126.9 42.43 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.31 -0.996 . . . . 2.3999999999999999 108.31 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.73 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -123.97 118.96 28.2 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.875 -1.13 . . . . 0.37 110.386 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 5.9 mt -92.76 141.9 27.94 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.505 -1.665 . . . . 0.33000000000000002 106.505 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.621 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 27.8 p90 -158.23 142.13 15.58 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 120.695 -1.253 . . . . 0.20999999999999999 109.751 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.8 m-20 -87.06 110.88 20.39 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.408 -0.917 . . . . 0.60999999999999999 108.728 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -46.3 114.1 0.74 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.61 -0.681 . . . . 0.13 109.398 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.425 ' OD1' ' C ' ' A' ' 44' ' ' ASN . 4.0 p30 -85.31 9.76 14.47 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.191 -0.943 . . . . 0.28999999999999998 109.425 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.565 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 6.0 pt20 -166.24 149.16 7.17 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.297 -0.877 . . . . 0.62 109.412 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -86.27 106.16 17.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.057 -1.027 . . . . 2.0600000000000001 108.963 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.88 154.32 38.47 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.293 -0.879 . . . . 0.40000000000000002 109.787 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.724 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 11.0 mmmt -89.22 -12.44 40.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.53000000000000003 109.755 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 p -146.47 137.35 24.17 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.156 0.979 . . . . 0.53000000000000003 110.195 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -127.93 149.17 50.44 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.357 -1.349 . . . . 0.51000000000000001 107.357 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.587 ' HD2' ' CB ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -135.27 140.58 45.31 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.646 -0.822 . . . . 2.04 110.492 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.576 ' O ' HG23 ' A' ' 52' ' ' ILE . 7.0 tt -109.6 124.66 66.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.271 -0.893 . . . . 1.3799999999999999 108.836 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 11.4 pt-20 -129.79 117.71 20.66 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.478 -1.304 . . . . 2.04 107.478 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.756 ' H ' HD12 ' A' ' 54' ' ' ILE . 3.8 mp -93.14 136.24 25.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 121.448 -0.782 . . . . 0.59999999999999998 109.146 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 64' ' ' ASP . 49.8 mttt -119.05 131.9 55.99 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.225 -1.028 . . . . 0.60999999999999999 108.225 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -116.33 154.38 30.3 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 120.7 -1.25 . . . . 0.77000000000000002 111.608 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.804 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -120.14 150.75 40.13 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.71 -1.219 . . . . 0.51000000000000001 107.71 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.844 HD13 ' CD ' ' A' ' 99' ' ' PRO . 3.4 mt -132.55 75.02 1.61 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.823 -1.173 . . . . 2.0 110.428 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER 40.51 25.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.596 -0.69 . . . . 1.73 110.274 179.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 152.35 -29.52 0.87 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.387 -1.387 . . . . 1.54 110.443 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.85 HD23 ' HG3' ' A' ' 99' ' ' PRO . 4.9 tp -110.3 110.02 20.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.848 -1.384 . . . . 2.4300000000000002 110.112 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 2.0 tt0 -112.75 119.85 39.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.201 -0.937 . . . . 1.53 108.887 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.616 HG13 ' N ' ' A' ' 64' ' ' ASP . 2.2 tp -126.32 164.44 26.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 122.171 0.986 . . . . 5.4199999999999999 109.65 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.616 ' N ' HG13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -83.38 110.15 17.91 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 105.64 -1.985 . . . . 1.5900000000000001 105.64 177.056 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.1 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 3.0 t -66.5 113.68 13.89 Favored Pre-proline 0 C--N 1.293 -1.867 0 O-C-N 121.322 -0.862 . . . . 0.71999999999999997 110.786 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.477 ' O ' HG23 ' A' ' 68' ' ' ILE . 37.5 Cg_endo -81.91 -165.7 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 123.121 2.547 . . . . 0.71999999999999997 109.757 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 93' ' ' ASN . . . 58.0 56.83 23.03 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.796 -1.322 . . . . 1.3799999999999999 109.796 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.563 HD13 ' O ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -149.12 -155.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.216 -1.167 . . . . 0.83999999999999997 109.002 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.532 ' N ' ' OH ' ' A' ' 90' ' ' TYR . 38.6 t0 -114.18 112.13 22.67 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.096 -0.642 . . . . 0.72999999999999998 109.575 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.587 ' CB ' ' HD2' ' A' ' 51' ' ' LYS . 21.2 p -90.39 42.41 1.1 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.645 -1.242 . . . . 0.70999999999999996 107.645 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.62 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 8.3 t30 176.94 88.33 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.497 -1.298 . . . . 2.0299999999999998 107.497 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.923 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -76.45 7.35 4.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.45000000000000001 112.613 -176.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.552 ' HA ' HG22 ' A' ' 76' ' ' VAL . 1.6 t -65.82 -12.99 58.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.225 -1.547 . . . . 0.23000000000000001 108.837 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -78.56 -21.02 49.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.056 -1.027 . . . . 0.54000000000000004 109.819 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.421 ' HB2' HG13 ' A' ' 88' ' ' ILE . 72.1 m-85 -108.74 -20.93 12.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 0.22 108.681 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.882 HG23 HD21 ' A' ' 80' ' ' LEU . 2.0 m -113.94 165.58 8.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.687 -1.227 . . . . 0.23999999999999999 107.687 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.614 ' HG2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -92.54 93.05 8.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.983 -1.073 . . . . 1.72 111.202 -178.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.479 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 15.7 p -86.69 153.06 55.12 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 107.316 -1.364 . . . . 0.14000000000000001 107.316 177.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.724 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.5 Cg_endo -69.52 132.13 21.04 Favored 'Cis proline' 0 C--N 1.311 -1.401 0 C-N-CA 124.363 -1.099 . . . . 0.25 112.778 2.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.882 HD21 HG23 ' A' ' 76' ' ' VAL . 11.1 mt -77.12 111.11 12.38 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.777 -1.564 . . . . 0.98999999999999999 106.777 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 85.6 t -78.32 144.31 11.43 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 121.715 0.769 . . . . 0.34999999999999998 110.782 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.565 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 14.2 ttpt -67.17 110.95 3.67 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.799 0.809 . . . . 0.67000000000000004 109.858 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 124.12 -12.24 8.1 Favored Glycine 0 C--N 1.298 -1.578 0 N-CA-C 109.479 -1.448 . . . . 0.23000000000000001 109.479 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.63 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 6.8 tp60 -103.28 151.6 22.5 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.839 -1.171 . . . . 0.28000000000000003 107.839 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -103.97 144.98 30.82 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.92 -1.141 . . . . 1.6299999999999999 107.92 179.037 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.63 ' CE1' ' HG3' ' A' ' 84' ' ' GLN . 38.9 m-85 -125.67 143.56 50.98 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.008 -1.057 . . . . 0.29999999999999999 110.212 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.29 115.7 30.49 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.845 -0.798 . . . . 2.8199999999999998 108.845 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.923 HD12 ' HB1' ' A' ' 72' ' ' ALA . 3.4 tt -111.06 119.1 58.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.109 -0.995 . . . . 0.22 111.406 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.421 ' HA ' ' CG ' ' A' ' 38' ' ' GLU . 0.9 OUTLIER -94.39 119.35 33.0 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 104.662 -2.347 . . . . 2.1699999999999999 104.662 175.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.607 ' CE2' ' O ' ' A' ' 91' ' ' THR . 24.0 t80 -132.7 143.04 49.36 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 117.539 -1.664 . . . . 0.62 113.982 -175.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.607 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -92.44 144.33 25.47 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 105.742 -1.947 . . . . 1.04 105.742 176.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.1 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 22.7 t90 -127.39 97.69 4.99 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.667 -1.271 . . . . 0.70999999999999996 110.724 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 2.9 m-80 -61.75 103.08 0.31 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.646 -0.872 . . . . 1.8799999999999999 108.646 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.731 HG13 ' HD2' ' A' ' 95' ' ' PRO . 88.3 t -59.23 144.02 83.96 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.325 -0.859 . . . . 0.94999999999999996 108.747 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.952 ' HG3' HG13 ' A' ' 65' ' ' VAL . 29.4 Cg_endo -71.23 121.37 7.73 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.0 1.8 . . . . 1.1499999999999999 110.165 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.486 ' HA ' ' HG2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -66.56 -0.98 3.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.818 -0.551 . . . . 3.02 110.971 -178.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.498 ' O ' ' C ' ' A' ' 98' ' ' ALA . 9.4 pt -92.41 -25.09 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.706 -1.246 . . . . 1.0600000000000001 109.29 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.718 ' HB3' ' HG3' ' A' ' 31' ' ' ARG . . . -28.62 122.45 0.26 Allowed Pre-proline 0 N--CA 1.491 1.613 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.782 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.85 ' HG3' HD23 ' A' ' 61' ' ' LEU . 36.8 Cg_endo -87.01 115.57 1.19 Allowed 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.377 2.052 . . . . 1.03 107.995 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.518 ' CD ' ' HA ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -38.42 92.44 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.742 0.782 . . . . 4.0999999999999996 108.946 -179.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 99' ' ' PRO . 1.4 t -102.76 115.03 29.79 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.33 -0.619 . . . . 0.62 109.33 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.472 ' O ' ' HE2' ' A' ' 126' ' ' LYS . 0.1 OUTLIER -41.15 -36.28 0.71 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.684 -0.635 . . . . 3.8399999999999999 109.573 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 125' ' ' GLY . 1.5 t30 -128.48 138.36 52.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 2.3199999999999998 110.097 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 1.026 HG21 HG13 ' A' ' 127' ' ' ILE . 20.2 t -135.79 150.54 28.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.573 -0.704 . . . . 1.3899999999999999 109.896 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.539 HG23 ' OG ' ' A' ' 57' ' ' SER . 2.9 t -123.33 117.62 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.229 -1.026 . . . . 0.82999999999999996 108.229 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.31 142.22 15.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 120.966 -1.084 . . . . 0.45000000000000001 110.195 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 34.3 m -125.9 117.05 22.49 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.802 -0.561 . . . . 0.38 109.586 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER -96.78 125.79 49.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 106.945 -1.502 . . . . 0.31 106.945 178.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.854 ' HD2' HD11 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -135.41 137.03 41.86 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.552 -1.342 . . . . 1.02 111.504 -177.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.856 ' C ' HD12 ' A' ' 111' ' ' ILE . 10.0 mt -113.87 139.97 48.73 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.66 -1.607 . . . . 0.37 106.66 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.856 HD12 ' C ' ' A' ' 110' ' ' LEU . 3.7 mp -134.17 115.99 21.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 120.707 -1.245 . . . . 0.28999999999999998 110.769 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.08 -150.85 16.26 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.364 -1.894 . . . . 0.62 108.364 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -96.65 -0.6 48.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.082 -1.246 . . . . 1.22 109.551 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.98 -2.52 12.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.095 -1.003 . . . . 4.25 110.401 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.28 -164.65 29.35 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.847 -1.301 . . . . 0.28000000000000003 109.847 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.568 ' CG1' ' CD ' ' A' ' 109' ' ' LYS . 1.8 t -77.97 112.02 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -1.128 . . . . 0.39000000000000001 109.671 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.93 -38.67 76.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 0.38 110.014 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.539 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -157.07 -171.05 3.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.001 -1.062 . . . . 0.35999999999999999 109.128 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -177.44 151.24 0.75 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.263 -0.898 . . . . 0.46999999999999997 109.393 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -149.63 153.2 36.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.045 . . . . 0.39000000000000001 109.771 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.5 mt -134.81 138.91 48.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.371 -0.831 . . . . 0.89000000000000001 108.783 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.07 133.62 34.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.84 -1.162 . . . . 0.91000000000000003 109.732 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -68.41 0.34 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.466 -0.771 . . . . 2.4900000000000002 109.928 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -128.76 142.07 51.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.9 . . . . 4.6600000000000001 110.322 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -156.83 175.32 34.4 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.895 -1.682 . . . . 0.40000000000000002 108.895 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' A' ' 102' ' ' GLU . 31.0 ttmt -153.07 138.44 17.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -1.14 . . . . 2.6200000000000001 108.45 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 1.026 HG13 HG21 ' A' ' 104' ' ' VAL . 62.0 mt -106.61 140.31 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.427 -1.421 . . . . 0.32000000000000001 109.738 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.518 ' HA ' ' CD ' ' A' ' 100' ' ' LYS . 10.4 mtt180 -132.42 174.93 9.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.401 -0.812 . . . . 2.02 108.948 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.2 t0 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.005 -1.06 . . . . 2.5699999999999998 109.702 -179.759 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 17' ' ' MET . 4.3 m-20 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.203 -0.665 . . . . 2.5800000000000001 109.203 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.531 ' CB ' ' HG2' ' A' ' 17' ' ' MET . 1.5 pt20 -109.08 154.33 22.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.166 -0.959 . . . . 1.73 109.991 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.586 HG21 HG23 ' A' ' 18' ' ' VAL . 2.3 m -105.58 162.97 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.33 -0.857 . . . . 0.20000000000000001 109.121 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.32 126.28 38.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 3.3599999999999999 109.141 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 121' ' ' ILE . 27.6 m -143.69 162.64 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.874 -0.787 . . . . 0.75 108.874 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -112.82 104.42 12.43 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.151 -1.055 . . . . 4.21 108.151 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -45.14 113.04 0.51 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.406 -0.809 . . . . 1.21 110.18 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.507 ' HB3' HG13 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -83.84 -7.47 59.44 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.636 -0.875 . . . . 0.91000000000000003 108.636 179.225 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.536 ' N ' ' HB3' ' A' ' 119' ' ' CYS . . . -88.54 -79.52 0.31 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.371 -0.83 . . . . 0.96999999999999997 109.5 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 178.83 61.13 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.761 -0.776 . . . . 1.3600000000000001 109.682 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 57.93 17.98 4.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.293 -0.879 . . . . 0.95999999999999996 109.362 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.412 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -67.83 -66.81 0.52 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.355 -0.841 . . . . 1.4099999999999999 109.606 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.695 HD13 ' HB1' ' A' ' 39' ' ' ALA . 0.9 OUTLIER -56.23 120.0 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.0 -1.063 . . . . 0.60999999999999999 109.769 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.596 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -61.0 -29.08 69.49 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.443 -0.786 . . . . 2.02 109.452 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.596 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 6.9 pttt 168.07 131.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.579 -0.897 . . . . 0.83999999999999997 108.579 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.104 HG23 ' HB2' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -108.18 130.79 60.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.054 -1.091 . . . . 0.42999999999999999 108.054 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.531 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 8.2 mtm -122.63 153.22 39.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.074 -1.016 . . . . 0.65000000000000002 111.012 -177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.075 HG11 ' CE2' ' A' ' 35' ' ' PHE . 2.5 t -127.0 128.36 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.577 -0.898 . . . . 0.62 108.577 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.79 -17.39 35.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.149 -0.969 . . . . 2.4500000000000002 110.496 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 21' ' ' CYS . . . -88.33 -94.68 1.01 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.646 -1.381 . . . . 1.1299999999999999 109.646 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' O ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -47.53 173.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.213 -1.169 . . . . 0.68999999999999995 108.975 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.493 ' NE2' ' CB ' ' A' ' 25' ' ' ASP . 5.5 p80 -139.48 3.34 2.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.927 -1.108 . . . . 4.3799999999999999 110.594 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.13 -157.51 27.91 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.054 -1.545 . . . . 1.21 110.951 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.468 ' O ' ' C ' ' A' ' 25' ' ' ASP . 5.0 t -41.35 -36.27 0.79 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.613 -0.934 . . . . 2.75 110.553 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.493 ' CB ' ' NE2' ' A' ' 22' ' ' HIS . 0.7 OUTLIER -39.92 157.18 0.15 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.5 -0.75 . . . . 2.1200000000000001 109.607 -179.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.82 138.88 19.22 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.957 2.438 . . . . 0.82999999999999996 110.746 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -116.25 132.66 56.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.446 -0.784 . . . . 0.93000000000000005 109.331 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.571 HG22 ' CD2' ' A' ' 30' ' ' HIS . 46.6 mm -101.97 109.31 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.019 -1.051 . . . . 0.65000000000000002 108.616 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.3 mt -92.53 113.43 27.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.212 -0.93 . . . . 0.62 109.391 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.571 ' CD2' HG22 ' A' ' 28' ' ' ILE . 5.7 m170 -89.63 105.97 18.15 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.468 -1.308 . . . . 1.3999999999999999 107.468 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.769 ' HA ' HG11 ' A' ' 94' ' ' VAL . 2.6 ptt180 -45.26 152.55 0.27 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.055 -1.028 . . . . 1.0800000000000001 110.051 -178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.453 ' HA2' ' HD3' ' A' ' 96' ' ' LYS . . . 94.58 -15.88 62.36 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.57 -1.412 . . . . 0.41999999999999998 109.57 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.505 ' HE2' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -102.3 152.51 38.3 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.178 -1.189 . . . . 2.1099999999999999 109.445 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -81.3 119.85 3.53 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.886 2.391 . . . . 0.5 110.825 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 1.075 ' CE2' HG11 ' A' ' 18' ' ' VAL . 5.2 t80 -97.83 116.81 30.78 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.945 -1.502 . . . . 0.68999999999999995 106.945 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.94 ' C ' HD13 ' A' ' 37' ' ' LEU . 28.3 m -96.21 131.03 43.12 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.15 -0.969 . . . . 0.68999999999999995 110.838 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.94 HD13 ' C ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -134.64 141.63 46.64 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.696 -0.854 . . . . 0.40999999999999998 108.696 178.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 0.7 OUTLIER -121.66 127.09 50.42 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.293 -1.003 . . . . 1.1599999999999999 108.293 -179.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 1.104 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -132.75 121.51 23.16 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.597 -1.314 . . . . 0.33000000000000002 110.513 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.578 HD23 ' HB3' ' A' ' 87' ' ' ASP . 2.3 mt -88.28 145.03 26.08 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 105.488 -2.041 . . . . 0.90000000000000002 105.488 177.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.659 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 28.2 p90 -157.15 141.93 16.84 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.143 -1.423 . . . . 0.27000000000000002 110.38 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 26.8 m-20 -85.51 111.01 19.61 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.202 -0.936 . . . . 1.3600000000000001 108.79 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -46.82 114.8 0.9 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.703 -0.623 . . . . 0.28999999999999998 109.329 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.453 ' OD1' HD23 ' A' ' 117' ' ' LEU . 38.8 p30 -83.66 7.85 16.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.096 -1.003 . . . . 1.9199999999999999 109.847 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.53 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 3.5 pt20 -168.39 162.02 12.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.068 -1.02 . . . . 0.84999999999999998 109.685 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 10.7 p-10 -89.1 120.55 30.59 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.215 -0.928 . . . . 2.75 109.245 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -141.6 141.74 33.46 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.56999999999999995 110.17 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.677 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 8.0 mmmt -84.12 -11.45 56.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.54 -0.725 . . . . 0.75 109.688 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.2 p -144.75 138.1 26.94 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.977 0.894 . . . . 0.55000000000000004 109.729 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -126.57 153.23 45.52 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.691 -0.855 . . . . 0.37 108.691 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 0.5 OUTLIER -132.09 136.92 47.52 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.959 -1.088 . . . . 0.40000000000000002 110.833 -179.035 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.696 HG22 ' O ' ' A' ' 69' ' ' ASP . 4.5 tt -93.61 148.95 4.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.527 -1.286 . . . . 0.68999999999999995 107.527 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.413 ' N ' HG12 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -139.07 116.8 11.47 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.146 -0.972 . . . . 0.77000000000000002 109.142 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.795 HD13 HG21 ' A' ' 68' ' ' ILE . 2.8 mp -116.12 116.84 53.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 119.256 -0.978 . . . . 0.29999999999999999 109.259 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.475 ' HA ' HG23 ' A' ' 65' ' ' VAL . 26.6 mtmt -114.87 159.45 20.65 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.181 -0.95 . . . . 0.87 108.993 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.59 122.56 22.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.884 -1.135 . . . . 0.28999999999999998 110.482 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -93.21 150.85 20.2 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.777 -0.823 . . . . 2.7000000000000002 108.777 179.261 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.823 HD11 HD11 ' A' ' 63' ' ' ILE . 20.4 mt -103.29 38.78 1.7 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.193 -0.942 . . . . 1.05 109.491 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 4.3 t0 72.58 5.46 5.24 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.512 -0.743 . . . . 2.0600000000000001 109.324 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.06 -35.68 0.03 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.911 -1.275 . . . . 1.6499999999999999 109.911 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 61' ' ' LEU . 7.0 mp -114.05 113.41 24.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.988 -1.301 . . . . 4.7999999999999998 109.664 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 17.0 tt0 -77.78 137.05 38.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.967 -1.083 . . . . 1.71 109.936 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.823 HD11 HD11 ' A' ' 58' ' ' LEU . 74.0 mt -123.01 169.54 14.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-O 121.687 0.756 . . . . 1.2 109.079 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.686 ' N ' HG22 ' A' ' 63' ' ' ILE . 3.6 m-20 -114.18 129.59 56.62 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.198 -1.408 . . . . 2.1800000000000002 107.198 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.066 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 2.7 t -103.26 112.67 65.86 Favored Pre-proline 0 C--N 1.303 -1.451 0 O-C-N 120.848 -1.157 . . . . 0.33000000000000002 111.418 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.565 ' O ' HG23 ' A' ' 68' ' ' ILE . 36.3 Cg_endo -82.71 -154.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.261 2.641 . . . . 0.42999999999999999 109.522 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.23 31.86 74.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.641 -1.384 . . . . 0.93000000000000005 109.641 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.795 HG21 HD13 ' A' ' 54' ' ' ILE . 17.8 pt -125.79 -165.33 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.315 -1.109 . . . . 0.40000000000000002 108.968 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.696 ' O ' HG22 ' A' ' 52' ' ' ILE . 38.7 t0 -103.05 112.32 25.1 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.221 -0.924 . . . . 1.47 109.495 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.515 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 10.3 p -87.11 45.46 1.27 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.492 -0.929 . . . . 0.34999999999999998 108.492 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 23.8 t30 -179.85 74.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.429 -1.322 . . . . 0.92000000000000004 107.429 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.617 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -59.5 -5.84 0.93 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.629 -0.669 . . . . 0.19 112.1 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.589 ' HA ' HG22 ' A' ' 76' ' ' VAL . 1.3 t -62.71 -14.34 43.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.43 -1.419 . . . . 0.20000000000000001 108.621 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -25.81 63.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.964 . . . . 0.92000000000000004 109.858 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.482 ' HB2' HG13 ' A' ' 88' ' ' ILE . 68.2 m-85 -111.62 -23.8 10.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.838 . . . . 0.27000000000000002 109.896 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.851 ' CG2' HD21 ' A' ' 80' ' ' LEU . 1.5 m -104.42 171.69 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.047 -1.094 . . . . 0.25 108.047 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.592 ' HG3' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -94.27 92.43 7.21 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.156 -0.965 . . . . 1.3200000000000001 110.82 -178.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.486 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 15.3 p -90.12 149.62 41.82 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 107.579 -1.267 . . . . 0.20999999999999999 107.579 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.677 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.7 Cg_endo -70.17 133.86 27.98 Favored 'Cis proline' 0 C--N 1.312 -1.367 0 C-N-CA 124.171 -1.179 . . . . 0.17000000000000001 112.906 2.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.851 HD21 ' CG2' ' A' ' 76' ' ' VAL . 14.0 mt -75.54 112.89 12.34 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.832 -1.544 . . . . 0.25 106.832 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 45.8 t -80.85 138.91 18.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 CA-C-O 121.668 0.746 . . . . 0.52000000000000002 110.679 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.53 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 34.9 tttt -64.24 112.43 3.04 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.666 0.746 . . . . 2.1200000000000001 109.326 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.87 -14.25 9.73 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 109.927 -1.269 . . . . 0.39000000000000001 109.927 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.617 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 2.9 tp-100 -101.17 153.12 19.87 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.83 -1.174 . . . . 2.3799999999999999 107.83 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -102.61 155.52 18.24 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.811 -1.181 . . . . 1.9099999999999999 107.811 178.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.648 ' CE2' HD23 ' A' ' 80' ' ' LEU . 63.3 m-85 -134.81 151.8 51.23 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.065 -1.022 . . . . 0.34000000000000002 109.981 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.578 ' HB3' HD23 ' A' ' 40' ' ' LEU . 4.5 p-10 -120.62 113.43 20.23 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.253 -0.905 . . . . 0.65000000000000002 109.624 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.717 ' HB ' HG12 ' A' ' 76' ' ' VAL . 5.4 tt -110.78 121.59 63.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.271 -0.893 . . . . 0.28000000000000003 111.705 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -104.11 109.75 21.66 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 104.741 -2.318 . . . . 2.75 104.741 175.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.632 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 39.7 t80 -125.42 142.33 51.56 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.83 -1.169 . . . . 0.41999999999999998 113.174 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.632 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.2 144.14 25.93 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.625 -1.62 . . . . 0.89000000000000001 106.625 176.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.066 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 24.7 t90 -118.83 87.79 2.8 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.896 -1.128 . . . . 0.68000000000000005 110.328 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -64.19 104.12 0.7 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.471 0.653 . . . . 1.5900000000000001 109.351 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.879 HG12 ' H ' ' A' ' 96' ' ' LYS . 52.2 t -56.14 143.56 63.1 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.524 -0.735 . . . . 1.8 109.312 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.7 ' HD2' HG13 ' A' ' 94' ' ' VAL . 25.0 Cg_endo -64.92 -3.35 6.86 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.835 2.356 . . . . 3.9300000000000002 111.992 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.879 ' H ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER 66.81 1.38 2.22 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.982 -1.074 . . . . 3.25 109.515 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.519 ' O ' ' C ' ' A' ' 98' ' ' ALA . 10.0 pt -100.45 -30.16 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 120.96 -1.087 . . . . 0.54000000000000004 108.399 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.574 ' HB1' HD13 ' A' ' 127' ' ' ILE . . . -33.15 117.93 0.44 Allowed Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.637 -0.875 . . . . 0.47999999999999998 108.637 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 98' ' ' ALA . 32.7 Cg_endo -79.18 174.5 11.97 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.541 2.161 . . . . 0.98999999999999999 110.19 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.516 ' HE3' ' HG2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -80.84 72.32 7.82 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.513 -0.921 . . . . 4.0499999999999998 108.513 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.867 ' OG ' HG23 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -81.84 103.85 11.8 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.595 -0.891 . . . . 2.2200000000000002 108.595 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.54 ' HG3' ' N ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -41.3 -30.17 0.17 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.34 -0.85 . . . . 5.0300000000000002 109.565 -179.161 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.54 ' N ' ' HG3' ' A' ' 102' ' ' GLU . 0.6 OUTLIER -132.96 132.01 41.46 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.152 -0.967 . . . . 2.4399999999999999 109.542 179.219 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.904 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.9 OUTLIER -132.05 144.59 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.342 -0.849 . . . . 0.84999999999999998 109.978 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 122' ' ' ALA . 31.8 t -119.79 113.83 42.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.468 -1.308 . . . . 0.46000000000000002 107.468 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.58 137.6 23.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 120.721 -1.237 . . . . 0.34000000000000002 110.361 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 81.5 m -118.59 125.27 49.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.811 -0.556 . . . . 0.55000000000000004 109.76 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -102.42 129.9 53.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.322 -1.362 . . . . 0.33000000000000002 107.322 178.2 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.55 ' HG2' ' CG1' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -141.04 131.15 24.74 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.078 -1.639 . . . . 1.8100000000000001 112.296 -178.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.659 ' CD1' ' CE2' ' A' ' 41' ' ' PHE . 16.2 mt -104.36 139.62 39.06 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.671 -1.603 . . . . 0.34999999999999998 106.671 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.615 HD12 ' C ' ' A' ' 110' ' ' LEU . 5.1 mp -138.66 112.06 7.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 120.66 -1.275 . . . . 0.39000000000000001 110.289 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.75 -150.19 7.81 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.481 -1.847 . . . . 0.56000000000000005 108.481 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.28 -1.74 50.83 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.219 -1.165 . . . . 1.6799999999999999 109.759 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -115.04 -0.36 13.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -0.956 . . . . 2.4900000000000002 110.714 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.62 -169.61 27.78 Favored Glycine 0 N--CA 1.496 2.662 0 C-N-CA 119.525 -1.322 . . . . 0.54000000000000004 110.305 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.55 ' CG1' ' HG2' ' A' ' 109' ' ' LYS . 44.4 t -77.5 111.2 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.296 -1.12 . . . . 1.0700000000000001 109.867 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.453 HD23 ' OD1' ' A' ' 44' ' ' ASN . 28.3 mt -60.35 -41.37 93.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.32000000000000001 109.874 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.645 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -151.75 176.15 11.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.967 -1.083 . . . . 0.68999999999999995 109.526 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.536 ' HB3' ' N ' ' A' ' 9' ' ' ALA . 42.8 t -164.13 154.05 14.53 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.042 -1.036 . . . . 0.56999999999999995 109.007 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -150.44 154.95 38.62 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.837 -1.164 . . . . 0.32000000000000001 110.353 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.507 HG13 ' HB3' ' A' ' 8' ' ' CYS . 72.4 mt -130.87 140.37 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.318 -0.864 . . . . 1.01 109.003 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.801 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -120.1 145.79 46.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.45 -1.406 . . . . 0.56999999999999995 109.033 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.92 170.45 15.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.084 -1.01 . . . . 2.7000000000000002 109.731 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 9.0 m80 64.34 40.52 6.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -0.848 . . . . 4.0 109.801 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 103' ' ' ASN . . . -111.13 162.78 12.37 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.273 -1.531 . . . . 0.57999999999999996 109.273 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.408 ' HB3' HD13 ' A' ' 28' ' ' ILE . 15.7 tttt -149.56 137.34 20.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -1.179 . . . . 4.3099999999999996 108.615 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.904 ' CD1' HG21 ' A' ' 104' ' ' VAL . 61.2 mt -105.53 139.74 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.604 -1.31 . . . . 0.37 110.255 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.516 ' HG2' ' HE3' ' A' ' 100' ' ' LYS . 1.4 mtm180 -133.76 162.87 30.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.467 -0.77 . . . . 4.7400000000000002 109.216 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.061 -0.971 . . . . 4.9299999999999997 109.201 179.559 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.438 -0.579 . . . . 2.9900000000000002 109.438 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -71.81 135.26 46.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.228 -0.92 . . . . 2.6600000000000001 109.407 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 3.0 m -105.49 169.03 2.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.226 -0.922 . . . . 1.1499999999999999 109.337 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -75.77 122.67 24.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 1.77 110.851 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -150.41 157.42 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.987 -1.116 . . . . 2.3500000000000001 107.987 178.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -117.42 110.26 17.79 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.083 -1.011 . . . . 3.3700000000000001 109.715 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.487 ' OD2' ' HB ' ' A' ' 13' ' ' ILE . 0.8 OUTLIER -49.65 152.49 1.42 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.482 -0.761 . . . . 1.6200000000000001 109.909 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.469 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.1 OUTLIER -128.47 27.24 5.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.264 -0.898 . . . . 2.6699999999999999 108.791 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.43 ' O ' ' OD1' ' A' ' 10' ' ' ASN . . . -116.25 -76.56 0.57 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.394 -0.816 . . . . 0.68000000000000005 109.773 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER 174.21 68.6 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.069 -0.715 . . . . 1.1699999999999999 109.069 -178.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 55.08 35.59 25.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.194 -0.941 . . . . 2.6699999999999999 108.874 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.5 ' O ' ' HE2' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -87.3 -79.2 0.28 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.456 -0.777 . . . . 1.1799999999999999 109.805 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.528 ' CD1' ' HB1' ' A' ' 118' ' ' ALA . 0.7 OUTLIER -46.36 127.64 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.53000000000000003 109.682 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.572 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -77.65 -24.99 49.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.477 -0.935 . . . . 1.1699999999999999 108.477 179.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER 167.61 129.56 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.781 -0.822 . . . . 1.9399999999999999 108.781 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.81 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -111.87 121.51 64.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.176 -1.046 . . . . 0.47999999999999998 108.176 179.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 3.4 mtm -110.48 150.78 28.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.924 -1.11 . . . . 1.3300000000000001 110.895 -178.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.641 HG11 ' CE2' ' A' ' 35' ' ' PHE . 51.5 t -119.0 159.42 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.411 -0.959 . . . . 0.59999999999999998 108.411 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.489 ' N ' HG12 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -105.12 69.19 0.84 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.017 -1.052 . . . . 1.3200000000000001 109.57 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.89 -50.41 0.27 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.648 -1.263 . . . . 0.96999999999999997 110.231 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 39.7 t -80.71 150.89 29.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.988 -1.301 . . . . 1.25 110.011 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.47 -177.08 3.97 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.415 -0.803 . . . . 3.3100000000000001 109.262 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 3' ' ' VAL . . . -65.0 -120.55 0.01 OUTLIER Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.069 -1.212 . . . . 1.9199999999999999 110.069 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLY . 14.1 p -38.55 -44.73 0.99 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.653 -0.91 . . . . 1.27 110.234 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -44.53 156.91 0.32 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.106 -0.996 . . . . 1.51 109.221 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 124' ' ' HIS . 35.9 Cg_endo -77.82 173.28 14.31 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.645 2.23 . . . . 1.3400000000000001 110.183 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.453 ' O ' HD13 ' A' ' 28' ' ' ILE . 5.4 m -122.11 135.91 54.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.068 -1.02 . . . . 0.79000000000000004 110.037 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 27' ' ' CYS . 7.7 mm -110.35 107.96 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.276 -0.89 . . . . 1.1399999999999999 108.664 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.409 HG23 HG21 ' A' ' 94' ' ' VAL . 1.4 mp -87.76 122.74 39.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.184 -0.948 . . . . 0.76000000000000001 109.632 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 12.7 m-70 -90.22 101.6 14.32 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.673 0.749 . . . . 1.1899999999999999 109.215 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.833 ' HG3' ' HB3' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -37.74 146.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.61 0.719 . . . . 1.79 111.114 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.67 -5.63 56.49 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.678 -0.969 . . . . 0.87 110.678 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -104.85 152.24 39.52 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.758 -1.436 . . . . 1.73 110.214 -179.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.81 118.41 3.1 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.101 2.534 . . . . 0.46000000000000002 111.291 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.641 ' CE2' HG11 ' A' ' 18' ' ' VAL . 2.6 t80 -97.75 123.69 41.79 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.135 -1.431 . . . . 0.65000000000000002 107.135 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.732 ' C ' HD13 ' A' ' 37' ' ' LEU . 61.8 m -107.37 136.16 47.63 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.515 -1.365 . . . . 0.34999999999999998 110.813 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.947 HD13 ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -141.21 123.59 15.79 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.938 -0.764 . . . . 0.78000000000000003 108.938 179.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -102.43 134.02 46.42 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.899 -1.148 . . . . 0.89000000000000001 107.899 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.81 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -129.62 120.14 24.76 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 118.767 -1.173 . . . . 0.41999999999999998 110.683 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.563 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 15.8 mt -89.56 140.63 29.35 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 105.378 -2.082 . . . . 0.79000000000000004 105.378 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 110' ' ' LEU . 27.3 p90 -155.2 139.2 16.38 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.046 -1.462 . . . . 0.39000000000000001 110.528 -178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 1.3 m-20 -84.54 108.96 17.58 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.987 -1.116 . . . . 1.1399999999999999 107.987 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -44.3 113.77 0.58 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.801 -0.814 . . . . 0.17000000000000001 108.801 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.477 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 7.2 p30 -83.5 10.3 9.25 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.073 -1.017 . . . . 0.57999999999999996 109.595 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.547 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 0.9 OUTLIER -168.28 158.11 9.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.382 -0.824 . . . . 0.73999999999999999 109.312 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -88.35 120.36 29.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.177 -0.952 . . . . 1.71 109.537 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.513 ' O ' ' CA ' ' A' ' 79' ' ' PRO . 3.3 t -143.74 153.09 42.07 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.244 -0.91 . . . . 0.37 109.313 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.673 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -98.61 -25.84 14.59 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.663 -1.236 . . . . 6.5099999999999998 107.663 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.408 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 24.6 p -111.3 138.33 47.91 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 122.134 0.968 . . . . 1.3999999999999999 109.766 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -142.21 154.23 44.64 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.837 -0.801 . . . . 0.46999999999999997 108.837 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.516 ' HD2' ' CB ' ' A' ' 70' ' ' THR . 1.6 mtmt -145.29 141.06 28.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.009 -1.057 . . . . 0.40000000000000002 111.038 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 69' ' ' ASP . 9.7 tt -94.69 152.05 3.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.227 -1.397 . . . . 0.45000000000000001 107.227 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -140.45 118.1 11.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.93 -1.106 . . . . 0.39000000000000001 110.15 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.781 HD12 ' N ' ' A' ' 54' ' ' ILE . 2.2 mp -117.78 115.56 48.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.017 -1.052 . . . . 0.28999999999999998 109.267 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 13.6 mttm -115.6 157.4 24.21 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.466 -0.938 . . . . 2.0899999999999999 108.466 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.52 123.95 26.09 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.692 -1.255 . . . . 0.34999999999999998 110.576 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 16.0 m -90.37 146.3 24.28 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.451 -0.944 . . . . 2.8999999999999999 108.451 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.874 HD11 ' CD1' ' A' ' 63' ' ' ILE . 15.9 mt -113.18 48.27 1.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.027 -1.045 . . . . 0.60999999999999999 109.989 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.401 ' OD2' ' CG ' ' A' ' 102' ' ' GLU . 0.4 OUTLIER 58.0 14.99 2.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.482 -0.761 . . . . 1.04 109.866 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.75 -41.61 0.16 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.964 -1.254 . . . . 1.03 109.964 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 58' ' ' LEU . 9.7 tp -106.53 111.32 23.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.204 -1.174 . . . . 0.83999999999999997 109.304 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 30.4 tt0 -83.96 134.51 34.65 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.289 -0.882 . . . . 0.69999999999999996 108.751 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.874 ' CD1' HD11 ' A' ' 58' ' ' LEU . 79.8 mt -124.89 166.46 20.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 122.011 0.91 . . . . 0.75 109.596 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.645 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -115.23 108.83 17.1 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 106.426 -1.694 . . . . 1.21 106.426 177.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.108 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 2.5 t -73.61 113.72 25.31 Favored Pre-proline 0 C--N 1.297 -1.688 0 O-C-N 121.267 -0.895 . . . . 0.40000000000000002 111.027 -177.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.511 ' O ' HG23 ' A' ' 68' ' ' ILE . 36.7 Cg_endo -83.41 -159.4 0.1 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.956 2.437 . . . . 0.71999999999999997 109.806 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.43 20.67 38.36 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.031 -1.228 . . . . 0.40999999999999998 110.031 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.762 HG22 ' CD1' ' A' ' 92' ' ' TRP . 34.0 pt -105.93 -165.93 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -1.177 . . . . 0.33000000000000002 109.09 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.67 ' O ' HG22 ' A' ' 52' ' ' ILE . 3.1 t70 -105.41 106.44 16.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 1.24 110.083 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.516 ' CB ' ' HD2' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -86.74 47.56 1.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.361 -0.977 . . . . 0.39000000000000001 108.361 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 73' ' ' CYS . 17.9 t-20 176.72 85.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.609 -1.256 . . . . 1.6200000000000001 107.609 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.654 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -73.02 8.07 1.76 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.333 -0.854 . . . . 0.34999999999999998 112.057 -177.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.486 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 2.1 m -65.13 -13.27 57.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.698 -1.251 . . . . 2.1400000000000001 109.485 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -82.27 -14.78 54.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.23 -0.919 . . . . 0.73999999999999999 109.864 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.54 ' CB ' HG13 ' A' ' 88' ' ' ILE . 35.0 m-85 -121.64 -14.15 8.22 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.205 -0.935 . . . . 0.65000000000000002 109.42 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.702 HG12 ' HB ' ' A' ' 88' ' ' ILE . 1.4 m -119.51 162.64 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.208 -0.932 . . . . 0.38 108.602 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.621 ' HG3' ' CD2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -96.65 84.2 3.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.221 -0.924 . . . . 5.7699999999999996 111.136 -178.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.525 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 5.0 p -83.09 159.51 62.4 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.694 -1.254 . . . . 0.82999999999999996 107.944 178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.673 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 23.7 Cg_endo -67.14 130.52 13.6 Favored 'Cis proline' 0 C--N 1.311 -1.422 0 C-N-CA 124.25 -1.146 . . . . 0.54000000000000004 112.281 2.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.628 HD23 ' CE2' ' A' ' 86' ' ' TYR . 14.7 mt -71.67 107.84 4.71 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.75 -1.204 . . . . 0.51000000000000001 107.75 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 61.0 t -78.69 136.11 24.54 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.347 0 CA-C-O 121.742 0.782 . . . . 0.29999999999999999 110.211 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 23.3 tttt -62.51 110.09 1.58 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.708 0.766 . . . . 2.6600000000000001 110.12 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 126.28 -16.76 6.69 Favored Glycine 0 N--CA 1.48 1.63 0 N-CA-C 110.185 -1.166 . . . . 0.14999999999999999 110.185 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.575 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 3.3 tp-100 -101.95 156.48 17.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.066 -1.255 . . . . 2.1299999999999999 108.141 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.555 ' C ' ' CD1' ' A' ' 86' ' ' TYR . 1.2 tt0 -106.02 153.69 21.68 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.096 -1.076 . . . . 1.99 108.096 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.628 ' CE2' HD23 ' A' ' 80' ' ' LEU . 23.4 m-85 -131.5 151.45 51.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.055 -1.028 . . . . 0.52000000000000002 110.218 -178.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.563 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -118.27 113.86 22.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.527 -0.733 . . . . 2.1899999999999999 110.063 -178.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.702 ' HB ' HG12 ' A' ' 76' ' ' VAL . 1.8 tt -115.59 119.41 61.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.181 -0.949 . . . . 0.47999999999999998 111.353 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -101.39 106.88 18.08 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 104.87 -2.27 . . . . 2.3100000000000001 104.87 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.627 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 32.2 t80 -119.97 141.23 49.87 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.869 -1.133 . . . . 0.38 112.544 -176.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.541 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -91.67 145.34 24.67 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.55 -1.648 . . . . 0.81999999999999995 106.55 177.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.108 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 51.3 t90 -127.03 94.26 3.98 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.243 -0.911 . . . . 0.89000000000000001 109.495 -177.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -57.42 104.88 0.19 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.66 -0.816 . . . . 2.1299999999999999 108.8 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.717 HG22 ' CZ3' ' A' ' 92' ' ' TRP . 71.4 t -58.85 141.56 85.38 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 107.879 -1.156 . . . . 0.62 107.879 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.944 ' HG3' HG13 ' A' ' 65' ' ' VAL . 29.8 Cg_endo -71.58 124.66 10.48 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 C-N-CA 121.781 1.654 . . . . 0.5 109.992 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.531 ' HA ' ' HG2' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -67.87 -2.75 7.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.534 -0.729 . . . . 3.0099999999999998 109.681 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 95' ' ' PRO . 3.8 pt -88.23 -24.59 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.54000000000000004 109.318 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.833 ' HB3' ' HG3' ' A' ' 31' ' ' ARG . . . -29.07 120.04 0.28 Allowed Pre-proline 0 N--CA 1.492 1.635 0 CA-C-N 116.054 -0.521 . . . . 0.73999999999999999 110.76 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.609 ' HG2' HD13 ' A' ' 58' ' ' LEU . 37.3 Cg_endo -86.09 133.29 4.07 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 122.565 2.176 . . . . 0.56000000000000005 108.688 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.557 ' HD2' ' N ' ' A' ' 129' ' ' ASP . 0.0 OUTLIER -50.98 91.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.851 -1.156 . . . . 5.4000000000000004 107.913 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.604 ' HB3' HG23 ' A' ' 104' ' ' VAL . 3.6 t -94.51 114.45 26.45 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.576 -0.702 . . . . 0.46000000000000002 109.465 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 11.4 pt-20 -38.85 -41.43 0.74 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.218 -0.66 . . . . 1.6000000000000001 109.218 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.429 ' N ' ' CG ' ' A' ' 102' ' ' GLU . 1.7 t-20 -134.67 140.73 46.23 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.497 -0.752 . . . . 3.0600000000000001 109.016 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.981 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.9 OUTLIER -133.47 146.74 31.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 121.344 -0.848 . . . . 0.64000000000000001 108.99 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 t -126.53 114.81 39.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.815 -1.18 . . . . 0.67000000000000004 107.815 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 55' ' ' LYS . 38.9 t -97.5 137.94 23.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.293 -0.963 . . . . 0.5 109.897 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 81.1 m -117.52 115.74 25.75 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.605 -0.684 . . . . 0.37 109.617 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.5 OUTLIER -94.79 128.57 45.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.466 -1.679 . . . . 0.45000000000000001 106.466 177.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.558 ' HG2' ' CG1' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -141.24 130.45 23.5 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.281 -1.512 . . . . 0.94999999999999996 112.378 -177.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.4 mt -102.53 139.49 38.06 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.165 -1.791 . . . . 0.80000000000000004 106.165 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.573 HD12 ' C ' ' A' ' 110' ' ' LEU . 4.5 mp -137.07 114.73 13.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.746 -1.221 . . . . 0.45000000000000001 110.25 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.475 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -87.97 -139.66 6.52 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.358 -1.897 . . . . 0.73999999999999999 108.358 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.99 -0.0 27.29 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.192 -1.181 . . . . 2.0499999999999998 109.592 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -116.41 4.53 13.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 2.0800000000000001 110.479 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 142.42 -160.23 27.26 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.709 -1.357 . . . . 0.55000000000000004 109.709 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.558 ' CG1' ' HG2' ' A' ' 109' ' ' LYS . 72.1 t -85.12 110.48 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -1.156 . . . . 1.1000000000000001 109.589 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.567 HD13 ' CD1' ' A' ' 80' ' ' LEU . 77.6 mt -57.87 -39.16 77.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.5 110.56 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.544 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -152.08 175.11 12.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.933 -1.104 . . . . 0.88 109.227 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 42.4 t -168.11 153.76 7.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.571 -1.33 . . . . 0.48999999999999999 110.018 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.13 149.79 29.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.05 -1.031 . . . . 0.45000000000000001 110.102 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.447 HD12 ' SG ' ' A' ' 8' ' ' CYS . 4.3 mt -134.58 116.66 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.941 -1.133 . . . . 0.70999999999999996 107.941 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.553 ' HB2' HG13 ' A' ' 5' ' ' VAL . . . -105.71 121.1 43.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.908 -1.12 . . . . 1.48 110.264 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.28 -156.79 0.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.438 -0.789 . . . . 2.4300000000000002 108.885 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 0.2 OUTLIER 46.54 30.41 1.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.003 -1.061 . . . . 2.1800000000000002 108.997 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -100.09 155.91 19.59 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.889 -1.148 . . . . 0.28999999999999998 110.535 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 39.7 mttm -154.0 136.33 14.92 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.435 -1.32 . . . . 2.9700000000000002 107.435 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.981 ' CD1' HG21 ' A' ' 104' ' ' VAL . 60.3 mt -107.68 134.71 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.327 -1.483 . . . . 0.26000000000000001 111.52 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.543 ' HA ' ' CD ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -116.15 177.02 4.84 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.797 -0.816 . . . . 3.1400000000000001 108.797 178.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.557 ' N ' ' HD2' ' A' ' 100' ' ' LYS . 24.6 t0 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.073 -0.965 . . . . 1.2 109.61 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.335 -0.617 . . . . 1.22 109.335 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.478 ' HB2' ' HG2' ' A' ' 17' ' ' MET . 9.3 tt0 -78.18 140.56 38.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 1.53 109.746 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.531 HG23 HG13 ' A' ' 5' ' ' VAL . 3.7 m -101.85 169.36 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.295 -0.878 . . . . 1.29 109.155 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.403 ' C ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -90.59 122.91 33.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 3.1099999999999999 110.806 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 3' ' ' VAL . 29.6 m -153.47 149.56 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.015 -1.106 . . . . 0.51000000000000001 108.015 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.27 110.31 20.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.781 -1.199 . . . . 5.0899999999999999 110.569 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.32 134.49 39.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 2.8399999999999999 108.916 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.47 ' HB3' HD13 ' A' ' 121' ' ' ILE . 4.3 p -106.61 -2.87 21.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.131 -0.98 . . . . 1.3700000000000001 110.017 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 10' ' ' ASN . . . -73.81 -58.29 3.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.13 -0.981 . . . . 1.02 109.435 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 0.2 OUTLIER 167.2 50.86 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.85 -1.167 . . . . 3.4399999999999999 107.85 -178.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 10' ' ' ASN . 3.9 t-20 63.8 15.83 9.34 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.017 -1.105 . . . . 2.0499999999999998 108.017 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.525 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -58.74 -62.1 2.12 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.501 -0.749 . . . . 1.28 109.266 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -59.19 128.27 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.37 109.583 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.567 ' O ' ' CB ' ' A' ' 15' ' ' LYS . 9.9 mmpt? -85.35 -13.98 47.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.461 -0.775 . . . . 0.59999999999999998 109.856 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.567 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.9 ttpt 156.96 127.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.06 -0.718 . . . . 1.3799999999999999 109.06 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.711 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -114.3 123.92 70.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.367 -0.833 . . . . 0.53000000000000003 108.949 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.478 ' HG2' ' HB2' ' A' ' 2' ' ' GLN . 2.8 mtm -115.76 147.84 40.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.13 -0.981 . . . . 0.82999999999999996 110.268 -179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.013 HG11 ' CE2' ' A' ' 35' ' ' PHE . 44.3 t -127.07 129.21 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.936 -0.764 . . . . 0.56000000000000005 108.936 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -83.27 87.26 6.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 1.4199999999999999 109.783 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.44 -68.07 0.22 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.531 -1.428 . . . . 0.95999999999999996 109.531 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.5 m -76.95 -167.6 0.89 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.354 -1.086 . . . . 3.25 109.418 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -141.57 175.83 9.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.041 -1.037 . . . . 4.5199999999999996 109.813 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 3' ' ' VAL . . . -114.09 150.44 18.6 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.364 -1.494 . . . . 3.3100000000000001 109.364 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER 72.71 1.5 4.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.042 -1.269 . . . . 2.0499999999999998 109.116 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.482 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 1.1 m-20 -135.43 176.01 3.18 Favored Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 108.267 -1.012 . . . . 1.6100000000000001 108.267 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 25' ' ' ASP . 34.4 Cg_endo -76.33 135.97 17.29 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.933 1.755 . . . . 0.75 109.66 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.66 139.34 47.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.369 -0.832 . . . . 2.4900000000000002 108.819 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.627 HG23 ' HG3' ' A' ' 128' ' ' ARG . 46.6 mm -112.11 115.78 50.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.167 -0.958 . . . . 0.91000000000000003 109.841 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.3 mt -103.93 118.13 50.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.505 -0.924 . . . . 0.84999999999999998 108.505 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.537 ' HB2' ' CE ' ' A' ' 33' ' ' LYS . 17.4 m-70 -84.87 125.02 32.28 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.156 -0.965 . . . . 1.04 109.241 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.579 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 3.2 ptt180 -70.78 125.47 26.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.124 -0.985 . . . . 1.29 109.84 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.56 -9.17 26.15 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.745 -1.342 . . . . 0.29999999999999999 109.745 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.537 ' CE ' ' HB2' ' A' ' 30' ' ' HIS . 1.6 ptpt -112.38 158.51 37.01 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.174 -1.192 . . . . 1.76 109.647 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 33' ' ' LYS . 36.2 Cg_endo -78.01 136.38 14.7 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 C-N-CA 122.981 2.454 . . . . 0.39000000000000001 111.484 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 1.013 ' CE2' HG11 ' A' ' 18' ' ' VAL . 2.5 t80 -117.67 116.88 27.94 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.673 -1.232 . . . . 0.73999999999999999 107.673 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.783 ' O ' HG13 ' A' ' 18' ' ' VAL . 23.1 m -96.93 137.16 36.45 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.95 -1.094 . . . . 0.93000000000000005 110.76 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.498 ' HB3' HG22 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -147.82 125.84 12.08 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.843 -0.799 . . . . 4.0099999999999998 108.843 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -100.23 125.32 46.38 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.723 -1.214 . . . . 1.4099999999999999 107.723 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.711 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -124.43 118.39 26.56 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.986 -1.086 . . . . 0.45000000000000001 110.809 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 12.3 mt -91.04 140.82 29.48 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.487 -1.671 . . . . 0.62 106.487 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.621 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 25.1 p90 -156.68 141.24 16.8 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 120.898 -1.126 . . . . 0.23999999999999999 109.193 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 7.7 m-20 -84.81 111.48 19.66 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 118.938 -1.105 . . . . 1.3600000000000001 109.057 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -45.33 113.46 0.58 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.958 -0.756 . . . . 0.13 108.958 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' OD1' ' C ' ' A' ' 44' ' ' ASN . 36.0 p30 -88.35 10.08 21.11 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.291 -0.88 . . . . 1.49 109.382 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.615 HE21 HD23 ' A' ' 117' ' ' LEU . 1.5 pt20 -165.95 144.09 5.74 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.285 -0.884 . . . . 1.9099999999999999 110.005 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -80.57 119.1 22.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -0.856 . . . . 1.3 108.998 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.54 HG21 ' HA3' ' A' ' 112' ' ' GLY . 0.1 OUTLIER -138.98 144.59 39.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.924 -1.11 . . . . 0.34999999999999998 109.849 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.69 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 20.0 mmmt -85.14 -9.37 57.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -0.888 . . . . 0.66000000000000003 109.676 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 48' ' ' LYS . 9.7 p -151.01 139.75 20.76 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.762 0.791 . . . . 0.40999999999999998 109.42 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -129.9 156.1 44.95 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 121.72 -0.613 . . . . 0.29999999999999999 109.384 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.552 ' HD2' ' CA ' ' A' ' 70' ' ' THR . 0.1 OUTLIER -128.98 127.61 42.02 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.327 -0.858 . . . . 0.57999999999999996 111.174 -178.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.757 ' HA ' HD23 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -101.57 127.58 54.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.834 -1.543 . . . . 1.21 106.834 176.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.589 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -140.71 116.68 10.44 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.1 -1.0 . . . . 4.6600000000000001 108.43 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.792 HD12 HD13 ' A' ' 68' ' ' ILE . 4.2 mp -94.2 129.94 43.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 109.335 -0.617 . . . . 0.85999999999999999 109.335 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -115.0 138.17 51.16 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.327 -0.858 . . . . 0.95999999999999996 109.64 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -119.63 128.17 53.61 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.492 -0.883 . . . . 0.51000000000000001 110.399 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.52 108.92 16.08 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.343 -0.984 . . . . 3.5899999999999999 108.343 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.827 HD23 ' N ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -77.87 -173.44 3.09 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.474 -0.766 . . . . 2.5099999999999998 110.141 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -52.57 -34.24 49.62 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.518 -0.739 . . . . 5.4199999999999999 110.371 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.67 1.06 0.8 Allowed Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.882 -1.628 . . . . 2.71 111.571 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.499 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 12.9 tp -113.39 107.69 16.2 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.528 -1.572 . . . . 3.1299999999999999 109.353 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -96.07 127.5 42.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.915 -1.116 . . . . 6.0999999999999996 108.501 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.65 ' CG2' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -149.13 171.9 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 122.302 1.048 . . . . 4.5300000000000002 109.438 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.65 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -110.89 116.32 31.04 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 106.789 -1.559 . . . . 4.6500000000000004 106.789 177.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.119 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 15.6 t -66.94 110.31 4.83 Favored Pre-proline 0 C--N 1.295 -1.766 0 O-C-N 121.667 -0.645 . . . . 0.45000000000000001 110.594 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.684 ' O ' HG23 ' A' ' 68' ' ' ILE . 42.2 Cg_endo -89.17 -157.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.719 2.946 . . . . 0.51000000000000001 109.99 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 50.85 45.86 49.29 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.26 -1.136 . . . . 0.91000000000000003 110.26 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.792 HD13 HD12 ' A' ' 54' ' ' ILE . 2.5 pt -140.43 -138.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.07 -1.253 . . . . 1.1599999999999999 109.59 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.502 ' N ' ' OH ' ' A' ' 90' ' ' TYR . 1.1 t70 -117.21 105.34 12.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.923 -1.111 . . . . 1.6000000000000001 111.178 -178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.552 ' CA ' ' HD2' ' A' ' 51' ' ' LYS . 11.0 p -92.44 49.92 1.55 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.366 -1.346 . . . . 0.73999999999999999 107.366 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 38.4 t30 177.55 81.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.231 -1.396 . . . . 0.73999999999999999 107.231 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.589 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . . . -65.58 -3.97 5.38 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.327 0.862 . . . . 0.40999999999999998 113.327 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.481 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 9.7 t -65.9 -9.19 27.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 119.928 -1.732 . . . . 0.45000000000000001 109.352 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.489 ' CD2' ' O ' ' A' ' 74' ' ' HIS . 3.3 t60 -76.26 -30.88 58.01 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.037 -1.04 . . . . 5.2000000000000002 108.34 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CD1' ' O ' ' A' ' 89' ' ' LYS . 88.3 m-85 -105.4 -17.88 14.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.1 -1.0 . . . . 0.72999999999999998 110.321 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.746 ' CG2' HD21 ' A' ' 80' ' ' LEU . 2.5 m -115.0 169.71 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.406 -0.961 . . . . 0.51000000000000001 108.406 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.624 ' HG3' ' CD2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -95.61 91.32 6.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.16 -0.963 . . . . 4.5899999999999999 111.723 -177.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.485 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 20.1 p -84.16 151.89 60.76 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 107.636 -1.246 . . . . 0.40999999999999998 107.636 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.69 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.0 Cg_endo -69.84 132.68 23.1 Favored 'Cis proline' 0 C--N 1.314 -1.259 0 C-N-CA 124.281 -1.133 . . . . 0.23999999999999999 112.226 2.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.746 HD21 ' CG2' ' A' ' 76' ' ' VAL . 16.1 mt -74.91 104.24 5.44 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.514 -1.291 . . . . 0.48999999999999999 107.514 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.527 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 73.2 t -71.66 139.03 20.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-O 121.559 0.695 . . . . 0.56999999999999995 109.919 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.596 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 14.5 ttpp -69.27 107.22 3.17 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.539 0.685 . . . . 2.4500000000000002 109.688 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 131.8 -18.08 4.87 Favored Glycine 0 N--CA 1.481 1.641 0 C-N-CA 119.584 -1.294 . . . . 0.42999999999999999 110.249 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.609 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 5.3 tp60 -98.86 151.42 20.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.102 -1.234 . . . . 0.44 108.306 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 1.9 tt0 -99.26 142.63 30.49 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.292 -1.373 . . . . 0.79000000000000004 107.292 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.716 ' CE2' HD23 ' A' ' 80' ' ' LEU . 32.9 m-85 -120.7 150.44 40.95 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.24 -0.913 . . . . 0.39000000000000001 110.295 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.536 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -115.63 115.06 25.77 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.415 -0.957 . . . . 2.1400000000000001 108.415 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.63 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 1.8 tt -108.2 116.54 51.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.031 -1.043 . . . . 0.23999999999999999 111.427 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.566 ' O ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -97.08 113.08 24.61 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 104.457 -2.423 . . . . 4.1500000000000004 104.457 176.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.585 ' CZ ' ' O ' ' A' ' 91' ' ' THR . 12.8 t80 -130.84 138.91 50.08 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.365 -1.334 . . . . 0.77000000000000002 113.082 -175.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.585 ' O ' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -89.56 142.25 27.85 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 105.583 -2.006 . . . . 0.89000000000000001 105.583 176.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.119 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 21.1 t90 -123.75 89.01 3.01 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 120.571 -1.331 . . . . 0.73999999999999999 110.731 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -60.58 103.55 0.26 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.468 -0.938 . . . . 2.7599999999999998 108.468 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.577 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 40.5 t -62.88 142.34 97.4 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.812 -0.81 . . . . 0.38 108.812 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.673 ' HG3' HG13 ' A' ' 65' ' ' VAL . 29.2 Cg_endo -71.17 127.55 13.63 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.764 1.642 . . . . 0.55000000000000004 109.389 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -69.19 3.25 2.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.506 -0.746 . . . . 3.6099999999999999 111.021 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 98' ' ' ALA . 12.5 pt -89.38 -26.29 5.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 O-C-N 120.708 -1.245 . . . . 0.41999999999999998 108.85 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.579 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . . . -39.38 116.62 1.09 Allowed Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 109.414 -0.587 . . . . 0.14000000000000001 109.414 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.555 ' HD2' ' CD1' ' A' ' 58' ' ' LEU . 36.6 Cg_endo -85.4 137.88 6.17 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 123.244 2.63 . . . . 0.17999999999999999 109.139 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.516 ' HG2' ' HA ' ' A' ' 128' ' ' ARG . 5.8 mtmt -54.59 90.88 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.015 -1.053 . . . . 1.54 108.732 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.602 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -98.84 129.27 45.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.585 -0.697 . . . . 0.87 109.587 -179.031 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 103' ' ' ASN . 17.7 pt-20 -39.11 -48.19 1.66 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.47 -0.769 . . . . 1.1799999999999999 110.595 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.521 ' N ' ' HG3' ' A' ' 102' ' ' GLU . 4.2 m120 -132.89 145.8 51.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.989 -1.069 . . . . 1.8200000000000001 110.478 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.766 HG21 HD12 ' A' ' 127' ' ' ILE . 82.9 t -135.87 149.17 27.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.777 -0.823 . . . . 0.58999999999999997 108.777 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 122' ' ' ALA . 98.2 t -121.31 117.8 53.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.045 -1.094 . . . . 0.46999999999999997 108.045 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.1 t -98.78 140.23 18.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 120.76 -1.212 . . . . 0.56000000000000005 109.965 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 27.0 m -126.7 118.79 25.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.68 -0.638 . . . . 0.5 109.714 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER -96.75 125.88 49.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.216 -1.402 . . . . 0.47999999999999998 107.216 177.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.948 ' HD2' HD11 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -133.99 150.85 51.27 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 120.647 -1.283 . . . . 1.1200000000000001 111.435 -177.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.757 HD23 ' HA ' ' A' ' 52' ' ' ILE . 13.4 mt -129.79 137.11 50.33 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.142 -1.429 . . . . 0.34999999999999998 107.142 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.948 HD11 ' HD2' ' A' ' 109' ' ' LYS . 4.5 mp -134.78 117.64 23.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.857 -1.152 . . . . 0.32000000000000001 110.205 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.54 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -86.94 -120.02 1.27 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.003 -1.639 . . . . 0.16 109.003 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -123.49 -4.98 8.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -1.089 . . . . 2.6400000000000001 109.403 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.437 ' HB3' ' OE1' ' A' ' 45' ' ' GLN . 4.1 t30 -114.5 -5.91 12.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 4.3099999999999996 110.116 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.506 ' N ' ' OE1' ' A' ' 45' ' ' GLN . . . 156.98 -162.53 31.78 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.714 -1.354 . . . . 0.44 109.714 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 118' ' ' ALA . 3.8 t -82.88 109.36 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -1.133 . . . . 0.53000000000000003 109.719 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.615 HD23 HE21 ' A' ' 45' ' ' GLN . 6.4 mt -51.19 -38.62 53.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.76000000000000001 110.749 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.594 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -155.32 -166.0 2.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.759 -1.213 . . . . 0.34999999999999998 109.401 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER 175.53 147.95 0.09 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.162 -0.962 . . . . 0.94999999999999996 109.529 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.646 ' C ' HD12 ' A' ' 121' ' ' ILE . . . -147.05 146.35 29.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.958 -1.088 . . . . 0.52000000000000002 109.254 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.646 HD12 ' C ' ' A' ' 120' ' ' ALA . 3.4 mp -133.75 136.11 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.128 -0.982 . . . . 1.97 109.418 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -112.76 132.75 55.09 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.185 -0.947 . . . . 0.64000000000000001 109.109 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.4 p -116.37 57.22 0.77 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.128 -0.983 . . . . 3.29 109.383 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.85 60.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.628 -0.878 . . . . 1.1399999999999999 108.628 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.485 ' C ' ' HG3' ' A' ' 126' ' ' LYS . . . -130.57 164.06 23.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.804 -1.318 . . . . 0.47999999999999998 109.804 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.485 ' HG3' ' C ' ' A' ' 125' ' ' GLY . 15.3 mtpt -152.07 145.11 24.52 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.964 -1.124 . . . . 1.28 107.964 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.766 HD12 HG21 ' A' ' 104' ' ' VAL . 52.3 mt -106.39 140.89 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.407 -1.433 . . . . 0.37 110.319 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.627 ' HG3' HG23 ' A' ' 28' ' ' ILE . 11.1 mtt180 -128.95 179.69 5.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.444 -0.785 . . . . 1.54 109.275 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.5 t0 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.111 -0.947 . . . . 1.6399999999999999 109.649 -179.814 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.27 0.557 . . . . 2.46 109.552 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.541 ' CB ' ' HG2' ' A' ' 17' ' ' MET . 0.5 OUTLIER -73.77 154.49 39.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.162 -0.962 . . . . 2.0899999999999999 109.889 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.474 ' O ' HG22 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -103.55 159.48 4.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.29 -0.881 . . . . 1.8700000000000001 109.13 179.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -70.12 119.23 14.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.086 -1.009 . . . . 1.4099999999999999 109.837 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.663 HG21 HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -139.6 140.16 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.383 -0.823 . . . . 1.6399999999999999 109.324 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.49 109.32 19.2 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.206 -0.934 . . . . 3.3599999999999999 109.385 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.438 ' CG ' ' HB ' ' A' ' 13' ' ' ILE . 1.4 m-20 -60.37 120.4 9.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 2.2400000000000002 108.943 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 p -95.59 23.12 6.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.03 -1.044 . . . . 0.34000000000000002 109.635 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 10' ' ' ASN . . . -96.52 -82.29 0.4 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.279 -0.888 . . . . 0.35999999999999999 109.829 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 0.8 OUTLIER 178.24 56.39 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.025 -0.67 . . . . 1.71 109.396 -178.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 10' ' ' ASN . 3.3 m120 67.26 51.61 0.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 4.7599999999999998 109.137 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.508 ' O ' ' HE3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -113.33 -61.72 1.7 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 1.0800000000000001 109.897 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.659 HG22 ' H ' ' A' ' 15' ' ' LYS . 1.1 mm -57.45 123.42 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.049 -1.032 . . . . 0.47999999999999998 109.939 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.606 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 4.6 mmpt? -71.77 -17.55 62.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.382 -0.824 . . . . 1.3300000000000001 108.808 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.659 ' H ' HG22 ' A' ' 13' ' ' ILE . 6.6 pttm 147.6 140.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.328 -1.36 . . . . 1.1799999999999999 107.328 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.803 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -115.27 128.91 72.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.271 -1.011 . . . . 0.40999999999999998 108.271 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.541 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -125.37 145.33 50.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.124 -0.985 . . . . 0.76000000000000001 110.434 -178.201 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 19' ' ' ASP . 50.2 t -98.24 165.63 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.403 -0.811 . . . . 1.02 108.918 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.553 ' N ' HG12 ' A' ' 18' ' ' VAL . 1.6 p-10 -47.29 -30.33 3.04 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.014 -1.054 . . . . 3.9300000000000002 108.919 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.405 ' N ' ' OD1' ' A' ' 19' ' ' ASP . . . 149.69 100.5 0.22 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.592 -1.29 . . . . 2.79 110.741 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 22' ' ' HIS . 3.5 t -128.48 -51.52 1.27 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.185 -1.185 . . . . 3.6600000000000001 109.139 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.489 ' CB ' ' O ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER 166.52 -84.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 4.2400000000000002 110.136 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 24' ' ' SER . . . 119.22 -107.45 1.38 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.571 -1.812 . . . . 1.23 108.571 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 23' ' ' GLY . 9.5 p -47.43 -40.99 19.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.97 -1.312 . . . . 1.4399999999999999 108.422 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.494 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -72.78 175.02 3.67 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 109.086 -0.709 . . . . 2.21 109.086 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 25' ' ' ASP . 34.8 Cg_endo -79.51 135.09 11.54 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.216 1.944 . . . . 1.3300000000000001 110.344 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.5 t -112.45 143.44 43.59 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.31 -0.996 . . . . 2.6800000000000002 108.31 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.513 HG23 ' HG3' ' A' ' 128' ' ' ARG . 46.9 mm -108.57 118.18 55.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.104 -0.998 . . . . 0.76000000000000001 110.247 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 127' ' ' ILE . 23.0 mt -98.79 118.36 45.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.245 -1.02 . . . . 0.83999999999999997 108.245 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -95.43 122.43 38.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.946 . . . . 1.1100000000000001 110.163 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.549 ' HA ' HG11 ' A' ' 94' ' ' VAL . 16.6 ptt180 -66.1 151.52 46.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 1.6100000000000001 109.475 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.9 -17.32 57.07 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.902 -1.679 . . . . 0.58999999999999997 108.902 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -107.45 148.68 37.65 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.282 -1.128 . . . . 1.26 109.143 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 36.3 Cg_endo -78.44 122.41 5.57 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.7 2.267 . . . . 0.31 111.147 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -100.55 122.55 43.43 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.149 -1.056 . . . . 0.32000000000000001 108.149 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.476 ' O ' HG13 ' A' ' 18' ' ' VAL . 64.2 m -100.7 137.55 38.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.898 -1.126 . . . . 0.67000000000000004 110.752 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -145.34 128.09 16.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.483 -0.76 . . . . 2.6899999999999999 109.05 179.402 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -105.07 129.58 53.46 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.547 -0.909 . . . . 1.3799999999999999 108.547 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.803 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -128.14 120.92 28.32 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.793 -1.192 . . . . 0.13 110.306 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.547 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 4.2 mt -91.16 140.95 29.32 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.332 -1.729 . . . . 0.58999999999999997 106.332 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.659 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 32.0 p90 -156.5 135.58 11.98 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.709 -1.196 . . . . 0.17000000000000001 109.778 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.6 OUTLIER -83.35 112.81 20.25 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.351 -0.981 . . . . 1.1699999999999999 108.351 179.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . -46.22 112.48 0.49 Allowed 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.672 -0.862 . . . . 0.25 108.672 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 44' ' ' ASN . 2.3 p30 -84.93 10.94 10.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.112 -0.993 . . . . 0.89000000000000001 109.45 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.562 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 1.8 pt20 -167.93 145.38 4.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.459 -0.776 . . . . 0.73999999999999999 108.968 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 2.4 p30 -84.46 119.17 24.83 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.145 -0.972 . . . . 0.77000000000000002 109.36 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.489 ' O ' ' CA ' ' A' ' 79' ' ' PRO . 2.6 t -137.2 159.68 41.2 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.265 -0.897 . . . . 0.33000000000000002 109.249 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.62 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -100.49 -28.54 12.85 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.127 -1.435 . . . . 6.8300000000000001 107.127 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.465 ' OG1' ' OD1' ' A' ' 113' ' ' ASP . 34.2 p -111.51 138.9 47.43 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 122.146 0.974 . . . . 1.6699999999999999 109.522 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -142.88 152.66 42.34 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 108.85 -0.796 . . . . 0.73999999999999999 108.85 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HD2' ' HB ' ' A' ' 70' ' ' THR . 6.4 mtmt -142.59 141.07 31.91 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.18 -0.95 . . . . 0.42999999999999999 110.332 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 69' ' ' ASP . 11.0 tt -94.28 150.46 4.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.193 -1.41 . . . . 0.53000000000000003 107.193 177.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -140.15 116.27 10.47 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.079 -1.013 . . . . 1.1799999999999999 110.156 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.779 HD13 HG21 ' A' ' 68' ' ' ILE . 2.7 mp -112.97 114.08 45.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.074 -1.016 . . . . 0.29999999999999999 108.51 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -115.17 130.65 56.98 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.109 -0.994 . . . . 0.60999999999999999 109.271 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 105' ' ' VAL . . . -107.92 128.45 54.64 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.192 -0.942 . . . . 0.28999999999999998 110.528 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.483 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . 42.7 t -97.26 150.55 20.81 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.537 -0.912 . . . . 1.5900000000000001 108.537 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 63' ' ' ILE . 35.8 mt -105.86 38.2 2.06 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.092 -1.005 . . . . 0.59999999999999998 109.961 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.44 12.24 5.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -0.872 . . . . 1.6899999999999999 109.456 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.26 -44.34 0.06 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.461 -1.456 . . . . 0.88 109.461 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.92 111.31 23.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -1.168 . . . . 4.0300000000000002 108.997 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -79.82 133.43 36.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.021 -1.049 . . . . 2.04 109.83 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.683 HD11 HD11 ' A' ' 58' ' ' LEU . 98.0 mt -123.87 167.24 17.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.177 -0.952 . . . . 0.80000000000000004 109.444 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.669 ' N ' HG22 ' A' ' 63' ' ' ILE . 35.9 m-20 -114.63 115.24 26.81 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.754 -1.573 . . . . 1.03 106.754 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.045 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 2.8 t -83.36 115.17 57.86 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.946 . . . . 0.34000000000000002 111.458 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.528 ' O ' HG23 ' A' ' 68' ' ' ILE . 37.5 Cg_endo -85.04 -156.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 123.1 2.533 . . . . 0.22 109.342 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.62 35.83 82.73 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.286 -1.126 . . . . 0.71999999999999997 110.286 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.779 HG21 HD13 ' A' ' 54' ' ' ILE . 18.2 pt -127.06 -156.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.157 -1.201 . . . . 0.29999999999999999 108.83 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.733 ' O ' HG22 ' A' ' 52' ' ' ILE . 38.7 t0 -108.58 108.75 19.76 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.244 -0.91 . . . . 1.4099999999999999 109.464 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 51' ' ' LYS . 1.4 p -88.07 46.56 1.4 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.628 -1.249 . . . . 0.41999999999999998 107.628 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 23.1 t30 175.49 83.54 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.645 -1.613 . . . . 1.3899999999999999 106.645 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.521 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -66.24 1.6 1.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.53 -0.731 . . . . 0.67000000000000004 111.822 -177.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 20.2 m -61.92 -13.65 26.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.817 -1.177 . . . . 2.3700000000000001 109.674 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -81.84 -14.69 55.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.111 -0.993 . . . . 0.85999999999999999 110.156 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.701 ' CE2' ' CD1' ' A' ' 90' ' ' TYR . 19.7 m-85 -122.54 -15.27 7.6 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.367 -0.833 . . . . 1.1100000000000001 109.739 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.622 ' CG1' ' HB ' ' A' ' 88' ' ' ILE . 3.1 m -122.15 169.05 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.35 -0.982 . . . . 0.75 108.35 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.614 ' HG2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -100.76 87.59 3.37 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.221 -0.925 . . . . 1.8100000000000001 112.248 -178.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.54 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 20.4 p -87.62 157.44 52.43 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.445 -1.41 . . . . 0.88 107.91 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.62 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 21.8 Cg_endo -65.08 125.19 5.16 Favored 'Cis proline' 0 C--N 1.314 -1.261 0 O-C-N 123.105 1.055 . . . . 0.54000000000000004 112.947 2.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.875 HD23 ' CE2' ' A' ' 86' ' ' TYR . 13.8 mt -70.75 117.06 11.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.531 -1.655 . . . . 0.60999999999999999 106.531 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 43.6 t -83.55 139.84 17.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 C-N-CA 119.606 -0.838 . . . . 0.56000000000000005 110.926 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.562 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 16.8 ttpt -66.48 108.51 2.42 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.644 0.735 . . . . 0.83999999999999997 109.562 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 127.66 -19.14 5.93 Favored Glycine 0 C--N 1.298 -1.555 0 N-CA-C 109.519 -1.432 . . . . 0.35999999999999999 109.519 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.601 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 4.0 tp60 -97.91 152.06 19.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.169 -1.195 . . . . 0.60999999999999999 107.799 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -104.96 143.63 32.91 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 118.99 -1.084 . . . . 0.28000000000000003 108.511 179.388 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.875 ' CE2' HD23 ' A' ' 80' ' ' LEU . 25.9 m-85 -121.05 150.06 41.76 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.279 -0.888 . . . . 0.76000000000000001 109.606 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.547 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 8.8 p-10 -119.76 109.85 16.1 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.951 -1.129 . . . . 0.62 107.951 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.622 ' HB ' ' CG1' ' A' ' 76' ' ' VAL . 6.9 tt -106.43 122.12 59.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 122.007 0.908 . . . . 0.35999999999999999 111.839 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -101.85 112.58 25.25 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 104.637 -2.357 . . . . 1.0 104.637 176.033 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.701 ' CD1' ' CE2' ' A' ' 75' ' ' PHE . 31.5 t80 -127.51 139.5 52.74 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.734 -1.229 . . . . 0.46999999999999997 112.405 -175.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.66 106.83 18.83 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.202 -1.407 . . . . 0.54000000000000004 107.202 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.045 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 29.9 t90 -82.2 94.32 7.26 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.494 0.664 . . . . 0.48999999999999999 109.832 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -67.71 109.82 3.49 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.487 -0.758 . . . . 2.8799999999999999 109.35 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.649 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 12.4 t -60.2 142.97 89.4 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.124 -1.065 . . . . 1.1100000000000001 108.124 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.649 ' HD2' ' CG1' ' A' ' 94' ' ' VAL . 23.7 Cg_endo -66.97 -11.84 33.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.508 2.139 . . . . 3.7999999999999998 111.755 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 95' ' ' PRO . 0.0 OUTLIER 76.21 -7.23 1.86 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 2.98 109.485 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.525 ' O ' ' C ' ' A' ' 98' ' ' ALA . 12.7 pt -93.5 -27.97 4.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 O-C-N 121.114 -0.991 . . . . 0.55000000000000004 108.444 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.525 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -32.84 117.6 0.43 Allowed Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 108.575 -0.898 . . . . 0.51000000000000001 108.575 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.594 ' O ' ' N ' ' A' ' 101' ' ' SER . 37.3 Cg_endo -83.86 138.94 8.36 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.747 2.298 . . . . 0.68999999999999995 110.015 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.531 ' HE3' ' HG2' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -50.22 90.47 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.897 -1.149 . . . . 3.2799999999999998 107.897 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.655 ' HB3' HG23 ' A' ' 104' ' ' VAL . 1.8 t -94.32 124.18 38.18 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.506 -0.746 . . . . 0.56000000000000005 109.271 -178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -43.13 -45.3 5.39 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.591 -0.892 . . . . 1.75 108.591 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.429 ' N ' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -131.44 141.48 49.82 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.497 -0.752 . . . . 0.93000000000000005 109.195 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.897 HG21 ' CD1' ' A' ' 127' ' ' ILE . 2.1 t -131.41 145.4 35.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.268 -0.895 . . . . 0.68000000000000005 109.497 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 57' ' ' SER . 73.4 t -126.27 114.72 39.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.878 -1.156 . . . . 0.32000000000000001 107.878 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.496 HG12 ' CG2' ' A' ' 54' ' ' ILE . 1.8 t -95.66 137.29 24.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.92 -1.112 . . . . 0.39000000000000001 109.372 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.608 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 34.3 m -118.72 112.24 19.51 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.15 -0.969 . . . . 0.44 109.584 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -92.7 125.25 45.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 106.647 -1.612 . . . . 0.53000000000000003 106.647 178.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.8 ' CD ' HD11 ' A' ' 111' ' ' ILE . 9.0 ttmt -141.26 131.51 24.97 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.134 -1.427 . . . . 2.0699999999999998 112.117 -176.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.872 ' C ' HD12 ' A' ' 111' ' ' ILE . 9.0 mt -104.16 138.15 41.07 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.209 -1.404 . . . . 0.78000000000000003 107.209 177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.872 HD12 ' C ' ' A' ' 110' ' ' LEU . 3.2 mp -129.69 120.57 50.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.101 -1.0 . . . . 0.28000000000000003 109.922 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.446 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -92.74 -145.95 17.92 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.754 -1.738 . . . . 0.85999999999999999 108.754 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.465 ' OD1' ' OG1' ' A' ' 49' ' ' THR . 0.1 OUTLIER -99.93 -1.5 37.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.128 -1.219 . . . . 1.24 109.941 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 114' ' ' ASN . 0.4 OUTLIER -114.68 -10.5 12.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.97 -1.081 . . . . 4.6699999999999999 110.247 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 111' ' ' ILE . . . 159.32 -148.0 16.2 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.521 -1.323 . . . . 0.29999999999999999 110.13 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.64 ' CG1' ' CG ' ' A' ' 109' ' ' LYS . 2.1 t -91.99 109.87 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -1.136 . . . . 0.25 110.13 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 110' ' ' LEU . 41.0 mt -52.85 -43.67 66.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.446 -0.784 . . . . 0.27000000000000002 109.782 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.481 ' HB1' HG12 ' A' ' 13' ' ' ILE . . . -158.71 -178.1 7.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.093 -1.005 . . . . 0.68000000000000005 109.357 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 120' ' ' ALA . 0.9 OUTLIER -166.36 156.07 11.75 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.044 -1.035 . . . . 0.62 110.191 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 107' ' ' THR . . . -152.4 149.63 28.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.105 -0.997 . . . . 0.46999999999999997 109.833 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.2 mt -138.1 121.08 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.068 -1.02 . . . . 0.83999999999999997 109.794 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.27 140.82 30.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.995 -1.065 . . . . 0.91000000000000003 108.923 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 55.1 p -125.02 171.81 9.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.134 -0.979 . . . . 2.75 109.873 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 61.55 29.5 18.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -0.811 . . . . 2.5600000000000001 109.513 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -98.93 162.85 20.27 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.728 -1.349 . . . . 0.40999999999999998 109.728 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 11.2 mtmt -151.2 134.19 15.86 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.465 -1.021 . . . . 0.68000000000000005 108.308 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.897 ' CD1' HG21 ' A' ' 104' ' ' VAL . 55.9 mt -99.22 141.5 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.692 -1.255 . . . . 0.72999999999999998 110.218 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.531 ' HG2' ' HE3' ' A' ' 100' ' ' LYS . 12.4 mtm180 -132.5 177.2 7.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.535 -0.728 . . . . 2.1299999999999999 109.299 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.049 -0.977 . . . . 2.3999999999999999 109.457 179.572 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 17' ' ' MET . 5.6 m-20 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.252 0.549 . . . . 2.96 109.573 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.549 ' CA ' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -65.25 156.65 31.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 2.7200000000000002 110.031 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.18 163.95 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.489 -0.757 . . . . 1.8600000000000001 109.096 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -71.74 119.02 15.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.103 -0.998 . . . . 2.1499999999999999 109.546 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.09 173.34 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.382 -0.824 . . . . 1.47 109.156 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.32 108.56 13.38 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.262 -0.899 . . . . 5.6299999999999999 109.616 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -77.41 118.88 20.3 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.213 -0.929 . . . . 2.6000000000000001 108.81 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.1 p -98.65 13.54 31.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.004 -1.06 . . . . 1.01 110.107 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 12' ' ' GLU . . . -93.65 -72.99 0.58 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.946 -1.096 . . . . 0.83999999999999997 109.425 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.472 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 19.8 t-20 172.5 63.48 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.762 -1.199 . . . . 5.0 107.762 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 11' ' ' ASN . 47.1 t-20 60.45 18.4 8.16 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.861 -1.163 . . . . 1.8600000000000001 107.861 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -57.79 -81.67 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.728 -0.607 . . . . 3.5899999999999999 109.57 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.605 HD13 ' HB1' ' A' ' 39' ' ' ALA . 0.9 OUTLIER -56.43 125.73 12.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.32 -0.952 . . . . 0.48999999999999999 109.423 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.612 ' O ' ' HB3' ' A' ' 15' ' ' LYS . 1.2 mmtt -75.57 -24.89 56.68 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.369 -0.832 . . . . 0.84999999999999998 108.866 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.89 ' HD3' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER 167.88 126.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.372 -0.973 . . . . 2.5899999999999999 108.372 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.958 HG23 ' CB ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -105.26 125.14 60.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.092 -1.077 . . . . 0.5 108.092 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.549 ' HG2' ' CA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -111.84 150.22 30.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.962 -1.086 . . . . 1.0700000000000001 110.811 -177.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 19' ' ' ASP . 46.6 t -109.48 163.52 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.3 -1.0 . . . . 0.81000000000000005 108.3 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.515 ' N ' HG12 ' A' ' 18' ' ' VAL . 4.7 t0 -86.49 64.12 8.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.07 -1.018 . . . . 1.4399999999999999 109.713 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 21' ' ' CYS . . . 163.02 -95.71 0.13 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.881 -1.288 . . . . 2.5600000000000001 109.881 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.414 ' C ' ' O ' ' A' ' 20' ' ' GLY . 93.5 m -42.39 155.11 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.339 -1.095 . . . . 1.52 109.974 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.585 ' CG ' ' O ' ' A' ' 22' ' ' HIS . 13.9 p-80 -162.87 107.66 1.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.324 -0.86 . . . . 4.1900000000000004 110.103 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.59 -148.45 16.69 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.912 -1.275 . . . . 3.0299999999999998 109.912 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.0 t -87.4 21.82 2.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.338 -1.095 . . . . 2.02 109.729 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.59 157.29 80.08 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.13 -0.982 . . . . 2.3300000000000001 109.313 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.8 158.84 31.47 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.743 2.295 . . . . 0.96999999999999997 110.257 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.5 141.91 50.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 2.6699999999999999 109.421 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.691 HG22 ' CD2' ' A' ' 30' ' ' HIS . 51.0 mm -113.0 113.31 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.061 -1.024 . . . . 0.81000000000000005 109.065 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.522 HG12 ' CE1' ' A' ' 35' ' ' PHE . 32.5 mt -99.22 112.34 31.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.201 -0.937 . . . . 0.68999999999999995 109.031 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.691 ' CD2' HG22 ' A' ' 28' ' ' ILE . 47.3 m170 -88.35 105.16 17.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.057 -1.09 . . . . 1.95 108.057 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.48 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 8.1 ptt180 -45.54 123.31 4.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.992 -1.068 . . . . 0.71999999999999997 109.822 -178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.577 ' HA2' ' CD ' ' A' ' 96' ' ' LYS . . . 116.87 -11.85 15.13 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.058 -1.617 . . . . 0.17000000000000001 109.058 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -103.87 149.97 37.73 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.355 -1.085 . . . . 1.3500000000000001 108.754 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 36.5 Cg_endo -79.44 121.66 4.83 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 122.379 2.053 . . . . 0.38 110.718 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.522 ' CE1' HG12 ' A' ' 29' ' ' ILE . 2.3 t80 -97.12 120.86 38.25 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.445 -1.317 . . . . 1.01 107.445 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.663 ' C ' HD13 ' A' ' 37' ' ' LEU . 73.3 m -100.99 127.32 47.54 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.684 -1.26 . . . . 0.58999999999999997 110.68 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.949 HD13 ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -138.19 124.12 20.08 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.96 -0.755 . . . . 0.67000000000000004 108.96 178.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -104.33 135.88 44.95 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.699 -1.223 . . . . 1.71 107.699 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.958 ' CB ' HG23 ' A' ' 16' ' ' VAL . . . -133.04 123.19 25.34 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.841 -1.143 . . . . 0.10000000000000001 110.562 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.89 HD12 ' HD3' ' A' ' 15' ' ' LYS . 8.7 mt -88.39 137.21 32.53 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.56 -2.015 . . . . 0.23000000000000001 105.56 177.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 110' ' ' LEU . 34.8 p90 -152.12 134.81 15.46 Favored 'General case' 0 C--N 1.288 -2.107 0 C-N-CA 118.171 -1.412 . . . . 0.22 110.168 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 85' ' ' GLN . 0.8 OUTLIER -82.72 107.81 15.63 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.446 -0.946 . . . . 0.66000000000000003 108.446 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . -45.67 114.36 0.75 Allowed 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.136 -0.69 . . . . 0.35999999999999999 109.136 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 44' ' ' ASN . 1.3 p30 -84.24 10.6 9.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.056 -1.027 . . . . 0.76000000000000001 109.23 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.578 ' CA ' ' HB2' ' A' ' 82' ' ' LYS . 8.4 pt20 -166.53 145.02 5.43 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.312 -0.868 . . . . 0.82999999999999996 109.253 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 9.4 p30 -83.93 110.04 18.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.76000000000000001 109.12 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.614 HG21 HD11 ' A' ' 117' ' ' LEU . 1.5 t -126.7 151.15 48.51 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.189 -0.944 . . . . 0.32000000000000001 109.795 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.783 ' HA ' ' HB3' ' A' ' 79' ' ' PRO . 1.1 mmmt -86.39 -20.61 27.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.332 -0.855 . . . . 0.39000000000000001 109.156 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.5 p -132.29 138.91 48.02 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.109 0.957 . . . . 0.25 110.137 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 71' ' ' ASN . . . -139.34 148.12 42.48 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.675 -1.232 . . . . 0.58999999999999997 107.675 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HD2' ' HA ' ' A' ' 70' ' ' THR . 1.0 OUTLIER -141.12 142.31 34.11 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.251 -0.906 . . . . 2.02 110.339 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.669 ' HA ' HD23 ' A' ' 110' ' ' LEU . 5.3 tt -91.84 149.47 4.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 107.622 -1.251 . . . . 0.59999999999999998 107.622 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.442 ' OE2' ' N ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -145.01 117.24 8.41 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.598 -0.89 . . . . 4.8399999999999999 108.598 -177.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.772 HD12 HD13 ' A' ' 68' ' ' ILE . 3.4 mp -109.67 134.95 50.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.806 -1.184 . . . . 0.59999999999999998 110.596 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -125.17 131.65 53.18 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.161 -0.962 . . . . 1.8700000000000001 108.952 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.25 146.96 34.75 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.71 -1.244 . . . . 0.81999999999999995 111.4 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.423 ' O ' HD23 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -107.24 150.86 26.18 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.033 -1.099 . . . . 0.71999999999999997 108.033 178.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 63' ' ' ILE . 44.4 mt -120.69 61.33 0.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.864 -1.148 . . . . 0.68999999999999995 110.486 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 58' ' ' LEU . 5.7 t0 41.71 26.72 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.593 -0.692 . . . . 1.1000000000000001 110.081 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 158.24 -49.35 0.42 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.597 -1.401 . . . . 0.34000000000000002 109.597 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.491 ' HG ' HD12 ' A' ' 58' ' ' LEU . 8.2 tp -97.93 113.03 24.76 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.394 -1.062 . . . . 0.78000000000000003 108.873 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -93.08 123.25 36.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.14 -0.975 . . . . 5.4699999999999998 109.636 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.65 HD12 HD11 ' A' ' 58' ' ' LEU . 12.8 mt -118.15 169.36 8.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 122.15 0.976 . . . . 0.54000000000000004 109.348 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.611 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 18.9 m-20 -108.52 134.56 51.13 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.131 -1.433 . . . . 0.62 107.131 177.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.96 HG11 ' CZ2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -104.05 107.82 58.2 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.839 -1.163 . . . . 0.85999999999999999 110.632 -178.44 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 64' ' ' ASP . 36.3 Cg_endo -81.32 -154.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 123.151 2.567 . . . . 0.55000000000000004 109.914 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.85 34.09 86.11 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.333 -1.507 . . . . 0.89000000000000001 109.333 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.772 HD13 HD12 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -108.04 179.84 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.354 -1.086 . . . . 2.5899999999999999 109.378 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.599 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -86.01 -1.1 57.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.92 -1.112 . . . . 3.1499999999999999 109.318 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.573 ' HA ' ' HD2' ' A' ' 51' ' ' LYS . 29.3 p 30.19 36.36 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.678 0.752 . . . . 0.64000000000000001 109.921 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 50' ' ' ALA . 14.7 t-20 174.56 90.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.685 -1.228 . . . . 1.3500000000000001 107.685 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.857 ' HB1' HD12 ' A' ' 88' ' ' ILE . . . -75.29 2.05 12.12 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.589 -0.694 . . . . 0.53000000000000003 110.973 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.461 ' HA ' HG22 ' A' ' 76' ' ' VAL . 84.2 m -66.79 -9.42 36.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.015 -1.053 . . . . 2.6699999999999999 109.229 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.14 -17.42 35.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.90000000000000002 109.522 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 75' ' ' PHE . 2.8 m-85 -116.87 -12.01 10.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 0.81999999999999995 109.111 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.88 HG23 HD21 ' A' ' 80' ' ' LEU . 1.7 m -120.99 165.73 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.362 -0.977 . . . . 0.47999999999999998 108.362 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.634 ' HG2' ' CD2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -90.0 98.87 12.02 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.921 -1.112 . . . . 2.3100000000000001 110.864 -178.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.492 ' HA ' ' C ' ' A' ' 79' ' ' PRO . 18.2 m -91.48 152.23 43.38 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.219 -0.926 . . . . 2.79 108.674 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.783 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 27.2 Cg_endo -70.13 139.26 54.62 Favored 'Cis proline' 0 C--N 1.312 -1.383 0 C-N-CA 124.117 -1.201 . . . . 0.40000000000000002 112.332 0.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.88 HD21 HG23 ' A' ' 76' ' ' VAL . 13.1 mt -77.86 112.14 14.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.625 -1.62 . . . . 0.90000000000000002 106.625 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 10.9 t -82.92 144.95 9.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 121.841 0.829 . . . . 0.62 110.946 -177.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.578 ' HB2' ' CA ' ' A' ' 45' ' ' GLN . 8.2 ttpt -68.53 117.42 10.26 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.703 0.763 . . . . 0.69999999999999996 109.754 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 119.43 -11.08 11.41 Favored Glycine 0 C--N 1.296 -1.675 0 N-CA-C 109.514 -1.434 . . . . 0.23999999999999999 109.514 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.527 ' HG3' ' N ' ' A' ' 85' ' ' GLN . 4.6 tp60 -107.8 157.02 18.5 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.144 -1.058 . . . . 0.55000000000000004 108.144 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.527 ' N ' ' HG3' ' A' ' 84' ' ' GLN . 1.5 tt0 -109.93 144.29 38.65 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.049 -1.032 . . . . 1.4399999999999999 108.438 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.634 ' CD2' ' HG2' ' A' ' 77' ' ' LYS . 38.6 m-85 -125.75 145.95 49.98 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.201 -0.937 . . . . 0.34999999999999998 110.033 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.569 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -111.45 113.62 26.18 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.759 -0.83 . . . . 1.71 108.759 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.857 HD12 ' HB1' ' A' ' 72' ' ' ALA . 2.3 tt -109.87 117.36 54.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.058 -1.026 . . . . 0.38 111.199 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -94.35 114.91 27.04 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.624 -2.362 . . . . 1.3400000000000001 104.624 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 69' ' ' ASP . 27.8 t80 -126.09 139.64 53.22 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.113 -1.435 . . . . 0.56000000000000005 113.366 -175.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.496 ' O ' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -93.08 131.67 37.9 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 105.119 -2.178 . . . . 0.64000000000000001 105.119 175.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.96 ' CZ2' HG11 ' A' ' 65' ' ' VAL . 29.9 t90 -109.92 96.81 6.48 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 121.351 -0.843 . . . . 0.77000000000000002 109.826 -176.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -68.32 104.49 1.87 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.347 0.594 . . . . 2.4300000000000002 109.868 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.642 ' CG1' ' HD2' ' A' ' 95' ' ' PRO . 30.0 t -61.55 143.83 93.11 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.324 -0.991 . . . . 1.6399999999999999 108.324 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.723 ' HD3' HG12 ' A' ' 65' ' ' VAL . 23.4 Cg_endo -64.55 -6.33 11.87 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.377 2.052 . . . . 3.9700000000000002 112.182 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.577 ' CD ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER 67.98 -4.13 1.08 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.998 -1.064 . . . . 1.48 110.425 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.528 ' O ' ' C ' ' A' ' 98' ' ' ALA . 16.2 pt -94.49 -26.52 4.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 O-C-N 120.789 -1.195 . . . . 0.55000000000000004 107.948 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 97' ' ' ILE . . . -30.59 118.49 0.34 Allowed Pre-proline 0 N--CA 1.488 1.47 0 CA-C-N 115.813 -0.63 . . . . 0.5 109.376 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.617 ' HG2' HD13 ' A' ' 58' ' ' LEU . 35.8 Cg_endo -82.99 131.46 5.98 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.689 2.259 . . . . 0.54000000000000004 108.473 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.609 ' CG ' ' HA ' ' A' ' 128' ' ' ARG . 1.6 ttpt -48.33 91.03 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.334 -0.946 . . . . 1.3999999999999999 108.952 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 99' ' ' PRO . 1.2 t -94.16 116.91 29.38 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.842 -0.799 . . . . 0.37 108.842 -179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 101' ' ' SER . 5.4 pt-20 -35.03 -47.5 0.37 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.805 -0.559 . . . . 1.4199999999999999 110.54 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -129.06 140.46 51.59 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.192 -0.942 . . . . 1.45 109.154 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.988 HG21 ' CD1' ' A' ' 127' ' ' ILE . 0.9 OUTLIER -131.75 143.58 39.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.358 -0.839 . . . . 1.0 109.831 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.873 HG13 ' O ' ' A' ' 122' ' ' ALA . 11.8 t -124.6 117.1 49.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.791 -1.559 . . . . 0.90000000000000002 106.791 178.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.15 141.68 14.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 C-N-CA 119.466 -0.893 . . . . 0.46000000000000002 110.594 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.607 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 51.7 m -116.15 138.27 51.41 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.387 -0.968 . . . . 1.02 108.387 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 0.4 OUTLIER -119.63 127.49 75.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 106.738 -1.579 . . . . 0.38 106.738 178.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.625 ' HD2' HD11 ' A' ' 111' ' ' ILE . 3.9 ttmt -140.14 129.1 23.43 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.1 -1.44 . . . . 2.4100000000000001 111.693 -177.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.669 HD23 ' HA ' ' A' ' 52' ' ' ILE . 6.5 mt -103.17 138.7 39.63 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.98 -1.489 . . . . 0.39000000000000001 106.98 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.625 HD11 ' HD2' ' A' ' 109' ' ' LYS . 4.5 mp -133.25 115.87 24.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.967 -1.083 . . . . 0.38 109.731 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.469 ' HA3' HG21 ' A' ' 47' ' ' THR . . . -87.87 -133.7 4.25 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.082 -1.607 . . . . 0.28000000000000003 109.082 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -110.53 -2.36 16.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -1.146 . . . . 2.9100000000000001 109.709 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.46 -0.09 12.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.073 -1.017 . . . . 1.8600000000000001 110.257 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 151.37 -157.31 27.14 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.916 -1.274 . . . . 0.33000000000000002 109.916 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 118' ' ' ALA . 21.3 t -86.48 110.54 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -1.14 . . . . 0.85999999999999999 109.626 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.614 HD11 HG21 ' A' ' 47' ' ' THR . 20.2 mt -58.03 -39.35 78.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.439 -0.788 . . . . 0.38 110.735 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.583 ' O ' HG12 ' A' ' 116' ' ' VAL . . . -150.43 177.2 10.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.721 -1.237 . . . . 0.64000000000000001 109.534 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -170.04 148.07 3.35 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.875 -1.141 . . . . 0.63 109.588 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -151.76 149.66 29.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.014 -1.054 . . . . 0.51000000000000001 109.743 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 85.0 mt -136.71 119.86 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.099 -1.001 . . . . 0.63 109.39 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.873 ' O ' HG13 ' A' ' 105' ' ' VAL . . . -88.36 150.88 22.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.857 -1.152 . . . . 0.55000000000000004 109.934 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.3 t -111.61 3.95 18.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.23 -0.919 . . . . 2.7599999999999998 110.424 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.421 ' CD2' ' C ' ' A' ' 124' ' ' HIS . 1.4 p-80 -133.46 173.81 11.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.889 -1.132 . . . . 8.0800000000000001 109.561 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 129.21 155.05 8.4 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.748 -1.215 . . . . 1.0900000000000001 110.369 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 6.0 mtmp? -152.08 141.14 21.23 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.146 -1.427 . . . . 2.79 107.146 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.988 ' CD1' HG21 ' A' ' 104' ' ' VAL . 81.6 mt -104.35 140.75 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.429 -1.42 . . . . 0.57999999999999996 111.147 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.609 ' HA ' ' CG ' ' A' ' 100' ' ' LYS . 4.4 mtt85 -127.85 174.82 8.83 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.274 -1.01 . . . . 3.1400000000000001 108.274 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 120.967 -1.083 . . . . 0.96999999999999997 109.527 179.858 . . . . . . . . 1 1 . 1 stop_ save_